<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Medicine - Combined Tests</title>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
  <style>
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
</style>
  <style>
  body {
    font-family: Arial, sans-serif;
    padding: 0;
    margin: 0;
  }

  button {
    margin: 5px;
    padding: 10px 15px;
    background: #ffffff;
    border: 1px solid #2d3748;
    border-radius: 4px;
    cursor: pointer;
    color: #000000;
    position: relative;
    top: 5px;
    font-size: 14px;
    transition: background 0.2s ease, color 0.2s ease, transform 0.1s ease;
  }

  button:hover {
    background: #f3f4f6;
    color: #000000;
    transform: translateY(-1px);
  }

  body, html {
            margin: 0;
            padding: 0;
            height: 100%;
            overflow: hidden;
        }
        .iframe-container {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            overflow: auto;
            -webkit-overflow-scrolling: touch;
        }
        .iframe-container iframe {
            width: 100%;
            height: 100%;
            border: none;
            display: block;
        }
    
    /* Mobile optimization */
    

  /* Dropdown styling */
  .dropdown-wrapper {
    position: absolute;
    top: 20px;
    right: 20px;
    z-index: 1100;
  }

  .dropdown-toggle {
    background: #2c5281;
    color: white;
    border: none;
    font-size: 14px;
    padding: 10px 18px;
    border-radius: 6px;
    font-weight: bold;
    letter-spacing: 0.5px;
  }

  .dropdown-toggle:hover {
    background: #24466c;
  }

  .dropdown-menu {
  display: none;
  position: absolute;
  right: 0;              /* keep aligned to right edge of toggle */
  margin-top: 6px;
  background: white;
  border: 1px solid #cbd5e0;
  border-radius: 8px;
  max-height: 350px;
  overflow-y: auto;
  box-shadow: 0 6px 16px rgba(0, 0, 0, 0.15);
  min-width: 250px;
  max-width: 90vw;       /* prevent it from going outside screen */
  word-wrap: break-word; /* wrap long names */
  white-space: normal;   /* allow text to wrap */
  animation: fadeIn 0.2s ease-in-out;
}

.dropdown-menu button {
  display: block;
  width: 100%;
  text-align: left;
  margin: 0;
  padding: 10px 15px;
  border-radius: 0;
  background: transparent;
  color: #2d3748;
  border: none;
  border-bottom: 1px solid #edf2f7;
  font-size: 13px;
  white-space: normal;   /* allow wrapping inside button */
  word-break: break-word;
}


  img {
    max-width: 100%;
    max-height: 400px;
    width: auto;
    height: auto;
    display: block;
    margin: 10px auto;
  }

  body > section:last-child {
    margin-bottom: 0 !important;
  }
  
</style>
  <script>
  function showTest(id) {
    document.querySelectorAll('.iframe-container').forEach(div => div.style.display = 'none');
    document.getElementById(id).style.display = 'block';
    document.getElementById('dropdownMenu').style.display = 'none';
    window.scrollTo(0, 0);
  }

  function toggleDropdown() {
    const menu = document.getElementById('dropdownMenu');
    menu.style.display = menu.style.display === 'block' ? 'none' : 'block';
  }

  document.addEventListener('click', function (event) {
    const toggle = document.getElementById('dropdownToggle');
    const menu = document.getElementById('dropdownMenu');
    if (!toggle.contains(event.target) && !menu.contains(event.target)) {
      menu.style.display = 'none';
    }
  });
</script>
<script src="../../../access-control.js"></script>
  <script src="../../../block.js"></script>
  <script src="../../../error-handler/link-checker.js"></script>
  <script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-5920367457745298"
     crossorigin="anonymous"></script>
</head>
<body>
<script>
      // Initialize access control for protected page
      if (!accessControl.initProtectedPage()) {
        throw new Error('Access denied - redirecting to index.html');
      }
    </script>
  <button onclick="history.back()" style="position: absolute; top: 20px; left: 20px; background: transparent; color: white; border: none; padding: 10px; cursor: pointer; z-index: 1001; font-size: 20px;">
  <i class="fas fa-arrow-left"></i>
</button>

<div class="dropdown-wrapper">
  <button class="dropdown-toggle" id="dropdownToggle" onclick="toggleDropdown()">â˜° INDEX</button>
  <div class="dropdown-menu" id="dropdownMenu">
<button onclick="showTest('test1')">Medicine E&D - Mission 1.5 - 13-02-2024 - 2024-02-13</button>
<button onclick="showTest('test2')">Medicine E&D - Mission 1.5, Lap 2 - 04-06-2024 - 2024-06-04</button>
<button onclick="showTest('test3')">Medicine E&D - Mission 2.0 (Batch 3) - 14-02-2025 - 2025-02-14</button>
<button onclick="showTest('test4')">Medicine E&D - Mission 2.0, Lap 2 - 19-03-2025 - 2025-03-19</button>
<button onclick="showTest('test5')">Medicine E&D Part 1 - Mission 2.0 (INICET) - 16-09-2024 - 2024-09-16</button>
<button onclick="showTest('test6')">Medicine E&D Part 2 - Mission 2.0 (INICET) - 18-09-2024 - 2024-09-18</button>
<button onclick="showTest('test7')">Medicine E&D Part-1 (Mission NEET PG) - 11-08-2023 - 2023-08-11</button>
<button onclick="showTest('test8')">Medicine E&D Part-1, Mission 3.0 (Early_Intern Batch) - 07-06-2025 - 2025-06-07</button>
<button onclick="showTest('test9')">Medicine E&D Part-2 (Mission NEET PG) - 10-11-2023 - 2023-11-10</button>
<button onclick="showTest('test10')">Medicine E&D Part-2, Mission 3.0 (Early_Intern Batch) - 13-06-2025 - 2025-06-13</button>
<button onclick="showTest('test11')">Medicine NEET PG Revision E&D - 30-11-2023 - 2023-11-30</button>
<button onclick="showTest('test12')">Medicine Test (The Champion Batch Hyderabad) - 15-01-2025 - 2025-01-15</button>
<button onclick="showTest('test13')">Medicine Test (The Champion Batch Hyderabad) - 15-12-2024 - 2024-12-15</button>
<button onclick="showTest('test14')">Medicine Test (The Champion Batch Hyderabad) - 25-09-2024 - 2024-09-25</button>
</div>
  </div>
  
<div id="test1" class="iframe-container" style="display:block;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D   Mission 1.5   13 02 2024   2024 02 13&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D   Mission 1.5   13 02 2024   2024 02 13&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                150 Questions | 600 Total Marks | 160 min Duration | ~64.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 23-year-old medical student with a 2-month history of palpitations, sweating, and restlessness. He also complains of sweaty palms. His appearance is as shown in the picture. Which among the following will help in the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid receptor antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Thyroglobulin Antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ultrasensitive thyrotropin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-thyroid peroxidase antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thyroid receptor antibody&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Thyroid receptor antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyroid receptor antibodies (TRAb) are the most specific test for diagnosing Graves&#x27; disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the given options, the murmur shown in the image is associated with?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic Regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral Regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral Stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic Stenosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mitral Regurgitation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mitral Regurgitation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A pansystolic murmur extending from S1 to S2 is characteristic of mitral regurgitation .&lt;/li&gt;&lt;li&gt;âž¤ pansystolic murmur&lt;/li&gt;&lt;li&gt;âž¤ S1 to S2&lt;/li&gt;&lt;li&gt;âž¤ mitral regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with hypertension is on multiple antihypertensive drugs. His ECG is shown in the image. Which drug is responsible for the following ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Spironolactone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone can cause hyperkalemia , leading to ECG changes like tall T waves , wide QRS complexes , and absent P waves .&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone&lt;/li&gt;&lt;li&gt;âž¤ hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ tall T waves&lt;/li&gt;&lt;li&gt;âž¤ wide QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ absent P waves&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old woman presents with a progressive decline in daily activity. She gives a history of staring into space with frequent visual hallucinations. Pathology reveals Lewy bodies in neurons. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parkinsonâ€™s Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prionâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Huntingtonâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s Disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Parkinsonâ€™s Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Parkinsonâ€™s Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of Lewy bodies and symptoms like visual hallucinations and progressive cognitive decline point to a diagnosis of Parkinsonâ€™s disease .&lt;/li&gt;&lt;li&gt;âž¤ Lewy bodies&lt;/li&gt;&lt;li&gt;âž¤ visual hallucinations&lt;/li&gt;&lt;li&gt;âž¤ progressive cognitive decline&lt;/li&gt;&lt;li&gt;âž¤ Parkinsonâ€™s disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dL and the presence of ketone bodies. What is the next best step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous fluids with S.C. long-acting insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous fluids with S.C. regular insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous insulin I.V. long-acting insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous fluids with I.V. regular insulin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Intravenous fluids with I.V. regular insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Intravenous fluids with I.V. regular insulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The management of diabetic ketoacidosis (DKA) includes IV fluids and IV regular insulin , which is the gold standard for rapidly controlling blood glucose levels and resolving ketosis.&lt;/li&gt;&lt;li&gt;âž¤ diabetic ketoacidosis (DKA)&lt;/li&gt;&lt;li&gt;âž¤ IV fluids&lt;/li&gt;&lt;li&gt;âž¤ IV regular insulin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with retro-positive status was started on 2nd line highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD4+ T cell count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Viral load&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;p24 antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Viral serotype&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Viral load&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Viral load&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Viral load is the best marker for monitoring the efficacy of antiretroviral therapy (HAART) in patients with HIV, aiming to reduce it to undetectable levels to prevent disease progression and transmission.&lt;/li&gt;&lt;li&gt;âž¤ Viral load&lt;/li&gt;&lt;li&gt;âž¤ antiretroviral therapy (HAART)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following would most likely lead to a decrease in the intensity of the murmur in a patient with hypertrophic cardiomyopathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Squatting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valsalva&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Squatting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Squatting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Squatting increases preload and afterload, leading to a decrease in the intensity of the murmur in patients with hypertrophic cardiomyopathy (HCM) by reducing left ventricular outflow tract obstruction.&lt;/li&gt;&lt;li&gt;âž¤ Squatting&lt;/li&gt;&lt;li&gt;âž¤ decrease in the intensity of the murmur&lt;/li&gt;&lt;li&gt;âž¤ hypertrophic cardiomyopathy (HCM)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a history of HTN, DM2, and DLP is brought to the ER because of reports of palpitations and dizziness. An ECG is ordered and shown in the image. His temperature is 36.8Â°C, PR is 106/min, RR is 18/min, BP is 84/46 mm Hg, and SpO2 is 92% on room air. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DC shock&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. DC shock&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) DC shock&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with hemodynamically unstable atrial fibrillation , DC cardioversion is the immediate and most appropriate treatment to restore normal rhythm and stabilize the patient.&lt;/li&gt;&lt;li&gt;âž¤ hemodynamically unstable atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ DC cardioversion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the best drug for acute management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flunarizine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sumatriptan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sumatriptan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sumatriptan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For acute migraine management , sumatriptan is the drug of choice, as it provides rapid relief of symptoms such as headache, nausea, and sensitivity to light and sound.&lt;/li&gt;&lt;li&gt;âž¤ acute migraine management&lt;/li&gt;&lt;li&gt;âž¤ sumatriptan&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with a history of dyslipidemia, hypertension, and aortic sclerosis presents to the emergency department with chest pain. He took 3 nitroglycerin (NTG) tablets with no relief. His vitals are stable, and cardiac enzymes were normal. An ECG on admission is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;STEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NSTEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stable Angina&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unstable Angina&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Unstable Angina&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture5.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Unstable Angina&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Unstable angina is a type of acute coronary syndrome where chest pain occurs without elevated cardiac enzymes or ST-segment elevation on ECG. This diagnosis is made when patients present with persistent chest pain despite normal initial tests, as seen in this case.&lt;/li&gt;&lt;li&gt;âž¤ Unstable angina&lt;/li&gt;&lt;li&gt;âž¤ acute coronary syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A hypertensive patient who is non-compliant with medication presents to you with sudden onset breathlessness. A chest X-ray was done, which is shown below. How will you manage this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous nitroglycerin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nebulization with salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxygen and antibiotics&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous nitroglycerin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intravenous nitroglycerin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Intravenous nitroglycerin is the first-line treatment for acute pulmonary edema secondary to hypertensive emergency , as it helps reduce both preload and afterload, alleviating the heartâ€™s workload and reducing pulmonary congestion.&lt;/li&gt;&lt;li&gt;âž¤ Intravenous nitroglycerin&lt;/li&gt;&lt;li&gt;âž¤ acute pulmonary edema&lt;/li&gt;&lt;li&gt;âž¤ hypertensive emergency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient collapsed and was brought to the casualty with no proper history. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Check for responsiveness&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secure airway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Shock: 300J&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Check for carotid pulse&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Check for responsiveness&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Check for responsiveness&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The first step in managing an unresponsive patient in Basic Life Support (BLS) is to check for responsiveness . This will guide subsequent actions such as checking for breathing and pulse, initiating CPR, and using defibrillation if necessary.&lt;/li&gt;&lt;li&gt;âž¤ Basic Life Support (BLS)&lt;/li&gt;&lt;li&gt;âž¤ check for responsiveness&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the strongest predictor of cardiovascular disease incidence and subsequent mortality due to CVD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TC/HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;hsCRP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. LDL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) LDL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Elevated LDL levels are the strongest predictor of cardiovascular disease incidence and subsequent mortality due to CVD, making LDL the primary target for therapy in both primary and secondary prevention of cardiovascular events.&lt;/li&gt;&lt;li&gt;âž¤ Elevated LDL levels&lt;/li&gt;&lt;li&gt;âž¤ cardiovascular disease incidence&lt;/li&gt;&lt;li&gt;âž¤ primary&lt;/li&gt;&lt;li&gt;âž¤ secondary&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on antidepressants presented to you with hypotension. An ECG was done, which showed wide QRS complexes and right axis deviation. How will you manage this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antiarrhythmics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV NaHCO3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IV NaHCO3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) IV NaHCO3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of tricyclic antidepressant toxicity with wide QRS complexes , intravenous sodium bicarbonate (NaHCO3) is the treatment of choice, as it helps reverse the sodium channel blockade and prevents further cardiac arrhythmias.&lt;/li&gt;&lt;li&gt;âž¤ tricyclic antidepressant toxicity&lt;/li&gt;&lt;li&gt;âž¤ wide QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ intravenous sodium bicarbonate (NaHCO3)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents to you with fever, night sweats, ptosis, and bilateral facial nerve palsy. Investigations showed leukocytosis and bilateral hilar lymphadenopathy. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypersensitive pneumonitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sarcoidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sarcoidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sarcoidosis is the most likely diagnosis in patients with bilateral hilar lymphadenopathy , fever , night sweats , and facial nerve palsy , a pattern commonly seen in this granulomatous disease .&lt;/li&gt;&lt;li&gt;âž¤ Sarcoidosis&lt;/li&gt;&lt;li&gt;âž¤ bilateral hilar lymphadenopathy&lt;/li&gt;&lt;li&gt;âž¤ fever&lt;/li&gt;&lt;li&gt;âž¤ night sweats&lt;/li&gt;&lt;li&gt;âž¤ facial nerve palsy&lt;/li&gt;&lt;li&gt;âž¤ granulomatous disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presented with chest pain and was noted to have 2 mm of ST-segment elevation in his inferior leads. He has a systolic blood pressure (SBP) of 84 mm Hg and a heart rate (HR) of 124 beats/min. On examination, he is disoriented, jugular venous pressure (JVP) is elevated, and his lungs are clear. Which of the following is the best treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Normal Saline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Nitroglycerin (NTG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV Normal Saline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV Normal Saline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of right ventricular infarction (RVMI) associated with hypotension and clear lungs , the best initial treatment is IV normal saline to optimize preload and improve cardiac output.&lt;/li&gt;&lt;li&gt;âž¤ right ventricular infarction (RVMI)&lt;/li&gt;&lt;li&gt;âž¤ hypotension&lt;/li&gt;&lt;li&gt;âž¤ clear lungs&lt;/li&gt;&lt;li&gt;âž¤ IV normal saline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old gentleman is brought into your ER after a syncope. The monitor showed a heart rate of 190 bpm with a blood pressure of 85/50 mmHg. His SpO2 is 98% (on NRPBM). The ECG shows a regular wide complex tachycardia (WCT) with no apparent P waves. With regard to the jugular venous pressure (JVP) waveform, which of these features would you expect to see?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Giant v waves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannon a waves&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prominent x descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Slow y descent&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cannon a waves&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cannon a waves&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ventricular tachycardia with AV dissociation , you would expect to see cannon a waves on the JVP waveform, resulting from the atria contracting against closed AV valves due to the lack of synchronization between atrial and ventricular contractions.&lt;/li&gt;&lt;li&gt;âž¤ ventricular tachycardia&lt;/li&gt;&lt;li&gt;âž¤ AV dissociation&lt;/li&gt;&lt;li&gt;âž¤ cannon a waves&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient with infertility presents with galactorrhea. Evaluation reveals a 7mm prolactinoma. She is worried about her chances of conception. What is the appropriate drug in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cabergoline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bromocriptine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pegvisomant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cabergoline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bromocriptine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For women with a prolactinoma who are trying to conceive , bromocriptine is the preferred treatment due to its well-established safety and efficacy in restoring fertility.&lt;/li&gt;&lt;li&gt;âž¤ prolactinoma&lt;/li&gt;&lt;li&gt;âž¤ trying to conceive&lt;/li&gt;&lt;li&gt;âž¤ bromocriptine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which among the following, according to the latest guidelines, is NOT an indication for infective endocarditis (IE) prophylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prior Infective Endocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral Valve Prolapse with severe MR&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unrepaired Cyanotic Congenital Heart Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac transplant with valvulopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mitral Valve Prolapse with severe MR&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mitral Valve Prolapse with severe MR&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ According to the latest guidelines, mitral valve prolapse with severe mitral regurgitation is not an indication for infective endocarditis prophylaxis, while other high-risk conditions such as prior IE, unrepaired cyanotic congenital heart disease, and cardiac transplant with valvulopathy are .&lt;/li&gt;&lt;li&gt;âž¤ mitral valve prolapse with severe mitral regurgitation&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ are&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a past medical history of coronary artery disease develops an MI. He got treated in CCU and before he is discharged, he undergoes echocardiography, which reveals a left ventricular ejection fraction of 35% to 40%. He is asymptomatic. What is this patientâ€™s heart failure stage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Stage B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Stage B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This patient, with structural heart disease but no symptoms , fits into Stage B heart failure according to the ACC/AHA heart failure stages .&lt;/li&gt;&lt;li&gt;âž¤ structural heart disease&lt;/li&gt;&lt;li&gt;âž¤ no symptoms&lt;/li&gt;&lt;li&gt;âž¤ Stage B&lt;/li&gt;&lt;li&gt;âž¤ ACC/AHA heart failure stages&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Laboratory investigations of a patient being evaluated for jaundice show elevated bilirubin and alkaline phosphatase (ALP) levels. Levels of the remaining liver enzymes are normal. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obstructive jaundice&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatic jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prehepatic jaundice&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Obstructive jaundice&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Obstructive jaundice&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Obstructive jaundice is characterized by elevated bilirubin and alkaline phosphatase (ALP) levels, while other liver enzymes (such as AST and ALT) remain normal, indicating a biliary obstruction as the likely cause.&lt;/li&gt;&lt;li&gt;âž¤ Obstructive jaundice&lt;/li&gt;&lt;li&gt;âž¤ bilirubin&lt;/li&gt;&lt;li&gt;âž¤ alkaline phosphatase&lt;/li&gt;&lt;li&gt;âž¤ biliary obstruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman presents with fever, arthralgia, ulcers, and fatigue for the past six months, along with new-onset hematuria. Urine examination reveals RBC casts and proteinuria. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Poststreptococcal glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lupus nephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lupus nephritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lupus nephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of systemic lupus erythematosus (SLE) symptoms and renal involvement (hematuria, RBC casts, and proteinuria) makes lupus nephritis the most likely diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ systemic lupus erythematosus (SLE) symptoms&lt;/li&gt;&lt;li&gt;âž¤ renal involvement&lt;/li&gt;&lt;li&gt;âž¤ lupus nephritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 11-year-old child who weighs 26 kg with a history of streptococcal pharyngitis presents with fever and arthralgia. There is no past history of rheumatic heart disease, carditis, or valvular disease. How often is benzathine penicillin recommended for the prophylaxis of rheumatic heart disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;600000 IU once in 3 weeks for 5 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;600000 IU once in 3 weeks for 10 years&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1200000 IU once in 3 weeks for 10 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1200000 IU once in 3 weeks for life&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 600000 IU once in 3 weeks for 10 years&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 600000 IU once in 3 weeks for 10 years&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a child under 27 kg with no history of carditis , 600000 IU of benzathine penicillin every 3 weeks is the recommended dose, and the duration should continue until 21 years of age or for 10 years from the time of diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ 27 kg&lt;/li&gt;&lt;li&gt;âž¤ no history of carditis&lt;/li&gt;&lt;li&gt;âž¤ 600000 IU&lt;/li&gt;&lt;li&gt;âž¤ benzathine penicillin&lt;/li&gt;&lt;li&gt;âž¤ 21 years of age&lt;/li&gt;&lt;li&gt;âž¤ 10 years&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A man on diuretics presents with weakness. An ECG was done which showed flat T waves and prominent U waves. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypomagnesemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypernatremia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypokalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypokalemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of flat T waves and prominent U waves on an ECG in a patient taking diuretics strongly suggests hypokalemia .&lt;/li&gt;&lt;li&gt;âž¤ flat T waves&lt;/li&gt;&lt;li&gt;âž¤ prominent U waves&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A male patient presents to the emergency department. The arterial blood gas (ABG) report is as follows: pH = 7.2 pCO2 = 81 mm Hg HCO3- = 40 meq/L Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute on chronic respiratory acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute on chronic respiratory acidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute on chronic respiratory acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of elevated pCO2 , elevated HCO3- , and a low pH suggests acute on chronic respiratory acidosis , commonly seen in patients with chronic respiratory conditions experiencing an acute exacerbation.&lt;/li&gt;&lt;li&gt;âž¤ elevated pCO2&lt;/li&gt;&lt;li&gt;âž¤ elevated HCO3-&lt;/li&gt;&lt;li&gt;âž¤ low pH&lt;/li&gt;&lt;li&gt;âž¤ acute on chronic respiratory acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient present with fever, jaundice, and malaise. Based on the following serology reports, what is the most incorrect diagnosis? Anti-HBc: Positive HBsAg: Negative Anti-HBs: Negative HBeAg: Negative&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic HBV infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Remote HBV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occult HBV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Window Period&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chronic HBV infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chronic HBV infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic HBV infection requires the persistence of HBsAg for more than 6 months. In this case, since HBsAg is negative , chronic infection is not possible , making it the most incorrect diagnosis .&lt;/li&gt;&lt;li&gt;âž¤ Chronic HBV infection&lt;/li&gt;&lt;li&gt;âž¤ HBsAg&lt;/li&gt;&lt;li&gt;âž¤ HBsAg is negative&lt;/li&gt;&lt;li&gt;âž¤ not possible&lt;/li&gt;&lt;li&gt;âž¤ incorrect diagnosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child presents to the emergency department with a history of ingestion of 10-20 ferrous sulfate tablets. Arterial blood gas reveals acidosis. Which of the following can be used in the management of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Whole Bowel Irrigation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Activated Charcoal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dimercaprol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Penicillamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Whole Bowel Irrigation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Whole Bowel Irrigation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of iron intoxication , Whole Bowel Irrigation is recommended, particularly if there are visible iron pills on abdominal X-ray. Activated charcoal is ineffective for iron overdose, and other chelators like Dimercaprol or Penicillamine are not used for iron toxicity.&lt;/li&gt;&lt;li&gt;âž¤ iron intoxication&lt;/li&gt;&lt;li&gt;âž¤ Whole Bowel Irrigation&lt;/li&gt;&lt;li&gt;âž¤ Activated charcoal&lt;/li&gt;&lt;li&gt;âž¤ Dimercaprol&lt;/li&gt;&lt;li&gt;âž¤ Penicillamine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male patient presented to the hospital with palpitations. Physical examination showed a diastolic murmur in the left 3rd intercostal space . What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tricuspid regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aortic regurgitation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aortic regurgitation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A diastolic murmur heard at the left 3rd intercostal space strongly suggests aortic regurgitation , where the aortic valve fails to close properly, allowing blood to flow back into the left ventricle during diastole.&lt;/li&gt;&lt;li&gt;âž¤ diastolic murmur&lt;/li&gt;&lt;li&gt;âž¤ left 3rd intercostal space&lt;/li&gt;&lt;li&gt;âž¤ aortic regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly male patient was brought by his son because he was not using his left arm for day-to-day functioning. He has an unkempt appearance on the left side of his body and has a history of bumping into door frames while walking through them. The evaluation performed is shown in the image (clock drawing). Where does a lesion in the brain cause this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right parietotemporal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left parietal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right parietal&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right premotor cortex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right parietal&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture7_Twkqvh4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Right parietal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Left-sided hemineglect results from a lesion in the right parietal lobe , particularly in the non-dominant hemisphere , which is responsible for spatial awareness and attention.&lt;/li&gt;&lt;li&gt;âž¤ Left-sided hemineglect&lt;/li&gt;&lt;li&gt;âž¤ right parietal lobe&lt;/li&gt;&lt;li&gt;âž¤ non-dominant hemisphere&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A person with dyspnea has a slight limitation in physical activity. Doing ordinary activities causes symptoms, but he is asymptomatic at rest. Which class of the New York Heart Association (NYHA) classification does he belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Class II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A patient who has slight limitations in physical activity but is asymptomatic at rest falls under NYHA Class II . Ordinary activities, such as walking or climbing stairs, result in symptoms.&lt;/li&gt;&lt;li&gt;âž¤ slight limitations in physical activity&lt;/li&gt;&lt;li&gt;âž¤ asymptomatic at rest&lt;/li&gt;&lt;li&gt;âž¤ NYHA Class II&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with headache and bitemporal hemianopia. Hormonal evaluation was normal. Which of the following is a likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gonadotroph adenoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mammotroph adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Corticotroph adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Somatotroph adenoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gonadotroph adenoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gonadotroph adenoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A patient with normal hormonal evaluation , headache , and bitemporal hemianopia is most likely to have a gonadotroph adenoma , which is the most common non-functioning pituitary adenoma .&lt;/li&gt;&lt;li&gt;âž¤ normal hormonal evaluation&lt;/li&gt;&lt;li&gt;âž¤ headache&lt;/li&gt;&lt;li&gt;âž¤ bitemporal hemianopia&lt;/li&gt;&lt;li&gt;âž¤ gonadotroph adenoma&lt;/li&gt;&lt;li&gt;âž¤ non-functioning pituitary adenoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman presents with prolonged menstrual bleeding. Her investigations showed normal platelet count, PT, and aPTT, while bleeding time was increased. Ristocetin test was normal. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bernard-Soulier syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glanzmann thrombasthenia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Haemophilia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Von Willebrand disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glanzmann thrombasthenia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glanzmann thrombasthenia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with prolonged menstrual bleeding , increased bleeding time , normal platelet count, and normal Ristocetin test , the most likely diagnosis is Glanzmann thrombasthenia , a platelet aggregation disorder.&lt;/li&gt;&lt;li&gt;âž¤ prolonged menstrual bleeding&lt;/li&gt;&lt;li&gt;âž¤ increased bleeding time&lt;/li&gt;&lt;li&gt;âž¤ normal Ristocetin test&lt;/li&gt;&lt;li&gt;âž¤ Glanzmann thrombasthenia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with chronic pain in his hands, knees, and hips, which is aggravated by activities such as climbing stairs. He reports increased hand pain when writing or typing. He also experiences morning stiffness in his joints, lasting around 30 minutes. An X-ray of his knee shows narrowed joint space with osteophytes. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bone tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteoporosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Osteoarthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Osteoarthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of chronic joint pain , morning stiffness lasting less than 1 hour , and X-ray findings of narrowed joint space with osteophytes is most consistent with osteoarthritis , a common non-inflammatory degenerative joint disease.&lt;/li&gt;&lt;li&gt;âž¤ chronic joint pain&lt;/li&gt;&lt;li&gt;âž¤ morning stiffness lasting less than 1 hour&lt;/li&gt;&lt;li&gt;âž¤ X-ray findings&lt;/li&gt;&lt;li&gt;âž¤ narrowed joint space with osteophytes&lt;/li&gt;&lt;li&gt;âž¤ osteoarthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with frequent urination, nocturia, and enuresis. A 24-hour urine volume was measured to be 7 liters, and the urine osmolarity was 260 mOsm/L. An ADH assay was performed, with a result of 0.8 pg/ml. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nephrogenic DI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mannitol infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary polydipsia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Central DI&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Central DI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Central Diabetes Insipidus (DI)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with low ADH levels , polyuria , and dilute urine , the most likely diagnosis is Central Diabetes Insipidus (DI) , where there is a deficiency of ADH leading to the inability of the kidneys to concentrate urine.&lt;/li&gt;&lt;li&gt;âž¤ low ADH levels&lt;/li&gt;&lt;li&gt;âž¤ polyuria&lt;/li&gt;&lt;li&gt;âž¤ dilute urine&lt;/li&gt;&lt;li&gt;âž¤ Central Diabetes Insipidus (DI)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is confirmatory to ensure that a central line is in the jugular vein?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ETCO2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blood color&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chest X-ray&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Chest X-ray&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most confirmatory method to ensure that a central line is placed correctly in the jugular vein or other central venous locations is a chest X-ray , which helps visualize the position of the catheter tip and detect any complications.&lt;/li&gt;&lt;li&gt;âž¤ jugular vein&lt;/li&gt;&lt;li&gt;âž¤ chest X-ray&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old medical student with a 2-month history of palpitations, sweating, restlessness, and complains of sweaty palms. Which of the following will help in diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid receptor antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Thyroglobulin Antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ultrasensitive thyrotropin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-thyroid peroxidase antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ultrasensitive thyrotropin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ultrasensitive thyrotropin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient presenting with symptoms suggestive of thyrotoxicosis , the most appropriate first step is to measure TSH with an ultrasensitive thyrotropin test to confirm the diagnosis before moving on to other investigations.&lt;/li&gt;&lt;li&gt;âž¤ thyrotoxicosis&lt;/li&gt;&lt;li&gt;âž¤ TSH&lt;/li&gt;&lt;li&gt;âž¤ ultrasensitive thyrotropin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman who recently received a kidney transplant 2 months ago developed a high-grade fever, dyspnea, and a hacking cough. Chest X-ray reveals bilateral interstitial infiltrates. Urine examination shows â€œowl eyeâ€ appearance of cells. Which of the following agents is most likely responsible for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Influenza virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory syncytial virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytomegalovirus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenovirus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cytomegalovirus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cytomegalovirus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a post-transplant patient with systemic symptoms and the characteristic \&quot;owl eye\&quot; inclusions , Cytomegalovirus (CMV) is the most likely causative agent, especially in the context of immunosuppression.&lt;/li&gt;&lt;li&gt;âž¤ \&quot;owl eye\&quot; inclusions&lt;/li&gt;&lt;li&gt;âž¤ Cytomegalovirus (CMV)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old presents with chest pain, dyspnea that worsens when lying down and is relieved when sitting upright. On examination, heart sounds are muffled and the lungs are clear. A chest X-ray is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute Pulmonary edema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute MI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac Tamponade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cardiac Tamponade&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture8_yDBr35W.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cardiac Tamponade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of dyspnea, chest pain relieved by sitting upright , muffled heart sounds , and X-ray findings (likely showing an enlarged heart silhouette) strongly suggests cardiac tamponade . This is a medical emergency that requires prompt diagnosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ dyspnea, chest pain relieved by sitting upright&lt;/li&gt;&lt;li&gt;âž¤ muffled heart sounds&lt;/li&gt;&lt;li&gt;âž¤ cardiac tamponade&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is a known case of hypertension is on multiple anti-hypertensive drugs. His ECG is shown below. Which drug is responsible for the following ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Spironolactone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture9_2Nn3yvQ.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone can lead to hyperkalemia , which manifests on ECG with tall T waves , widened QRS complexes , and potential absent P waves . This is the most likely cause of the ECG changes in this hypertensive patient on multiple antihypertensive medications.&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone&lt;/li&gt;&lt;li&gt;âž¤ hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ tall T waves&lt;/li&gt;&lt;li&gt;âž¤ widened QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ absent P waves&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The patient has a fever, cough, and cold. The chest x-ray is given below. What will be the examination finding in the infra-scapular region?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperresonance on percussion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coarse crackles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dull note on percussion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural rub&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dull note on percussion&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture1_q53ZiqE.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dull note on percussion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of pleural effusion , a dull note on percussion is the key examination finding due to the accumulation of fluid in the pleural space.&lt;/li&gt;&lt;li&gt;âž¤ pleural effusion&lt;/li&gt;&lt;li&gt;âž¤ dull note on percussion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hamman sign is seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pneumoperitoneum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pneumopericardium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumomediastinum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydropneumothorax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pneumomediastinum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-10-28%20170410.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pneumomediastinum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hammanâ€™s sign is a crunching sound synchronous with the heartbeat, and it is most commonly associated with pneumomediastinum , often heard over the precordium.&lt;/li&gt;&lt;li&gt;âž¤ Hammanâ€™s sign&lt;/li&gt;&lt;li&gt;âž¤ pneumomediastinum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female presented with loss of pain and temperature, but her touch sensation was intact. Imaging showed cavitation around the central canal. What is the probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brown-Sequard syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tabes dorsalis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute combined degeneration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Syringomyelia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Syringomyelia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Syringomyelia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Syringomyelia causes a selective loss of pain and temperature sensation with preservation of touch and proprioception, due to damage near the central canal of the spinal cord where the spinothalamic tract fibers cross.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has muffled heart sounds with low BP and elevated JVP. What is the likely JVP finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Absent a wave&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Absent y descent&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prominent y descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Absent x descent&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Absent y descent&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Absent y descent&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cardiac tamponade , the y descent is absent due to impaired right atrial emptying caused by the external pressure from pericardial fluid. This finding, along with muffled heart sounds, hypotension, and elevated JVP, points to the diagnosis of cardiac tamponade.&lt;/li&gt;&lt;li&gt;âž¤ cardiac tamponade&lt;/li&gt;&lt;li&gt;âž¤ y descent is absent&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old lady develops sudden onset facial deviation with slurring of speech and inability to raise right arm. The symptoms spontaneously begin to reduce and has significant improvement over the next 2 hours. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transient Ischemic Attack&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemorrhagic Stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardio-embolic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Paradoxical embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Transient Ischemic Attack&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Transient Ischemic Attack (TIA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A Transient Ischemic Attack (TIA) is characterized by the sudden onset of focal neurological symptoms that resolve within 24 hours , usually within minutes to hours. It is important to recognize TIA as it is a warning sign of a potential future stroke.&lt;/li&gt;&lt;li&gt;âž¤ Transient Ischemic Attack (TIA)&lt;/li&gt;&lt;li&gt;âž¤ sudden onset of focal neurological symptoms&lt;/li&gt;&lt;li&gt;âž¤ 24 hours&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient had a drop in Systolic Blood Pressure of 15 mm Hg during inspiration. Which of the following is NOT associated with it?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac Tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Status Asthmaticus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertrophic Cardiomyopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tension Pneumothorax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypertrophic Cardiomyopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Hypertrophic Cardiomyopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulsus paradoxus is associated with conditions that significantly increase intrathoracic pressure during inspiration, such as cardiac tamponade , status asthmaticus , and tension pneumothorax , but not hypertrophic cardiomyopathy , which is more likely to cause pulsus bisferiens .&lt;/li&gt;&lt;li&gt;âž¤ Pulsus paradoxus&lt;/li&gt;&lt;li&gt;âž¤ intrathoracic pressure&lt;/li&gt;&lt;li&gt;âž¤ cardiac tamponade&lt;/li&gt;&lt;li&gt;âž¤ status asthmaticus&lt;/li&gt;&lt;li&gt;âž¤ tension pneumothorax&lt;/li&gt;&lt;li&gt;âž¤ not hypertrophic cardiomyopathy&lt;/li&gt;&lt;li&gt;âž¤ pulsus bisferiens&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An An HIV patient presents with fever and neck stiffness. Lumbar puncture was done and CSF examination shows lymphocytosis, reduced An HIV patient presents with fever and neck stiffness. Lumbar puncture was done and CSF examination shows lymphocytosis, reduced HIV patient presents with fever and neck stiffness. Lumbar puncture was done and CSF examination shows lymphocytosis, reduced glucose, and increased protein. What is NOT helpful in identifying the likely causative organism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CSF Cryptococcal Antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CSF Adenosine Deaminase Levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CSF Viral PCR Assay&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CSF India Ink Staining&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CSF Viral PCR Assay&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) CSF Viral PCR Assay&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In HIV patients with meningitis-like symptoms and CSF findings of reduced glucose and increased protein , tests for Cryptococcal meningitis and tuberculous meningitis are most useful. CSF Viral PCR Assay is not typically helpful in this context; as viral meningitis does not usually cause the same CSF abnormalities.&lt;/li&gt;&lt;li&gt;âž¤ reduced glucose&lt;/li&gt;&lt;li&gt;âž¤ increased protein&lt;/li&gt;&lt;li&gt;âž¤ Cryptococcal meningitis&lt;/li&gt;&lt;li&gt;âž¤ tuberculous meningitis&lt;/li&gt;&lt;li&gt;âž¤ CSF Viral PCR Assay&lt;/li&gt;&lt;li&gt;âž¤ not typically helpful&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month-pregnant female presents with swelling in her legs and is diagnosed with Deep Vein Thrombosis (DVT). She requires anticoagulation. Which of the following is preferred?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apixaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enoxaparin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Enoxaparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In pregnancy, Enoxaparin (low molecular weight heparin) is the anticoagulant of choice for treating DVT due to its safety profile and effectiveness , while Warfarin and DOACs are contraindicated or not recommended during pregnancy.&lt;/li&gt;&lt;li&gt;âž¤ Enoxaparin (low molecular weight heparin)&lt;/li&gt;&lt;li&gt;âž¤ safety profile&lt;/li&gt;&lt;li&gt;âž¤ effectiveness&lt;/li&gt;&lt;li&gt;âž¤ Warfarin&lt;/li&gt;&lt;li&gt;âž¤ DOACs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A chronic smoker presents with weight gain and hyperpigmentation. A high-dose dexamethasone suppression test was done, and ACTH remained high before and after the test. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pituitary adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ectopic ACTH-producing tumor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exogenous source&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal adenoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ectopic ACTH-producing tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When ACTH remains high after a high-dose dexamethasone suppression test in a patient with signs of Cushing&#x27;s syndrome , the most likely diagnosis is an ectopic ACTH-producing tumor â€”a common source being small cell lung carcinoma in chronic smokers.&lt;/li&gt;&lt;li&gt;âž¤ ACTH remains high&lt;/li&gt;&lt;li&gt;âž¤ Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ ectopic ACTH-producing tumor&lt;/li&gt;&lt;li&gt;âž¤ small cell lung carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The patient is having the following hand movements. Which of the following conditions is responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyrotoxicosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypercarbia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemiballismus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypoxia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypercarbia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-10-28%20173813.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A flapping tremor (asterixis) is most commonly seen in hypercarbia and hepatic encephalopathy . It indicates underlying metabolic or toxic encephalopathy, particularly in conditions of CO2 retention.&lt;/li&gt;&lt;li&gt;âž¤ flapping tremor (asterixis)&lt;/li&gt;&lt;li&gt;âž¤ hypercarbia&lt;/li&gt;&lt;li&gt;âž¤ hepatic encephalopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman presented with unilateral pulsatile headache, photophobia, phonophobia, and nausea, which is exaggerated on skipping her meals. What is your diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Migraine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tension headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cluster headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Malingering&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Migraine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Migraine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A migraine typically presents with unilateral, pulsatile headache associated with nausea , photophobia , and phonophobia , and it may be triggered by factors like skipping meals or stress.&lt;/li&gt;&lt;li&gt;âž¤ migraine&lt;/li&gt;&lt;li&gt;âž¤ unilateral, pulsatile headache&lt;/li&gt;&lt;li&gt;âž¤ nausea&lt;/li&gt;&lt;li&gt;âž¤ photophobia&lt;/li&gt;&lt;li&gt;âž¤ phonophobia&lt;/li&gt;&lt;li&gt;âž¤ skipping meals&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old patient has fever with severe shortness of breath and red currant jelly sputum. On examination, he has altered sensorium with respiratory rate of 35 breaths/min. Lab investigations show serum creatinine of 1.9 mg/dl. CXR is done and it shows multi-lobar infiltrates. What is correct regarding the management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;OPD management&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IPD management&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ICU management (oral drugs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ICU management (IV drugs)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. ICU management (IV drugs)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) ICU management (IV drugs)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Severe pneumonia with respiratory distress , altered sensorium , and multi-lobar infiltrates requires ICU management with IV antibiotics to ensure effective and rapid treatment, especially in suspected cases of Klebsiella pneumoniae pneumonia.&lt;/li&gt;&lt;li&gt;âž¤ respiratory distress&lt;/li&gt;&lt;li&gt;âž¤ altered sensorium&lt;/li&gt;&lt;li&gt;âž¤ multi-lobar infiltrates&lt;/li&gt;&lt;li&gt;âž¤ ICU management with IV antibiotics&lt;/li&gt;&lt;li&gt;âž¤ Klebsiella pneumoniae&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;60-year-old obese lady underwent cholecystectomy. After 3 days she develops respiratory distress. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Air embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atelectasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myocardial Infarction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary embolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Pulmonary embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Post-operative respiratory distress, especially in an obese patient, should raise a high suspicion for pulmonary embolism , a common complication after surgery due to immobility and increased risk of thromboembolism. Early identification and management are crucial.&lt;/li&gt;&lt;li&gt;âž¤ pulmonary embolism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following rules out Exudative pleural effusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High Protein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low Fibrin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High Specific gravity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High cellular content&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Low Fibrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Low fibrin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A low fibrin level would rule out exudative pleural effusion, as exudates are typically associated with high fibrin content due to inflammation.&lt;/li&gt;&lt;li&gt;âž¤ low fibrin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient had features of resting tremors, bradykinesia, and postural instability. He became bedridden and died due to respiratory failure. Brain biopsy is likely to show which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lewy bodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hirano bodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Guarneri bodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Negri bodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lewy bodies&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture3_uF6BqbJ.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Lewy bodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lewy bodies, composed mainly of alpha-synuclein, are a hallmark of Parkinsonâ€™s disease and are typically seen on brain biopsy in patients with this neurodegenerative disorder.&lt;/li&gt;&lt;li&gt;âž¤ Parkinsonâ€™s disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A morbidly obese diabetic woman was on Metformin but could not achieve glycemic control. She has had a previous osteoporotic fracture and has a history of pancreatitis. The patient does not want to take injections. Which of the following would be suitable to reduce her glucose levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Semaglutide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a morbidly obese diabetic patient with a history of osteoporosis and pancreatitis , Empagliflozin is the best choice for glucose management as it promotes weight loss , does not increase the risk of pancreatitis, and avoids worsening osteoporosis.&lt;/li&gt;&lt;li&gt;âž¤ morbidly obese&lt;/li&gt;&lt;li&gt;âž¤ osteoporosis&lt;/li&gt;&lt;li&gt;âž¤ pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 31-year-old woman with rheumatoid arthritis (RA) gets pregnant. She is currently on hydroxychloroquine and sulfasalazine, but her disease is progressively worsening at 32 weeks of gestation. Which drug can she be started on?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leflunomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NSAIDs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Certolizumab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Certolizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Certolizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For pregnant women with rheumatoid arthritis , Certolizumab is the safest TNF-alpha inhibitor that can be used throughout pregnancy, particularly in the later stages, because it does not cross the placenta.&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ Certolizumab&lt;/li&gt;&lt;li&gt;âž¤ TNF-alpha inhibitor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman is referred for evaluation due to a 5-year history of Raynaud phenomenon and thickening of the skin over her fingers. Routine laboratory tests are within normal limits. DLCO (diffusing capacity of the lungs for carbon monoxide) is 44% of normal, with normal lung volumes. What is the likely diagnosis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic obstructive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interstitial Lung Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrictive lung disease secondary to pleural disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pulmonary hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with systemic sclerosis , pulmonary arterial hypertension (PAH) is a common complication, especially when there is a reduced DLCO with normal lung volumes , as seen in this patient.&lt;/li&gt;&lt;li&gt;âž¤ systemic sclerosis&lt;/li&gt;&lt;li&gt;âž¤ pulmonary arterial hypertension (PAH)&lt;/li&gt;&lt;li&gt;âž¤ reduced DLCO&lt;/li&gt;&lt;li&gt;âž¤ normal lung volumes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female patient with chronic hepatitis B who is HBeAg negative is evaluated for treatment. ALT is normal and HBV DNA is 800 IU/mL. Which of the following would you recommend for treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peg-interferon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lamivudine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adefovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Observation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Observation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In chronic hepatitis B patients who are HBeAg negative , with HBV DNA &amp;lt; 2000 IU/mL and normal ALT , the correct management is observation and periodic monitoring. No immediate antiviral treatment is needed unless there is a change in viral load or liver enzyme levels.&lt;/li&gt;&lt;li&gt;âž¤ chronic hepatitis B&lt;/li&gt;&lt;li&gt;âž¤ HBeAg negative&lt;/li&gt;&lt;li&gt;âž¤ HBV DNA &amp;lt; 2000 IU/mL&lt;/li&gt;&lt;li&gt;âž¤ normal ALT&lt;/li&gt;&lt;li&gt;âž¤ observation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-diabetic drug can cause euglycemic Ketoacidosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glimepiride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acarbose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin , an SGLT2 inhibitor, can cause euglycemic ketoacidosis , where ketoacidosis occurs with normal or mildly elevated blood glucose levels. This is a key side effect to monitor in patients treated with SGLT2 inhibitors.&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin&lt;/li&gt;&lt;li&gt;âž¤ euglycemic ketoacidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old man was brought to casualty with a history of GTCS, presented with 4-5 episodes of seizures and seizures are present for more than 45 minutes. The ambulance crew administered 4 mg of lorazepam already. What will be the management in the Emergency Room?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lacosamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lorazepam&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lorazepam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Lorazepam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In status epilepticus, lorazepam is the first-line treatment. If the initial dose does not control the seizures, a repeat dose of lorazepam can be administered before moving on to second-line agents like phenytoin or valproate.&lt;/li&gt;&lt;li&gt;âž¤ lorazepam&lt;/li&gt;&lt;li&gt;âž¤ a repeat dose of lorazepam&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old patient with long-standing type 2 diabetes came to the OPD with complaints of fatigue and frequent urination. His FBS = 144 mg/dl &amp;amp; PPBS = 210 mg/dl. What is the target HbA1C for adequate control of diabetes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 6.0&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 6.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt; 7.0&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt; 7.5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &lt; 7.0&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) &amp;lt; 7.0&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The recommended target HbA1C for most patients with type 2 diabetes is &amp;lt; 7% , as it balances good glycemic control with minimizing the risk of hypoglycemia and long-term complications.&lt;/li&gt;&lt;li&gt;âž¤ &amp;lt; 7%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are features of Connâ€™s syndrome except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metabolic acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Muscle cramps&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Metabolic acidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Metabolic acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The hallmark features of Connâ€™s syndrome are metabolic alkalosis , hypertension , and hypokalemia , which can result in muscle cramps. Metabolic acidosis is not associated with Connâ€™s syndrome.&lt;/li&gt;&lt;li&gt;âž¤ metabolic alkalosis&lt;/li&gt;&lt;li&gt;âž¤ hypertension&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ Metabolic acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman has ptosis and limb weakness that worsens in the evening. She was diagnosed with myasthenia gravis. What is the first line drug used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyridostigmine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plasma exchange&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pyridostigmine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pyridostigmine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In myasthenia gravis , the first-line treatment is pyridostigmine , a cholinesterase inhibitor that improves muscle strength by increasing acetylcholine levels at the neuromuscular junction. Immunosuppressive therapies like prednisolone or cyclosporine are reserved for more severe or refractory cases. Plasma exchange is used in acute exacerbations or pre-surgical management.&lt;/li&gt;&lt;li&gt;âž¤ myasthenia gravis&lt;/li&gt;&lt;li&gt;âž¤ pyridostigmine&lt;/li&gt;&lt;li&gt;âž¤ prednisolone&lt;/li&gt;&lt;li&gt;âž¤ cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ Plasma exchange&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Preferred sample for testing random blood sugar is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Venous&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arterial&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Capillary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arteriole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Venous&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Venous&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The preferred sample for testing random blood sugar is venous blood because it provides the most accurate and consistent results in clinical settings. Capillary blood is often used for home monitoring and quick testing, but venous samples remain the standard for laboratory diagnostics.&lt;/li&gt;&lt;li&gt;âž¤ preferred sample&lt;/li&gt;&lt;li&gt;âž¤ random blood sugar&lt;/li&gt;&lt;li&gt;âž¤ venous blood&lt;/li&gt;&lt;li&gt;âž¤ Capillary blood&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which value is derived in ABG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ph&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;pO2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;pCO2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bicarbonate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Bicarbonate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Bicarbonate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ABG analysis , the values for pH, pO2, and pCO2 are directly measured, while bicarbonate (HCOâ‚ƒâ») is derived using formulas based on the measured values.&lt;/li&gt;&lt;li&gt;âž¤ ABG analysis&lt;/li&gt;&lt;li&gt;âž¤ pH, pO2, and pCO2&lt;/li&gt;&lt;li&gt;âž¤ bicarbonate (HCOâ‚ƒâ»)&lt;/li&gt;&lt;li&gt;âž¤ derived&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old male presented with infertility, and he has chronic sinusitis, bronchiectasis, and situs inversus. What is the likely disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Kartagenerâ€™s syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cystic fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mucoviscidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Klinefelter syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Kartagenerâ€™s syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Kartagenerâ€™s syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Kartagenerâ€™s syndrome is characterized by infertility , chronic sinusitis , bronchiectasis , and situs inversus , all due to defective ciliary movement.&lt;/li&gt;&lt;li&gt;âž¤ Kartagenerâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ infertility&lt;/li&gt;&lt;li&gt;âž¤ chronic sinusitis&lt;/li&gt;&lt;li&gt;âž¤ bronchiectasis&lt;/li&gt;&lt;li&gt;âž¤ situs inversus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is likely with ascitic fluid protein 1.9 g/dL and a SAAG (Serum-Ascites Albumin Gradient) of 1.4?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic cirrhosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peritoneal malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Veno-occlusive disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alcoholic cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alcoholic cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A SAAG â‰¥ 1.1 g/dL and ascitic fluid protein &amp;lt; 2.5 g/dL are most consistent with portal hypertension due to alcoholic cirrhosis .&lt;/li&gt;&lt;li&gt;âž¤ SAAG â‰¥ 1.1 g/dL&lt;/li&gt;&lt;li&gt;âž¤ ascitic fluid protein &amp;lt; 2.5 g/dL&lt;/li&gt;&lt;li&gt;âž¤ portal hypertension&lt;/li&gt;&lt;li&gt;âž¤ alcoholic cirrhosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old pilot presents to a neurologist with rapidly progressive dementia, myoclonus, ataxia, and visual disturbances. EEG showed periodic complexes. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Creutzfeldt-Jakob Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Whipple disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vascular dementia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Creutzfeldt-Jakob Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Creutzfeldt-Jakob Disease (CJD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with rapidly progressive dementia , myoclonus , ataxia , and periodic complexes on EEG, the most likely diagnosis is Creutzfeldt-Jakob Disease (CJD) , a rapidly fatal neurodegenerative disease caused by prions.&lt;/li&gt;&lt;li&gt;âž¤ rapidly progressive dementia&lt;/li&gt;&lt;li&gt;âž¤ myoclonus&lt;/li&gt;&lt;li&gt;âž¤ ataxia&lt;/li&gt;&lt;li&gt;âž¤ periodic complexes&lt;/li&gt;&lt;li&gt;âž¤ Creutzfeldt-Jakob Disease (CJD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female with a history of recurrent headaches presented for further evaluation. Laboratory tests revealed normal hemoglobin and WBC counts, with an elevated platelet count. Bone marrow evaluation showed increased megakaryocytes and a JAK2 mutation. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Essential thrombocytosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polycythemia vera&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic myelogenous leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary myelofibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Essential thrombocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Essential thrombocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of an elevated platelet count , normal hemoglobin and WBC counts , increased megakaryocytes in the bone marrow, and a JAK2 mutation is most consistent with Essential Thrombocytosis (ET) , a myeloproliferative disorder characterized by excessive platelet production.&lt;/li&gt;&lt;li&gt;âž¤ elevated platelet count&lt;/li&gt;&lt;li&gt;âž¤ normal hemoglobin and WBC counts&lt;/li&gt;&lt;li&gt;âž¤ increased megakaryocytes&lt;/li&gt;&lt;li&gt;âž¤ JAK2 mutation&lt;/li&gt;&lt;li&gt;âž¤ Essential Thrombocytosis (ET)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man is evaluated for shortness of breath on exertion and dry cough that have worsened over the course of 6 months. He has clubbing, and his vitals are stable. Pulmonary function tests (PFT) reveal: FEV1: 65% FVC: 67% FEV1/FVC: 74% TLC: 68% DLCO: 62% Which test is most likely to determine the etiology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoscopy with transbronchial lung biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HRCT chest&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PET CT of whole body&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HRCT chest&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HRCT chest&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with progressive dyspnea , cough , and PFT findings suggestive of a restrictive lung disease , the most appropriate next step to determine the etiology is HRCT of the chest . This imaging modality is particularly useful in diagnosing interstitial lung diseases , including idiopathic pulmonary fibrosis (IPF) .&lt;/li&gt;&lt;li&gt;âž¤ progressive dyspnea&lt;/li&gt;&lt;li&gt;âž¤ cough&lt;/li&gt;&lt;li&gt;âž¤ restrictive lung disease&lt;/li&gt;&lt;li&gt;âž¤ HRCT of the chest&lt;/li&gt;&lt;li&gt;âž¤ interstitial lung diseases&lt;/li&gt;&lt;li&gt;âž¤ idiopathic pulmonary fibrosis (IPF)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a long history of alcoholism presents with acute pain and swelling of the left great toe. Synovial fluid analysis shows raised leucocytes. Investigation shows normal serum uric acid levels. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute Gout.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Septic Arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudogout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reactive Arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute Gout.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute Gout&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute gout should be strongly suspected in a patient with acute pain and swelling of the great toe (podagra), even if serum uric acid levels are normal at the time of presentation. This is because serum uric acid can be normal in up to 30-40% of acute gout cases.&lt;/li&gt;&lt;li&gt;âž¤ Acute gout&lt;/li&gt;&lt;li&gt;âž¤ acute pain and swelling of the great toe&lt;/li&gt;&lt;li&gt;âž¤ serum uric acid levels are normal&lt;/li&gt;&lt;li&gt;âž¤ serum uric acid&lt;/li&gt;&lt;li&gt;âž¤ 30-40% of acute gout&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A farmer tried to commit suicide by ingesting about 2 glasses of paraquat. What is the primary system affected in paraquat toxicity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dermatologic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neurologic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pulmonary&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In paraquat poisoning , the pulmonary system is the primary system affected, with acute lung injury and eventual pulmonary fibrosis being the most critical complications.&lt;/li&gt;&lt;li&gt;âž¤ paraquat poisoning&lt;/li&gt;&lt;li&gt;âž¤ pulmonary system&lt;/li&gt;&lt;li&gt;âž¤ acute lung injury&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female presents with complaints of chest pain, palpitation, and shortness of breath. On auscultation, a mid-diastolic murmur is heard, and on examination, a prominent &#x27;a&#x27; wave on the JVP is noted. What is the most appropriate diagnosis among the following options?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitral Stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tricuspid Stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tricuspid Regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitral Regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tricuspid Stenosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tricuspid Stenosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A mid-diastolic murmur heard at the left sternal border, combined with a prominent &#x27;a&#x27; wave in the JVP, is most consistent with tricuspid stenosis , which causes elevated right atrial pressure and a characteristic JVP waveform.&lt;/li&gt;&lt;li&gt;âž¤ mid-diastolic murmur&lt;/li&gt;&lt;li&gt;âž¤ prominent &#x27;a&#x27; wave&lt;/li&gt;&lt;li&gt;âž¤ tricuspid stenosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presented to the OPD with complaints of early morning backache and stiffness that improves with exercise and persistent red eyes. On examination, lung expansion was less than 3 cm. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pagetâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ankylosing Spondylitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Healed Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteopetrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ankylosing Spondylitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ankylosing Spondylitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ankylosing Spondylitis should be strongly suspected in young patients with morning back pain , stiffness that improves with exercise , reduced chest expansion , and extra-articular manifestations like anterior uveitis .&lt;/li&gt;&lt;li&gt;âž¤ Ankylosing Spondylitis&lt;/li&gt;&lt;li&gt;âž¤ morning back pain&lt;/li&gt;&lt;li&gt;âž¤ stiffness that improves with exercise&lt;/li&gt;&lt;li&gt;âž¤ reduced chest expansion&lt;/li&gt;&lt;li&gt;âž¤ extra-articular manifestations&lt;/li&gt;&lt;li&gt;âž¤ anterior uveitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;FeNO in bronchial asthma is related to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoconstriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mucus hypersecretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophilic inflammation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Airway hyperreactivity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eosinophilic inflammation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Eosinophilic inflammation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In bronchial asthma , FeNO is primarily used to assess eosinophilic inflammation , which is associated with TH2-type inflammation. Elevated FeNO levels can help in guiding the use of biologic therapies for asthma.&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ FeNO&lt;/li&gt;&lt;li&gt;âž¤ eosinophilic inflammation&lt;/li&gt;&lt;li&gt;âž¤ TH2-type&lt;/li&gt;&lt;li&gt;âž¤ biologic therapies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with severe restlessness and tremors to the emergency department. She has a history of bronchial asthma. On examination, a swollen neck is observed, and her blood pressure and heart rate are elevated. An ECG shows atrial fibrillation. Which of the following drugs can be given in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Esmolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diltiazem&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diltiazem&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with thyrotoxicosis-induced atrial fibrillation and a history of bronchial asthma , diltiazem is the safest choice to control the heart rate without exacerbating bronchospasm.&lt;/li&gt;&lt;li&gt;âž¤ thyrotoxicosis-induced atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ diltiazem&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient undergoing hemodialysis for hyperkalemia and raised urea levels develops drowsiness, has a seizure, and becomes hypotensive during the procedure. What can be given for treatment in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mannitol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethacrynic Acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bumetanide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mannitol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mannitol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dialysis disequilibrium syndrome can occur during hemodialysis , especially in patients with high urea levels, causing cerebral edema . Mannitol is the treatment of choice to reduce cerebral swelling in this condition.&lt;/li&gt;&lt;li&gt;âž¤ Dialysis disequilibrium syndrome&lt;/li&gt;&lt;li&gt;âž¤ hemodialysis&lt;/li&gt;&lt;li&gt;âž¤ cerebral edema&lt;/li&gt;&lt;li&gt;âž¤ Mannitol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following situations would Non-Invasive Ventilation (NIV) be considered contraindicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AECOPD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ARDS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute MI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Post-extubation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute MI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute MI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NIV is contraindicated in patients with hemodynamically unstable acute myocardial infarction (MI) because it can exacerbate cardiac dysfunction. In cases of respiratory failure associated with AECOPD, ARDS (mild/moderate), or post-extubation, NIV can be beneficial.&lt;/li&gt;&lt;li&gt;âž¤ NIV is contraindicated in patients with hemodynamically unstable acute myocardial infarction (MI)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following improves survival in ARDS (Acute Respiratory Distress Syndrome)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early use of paralytic agents&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluid restriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low tidal volume&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prone positioning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Low tidal volume&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Low tidal volume&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ARDS , low tidal volume ventilation (LTVV) is a key intervention that improves survival by reducing ventilator-induced lung injury. Prone positioning is also beneficial, particularly in severe ARDS, but LTVV is the most established intervention for improving survival.&lt;/li&gt;&lt;li&gt;âž¤ ARDS&lt;/li&gt;&lt;li&gt;âž¤ low tidal volume ventilation (LTVV)&lt;/li&gt;&lt;li&gt;âž¤ survival&lt;/li&gt;&lt;li&gt;âž¤ Prone positioning&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Indications for a chest drain in a parapneumonic effusion include all of the following except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Loculated pleural fluid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleural fluid pH &amp;lt; 7.2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pleural fluid glucose &amp;lt; 60 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural fluid LDH &amp;gt; 1000&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pleural fluid LDH &gt; 1000&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pleural fluid LDH &amp;gt; 1000&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Indications for chest drainage in parapneumonic effusion include loculated fluid , pleural fluid pH &amp;lt; 7.2 , and glucose &amp;lt; 60 mg/dL . Elevated LDH &amp;gt; 1000 alone is not a sufficient indication for drainage without additional signs of complication.&lt;/li&gt;&lt;li&gt;âž¤ chest drainage&lt;/li&gt;&lt;li&gt;âž¤ parapneumonic effusion&lt;/li&gt;&lt;li&gt;âž¤ loculated fluid&lt;/li&gt;&lt;li&gt;âž¤ pleural fluid pH &amp;lt; 7.2&lt;/li&gt;&lt;li&gt;âž¤ glucose &amp;lt; 60 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ LDH &amp;gt; 1000&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old smoker presents with shortness of breath (SOB) on exertion. Resting SpO2 is 94%, which reduces to 85% after walking 100 meters. Examination reveals bilateral end-inspiratory crackles. The chest CT (shown) reveals honeycombing and a pattern consistent with pulmonary fibrosis. A serologic workup for autoimmune disease is unremarkable. What is the next therapeutic option?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nintedanib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nintedanib&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102511.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nintedanib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For idiopathic pulmonary fibrosis (IPF) , which is characterized by progressive fibrosis of the lungs, nintedanib is an appropriate therapeutic option as it helps to slow the progression of the disease. Other options like immunosuppressants or steroids are not effective in IPF and may be harmful.&lt;/li&gt;&lt;li&gt;âž¤ idiopathic pulmonary fibrosis (IPF)&lt;/li&gt;&lt;li&gt;âž¤ progressive fibrosis&lt;/li&gt;&lt;li&gt;âž¤ nintedanib&lt;/li&gt;&lt;li&gt;âž¤ immunosuppressants&lt;/li&gt;&lt;li&gt;âž¤ steroids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A soldier operating in the Siachen Glacier presents with numbness of his legs. Based on the image provided, which of the following statements is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rewarming is the treatment of choice&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Analgesics are contraindicated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombolytics cannot be used&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amputation is not required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rewarming is the treatment of choice&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102531.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Rewarming is the treatment of choice&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of frostbite , like that seen in the image, rewarming is the immediate treatment of choice. Pain management is important, and in severe cases, other interventions such as thrombolytics or, in extreme situations, amputation may be considered.&lt;/li&gt;&lt;li&gt;âž¤ frostbite&lt;/li&gt;&lt;li&gt;âž¤ rewarming&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old male presents to the ER with the acute onset of ataxia. Neurological examination shows loss of pain and temperature sensation from the face on the left side and loss of pain and temperature sensation from the right half of the body. He also has dysarthria, dysphagia, and diminished gag reflex with ptosis, miosis, and anhidrosis on the left. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lateral pontine syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medial medullary syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lateral medullary syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Locked in Syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lateral medullary syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lateral medullary syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The patientâ€™s symptoms of crossed sensory loss , dysarthria , dysphagia , and Hornerâ€™s syndrome are characteristic of lateral medullary syndrome (Wallenberg syndrome) , most often due to posterior inferior cerebellar artery (PICA) infarction.&lt;/li&gt;&lt;li&gt;âž¤ crossed sensory loss&lt;/li&gt;&lt;li&gt;âž¤ dysarthria&lt;/li&gt;&lt;li&gt;âž¤ dysphagia&lt;/li&gt;&lt;li&gt;âž¤ Hornerâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ lateral medullary syndrome (Wallenberg syndrome)&lt;/li&gt;&lt;li&gt;âž¤ posterior inferior cerebellar artery (PICA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient comes to the ER with a headache, describing it as the worst headache of his life. Initial NCCT (non-contrast CT) shows subarachnoid hemorrhage (SAH). What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT Angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lumbar puncture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MRI brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;V-P shunt&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CT Angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CT Angiography&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with confirmed SAH on non-contrast CT , the next step is CT Angiography (CTA) to identify the cause, typically a ruptured aneurysm , for further therapeutic intervention.&lt;/li&gt;&lt;li&gt;âž¤ confirmed SAH&lt;/li&gt;&lt;li&gt;âž¤ non-contrast CT&lt;/li&gt;&lt;li&gt;âž¤ CT Angiography (CTA)&lt;/li&gt;&lt;li&gt;âž¤ aneurysm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old man is investigated for progressive cognitive impairment. Which one of the following features is most suggestive of Lewy body dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disinhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Emotional lability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neuroleptic sensitivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary incontinence&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neuroleptic sensitivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neuroleptic sensitivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neuroleptic sensitivity is a key feature of Lewy body dementia (LBD) . Patients with LBD are at risk of experiencing severe adverse reactions to antipsychotic medications, making this a distinguishing clinical feature of the disease.&lt;/li&gt;&lt;li&gt;âž¤ Neuroleptic sensitivity&lt;/li&gt;&lt;li&gt;âž¤ Lewy body dementia (LBD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In Wernicke&#x27;s encephalopathy, the earliest clinical feature to recover is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ophthalmoparesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Confusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Memory loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ophthalmoparesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ophthalmoparesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Wernicke&#x27;s encephalopathy , ophthalmoparesis is the earliest clinical feature to recover following thiamine therapy .&lt;/li&gt;&lt;li&gt;âž¤ Wernicke&#x27;s encephalopathy&lt;/li&gt;&lt;li&gt;âž¤ ophthalmoparesis&lt;/li&gt;&lt;li&gt;âž¤ earliest clinical feature&lt;/li&gt;&lt;li&gt;âž¤ thiamine therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are accepted diagnostic criteria for acute pancreatitis except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Confirmatory findings of acute pancreatitis on cross-sectional imaging&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PaO2 &amp;lt; 60 mm Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â‰¥ 3x elevation in serum lipase and/or amylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Typical abdominal pain in the epigastrium that may radiate to the back&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. PaO2 &lt; 60 mm Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) PaO2 &amp;lt; 60 mm Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For diagnosing acute pancreatitis , the accepted criteria are abdominal pain , elevated enzymes (amylase or lipase) , and imaging findings . A PaO2 &amp;lt; 60 mm Hg is part of the Ranson&#x27;s criteria used for prognosis , not for diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ acute pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ abdominal pain&lt;/li&gt;&lt;li&gt;âž¤ elevated enzymes (amylase or lipase)&lt;/li&gt;&lt;li&gt;âž¤ imaging findings&lt;/li&gt;&lt;li&gt;âž¤ PaO2 &amp;lt; 60 mm Hg&lt;/li&gt;&lt;li&gt;âž¤ Ranson&#x27;s criteria&lt;/li&gt;&lt;li&gt;âž¤ prognosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Paraneoplastic neurological syndromes (PNS) characterized by anti-Yo antibodies are associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebellar Degeneration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stiff Person Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Optic Neuritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Retinopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cerebellar Degeneration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cerebellar Degeneration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-Yo antibodies are most commonly associated with paraneoplastic cerebellar degeneration , particularly in patients with gynecological cancers like ovarian and breast cancer . This condition is characterized by progressive cerebellar ataxia and other cerebellar signs.&lt;/li&gt;&lt;li&gt;âž¤ Anti-Yo antibodies&lt;/li&gt;&lt;li&gt;âž¤ paraneoplastic cerebellar degeneration&lt;/li&gt;&lt;li&gt;âž¤ gynecological cancers&lt;/li&gt;&lt;li&gt;âž¤ ovarian&lt;/li&gt;&lt;li&gt;âž¤ breast cancer&lt;/li&gt;&lt;li&gt;âž¤ progressive cerebellar ataxia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 20-year-old man who complains of edema and frothy urine for 2 months. Labs reveal normal serum creatinine and 4+ protein in urine without blood or bacteria. He undergoes a kidney biopsy, which is normal on light microscopy. What is the best treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prednisolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a young adult presenting with nephrotic syndrome and a normal kidney biopsy on light microscopy, minimal change disease (MCD) is the most likely diagnosis. The best initial treatment is prednisolone , as most cases of MCD respond rapidly to corticosteroid therapy.&lt;/li&gt;&lt;li&gt;âž¤ nephrotic syndrome&lt;/li&gt;&lt;li&gt;âž¤ normal kidney biopsy&lt;/li&gt;&lt;li&gt;âž¤ minimal change disease (MCD)&lt;/li&gt;&lt;li&gt;âž¤ prednisolone&lt;/li&gt;&lt;li&gt;âž¤ MCD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the expected MCV in the CBC based on the peripheral smear (PS) image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 80 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 60 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;80-100 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 100 fL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. &gt; 100 fL&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102621.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) &amp;gt; 100 fL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of hypersegmented neutrophils and macrocytes on the peripheral smear suggests megaloblastic anemia , with an MCV typically &amp;gt; 100 fL . This condition is commonly caused by vitamin B12 or folate deficiency .&lt;/li&gt;&lt;li&gt;âž¤ hypersegmented neutrophils&lt;/li&gt;&lt;li&gt;âž¤ macrocytes&lt;/li&gt;&lt;li&gt;âž¤ peripheral smear&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ MCV&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt; 100 fL&lt;/li&gt;&lt;li&gt;âž¤ vitamin B12&lt;/li&gt;&lt;li&gt;âž¤ folate deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man has an MI complicated by shock. He recovers well from the MI, but several days later, his renal function deteriorates. One week after his MI, he becomes oliguric with BUN of 53 mg/dL and creatinine of 3.9 mg/dL. What is the likely value of FeNa?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt; 2%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 1%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt; 35%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 50%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &gt; 2%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) &amp;gt; 2%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of acute tubular necrosis (ATN) , which is common after prolonged ischemia or shock, the FeNa is typically greater than 2% due to the loss of the kidneyâ€™s ability to properly reabsorb sodium.&lt;/li&gt;&lt;li&gt;âž¤ acute tubular necrosis (ATN)&lt;/li&gt;&lt;li&gt;âž¤ FeNa&lt;/li&gt;&lt;li&gt;âž¤ greater than 2%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most likely mechanism of gentamicin-related AKI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute tubular necrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic injury&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute tubular necrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acute tubular necrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most likely mechanism of gentamicin-related acute kidney injury is acute tubular necrosis (ATN) , resulting from direct toxic damage to the proximal tubular cells of the kidney.&lt;/li&gt;&lt;li&gt;âž¤ gentamicin-related acute kidney injury&lt;/li&gt;&lt;li&gt;âž¤ acute tubular necrosis (ATN)&lt;/li&gt;&lt;li&gt;âž¤ toxic damage to the proximal tubular cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following would be important for the prevention of tumor lysis syndrome (TLS) EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of allopurinol 300 mg/mÂ² daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administration of IV fluids at a minimum of 3000 mL/mÂ² daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alkalinization of the urine by administration of NaHCO3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Frequent monitoring of serum chemistries every 4 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alkalinization of the urine by administration of NaHCO3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Alkalinization of the urine by administration of NaHCO3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While hydration , allopurinol , and frequent serum monitoring are critical in tumor lysis syndrome (TLS) prevention, urine alkalinization is not recommended because it increases the risk of kidney complications, such as calcium phosphate precipitation .&lt;/li&gt;&lt;li&gt;âž¤ hydration&lt;/li&gt;&lt;li&gt;âž¤ allopurinol&lt;/li&gt;&lt;li&gt;âž¤ frequent serum monitoring&lt;/li&gt;&lt;li&gt;âž¤ tumor lysis syndrome (TLS)&lt;/li&gt;&lt;li&gt;âž¤ urine alkalinization&lt;/li&gt;&lt;li&gt;âž¤ not recommended&lt;/li&gt;&lt;li&gt;âž¤ calcium phosphate precipitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old woman comes to the ER complaining of bleeding due to Warfarin. She received IV vitamin K, 4 U PRBCs, and 4 U FFP. Eight hours later, she begins to complain of SOB. Her vitals are T - 39Â°C, RR 35/min, SpO2 84% on room air, and BP 100/52 mm Hg. Exam reveals bilateral crackles, and the patient was intubated for respiratory failure. A chest X-ray (CXR) is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anaphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TACO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TRALI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspiration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. TRALI&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102649.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) TRALI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TRALI presents as acute respiratory distress , hypoxemia , and bilateral pulmonary infiltrates within 6 hours of transfusion, and it is caused by an immune-mediated response to blood products like FFP or PRBCs . This is distinct from TACO , which is related to fluid overload.&lt;/li&gt;&lt;li&gt;âž¤ TRALI&lt;/li&gt;&lt;li&gt;âž¤ acute respiratory distress&lt;/li&gt;&lt;li&gt;âž¤ hypoxemia&lt;/li&gt;&lt;li&gt;âž¤ bilateral pulmonary infiltrates&lt;/li&gt;&lt;li&gt;âž¤ 6 hours&lt;/li&gt;&lt;li&gt;âž¤ FFP&lt;/li&gt;&lt;li&gt;âž¤ PRBCs&lt;/li&gt;&lt;li&gt;âž¤ TACO&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a 5-year history of ulcerative colitis (UC) presents with acute abdominal pain, fever, and leukocytosis. A plain film is shown below. What is the next management step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Methylprednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subtotal colectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV Methylprednisolone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102706.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV Methylprednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For severe ulcerative colitis flare-ups or early toxic megacolon , IV Methylprednisolone is the initial treatment of choice. Surgical options like subtotal colectomy are considered if there is no response to medical treatment within 48 hours or if complications arise.&lt;/li&gt;&lt;li&gt;âž¤ ulcerative colitis flare-ups&lt;/li&gt;&lt;li&gt;âž¤ toxic megacolon&lt;/li&gt;&lt;li&gt;âž¤ IV Methylprednisolone&lt;/li&gt;&lt;li&gt;âž¤ subtotal colectomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the immune mechanism leading to organ damage in Goodpasture syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibody-dependent cellular cytotoxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complement-activating autoantibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inactivating autoantibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulating autoantibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Complement-activating autoantibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Complement-activating autoantibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The immune mechanism leading to organ damage in Goodpasture syndrome involves complement-activating autoantibodies against the basement membrane in the kidneys and lungs, causing glomerulonephritis and pulmonary hemorrhage .&lt;/li&gt;&lt;li&gt;âž¤ immune mechanism&lt;/li&gt;&lt;li&gt;âž¤ Goodpasture syndrome&lt;/li&gt;&lt;li&gt;âž¤ complement-activating autoantibodies&lt;/li&gt;&lt;li&gt;âž¤ basement membrane&lt;/li&gt;&lt;li&gt;âž¤ glomerulonephritis&lt;/li&gt;&lt;li&gt;âž¤ pulmonary hemorrhage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients with rheumatoid arthritis (RA) are at higher risk for all of the following EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Colorectal Cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary Artery Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoandrogenism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Colorectal Cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Colorectal Cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with rheumatoid arthritis are at increased risk for several comorbid conditions, including coronary artery disease , hypoandrogenism , and lymphoma , but there is no clear evidence suggesting an increased risk of colorectal cancer .&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ coronary artery disease&lt;/li&gt;&lt;li&gt;âž¤ hypoandrogenism&lt;/li&gt;&lt;li&gt;âž¤ lymphoma&lt;/li&gt;&lt;li&gt;âž¤ no clear evidence&lt;/li&gt;&lt;li&gt;âž¤ colorectal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old alcoholic with ascites and jaundice presents with an acute upper gastrointestinal (UGI) bleed. All of the following are appropriate treatment options EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endoscopic variceal ligation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TIPS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For acute variceal bleeding, treatment options include endoscopic variceal ligation , octreotide , and possibly TIPS in refractory cases. Propranolol , although effective for prevention , is not appropriate for the acute management of an ongoing variceal bleed.&lt;/li&gt;&lt;li&gt;âž¤ endoscopic variceal ligation&lt;/li&gt;&lt;li&gt;âž¤ octreotide&lt;/li&gt;&lt;li&gt;âž¤ TIPS&lt;/li&gt;&lt;li&gt;âž¤ Propranolol&lt;/li&gt;&lt;li&gt;âž¤ prevention&lt;/li&gt;&lt;li&gt;âž¤ not appropriate&lt;/li&gt;&lt;li&gt;âž¤ acute management&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a diagnosis of diffuse cutaneous scleroderma presents with malignant hypertension, oliguria, hemolysis, and renal failure. Which of the following is the recommended treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Captopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Captopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Captopril (an ACE inhibitor) is the first-line treatment for scleroderma renal crisis , addressing the hypertensive emergency and improving renal function by inhibiting the renin-angiotensin system . Other antihypertensives are less effective in this specific context.&lt;/li&gt;&lt;li&gt;âž¤ Captopril&lt;/li&gt;&lt;li&gt;âž¤ first-line treatment&lt;/li&gt;&lt;li&gt;âž¤ scleroderma renal crisis&lt;/li&gt;&lt;li&gt;âž¤ renin-angiotensin system&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are effective in treating Psoriatic arthritis except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secukinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ustekinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rituximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Rituximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rituximab is not effective for psoriatic arthritis , as it targets B cells rather than the TNF-alpha , IL-17 , or IL-12/23 pathways that are central to the inflammation in PsA. Effective biologic therapies for PsA typically target cytokine-mediated pathways.&lt;/li&gt;&lt;li&gt;âž¤ Rituximab&lt;/li&gt;&lt;li&gt;âž¤ not effective&lt;/li&gt;&lt;li&gt;âž¤ psoriatic arthritis&lt;/li&gt;&lt;li&gt;âž¤ TNF-alpha&lt;/li&gt;&lt;li&gt;âž¤ IL-17&lt;/li&gt;&lt;li&gt;âž¤ IL-12/23&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A stale potato curry causes severe gastroenteritis in a picnic group. A 36-year-old man recovers from the diarrhea, but 2 weeks later develops arthritis in his right knee and severe left-sided Achilles tendinitis. What is the most likely organism implicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C. jejuni&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S. flexneri&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;H. pylori&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C. difficile&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S. flexneri&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) S. flexneri&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ S. flexneri is the most likely organism implicated in a case of reactive arthritis following a gastrointestinal infection, presenting with joint inflammation and tendinitis.&lt;/li&gt;&lt;li&gt;âž¤ S. flexneri&lt;/li&gt;&lt;li&gt;âž¤ reactive arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is incorrect with regards to allopurinol in gout?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allopurinol should not be used with Colchicine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allopurinol dosing should be adjusted for renal function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allopurinol dosing should be titrated to a S. UA &amp;lt; 6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allopurinol hypersensitivity is associated with HLA B5801&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Allopurinol should not be used with Colchicine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Allopurinol should not be used with Colchicine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The incorrect statement is \&quot;Allopurinol should not be used with Colchicine,\&quot; as Colchicine is commonly co-prescribed with Allopurinol to prevent gout flares during the initiation of treatment.&lt;/li&gt;&lt;li&gt;âž¤ \&quot;Allopurinol should not be used with Colchicine,\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Colchicine&lt;/li&gt;&lt;li&gt;âž¤ Allopurinol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Management of Hepatorenal Syndrome includes all EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Volume expansion with IV albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuresis with furosemide + spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Midodrine and octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Referral to liver transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Diuresis with furosemide + spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Diuresis with furosemide + spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In hepatorenal syndrome , diuretics like furosemide and spironolactone are contraindicated as they can worsen renal hypoperfusion. The primary treatment involves volume expansion with IV albumin , vasoactive agents (e.g., midodrine and octreotide ), and consideration of liver transplantation for definitive management.&lt;/li&gt;&lt;li&gt;âž¤ hepatorenal syndrome&lt;/li&gt;&lt;li&gt;âž¤ diuretics&lt;/li&gt;&lt;li&gt;âž¤ furosemide and spironolactone&lt;/li&gt;&lt;li&gt;âž¤ contraindicated&lt;/li&gt;&lt;li&gt;âž¤ volume expansion with IV albumin&lt;/li&gt;&lt;li&gt;âž¤ vasoactive agents&lt;/li&gt;&lt;li&gt;âž¤ midodrine and octreotide&lt;/li&gt;&lt;li&gt;âž¤ liver transplantation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is false with regards to Klinefelterâ€™s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Androgen supplementation is useful&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients are at increased risk for breast tumors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduced plasma estrogen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most cases are diagnosed after puberty&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduced plasma estrogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reduced plasma estrogen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The statement \&quot;Reduced plasma estrogen\&quot; is false in Klinefelter&#x27;s syndrome , as patients have increased estrogen levels due to testicular failure . Testosterone therapy is beneficial, and there is an increased risk of breast cancer in these patients. Most cases are diagnosed after puberty.&lt;/li&gt;&lt;li&gt;âž¤ \&quot;Reduced plasma estrogen\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Klinefelter&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ increased estrogen levels&lt;/li&gt;&lt;li&gt;âž¤ testicular failure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has neurosurgery for a pituitary tumor that requires resection of the gland. Which of the following functions of the adrenal gland will be preserved postoperatively?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Morning peak of plasma cortisol level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Release of cortisol in response to stress&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium retention in response to hypovolemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Synthesis of adrenal sex steroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sodium retention in response to hypovolemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Sodium retention in response to hypovolemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The adrenal glandâ€™s ability to retain sodium in response to hypovolemia is preserved post-pituitary resection because it is governed by the renin-angiotensin-aldosterone system (RAAS) , which does not depend on ACTH . However, functions dependent on ACTH , such as cortisol production and adrenal androgen synthesis , will be compromised.&lt;/li&gt;&lt;li&gt;âž¤ sodium&lt;/li&gt;&lt;li&gt;âž¤ hypovolemia&lt;/li&gt;&lt;li&gt;âž¤ renin-angiotensin-aldosterone system (RAAS)&lt;/li&gt;&lt;li&gt;âž¤ ACTH&lt;/li&gt;&lt;li&gt;âž¤ ACTH&lt;/li&gt;&lt;li&gt;âž¤ cortisol production&lt;/li&gt;&lt;li&gt;âž¤ adrenal androgen synthesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is true regarding the management of pheochromocytoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î²-blockers are contraindicated in pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salt and fluid intake should be restricted&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV phentolamine is indicated for hypertensive crisis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgery is rarely required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV phentolamine is indicated for hypertensive crisis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IV phentolamine is indicated for hypertensive crisis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In pheochromocytoma , IV phentolamine is the first-line treatment for a hypertensive crisis . While beta-blockers can be used, they should only be given after alpha-blockade to avoid unopposed alpha stimulation. Surgery is the definitive treatment , and salt and fluid restriction should be avoided to prevent postoperative hypotension.&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ IV phentolamine&lt;/li&gt;&lt;li&gt;âž¤ hypertensive crisis&lt;/li&gt;&lt;li&gt;âž¤ after alpha-blockade&lt;/li&gt;&lt;li&gt;âž¤ definitive treatment&lt;/li&gt;&lt;li&gt;âž¤ salt and fluid restriction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old female develops eye pain and reduced visual acuity following the initiation of treatment for her recently diagnosed Graves&#x27; disease. Which one of the following treatments is likely to have been started?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radioactive Iodine Ablation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thyroidectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbimazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Radioactive Iodine Ablation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Radioactive Iodine Ablation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Radioactive iodine ablation is associated with an increased risk of worsening Graves&#x27; orbitopathy , especially in patients with existing eye symptoms. It is important to consider the risks of exacerbating eye problems when selecting treatment for patients with Graves&#x27; disease who have orbital involvement.&lt;/li&gt;&lt;li&gt;âž¤ Radioactive iodine ablation&lt;/li&gt;&lt;li&gt;âž¤ Graves&#x27; orbitopathy&lt;/li&gt;&lt;li&gt;âž¤ Graves&#x27; disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is the characteristic pattern seen in Brown-Sequard syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contralateral loss of joint sense and position&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Contralateral loss of pain sensation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ipsilateral loss of complete sensory functions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Contralateral motor function loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Contralateral loss of pain sensation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Contralateral loss of pain sensation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Brown-Sequard syndrome , the classic characteristic is contralateral loss of pain and temperature sensation due to damage to the spinothalamic tract and ipsilateral loss of motor function and proprioception below the level of the lesion.&lt;/li&gt;&lt;li&gt;âž¤ Brown-Sequard syndrome&lt;/li&gt;&lt;li&gt;âž¤ contralateral loss of pain and temperature sensation&lt;/li&gt;&lt;li&gt;âž¤ spinothalamic tract&lt;/li&gt;&lt;li&gt;âž¤ ipsilateral loss of motor function and proprioception&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with thalassemia has a history of multiple blood transfusions, iron overload, and cardiac arrhythmia. She has now come for a blood transfusion and during the process, complains of backache and looks very anxious. What would you do next?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stop the blood transfusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continue the transfusion but do an ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stop the transfusion and wait for the patient to become normal to start it again&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Do a clerical check and get an ECG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stop the blood transfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Stop the blood transfusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In any suspected acute transfusion reaction , such as in the case of backache and anxiety during a blood transfusion, the immediate step is to stop the transfusion to prevent further complications, followed by investigations to confirm the cause of the reaction.&lt;/li&gt;&lt;li&gt;âž¤ suspected acute transfusion reaction&lt;/li&gt;&lt;li&gt;âž¤ backache&lt;/li&gt;&lt;li&gt;âž¤ anxiety&lt;/li&gt;&lt;li&gt;âž¤ immediate step&lt;/li&gt;&lt;li&gt;âž¤ stop the transfusion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has recurrent optic neuritis of both eyes with extensive transverse myelitis. Visual acuity in the right eye is 6/60 and visual acuity in the left eye 6/18. The patient showed a partial response to steroids. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neuromyelitis optica&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute combined degeneration of spinal cord&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neurosyphilis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Neuromyelitis optica&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Neuromyelitis optica&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neuromyelitis optica (NMO) presents with recurrent bilateral optic neuritis and extensive transverse myelitis . It often requires more aggressive immunosuppressive therapy beyond steroids and is distinguished from multiple sclerosis by the pattern of spinal cord involvement and optic neuritis.&lt;/li&gt;&lt;li&gt;âž¤ Neuromyelitis optica (NMO)&lt;/li&gt;&lt;li&gt;âž¤ recurrent bilateral optic neuritis&lt;/li&gt;&lt;li&gt;âž¤ extensive transverse myelitis&lt;/li&gt;&lt;li&gt;âž¤ multiple sclerosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old man with a diagnosis of acute myeloid leukemia with a blood type O negative presents to the transplant clinic to discuss proceeding with an allogeneic stem cell transplant. Which of the following would be an optimal donor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;His identical twin brother&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Umbilical cord transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;An HLA identical matched unrelated donor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;His HLA identical 50-year-old brother&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. His HLA identical 50-year-old brother&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) His HLA identical 50-year-old brother&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The optimal donor for an allogeneic stem cell transplant is typically an HLA identical sibling , as this provides the best balance between minimizing the risk of complications (such as graft-versus-host disease) and maintaining the graft-versus-leukemia effect. An HLA identical sibling is the preferred choice over unrelated donors or umbilical cord transplants.&lt;/li&gt;&lt;li&gt;âž¤ optimal donor&lt;/li&gt;&lt;li&gt;âž¤ HLA identical sibling&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young child presented with nocturnal chest pain and a history of syncope, has the ECG shown below. What is the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HOCM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brugada syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DCM&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Brugada syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102826.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Brugada syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brugada syndrome presents with characteristic ST-segment elevation in leads V1-V3 and is associated with a risk of sudden cardiac death due to ventricular arrhythmias. It should be suspected in young individuals with syncope and nocturnal chest pain, especially if these characteristic ECG findings are present.&lt;/li&gt;&lt;li&gt;âž¤ Brugada syndrome&lt;/li&gt;&lt;li&gt;âž¤ ST-segment elevation in leads V1-V3&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An old man presents with dyspnea and swelling of his feet. On examination, rales are heard and he is found to have an enlarged heart on chest x-ray. Which of the following will delay the progression?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vericiguat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Captopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Captopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with heart failure, Captopril (an ACE inhibitor) delays disease progression by reducing ventricular remodeling, afterload, and the progression of heart failure. It is a key drug that improves survival, unlike diuretics or digoxin, which mainly provide symptom relief.&lt;/li&gt;&lt;li&gt;âž¤ Captopril (an ACE inhibitor)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old with a history of COPD is brought to the ER with worsening dyspnea. ABG was done and pH was 7.3, pCO2 was 60 mmHg with HCO3- being 28 mEq/L. Which of the following is seen in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Respiratory acidosis, hyperventilation, inadequate metabolic compensation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory alkalosis, hypoventilation, inadequate metabolic compensation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Respiratory acidosis, hypoventilation, inadequate metabolic compensation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory acidosis, hypoventilation, adequate metabolic compensation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Respiratory acidosis, hypoventilation, inadequate metabolic compensation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Respiratory acidosis, hypoventilation, inadequate metabolic compensation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The patient with COPD presents with respiratory acidosis due to hypoventilation and inadequate metabolic compensation , which is expected in an acute or decompensated state. The pH of 7.3 and pCO2 of 60 mmHg confirm the diagnosis of respiratory acidosis, and the mildly elevated bicarbonate (HCO3-) suggests that compensation is incomplete.&lt;/li&gt;&lt;li&gt;âž¤ respiratory acidosis due to hypoventilation&lt;/li&gt;&lt;li&gt;âž¤ inadequate metabolic compensation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the diagnosis in the ECG shown below?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;First degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Third degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Wenckebach heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mobitz type 2 block&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mobitz type 2 block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102855.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mobitz type 2 block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mobitz type 2 block is characterized by a constant PR interval with intermittent dropped QRS complexes and grouped beats. It is a more severe type of AV block compared to Wenckebach and often requires pacemaker insertion due to the risk of progressing to complete heart block.&lt;/li&gt;&lt;li&gt;âž¤ Mobitz type 2 block&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old female presents to the ER with menorrhagia. She mentions that her father and sister also suffer from bleeding disorders. Which of the following is likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor X deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Factor VIII deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Factor IX deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Von Willebrand Disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Von Willebrand Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Von Willebrand Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, presenting with mucosal bleeding like menorrhagia, and it affects both males and females due to its autosomal dominant inheritance pattern.&lt;/li&gt;&lt;li&gt;âž¤ Von Willebrand Disease (VWD)&lt;/li&gt;&lt;li&gt;âž¤ autosomal dominant&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman comes with complaints of hyperpigmentation of her palms after an adrenalectomy. She also has new onset vision deficits. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nelson syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sheehan syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Conn&#x27;s syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Addisonâ€™s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nelson syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nelson syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nelson syndrome is characterized by hyperpigmentation and visual disturbances following bilateral adrenalectomy due to the unregulated growth of an ACTH-secreting pituitary adenoma.&lt;/li&gt;&lt;li&gt;âž¤ Nelson syndrome&lt;/li&gt;&lt;li&gt;âž¤ hyperpigmentation&lt;/li&gt;&lt;li&gt;âž¤ visual disturbances&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common cause of hypercalcemia in hospitalized patients is -&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Malignancy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin D toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Familial hypocalciuric hypercalcemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Malignancy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Malignancy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Malignancy is the most common cause of hypercalcemia in hospitalized patients due to mechanisms like PTHrP secretion , osteolytic metastases , or increased calcitriol production .&lt;/li&gt;&lt;li&gt;âž¤ Malignancy&lt;/li&gt;&lt;li&gt;âž¤ hypercalcemia&lt;/li&gt;&lt;li&gt;âž¤ PTHrP secretion&lt;/li&gt;&lt;li&gt;âž¤ osteolytic metastases&lt;/li&gt;&lt;li&gt;âž¤ increased calcitriol production&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the ECG given below, which of the following drugs is not used in the management of the condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adenosine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102929.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Adenosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Adenosine is not used in the management of atrial fibrillation , while beta-blockers, calcium channel blockers, and amiodarone are commonly used to control the rate or rhythm in AF.&lt;/li&gt;&lt;li&gt;âž¤ Adenosine&lt;/li&gt;&lt;li&gt;âž¤ atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ beta-blockers, calcium channel blockers, and amiodarone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is seen in MEN 2B syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cafe au lait spot&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medullary thyroid carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Parathyroid adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Optic nerve glioma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Medullary thyroid carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Medullary thyroid carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma is a key feature of MEN 2B syndrome , while cafe au lait spots, parathyroid adenoma, and optic nerve glioma are associated with other genetic disorders, particularly neurofibromatosis or MEN 1/2A .&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ MEN 2B syndrome&lt;/li&gt;&lt;li&gt;âž¤ cafe au lait spots, parathyroid adenoma, and optic nerve glioma&lt;/li&gt;&lt;li&gt;âž¤ neurofibromatosis&lt;/li&gt;&lt;li&gt;âž¤ MEN 1/2A&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A physician reviewed a patientâ€™s chest X-ray and diagnosed COPD. The patientâ€™s room air SaO2 is 88% and paO2 is 54 mm Hg. Which of the following will improve survival?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LAMA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary rehabilitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Supplemental O2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhaled Corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Supplemental O2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Supplemental O2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with COPD and significant hypoxemia , the intervention that has been shown to improve survival is long-term supplemental oxygen therapy .&lt;/li&gt;&lt;li&gt;âž¤ COPD&lt;/li&gt;&lt;li&gt;âž¤ hypoxemia&lt;/li&gt;&lt;li&gt;âž¤ improve survival&lt;/li&gt;&lt;li&gt;âž¤ long-term supplemental oxygen therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is brought to the OPD by his wife who reports that he has difficulty expressing emotions. On examination, resting tremors and rigidity are present. Which part of the brain among the following options is primarily affected in this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Basal Ganglia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Substantia Nigra&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hippocampus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Substantia Nigra&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Substantia Nigra&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Parkinson&#x27;s disease , the primary site of pathology is the substantia nigra , where the loss of dopaminergic neurons leads to the characteristic motor symptoms such as resting tremors , rigidity , and bradykinesia .&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ substantia nigra&lt;/li&gt;&lt;li&gt;âž¤ resting tremors&lt;/li&gt;&lt;li&gt;âž¤ rigidity&lt;/li&gt;&lt;li&gt;âž¤ bradykinesia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with sensory loss and weakness of limbs for 3 months. He also has angular stomatitis. On examination, there is loss of proprioception and vibration sensations, UMN-type weakness of the lower limbs, and absent ankle reflexes. What is the probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyotrophic Lateral Sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple Sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intramedullary tumour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subacute combined degeneration of the cord&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Subacute combined degeneration of the cord&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Subacute combined degeneration of the cord&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Subacute combined degeneration of the cord due to vitamin B12 deficiency is characterized by loss of proprioception , vibration sensation , UMN-type weakness , and absent reflexes , along with other signs of nutritional deficiency like angular stomatitis .&lt;/li&gt;&lt;li&gt;âž¤ Subacute combined degeneration of the cord&lt;/li&gt;&lt;li&gt;âž¤ vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;âž¤ loss of proprioception&lt;/li&gt;&lt;li&gt;âž¤ vibration sensation&lt;/li&gt;&lt;li&gt;âž¤ UMN-type weakness&lt;/li&gt;&lt;li&gt;âž¤ absent reflexes&lt;/li&gt;&lt;li&gt;âž¤ angular stomatitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young female presented with wheezing and shortness of breath with the use of accessory muscles. She complains of similar episodes in the past in early mornings. Spirometry findings are as follows: FEV1/FVC ratio &amp;lt; 0.7 and FEV1 &amp;lt; 80% of the predicted value in a female patient.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interstitial Lung Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic Pulmonary Fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Silicosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Asthma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Asthma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Asthma typically presents with wheezing , reversible airflow obstruction , and diurnal variation, such as worsening symptoms in the early morning . Spirometry reveals an FEV1/FVC ratio &amp;lt; 0.7 and a decreased FEV1 indicative of obstructive lung disease.&lt;/li&gt;&lt;li&gt;âž¤ wheezing&lt;/li&gt;&lt;li&gt;âž¤ reversible airflow obstruction&lt;/li&gt;&lt;li&gt;âž¤ worsening symptoms in the early morning&lt;/li&gt;&lt;li&gt;âž¤ FEV1/FVC ratio &amp;lt; 0.7&lt;/li&gt;&lt;li&gt;âž¤ decreased FEV1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient having hypertension, is on thiazides and is complaining of fatigue and hypokalemia. Which of the following drug can prevent potassium loss?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Indapamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Amiloride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Amiloride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amiloride , a potassium-sparing diuretic , can be used to prevent potassium loss in patients taking thiazide diuretics for hypertension, as it inhibits potassium excretion.&lt;/li&gt;&lt;li&gt;âž¤ Amiloride&lt;/li&gt;&lt;li&gt;âž¤ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;âž¤ potassium loss&lt;/li&gt;&lt;li&gt;âž¤ thiazide diuretics&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with hemolytic anemia presents with index finger pain and chest pain. The patient has Hb of 5.6 gm/dl and an increase in unconjugated bilirubin in serum. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Microangiopathic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sickling crisis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Autoimmune hemolytic anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sickling crisis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sickling crisis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell crisis (sickling crisis) is characterized by acute pain due to vaso-occlusive episodes affecting bones and organs, such as dactylitis and acute chest syndrome. These crises are accompanied by hemolytic anemia and elevated unconjugated bilirubin levels due to increased RBC destruction.&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell crisis&lt;/li&gt;&lt;li&gt;âž¤ acute pain&lt;/li&gt;&lt;li&gt;âž¤ vaso-occlusive episodes&lt;/li&gt;&lt;li&gt;âž¤ hemolytic anemia&lt;/li&gt;&lt;li&gt;âž¤ unconjugated bilirubin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient came to the emergency with severe breathlessness. CXR is taken and shown below. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pneumothorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Consolidation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Collapse&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural effusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Collapse&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture4_U8DIyUl.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Collapse&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In lung collapse (atelectasis) , the key features include tracheal shift towards the side of the collapse and hyperinflation of the contralateral lung . These findings, along with an opaque hemithorax, help differentiate collapse from other conditions like pneumothorax and pleural effusion.&lt;/li&gt;&lt;li&gt;âž¤ lung collapse (atelectasis)&lt;/li&gt;&lt;li&gt;âž¤ tracheal shift towards the side of the collapse&lt;/li&gt;&lt;li&gt;âž¤ hyperinflation of the contralateral lung&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the likely ECG change associated with Fluroquinolones?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;QT prolongation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PR prolongation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ST elevation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Wide QRS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. QT prolongation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) QT prolongation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fluoroquinolones, such as levofloxacin and ciprofloxacin, are associated with QT interval prolongation , which can predispose patients to potentially serious arrhythmias like Torsades de Pointes, especially in individuals with predisposing conditions.&lt;/li&gt;&lt;li&gt;âž¤ QT interval prolongation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Reiterâ€™s syndrome is associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HLA B51&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HLA B27&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HLA DR4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HLA B8&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. HLA B27&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) HLA B27&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Reiterâ€™s syndrome (reactive arthritis) is strongly associated with HLA-B27 , a genetic marker found in many patients with seronegative spondyloarthropathies.&lt;/li&gt;&lt;li&gt;âž¤ Reiterâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ HLA-B27&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A person is admitted in hospital with history of stroke. He is unable to understand what his friend is talking but he is speaking fluently. Which part of brain is most likely to be injured in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wernicke&#x27;s area&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Broca&#x27;s area&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Angular gyrus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arcuate Fasciculus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Wernicke&#x27;s area&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Wernicke&#x27;s area&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What will be the most common karyotype of a patient with primary amenorrhea?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;46XXY&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;45XX&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;45X0&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;46XY&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 45X0&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 45X0&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common karyotype associated with primary amenorrhea is 45X0 , which is seen in Turner syndrome .&lt;/li&gt;&lt;li&gt;âž¤ primary amenorrhea&lt;/li&gt;&lt;li&gt;âž¤ 45X0&lt;/li&gt;&lt;li&gt;âž¤ Turner syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old patient with history of mitral valve replacement on anticoagulation with warfarin is about to undergo hernioplasty for inguinal hernia. What is the target INR prior to surgery?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.5-0.8&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 1.5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1.5-2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2-3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. &lt; 1.5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) &amp;lt; 1.5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For patients on warfarin who are undergoing elective surgery, the target INR prior to surgery should be less than 1.5 to minimize bleeding risk.&lt;/li&gt;&lt;li&gt;âž¤ warfarin&lt;/li&gt;&lt;li&gt;âž¤ less than 1.5&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with fatigue, pallor. Investigations show Hb = 5.8 gm/dl, low MCV, low ferritin, high TIBC, and high RDW. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron Deficiency Anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Megaloblastic Anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anemia of Chronic Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sideroblastic Anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Iron Deficiency Anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Iron Deficiency Anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Iron deficiency anemia is characterized by low hemoglobin , low MCV , low ferritin , high TIBC , and high RDW , which together point towards iron deficiency as the cause of the anemia.&lt;/li&gt;&lt;li&gt;âž¤ Iron deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ low hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ low MCV&lt;/li&gt;&lt;li&gt;âž¤ low ferritin&lt;/li&gt;&lt;li&gt;âž¤ high TIBC&lt;/li&gt;&lt;li&gt;âž¤ high RDW&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A chronic alcoholic presented with pruritic eczematous rash on the neck and dorsum of the hands. What is the likely nutritional deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin B3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Vitamin B3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Vitamin B3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A pruritic, photosensitive rash in a chronic alcoholic is most suggestive of pellagra , which results from Vitamin B3 (Niacin) deficiency. Alcoholism is a known risk factor for this deficiency.&lt;/li&gt;&lt;li&gt;âž¤ pellagra&lt;/li&gt;&lt;li&gt;âž¤ Vitamin B3 (Niacin)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient was given 0.5% bupivacaine for a supraclavicular brachial plexus block and suddenly developed hypotension and arrhythmias. Which of the following is the 1st line of management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20% IV Intralipid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Soda Bicarbonate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 20% IV Intralipid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 20% IV Intralipid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of bupivacaine toxicity resulting in cardiovascular complications like hypotension and arrhythmias, 20% IV Intralipid is the first-line therapy. It acts by sequestering the local anesthetic, thereby reducing its toxicity to the heart and other organs.&lt;/li&gt;&lt;li&gt;âž¤ bupivacaine toxicity&lt;/li&gt;&lt;li&gt;âž¤ 20% IV Intralipid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with suspected tuberculosis underwent CBNAAT testing and is started on HRZE. CBNAAT is helpful for which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mycobacterium tuberculosis (MTB)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MTB + Rifampicin resistance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MTB + Isoniazid resistance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MTB + Ethambutol and Rifampicin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MTB + Rifampicin resistance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) MTB + Rifampicin resistance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CBNAAT is a valuable tool for detecting Mycobacterium tuberculosis and rifampicin resistance , but it does not provide information on resistance to other drugs like isoniazid or ethambutol. For broader drug resistance testing, other methods such as line probe assays are required.&lt;/li&gt;&lt;li&gt;âž¤ CBNAAT&lt;/li&gt;&lt;li&gt;âž¤ Mycobacterium tuberculosis&lt;/li&gt;&lt;li&gt;âž¤ rifampicin resistance&lt;/li&gt;&lt;li&gt;âž¤ line probe assays&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant female who is a known case of bronchial asthma presented to hospital with blood pressure of 210/110 mm Hg. Which of the following is the preferred drug for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ramipril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nifedipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nifedipine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In pregnant women with hypertension and a history of bronchial asthma , Nifedipine is the preferred treatment as it effectively lowers blood pressure without causing bronchospasm, while beta-blockers like labetalol and ACE inhibitors like ramipril are contraindicated.&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ Nifedipine&lt;/li&gt;&lt;li&gt;âž¤ beta-blockers&lt;/li&gt;&lt;li&gt;âž¤ labetalol&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ ramipril&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In primary accidental hypothermia, what is the usual rate of rewarming with passive external rewarming?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.5-1Â°C per hour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;0.5-1Â°C per 2 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;0.5-2Â°C per hour&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;0.5-2Â°C per 4 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 0.5-2Â°C per hour&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 0.5-2Â°C per hour&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The usual rate of rewarming with passive external rewarming in primary accidental hypothermia is 0.5-2Â°C per hour , allowing the body to generate its own heat and recover gradually.&lt;/li&gt;&lt;li&gt;âž¤ passive external rewarming&lt;/li&gt;&lt;li&gt;âž¤ primary accidental hypothermia&lt;/li&gt;&lt;li&gt;âž¤ 0.5-2Â°C per hour&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following when consumed with oral iron reduces its absorption?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lemon juice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amla juice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tea&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sprouts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tea&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tea consumption along with oral iron can reduce its absorption due to the presence of tannins, whereas foods rich in vitamin C, such as lemon or amla juice, enhance iron absorption.&lt;/li&gt;&lt;li&gt;âž¤ Tea&lt;/li&gt;&lt;li&gt;âž¤ reduce its absorption&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patient after road traffic accident was brought to the emergency. His pulse rate was 50 beats per minute, Blood pressure was 80/ 60 mm of Hg. On evaluation his ECG was normal, eFAST was negative and chest X-Ray was normal. This status of patient could be best classified under which type of shock?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemorrhagic shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiogenic shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neurogenic shock&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaphylactic shock&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neurogenic shock&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neurogenic shock&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neurogenic shock is characterized by bradycardia and hypotension in the absence of blood loss or cardiac issues, often following trauma, particularly spinal injury.&lt;/li&gt;&lt;li&gt;âž¤ Neurogenic shock&lt;/li&gt;&lt;li&gt;âž¤ bradycardia&lt;/li&gt;&lt;li&gt;âž¤ hypotension&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;CT scan given in the image is suggestive of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Extradural hematoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subdural hematoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subarachnoid haemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intraparenchymal hemorrhage&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Subdural hematoma&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture5_0OorTav.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Subdural hematoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A crescent-shaped hyperdense lesion on a CT scan is characteristic of a subdural hematoma , typically resulting from venous bleeding following trauma.&lt;/li&gt;&lt;li&gt;âž¤ crescent-shaped hyperdense lesion&lt;/li&gt;&lt;li&gt;âž¤ subdural hematoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the lesion in the chest X-ray:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Septic emboli&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannon ball metastases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung abscess&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cannon ball metastases&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture6_2cDz386.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cannon ball metastases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cannon ball metastases are large, round nodules seen in both lung fields on a chest X-ray and are associated with metastatic cancer, most commonly from renal cell carcinoma and other malignancies.&lt;/li&gt;&lt;li&gt;âž¤ Cannon ball metastases&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Plasmodium species that commonly cause Membranous nephropathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vivax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Falciparum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malariae&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ovale&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Malariae&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Malariae&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Plasmodium malariae is the species most commonly linked to membranous nephropathy in malaria-endemic regions, causing immune complex-mediated kidney damage leading to nephrotic syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Plasmodium malariae&lt;/li&gt;&lt;li&gt;âž¤ membranous nephropathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month-old pregnant female presented with vivax malaria. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloroquine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Artemisinin Combination Therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chloroquine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chloroquine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For the treatment of Plasmodium vivax malaria in early pregnancy, chloroquine is the drug of choice due to its safety profile for both the mother and fetus.&lt;/li&gt;&lt;li&gt;âž¤ chloroquine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What adverse effect is NOT seen with amiodarone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gynaecomastia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gynaecomastia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gynaecomastia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone is associated with multiple adverse effects, including thyroid dysfunction (both hypo- and hyperthyroidism) and pulmonary fibrosis. Gynaecomastia is not a typical side effect of amiodarone.&lt;/li&gt;&lt;li&gt;âž¤ Gynaecomastia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A schizophrenic patient after receiving haloperidol developed torticollis and dystonia. What will be the best drug in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase haloperidol dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Change haloperidol to clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Give benzhexol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Change haloperidol to fluphenazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Give benzhexol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Give benzhexol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The best treatment for acute dystonia caused by typical antipsychotics like haloperidol is to administer an anticholinergic medication such as benzhexol (trihexyphenidyl) , which can quickly relieve the symptoms.&lt;/li&gt;&lt;li&gt;âž¤ acute dystonia&lt;/li&gt;&lt;li&gt;âž¤ anticholinergic medication&lt;/li&gt;&lt;li&gt;âž¤ benzhexol (trihexyphenidyl)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the pathology from the given flow-volume loop:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fixed distal airway obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fixed central airway obstruction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Variable intrathoracic obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Variable extrathoracic obstruction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fixed central airway obstruction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture7_eiyU3Em.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fixed central airway obstruction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A flow-volume loop showing flattening of both the inspiratory and expiratory limbs indicates a fixed central airway obstruction , which can be caused by tracheal stenosis or large airway tumors.&lt;/li&gt;&lt;li&gt;âž¤ flow-volume loop&lt;/li&gt;&lt;li&gt;âž¤ fixed central airway obstruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the urinary crystal shown below:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium oxalate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Calcium phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uric acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cysteine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Calcium oxalate&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture8_ZxDEfqE.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Calcium oxalate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Calcium oxalate crystals have a distinct envelope shape and are commonly found in various urinary conditions, particularly in patients with kidney stones.&lt;/li&gt;&lt;li&gt;âž¤ envelope shape&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man suddenly developed right-sided weakness and aphasia within 2 hours. His BP recorded was 160/100 mmHg and NCCT was normal. What is the next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT angiography to look for large vessel occlusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MRI to look for infarct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tab labetalol 10 mg stat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombolysis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Thrombolysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Thrombolysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with acute ischemic stroke presenting within the therapeutic window and a normal NCCT, thrombolysis is the immediate next step in management, aiming to restore blood flow and improve outcomes.&lt;/li&gt;&lt;li&gt;âž¤ thrombolysis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For the diagnosis of resistant hypertension, the patient should have uncontrolled hypertension despite taking three antihypertensive drugs. This should include at least one:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium channel blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alpha blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diuretic&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diuretic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diuretic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a diagnosis of resistant hypertension , the patient must have uncontrolled blood pressure despite taking three antihypertensive agents, including at least one diuretic .&lt;/li&gt;&lt;li&gt;âž¤ resistant hypertension&lt;/li&gt;&lt;li&gt;âž¤ one diuretic&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 160 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test2" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D   Mission 1.5, Lap 2   04 06 2024   2024 06 04&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D   Mission 1.5, Lap 2   04 06 2024   2024 06 04&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following findings are seen in patients with stable angina?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â†‘TropI â†‘Myoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â†‘CKMB, Normal Trop I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â†‘Myoglobin, Normal CK-MB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal cardiac enzymes&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Normal cardiac enzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Normal cardiac enzymes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Stable angina is associated with normal cardiac enzymes because there is no myocardial injury or necrosis in this condition.&lt;/li&gt;&lt;li&gt;âž¤ normal cardiac enzymes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the maximum predicted heart rate in a 45-year-old gentleman on exercise tolerance test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;165/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;175/min&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;185/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;195/min&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 175/min&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) 175/min&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The maximum predicted heart rate during exercise is calculated as 220 minus the person&#x27;s age . For a 45-year-old, the MHR is 175 beats per minute .&lt;/li&gt;&lt;li&gt;âž¤ maximum predicted heart rate&lt;/li&gt;&lt;li&gt;âž¤ 220 minus the person&#x27;s age&lt;/li&gt;&lt;li&gt;âž¤ 175 beats per minute&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements regarding myocardial stunning are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stunning is a state of depressed myocardial function due to chronic hypoperfusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stunning can be global or regional&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen free radicals and excess intracellular calcium likely contribute to stunning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stunning affects both systolic and diastolic function&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stunning is a state of depressed myocardial function due to chronic hypoperfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Stunning is a state of depressed myocardial function due to chronic hypoperfusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myocardial stunning occurs after acute ischemic injury or reperfusion and is not associated with chronic hypoperfusion . It involves temporary, reversible dysfunction of the heart muscle without permanent damage.&lt;/li&gt;&lt;li&gt;âž¤ acute ischemic injury&lt;/li&gt;&lt;li&gt;âž¤ reperfusion&lt;/li&gt;&lt;li&gt;âž¤ not associated with chronic hypoperfusion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the earliest finding in patient with suspect acute MI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prolonged QT interval&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tall T wave&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Terminal QRS Distortion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ST depression&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tall T wave&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â  B) Tall T wave&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The earliest ECG finding in acute MI is typically the tall, peaked T wave , which reflects early ischemic changes.&lt;/li&gt;&lt;li&gt;âž¤ earliest ECG finding in acute MI&lt;/li&gt;&lt;li&gt;âž¤ tall, peaked T wave&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old is brought to the ER with sudden onset chest pain, diaphoresis, and giddiness. On arrival, BP is 86/60 mmHg. Immediate ECG is performed (see image). Which of the following is useful in the management of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sublingual nitrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV nitrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV fluids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. IV fluids&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-105622.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â  D) IV fluids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of inferior MI with associated right ventricular infarction , avoid preload-reducing agents like nitrates or morphine. IV fluids are the first-line treatment to support preload and maintain cardiac output in hypotensive patients.&lt;/li&gt;&lt;li&gt;âž¤ inferior MI with associated right ventricular infarction&lt;/li&gt;&lt;li&gt;âž¤ IV fluids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Falsely low BNP values can be seen in which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Advanced age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Female gender&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoking&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Obesity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Obesity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Obesity is a key condition where BNP values may be falsely low , despite the presence of heart failure symptoms, due to reduced myocardial stretch and altered hormone metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Obesity&lt;/li&gt;&lt;li&gt;âž¤ falsely low&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Risk of sudden cardiac death in heart failure is maximum among which of the following NYHA class?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Class II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with NYHA Class II heart failure have the highest proportion of sudden cardiac death due to ventricular arrhythmias, even though total mortality is higher in more severe classes like Class IV.&lt;/li&gt;&lt;li&gt;âž¤ NYHA Class II&lt;/li&gt;&lt;li&gt;âž¤ proportion of sudden cardiac death&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following disorders is characterized by myocyte disarray on myocardial biopsy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fabry disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Keshan&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypereosinophilic syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fabry disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â  A) Fabry disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fabry disease is associated with myocyte disarray on myocardial biopsy and causes reversible hypertrophic cardiomyopathy . It is important to differentiate this condition from other types of cardiomyopathies based on its clinical presentation and pathology.&lt;/li&gt;&lt;li&gt;âž¤ Fabry disease&lt;/li&gt;&lt;li&gt;âž¤ myocyte disarray&lt;/li&gt;&lt;li&gt;âž¤ reversible hypertrophic cardiomyopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Brockenbrough-Braunwald-Morrow sign is seen in which of the following condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertrophic Cardiomyopathy (HCM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dilated Cardiomyopathy (DCM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Restrictive cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Takotsubo cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypertrophic Cardiomyopathy (HCM)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Hypertrophic Cardiomyopathy (HCM)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Brockenbrough-Braunwald-Morrow sign is a diagnostic hallmark of hypertrophic cardiomyopathy (HCM) and reflects the hemodynamic effects of left ventricular outflow tract obstruction following premature ventricular contractions.&lt;/li&gt;&lt;li&gt;âž¤ Brockenbrough-Braunwald-Morrow sign&lt;/li&gt;&lt;li&gt;âž¤ hypertrophic cardiomyopathy (HCM)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male with Marfans syndrome developed worsening chest pain and dyspnea. On examination asymmetrical pulses was noted. CXR showed widened mediastinum. CT angiogram was done to evaluate this patient. Which of the following is true regarding management of the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Operative repair indicated if diameter &amp;gt;5.5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Operative repair if diameter &amp;gt;4-5 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Operative repair if diameter&amp;gt;6 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Operative repair if diameter &amp;gt;4.5 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Operative repair if diameter &gt;4-5 cm&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-110835.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Operative repair if diameter &amp;gt;4-5 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with Marfan syndrome , operative repair of the aorta is generally recommended when the aortic diameter reaches 4 to 5 cm to prevent aortic dissection, a life-threatening complication of the condition.&lt;/li&gt;&lt;li&gt;âž¤ Marfan syndrome&lt;/li&gt;&lt;li&gt;âž¤ operative repair of the aorta&lt;/li&gt;&lt;li&gt;âž¤ 4 to 5 cm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the likely cardiac axis marked A in the image given below?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right axis deviation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left axis deviation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extreme axis deviation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Physiological left axis deviation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Right axis deviation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-111250.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Right axis deviation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The cardiac axis labeled A represents right axis deviation , which falls between +90Â° and +180Â° on the cardiac axis circle.&lt;/li&gt;&lt;li&gt;âž¤ cardiac axis labeled A&lt;/li&gt;&lt;li&gt;âž¤ right axis deviation&lt;/li&gt;&lt;li&gt;âž¤ +90Â° and +180Â°&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;40-year-old on anti-depressants presented with giddiness and fatigue. On arrival Bp 80/60mmhg. ECG done showed the following. Which of the following drugs is appropriate in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antiarrhythmics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous sodium bicarbonate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous sodium bicarbonate&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-111447.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Intravenous sodium bicarbonate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of tricyclic antidepressant (TCA) toxicity , with signs such as ventricular arrhythmias and wide QRS complexes , the drug of choice for management is intravenous sodium bicarbonate .&lt;/li&gt;&lt;li&gt;âž¤ tricyclic antidepressant (TCA) toxicity&lt;/li&gt;&lt;li&gt;âž¤ ventricular arrhythmias&lt;/li&gt;&lt;li&gt;âž¤ wide QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ intravenous sodium bicarbonate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;40-year-old male with recent post CABG status presented with chest pain. On arrival BP was found to be 60/30mmHg with HR of 30/min. ECG showed narrow complex arrhythmia. Patient immediately received three boluses of IV atropine. While awaiting Transcutaneous pacing, which of the following is next appropriate step in the management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Another bolus of atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Norepinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Dopamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV Dopamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IV Dopamine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of severe symptomatic bradycardia unresponsive to atropine, IV dopamine or epinephrine is recommended while awaiting transcutaneous pacing. Avoid agents like norepinephrine and dobutamine in these settings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;30-year-old IT employee developed sudden loss of consciousness on listening to ambulance alarm. On arrival to ER patient was hemodynamically stable. She gives h/o similar episodes in the past. ECG done given below. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congenital Long QT type 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congenital Long QT syndrome type 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Catecholaminergic polymorphic VT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Short QT syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Congenital Long QT syndrome type 2&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-111905.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Congenital Long QT syndrome type 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Congenital Long QT syndrome type 2 is often triggered by sudden auditory stimuli and is characterized by a prolonged QT interval with arrhythmias, particularly in response to loud noises.&lt;/li&gt;&lt;li&gt;âž¤ Congenital Long QT syndrome type 2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;30-year-old male presented with episodes of palpitation. On arrival patient stable. ECG given below. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right Bundle Branch Block (RBBB)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left Bundle Branch Block (LBBB)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brugada syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Wolff-Parkinson-White (WPW) syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Brugada syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-112114.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Brugada syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brugada syndrome is characterized by a pseudo-right bundle branch block pattern and coved-type ST elevation in leads V1 to V3 , which can predispose to sudden cardiac death due to ventricular arrhythmias.&lt;/li&gt;&lt;li&gt;âž¤ Brugada syndrome&lt;/li&gt;&lt;li&gt;âž¤ pseudo-right bundle branch block&lt;/li&gt;&lt;li&gt;âž¤ coved-type ST elevation&lt;/li&gt;&lt;li&gt;âž¤ V1 to V3&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant lady, G2P1L1, currently 37 weeks pregnant, presented with worsening headache, blurring of vision, and reduced perception of fetal movements. On arrival, BP was 200/100 mmHg. The patientâ€™s ECG is given below. Which of the following is the best management for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV MgSO 4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defibrillation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV MgSO 4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-112357.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) IV MgSOâ‚„&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of torsades de pointes , particularly in the setting of preeclampsia , the best management is IV magnesium sulfate , which can effectively treat the arrhythmia and prevent further complications.&lt;/li&gt;&lt;li&gt;âž¤ torsades de pointes&lt;/li&gt;&lt;li&gt;âž¤ preeclampsia&lt;/li&gt;&lt;li&gt;âž¤ IV magnesium sulfate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a contraindication for thrombolysis in stroke?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sustained BP &amp;gt;185/110 mmHg despite treatment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastrointestinal bleeding in preceding 21 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Major surgery in preceding 14 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thrombolysis in stroke has strict contraindications, including uncontrolled hypertension (BP &amp;gt;185/110 mmHg) , recent gastrointestinal bleeding , and major surgery in the last 14 days due to the heightened risk of life-threatening bleeding.&lt;/li&gt;&lt;li&gt;âž¤ uncontrolled hypertension (BP &amp;gt;185/110 mmHg)&lt;/li&gt;&lt;li&gt;âž¤ recent gastrointestinal bleeding&lt;/li&gt;&lt;li&gt;âž¤ major surgery in the last 14 days&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are components of the ABCD2 score, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Creatinine levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Creatinine levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Creatinine levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The ABCD2 score helps assess stroke risk after a TIA and includes factors such as age , blood pressure , clinical features , duration of symptoms , and diabetes . Creatinine levels are not part of this score.&lt;/li&gt;&lt;li&gt;âž¤ ABCD2 score&lt;/li&gt;&lt;li&gt;âž¤ age&lt;/li&gt;&lt;li&gt;âž¤ blood pressure&lt;/li&gt;&lt;li&gt;âž¤ clinical features&lt;/li&gt;&lt;li&gt;âž¤ duration of symptoms&lt;/li&gt;&lt;li&gt;âž¤ diabetes&lt;/li&gt;&lt;li&gt;âž¤ Creatinine levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following strategies does not have a mortality benefit in ARDS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low tidal volume ventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High PEEP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prone ventilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Corticosteroids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In non-COVID-19 ARDS , corticosteroids do not provide a mortality benefit. In contrast, low tidal volume ventilation , high PEEP , and prone ventilation are all strategies associated with better outcomes and improved survival in ARDS.&lt;/li&gt;&lt;li&gt;âž¤ non-COVID-19 ARDS&lt;/li&gt;&lt;li&gt;âž¤ corticosteroids&lt;/li&gt;&lt;li&gt;âž¤ low tidal volume ventilation&lt;/li&gt;&lt;li&gt;âž¤ high PEEP&lt;/li&gt;&lt;li&gt;âž¤ prone ventilation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common site for hypertensive hemorrhage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thalamus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Putamen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pons&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Putamen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Putamen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The putamen is the most common site for hypertensive hemorrhage , followed by the thalamus . This is due to the vulnerability of the small blood vessels in the basal ganglia to damage from chronic hypertension.&lt;/li&gt;&lt;li&gt;âž¤ putamen&lt;/li&gt;&lt;li&gt;âž¤ hypertensive hemorrhage&lt;/li&gt;&lt;li&gt;âž¤ thalamus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old reformed smoker with COPD (GOLD Category E) presents with worsening dyspnea and cough. The patient was started on salbutamol nebulizations, IV antibiotics, and corticosteroids. Repeat ABG shows: pH: 7.25 pCO2: 60 mmHg pO2: 49.5 mmHg RR: 26/min Which is the next step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxygen with NIV&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CPAP and Oxygen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Invasive Mechanical ventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;I.V. salbutamol, morphine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oxygen with NIV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Oxygen with NIV (Non-Invasive Ventilation)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with acute hypercapnic respiratory failure due to COPD exacerbation , the next appropriate step is to initiate Non-Invasive Ventilation (NIV) with supplemental oxygen to improve gas exchange and avoid invasive mechanical ventilation if possible.&lt;/li&gt;&lt;li&gt;âž¤ acute hypercapnic respiratory failure&lt;/li&gt;&lt;li&gt;âž¤ COPD exacerbation&lt;/li&gt;&lt;li&gt;âž¤ Non-Invasive Ventilation (NIV)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Autosomal recessive inactivating mutations in Calcium Sensing Receptor cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Familial hypocalciuric hypercalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Familial hypocalciuric hypocalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neonatal severe hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Familial hypocalcemic hypercalciuria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neonatal severe hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Neonatal severe hyperparathyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Autosomal recessive inactivating mutations in the calcium-sensing receptor (CaSR) lead to Neonatal Severe Hyperparathyroidism (NSHPT) , characterized by severe hypercalcemia and hyperparathyroidism from birth.&lt;/li&gt;&lt;li&gt;âž¤ calcium-sensing receptor (CaSR)&lt;/li&gt;&lt;li&gt;âž¤ Neonatal Severe Hyperparathyroidism (NSHPT)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Giant aneurysms have a diameter of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt;1.5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;gt;2.0 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt;2.5 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt;3.0 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &gt;2.5 cm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) &amp;gt;2.5 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Giant aneurysms are those with a diameter of more than 2.5 cm and carry a higher risk of rupture and complications.&lt;/li&gt;&lt;li&gt;âž¤ Giant aneurysms&lt;/li&gt;&lt;li&gt;âž¤ more than 2.5 cm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman presents with a 4-week history of dry coughing and dyspnea with exertion. She has been receiving treatment for her swollen joints and morning stiffness for a few years. Inspiratory fine crackles are audible on auscultation. A basilar, subpleural, and bilateral honeycombing pattern is visible on HRCT. Which of the following patterns is the patient&#x27;s pulmonary function test (PFT) most likely to display?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;lt;0.7 and DLCO increases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;lt;0.7 and DLCO decreases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;gt;0.7 and DLCO decreases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;gt;0.7 and DLCO increases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. FEV1/FVC ratio &gt;0.7 and DLCO decreases&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) FEV1/FVC ratio &amp;gt;0.7 and DLCO decreases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In interstitial lung disease (ILD) , such as idiopathic pulmonary fibrosis , the FEV1/FVC ratio is typically &amp;gt;0.7 , and the DLCO is decreased due to impaired gas exchange caused by alveolar fibrosis.&lt;/li&gt;&lt;li&gt;âž¤ interstitial lung disease (ILD)&lt;/li&gt;&lt;li&gt;âž¤ idiopathic pulmonary fibrosis&lt;/li&gt;&lt;li&gt;âž¤ FEV1/FVC ratio&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt;0.7&lt;/li&gt;&lt;li&gt;âž¤ DLCO is decreased&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hamman-Rich syndrome is a synonym of which of the following disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Usual interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cryptogenic organising pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Respiratory bronchiolitis associated ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute interstitial pneumonia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acute interstitial pneumonia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Acute interstitial pneumonia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hamman-Rich syndrome is an older term for acute interstitial pneumonia (AIP) , a rapidly progressive form of interstitial lung disease that can lead to severe respiratory failure.&lt;/li&gt;&lt;li&gt;âž¤ Hamman-Rich syndrome&lt;/li&gt;&lt;li&gt;âž¤ acute interstitial pneumonia (AIP)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Lymphocytic Hypophysitis most commonly occurs in which of the following patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HIV AIDS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intracranial Metastasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Postpartum women&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postmenopausal women&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Postpartum women&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Postpartum women&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lymphocytic hypophysitis most commonly occurs in pregnant and postpartum women , and can also be seen with the use of immune checkpoint inhibitors. The most important differential diagnosis is Sheehan syndrome , especially in the postpartum period.&lt;/li&gt;&lt;li&gt;âž¤ Lymphocytic hypophysitis&lt;/li&gt;&lt;li&gt;âž¤ pregnant and postpartum women&lt;/li&gt;&lt;li&gt;âž¤ Sheehan syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Antonâ€™s syndrome is produced due to lesion in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal ACAs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal MCAs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal PCAs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Any of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bilateral infarction in the distal PCAs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Bilateral infarction in the distal PCAs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Antonâ€™s syndrome is caused by bilateral infarctions in the distal posterior cerebral arteries (PCAs) , leading to cortical blindness with denial of blindness (visual anosognosia) .&lt;/li&gt;&lt;li&gt;âž¤ Antonâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ bilateral infarctions in the distal posterior cerebral arteries (PCAs)&lt;/li&gt;&lt;li&gt;âž¤ cortical blindness&lt;/li&gt;&lt;li&gt;âž¤ denial of blindness (visual anosognosia)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old lady presented with significant weight loss, fatigue, myalgia, and difficulty getting up from bed or from a squatting position. Physical examination revealed papular lesions over the knuckles and fine crackles on auscultation with a restrictive PFT pattern. HRCT was performed and revealed interstitial lung disease. What is the expected lung biopsy finding in this patient. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-Synthetase syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CREST Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NERDS syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hermansky Pudlak syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anti-Synthetase syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/picture2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Anti-Synthetase syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of proximal muscle weakness , dermatomyositis , and interstitial lung disease strongly suggests Anti-Synthetase syndrome , most commonly associated with anti-Jo-1 antibodies .&lt;/li&gt;&lt;li&gt;âž¤ proximal muscle weakness&lt;/li&gt;&lt;li&gt;âž¤ dermatomyositis&lt;/li&gt;&lt;li&gt;âž¤ interstitial lung disease&lt;/li&gt;&lt;li&gt;âž¤ Anti-Synthetase syndrome&lt;/li&gt;&lt;li&gt;âž¤ anti-Jo-1 antibodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Subclavian steal is seen in which of the following lesions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Occlusion distal to the origin of the vertebral artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Occlusion in V1 segment of vertebral artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occlusion proximal to the origin of the vertebral artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Occlusion in V2 segment of vertebral artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Occlusion proximal to the origin of the vertebral artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Occlusion proximal to the origin of the vertebral artery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Subclavian steal syndrome is caused by occlusion or stenosis of the subclavian artery proximal to the origin of the vertebral artery , resulting in reversal of vertebral artery blood flow and symptoms of vertebrobasilar insufficiency.&lt;/li&gt;&lt;li&gt;âž¤ Subclavian steal syndrome&lt;/li&gt;&lt;li&gt;âž¤ occlusion or stenosis of the subclavian artery proximal to the origin of the vertebral artery&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are true about pituitary tumors, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pituitary adenomas frequently extend in a suprasellar direction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Headache is a common feature&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Headache severity correlates with adenoma size or extension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Suprasellar extension can lead to visual loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Headache severity correlates with adenoma size or extension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Headache severity correlates with adenoma size or extension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Headaches are common in patients with pituitary adenomas , but the severity of the headache does not correlate with the size or extension of the tumor. Visual loss can occur due to suprasellar extension and compression of the optic chiasm .&lt;/li&gt;&lt;li&gt;âž¤ pituitary adenomas&lt;/li&gt;&lt;li&gt;âž¤ severity of the headache does not correlate&lt;/li&gt;&lt;li&gt;âž¤ suprasellar extension&lt;/li&gt;&lt;li&gt;âž¤ optic chiasm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following describes the best method to diagnose bronchial asthma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chest Xray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Skin prick test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1 measurement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reversible obstruction demonstration on PFT.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Reversible obstruction demonstration on PFT.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Reversible obstruction demonstration on PFT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The best method to diagnose bronchial asthma is by demonstrating reversible airway obstruction using pulmonary function tests (PFTs) , typically through spirometry .&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ reversible airway obstruction&lt;/li&gt;&lt;li&gt;âž¤ pulmonary function tests (PFTs)&lt;/li&gt;&lt;li&gt;âž¤ spirometry&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the screening test for Acromegaly?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum GH levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ACTH reserve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum IGF-1 levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin tolerance test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Serum IGF-1 levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Serum IGF-1 levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The screening test for acromegaly is serum IGF-1 levels , as it reliably reflects the chronic overproduction of growth hormone.&lt;/li&gt;&lt;li&gt;âž¤ screening test for acromegaly&lt;/li&gt;&lt;li&gt;âž¤ serum IGF-1 levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The Gold&#x27;s criteria for very severe COPD is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt; 30%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt;70%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1/FVC&amp;lt;0.7 and FEV1&amp;lt; 50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. FEV1/FVC &lt;0.7 and FEV1 &lt; 30%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt;30%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Very severe COPD according to GOLD criteria is defined as FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt;30% of predicted , with or without chronic respiratory failure.&lt;/li&gt;&lt;li&gt;âž¤ Very severe COPD&lt;/li&gt;&lt;li&gt;âž¤ GOLD criteria&lt;/li&gt;&lt;li&gt;âž¤ FEV1/FVC &amp;lt;0.7&lt;/li&gt;&lt;li&gt;âž¤ FEV1 &amp;lt;30% of predicted&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following situations would NIV be considered contraindicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute exacerbation of chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute hypoxemic respiratory failure in an individual with ARDS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute myocardial infarction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decompensated systolic heart failure without acute myocardial ischemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute myocardial infarction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute myocardial infarction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NIV is contraindicated in acute myocardial infarction due to the potential for increased intrathoracic pressure to impair coronary perfusion, posing a risk in the setting of cardiac ischemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following features are characteristic of Maturity-onset diabetes of the young (MODY)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autosomal dominant inheritance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early onset of hyperglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Impaired insulin secretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MODY is characterized by autosomal dominant inheritance , early onset hyperglycemia , and impaired insulin secretion , distinguishing it from other forms of diabetes.&lt;/li&gt;&lt;li&gt;âž¤ MODY&lt;/li&gt;&lt;li&gt;âž¤ autosomal dominant inheritance&lt;/li&gt;&lt;li&gt;âž¤ early onset hyperglycemia&lt;/li&gt;&lt;li&gt;âž¤ impaired insulin secretion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are cardinal motor features of Parkinsonâ€™s disease, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rest tremor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradykinesia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Masked facies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postural instability&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Masked facies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â C) Masked facies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The cardinal motor features of Parkinsonâ€™s disease include tremor , rigidity , bradykinesia , and postural instability . Masked facies is a common feature but not a cardinal motor feature.&lt;/li&gt;&lt;li&gt;âž¤ Parkinsonâ€™s disease&lt;/li&gt;&lt;li&gt;âž¤ tremor&lt;/li&gt;&lt;li&gt;âž¤ rigidity&lt;/li&gt;&lt;li&gt;âž¤ bradykinesia&lt;/li&gt;&lt;li&gt;âž¤ postural instability&lt;/li&gt;&lt;li&gt;âž¤ Masked facies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are seen in fasting state, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased glycogenolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased glucose uptake in skeletal muscle and fat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased lipolysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased glucose uptake in skeletal muscle and fat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Increased glucose uptake in skeletal muscle and fat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the fasting state , processes like gluconeogenesis , glycogenolysis , and lipolysis increase, while glucose uptake in skeletal muscle and fat decreases due to low insulin levels.&lt;/li&gt;&lt;li&gt;âž¤ fasting state&lt;/li&gt;&lt;li&gt;âž¤ gluconeogenesis&lt;/li&gt;&lt;li&gt;âž¤ glycogenolysis&lt;/li&gt;&lt;li&gt;âž¤ lipolysis&lt;/li&gt;&lt;li&gt;âž¤ glucose uptake&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Bullâ€™s head sign on Radionuclide bone scan is seen in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Psoriatic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IBD-Associated Arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SAPHO syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. SAPHO syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-113753.JPG&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) SAPHO syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;Bullâ€™s head sign\&quot; on a radionuclide bone scan is a diagnostic imaging feature seen in SAPHO syndrome , reflecting involvement of the sternum and clavicles.&lt;/li&gt;&lt;li&gt;âž¤ SAPHO syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female is referred for chronic cough and dyspnea with exertion. Over the past year, her cough and dyspnea have steadily gotten worse. According to pulmonary function testing, the FVC:72%, FEV1: 80%, DLCO 38%. CT given below. Lung biopsy done to evaluate cause of CT abnormalities reveals foci of scarring that are dispersed and surrounded by healthy lung parenchyma and fibroblasts. Which of the following is the appropriate therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pirfenidone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bosentan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetylcysteine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone/azathioprine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pirfenidone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/picture3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Pirfenidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Idiopathic Pulmonary Fibrosis (IPF) , the appropriate treatment involves the use of anti-fibrotic agents such as Pirfenidone or Nintedanib to slow the progression of fibrosis. Immunosuppressive therapy should be avoided in IPF.&lt;/li&gt;&lt;li&gt;âž¤ Idiopathic Pulmonary Fibrosis (IPF)&lt;/li&gt;&lt;li&gt;âž¤ anti-fibrotic agents&lt;/li&gt;&lt;li&gt;âž¤ Pirfenidone&lt;/li&gt;&lt;li&gt;âž¤ Nintedanib&lt;/li&gt;&lt;li&gt;âž¤ Immunosuppressive therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Levodopa-induced motor complications are seen more commonly in all of the following patients, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Old patients&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Severe disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Higher doses of levodopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Women&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Old patients&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Old patients&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Levodopa-induced motor complications are more commonly seen in patients with severe disease , those on higher doses of levodopa , and women , but they are less common in older patients .&lt;/li&gt;&lt;li&gt;âž¤ Levodopa-induced motor complications&lt;/li&gt;&lt;li&gt;âž¤ severe disease&lt;/li&gt;&lt;li&gt;âž¤ higher doses of levodopa&lt;/li&gt;&lt;li&gt;âž¤ women&lt;/li&gt;&lt;li&gt;âž¤ less common in older patients&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The definitive treatment for Hepato-renal syndrome is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Terlipressin + Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Terlipressin + Octreotide + Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Orthotopic liver transplantation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Simultaneous liver-kidney transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Orthotopic liver transplantation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Orthotopic liver transplantation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The definitive treatment for Hepatorenal Syndrome (HRS) is orthotopic liver transplantation , as it targets the underlying cause of liver failure and can restore kidney function. Terlipressin and albumin are supportive therapies used while awaiting transplantation.&lt;/li&gt;&lt;li&gt;âž¤ definitive treatment&lt;/li&gt;&lt;li&gt;âž¤ Hepatorenal Syndrome (HRS)&lt;/li&gt;&lt;li&gt;âž¤ orthotopic liver transplantation&lt;/li&gt;&lt;li&gt;âž¤ Terlipressin and albumin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug approved in delaying the onset of stage 3 T1D in high-risk individuals ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teplizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Golimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Teprotumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Teplizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Teplizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Teplizumab is the first drug approved to delay the onset of stage 3 Type 1 Diabetes in high-risk individuals by modulating the autoimmune process involved in the destruction of pancreatic beta cells.&lt;/li&gt;&lt;li&gt;âž¤ Teplizumab&lt;/li&gt;&lt;li&gt;âž¤ delay the onset of stage 3 Type 1 Diabetes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Class IV Lupus Nephritis consist of ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mesangial Proliferative Lupus Nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Focal Lupus Nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse Lupus Nephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Membranous Lupus Nephritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diffuse Lupus Nephritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diffuse Lupus Nephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Class IV Lupus Nephritis is also known as Diffuse Lupus Nephritis , characterized by the involvement of more than 50% of the glomeruli, and is the most severe form of lupus-related kidney disease.&lt;/li&gt;&lt;li&gt;âž¤ Diffuse Lupus Nephritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are complications due to peritoneal dialysis therapy EXCEPT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertriglyceridemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperphosphatemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Hypoglycemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypoglycemia is not a complication of peritoneal dialysis . The common metabolic complications include hyperglycemia , hypoproteinemia , hypertriglyceridemia , and hyperphosphatemia .&lt;/li&gt;&lt;li&gt;âž¤ Hypoglycemia&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ peritoneal dialysis&lt;/li&gt;&lt;li&gt;âž¤ hyperglycemia&lt;/li&gt;&lt;li&gt;âž¤ hypoproteinemia&lt;/li&gt;&lt;li&gt;âž¤ hypertriglyceridemia&lt;/li&gt;&lt;li&gt;âž¤ hyperphosphatemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following autoantibody is detected by Dilute Russel viper venom test ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibodies against cardiolipin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antibodies against Î²2 GPI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lupus anticoagulant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antiphosphatidylserine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lupus anticoagulant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lupus anticoagulant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Dilute Russell Viper Venom Test (dRVVT) is specifically used to detect lupus anticoagulant , an important marker for antiphospholipid syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Dilute Russell Viper Venom Test (dRVVT)&lt;/li&gt;&lt;li&gt;âž¤ lupus anticoagulant&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Parkinsonâ€™s patient who developed Dementia, which of the following drugs are stopped first?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dopamine agonists&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amantadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anticholinergics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;COMT inhibitors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anticholinergics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Anticholinergics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a Parkinsonâ€™s patient who develops dementia, anticholinergic drugs are stopped first due to their significant potential to worsen cognitive function and contribute to dementia.&lt;/li&gt;&lt;li&gt;âž¤ anticholinergic drugs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The fructosamine assay reflects the glycemic status for the prior:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 Week&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 Weeks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3 Weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4 Weeks&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 2 Weeks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) 2 Weeks&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The fructosamine assay provides information on glycemic control over the past 2 weeks and is useful for short-term monitoring.&lt;/li&gt;&lt;li&gt;âž¤ fructosamine assay&lt;/li&gt;&lt;li&gt;âž¤ 2 weeks&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Placement of hemodialysis catheter at which site is associated with greater risk of stenosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Femoral&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subclavian&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left Internal jugular&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right Internal jugular&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Subclavian&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Subclavian&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The subclavian vein is associated with a greater risk of stenosis when used for hemodialysis catheter placement, which can complicate future vascular access options for dialysis.&lt;/li&gt;&lt;li&gt;âž¤ subclavian vein&lt;/li&gt;&lt;li&gt;âž¤ greater risk of stenosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following vasculitis are due to the production of antineutrophilic cytoplasmic antibodies (ANCA), except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granulomatosis with polyangiitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgA vasculitis (Henoch-SchÃ¶nlein)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Microscopic polyangiitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eosinophilic granulomatosis with polyangiitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IgA vasculitis (Henoch-SchÃ¶nlein)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) IgA vasculitis (Henoch-SchÃ¶nlein)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IgA vasculitis (Henoch-SchÃ¶nlein) is not associated with ANCA production, distinguishing it from other vasculitides like Granulomatosis with polyangiitis, Microscopic polyangiitis, and Eosinophilic granulomatosis with polyangiitis, which are ANCA-associated.&lt;/li&gt;&lt;li&gt;âž¤ IgA vasculitis (Henoch-SchÃ¶nlein)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Swan-neck deformity in Rheumatoid arthritis is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flexion of the PIP joint with hyperextension of the DIP joint&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperextension of the PIP joint with flexion of the DIP joint&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subluxation of the first MCP joint with hyperextension of the first interphalangeal (IP) joint&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hyperextension of the PIP joint with flexion of the DIP joint&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-10-30%20153455.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hyperextension of the PIP joint with flexion of the DIP joint&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Swan-neck deformity in rheumatoid arthritis is characterized by hyperextension of the PIP joint and flexion of the DIP joint .&lt;/li&gt;&lt;li&gt;âž¤ Swan-neck deformity&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ hyperextension of the PIP joint&lt;/li&gt;&lt;li&gt;âž¤ flexion of the DIP joint&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Familial hemiplegic migraine type 1 is caused due to mutation in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CACNA1A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ATP1A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SCN1A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SCN2A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CACNA1A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) CACNA1A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Familial hemiplegic migraine type 1 is caused by mutations in the CACNA1A gene , which encodes a voltage-gated calcium channel.&lt;/li&gt;&lt;li&gt;âž¤ Familial hemiplegic migraine type 1&lt;/li&gt;&lt;li&gt;âž¤ CACNA1A gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-diabetic medications is contraindicated in individuals with medullary carcinoma of the thyroid or multiple endocrine neoplasia (MEN)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Canagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liraglutide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Liraglutide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ GLP-1 receptor agonists like liraglutide are contraindicated in individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) due to the risk of medullary thyroid cancer.&lt;/li&gt;&lt;li&gt;âž¤ GLP-1 receptor agonists&lt;/li&gt;&lt;li&gt;âž¤ liraglutide&lt;/li&gt;&lt;li&gt;âž¤ medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ multiple endocrine neoplasia type 2 (MEN2)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Feltyâ€™s syndrome is characterized by all of the following except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neutropenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neutrophilia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Splenomegaly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nodular RA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neutrophilia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Neutrophilia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Feltyâ€™s syndrome is defined by neutropenia , splenomegaly , and nodular rheumatoid arthritis . Neutrophilia is not a feature of this syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Feltyâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ neutropenia&lt;/li&gt;&lt;li&gt;âž¤ splenomegaly&lt;/li&gt;&lt;li&gt;âž¤ nodular rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ Neutrophilia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are involved in Polyarteritis nodosa, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Renal arteries&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heart vasculature&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary arteries&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pulmonary arteries&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pulmonary arteries&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Polyarteritis nodosa (PAN) , the pulmonary arteries are not involved , which is an important distinguishing feature of this vasculitis.&lt;/li&gt;&lt;li&gt;âž¤ Polyarteritis nodosa (PAN)&lt;/li&gt;&lt;li&gt;âž¤ pulmonary arteries are not involved&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the treatment of choice for an acute attack of cluster headache?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral sumatriptan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lidocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen inhalation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oxygen inhalation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Oxygen inhalation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The treatment of choice for an acute attack of cluster headache is oxygen inhalation at 12 to 15 L/min via a non-rebreather mask.&lt;/li&gt;&lt;li&gt;âž¤ treatment of choice&lt;/li&gt;&lt;li&gt;âž¤ cluster headache&lt;/li&gt;&lt;li&gt;âž¤ oxygen inhalation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of Diabetic Ketoacidosis (DKA), except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sodium concentration of 125mmol/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum osmolality of 300 m0sm/mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urine ketones positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum bicarbonate &amp;gt;18mmol/L&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum bicarbonate &gt;18mmol/L&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DKA is characterized by metabolic acidosis with serum bicarbonate &amp;lt;18 mmol/L , hyponatremia , increased serum osmolality , and positive urine ketones . The correct answer is D , as bicarbonate levels are typically below 18 mmol/L in DKA.&lt;/li&gt;&lt;li&gt;âž¤ metabolic acidosis&lt;/li&gt;&lt;li&gt;âž¤ serum bicarbonate &amp;lt;18 mmol/L&lt;/li&gt;&lt;li&gt;âž¤ hyponatremia&lt;/li&gt;&lt;li&gt;âž¤ increased serum osmolality&lt;/li&gt;&lt;li&gt;âž¤ positive urine ketones&lt;/li&gt;&lt;li&gt;âž¤ D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common pulmonary manifestation of Rheumatoid Arthritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleuritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary nodules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung malignancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pleuritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â B) Pleuritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common pulmonary manifestation of rheumatoid arthritis is pleuritis , characterized by pleuritic chest pain and pleural effusion.&lt;/li&gt;&lt;li&gt;âž¤ most common pulmonary manifestation&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ pleuritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are true about isolated polymyalgia rheumatica, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-cyclic citrullinated peptide (CCP) is negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prompt therapeutic response to low-dose prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid factor is positive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased ESR&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rheumatoid factor is positive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Rheumatoid factor is positive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In polymyalgia rheumatica (PMR) , rheumatoid factor (RF) is typically negative , unlike in rheumatoid arthritis where it is often positive. The disease responds well to low-dose prednisone and is associated with increased ESR.&lt;/li&gt;&lt;li&gt;âž¤ polymyalgia rheumatica (PMR)&lt;/li&gt;&lt;li&gt;âž¤ negative&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of noninflammatory joint disorders, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pain without synovial swelling&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Absence of inflammatory or systemic features&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolonged morning stiffness&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Negative laboratory investigations&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prolonged morning stiffness&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Prolonged morning stiffness&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prolonged morning stiffness is a feature of inflammatory joint disorders and not noninflammatory joint disorders , which typically present with mechanical pain, no synovial swelling, and negative lab findings.&lt;/li&gt;&lt;li&gt;âž¤ Prolonged morning stiffness&lt;/li&gt;&lt;li&gt;âž¤ inflammatory joint disorders&lt;/li&gt;&lt;li&gt;âž¤ noninflammatory joint disorders&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common blood vessel involved in trigeminal neuralgia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Basilar artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Posterior communicating artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Superior cerebellar artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inferior cerebellar artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Superior cerebellar artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Superior cerebellar artery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The superior cerebellar artery is the most common blood vessel involved in trigeminal neuralgia , often causing compression of the trigeminal nerve and resulting in facial pain.&lt;/li&gt;&lt;li&gt;âž¤ superior cerebellar artery&lt;/li&gt;&lt;li&gt;âž¤ trigeminal neuralgia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the most common feature of MEN 1?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastrinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolactinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal cortical tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Primary hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Primary hyperparathyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common feature of MEN 1 is primary hyperparathyroidism , which is present in about 90% of patients and leads to hypercalcemia.&lt;/li&gt;&lt;li&gt;âž¤ MEN 1&lt;/li&gt;&lt;li&gt;âž¤ primary hyperparathyroidism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common cause of myositis in those aged &amp;gt;50 years?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inclusion body myositis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polymyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune mediated necrotizing myopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inclusion body myositis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inclusion body myositis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inclusion body myositis (IBM) is the most common cause of myositis in individuals aged over 50, characterized by slowly progressive muscle weakness, particularly affecting the quadriceps and forearm muscles.&lt;/li&gt;&lt;li&gt;âž¤ Inclusion body myositis (IBM)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following ANA has Speckled pattern?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti RNA polymerase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti Kinetochore&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti Scl-70&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti histone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti Scl-70&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-10-30%20155234.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti Scl-70&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The speckled ANA pattern is associated with several antigens, including Anti Scl-70 , which is commonly seen in systemic sclerosis . Other antibodies, such as anti-Ro, anti-La, anti-Smith, and anti-Jo-1 , can also produce a speckled pattern.&lt;/li&gt;&lt;li&gt;âž¤ speckled ANA pattern&lt;/li&gt;&lt;li&gt;âž¤ Anti Scl-70&lt;/li&gt;&lt;li&gt;âž¤ systemic sclerosis&lt;/li&gt;&lt;li&gt;âž¤ anti-Ro, anti-La, anti-Smith, and anti-Jo-1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the first manifestation of APS 1 (Autoimmune Polyglandular Syndrome type 1)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 1 DM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mucocutaneous candidiasis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal insufficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mucocutaneous candidiasis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Mucocutaneous candidiasis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The first manifestation of APS 1 is most commonly mucocutaneous candidiasis , followed by hypoparathyroidism and adrenal insufficiency .&lt;/li&gt;&lt;li&gt;âž¤ first manifestation&lt;/li&gt;&lt;li&gt;âž¤ APS 1&lt;/li&gt;&lt;li&gt;âž¤ mucocutaneous candidiasis&lt;/li&gt;&lt;li&gt;âž¤ hypoparathyroidism&lt;/li&gt;&lt;li&gt;âž¤ adrenal insufficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of Inflammatory fluid in synovial fluid analysis, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inflammatory fluid is turbid and yellow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polymorphonuclear leukocyte predominance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of stringing effect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased WBC count (2000â€“50,000/Î¼L)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of stringing effect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Presence of stringing effect&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In inflammatory synovial fluid , the stringing effect is absent due to the reduction in viscosity. Other features include turbid and yellow appearance , polymorphonuclear leukocyte predominance , and elevated WBC count .&lt;/li&gt;&lt;li&gt;âž¤ inflammatory synovial fluid&lt;/li&gt;&lt;li&gt;âž¤ stringing effect&lt;/li&gt;&lt;li&gt;âž¤ absent&lt;/li&gt;&lt;li&gt;âž¤ turbid and yellow appearance&lt;/li&gt;&lt;li&gt;âž¤ polymorphonuclear leukocyte predominance&lt;/li&gt;&lt;li&gt;âž¤ elevated WBC count&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with neck neck and back pain and the Xray is shown. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diffuse idiopathic skeletal hyperostosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TB spine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spine metastases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Diffuse idiopathic skeletal hyperostosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/picture4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Diffuse idiopathic skeletal hyperostosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diffuse idiopathic skeletal hyperostosis (DISH) is diagnosed by the presence of flowing ossifications over at least four contiguous vertebrae and is associated with back pain in elderly individuals.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female evaluated for Iron deficiency anemia. Her iron studies revealed following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal iron balance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Negative iron balance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron deficient erythropoiesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Iron deficient erythropoiesis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-113810.JPG&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Iron-deficient erythropoiesis represents an intermediate stage in iron depletion, where the marrow lacks adequate iron for red cell production, but anemia may not yet be present.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following parameters can be obtained by the following graph?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Residual volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Total lung capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Functional residual capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FEV1/FVC&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. FEV1/FVC&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-114635.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) FEV1/FVC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The flow-volume loop is primarily used to assess parameters such as FEV1/FVC to help evaluate pulmonary function and diagnose lung diseases.&lt;/li&gt;&lt;li&gt;âž¤ flow-volume loop&lt;/li&gt;&lt;li&gt;âž¤ FEV1/FVC&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are in favour of Psoriatic arthritis when compared to Rheumatoid arthritis, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Distal interphalangeal (DIP) joint is involved&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Familial aggregation is seen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arthritis is usually seropositive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spine and sacroiliac joints are involved&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Arthritis is usually seropositive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Arthritis is usually seropositive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Psoriatic arthritis is usually seronegative for rheumatoid factor and anti-CCP antibodies, which contrasts with rheumatoid arthritis, where these markers are commonly positive.&lt;/li&gt;&lt;li&gt;âž¤ seronegative&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Bulbar weakness and more frequent episodes of respiratory depression can be especially prominent in Myasthenia gravis with antibodies to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AntiAChR antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AntiMuSK antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti LRP 4 antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti GQ1b antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. AntiMuSK antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â B) Anti-MuSK antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-MuSK antibodies in Myasthenia Gravis are associated with bulbar weakness , respiratory depression , and neck weakness , and often require treatment with rituximab .&lt;/li&gt;&lt;li&gt;âž¤ Anti-MuSK antibodies&lt;/li&gt;&lt;li&gt;âž¤ bulbar weakness&lt;/li&gt;&lt;li&gt;âž¤ respiratory depression&lt;/li&gt;&lt;li&gt;âž¤ neck weakness&lt;/li&gt;&lt;li&gt;âž¤ rituximab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;P-selectin-blocking monoclonal antibody used in sickle cell anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Teplizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Voxelotor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crizanlizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ofatumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Crizanlizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Crizanlizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Crizanlizumab is a P-selectin-blocking monoclonal antibody used in sickle cell anemia to reduce the frequency of vaso-occlusive crises.&lt;/li&gt;&lt;li&gt;âž¤ Crizanlizumab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man is evaluated for a 5-year history of gradually progressive dyspnea and dry cough without wheezing or hemoptysis. He has not had fever or lost weight. He smoked one pack of cigarettes a day from the age of 18 to 60 years. He worked as a roofer for 40 years. Physical examination shows no digital clubbing or cyanosis. Auscultation of the lungs reveals bilateral end-inspiratory crackles. Pulmonary function testing shows: Total lung capacity - 67% of predicted, Residual volume - 72% of predicted, FVC-65% of predicted, FEVI-75% of predicted, FEV I/FVC ratio - 89% (Normal), DLCO - 52% of predicted. His chest radiograph is suggestive of Bilateral lower zone predominant lesions. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Emphysema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Asbestosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchogenic Carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Asbestosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Asbestosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most likely diagnosis in a patient with a history of asbestos exposure, progressive dyspnea, restrictive lung disease, and bilateral lower zone lung involvement is asbestosis .&lt;/li&gt;&lt;li&gt;âž¤ asbestosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hb Bartâ€™s is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î±3 Î³1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î± Î³3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î±2 Î³2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î³4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Î³4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Î³â‚„&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hb Bartâ€™s (Î³â‚„) is an abnormal hemoglobin made up of four gamma chains and is typically seen in severe forms of alpha-thalassemia.&lt;/li&gt;&lt;li&gt;âž¤ Hb Bartâ€™s (Î³â‚„)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a true statement regarding repetitive nerve stimulation for Myasthenia Gravis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-AChE medication should be stopped 6â€“12 h before testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is best to test weak muscles or proximal muscle groups&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;In myasthenic patients, there is a rapid reduction of &amp;gt;10% in the amplitude of the evoked responses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All are true&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All are true&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) All are true&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Repetitive nerve stimulation in Myasthenia Gravis involves testing weak or proximal muscles, stopping anti-acetylcholinesterase medications before testing, and observing for a &amp;gt;10% decrement in the amplitude of responses.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;60-year-old male being treated for Carcinoma prostrate presented with worsening breathlessness, chest pain and syncope. On arrival HR 125 with Shock index &amp;gt;1. CTPA confirmed diagnosis of pulmonary embolism. Cardiac troponin, BNP levels are normal. ECHO shows reduced RV function. Which of the following is recommended for in-hospital treatment of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LMWH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bivalrudin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alteplase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. LMWH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â A) LMWH&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For cancer-associated pulmonary embolism , Low Molecular Weight Heparin (LMWH) is the preferred in-hospital treatment due to its efficacy and safety profile.&lt;/li&gt;&lt;li&gt;âž¤ cancer-associated pulmonary embolism&lt;/li&gt;&lt;li&gt;âž¤ Low Molecular Weight Heparin (LMWH)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Imerslundâ€™s Syndrome is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Selective Malabsorption of folate with Proteinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Selective Malabsorption of Cobalamin with folate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Selective Malabsorption of Cobalamin with Proteinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Selective Malabsorption of Cobalamin with Lymphopenia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Selective Malabsorption of Cobalamin with Proteinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Selective Malabsorption of Cobalamin with Proteinuria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Imerslund-GrÃ¤sbeck syndrome involves the selective malabsorption of cobalamin (vitamin B12) with associated proteinuria , leading to vitamin B12 deficiency.&lt;/li&gt;&lt;li&gt;âž¤ Imerslund-GrÃ¤sbeck syndrome&lt;/li&gt;&lt;li&gt;âž¤ selective malabsorption of cobalamin (vitamin B12)&lt;/li&gt;&lt;li&gt;âž¤ proteinuria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following Hormone uses Receptor Tyrosine Kinase signalling?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Growth hormone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Activin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TGF-Î²&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Insulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Insulin uses receptor tyrosine kinase (RTK) signaling , while hormones like growth hormone , activin , and TGF-Î² use different pathways (JAK-STAT and SMAD pathways, respectively).&lt;/li&gt;&lt;li&gt;âž¤ Insulin&lt;/li&gt;&lt;li&gt;âž¤ receptor tyrosine kinase (RTK) signaling&lt;/li&gt;&lt;li&gt;âž¤ growth hormone&lt;/li&gt;&lt;li&gt;âž¤ activin&lt;/li&gt;&lt;li&gt;âž¤ TGF-Î²&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old gentleman with a family history of colorectal cancer presented with palpitations and syncope. On arrival ECG given below. What is not true about ECG finding in Pulmonary embolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sinus tachycardia is the most common finding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S1Q3T3 is pathognomonic of Pulmonary embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T-wave inversion in septal and inferior leads suggest PE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Above ECG shows RV strain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S1Q3T3 is pathognomonic of Pulmonary embolism&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-115056.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) S1Q3T3 is pathognomonic of Pulmonary embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While the S1Q3T3 pattern can be seen in pulmonary embolism , it is not pathognomonic for the condition and may be seen in other situations involving right heart strain. The most common ECG finding in pulmonary embolism is sinus tachycardia , and evidence of right ventricular strain is crucial for diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ S1Q3T3 pattern&lt;/li&gt;&lt;li&gt;âž¤ pulmonary embolism&lt;/li&gt;&lt;li&gt;âž¤ sinus tachycardia&lt;/li&gt;&lt;li&gt;âž¤ right ventricular strain&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Donath-Landsteiner antibody is characteristic of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Paroxysmal nocturnal hemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;March hemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paroxysmal cold hemoglobinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WAIHA (Warm Autoimmune Hemolytic Anemia)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paroxysmal cold hemoglobinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Paroxysmal cold hemoglobinuria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Donath-Landsteiner antibody is a biphasic hemolysin characteristic of Paroxysmal Cold Hemoglobinuria (PCH) , causing hemolysis when red blood cells are exposed to cold and then warmed to body temperature.&lt;/li&gt;&lt;li&gt;âž¤ Donath-Landsteiner antibody&lt;/li&gt;&lt;li&gt;âž¤ Paroxysmal Cold Hemoglobinuria (PCH)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old banker complains of shortness of breath (SOB) on climbing two flights of stairs. After one flight, he develops chest tightness and has had multiple syncopal episodes in the past. His past medical history is significant for deep vein thrombosis (DVT) due to limb immobilization 5 years ago. Pulmonary function tests (PFTs) are normal, but his DLCO is reduced. ECHO shows right ventricular systolic pressure (RVSP) of 50 mmHg with normal left ventricular (LV) function. What is the most appropriate management strategy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI angio of the thorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CTPA (CT pulmonary angio)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start oral prostacyclin therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CTPA (CT pulmonary angio)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) CTPA (CT pulmonary angio)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with a history of DVT , reduced DLCO , and elevated RVSP , the most appropriate next step is to perform CT pulmonary angiography (CTPA) to confirm the diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) .&lt;/li&gt;&lt;li&gt;âž¤ DVT&lt;/li&gt;&lt;li&gt;âž¤ reduced DLCO&lt;/li&gt;&lt;li&gt;âž¤ elevated RVSP&lt;/li&gt;&lt;li&gt;âž¤ CT pulmonary angiography (CTPA)&lt;/li&gt;&lt;li&gt;âž¤ chronic thromboembolic pulmonary hypertension (CTEPH)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Antibodies implicated in pathogenesis of Heparin-Induced Thrombocytopenia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platelet factor 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Platelet factor 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Platelet factor 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Platelet factor 4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Platelet factor 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Platelet factor 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The antibodies implicated in Heparin-Induced Thrombocytopenia (HIT) are directed against complexes of Platelet Factor 4 (PF4) and heparin, leading to platelet activation and a prothrombotic state.&lt;/li&gt;&lt;li&gt;âž¤ Heparin-Induced Thrombocytopenia (HIT)&lt;/li&gt;&lt;li&gt;âž¤ Platelet Factor 4 (PF4)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old smoker presented with progressive breathlessness over 1 year. Chest X-ray (CXR) reveals hyperinflated lungs. Pulmonary function tests (PFTs) show moderate obstruction. Echocardiogram shows right ventricular systolic pressure (RVSP) of 60 mmHg. Which category of pulmonary hypertension does this patient belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;WHO Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;WHO class II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;WHO Class III&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WHO Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. WHO Class III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) WHO Class III&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This patientâ€™s COPD -related pulmonary hypertension places him in WHO Class III , which is pulmonary hypertension due to lung diseases or hypoxia .&lt;/li&gt;&lt;li&gt;âž¤ COPD&lt;/li&gt;&lt;li&gt;âž¤ WHO Class III&lt;/li&gt;&lt;li&gt;âž¤ lung diseases or hypoxia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Single most powerful predictor of survival in Multiple myeloma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated LDH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-risk gene expression profile&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î²2-microglobulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;De novo plasma cell leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Î²2-microglobulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Î²2-microglobulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Î²2-microglobulin levels are the most powerful predictor of survival in patients with Multiple Myeloma , reflecting both disease burden and kidney function.&lt;/li&gt;&lt;li&gt;âž¤ Î²2-microglobulin&lt;/li&gt;&lt;li&gt;âž¤ Multiple Myeloma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;ADAMTS13 activity levels of diagnostic of TTP ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt;5%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt;15%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt;10%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt;20%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &lt;10%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;lt;10%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A severe deficiency of ADAMTS13 activity (&amp;lt;10%) is diagnostic of Thrombotic Thrombocytopenic Purpura (TTP) and distinguishes it from other thrombotic microangiopathies.&lt;/li&gt;&lt;li&gt;âž¤ ADAMTS13 activity (&amp;lt;10%)&lt;/li&gt;&lt;li&gt;âž¤ Thrombotic Thrombocytopenic Purpura (TTP)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Thrombosis in which of the following is least likely to cause pulmonary embolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Superficial femoral vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Great saphenous vein&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Common femoral vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Popliteal vein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Great saphenous vein&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Great saphenous vein&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thrombosis in the great saphenous vein (a superficial vein) is least likely to cause a pulmonary embolism, whereas thrombosis in deep veins such as the femoral or popliteal veins poses a higher risk for PE.&lt;/li&gt;&lt;li&gt;âž¤ great saphenous vein&lt;/li&gt;&lt;li&gt;âž¤ deep veins&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Maddrey discriminant function is calculated with?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 4.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 4.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Maddrey Discriminant Function is calculated using the formula 4.6 Ã— [prolongation of prothrombin time above control] + serum bilirubin and is used primarily to assess the severity of alcoholic hepatitis and the need for corticosteroid therapy.&lt;/li&gt;&lt;li&gt;âž¤ Maddrey Discriminant Function&lt;/li&gt;&lt;li&gt;âž¤ 4.6 Ã— [prolongation of prothrombin time above control] + serum bilirubin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hyâ€™s Law is used in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic Hepatitis B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug induced liver injury&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Drug induced liver injury&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Drug-induced liver injury&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyâ€™s Law is used to predict severe outcomes in drug-induced liver injury (DILI) by assessing hepatocellular injury, elevated bilirubin, and excluding other causes of jaundice.&lt;/li&gt;&lt;li&gt;âž¤ Hyâ€™s Law&lt;/li&gt;&lt;li&gt;âž¤ drug-induced liver injury (DILI)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Gene defective in Dubin Johnson syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ABCCA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SLCO1B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ATP8B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ABCB11&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ABCCA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) ABCCA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The genetic defect in Dubin-Johnson syndrome involves the ABCC2 gene, which is responsible for impaired bilirubin transport, leading to conjugated hyperbilirubinemia.&lt;/li&gt;&lt;li&gt;âž¤ Dubin-Johnson syndrome&lt;/li&gt;&lt;li&gt;âž¤ ABCC2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are true regarding Henoch-SchÃ¶nlein purpura (HSP), except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Often preceded by an upper respiratory infection, commonly with streptococcal pharyngitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal impairment may occur&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PT, aPTT are increased&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucocorticoids can provide symptomatic relief&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PT, aPTT are increased&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) PT, aPTT are increased&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Henoch-SchÃ¶nlein purpura (HSP) , PT and aPTT are typically normal because the disorder is a vasculitis, not a coagulopathy.&lt;/li&gt;&lt;li&gt;âž¤ Henoch-SchÃ¶nlein purpura (HSP)&lt;/li&gt;&lt;li&gt;âž¤ normal&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Clinically significant portal hypertension is defined as HVPG of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 5mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5-10mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt;10mmHg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt;10mmHg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &gt;10mmHg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;gt;10 mmHg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Clinically significant portal hypertension is defined as a hepatic venous pressure gradient (HVPG) of greater than 10 mmHg , which is associated with complications like variceal bleeding and ascites.&lt;/li&gt;&lt;li&gt;âž¤ portal hypertension&lt;/li&gt;&lt;li&gt;âž¤ greater than 10 mmHg&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Virtually no VWF protein and usually FVIII levels &amp;lt;10% is seen in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 1 VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type 2 VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 3 VWD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type 4 VWD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Type 3 VWD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Type 3 VWD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Type 3 VWD is the most severe form, characterized by virtually no VWF protein and very low factor VIII levels (&amp;lt;10%), leading to a severe bleeding phenotype.&lt;/li&gt;&lt;li&gt;âž¤ Type 3 VWD&lt;/li&gt;&lt;li&gt;âž¤ virtually no VWF protein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following Endoscopic image is diagnostic of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reflux esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Herpes simplex virus esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophilic esophagitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Candida esophagitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eosinophilic esophagitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-115848.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Eosinophilic esophagitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of concentric rings (trachealization) in the esophagus on endoscopy is highly indicative of Eosinophilic Esophagitis (EoE) , a condition often associated with allergies and presenting with dysphagia.&lt;/li&gt;&lt;li&gt;âž¤ concentric rings (trachealization)&lt;/li&gt;&lt;li&gt;âž¤ Eosinophilic Esophagitis (EoE)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cytogenetic rearrangement in Acute promyelocytic leukemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(9;22)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(8;14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(8;16)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. t(15;17)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) t(15;17)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The characteristic cytogenetic abnormality in Acute Promyelocytic Leukemia (APL) is the t(15;17) translocation , which creates the PML-RARÎ± fusion protein and is a target for therapy with all-trans retinoic acid (ATRA).&lt;/li&gt;&lt;li&gt;âž¤ Acute Promyelocytic Leukemia (APL)&lt;/li&gt;&lt;li&gt;âž¤ t(15;17) translocation&lt;/li&gt;&lt;li&gt;âž¤ PML-RARÎ± fusion protein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following Esophageal pressure topography is suggestive of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Jackhammer esophagus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Achalasia cardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse esophageal spasm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Esophageal carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diffuse esophageal spasm&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-120013.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diffuse esophageal spasm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A distal latency of less than 4.5 seconds on esophageal pressure topography is indicative of Diffuse Esophageal Spasm (DES) , which is characterized by uncoordinated contractions of the distal esophagus, leading to dysphagia and chest pain.&lt;/li&gt;&lt;li&gt;âž¤ distal latency of less than 4.5 seconds&lt;/li&gt;&lt;li&gt;âž¤ Diffuse Esophageal Spasm (DES)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;TKI active in the setting of the T315I mutation in Chronic Myeloid Leukemia (CML)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dasatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nilotinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ponatinib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bosutinib&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ponatinib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ponatinib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ponatinib is the TKI that remains effective in CML patients with the T315I mutation , which is resistant to most other tyrosine kinase inhibitors.&lt;/li&gt;&lt;li&gt;âž¤ Ponatinib&lt;/li&gt;&lt;li&gt;âž¤ T315I mutation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Granulomatous colitis, oculocutaneous albinism, platelet dysfunction, and pulmonary fibrosis are seen in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wiskott-Aldrich syndrome (WAS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hermansky-Pudlak syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune dysregulation polyendocrinopathy, enteropathy X-linked (IPEX)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogen storage disease type B1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hermansky-Pudlak syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hermansky-Pudlak syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hermansky-Pudlak syndrome is characterized by a combination of oculocutaneous albinism , platelet dysfunction , granulomatous colitis , and pulmonary fibrosis , distinguishing it from other genetic syndromes.&lt;/li&gt;&lt;li&gt;âž¤ Hermansky-Pudlak syndrome&lt;/li&gt;&lt;li&gt;âž¤ oculocutaneous albinism&lt;/li&gt;&lt;li&gt;âž¤ platelet dysfunction&lt;/li&gt;&lt;li&gt;âž¤ granulomatous colitis&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Doubling time in Burkittâ€™s lymphoma is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt;24 h&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;48 h&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;72 h&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;96 h&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &lt;24 h&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) &amp;lt;24 h&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The doubling time in Burkittâ€™s lymphoma is typically less than 24 hours , reflecting the highly aggressive nature of this lymphoma.&lt;/li&gt;&lt;li&gt;âž¤ doubling time&lt;/li&gt;&lt;li&gt;âž¤ Burkittâ€™s lymphoma&lt;/li&gt;&lt;li&gt;âž¤ less than 24 hours&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Presence of scleral icterus indicates a serum bilirubin level of at least?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 3 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 3 mg/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of scleral icterus typically indicates a serum bilirubin level of at least 3 mg/dL .&lt;/li&gt;&lt;li&gt;âž¤ scleral icterus&lt;/li&gt;&lt;li&gt;âž¤ at least 3 mg/dL&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is/are expressed in cells with Hairy cell leukemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD22&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD103&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD25&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Hairy Cell Leukemia (HCL) , the leukemic cells express CD22 , CD103 , and CD25 , making these markers important for diagnosis and differentiation from other hematologic malignancies.&lt;/li&gt;&lt;li&gt;âž¤ Hairy Cell Leukemia (HCL)&lt;/li&gt;&lt;li&gt;âž¤ CD22&lt;/li&gt;&lt;li&gt;âž¤ CD103&lt;/li&gt;&lt;li&gt;âž¤ CD25&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient came for evaluation of ascites. His serum albumin is 3.5 g/dL, and his ascites fluid albumin is 1.8 g/dL. Which of the following can be a cause of ascites for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peritoneal carcinomatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nephrotic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cirrhosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A SAAG â‰¥ 1.1 g/dL suggests that the ascites is caused by portal hypertension , most commonly due to cirrhosis .&lt;/li&gt;&lt;li&gt;âž¤ SAAG â‰¥ 1.1 g/dL&lt;/li&gt;&lt;li&gt;âž¤ portal hypertension&lt;/li&gt;&lt;li&gt;âž¤ cirrhosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test3" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D   Mission 2.0 (Batch 3)   14 02 2025   2025 02 14&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D   Mission 2.0 (Batch 3)   14 02 2025   2025 02 14&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Rajesh, a 55-year-old businessman from Delhi, visits your clinic with complaints of chest discomfort and tightness that occurs during brisk walking and resolves within 5 minutes of rest. He mentions that these symptoms have been consistent over the past three months and are reproducible with similar levels of exertion. There are no associated symptoms like sweating or nausea at rest. Laboratory investigations are ordered. Which of the following findings are typically seen in such a case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â†‘Trop I, â†‘Myoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â†‘CK-MB, Normal Trop I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â†‘Myoglobin, Normal CK-MB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal cardiac enzymes&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Normal cardiac enzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Normal cardiac enzymes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Stable angina is characterized by predictable chest discomfort triggered by exertion or stress, which resolves with rest or nitroglycerin. It occurs due to a fixed atherosclerotic plaque limiting coronary blood flow without causing myocardial injury. Since there is no myocardial necrosis or significant injury, cardiac biomarkers such as Troponin I (Trop I), CK-MB, and Myoglobin remain within normal ranges.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. â†‘Trop I, â†‘Myoglobin: Elevated cardiac enzymes indicate myocardial injury, which is seen in acute coronary syndromes, not stable angina.&lt;/li&gt;&lt;li&gt;â€¢ Option A. â†‘Trop I, â†‘Myoglobin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. â†‘CK-MB, Normal Trop I: This pattern is also indicative of myocardial injury or ischemia, potentially from unstable angina or early myocardial infarction.&lt;/li&gt;&lt;li&gt;â€¢ Option B. â†‘CK-MB, Normal Trop I:&lt;/li&gt;&lt;li&gt;â€¢ Option C. â†‘Myoglobin, Normal CK-MB: Myoglobin elevation is non-specific and typically an early marker of myocardial injury, which does not occur in stable angina.&lt;/li&gt;&lt;li&gt;â€¢ Option C. â†‘Myoglobin, Normal CK-MB:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In stable angina, cardiac enzymes remain normal, as the condition reflects ischemia without myocardial injury or necrosis. Any rise in cardiac biomarkers should prompt evaluation for acute coronary syndromes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Vikram, a 45-year-old school teacher, is undergoing an exercise tolerance test as part of his cardiac evaluation for chest discomfort during exertion. He is asked to achieve his maximum predicted heart rate during the test for accurate assessment. What is his maximum predicted heart rate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;165/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;175/min&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;185/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;195/min&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 175/min&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) 175/min&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The maximum predicted heart rate (MPHR) during an exercise tolerance test is calculated using the formula:&lt;/li&gt;&lt;li&gt;â€¢ MPHR = 220 - Age&lt;/li&gt;&lt;li&gt;â€¢ MPHR = 220 - Age&lt;/li&gt;&lt;li&gt;â€¢ For a 45-year-old individual:&lt;/li&gt;&lt;li&gt;â€¢ MPHR = 220 - 45 = 175/min.&lt;/li&gt;&lt;li&gt;â€¢ Reaching this level indicates the maximum physiological heart rate under exertion. For a satisfactory test, the person should reach at least 85% of their MPHR (approximately 149/min in this case).&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 165/min: This is lower than the calculated MPHR for a 45-year-old and does not match the formula.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 165/min:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 185/min: This is higher than the calculated MPHR and represents an overestimation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 185/min:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 195/min: This is an even greater overestimation, unlikely for a 45-year-old based on the standard formula.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 195/min:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The maximum predicted heart rate is derived from the formula 220 - Age and is a crucial parameter in assessing exercise tolerance during a treadmill test.&lt;/li&gt;&lt;li&gt;âž¤ 220 - Age&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man from Kolkata is admitted with chest pain and diagnosed with a non-ST-elevation myocardial infarction (NSTEMI). Following a brief period of ischemia, his echocardiogram reveals prolonged myocardial dysfunction without infarction. Which of the following statements regarding myocardial stunning is not true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stunning is a state of depressed myocardial function due to chronic hypoperfusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stunning can be global or regional&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen free radicals and excess intracellular calcium likely contribute to stunning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stunning affects both systolic and diastolic function&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stunning is a state of depressed myocardial function due to chronic hypoperfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Stunning is a state of depressed myocardial function due to chronic hypoperfusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Myocardial stunning refers to reversible, prolonged myocardial dysfunction that occurs after a brief period of severe ischemia, even after reperfusion restores normal coronary blood flow. It is not caused by chronic hypoperfusion; this is a feature of myocardial hibernation. Oxygen free radicals, excess intracellular calcium, and inflammatory mediators play a role in the pathogenesis of stunning. Both systolic and diastolic functions are affected in stunning, and it may occur globally or regionally in ischemic myocardium.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stunning can be global or regional: This is true, as stunning may affect the entire myocardium or specific ischemic regions.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stunning can be global or regional:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oxygen free radicals and excess intracellular calcium likely contribute to stunning: These are important mediators in the pathophysiology of myocardial stunning.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Oxygen free radicals and excess intracellular calcium likely contribute to stunning:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stunning affects both systolic and diastolic function: Stunning impacts the contractility (systolic function) and relaxation (diastolic function) of the myocardium.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stunning affects both systolic and diastolic function:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myocardial stunning is a reversible condition resulting from transient ischemia and reperfusion injury, distinct from chronic hypoperfusion (myocardial hibernation). Understanding its mechanisms helps guide appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man presents to the emergency department with sudden onset chest pain radiating to his left arm. An ECG is performed immediately. Which of the following is the earliest finding in a patient with suspected acute myocardial infarction (AMI)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prolonged QT interval&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tall T wave&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Terminal QRS distortion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ST depression&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tall T wave&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tall T wave&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In the early stages of acute myocardial infarction, tall, broad-based, and symmetrical T waves appear due to local hyperkalemia in ischemic myocardial cells. These T waves are often referred to as \&quot;hyperacute T waves\&quot; and are one of the earliest ECG changes seen in AMI, occurring even before ST-segment changes.&lt;/li&gt;&lt;li&gt;â€¢ tall, broad-based, and symmetrical T waves&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prolonged QT interval: While QT prolongation can occur, it is not an immediate finding and typically follows T-wave changes in the ischemic cascade.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prolonged QT interval:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Terminal QRS distortion: This finding lacks a defined timeframe and may not be present in all patients with AMI.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Terminal QRS distortion:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ST depression: This is typically seen in reciprocal leads in the context of ST-elevation myocardial infarction (STEMI) and is not the earliest change.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ST depression:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyperacute T waves are the earliest ECG changes in acute myocardial infarction and should prompt immediate attention and further evaluation for timely intervention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man is brought to the emergency room with complaints of sudden onset chest pain, diaphoresis, and giddiness. On arrival, his blood pressure is 86/60 mmHg. An immediate ECG reveals signs of inferoposterior wall myocardial infarction (MI). Which of the following is most useful in the management of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sublingual nitrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV nitrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV fluids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. IV fluids&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20133439.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) IV fluids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patientâ€™s clinical presentation and ECG findings suggest an inferoposterior wall MI, which is commonly associated with right ventricular myocardial infarction (RVMI). Low blood pressure in RVMI is often due to reduced preload caused by impaired right ventricular function. Administration of IV fluids is essential to optimize preload and maintain adequate cardiac output.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sublingual nitrate: Nitrates reduce preload and may worsen hypotension in RVMI; they are contraindicated.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sublingual nitrate:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV nitrates: Similar to sublingual nitrates, IV nitrates decrease preload and can exacerbate hemodynamic instability.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV nitrates:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Morphine: While morphine can help alleviate pain, it also causes vasodilation and further reduces preload, which is detrimental in RVMI.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Morphine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with RVMI, maintaining adequate preload with IV fluids is crucial for stabilizing hemodynamics. Nitrates and preload-reducing medications should be avoided as they can exacerbate hypotension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with a history of obesity and hypertension presents with symptoms of dyspnea and orthopnea. Brain natriuretic peptide (BNP) levels are assessed to evaluate heart failure. In which of the following conditions might falsely low BNP values be observed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Advanced age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Female gender&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoking&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Obesity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Obesity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Obesity is associated with increased clearance and metabolism of BNP, resulting in lower-than-expected levels. Despite the presence of heart failure, obese individuals may show reduced BNP levels due to altered natriuretic peptide physiology. Other conditions such as constrictive pericarditis, cardiac tamponade, and flash pulmonary edema can also lead to lower BNP values.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Advanced age: BNP levels tend to increase with age due to reduced renal clearance and ventricular stiffness.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Advanced age:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Female gender: BNP levels are higher in females due to hormonal differences, particularly estrogen effects.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Female gender:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Smoking: Smoking is associated with elevated BNP levels due to endothelial dysfunction and subclinical cardiac stress.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Smoking:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Obesity can result in falsely low BNP levels due to increased clearance and metabolism, and clinicians should interpret BNP values cautiously in this population when evaluating for heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with heart failure is being evaluated for the risk of sudden cardiac death (SCD). Based on NYHA classification, in which of the following classes is the risk of sudden cardiac death proportionally highest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Class II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Patients with NYHA Class II heart failure have a high risk of sudden cardiac death (SCD) relative to their total mortality. Although absolute mortality increases with the severity of heart failure, the proportion of deaths due to SCD decreases in advanced heart failure. The MERIT-HF trial demonstrated that while patients with NYHA Class II, III, and IV had increasing absolute rates of SCD (6.3%, 10.5%, and 18.6%, respectively), the percentage of total deaths attributed to SCD decreased (64%, 59%, and 33%, respectively).&lt;/li&gt;&lt;li&gt;â€¢ NYHA Class II heart failure&lt;/li&gt;&lt;li&gt;â€¢ MERIT-HF trial&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class I: Incorrect. NYHA Class I patients have a low risk of death.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Class I:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Class III: SCD risk is high but represents a smaller proportion of total mortality compared to Class II.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Class III:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class IV: Although the absolute risk of death is highest, most deaths are due to progressive pump failure rather than SCD.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Class IV:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The risk of sudden cardiac death is proportionally highest in patients with NYHA Class II heart failure, making this group a key target for preventive strategies like implantable cardioverter-defibrillators (ICDs).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man presents with exertional dyspnea and left ventricular hypertrophy on echocardiography. Myocardial biopsy reveals myocyte disarray and interstitial fibrosis. Which of the following disorders is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fabry disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Keshan&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypereosinophilic syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fabry disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fabry disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Fabry disease, an X-linked lysosomal storage disorder, is caused by a deficiency of Î±-galactosidase A leading to the accumulation of globotriaosylceramide. This results in hypertrophic cardiomyopathy (HCM), characterized by myocyte disarray and interstitial fibrosis on myocardial biopsy. These histological changes correlate with an increased risk of sudden cardiac death in affected individuals.&lt;/li&gt;&lt;li&gt;â€¢ Î±-galactosidase A&lt;/li&gt;&lt;li&gt;â€¢ myocyte disarray and interstitial fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pheochromocytoma: Causes dilated cardiomyopathy (DCM) due to catecholamine-induced myocardial injury, not hypertrophy or myocyte disarray.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pheochromocytoma:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Keshan&#x27;s disease: A selenium deficiency-related cardiomyopathy, presenting as DCM with no myocyte disarray.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Keshan&#x27;s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypereosinophilic syndrome: Characterized by eosinophilic infiltration causing endomyocardial fibrosis, not myocyte disarray.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypereosinophilic syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myocyte disarray and interstitial fibrosis on myocardial biopsy are hallmark features of hypertrophic cardiomyopathy (HCM), which can be seen in genetic conditions like Fabry disease. Early recognition and management are crucial to reduce the risk of sudden cardiac death.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The Brockenbrough-Braunwald-Morrow sign, characterized by a decrease in systolic blood pressure and an increase in left ventricular systolic pressure following a premature ventricular contraction (PVC), is seen in which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertrophic cardiomyopathy (HCM)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dilated cardiomyopathy (DCM)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Restrictive cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Takotsubo cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypertrophic cardiomyopathy (HCM)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypertrophic cardiomyopathy (HCM)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Brockenbrough-Braunwald-Morrow sign is a hallmark of hypertrophic cardiomyopathy (HCM) with left ventricular outflow tract (LVOT) obstruction. In HCM, a post-PVC beat leads to an increase in contractility, worsening the obstruction and resulting in a paradoxical decrease in systolic blood pressure despite an increase in left ventricular systolic pressure .&lt;/li&gt;&lt;li&gt;â€¢ Brockenbrough-Braunwald-Morrow sign&lt;/li&gt;&lt;li&gt;â€¢ decrease in systolic blood pressure&lt;/li&gt;&lt;li&gt;â€¢ left ventricular systolic pressure&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dilated cardiomyopathy (DCM): Characterized by systolic dysfunction and chamber dilation, DCM does not cause LVOT obstruction or this sign.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Dilated cardiomyopathy (DCM):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Restrictive cardiomyopathy: Marked by impaired diastolic filling with normal ventricular dimensions, it is not associated with dynamic LVOT obstruction or this sign.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Restrictive cardiomyopathy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Takotsubo cardiomyopathy: A stress-induced cardiomyopathy causing transient systolic dysfunction, unrelated to LVOT obstruction or this phenomenon.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Takotsubo cardiomyopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Brockenbrough-Braunwald-Morrow sign is a specific finding in HCM with dynamic LVOT obstruction and helps differentiate it from other cardiomyopathies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man with Marfan syndrome presents with worsening chest pain and dyspnea. On examination, asymmetrical pulses are noted, and a chest X-ray reveals a widened mediastinum. A CT angiogram confirms thoracic aortic aneurysm. Which of the following is true regarding the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Operative repair indicated if diameter &amp;gt;5.5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Operative repair if diameter &amp;gt;4-5 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Operative repair if diameter &amp;gt;6 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Operative repair if diameter &amp;gt;4.5 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Operative repair if diameter &gt;4-5 cm&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20133521.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Operative repair if diameter &amp;gt;4-5 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In Marfan syndrome, the risk of aortic dissection increases at smaller aortic diameters compared to the general population. Current guidelines recommend operative repair for thoracic aortic aneurysms in Marfan syndrome patients:&lt;/li&gt;&lt;li&gt;â€¢ operative repair for thoracic aortic aneurysms&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;5.0 cm in asymptomatic patients or those with a family history of aortic dissection. &amp;gt;4.0 cm in women planning pregnancy. &amp;gt;4.5 cm when undergoing other cardiothoracic surgeries.&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;5.0 cm in asymptomatic patients or those with a family history of aortic dissection.&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;5.0 cm&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;4.0 cm in women planning pregnancy.&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;4.0 cm&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;4.5 cm when undergoing other cardiothoracic surgeries.&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;4.5 cm&lt;/li&gt;&lt;li&gt;â€¢ The vignette describes a Marfan syndrome patient with features suggestive of aortic dissection or aneurysm, where a diameter of 4â€“5 cm warrants repair to prevent catastrophic rupture or dissection.&lt;/li&gt;&lt;li&gt;â€¢ 4â€“5 cm warrants repair&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;gt;5.5 cm: This is the threshold for repair in patients without Marfan syndrome or bicuspid aortic valve (BAV).&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;gt;5.5 cm:&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;gt;6 cm: This is the threshold for descending thoracic aortic aneurysms, not applicable here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;gt;6 cm:&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;4.5 cm: While significant, this threshold applies in patients undergoing concurrent cardiothoracic surgery.&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;4.5 cm:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with Marfan syndrome require earlier surgical intervention for thoracic aortic aneurysms due to their increased risk of dissection. Aneurysms &amp;gt;4â€“5 cm should prompt consideration for operative repair.&lt;/li&gt;&lt;li&gt;âž¤ Aneurysms &amp;gt;4â€“5 cm should prompt consideration for operative repair.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents to the clinic with complaints of progressive exertional dyspnea and fatigue. An ECG is performed and is shown below. What is the likely cardiac axis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right axis deviation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left axis deviation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extreme axis deviation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Physiological left axis deviation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Right axis deviation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20170945.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Right axis deviation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The ECG findings of a negative QRS complex in Lead I and a positive QRS complex in Lead aVF indicate right axis deviation (RAD) . This axis shift is commonly associated with conditions like COPD, pulmonary hypertension, or right ventricular hypertrophy.&lt;/li&gt;&lt;li&gt;â€¢ negative QRS complex in Lead I&lt;/li&gt;&lt;li&gt;â€¢ positive QRS complex in Lead aVF&lt;/li&gt;&lt;li&gt;â€¢ right axis deviation (RAD)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left axis deviation: Requires a positive Lead I and a negative Lead aVF , not seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left axis deviation:&lt;/li&gt;&lt;li&gt;â€¢ positive Lead I&lt;/li&gt;&lt;li&gt;â€¢ negative Lead aVF&lt;/li&gt;&lt;li&gt;â€¢ Option C. Extreme axis deviation: Requires both Lead I (-) and Lead aVF (-) .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Extreme axis deviation:&lt;/li&gt;&lt;li&gt;â€¢ Lead I (-)&lt;/li&gt;&lt;li&gt;â€¢ Lead aVF (-)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Physiological left axis deviation: This is a mild leftward axis shift seen with Lead I (+) and Lead II (+) , which is not consistent with the given findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Physiological left axis deviation:&lt;/li&gt;&lt;li&gt;â€¢ Lead I (+)&lt;/li&gt;&lt;li&gt;â€¢ Lead II (+)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Right axis deviation is often associated with pulmonary diseases and conditions causing right ventricular overload. It is characterized by a negative Lead I and a positive Lead aVF on ECG.&lt;/li&gt;&lt;li&gt;âž¤ negative Lead I&lt;/li&gt;&lt;li&gt;âž¤ positive Lead aVF&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man with a history of depression, presents to the emergency room with giddiness and fatigue. On arrival, his blood pressure is 80/60 mmHg. ECG is done and it is shown. Which of the following drugs is appropriate for the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antiarrhythmics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous sodium bicarbonate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous sodium bicarbonate&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20133622.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intravenous sodium bicarbonate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patientâ€™s presentation suggests tricyclic antidepressant (TCA) toxicity , characterized by sodium channel blockade leading to wide QRS complexes, sinus tachycardia, hypotension, and specific ECG findings (e.g., an \&quot;S\&quot; wave in lead I and a terminal R wave in lead aVR). Intravenous sodium bicarbonate is the first-line treatment as it:&lt;/li&gt;&lt;li&gt;â€¢ tricyclic antidepressant (TCA) toxicity&lt;/li&gt;&lt;li&gt;â€¢ Intravenous sodium bicarbonate&lt;/li&gt;&lt;li&gt;â€¢ Alkalinizes the serum, reducing drug binding to sodium channels. Increases extracellular sodium concentration, overcoming sodium channel blockade.&lt;/li&gt;&lt;li&gt;â€¢ Alkalinizes the serum, reducing drug binding to sodium channels.&lt;/li&gt;&lt;li&gt;â€¢ Increases extracellular sodium concentration, overcoming sodium channel blockade.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antiarrhythmics: Drugs like class IA, IC, or amiodarone may worsen sodium channel blockade and are contraindicated.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antiarrhythmics:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Propranolol: A beta-blocker that can exacerbate hypotension and bradycardia in TCA toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Propranolol:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenytoin: Not effective in managing sodium channel blockade caused by TCA overdose.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Phenytoin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TCA toxicity causes life-threatening arrhythmias and hypotension due to sodium channel blockade. IV sodium bicarbonate is the antidote, and early administration is critical to prevent complications like seizures and arrhythmias.&lt;/li&gt;&lt;li&gt;âž¤ TCA toxicity&lt;/li&gt;&lt;li&gt;âž¤ IV sodium bicarbonate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male with a recent history of CABG presents with chest pain. On arrival, his BP is 60/30 mmHg, and his HR is 30/min. The ECG shows a narrow-complex bradyarrhythmia. He receives three boluses of IV atropine without improvement. While awaiting transcutaneous pacing, what is the next appropriate step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Another bolus of atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV norepinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV dopamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV dobutamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV dopamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20133643.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IV dopamine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ IV dopamine is the next step in managing symptomatic bradycardia when atropine is ineffective. Dopamine stimulates D1 , B1 , and A1 receptors , increasing both heart rate and blood pressure. This dual effect is particularly beneficial in patients with bradycardia and hypotension. Dopamine is a recommended vasopressor and inotrope in the ACLS algorithm for symptomatic bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ D1&lt;/li&gt;&lt;li&gt;â€¢ B1&lt;/li&gt;&lt;li&gt;â€¢ A1 receptors&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Another bolus of atropine: ACLS guidelines limit atropine to a maximum of three boluses for symptomatic bradycardia. Additional doses are unlikely to be beneficial.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Another bolus of atropine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV norepinephrine: Although norepinephrine raises BP through A1 agonism , it may cause reflex bradycardia and is not first-line for bradyarrhythmia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV norepinephrine:&lt;/li&gt;&lt;li&gt;â€¢ A1 agonism&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV dobutamine: Dobutamine predominantly acts on B1 and B2 receptors , enhancing inotropy but causing peripheral vasodilation due to B2 stimulation, which could exacerbate hypotension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV dobutamine:&lt;/li&gt;&lt;li&gt;â€¢ B1 and B2 receptors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In symptomatic bradycardia unresponsive to atropine, IV dopamine is a logical next step while preparing for transcutaneous pacing, as it effectively increases both heart rate and blood pressure.&lt;/li&gt;&lt;li&gt;âž¤ IV dopamine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old IT employee developed sudden loss of consciousness after hearing an ambulance alarm. On arrival to the emergency room, she was hemodynamically stable. She reports a history of similar episodes in the past. An ECG is performed and it is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congenital Long QT syndrome Type 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congenital Long QT syndrome Type 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Catecholaminergic polymorphic ventricular tachycardia (VT)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Short QT syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Congenital Long QT syndrome Type 2&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20133700.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Congenital Long QT syndrome Type 2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation of syncope triggered by a startling noise (e.g., an ambulance alarm) with a prolonged QT interval and bifid T waves on ECG strongly suggests Congenital Long QT syndrome Type 2 (LQT2) .&lt;/li&gt;&lt;li&gt;â€¢ startling noise&lt;/li&gt;&lt;li&gt;â€¢ bifid T waves&lt;/li&gt;&lt;li&gt;â€¢ Congenital Long QT syndrome Type 2 (LQT2)&lt;/li&gt;&lt;li&gt;â€¢ LQT2 is caused by mutations in the KCNH2 gene, which affects the delayed rectifier potassium current (IKr). The condition is typically triggered by sudden loud noises, alarms, or emotional stress. Beta-blockers Â± ICD (implantable cardioverter-defibrillator) are the standard treatment.&lt;/li&gt;&lt;li&gt;â€¢ LQT2 is caused by mutations in the KCNH2 gene, which affects the delayed rectifier potassium current (IKr).&lt;/li&gt;&lt;li&gt;â€¢ LQT2&lt;/li&gt;&lt;li&gt;â€¢ KCNH2&lt;/li&gt;&lt;li&gt;â€¢ The condition is typically triggered by sudden loud noises, alarms, or emotional stress.&lt;/li&gt;&lt;li&gt;â€¢ Beta-blockers Â± ICD (implantable cardioverter-defibrillator) are the standard treatment.&lt;/li&gt;&lt;li&gt;â€¢ Beta-blockers Â± ICD (implantable cardioverter-defibrillator)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congenital Long QT syndrome Type 1: Associated with exercise or swimming as triggers and wide-based T waves on ECG, not bifid T waves.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congenital Long QT syndrome Type 1:&lt;/li&gt;&lt;li&gt;â€¢ exercise or swimming&lt;/li&gt;&lt;li&gt;â€¢ Option C. Catecholaminergic polymorphic VT: Triggers include exercise or emotional stress , but the ECG is typically normal at rest, showing polymorphic VT during stress.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Catecholaminergic polymorphic VT:&lt;/li&gt;&lt;li&gt;â€¢ exercise or emotional stress&lt;/li&gt;&lt;li&gt;â€¢ Option D. Short QT syndrome: Characterized by a shortened QT interval and high risk of arrhythmias but not associated with noise-triggered syncope.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Short QT syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Congenital Long QT syndrome Type 2 (LQT2) presents with syncope triggered by auditory or emotional stimuli and bifid T waves on ECG. Early diagnosis and treatment are critical to prevent sudden cardiac death.&lt;/li&gt;&lt;li&gt;âž¤ Congenital Long QT syndrome Type 2 (LQT2)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with recurrent episodes of palpitations. On arrival, he is stable, and an ECG is performed and shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RBBB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LBBB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brugada syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WPW syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Brugada syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20133720.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Brugada syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The ECG findings of RBBB-like morphology , ST-segment elevation with a \&quot;coved\&quot; pattern in leads V1â€“V3 , and T-wave inversion in V1â€“V4 are characteristic of Brugada syndrome . This condition is associated with mutations in sodium channel genes (e.g., SCN5A) and carries a high risk of sudden cardiac death due to ventricular arrhythmias.&lt;/li&gt;&lt;li&gt;â€¢ RBBB-like morphology&lt;/li&gt;&lt;li&gt;â€¢ ST-segment elevation with a \&quot;coved\&quot; pattern in leads V1â€“V3&lt;/li&gt;&lt;li&gt;â€¢ T-wave inversion in V1â€“V4&lt;/li&gt;&lt;li&gt;â€¢ Brugada syndrome&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. RBBB: RBBB does not cause ST-segment elevation or T-wave inversions in the anterior leads. It follows an \&quot;appropriate discordance\&quot; rule where ST changes are opposite to the terminal deflection of the QRS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. RBBB:&lt;/li&gt;&lt;li&gt;â€¢ Option B. LBBB: LBBB shows wide QRS complexes with characteristic patterns, but it does not produce ST-segment elevation in V1â€“V3.&lt;/li&gt;&lt;li&gt;â€¢ Option B. LBBB:&lt;/li&gt;&lt;li&gt;â€¢ Option D. WPW syndrome: Characterized by delta waves , a short PR interval , and wide QRS complexes , none of which are present in this ECG.&lt;/li&gt;&lt;li&gt;â€¢ Option D. WPW syndrome:&lt;/li&gt;&lt;li&gt;â€¢ delta waves&lt;/li&gt;&lt;li&gt;â€¢ short PR interval&lt;/li&gt;&lt;li&gt;â€¢ wide QRS complexes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brugada syndrome is identified by its unique ECG pattern in V1â€“V3 and is a significant cause of sudden cardiac death in young individuals. Early diagnosis is critical, with ICD placement often recommended for high-risk patients.&lt;/li&gt;&lt;li&gt;âž¤ Brugada syndrome&lt;/li&gt;&lt;li&gt;âž¤ ICD placement&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old pregnant woman, G2P1L1, at 37 weeks of gestation presents with worsening headache, blurred vision, and reduced perception of fetal movements. On arrival, her BP is 200/100 mmHg. ECG is taken and shown. What is the best management for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV MgSO4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defibrillation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV MgSO4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20133741.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV MgSO4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient has torsades de pointes , characterized by polymorphic ventricular tachycardia associated with a prolonged QT interval. The definitive treatment is intravenous magnesium sulfate (IV MgSO4) , which stabilizes the myocardial membrane and prevents recurrent episodes by shortening the QT interval. IV MgSO4 is also safe during pregnancy, making it the treatment of choice.&lt;/li&gt;&lt;li&gt;â€¢ torsades de pointes&lt;/li&gt;&lt;li&gt;â€¢ intravenous magnesium sulfate (IV MgSO4)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV Lignocaine: Used for monomorphic ventricular tachycardia, particularly in ischemic heart disease, but it is not effective for torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IV Lignocaine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV Amiodarone: Appropriate for wide-complex tachycardias, but it can prolong the QT interval, worsening torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. IV Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Defibrillation: Indicated for pulseless ventricular tachycardia or ventricular fibrillation, but not for hemodynamically stable torsades de pointes.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Defibrillation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In torsades de pointes , particularly in the setting of prolonged QT interval, IV magnesium sulfate is the first-line treatment, even during pregnancy, due to its safety and efficacy.&lt;/li&gt;&lt;li&gt;âž¤ torsades de pointes&lt;/li&gt;&lt;li&gt;âž¤ IV magnesium sulfate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man presents to the emergency department with sudden onset right-sided weakness and slurred speech that began 3 hours ago. His blood pressure on arrival is 190/110 mmHg. He has a history of myocardial infarction 2 months ago and a history of gastrointestinal bleeding 15 days ago. A non-contrast CT head shows no hemorrhage. Which of the following is a contraindication for thrombolysis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BP &amp;gt;185/110 mmHg despite treatment&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myocardial infarction 2 months ago&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gastrointestinal bleeding in the preceding 21 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Age &amp;gt;60 years&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. BP &gt;185/110 mmHg despite treatment&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) BP &amp;gt;185/110 mmHg despite treatment&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Thrombolysis in acute ischemic stroke requires strict adherence to contraindication criteria. Sustained increased BP &amp;gt;185/110 mmHg despite treatment is an absolute contraindication because of the high risk of intracranial hemorrhage. Blood pressure must be lowered to below this threshold before considering thrombolysis. Other absolute contraindications include recent gastrointestinal bleeding (within 21 days), major surgery (within 14 days), or recent myocardial infarction (if high hemorrhagic risk).&lt;/li&gt;&lt;li&gt;â€¢ Sustained increased BP &amp;gt;185/110 mmHg despite treatment&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myocardial infarction 2 months ago: This is not an absolute contraindication unless the patient has ongoing hemorrhagic risk.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Myocardial infarction 2 months ago:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gastrointestinal bleeding in the preceding 21 days: While a contraindication, it is not the most relevant answer in this vignette, where uncontrolled BP is the immediate concern.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Gastrointestinal bleeding in the preceding 21 days:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Age &amp;gt;60 years: Age alone is not a contraindication for thrombolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Age &amp;gt;60 years:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thrombolysis in ischemic stroke requires careful evaluation of contraindications, with uncontrolled hypertension being a critical factor to address before administration. Treat BP aggressively to below 185/110 mmHg before initiating rtPA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents with recurrent episodes of migraine headaches, progressive memory loss, and multiple transient ischemic attacks over the past few years. His family history reveals similar symptoms in his father and grandfather, both of whom developed dementia in their 50s. MRI of the brain shows diffuse white matter hyperintensities, particularly in the anterior temporal lobes. Genetic testing is performed. Which gene is most likely mutated in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Notch-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Notch-2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Notch-3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Notch-4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Notch-3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Notch-3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ CADASIL is an inherited disorder of the small cerebral arteries leading to recurrent subcortical strokes , progressive dementia, and white matter changes on MRI, especially in the anterior temporal lobes . It is caused by mutations in the Notch-3 gene located on chromosome 19, which encodes a transmembrane receptor involved in vascular smooth muscle function. These mutations result in abnormal accumulation of granular osmiophilic material (GOM) in vascular smooth muscle cells, leading to progressive vascular damage.&lt;/li&gt;&lt;li&gt;â€¢ recurrent subcortical strokes&lt;/li&gt;&lt;li&gt;â€¢ anterior temporal lobes&lt;/li&gt;&lt;li&gt;â€¢ Notch-3 gene&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Notch-1: Associated with other developmental and oncological disorders, not CADASIL.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Notch-1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Notch-2: Implicated in Alagille syndrome, a genetic disorder affecting the liver, heart, and skeletal system.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Notch-2:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Notch-4: Has limited known associations with human vascular diseases.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Notch-4:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Notch-3 mutations are pathognomonic for CADASIL , an autosomal dominant disorder characterized by recurrent strokes, dementia, and anterior temporal lobe involvement on MRI. Early recognition is critical for genetic counseling and management.&lt;/li&gt;&lt;li&gt;âž¤ Notch-3 mutations&lt;/li&gt;&lt;li&gt;âž¤ CADASIL&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman with a history of atrial fibrillation presents for routine follow-up. She has a history of hypertension and diabetes but denies any recent symptoms. Her medications include antihypertensives and oral hypoglycemics. On examination, she is in normal sinus rhythm. Her physician decides to assess her stroke risk. Which of the following is not a component of the score used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congestive heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Smoking&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Previous stroke&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Smoking&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Smoking&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The CHAâ‚‚DSâ‚‚-VASc score is used to estimate stroke risk in patients with atrial fibrillation. It includes:&lt;/li&gt;&lt;li&gt;â€¢ CHAâ‚‚DSâ‚‚-VASc score&lt;/li&gt;&lt;li&gt;â€¢ C : Congestive heart failure (+1) H : Hypertension (+1) Aâ‚‚ : Age â‰¥75 years (+2) D : Diabetes mellitus (+1) Sâ‚‚ : Prior stroke, TIA, or thromboembolism (+2) V : Vascular disease (e.g., prior MI, PAD) (+1) A : Age 65â€“74 years (+1) Sc : Sex category (female) (+1)&lt;/li&gt;&lt;li&gt;â€¢ C : Congestive heart failure (+1)&lt;/li&gt;&lt;li&gt;â€¢ C&lt;/li&gt;&lt;li&gt;â€¢ H : Hypertension (+1)&lt;/li&gt;&lt;li&gt;â€¢ H&lt;/li&gt;&lt;li&gt;â€¢ Aâ‚‚ : Age â‰¥75 years (+2)&lt;/li&gt;&lt;li&gt;â€¢ Aâ‚‚&lt;/li&gt;&lt;li&gt;â€¢ D : Diabetes mellitus (+1)&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ Sâ‚‚ : Prior stroke, TIA, or thromboembolism (+2)&lt;/li&gt;&lt;li&gt;â€¢ Sâ‚‚&lt;/li&gt;&lt;li&gt;â€¢ V : Vascular disease (e.g., prior MI, PAD) (+1)&lt;/li&gt;&lt;li&gt;â€¢ V&lt;/li&gt;&lt;li&gt;â€¢ A : Age 65â€“74 years (+1)&lt;/li&gt;&lt;li&gt;â€¢ A&lt;/li&gt;&lt;li&gt;â€¢ Sc : Sex category (female) (+1)&lt;/li&gt;&lt;li&gt;â€¢ Sc&lt;/li&gt;&lt;li&gt;â€¢ Smoking is not a component of this score but is an independent cardiovascular risk factor.&lt;/li&gt;&lt;li&gt;â€¢ not a component&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congestive heart failure: A key component of the score, contributing 1 point.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congestive heart failure:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Age: Age â‰¥75 years scores 2 points, and 65â€“74 years scores 1 point.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Age:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Previous stroke: A prior stroke, TIA, or thromboembolism adds 2 points, reflecting a high risk of recurrence.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Previous stroke:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The CHAâ‚‚DSâ‚‚-VASc score is a validated tool for assessing stroke risk in atrial fibrillation, excluding factors like smoking, which are not part of its criteria.&lt;/li&gt;&lt;li&gt;âž¤ CHAâ‚‚DSâ‚‚-VASc score&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man presents to the emergency department with sudden onset weakness on the left side of his body and altered consciousness. On arrival, his Glasgow Coma Scale (GCS) score is 10. A CT scan reveals a supratentorial intracerebral hemorrhage measuring 40 mL with intraventricular extension. His vitals are stable, and his family denies any significant past medical history. Which of the following is not a component of the score used to predict his prognosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;GCS score&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Volume of blood&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gender&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Gender&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Gender&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The ICH score is a validated tool used to predict mortality in patients with intracerebral hemorrhage. It includes the following components:&lt;/li&gt;&lt;li&gt;â€¢ ICH score&lt;/li&gt;&lt;li&gt;â€¢ Glasgow Coma Scale (GCS): Lower scores indicate worse prognosis (3â€“4 = 2 points, 5â€“12 = 1 point, 13â€“15 = 0 points). ICH Volume: Hemorrhages &amp;gt;30 mL score 1 point; â‰¤30 mL score 0 points. Intraventricular Hemorrhage (IVH): Presence of IVH scores 1 point; absence scores 0 points. Location: Infratentorial hemorrhages score 1 point; supratentorial score 0 points. Age: Age &amp;gt;80 years scores 1 point; â‰¤80 years scores 0 points.&lt;/li&gt;&lt;li&gt;â€¢ Glasgow Coma Scale (GCS): Lower scores indicate worse prognosis (3â€“4 = 2 points, 5â€“12 = 1 point, 13â€“15 = 0 points).&lt;/li&gt;&lt;li&gt;â€¢ Glasgow Coma Scale (GCS):&lt;/li&gt;&lt;li&gt;â€¢ ICH Volume: Hemorrhages &amp;gt;30 mL score 1 point; â‰¤30 mL score 0 points.&lt;/li&gt;&lt;li&gt;â€¢ ICH Volume:&lt;/li&gt;&lt;li&gt;â€¢ Intraventricular Hemorrhage (IVH): Presence of IVH scores 1 point; absence scores 0 points.&lt;/li&gt;&lt;li&gt;â€¢ Intraventricular Hemorrhage (IVH):&lt;/li&gt;&lt;li&gt;â€¢ Location: Infratentorial hemorrhages score 1 point; supratentorial score 0 points.&lt;/li&gt;&lt;li&gt;â€¢ Location:&lt;/li&gt;&lt;li&gt;â€¢ Age: Age &amp;gt;80 years scores 1 point; â‰¤80 years scores 0 points.&lt;/li&gt;&lt;li&gt;â€¢ Age:&lt;/li&gt;&lt;li&gt;â€¢ Gender is not a component of the ICH score.&lt;/li&gt;&lt;li&gt;â€¢ Gender&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. GCS score: A critical determinant of prognosis in ICH patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. GCS score:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Volume of blood: Larger hematomas (&amp;gt; 30mL) are associated with higher mortality.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Volume of blood:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Age: Older age (&amp;gt;80 years) worsens prognosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Age:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The ICH score assesses prognosis in intracerebral hemorrhage based on GCS , ICH volume , IVH presence , location , and age , but it does not include gender as a factor.&lt;/li&gt;&lt;li&gt;âž¤ ICH score&lt;/li&gt;&lt;li&gt;âž¤ GCS&lt;/li&gt;&lt;li&gt;âž¤ ICH volume&lt;/li&gt;&lt;li&gt;âž¤ IVH presence&lt;/li&gt;&lt;li&gt;âž¤ location&lt;/li&gt;&lt;li&gt;âž¤ age&lt;/li&gt;&lt;li&gt;âž¤ gender&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with a history of hypertension presents with sudden onset right-sided weakness and numbness. Which of the following is incorrect regarding MCA infarcts?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contralateral hemiplegia, hemianesthesia, and homonymous hemianopia are seen if the entire MCA is occluded at its origin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dysarthria is rare in MCA lesions.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;When the dominant hemisphere is involved, global aphasia is present.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;When the nondominant hemisphere is affected, anosognosia, constructional apraxia, and neglect are found.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dysarthria is rare in MCA lesions.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dysarthria is rare in MCA lesions.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Dysarthria is common in MCA lesions due to facial weakness caused by involvement of the motor cortex areas supplying the face and mouth. The MCA supplies both cortical and penetrating branches that affect motor and sensory functions on the contralateral side.&lt;/li&gt;&lt;li&gt;â€¢ Dysarthria is common&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contralateral hemiplegia, hemianesthesia, and homonymous hemianopia: These findings are characteristic of MCA occlusion at its origin due to disruption of both penetrating and cortical branches.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contralateral hemiplegia, hemianesthesia, and homonymous hemianopia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. When the dominant hemisphere is involved, global aphasia is present: This is true as the dominant hemisphere (usually the left) includes Brocaâ€™s and Wernickeâ€™s areas.&lt;/li&gt;&lt;li&gt;â€¢ Option C. When the dominant hemisphere is involved, global aphasia is present:&lt;/li&gt;&lt;li&gt;â€¢ Option D. When the nondominant hemisphere is affected, anosognosia, constructional apraxia, and neglect are found: These symptoms occur due to spatial and attentional deficits linked to nondominant hemisphere involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option D. When the nondominant hemisphere is affected, anosognosia, constructional apraxia, and neglect are found:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MCA infarctions produce significant neurological deficits, including contralateral motor and sensory loss, aphasia (dominant hemisphere), or neglect (nondominant hemisphere) . Dysarthria is a common symptom due to facial muscle involvement.&lt;/li&gt;&lt;li&gt;âž¤ contralateral motor and sensory loss, aphasia (dominant hemisphere), or neglect (nondominant hemisphere)&lt;/li&gt;&lt;li&gt;âž¤ common symptom&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly patient presents with difficulty in visual scanning and spatial perception. On examination, simultagnosia is identified. Lesions in which region of the brain are most likely to cause this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Watershed area between anterior and middle cerebral artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Watershed area between posterior and middle cerebral artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal PCAs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal ACAs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Watershed area between posterior and middle cerebral artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Watershed area between posterior and middle cerebral artery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Balintâ€™s syndrome is caused by bilateral damage to the visual association areas in the brain. This typically occurs in the \&quot;watershed\&quot; zone between the posterior cerebral artery (PCA) and the middle cerebral artery (MCA), where the blood supply is most vulnerable to ischemia during low-flow states such as cardiac arrest or systemic hypotension. The syndrome is characterized by three primary features: simultanagnosia (inability to perceive multiple objects simultaneously), optic ataxia (difficulty in reaching for objects under visual guidance), and ocular apraxia (difficulty in initiating voluntary eye movements).&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Watershed area between anterior and middle cerebral artery : Lesions here predominantly affect motor or executive functions rather than visual-spatial integration.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A&lt;/li&gt;&lt;li&gt;â€¢ Watershed area between anterior and middle cerebral artery&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bilateral infarction in the distal PCAs : While bilateral PCA infarctions can cause visual deficits like cortical blindness, but Balint syndrome is more specific to watershed infarctions between the posterior and middle cerebral arteries.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Bilateral infarction in the distal PCAs&lt;/li&gt;&lt;li&gt;â€¢ Option D . Bilateral infarction in the distal ACAs : These infarctions are associated with frontal lobe dysfunctions, such as behavioral changes or lower limb weakness, not visual-spatial deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Bilateral infarction in the distal ACAs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Balintâ€™s syndrome results from bilateral ischemic damage in the watershed zone between the PCA and MCA territories, emphasizing the vulnerability of this region during low-flow states like cardiac arrest.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man, Rajesh, presents to the emergency department with complaints of sudden-onset dizziness, difficulty swallowing, hoarseness of voice, and numbness on the left side of his face and the right side of his body. He also reports blurred vision and unsteadiness while walking. On examination, he has left-sided ptosis, miosis, and decreased pain and temperature sensation on the left side of the face. There is also loss of pain and temperature sensation on the right side of his body. Which artery is most likely occluded in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ACA occlusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;M1 segment of MCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;V4 segment of vertebral artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;M2 segment of MCA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. V4 segment of vertebral artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) V4 segment of vertebral artery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Wallenbergâ€™s syndrome occurs due to ischemia in the lateral medulla, which is primarily supplied by branches of the vertebral artery, especially the V4 segment. Occlusion of this segment leads to characteristic symptoms such as vertigo, ipsilateral facial numbness, contralateral limb numbness, hoarseness, dysphagia, diplopia, dysarthria, and ipsilateral Hornerâ€™s syndrome. The constellation of these findings is diagnostic of lateral medullary syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACA occlusion: ACA occlusion typically affects the medial frontal and parietal lobes, causing contralateral leg weakness and sensory deficits but not lateral medullary symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. ACA occlusion:&lt;/li&gt;&lt;li&gt;â€¢ Option B. M1 segment of MCA: M1 segment occlusion affects cortical areas supplied by the MCA, leading to hemiplegia, aphasia, or neglect depending on the hemisphere involved.&lt;/li&gt;&lt;li&gt;â€¢ Option B. M1 segment of MCA:&lt;/li&gt;&lt;li&gt;â€¢ Option D. M2 segment of MCA: M2 segment occlusion results in cortical strokes with symptoms such as aphasia or visual field deficits, not medullary findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. M2 segment of MCA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Wallenbergâ€™s syndrome is caused by ischemia in the lateral medulla, most commonly due to occlusion of the V4 segment of the vertebral artery, resulting in a characteristic cluster of neurological deficits.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man, Ravi, presents with symptoms of slowness of movement, stiffness, and autonomic disturbances, including orthostatic hypotension. On examination, he has features resembling Parkinsonâ€™s disease but does not respond well to levodopa therapy. MRI of the brain reveals high signal changes along the external surface of the putamen on T2-weighted imaging. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Corticobasal syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple system atrophy - P&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Multiple system atrophy - C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Progressive supranuclear palsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Multiple system atrophy - P&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Multiple system atrophy - P&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The putaminal rim sign is a characteristic MRI finding in Multiple System Atrophy - Parkinsonian type (MSA-P) . It represents a hyperintense signal on T2-weighted imaging along the external surface of the putamen due to pathological iron deposition and gliosis. MSA is a neurodegenerative disorder presenting with atypical parkinsonian features (poor levodopa response) along with autonomic dysfunction and, in some cases, cerebellar symptoms.&lt;/li&gt;&lt;li&gt;â€¢ putaminal rim sign&lt;/li&gt;&lt;li&gt;â€¢ Multiple System Atrophy - Parkinsonian type (MSA-P)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Corticobasal syndrome: Primarily involves asymmetric cortical dysfunction with dystonia, myoclonus, and alien limb phenomenon. MRI findings do not include the putaminal rim sign.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Corticobasal syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Multiple system atrophy - C: The cerebellar form of MSA (MSA-C) is characterized by ataxia and cerebellar symptoms with MRI findings such as brainstem and cerebellar atrophy and the classic \&quot;hot cross bun\&quot; sign in the pons.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Multiple system atrophy - C:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Progressive supranuclear palsy: Presents with vertical gaze palsy, early falls, and axial rigidity. MRI findings include midbrain atrophy with the \&quot;hummingbird\&quot; or \&quot;penguin\&quot; sign but not the putaminal rim sign.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Progressive supranuclear palsy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The putaminal rim sign on MRI is specific to MSA-P , helping distinguish it from other atypical parkinsonian syndromes. Proper recognition of these imaging findings aids in diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ putaminal rim sign&lt;/li&gt;&lt;li&gt;âž¤ MSA-P&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a feature of atypical parkinsonism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early involvement of speech and gait&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lack of motor asymmetry&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of Rest tremor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Poor response to levodopa&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of Rest tremor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Presence of Rest tremor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Rest tremor is a hallmark feature of Parkinsonâ€™s disease (PD) but is typically absent in atypical parkinsonism . Atypical parkinsonism includes disorders such as multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal syndrome (CBS). These conditions exhibit parkinsonian features (rigidity and bradykinesia) but differ from PD with their early involvement of speech and gait, symmetrical motor symptoms, poor levodopa response, and more aggressive progression.&lt;/li&gt;&lt;li&gt;â€¢ Parkinsonâ€™s disease (PD)&lt;/li&gt;&lt;li&gt;â€¢ absent&lt;/li&gt;&lt;li&gt;â€¢ atypical parkinsonism&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Early involvement of speech and gait: This is a common feature in atypical parkinsonism, unlike PD, where speech and gait involvement occur later.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Early involvement of speech and gait:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lack of motor asymmetry: Motor symptoms are typically symmetrical in atypical parkinsonism, unlike PD, where asymmetry is a key feature.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lack of motor asymmetry:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Poor response to levodopa: Atypical parkinsonism usually responds poorly to levodopa, differentiating it from PD, where levodopa is highly effective.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Poor response to levodopa:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atypical parkinsonism is characterized by early speech and gait issues, symmetrical symptoms, poor response to levodopa, and absence of rest tremor , distinguishing it from Parkinsonâ€™s disease.&lt;/li&gt;&lt;li&gt;âž¤ absence of rest tremor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man, Arjun, with advanced Parkinsonâ€™s disease, is being evaluated for deep brain stimulation (DBS) to manage his motor symptoms. He has a history of depression that has settled over time. Which of the following DBS is preferred in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Globus pallidus externa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Globus pallidus interna&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subthalamic nucleus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventral intermediate (VIM) nucleus of the thalamus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Globus pallidus interna&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Globus pallidus interna&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ DBS targeting the globus pallidus interna (GPi) has been shown to have comparable motor benefits to subthalamic nucleus (STN) stimulation, but studies suggest that GPi stimulation may be associated with a lower frequency of depression. GPi stimulation may provide better emotional and cognitive outcomes in patients with Parkinsonâ€™s disease who have pre-existing mood disturbances.&lt;/li&gt;&lt;li&gt;â€¢ globus pallidus interna (GPi)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Globus pallidus externa: This structure is not a standard DBS target for Parkinsonâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Globus pallidus externa:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subthalamic nucleus: While effective for motor symptoms, STN stimulation has been associated with an increased risk of mood disturbances, including depression.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subthalamic nucleus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventral intermediate (VIM) nucleus of the thalamus: VIM DBS is primarily used for tremor control in essential tremor and is not a preferred target for Parkinsonâ€™s disease (unless the patient has refractory tremors).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ventral intermediate (VIM) nucleus of the thalamus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DBS of the GPi is associated with a reduced frequency of depression in Parkinsonâ€™s disease compared to STN stimulation, making it a preferable choice in patients with pre-existing mood disturbances.&lt;/li&gt;&lt;li&gt;âž¤ DBS of the GPi&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman, Sneha, presents with recurrent migraine attacks that are not relieved by over-the-counter medications. She has a history of coronary artery disease, and her physician decides to prescribe a medication that selectively targets a different serotonin receptor to manage her migraine. Which of the following drugs is the most appropriate choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eletriptan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rimegepant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lasmiditan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ubrogepant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lasmiditan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lasmiditan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Lasmiditan is a selective 5-HT1F receptor agonist , categorized as a \&quot;ditan,\&quot; used for the acute management of migraines. Unlike triptans, lasmiditan does not cause vasoconstriction, making it suitable for patients with cardiovascular risk factors, such as Sneha. It acts by modulating neuronal activity associated with migraine pathophysiology, particularly in the trigeminal system.&lt;/li&gt;&lt;li&gt;â€¢ Lasmiditan&lt;/li&gt;&lt;li&gt;â€¢ 5-HT1F receptor agonist&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Eletriptan: A 5-HT1B/1D receptor agonist (triptan) effective for migraines but contraindicated in patients with cardiovascular conditions due to its vasoconstrictive properties.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Eletriptan:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rimegepant: A CGRP receptor antagonist (gepant) used for both acute and preventive migraine management but does not act on 5serotonin receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rimegepant:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ubrogepant: Another CGRP receptor antagonist effective for migraines but unrelated to the serontonin receptor pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ubrogepant:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lasmiditan , a 5-HT1F receptor agonist, is a safe and effective option for migraine patients, especially those with contraindications to vasoconstrictive therapies like triptans.&lt;/li&gt;&lt;li&gt;âž¤ Lasmiditan&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman, Shanta, reports experiencing recurrent headaches that wake her from sleep every night around the same time. The pain is dull and generalized, lasting 30â€“60 minutes. She has no associated nausea, photophobia, or phonophobia. Her neurological examination is normal. Based on her diagnosis, which of the following is the treatment of choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluoxetine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diazepam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amitriptyline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lithium&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lithium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lithium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient is suffering from hypnic headache and Lithium carbonate (200â€“600 mg at bedtime) is the treatment of choice. Hypnic headache, a rare primary headache disorder that predominantly affects older adults and wakes up people from sleep. Lithium is effective in preventing nocturnal attacks, likely by modulating the brain&#x27;s circadian rhythms. For patients intolerant to lithium, verapamil may be used as an alternative.&lt;/li&gt;&lt;li&gt;â€¢ The patient is suffering from hypnic headache and Lithium carbonate&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fluoxetine: This selective serotonin reuptake inhibitor (SSRI) is not effective in treating hypnic headache.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fluoxetine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diazepam: This benzodiazepine is used for anxiety and sleep disorders but has no role in managing hypnic headache.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diazepam:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amitriptyline: While amitriptyline can be used for certain headache disorders, it is not the first-line treatment for hypnic headache.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amitriptyline:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The treatment of choice for hypnic headache is lithium carbonate , given at bedtime to prevent nocturnal headache attacks. Alternative treatments, such as verapamil, may be considered for patients unable to tolerate lithium.&lt;/li&gt;&lt;li&gt;âž¤ treatment of choice for hypnic headache&lt;/li&gt;&lt;li&gt;âž¤ lithium carbonate&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man, Ramesh, presents with acute onset diplopia, ataxia, and areflexia following a mild respiratory infection two weeks ago. Neurological examination reveals ophthalmoplegia, gait instability, and absent reflexes. Cerebrospinal fluid analysis shows albuminocytological dissociation. Which of the following antibodies is characteristic of this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-GM1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-GD1a&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-GQ1b&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-GQ1b&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-GQ1b&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The case scenario is suggestive of Miller Fisher syndrome (MFS), a variant of Guillain-BarrÃ© syndrome (GBS). Anti-GQ1b IgG antibodies are found in over 90% of patients with MFS. These antibodies target gangliosides, particularly in the peripheral nerves and extraocular motor nerves, and are highest early in the disease course. Their presence is a diagnostic marker for MFS and distinguishes it from other GBS variants.&lt;/li&gt;&lt;li&gt;â€¢ The case scenario is suggestive of Miller Fisher syndrome (MFS),&lt;/li&gt;&lt;li&gt;â€¢ Anti-GQ1b IgG antibodies&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-GM1: Found in other GBS variants, particularly those with motor axonal involvement, but not characteristic of MFS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-GM1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-GD1a: Associated with motor axonal GBS but not with MFS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-GD1a:&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above: This is incorrect as anti-GQ1b antibodies are specific for MFS.&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above:&lt;/li&gt;&lt;li&gt;â€¢ anti-GQ1b antibodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-GQ1b antibodies are a hallmark of Miller Fisher syndrome , aiding in its diagnosis and distinguishing it from other forms of Guillain-BarrÃ© syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Anti-GQ1b antibodies&lt;/li&gt;&lt;li&gt;âž¤ Miller Fisher syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man, Ravi, presents with progressive weakness in his legs, difficulty climbing stairs, and dry mouth over the past few months. Neurological examination reveals reduced deep tendon reflexes that improve after exercise. Blood tests reveal the presence of anti-voltage-gated calcium channel antibodies. Imaging is ordered to rule out an associated malignancy. Which of the following cancers is most commonly associated with the disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Non-small-cell lung cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Small-cell lung cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thymoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Breast cancer&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Small-cell lung cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Small-cell lung cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder often associated with small-cell lung cancer (SCLC) in older adults. The malignancy expresses voltage-gated calcium channels (VGCCs), triggering an autoimmune response that impairs acetylcholine release at the neuromuscular junction. Around 50â€“60% of LEMS cases in older adults are associated with malignancy, with SCLC being the most common.&lt;/li&gt;&lt;li&gt;â€¢ Lambert-Eaton myasthenic syndrome (LEMS)&lt;/li&gt;&lt;li&gt;â€¢ small-cell lung cancer (SCLC)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-small-cell lung cancer: Rarely associated with LEMS compared to small-cell lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-small-cell lung cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thymoma: Commonly associated with myasthenia gravis , not LEMS.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thymoma:&lt;/li&gt;&lt;li&gt;â€¢ myasthenia gravis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Breast cancer: LEMS is not typically associated with breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Breast cancer:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Small-cell lung cancer (SCLC) is the malignancy most commonly associated with Lambert-Eaton myasthenic syndrome , highlighting the importance of cancer screening in older adults diagnosed with LEMS.&lt;/li&gt;&lt;li&gt;âž¤ Small-cell lung cancer (SCLC)&lt;/li&gt;&lt;li&gt;âž¤ Lambert-Eaton myasthenic syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following hormones uses Receptor Tyrosine Kinase (RTK) signaling?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Growth hormone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Activin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TGF-Î²&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Insulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Insulin exerts its effects via the Receptor Tyrosine Kinase (RTK) signaling pathway. RTKs are membrane-bound receptors that, upon ligand binding, activate intracellular kinase domains, leading to phosphorylation cascades. This mechanism is shared by insulin, insulin-like growth factor-1 (IGF-1) , epidermal growth factor (EGF), and nerve growth factor (NGF).&lt;/li&gt;&lt;li&gt;â€¢ Insulin&lt;/li&gt;&lt;li&gt;â€¢ Receptor Tyrosine Kinase (RTK)&lt;/li&gt;&lt;li&gt;â€¢ insulin-like growth factor-1 (IGF-1)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Growth hormone: Uses the cytokine receptor-linked kinase pathway, involving the JAK-STAT signaling cascade.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Growth hormone:&lt;/li&gt;&lt;li&gt;â€¢ cytokine receptor-linked kinase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Activin: Uses the serine/threonine kinase signaling pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Activin:&lt;/li&gt;&lt;li&gt;â€¢ serine/threonine kinase&lt;/li&gt;&lt;li&gt;â€¢ Option D. TGF-Î²: Activates the serine/threonine kinase receptors to regulate gene transcription.&lt;/li&gt;&lt;li&gt;â€¢ Option D. TGF-Î²:&lt;/li&gt;&lt;li&gt;â€¢ serine/threonine kinase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Receptor Tyrosine Kinase (RTK) signaling is the primary pathway for hormones like insulin and IGF-1, which regulate critical metabolic and growth functions. Other hormones may use different receptor types and signaling mechanisms.&lt;/li&gt;&lt;li&gt;âž¤ Receptor Tyrosine Kinase (RTK) signaling&lt;/li&gt;&lt;li&gt;âž¤ insulin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neonate presents with failure to thrive, and signs of skeletal demineralization. Genetic testing reveals an autosomal recessive inactivating mutation in the calcium-sensing receptor (CaSR) gene. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Familial hypocalciuric hypercalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Familial hypocalciuric hypocalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neonatal severe hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Familial hypocalcemic hypercalciuria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neonatal severe hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neonatal severe hyperparathyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Neonatal severe hyperparathyroidism (NSHPT) is caused by autosomal recessive (AR) inactivating mutations in the calcium-sensing receptor (CaSR) gene. The loss of function in CaSR reduces the sensitivity of the parathyroid gland and kidneys to serum calcium levels, leading to severe hypercalcemia, profound hyperparathyroidism, and skeletal abnormalities in neonates. This condition is life-threatening and often requires prompt surgical intervention.&lt;/li&gt;&lt;li&gt;â€¢ Neonatal severe hyperparathyroidism (NSHPT)&lt;/li&gt;&lt;li&gt;â€¢ autosomal recessive (AR)&lt;/li&gt;&lt;li&gt;â€¢ calcium-sensing receptor (CaSR)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Familial hypocalciuric hypercalcemia (FHH): Caused by autosomal dominant (AD) inactivating mutations in CaSR, leading to mild hypercalcemia with hypocalciuria, not the severe symptoms seen in NSHPT.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Familial hypocalciuric hypercalcemia (FHH):&lt;/li&gt;&lt;li&gt;â€¢ autosomal dominant (AD)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Familial hypocalciuric hypocalcemia: Not a recognized clinical entity; likely a misinterpretation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Familial hypocalciuric hypocalcemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Familial hypocalcemic hypercalciuria: Caused by AD activating mutations in CaSR, resulting in hypocalcemia and hypercalciuria, which contrasts with the hypercalcemia in NSHPT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Familial hypocalcemic hypercalciuria:&lt;/li&gt;&lt;li&gt;â€¢ AD activating mutations&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neonatal severe hyperparathyroidism results from AR inactivating mutations in the CaSR gene , leading to life-threatening hypercalcemia and hyperparathyroidism in neonates, distinct from the milder phenotype of FHH.&lt;/li&gt;&lt;li&gt;âž¤ Neonatal severe hyperparathyroidism&lt;/li&gt;&lt;li&gt;âž¤ AR inactivating mutations&lt;/li&gt;&lt;li&gt;âž¤ CaSR gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman, Anita, presents with irregular menstrual cycles and galactorrhea. Blood tests reveal elevated prolactin levels, and an MRI shows a small pituitary adenoma. The physician explains that dopamine normally inhibits prolactin synthesis via specific receptors. Which dopamine receptor mediates this effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;D1 receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;D2 receptor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;D3 receptor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;D4 receptor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. D2 receptor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) D2 receptor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Dopamine inhibits prolactin (PRL) synthesis and secretion by acting on D2 receptors located on lactotrophs in the anterior pituitary gland. Activation of these receptors suppresses PRL release and reduces lactotroph proliferation. Disruption of D2 receptor signaling, such as in gene knockout studies, leads to hyperprolactinemia and lactotroph hyperplasia. Dopamine agonists like bromocriptine and cabergoline are used to manage hyperprolactinemic disorders by targeting D2 receptors.&lt;/li&gt;&lt;li&gt;â€¢ prolactin (PRL) synthesis and secretion&lt;/li&gt;&lt;li&gt;â€¢ D2 receptors&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. D1 receptor: Primarily involved in excitatory pathways in the central nervous system, not in prolactin inhibition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. D1 receptor:&lt;/li&gt;&lt;li&gt;â€¢ Option C. D3 receptor: Has a minor role in dopamine signaling but is not the main receptor for prolactin regulation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. D3 receptor:&lt;/li&gt;&lt;li&gt;â€¢ Option D. D4 receptor: Primarily implicated in neurological functions, not prolactin regulation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. D4 receptor:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dopamine inhibits prolactin synthesis and secretion through D2 receptors in the anterior pituitary, making these receptors a critical target for treating hyperprolactinemia.&lt;/li&gt;&lt;li&gt;âž¤ prolactin synthesis and secretion&lt;/li&gt;&lt;li&gt;âž¤ D2 receptors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old boy presents with concerns about short stature. His fatherâ€™s height is 175 cm, and his motherâ€™s height is 165 cm. Based on this information, what is his mid-parental height (MPH)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;170 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;176.5 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;163.5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;168.5 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 176.5 cm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 176.5 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The mid-parental height (MPH) for boys is calculated using the formula:&lt;/li&gt;&lt;li&gt;â€¢ mid-parental height (MPH)&lt;/li&gt;&lt;li&gt;â€¢ MPH= (Fatherâ€™s Height + Motherâ€™s Height/2) +6.5â€‰cm [-6.5cm for girls]&lt;/li&gt;&lt;li&gt;â€¢ Substitute the values:&lt;/li&gt;&lt;li&gt;â€¢ MPH=(175+165/2)+6.5 =170+6.5 = 176.5â€‰cm&lt;/li&gt;&lt;li&gt;â€¢ This value represents the estimated adult height based on parental heights.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 170 cm: This value is the average of the parents&#x27; heights without adding the gender adjustment.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 170 cm:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 163.5 cm: This is incorrect and it is the MPH for a girl (170-6.5 = 163.5)&lt;/li&gt;&lt;li&gt;â€¢ Option C. 163.5 cm:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 168.5 cm: This value does not match the formula for calculating the mid-parental height.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 168.5 cm:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The mid-parental height (MPH) for boys is calculated by averaging the parents&#x27; heights and adding 6.5 cm , giving an estimate of the childâ€™s adult height potential.&lt;/li&gt;&lt;li&gt;âž¤ mid-parental height (MPH)&lt;/li&gt;&lt;li&gt;âž¤ 6.5 cm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman, Priya, presents with galactorrhea, amenorrhea, and fatigue. Her prolactin level is found to be 260 Î¼g/L. She has a history of psychiatric illness and is on long-term medication. Which of the following drugs is most likely responsible for her elevated prolactin levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methyldopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Risperidone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoclopramide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Risperidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Risperidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Risperidone , an atypical antipsychotic, blocks dopamine D2 receptors in the tuberoinfundibular pathway, leading to decreased inhibition of prolactin release and resulting in hyperprolactinemia. Risperidone is well-known to cause significant increases in prolactin levels, sometimes exceeding 200 Î¼g/L. This is a common side effect and may require management in symptomatic patients.&lt;/li&gt;&lt;li&gt;â€¢ Risperidone&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Verapamil: Verapamil can cause mild hyperprolactinemia by inhibiting dopamine release but rarely results in prolactin levels as high as 200 Î¼g/L.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Verapamil:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methyldopa: Methyldopa inhibits dopamine synthesis, leading to mild-to-moderate increases in prolactin but not to the extent caused by risperidone.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methyldopa:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoclopramide: Metoclopramide, a dopamine antagonist used as an antiemetic, can elevate prolactin levels but typically does not exceed 200 Î¼g/L unless used in high doses.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Metoclopramide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Risperidone is a frequent cause of significant hyperprolactinemia, with prolactin levels potentially exceeding 200 Î¼g/L , due to its potent dopamine D2 receptor antagonism.&lt;/li&gt;&lt;li&gt;âž¤ Risperidone&lt;/li&gt;&lt;li&gt;âž¤ 200 Î¼g/L&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman, Anita, diagnosed with acromegaly, is being treated with a medication that normalizes her serum IGF-1 levels but causes elevated GH levels. Which of the following drugs used for acromegaly is most likely responsible for this effect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lanreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pegvisomant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pasireotide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pegvisomant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pegvisomant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Pegvisomant is a growth hormone receptor antagonist that blocks the peripheral action of endogenous GH by preventing its binding to receptors. While this reduces serum IGF-1 levels and alleviates the effects of GH excess, it causes resistance to GH action, causing elevated GH levels. Pegvisomant is effective in normalizing IGF-1 levels in ~70% of patients with acromegaly.&lt;/li&gt;&lt;li&gt;â€¢ Pegvisomant&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Octreotide: A somatostatin analog that suppresses GH secretion from the pituitary adenoma, leading to reduced GH and IGF-1 levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Octreotide:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lanreotide: Another somatostatin analog similar to octreotide, which lowers both GH and IGF-1 levels.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lanreotide:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pasireotide: A broader-spectrum somatostatin analog that also suppresses GH secretion from the adenoma, reducing GH and IGF-1 levels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pasireotide:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pegvisomant reduces IGF-1 levels by blocking GH receptors but does not target the pituitary adenoma, so GH levels remain elevated , making it unique among drugs used to treat acromegaly. Tumor size should be monitored during therapy.&lt;/li&gt;&lt;li&gt;âž¤ Pegvisomant&lt;/li&gt;&lt;li&gt;âž¤ GH levels remain elevated&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man presents for a routine health check-up. His lab reports show the following: Fasting Blood Glucose (FBS): 98 mg/dL 2-hour Postprandial Glucose (PG): 130 mg/dL HbA1c: 5.0% What is the most appropriate diagnosis based on these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal glucose tolerance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Impaired glucose tolerance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetes Mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Normal glucose tolerance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20161825.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Normal glucose tolerance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patientâ€™s glucose values fall within the normal range for glucose tolerance based on the criteria:&lt;/li&gt;&lt;li&gt;â€¢ normal range&lt;/li&gt;&lt;li&gt;â€¢ Fasting Blood Glucose (FBS): &amp;lt;100 mg/dL (normal: &amp;lt;100 mg/dL) 2-hour Postprandial Glucose (PG): &amp;lt;140 mg/dL (normal: &amp;lt;140 mg/dL) HbA1c: &amp;lt;5.7% (normal: &amp;lt;5.7%)&lt;/li&gt;&lt;li&gt;â€¢ Fasting Blood Glucose (FBS): &amp;lt;100 mg/dL (normal: &amp;lt;100 mg/dL)&lt;/li&gt;&lt;li&gt;â€¢ Fasting Blood Glucose (FBS):&lt;/li&gt;&lt;li&gt;â€¢ 2-hour Postprandial Glucose (PG): &amp;lt;140 mg/dL (normal: &amp;lt;140 mg/dL)&lt;/li&gt;&lt;li&gt;â€¢ 2-hour Postprandial Glucose (PG):&lt;/li&gt;&lt;li&gt;â€¢ HbA1c: &amp;lt;5.7% (normal: &amp;lt;5.7%)&lt;/li&gt;&lt;li&gt;â€¢ HbA1c:&lt;/li&gt;&lt;li&gt;â€¢ These values indicate normal glucose tolerance , with no evidence of prediabetes or diabetes.&lt;/li&gt;&lt;li&gt;â€¢ normal glucose tolerance&lt;/li&gt;&lt;li&gt;â€¢ Diagnostic Criteria for Glucose Tolerance:&lt;/li&gt;&lt;li&gt;â€¢ Diagnostic Criteria for Glucose Tolerance:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Impaired glucose tolerance: Requires 2-hour postprandial glucose of 140â€“199 mg/dL or FBS of 100â€“125 mg/dL , which this patient does not have.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Impaired glucose tolerance:&lt;/li&gt;&lt;li&gt;â€¢ 140â€“199 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ 100â€“125 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diabetes Mellitus: Requires FBS â‰¥126 mg/dL, 2-hour PG â‰¥200 mg/dL, or HbA1c â‰¥6.5%.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diabetes Mellitus:&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above: Incorrect as the patient meets the criteria for normal glucose tolerance .&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above:&lt;/li&gt;&lt;li&gt;â€¢ normal glucose tolerance&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This patientâ€™s lab values indicate normal glucose tolerance based on fasting glucose, 2-hour postprandial glucose, and HbA1c, confirming no evidence of diabetes or prediabetes.&lt;/li&gt;&lt;li&gt;âž¤ normal glucose tolerance&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 14-year-old boy presents with weight loss, polyuria, and polydipsia. Lab tests reveal hyperglycemia, and he is diagnosed with type 1 diabetes mellitus. Autoantibody testing is ordered to confirm the autoimmune etiology. Which of the following autoantibodies are associated with it?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;GAD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ZnT-8&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IA-2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Islet cell autoantibodies (ICAs) are markers of the autoimmune process in type 1 diabetes mellitus (T1DM). These antibodies are directed against various pancreatic islet cell antigens, including:&lt;/li&gt;&lt;li&gt;â€¢ Islet cell autoantibodies (ICAs)&lt;/li&gt;&lt;li&gt;â€¢ GAD (Glutamic Acid Decarboxylase): Commonly detected in T1DM and associated with Î²-cell destruction. ZnT-8 (Zinc Transporter 8): Highly specific to T1DM and contributes to Î²-cell dysfunction. IA-2 (Islet Antigen-2): A tyrosine phosphatase protein targeted by autoantibodies in T1DM.&lt;/li&gt;&lt;li&gt;â€¢ GAD (Glutamic Acid Decarboxylase): Commonly detected in T1DM and associated with Î²-cell destruction.&lt;/li&gt;&lt;li&gt;â€¢ GAD (Glutamic Acid Decarboxylase):&lt;/li&gt;&lt;li&gt;â€¢ ZnT-8 (Zinc Transporter 8): Highly specific to T1DM and contributes to Î²-cell dysfunction.&lt;/li&gt;&lt;li&gt;â€¢ ZnT-8 (Zinc Transporter 8):&lt;/li&gt;&lt;li&gt;â€¢ IA-2 (Islet Antigen-2): A tyrosine phosphatase protein targeted by autoantibodies in T1DM.&lt;/li&gt;&lt;li&gt;â€¢ IA-2 (Islet Antigen-2):&lt;/li&gt;&lt;li&gt;â€¢ The presence of one or more of these autoantibodies is diagnostic of autoimmune T1DM and helps differentiate it from other forms of diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Each autoantibody (A, B, C) is individually correct, making the most appropriate answer D. All of the above .&lt;/li&gt;&lt;li&gt;â€¢ D. All of the above&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Type 1 diabetes mellitus is characterized by the presence of islet cell autoantibodies , including GAD , ZnT-8 , and IA-2 , which serve as markers of the autoimmune destruction of pancreatic Î²-cells.&lt;/li&gt;&lt;li&gt;âž¤ islet cell autoantibodies&lt;/li&gt;&lt;li&gt;âž¤ GAD&lt;/li&gt;&lt;li&gt;âž¤ ZnT-8&lt;/li&gt;&lt;li&gt;âž¤ IA-2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with central obesity and a BMI of 32 kg/mÂ² is being evaluated for insulin resistance. Lab studies reveal elevated levels of inflammatory markers and metabolic byproducts. Which of the following is unlikely to be elevated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Free fatty acids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TNF-Î±&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adiponectin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IL-6&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adiponectin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Adiponectin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Adiponectin is an insulin-sensitizing peptide secreted by adipocytes. Unlike other adipocyte-derived factors, its levels are reduced in obesity and insulin resistance. Lower adiponectin levels contribute to hepatic and systemic insulin resistance, highlighting its protective role in glucose metabolism and inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Adiponectin&lt;/li&gt;&lt;li&gt;â€¢ insulin-sensitizing peptide&lt;/li&gt;&lt;li&gt;â€¢ reduced&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Free fatty acids: Elevated in insulin resistance due to increased lipolysis in adipocytes, contributing to impaired insulin signaling.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Free fatty acids:&lt;/li&gt;&lt;li&gt;â€¢ Option B. TNF-Î±: Increased levels are secreted by adipocytes and macrophages in obese individuals, promoting systemic inflammation and insulin resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option B. TNF-Î±:&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL-6: Elevated in obesity, IL-6 promotes inflammation and is linked to insulin resistance.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IL-6:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In insulin resistance , most adipocyte-derived factors like free fatty acids , TNF-Î± , and IL-6 are elevated, while adiponectin levels are reduced , contributing to impaired insulin sensitivity and metabolic dysfunction.&lt;/li&gt;&lt;li&gt;âž¤ insulin resistance&lt;/li&gt;&lt;li&gt;âž¤ free fatty acids&lt;/li&gt;&lt;li&gt;âž¤ TNF-Î±&lt;/li&gt;&lt;li&gt;âž¤ IL-6&lt;/li&gt;&lt;li&gt;âž¤ adiponectin levels are reduced&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with type 2 diabetes mellitus is started on an antidiabetic medication that works by reducing insulin resistance and is weight neutral. What is the exact mechanism of action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stimulating AMP kinase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stimulating GLP1R&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inhibiting ATP-sensitive potassium channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activating PPAR-Î³&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stimulating AMP kinase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Stimulating AMP kinase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The medication described is most likely metformin. Metformin works by stimulating AMP-activated protein kinase (AMPK), an enzyme that plays a crucial role in cellular energy homeostasis. Activation of AMPK reduces hepatic gluconeogenesis, increases insulin sensitivity, and promotes glucose uptake in peripheral tissues. Metformin is weight neutral and does not directly increase insulin secretion.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stimulating GLP1R : Refers to GLP-1 receptor agonists, which enhance insulin secretion, slow gastric emptying, and promote weight loss, not weight neutrality.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stimulating GLP1R&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibiting ATP-sensitive potassium channels: Is the mechanism of sulfonylureas, which stimulate insulin release and are associated with weight gain.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Inhibiting ATP-sensitive potassium channels:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activating PPAR-Î³: Is the mechanism of thiazolidinediones (TZDs), which improve insulin sensitivity but are often associated with weight gain.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activating PPAR-Î³:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Metformin stimulates AMP kinase, reduces hepatic gluconeogenesis, and improves insulin sensitivity while being weight neutral, making it a first-line treatment for type 2 diabetes mellitus.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with type 2 diabetes mellitus is started on an antidiabetic medication. Over the next few months, she reports worsening vision. On examination, she has evidence of diabetic macular edema. Which of the following medications is most likely responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Canagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pioglitazone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pioglitazone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Pioglitazone , a thiazolidinedione (TZD) , is associated with fluid retention and peripheral edema, which can exacerbate diabetic macular edema in rare cases. The FDA has issued a warning regarding this potential adverse effect. TZDs increase plasma volume and vascular permeability, which may worsen retinal edema, leading to a decline in vision in some patients.&lt;/li&gt;&lt;li&gt;â€¢ Pioglitazone&lt;/li&gt;&lt;li&gt;â€¢ thiazolidinedione (TZD)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metformin: Does not affect fluid retention or vascular permeability and is not associated with macular edema.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metformin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liraglutide: A GLP-1 receptor agonist not linked to worsening macular edema.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Liraglutide:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Canagliflozin: An SGLT2 inhibitor that promotes glycosuria; it has no reported effects on macular edema.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Canagliflozin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pioglitazone , a TZD, may rarely worsen diabetic macular edema due to fluid retention and vascular permeability changes, necessitating caution in patients with preexisting macular edema.&lt;/li&gt;&lt;li&gt;âž¤ Pioglitazone&lt;/li&gt;&lt;li&gt;âž¤ diabetic macular edema&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man, Rajesh, presents with recurrent kidney stones, visual disturbances, and recurrent admissions for hypoglycemic episodes. Which of the following tumors is not characteristic of this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parathyroid tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pancreatic tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pituitary tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thyroid tumor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Thyroid tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Thyroid tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is suggestive of Multiple Endocrine Neoplasia type 1 (MEN1). This syndrome is characterized by the \&quot;3 P&#x27;s\&quot;: parathyroid tumors (leading to primary hyperparathyroidism), pancreatic neuroendocrine tumors (such as insulinomas causing hypoglycemia), and pituitary tumors (e.g., prolactinomas causing visual disturbances). Thyroid tumors are not characteristic of MEN1 and are more commonly associated with MEN2.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Parathyroid tumor: Is a defining feature of MEN1 and typically presents as primary hyperparathyroidism with symptoms like recurrent kidney stones.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Parathyroid tumor:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pancreatic tumor: Such as insulinoma or gastrinoma, is a common manifestation of MEN1 and explains the hypoglycemic episodes.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pancreatic tumor:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pituitary tumor : Is another hallmark of MEN1, often presenting with hormone-related symptoms and visual disturbances due to compression of the optic chiasm.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pituitary tumor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MEN1 is characterized by tumors of the parathyroid, pancreas, and pituitary. Thyroid tumors are not associated with MEN1 but are a feature of MEN2 syndromes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman presents with features of weight gain, central obesity, and purple abdominal striae. She also has multiple pigmented skin lesions and a family history of similar findings. She recently underwent surgery for atrial myxoma. Which of the following is the most common endocrine manifestation of this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cushingâ€™s syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Addisonâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cushingâ€™s syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cushingâ€™s syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This presentation is consistent with Carney complex, a genetic condition characterized by a combination of endocrine and non-endocrine tumors, pigmented skin lesions, and atrial myxomas. The most common endocrine manifestation is Cushingâ€™s syndrome, which occurs due to primary pigmented nodular adrenal disease (PPNAD).&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Addisonâ€™s disease: Is not associated with Carney complex; it is related to autoimmune adrenalitis or APS-1.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Addisonâ€™s disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperparathyroidism: Is more characteristic of multiple endocrine neoplasia (MEN) syndromes, not Carney complex.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hyperparathyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypothyroidism: Is not commonly seen in Carney complex and is unrelated to the described presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypothyroidism:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cushingâ€™s syndrome, due to primary pigmented nodular adrenal disease, is the most common endocrine manifestation of Carney complex, a rare genetic syndrome often associated with atrial myxomas and pigmented skin lesions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-month-old boy presents with severe diarrhea, eczema, and hyperglycemia. His family history is significant for autoimmune diseases in male relatives. Which of the following genes is likely to be mutated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AIRE gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CDKN1B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FOXP3 gene&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RET&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. FOXP3 gene&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) FOXP3 gene&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ IPEX syndrome (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked) is caused by mutations in the FOXP3 gene , which encodes a transcription factor critical for the development and function of regulatory T cells (Tregs). Loss of FOXP3 function leads to impaired immune regulation and widespread autoimmunity. Key clinical features include:&lt;/li&gt;&lt;li&gt;â€¢ IPEX syndrome&lt;/li&gt;&lt;li&gt;â€¢ FOXP3 gene&lt;/li&gt;&lt;li&gt;â€¢ Severe enteropathy (diarrhea). Type 1 diabetes mellitus (T1DM). Dermatitis (eczema). Other autoimmune manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Severe enteropathy (diarrhea).&lt;/li&gt;&lt;li&gt;â€¢ Type 1 diabetes mellitus (T1DM).&lt;/li&gt;&lt;li&gt;â€¢ Dermatitis (eczema).&lt;/li&gt;&lt;li&gt;â€¢ Other autoimmune manifestations.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. AIRE gene: Mutations in AIRE cause autoimmune polyendocrine syndrome type 1 (APS 1), not IPEX.&lt;/li&gt;&lt;li&gt;â€¢ Option A. AIRE gene:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDKN1B: Mutations in CDKN1B are associated with MEN 4, not IPEX.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDKN1B:&lt;/li&gt;&lt;li&gt;â€¢ Option D. RET: Mutations in RET are associated with MEN 2, not IPEX.&lt;/li&gt;&lt;li&gt;â€¢ Option D. RET:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IPEX syndrome is caused by mutations in the FOXP3 gene , leading to severe autoimmunity due to defective regulatory T cell function. It presents in infancy with enteropathy, T1DM, and skin manifestations.&lt;/li&gt;&lt;li&gt;âž¤ IPEX syndrome&lt;/li&gt;&lt;li&gt;âž¤ FOXP3 gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with progressive shortness of breath and wheezing. Pulmonary function testing includes the measurement of diffusing capacity of the lungs for carbon monoxide (DLCO). Which of the following conditions is not typically associated with a decreased DLCO?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;COPD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ARDS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Asthma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Asthma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In asthma , DLCO is typically normal or increased due to factors such as increased pulmonary blood flow and capillary recruitment during bronchospasm. Asthma does not cause structural damage to the alveolar-capillary interface, which is necessary to decrease DLCO.&lt;/li&gt;&lt;li&gt;â€¢ asthma&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. COPD: In emphysema, destruction of alveolar walls leads to reduced alveolar surface area and impaired gas exchange, resulting in decreased DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Option B. COPD:&lt;/li&gt;&lt;li&gt;â€¢ Option C. ILD: Interstitial lung disease causes thickening of the alveolar-capillary membrane, reducing the transfer of gas and decreasing DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Option C. ILD:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ARDS: Acute damage to the alveolar-capillary barrier in ARDS impairs gas exchange, leading to a decreased DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ARDS:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Decreased DLCO is seen in conditions that disrupt the alveolar-capillary membrane, such as COPD (emphysema), ILD, ARDS , and others. In contrast, asthma does not typically decrease DLCO and may even increase it due to enhanced pulmonary blood flow.&lt;/li&gt;&lt;li&gt;âž¤ Decreased DLCO&lt;/li&gt;&lt;li&gt;âž¤ COPD (emphysema), ILD, ARDS&lt;/li&gt;&lt;li&gt;âž¤ asthma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents for follow-up after being treated for deep vein thrombosis (DVT) 6 months ago. He is concerned about the risk of recurrence of venous thromboembolism. Which of the following risk factors has the highest risk of recurrent venous thromboembolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prior DVT&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Genetic thrombophilia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;OCP use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Malignancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prior DVT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Prior DVT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The prior history of DVT is the most significant risk factor for recurrent venous thromboembolism (VTE) . Individuals who have experienced a previous VTE event, such as DVT or pulmonary embolism, have a higher likelihood of recurrence, even if other risk factors are managed or absent. The recurrence risk is highest in the first 6â€“12 months following the initial event.&lt;/li&gt;&lt;li&gt;â€¢ prior history of DVT&lt;/li&gt;&lt;li&gt;â€¢ recurrent venous thromboembolism (VTE)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Genetic thrombophilia: While genetic thrombophilia (e.g., Factor V Leiden mutation, prothrombin gene mutation) increases the risk of VTE, it is still not as high as the risk posed by a prior DVT, which indicates the individual has already experienced a thrombotic event.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Genetic thrombophilia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. OCP use: Oral contraceptive use increases the risk of VTE, but the risk is lower compared to the recurrence risk seen in patients with a prior DVT, particularly once the OCP is discontinued.&lt;/li&gt;&lt;li&gt;â€¢ Option C. OCP use:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Malignancy: Malignancy is a significant risk factor for VTE, particularly in the context of certain cancers, but prior DVT still poses a higher recurrence risk.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Malignancy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prior DVT is the most significant risk factor for the recurrence of venous thromboembolism, and patients with a history of DVT require careful management and monitoring for recurrence.&lt;/li&gt;&lt;li&gt;âž¤ Prior DVT&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old patient with a history of allergic bronchopulmonary aspergillosis (ABPA) on chronic steroids presents to the emergency room with swelling and pain in the left lower limb and sudden onset breathlessness. On arrival, the patient is hemodynamically stable, but the shock index is &amp;gt;1. A compression ultrasound confirms a left lower limb deep vein thrombosis (DVT). Which of the following tests will best confirm the underlying diagnosis of a pulmonary embolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT Pulmonary angiogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MRI Thorax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CT Pulmonary angiogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CT Pulmonary angiogram&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A CT pulmonary angiogram (CTPA) is the gold standard for diagnosing pulmonary embolism (PE) . In a patient with DVT and sudden-onset breathlessness, a CTPA will allow direct visualization of the pulmonary arteries and detect filling defects , which are characteristic of a pulmonary embolism. It provides detailed imaging of the pulmonary vasculature, which is crucial in confirming the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ CT pulmonary angiogram (CTPA)&lt;/li&gt;&lt;li&gt;â€¢ pulmonary embolism (PE)&lt;/li&gt;&lt;li&gt;â€¢ DVT&lt;/li&gt;&lt;li&gt;â€¢ filling defects&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ECG: An ECG may show sinus tachycardia or signs of right ventricular strain (e.g., S1Q3T3 pattern), but it cannot confirm the diagnosis of pulmonary embolism, as these findings are nonspecific.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ECG:&lt;/li&gt;&lt;li&gt;â€¢ right ventricular strain&lt;/li&gt;&lt;li&gt;â€¢ confirm the diagnosis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Echocardiogram: While an echocardiogram can assess right ventricular (RV) dysfunction , it is not diagnostic for pulmonary embolism . RV dilation or hypokinesis may be seen in PE, but these findings are also present in other conditions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Echocardiogram:&lt;/li&gt;&lt;li&gt;â€¢ right ventricular (RV) dysfunction&lt;/li&gt;&lt;li&gt;â€¢ pulmonary embolism&lt;/li&gt;&lt;li&gt;â€¢ Option D. MRI Thorax: While MRI is useful in some cases, it is not the first-line imaging modality for diagnosing PE. It is more time-consuming and not preferred for acute cases of pulmonary embolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. MRI Thorax:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with suspected pulmonary embolism , especially when DVT is present, a CT pulmonary angiogram (CTPA) is the preferred and most accurate diagnostic test to confirm the diagnosis by detecting filling defects in the pulmonary arteries.&lt;/li&gt;&lt;li&gt;âž¤ pulmonary embolism&lt;/li&gt;&lt;li&gt;âž¤ DVT&lt;/li&gt;&lt;li&gt;âž¤ CT pulmonary angiogram (CTPA)&lt;/li&gt;&lt;li&gt;âž¤ filling defects&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old banker presents with shortness of breath (SOB) after climbing 2 flights of stairs. He develops chest tightness after 1 flight of stairs and has had multiple syncopal episodes in the past. His past medical history is significant for deep vein thrombosis (DVT) following limb immobilization 5 years ago. Pulmonary function tests (PFT) are normal, but his diffusing capacity for carbon monoxide (DLCO) is reduced. Echocardiogram shows right ventricular systolic pressure (RVSP) of 50 mmHg with normal left ventricular function. What is the most appropriate management strategy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI angiography of the thorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CTPA (CT pulmonary angiography)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start oral prostacyclin therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CTPA (CT pulmonary angiography)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CTPA (CT pulmonary angiography)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient likely has chronic thromboembolic pulmonary hypertension (CTEPH) , a condition that develops after unresolved pulmonary embolism (PE), where thromboembolic material causes pulmonary vessel obstruction and increased right heart pressures. CTEPH can occur after a history of DVT , which has been shown to lead to small emboli that are not completely resolved, resulting in chronic obstruction and increasing right ventricular systolic pressure (RVSP) . CTPA is the diagnostic test of choice to visualize the pulmonary vasculature and assess the feasibility of surgical intervention , such as pulmonary thromboendarterectomy , which is the most effective treatment for CTEPH. This test helps identify residual emboli or chronic thromboembolic material in the pulmonary arteries.&lt;/li&gt;&lt;li&gt;â€¢ chronic thromboembolic pulmonary hypertension (CTEPH)&lt;/li&gt;&lt;li&gt;â€¢ pulmonary vessel obstruction&lt;/li&gt;&lt;li&gt;â€¢ history of DVT&lt;/li&gt;&lt;li&gt;â€¢ right ventricular systolic pressure (RVSP)&lt;/li&gt;&lt;li&gt;â€¢ CTPA&lt;/li&gt;&lt;li&gt;â€¢ feasibility of surgical intervention&lt;/li&gt;&lt;li&gt;â€¢ pulmonary thromboendarterectomy&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI angiography of the thorax: MRI angiography is not the preferred imaging modality for diagnosing CTEPH. CTPA is more effective in visualizing pulmonary artery thromboembolic material and assessing the lung parenchyma.&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI angiography of the thorax:&lt;/li&gt;&lt;li&gt;â€¢ MRI angiography&lt;/li&gt;&lt;li&gt;â€¢ CTPA&lt;/li&gt;&lt;li&gt;â€¢ pulmonary artery thromboembolic material&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary angiography: This test evaluates epicardial coronary vessels for obstructive coronary artery disease, which is unrelated to the pulmonary vascular pathology seen in CTEPH .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary angiography:&lt;/li&gt;&lt;li&gt;â€¢ epicardial coronary vessels&lt;/li&gt;&lt;li&gt;â€¢ CTEPH&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start oral prostacyclin therapy: Oral prostacyclin (or PDE-5 inhibitors) are typically used in advanced pulmonary hypertension , particularly when endarterectomy is not feasible. However, surgical intervention should be prioritized if the patient is a candidate for pulmonary thromboendarterectomy .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start oral prostacyclin therapy:&lt;/li&gt;&lt;li&gt;â€¢ Oral prostacyclin (or PDE-5 inhibitors)&lt;/li&gt;&lt;li&gt;â€¢ advanced pulmonary hypertension&lt;/li&gt;&lt;li&gt;â€¢ endarterectomy&lt;/li&gt;&lt;li&gt;â€¢ pulmonary thromboendarterectomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CTPA is the gold standard for diagnosing CTEPH and should be performed in patients with a history of DVT and symptoms of pulmonary hypertension , such as dyspnea and syncope. If CTEPH is confirmed, further evaluation with right heart catheterization and surgical options such as pulmonary thromboendarterectomy may be pursued. If surgery is not feasible, oral prostacyclin therapy is considered for managing pulmonary hypertension.&lt;/li&gt;&lt;li&gt;âž¤ CTPA&lt;/li&gt;&lt;li&gt;âž¤ gold standard&lt;/li&gt;&lt;li&gt;âž¤ CTEPH&lt;/li&gt;&lt;li&gt;âž¤ DVT&lt;/li&gt;&lt;li&gt;âž¤ pulmonary hypertension&lt;/li&gt;&lt;li&gt;âž¤ CTEPH&lt;/li&gt;&lt;li&gt;âž¤ right heart catheterization&lt;/li&gt;&lt;li&gt;âž¤ pulmonary thromboendarterectomy&lt;/li&gt;&lt;li&gt;âž¤ oral prostacyclin therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old smoker presents with progressive breathlessness over the past year. Chest X-ray (CXR) reveals hyperinflated lungs, pulmonary function testing (PFT) shows moderate obstruction, and echocardiography (ECHO) indicates a right ventricular systolic pressure (RVSP) of 60 mmHg. Which category of pulmonary hypertension does this patient most likely belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;WHO Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;WHO Class II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;WHO Class III&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WHO Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. WHO Class III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) WHO Class III&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient has pulmonary hypertension secondary to underlying lung disease (likely chronic obstructive pulmonary disease, or COPD), as indicated by the hyperinflated lungs, moderate obstruction on PFT, and elevated RVSP. According to the World Health Organization (WHO) Classification of Pulmonary Hypertension , this patient falls into Class III , which is defined as pulmonary hypertension due to chronic lung disease , including obstructive and restrictive lung conditions. Group 3 includes conditions like COPD, interstitial lung disease, and other pulmonary diseases that cause pulmonary hypertension.&lt;/li&gt;&lt;li&gt;â€¢ pulmonary hypertension secondary to underlying lung disease&lt;/li&gt;&lt;li&gt;â€¢ World Health Organization (WHO) Classification of Pulmonary Hypertension&lt;/li&gt;&lt;li&gt;â€¢ Class III&lt;/li&gt;&lt;li&gt;â€¢ pulmonary hypertension due to chronic lung disease&lt;/li&gt;&lt;li&gt;â€¢ COPD, interstitial lung disease, and other pulmonary diseases&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. WHO Class I: This class refers to pulmonary arterial hypertension (PAH) , which can be idiopathic, familial, or associated with other conditions like connective tissue disease, left-to-right shunt, HIV, or portopulmonary hypertension. It does not apply to pulmonary hypertension caused by lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. WHO Class I:&lt;/li&gt;&lt;li&gt;â€¢ pulmonary arterial hypertension (PAH)&lt;/li&gt;&lt;li&gt;â€¢ Option B. WHO Class II: This class refers to pulmonary hypertension secondary to heart disease , including left ventricular or atrial causes, and does not apply in this case, as the patientâ€™s primary problem is lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. WHO Class II:&lt;/li&gt;&lt;li&gt;â€¢ pulmonary hypertension secondary to heart disease&lt;/li&gt;&lt;li&gt;â€¢ Option D. WHO Class IV: This class refers to chronic thromboembolic pulmonary hypertension (CTEPH) , where pulmonary hypertension is caused by unresolved pulmonary embolism leading to obstruction in the pulmonary vasculature. This is not suggested by the patientâ€™s history or diagnostic findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. WHO Class IV:&lt;/li&gt;&lt;li&gt;â€¢ chronic thromboembolic pulmonary hypertension (CTEPH)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ WHO Class III pulmonary hypertension occurs due to underlying lung diseases , including COPD, interstitial lung disease , and other pulmonary conditions. The patientâ€™s history of smoking and lung disease, combined with elevated RVSP, points to this classification.&lt;/li&gt;&lt;li&gt;âž¤ WHO Class III&lt;/li&gt;&lt;li&gt;âž¤ underlying lung diseases&lt;/li&gt;&lt;li&gt;âž¤ COPD, interstitial lung disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents with swelling and redness in his left leg. Compression ultrasound confirms a deep vein thrombosis (DVT) in one of the veins of the leg. Which of the following venous thromboses is least likely to cause a pulmonary embolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Superficial femoral vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Great saphenous vein&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Common femoral vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Popliteal vein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Great saphenous vein&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Great saphenous vein&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The great saphenous vein is part of the superficial venous system , which carries blood from the skin and subcutaneous tissues but does not directly connect to the deep venous system of the leg. Because of this, thrombosis in the great saphenous vein is very unlikely to cause a pulmonary embolism, as the thrombus would not typically propagate to the deep venous system, where it could then travel to the lungs.&lt;/li&gt;&lt;li&gt;â€¢ great saphenous vein&lt;/li&gt;&lt;li&gt;â€¢ superficial venous system&lt;/li&gt;&lt;li&gt;â€¢ thrombosis in the great saphenous vein&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Superficial femoral vein: Although termed \&quot;superficial,\&quot; the superficial femoral vein (SFV) is actually part of the deep venous system and is capable of propagating a clot that could travel to the lungs, causing a pulmonary embolism.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Superficial femoral vein:&lt;/li&gt;&lt;li&gt;â€¢ superficial femoral vein (SFV)&lt;/li&gt;&lt;li&gt;â€¢ deep venous system&lt;/li&gt;&lt;li&gt;â€¢ Option C. Common femoral vein: This vein is part of the deep venous system and is directly connected to the iliac veins , where a thrombus can propagate and reach the pulmonary arteries, leading to pulmonary embolism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Common femoral vein:&lt;/li&gt;&lt;li&gt;â€¢ deep venous system&lt;/li&gt;&lt;li&gt;â€¢ iliac veins&lt;/li&gt;&lt;li&gt;â€¢ Option D. Popliteal vein: The popliteal vein is part of the deep venous system and can also lead to pulmonary embolism if a thrombus propagates from it to the larger venous channels.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Popliteal vein:&lt;/li&gt;&lt;li&gt;â€¢ popliteal vein&lt;/li&gt;&lt;li&gt;â€¢ deep venous system&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thrombosis in the great saphenous vein , being part of the superficial venous system, is least likely to cause pulmonary embolism , while thrombosis in the deep venous system (e.g., SFV, common femoral vein, and popliteal vein) is much more likely to propagate and cause a pulmonary embolism.&lt;/li&gt;&lt;li&gt;âž¤ great saphenous vein&lt;/li&gt;&lt;li&gt;âž¤ least likely to cause pulmonary embolism&lt;/li&gt;&lt;li&gt;âž¤ deep venous system&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with a history of hypertension and diabetes mellitus presents to the emergency department with acute shortness of breath, hypoxia, and X ray is shown. His oxygen saturation is 85% on room air. The patient is intubated and placed on mechanical ventilation. Which of the following strategies does not have a mortality benefit?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low tidal volume ventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High PEEP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prone ventilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Corticosteroids&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20161904.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Corticosteroids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Corticosteroids have no proven mortality benefit in the management of ARDS, except for COVID-19-related ARDS. Studies show that corticosteroids might help reduce inflammation but do not improve overall survival in non-COVID ARDS. The use of corticosteroids is limited to specific circumstances, such as refractory ARDS or COVID-19-associated ARDS, where they may help in reducing inflammation and improving oxygenation.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low tidal volume ventilation: Low tidal volume ventilation (6 mL/kg of predicted body weight) is a cornerstone of ARDS management and has been shown to improve survival by preventing ventilator-induced lung injury. It is a lung-protective strategy that minimizes barotrauma and volutrauma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Low tidal volume ventilation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. High PEEP: Higher levels of PEEP (positive end-expiratory pressure) can help prevent alveolar collapse and improve oxygenation in ARDS patients. It has been demonstrated to reduce mortality in ARDS by optimizing oxygenation and lung recruitment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. High PEEP:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prone ventilation: Prone positioning, especially when maintained for 16 hours per day, has been shown to improve oxygenation and reduce mortality in ARDS patients. It helps recruit posterior lung zones, improving gas exchange and reducing ventilator-induced injury.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prone ventilation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Corticosteroids should not be routinely used in ARDS management except in COVID-19-related ARDS, while low tidal volume ventilation, high PEEP, and prone positioning are proven strategies for improving survival in ARDS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male, a reformed smoker with COPD (GOLD Stage E), presents with worsening dyspnea and cough. He is started on salbutamol nebulizations, IV antibiotics, and corticosteroids. A repeat ABG shows pH 7.25, pCO2 60 mmHg, pO2 49.5 mmHg, RR 26/min. Which of the following is the next step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxygen with NIV&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CPAP and Oxygen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Invasive Mechanical Ventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV salbutamol, morphine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oxygen with NIV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Oxygen with NIV&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In patients with COPD exacerbations who have acid-base disturbances (pH &amp;lt; 7.35, pCO2 &amp;gt; 45 mmHg), non-invasive ventilation (NIV) is the preferred next step in management. NIV helps improve both oxygenation and ventilation (CO2 removal), making it particularly useful in preventing respiratory failure. The patient&#x27;s ABG showing respiratory acidosis (pCO2 60 mmHg and pH 7.25) suggests CO2 retention, which can be alleviated with NIV. NIV also reduces the work of breathing, improves gas exchange, and avoids the complications of invasive mechanical ventilation.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CPAP and Oxygen: CPAP (Continuous Positive Airway Pressure) primarily helps improve oxygenation but does not assist in CO2 removal. Since the patient&#x27;s pCO2 is elevated, NIV is preferred over CPAP for improving ventilation as well as oxygenation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CPAP and Oxygen:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Invasive Mechanical Ventilation: Invasive mechanical ventilation should be avoided initially in patients with COPD exacerbations, as most patients will respond to NIV. Intubation and mechanical ventilation are considered only if NIV fails or if there is hemodynamic instability, persistent respiratory acidosis, or other complications.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Invasive Mechanical Ventilation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV salbutamol, morphine: While IV salbutamol may help in managing bronchoconstriction, morphine should be avoided in this scenario. Morphine can worsen respiratory acidosis by causing central hypoventilation, and it is not indicated for the management of respiratory failure in this context.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV salbutamol, morphine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with COPD exacerbations and respiratory acidosis, non-invasive ventilation (NIV) is the preferred treatment to improve both oxygenation and ventilation, and it should be initiated early to avoid the need for invasive mechanical ventilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman presents with a 4-week history of dry cough and dyspnea on exertion. She has been receiving treatment for swollen joints and morning stiffness for several years. Inspiratory fine crackles were audible on auscultation. HRCT is shown. Which of the following patterns is the patientâ€™s pulmonary function test (PFT) most likely to display?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;lt; 0.7 and DLCO increases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;lt; 0.7 and DLCO decreases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;gt; 0.7 and DLCO decreases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;gt; 0.7 and DLCO increases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. FEV1/FVC ratio &gt; 0.7 and DLCO decreases&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20161941.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) FEV1/FVC ratio &amp;gt; 0.7 and DLCO decreases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient likely has interstitial lung disease (ILD) due to a connective tissue disease (CTD), such as rheumatoid arthritis (RA), as indicated by her chronic joint pain, dry cough, and HRCT findings of honeycombing, which is characteristic of Usual Interstitial Pneumonia (UIP) pattern. ILD, especially UIP, typically presents as restrictive lung disease, meaning there is a normal FEV1/FVC ratio (greater than 0.7), but a reduced diffusing capacity for carbon monoxide (DLCO). The reduced DLCO is due to impaired gas exchange in the damaged alveolar-capillary membrane seen in UIP.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. FEV1/FVC ratio &amp;lt; 0.7 and DLCO increases: An FEV1/FVC ratio less than 0.7 indicates obstructive lung disease, which is not typically seen in ILD or the UIP pattern. Additionally, DLCO increases in conditions such as pulmonary hemorrhage or high-output states, but it is unlikely in interstitial lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. FEV1/FVC ratio &amp;lt; 0.7 and DLCO increases:&lt;/li&gt;&lt;li&gt;â€¢ Option B. FEV1/FVC ratio &amp;lt; 0.7 and DLCO decreases: This combination is more characteristic of obstructive lung diseases like chronic obstructive pulmonary disease (COPD) or asthma. It is not consistent with restrictive lung disease (as seen in ILD) where FEV1/FVC remains normal.&lt;/li&gt;&lt;li&gt;â€¢ Option B. FEV1/FVC ratio &amp;lt; 0.7 and DLCO decreases:&lt;/li&gt;&lt;li&gt;â€¢ Option D. FEV1/FVC ratio &amp;gt; 0.7 and DLCO increases: An increased DLCO would not be expected in UIP or other forms of ILD. In restrictive lung disease, DLCO is typically decreased due to the thickening of the alveolar walls and impaired gas exchange.&lt;/li&gt;&lt;li&gt;â€¢ Option D. FEV1/FVC ratio &amp;gt; 0.7 and DLCO increases:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In interstitial lung diseases like UIP (seen in rheumatoid arthritis), patients typically present with restrictive lung patterns on PFTs, characterized by a normal FEV1/FVC ratio (greater than 0.7) and a decreased DLCO, reflecting impaired gas exchange.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hamman-Rich syndrome is a synonym of which of the following diseases?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Usual interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cryptogenic organizing pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Respiratory bronchiolitis-associated ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute interstitial pneumonia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acute interstitial pneumonia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Acute interstitial pneumonia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hamman-Rich syndrome is a term used synonymously with acute interstitial pneumonia (AIP), a rare and rapidly progressive form of idiopathic interstitial pneumonia. It has a fulminant course, presenting similarly to acute respiratory distress syndrome (ARDS) with rapid onset of hypoxemia and diffuse bilateral infiltrates. The condition has a poor prognosis with a mortality rate exceeding 60%. The exact pathophysiology is unclear, and treatment is generally supportive, primarily focusing on lung-protective ventilation.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Usual interstitial pneumonia (UIP): UIP is a pattern of lung injury often associated with idiopathic pulmonary fibrosis (IPF). It presents with a more chronic course compared to AIP and is not associated with the acute and rapidly progressive nature seen in Hamman-Rich syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Usual interstitial pneumonia (UIP):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cryptogenic organizing pneumonia (COP): COP is characterized by the presence of polypoid plugs of organizing connective tissue in small airways and alveolar ducts. It generally presents with subacute symptoms and can improve with corticosteroid therapy, unlike the fulminant course of AIP.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cryptogenic organizing pneumonia (COP):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Respiratory bronchiolitis-associated ILD: This form of interstitial lung disease is commonly associated with smoking and presents with a more chronic or insidious onset. It typically involves the respiratory bronchioles, unlike the diffuse alveolar involvement seen in AIP.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Respiratory bronchiolitis-associated ILD:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hamman-Rich syndrome refers to acute interstitial pneumonia, a rare and severe form of idiopathic interstitial lung disease characterized by a rapid and progressive course, often resembling ARDS. It is associated with a high mortality rate and requires supportive care.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old lady presents with significant weight loss, fatigue, myalgia, and difficulty getting up from bed, particularly in a squatting position. Physical examination reveals papular lesions over the knuckles and fine crackles on auscultation, with a restrictive pulmonary function test (PFT) pattern. High-resolution CT (HRCT) reveals findings consistent with an interstitial lung disease pattern. What is the expected lung biopsy finding in this patient, and what is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-Synthetase syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CREST Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NERDS Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hermansky-Pudlak syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anti-Synthetase syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20162007.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Anti-Synthetase syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient&#x27;s presentation with weight loss, fatigue, myalgia, difficulty with movements (suggesting muscle weakness), skin changes (papular lesions on the knuckles), and fine crackles on auscultation is characteristic of a condition related to chronic inflammation and muscle weakness, which are typical features of dermatomyositis. The HRCT showing a pattern suggestive of non-specific interstitial pneumonia (NSIP) further points towards interstitial lung disease, often seen in autoimmune conditions. Anti-Synthetase syndrome, associated with amino-acyl tRNA antibodies (Jo-1), includes both muscle weakness and interstitial lung disease, fitting this patient&#x27;s clinical picture.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CREST Syndrome: CREST syndrome is a limited form of systemic sclerosis, characterized by Calcinosis, Raynaudâ€™s phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia. It does not typically present with muscle weakness or the skin lesions described in this patient, nor would it be associated with an NSIP pattern on HRCT.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CREST Syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option C. NERDS Syndrome: NERDS is an eosinophilic disorder recently described in literature and is characterized by an association of nodules, eosinophilia, rheumatism, dermatitis and swelling.&lt;/li&gt;&lt;li&gt;â€¢ Option C. NERDS Syndrome:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hermansky-Pudlak Syndrome: Hermansky-Pudlak syndrome is a rare genetic condition characterized by albinism, bleeding tendencies, and lung disease, particularly in the form of pulmonary fibrosis. However, it does not typically present with muscle weakness or the skin lesions described in this case, nor would it be expected to cause a restrictive PFT pattern in the same way as Anti-Synthetase syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hermansky-Pudlak Syndrome:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-Synthetase syndrome is a condition characterized by the presence of antibodies to amino-acyl tRNA synthetase (Jo-1) and often involves a combination of muscle weakness (myositis), skin changes (like papular lesions on the knuckles), and interstitial lung disease with an NSIP pattern on HRCT. It is a key consideration in patients presenting with these features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents to the clinic with a 3-month history of recurrent episodes of wheezing, shortness of breath, and chest tightness, particularly at night. He reports that his symptoms worsen with exercise and exposure to cold air. He has a family history of asthma, and he is a non-smoker. On physical examination, his lung auscultation reveals widespread wheezing. Spirometry shows a reduced FEV1/FVC ratio. After administration of a bronchodilator, his FEV1 improves by 15% and 250 mL. What is the most appropriate method for confirming the diagnosis of his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Skin prick test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1 measurement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reversible obstruction on PFT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Reversible obstruction on PFT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Reversible obstruction on PFT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The best method to diagnose bronchial asthma is to demonstrate reversible airway obstruction on pulmonary function tests (PFTs). Reversibility is confirmed when there is a greater than 12% and 200 mL increase in the forced expiratory volume in 1 second (FEV1) after administering a bronchodilator (such as a beta-2 agonist). This reversibility is a hallmark of asthma and helps confirm the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chest X-ray: A chest X-ray is typically normal in bronchial asthma, as asthma is primarily a functional disorder of the airways rather than a structural problem. Chest X-rays may only show changes during an asthma exacerbation or if there are complications like pneumonia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Chest X-ray:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Skin prick test: While the skin prick test can be helpful in identifying allergic triggers for asthma exacerbations, it does not diagnose asthma itself. It is used to evaluate the presence of atopy or identify specific allergens, but it does not directly confirm bronchial asthma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Skin prick test:&lt;/li&gt;&lt;li&gt;â€¢ Option C. FEV1 measurement: FEV1 measurement alone does not confirm the diagnosis of asthma. The FEV1/FVC ratio can help assess the degree of obstruction, but the diagnosis of asthma requires demonstrating reversible airflow obstruction, which is not determined by FEV1 measurement alone.&lt;/li&gt;&lt;li&gt;â€¢ Option C. FEV1 measurement:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The definitive method to diagnose bronchial asthma is by demonstrating reversible airway obstruction on pulmonary function tests, typically showing a significant improvement in FEV1 after bronchodilator administration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The Gold&#x27;s criteria for very severe COPD is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 30%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 70%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. FEV1/FVC &lt; 0.7 and FEV1 &lt; 30%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 30%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ According to the GOLD 2023 guidelines, very severe COPD (Stage IV) is defined by FEV1/FVC &amp;lt; 0.7 (common across all stages) and an FEV1 less than 30% of the predicted value. This stage indicates a significant reduction in airflow and severe impairment in lung function, often associated with respiratory failure and the need for long-term oxygen therapy.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 70%: This criteria describes moderate COPD (Stage II), where FEV1 is between 50% and 80% of the predicted value. It is not indicative of very severe COPD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 70%:&lt;/li&gt;&lt;li&gt;â€¢ Option C. FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 50%: This criteria refers to severe COPD (Stage III), where FEV1 is between 30% and 50% of the predicted value, but it does not qualify as very severe COPD, which requires an FEV1 of less than 30%.&lt;/li&gt;&lt;li&gt;â€¢ Option C. FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 50%:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Both A and C: This option is incorrect because Stage III (FEV1 &amp;lt; 50%) is not considered \&quot;very severe\&quot; COPD, which is defined by FEV1 &amp;lt; 30%.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Both A and C:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Very severe COPD (Stage IV) is classified by FEV1/FVC &amp;lt; 0.7 and FEV1 &amp;lt; 30% of the predicted value, indicating significant impairment in lung function and often requiring intensive management, including oxygen therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following situations would non-invasive ventilation (NIV) be considered contraindicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute exacerbation of chronic obstructive pulmonary disease (AECOPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute hypoxemic respiratory failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute myocardial infarction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute decompensated heart failure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute myocardial infarction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute myocardial infarction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Non-invasive ventilation (NIV) is contraindicated in patients with acute myocardial infarction (MI) due to the risk of exacerbating cardiovascular instability. NIV can increase intrathoracic pressure, reducing venous return to the heart and potentially worsening hemodynamics in the acute MI setting. Additionally, NIV can cause barotrauma or lead to discomfort, potentially worsening the patient&#x27;s condition in such a critical phase. Unstable angina and acute MI are both contraindications for NIV.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD): NIV is commonly used in the management of acute exacerbations of COPD, especially when the patient shows respiratory acidosis (pH between 7.25-7.35). It is effective in improving ventilation and reducing the need for intubation, making it a valuable treatment for patients with COPD exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute hypoxemic respiratory failure: NIV can be used in patients with acute hypoxemic respiratory failure, particularly when they are able to tolerate the interface and the condition is not too severe. It helps improve oxygenation and avoid intubation in appropriate cases.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Acute hypoxemic respiratory failure:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute decompensated heart failure: In decompensated systolic heart failure, NIV can be beneficial by providing positive end-expiratory pressure (PEEP), which helps reduce preload and afterload, improving symptoms. It is particularly helpful in patients with pulmonary edema and can stabilize the patient by improving gas exchange and decreasing the work of breathing.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Acute decompensated heart failure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NIV is contraindicated in acute myocardial infarction due to potential hemodynamic instability. It is, however, beneficial in conditions like COPD exacerbations, mild ARDS, and decompensated heart failure without acute ischemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female is referred for chronic cough and dyspnea with exertion. Over the past year, her cough and dyspnea have steadily worsened. According to pulmonary function testing, the FVC is 72%, FEV1 is 80%, and DLCO is 38%. HRCT is shown. A lung biopsy reveals foci of scarring dispersed and surrounded by healthy lung parenchyma with fibroblasts. Serology for autoimmune disease is negative. Which of the following is the appropriate therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pirfenidone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bosentan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetylcysteine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone/azathioprine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pirfenidone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20162035.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pirfenidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient&#x27;s presentation, including chronic cough, dyspnea on exertion, and pulmonary function test findings (low DLCO), negative serology, along with the CT showing a usual interstitial pneumonia (UIP) pattern and biopsy findings of scarring, is consistent with idiopathic pulmonary fibrosis (IPF). IPF is a progressive, fibrotic lung disease typically seen in individuals over 50 years old. The appropriate treatment for IPF includes antifibrotic agents like pirfenidone, which has been shown to slow disease progression and improve outcomes.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bosentan: Bosentan is an endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension (PAH), not in the management of idiopathic pulmonary fibrosis. While it is effective for PAH, it is not appropriate for IPF.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bosentan:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acetylcysteine: Acetylcysteine is used as a mucolytic agent in conditions like chronic obstructive pulmonary disease (COPD) and cystic fibrosis, but it has not been shown to have a role in the treatment of idiopathic pulmonary fibrosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Acetylcysteine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prednisolone/azathioprine: Prednisolone and azathioprine are often used in the treatment of inflammatory interstitial lung diseases, but they are not recommended for IPF, which is a fibrotic disease rather than primarily inflammatory. In fact, immunosuppressive therapy can worsen the prognosis in IPF.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Prednisolone/azathioprine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pirfenidone and Nintedanib are appropriate options for idiopathic pulmonary fibrosis, as it slows the progression of fibrosis in IPF. It is important to recognize the UIP pattern on CT and confirm the diagnosis with biopsy, as management strategies for IPF differ from those of other ILDs.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old male with a history of cirrhosis and chronic alcoholic liver disease presents with worsening ascites, confusion, and oliguria over the past week. He has been on diuretics for ascites management but has had poor urine output despite increasing doses. On examination, he is hypotensive with a heart rate of 100 bpm and has asterixis. Laboratory tests show elevated serum creatinine, low urine sodium, and normal ascitic fluid analysis. The patientâ€™s condition has not improved with conventional treatments. What is the definitive treatment for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Terlipressin + Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Terlipressin + Octreotide + Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Orthotopic liver transplantation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Simultaneous liver-kidney transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Orthotopic liver transplantation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Orthotopic liver transplantation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patientâ€™s presentation, including ascites, elevated serum creatinine, low urine sodium, and normal ascitic fluid analysis, suggests hepatorenal syndrome (HRS), a type of renal failure that occurs in cirrhosis. The definitive treatment for HRS is orthotopic liver transplantation (OLT), as it resolves both the liver dysfunction and the associated renal failure. HRS is a progressive condition, and without liver transplantation, kidney function typically does not improve.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Terlipressin + Albumin: Terlipressin (a vasopressin analog) combined with albumin can be used as a bridging therapy for HRS, improving renal perfusion and reducing renal failure. However, it does not cure the underlying liver disease, making it a short-term solution while waiting for liver transplantation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Terlipressin + Albumin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Terlipressin + Octreotide + Albumin: This combination therapy has been used as a bridge for patients with HRS, but it is not curative. While it may improve renal function temporarily, liver transplantation remains the definitive treatment for HRS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Terlipressin + Octreotide + Albumin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Simultaneous liver-kidney transplantation: Simultaneous liver-kidney transplantation is typically reserved for patients whose kidney function does not improve after liver transplantation or for those who have significant renal impairment prior to liver transplantation. In most cases of HRS, liver transplantation alone is sufficient to resolve renal failure.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Simultaneous liver-kidney transplantation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The definitive treatment for hepatorenal syndrome, a complication of cirrhosis and portal hypertension, is orthotopic liver transplantation. Bridge therapies like terlipressin and albumin can help stabilize patients, but liver transplantation is required for long-term resolution.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with end-stage kidney disease (ESKD) has been undergoing peritoneal dialysis for the past 6 months. Which of the following is not a common complication of peritoneal dialysis therapy in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertriglyceridemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperphosphatemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypoglycemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hypoglycemia is not a common complication of peritoneal dialysis therapy. In fact, peritoneal dialysis typically leads to hyperglycemia due to the absorption of glucose from the dialysate, especially in patients with diabetes. The use of glucose-based dialysates often leads to weight gain and increased caloric intake, which can exacerbate insulin resistance and contribute to hyperglycemia rather than hypoglycemia.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoproteinemia: Hypoproteinemia can occur in peritoneal dialysis patients due to the loss of proteins through the peritoneal membrane, which can lead to decreased serum albumin levels. It is a known complication, especially in patients with high-volume dialysate exchanges or those with infections.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hypoproteinemia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypertriglyceridemia: Hypertriglyceridemia is a common complication of peritoneal dialysis, particularly in patients with diabetes. The absorption of glucose from the dialysate leads to an increase in insulin resistance, which can promote hypertriglyceridemia. The increased caloric intake from glucose also contributes to this issue.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypertriglyceridemia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperphosphatemia: Hyperphosphatemia is a common complication in patients with kidney disease, including those on peritoneal dialysis, due to impaired renal clearance of phosphate. It is typically managed with phosphate binders, but it remains a common issue.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hyperphosphatemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypoglycemia is not a common complication of peritoneal dialysis. Instead, hyperglycemia and associated issues like hypertriglyceridemia and weight gain due to glucose absorption are more frequently encountered, especially in diabetic patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of chronic kidney disease (CKD) requiring hemodialysis has recently had a central venous catheter placed for dialysis. After several weeks, he presents with signs of poor blood flow during dialysis. Imaging reveals narrowing in the vein used for the catheter insertion. Which of the following sites is most likely to have caused this complication due to stenosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Femoral&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subclavian&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left Internal jugular&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right Internal jugular&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Subclavian&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Subclavian&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The subclavian vein is associated with a high risk of stenosis following catheter placement for hemodialysis. While it typically provides good flow rates initially, subclavian stenosis can develop over time, leading to compromised dialysis access. This stenosis can complicate future access and may prevent the use of that extremity for permanent vascular access (such as a fistula or graft).&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Femoral: While femoral vein access carries a higher risk of infection and is not typically preferred for long-term dialysis, it is not associated with the same risk of stenosis as the subclavian vein. The femoral vein is often used in emergency situations or for short-term access.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Femoral:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Left Internal jugular: The left internal jugular vein is a commonly used site for hemodialysis catheters and is less prone to stenosis compared to the subclavian vein. It provides reliable access for dialysis with fewer long-term complications related to stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Left Internal jugular:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Right Internal jugular: The right internal jugular vein is frequently used for hemodialysis catheter placement due to its accessibility and low risk of stenosis. It does not carry the same complication risk as the subclavian vein for stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Right Internal jugular:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Subclavian veins, although providing good flow for dialysis, are prone to stenosis, which can hinder long-term dialysis access and complicate future vascular access procedures.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female with a 10-year history of rheumatoid arthritis presents to the clinic with deformities in her fingers. On examination, you see a swan-neck deformity. Which of the following is the most likely description of this deformity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flexion of the PIP joint with hyperextension of the DIP joint&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperextension of the PIP joint with flexion of the DIP joint&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subluxation of the first MCP joint with hyperextension of the first interphalangeal (IP) joint&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hyperextension of the PIP joint with flexion of the DIP joint&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hyperextension of the PIP joint with flexion of the DIP joint&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The deformity described in this patient, with hyperextension of the proximal interphalangeal (PIP) joint and flexion of the distal interphalangeal (DIP) joint, is known as \&quot;swan-neck deformity.\&quot; This deformity is commonly seen in rheumatoid arthritis and results from damage to the tendons, joint capsule, and soft tissues around the finger joints. The deformity can arise due to imbalances between the flexor and extensor tendons, leading to this characteristic presentation.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Flexion of the PIP joint with hyperextension of the DIP joint: This description is incorrect for swan-neck deformity. It actually describes \&quot;boutonniÃ¨re deformity,\&quot; which is characterized by the flexion of the PIP joint with hyperextension of the DIP joint, a different type of deformity commonly seen in rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Flexion of the PIP joint with hyperextension of the DIP joint:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subluxation of the first MCP joint with hyperextension of the first interphalangeal (IP) joint: This describes a different deformity known as \&quot;Z-line deformity,\&quot; which involves the first metacarpophalangeal (MCP) joint and the first interphalangeal (IP) joint. It is not associated with the swan-neck deformity.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subluxation of the first MCP joint with hyperextension of the first interphalangeal (IP) joint:&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above: This option is incorrect because the correct description is provided in option B for swan-neck deformity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Swan-neck deformity in rheumatoid arthritis is characterized by hyperextension of the PIP joint with flexion of the DIP joint. It is caused by imbalances in tendon and joint capsule function, commonly seen in the progression of rheumatoid arthritis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female with a long history of rheumatoid arthritis (RA) presents with increasing difficulty in fighting off infections. On examination, she has splenomegaly, and her lab results show neutropenia. Her RA is complicated by nodular disease. Which of the following is not characteristic of Feltyâ€™s syndrome in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neutropenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neutrophilia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Splenomegaly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nodular RA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neutrophilia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Neutrophilia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Feltyâ€™s syndrome is characterized by the clinical triad of neutropenia , splenomegaly , and nodular rheumatoid arthritis (RA) . Neutropenia refers to an abnormally low neutrophil count, which makes patients more prone to infections. This syndrome is seen in a small percentage of patients with RA, often in those with long-standing and severe disease. Neutrophilia (an elevated neutrophil count) is not a characteristic feature of Feltyâ€™s syndrome, making option B the correct answer.&lt;/li&gt;&lt;li&gt;â€¢ neutropenia&lt;/li&gt;&lt;li&gt;â€¢ splenomegaly&lt;/li&gt;&lt;li&gt;â€¢ nodular rheumatoid arthritis (RA)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neutropenia: Neutropenia is one of the hallmark features of Feltyâ€™s syndrome. It occurs due to the increased destruction of neutrophils or impaired production by the bone marrow, leading to a reduced neutrophil count, which is a key aspect of the syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Neutropenia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Splenomegaly: Splenomegaly is another characteristic feature of Feltyâ€™s syndrome. The spleen enlarges due to the increased removal of neutrophils and other immune cells, contributing to the patientâ€™s susceptibility to infections.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Splenomegaly:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nodular RA: Nodular rheumatoid arthritis (RA) refers to the development of rheumatoid nodules, which are firm, non-tender lumps that can occur under the skin, particularly in areas of pressure. These nodules are a common finding in Feltyâ€™s syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Nodular RA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Feltyâ€™s syndrome is characterized by neutropenia, splenomegaly, and nodular RA. Neutrophilia is not a feature of this syndrome, and its presence would point toward other underlying conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female with a long history of rheumatoid arthritis (RA) presents with shortness of breath. What is the most likely pulmonary manifestation of rheumatoid arthritis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleuritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary nodules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung malignancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pleuritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pleuritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Pleuritis is the most common pulmonary manifestation of rheumatoid arthritis (RA). It occurs due to inflammation of the pleura, and patients typically present with pleuritic chest pain, dyspnea, and a pleural friction rub. Pleural effusions associated with RA tend to be exudative, with an increased number of monocytes and neutrophils in the pleural fluid, as described in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. ILD (Interstitial Lung Disease): Interstitial lung disease (ILD) is another pulmonary manifestation of RA but is less common than pleuritis. ILD typically presents with progressive dyspnea, a restrictive pattern on pulmonary function tests, and characteristic findings on high-resolution CT scans. However, pleuritis remains the most common manifestation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. ILD (Interstitial Lung Disease):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary nodules: Rheumatoid pulmonary nodules are common in patients with RA, particularly those with long-standing disease. These nodules are typically found on imaging but are less likely to be the cause of pleuritic chest pain, and the patient&#x27;s effusion and pleural friction rub point more toward pleuritis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pulmonary nodules:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung malignancy: Lung malignancy can occur in patients with rheumatoid arthritis, but it is not the most common pulmonary manifestation. Furthermore, the presence of a pleural effusion with an inflammatory profile and pleuritic chest pain is more consistent with pleuritis than lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lung malignancy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pleuritis is the most common pulmonary manifestation of rheumatoid arthritis and is characterized by pleuritic chest pain, dyspnea, and exudative pleural effusion with a predominance of monocytes and neutrophils.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female presents with morning stiffness, joint pain, and swelling in her hands and wrists. Laboratory tests reveal positive rheumatoid factor and anti-citrullinated protein antibody (ACPA). Which of the following is most likely true regarding this patient&#x27;s genetic risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HLA-DRB1*1301&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HLA-DRB1*1302&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HLA-DRB1*0401&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HLA-DRB1*0401&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HLA-DRB1*0401&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ HLA-DRB1*0401 is a high-risk allele for rheumatoid arthritis (RA), significantly increasing the likelihood of developing the disease. The presence of this allele, particularly in individuals with a family history of RA, suggests a genetic predisposition to the disease. The allele is associated with an increased risk of ACPA-positive RA, a subtype of RA characterized by the presence of antibodies against citrullinated proteins.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. HLA-DRB1*1301: This allele is associated with a protective effect against ACPA-positive RA. It confers protection from developing the disease rather than increasing the risk, making it an unlikely genetic factor for this patient&#x27;s RA.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HLA-DRB1*1301:&lt;/li&gt;&lt;li&gt;â€¢ protective&lt;/li&gt;&lt;li&gt;â€¢ Option B. HLA-DRB1*1302: HLA-DRB1*1302, similar to *1301, also confers protection from ACPA-positive RA. It is not a risk allele and would not contribute to the development of RA in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. HLA-DRB1*1302:&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above: This option is incorrect because HLA-DRB1*0401 is indeed a high-risk allele for RA, as explained.&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above:&lt;/li&gt;&lt;li&gt;â€¢ HLA-DRB1*0401&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The HLA-DRB1*0401 allele is a high-risk genetic factor for rheumatoid arthritis, particularly in individuals with a family history of the disease. It is strongly associated with ACPA-positive RA. In contrast, alleles such as HLA-DRB1*1301 and HLA-DRB1*1302 are protective against RA.&lt;/li&gt;&lt;li&gt;âž¤ HLA-DRB1*0401&lt;/li&gt;&lt;li&gt;âž¤ HLA-DRB1*1301&lt;/li&gt;&lt;li&gt;âž¤ HLA-DRB1*1302&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents to the clinic with joint pain, especially in the knees and hips, that worsens with activity but improves with rest. Which of the following is not typical of a noninflammatory joint disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pain without synovial swelling&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Absence of inflammatory or systemic features&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolonged morning stiffness&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Negative laboratory investigations&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prolonged morning stiffness&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Prolonged morning stiffness&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Prolonged morning stiffness lasting for more than 60 minutes is typical of inflammatory joint disorders, such as rheumatoid arthritis (RA) or polymyalgia rheumatica (PMR). In noninflammatory joint disorders, such as osteoarthritis (OA), the morning stiffness is usually brief (less than 60 minutes) and tends to improve with activity. The patientâ€™s clinical features, including brief morning stiffness, pain without synovial swelling, and normal inflammatory markers, are consistent with a noninflammatory joint disorder like osteoarthritis, which does not typically cause prolonged morning stiffness.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pain without synovial swelling: Pain without synovial swelling is a hallmark feature of noninflammatory joint disorders, like osteoarthritis. Inflammatory joint disorders typically present with synovial swelling and warmth due to active inflammation in the joints.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pain without synovial swelling:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Absence of inflammatory or systemic features: Noninflammatory joint disorders typically do not cause systemic symptoms, such as fever, weight loss, or fatigue, that are often seen in inflammatory conditions. The absence of systemic features is consistent with a noninflammatory condition.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Absence of inflammatory or systemic features:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Negative laboratory investigations: Negative laboratory investigations, including normal inflammatory markers (such as ESR and CRP), are typical of noninflammatory joint disorders. In contrast, inflammatory conditions usually present with elevated markers of inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Negative laboratory investigations:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prolonged morning stiffness (lasting longer than 60 minutes) is characteristic of inflammatory joint disorders, whereas noninflammatory joint disorders, like osteoarthritis, typically present with shorter morning stiffness and no synovial swelling or systemic features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old female presents with skin thickening involving the limbs and trunk, Raynaudâ€™s phenomenon, and difficulty swallowing. Laboratory tests reveal a positive antinuclear antibody (ANA) test with a speckled pattern. Which of the following is most likely to be positive?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti Jo-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti Centromeric Antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti Scl-70&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti Histone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti Scl-70&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti Scl-70&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is consistent with systemic sclerosis (scleroderma), particularly the diffuse subtype. Anti-Scl-70 (anti-topoisomerase I antibody) is strongly associated with diffuse systemic sclerosis, which involves extensive skin thickening and internal organ involvement, such as esophageal dysmotility.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti Jo-1 : Is associated with polymyositis and dermatomyositis, not systemic sclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Anti Jo-1&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti Centromeric Antibody: Is commonly associated with the limited form of systemic sclerosis (CREST syndrome), which involves localized skin thickening, primarily of the distal extremities, and less severe internal organ involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti Centromeric Antibody:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti Histone : Is typically associated with drug-induced lupus, not systemic sclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti Histone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-Scl-70 is a key marker for diffuse systemic sclerosis, characterized by widespread skin involvement and significant internal organ complications, such as esophageal dysmotility.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with joint swelling, warmth, and pain in the knee. The physician performs a joint aspiration, and synovial fluid is sent for analysis. Which of the following is not characteristic of the synovial fluid analysis in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inflammatory fluid is turbid and yellow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polymorphonuclear leukocyte predominance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of stringing effect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased WBC count (2000â€“50,000/Î¼L)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of stringing effect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Presence of stringing effect&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The presence of a stringing effect is not characteristic of inflammatory synovial fluid. Inflammatory synovial fluid has reduced viscosity , which results in the absence of stringing or a long tail behind the drop when the fluid is expressed. In contrast, non-inflammatory synovial fluid (such as in osteoarthritis or trauma) has normal viscosity, which produces a stringing effect.&lt;/li&gt;&lt;li&gt;â€¢ stringing effect&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ reduced viscosity&lt;/li&gt;&lt;li&gt;â€¢ non-inflammatory&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inflammatory fluid is turbid and yellow: This is characteristic of inflammatory synovial fluid. Inflammatory effusions, such as those seen in rheumatoid arthritis, gout, or infection, often appear turbid and yellow due to the presence of inflammatory cells, such as neutrophils.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Inflammatory fluid is turbid and yellow:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polymorphonuclear leukocyte predominance: This is a key feature of inflammatory synovial fluid. Polymorphonuclear leukocytes (PMNs or neutrophils) predominate in inflammatory conditions, often reflecting acute inflammation or infection in the joint.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Polymorphonuclear leukocyte predominance:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased WBC count (2000â€“50,000/Î¼L): An elevated white blood cell (WBC) count in the synovial fluid, typically between 2000-50,000/Î¼L , is characteristic of inflammatory conditions. Higher levels may indicate infection (septic arthritis), while lower counts may suggest conditions like gout or rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased WBC count (2000â€“50,000/Î¼L):&lt;/li&gt;&lt;li&gt;â€¢ 2000-50,000/Î¼L&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inflammatory synovial fluid has reduced viscosity and no stringing effect , with polymorphonuclear leukocyte predominance , increased WBC count, and a turbid yellow appearance. A stringing effect is seen in non-inflammatory fluid, typically associated with conditions like osteoarthritis.&lt;/li&gt;&lt;li&gt;âž¤ reduced viscosity&lt;/li&gt;&lt;li&gt;âž¤ no stringing effect&lt;/li&gt;&lt;li&gt;âž¤ polymorphonuclear leukocyte predominance&lt;/li&gt;&lt;li&gt;âž¤ non-inflammatory&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents with neck and back pain. X-ray is taken and shown. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diffuse idiopathic skeletal hyperostosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TB spine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spine metastases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Diffuse idiopathic skeletal hyperostosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20162155.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Diffuse idiopathic skeletal hyperostosis (DISH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The X-ray findings of calcification and ossification of the paraspinous ligaments with a \&quot;flowing wax\&quot; appearance on the anterior vertebral bodies are characteristic of diffuse idiopathic skeletal hyperostosis (DISH) . DISH is a condition that typically affects middle-aged or older adults and is often asymptomatic, though it can present with neck and back pain. The hallmark of DISH is the calcification of the ligaments, leading to the characteristic appearance on X-ray. It usually involves the thoracic spine but can affect other regions as well.&lt;/li&gt;&lt;li&gt;â€¢ diffuse idiopathic skeletal hyperostosis (DISH)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ankylosing spondylitis: Ankylosing spondylitis typically involves the sacroiliac joints and causes bilateral sacroiliitis with spinal involvement. It is associated with bamboo spine appearance on X-ray, characterized by syndesmophytes and fused vertebrae. The calcification seen in DISH is different from the characteristic changes seen in ankylosing spondylitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ankylosing spondylitis:&lt;/li&gt;&lt;li&gt;â€¢ bamboo spine&lt;/li&gt;&lt;li&gt;â€¢ Option C. TB spine: Tuberculosis of the spine (Pottâ€™s disease) can present with back pain and deformity but is typically associated with vertebral destruction and collapse, which is not seen in the \&quot;flowing wax\&quot; appearance of DISH. The X-ray would typically show vertebral body collapse and paraspinal abscesses in Pottâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. TB spine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spine metastases: Spinal metastases usually present with a history of primary malignancy and would show irregular lesions in the vertebral bodies with possible collapse or destruction. The calcified ligaments seen in DISH would not be seen in spine metastases, which often involve lytic or blastic lesions rather than ossification of ligaments.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spine metastases:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diffuse idiopathic skeletal hyperostosis (DISH) is characterized by the calcification and ossification of paraspinous ligaments, giving a \&quot;flowing wax\&quot; appearance on X-ray. It typically affects older adults and can lead to neck and back pain, though it is often asymptomatic.&lt;/li&gt;&lt;li&gt;âž¤ Diffuse idiopathic skeletal hyperostosis (DISH)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male with a history of psoriasis presents with joint pain and swelling. The patient has involvement of the distal interphalangeal (DIP) joints, and his X-rays show changes in the sacroiliac joints. Family members have a similar history of psoriasis and arthritis. Based on this, which of the following characteristics does not favor the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Distal interphalangeal (DIP) joint is involved&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Familial aggregation is seen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arthritis is usually seropositive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spine and sacroiliac joints are involved&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Arthritis is usually seropositive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Arthritis is usually seropositive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Unlike rheumatoid arthritis (RA), psoriatic arthritis (PsA) is usually seronegative for rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA). In contrast, RA is typically seropositive , meaning that most patients with RA have positive RF or ACPA. Therefore, the statement that arthritis is usually seropositive does not favor PsA and is more typical of RA.&lt;/li&gt;&lt;li&gt;â€¢ psoriatic arthritis (PsA)&lt;/li&gt;&lt;li&gt;â€¢ seronegative&lt;/li&gt;&lt;li&gt;â€¢ seropositive&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Distal interphalangeal (DIP) joint is involved: In psoriatic arthritis, the distal interphalangeal (DIP) joints are often involved, which is a key distinguishing feature from RA. RA typically affects the proximal joints (such as the metacarpophalangeal (MCP) joints), whereas PsA commonly affects the DIP joints.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Distal interphalangeal (DIP) joint is involved:&lt;/li&gt;&lt;li&gt;â€¢ distal interphalangeal (DIP)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Familial aggregation is seen: Psoriatic arthritis has a strong familial aggregation . A family history of psoriasis or PsA is common in patients with PsA, which distinguishes it from RA, where familial aggregation is less pronounced.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Familial aggregation is seen:&lt;/li&gt;&lt;li&gt;â€¢ familial aggregation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spine and sacroiliac joints are involved: Psoriatic arthritis often affects the spine and sacroiliac joints . This axial involvement is more common in PsA than in RA, which tends to spare these areas in favor of peripheral joints. Sacroiliitis and spondylitis are common features in PsA, especially in patients with the spondyloarthritis subtype.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spine and sacroiliac joints are involved:&lt;/li&gt;&lt;li&gt;â€¢ spine&lt;/li&gt;&lt;li&gt;â€¢ sacroiliac joints&lt;/li&gt;&lt;li&gt;â€¢ spondyloarthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Psoriatic arthritis is typically seronegative , unlike rheumatoid arthritis, which is usually seropositive . PsA is characterized by involvement of the DIP joints, familial aggregation, and potential involvement of the spine and sacroiliac joints.&lt;/li&gt;&lt;li&gt;âž¤ seronegative&lt;/li&gt;&lt;li&gt;âž¤ seropositive&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male with a history of joint pain presents for evaluation. A radionuclide bone scan is done and shown. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Psoriatic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IBD-associated arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SAPHO syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. SAPHO syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20162213.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) SAPHO syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The \&quot;bullâ€™s head\&quot; sign on a radionuclide bone scan is characteristic of SAPHO syndrome , which stands for Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis . This syndrome is a rare disorder that involves the skin and joints, often affecting the sternoclavicular joints and clavicles. The radionuclide bone scan is particularly useful in identifying the involvement of the clavicles and sternoclavicular joints, which is key to the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ SAPHO syndrome&lt;/li&gt;&lt;li&gt;â€¢ Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Psoriatic arthritis: Psoriatic arthritis can involve the joints, including the fingers, toes, and spine, but it does not typically present with the \&quot;bullâ€™s head\&quot; sign. Psoriatic arthritis is associated with other radiographic findings, such as pencil-in-cup deformities in the fingers, but not the characteristic pattern seen in SAPHO syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Psoriatic arthritis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IBD-associated arthritis: Inflammatory bowel disease (IBD)-associated arthritis can affect peripheral joints and the spine but is not typically associated with the \&quot;bullâ€™s head\&quot; sign. IBD-associated arthritis is more commonly seen with enteropathic arthritis, which involves the sacroiliac joints and peripheral joints, not the sternoclavicular joints.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IBD-associated arthritis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ankylosing spondylitis: Ankylosing spondylitis typically affects the sacroiliac joints and spine, with characteristic findings such as the \&quot;bamboo spine\&quot; on radiographs. It is not associated with the \&quot;bullâ€™s head\&quot; sign, which is specific to SAPHO syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ankylosing spondylitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;bullâ€™s head\&quot; sign on a radionuclide bone scan is a classic finding in SAPHO syndrome , which is characterized by skin involvement (such as acne and pustulosis) and joint symptoms, particularly affecting the sternoclavicular joints and clavicles.&lt;/li&gt;&lt;li&gt;âž¤ SAPHO syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female with a history of systemic lupus erythematosus (SLE) presents with worsening proteinuria, hematuria, and swelling in her legs. A kidney biopsy is performed and the findings are consistent with lupus nephritis. What is the most accurate description of the most common type of lupus nephritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mesangial Proliferative Lupus Nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Focal Lupus Nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse Lupus Nephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Membranous Lupus Nephritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diffuse Lupus Nephritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diffuse Lupus Nephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The most common type of lupus nephritis is class IV lupus nephritis and is characterized by diffuse lupus nephritis , which involves widespread inflammation affecting both kidneys. This is the most severe form of lupus nephritis and typically presents with significant proteinuria, hematuria, and nephrotic syndrome. It can lead to renal failure if not properly treated. On biopsy, the findings show diffuse glomerular involvement with inflammation, often requiring aggressive treatment to prevent progression to end-stage renal disease.&lt;/li&gt;&lt;li&gt;â€¢ The most common type of lupus nephritis is class IV lupus nephritis&lt;/li&gt;&lt;li&gt;â€¢ diffuse lupus nephritis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mesangial Proliferative Lupus Nephritis: Class II lupus nephritis is classified as mesangial proliferative and is the mildest form of lupus nephritis. It primarily involves the mesangium, with minimal glomerular damage and usually does not cause significant clinical symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mesangial Proliferative Lupus Nephritis:&lt;/li&gt;&lt;li&gt;â€¢ mesangial proliferative&lt;/li&gt;&lt;li&gt;â€¢ Option B. Focal Lupus Nephritis: Class III lupus nephritis is focal lupus nephritis , where fewer than 50% of the glomeruli are affected by inflammation. It can present with some symptoms but is typically less severe than class IV.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Focal Lupus Nephritis:&lt;/li&gt;&lt;li&gt;â€¢ focal lupus nephritis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Membranous Lupus Nephritis: Class V lupus nephritis is membranous lupus nephritis , characterized by thickening of the glomerular basement membrane. It is more commonly associated with nephrotic syndrome but does not present with the diffuse, widespread inflammation seen in class IV.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Membranous Lupus Nephritis:&lt;/li&gt;&lt;li&gt;â€¢ membranous lupus nephritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Class IV lupus nephritis is characterized by diffuse lupus nephritis , the most common and the most severe form of lupus nephritis, involving widespread inflammation and often requiring aggressive treatment to prevent kidney failure.&lt;/li&gt;&lt;li&gt;âž¤ Class IV lupus nephritis&lt;/li&gt;&lt;li&gt;âž¤ diffuse lupus nephritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old female with a history of recurrent miscarriages presents to the clinic for evaluation of possible antiphospholipid syndrome. Which of the following autoantibodies is detected by the dilute Russell viper venom test (DRVVT)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibodies against cardiolipin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antibodies against Î²2 GPI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lupus anticoagulant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antiphosphatidylserine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lupus anticoagulant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lupus anticoagulant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The dilute Russell viper venom test (DRVVT) is used to detect lupus anticoagulant (LA) , which is an antibody associated with antiphospholipid syndrome (APS). The DRVVT is a clotting test that measures the effect of lupus anticoagulant on the clotting cascade. LA is an antibody that interferes with normal phospholipid-dependent clotting reactions, leading to prolonged clotting times, as seen in the DRVVT.&lt;/li&gt;&lt;li&gt;â€¢ dilute Russell viper venom test (DRVVT)&lt;/li&gt;&lt;li&gt;â€¢ lupus anticoagulant (LA)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antibodies against cardiolipin: Antibodies against cardiolipin (aCL) are detected using an enzyme-linked immunosorbent assay (ELISA), not by DRVVT. These antibodies are one of the markers for antiphospholipid syndrome but are different from lupus anticoagulant.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Antibodies against cardiolipin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antibodies against Î²2 GPI: Antibodies against Î²2 glycoprotein I (Î²2 GPI) are typically detected using an ELISA, similar to the test for cardiolipin antibodies. These antibodies are associated with antiphospholipid syndrome but are not detected by DRVVT.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Antibodies against Î²2 GPI:&lt;/li&gt;&lt;li&gt;â€¢ Î²2 glycoprotein I (Î²2 GPI)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antiphosphatidylserine: Antibodies against phosphatidylserine are not typically measured in routine antiphospholipid syndrome testing. Phosphatidylserine is involved in clotting processes, but this antibody is not a standard test for APS and is not detected by DRVVT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antiphosphatidylserine:&lt;/li&gt;&lt;li&gt;â€¢ phosphatidylserine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The dilute Russell viper venom test (DRVVT) is specifically used to detect lupus anticoagulant (LA) , an antibody often present in antiphospholipid syndrome, and is crucial for evaluating patients with a prolonged aPTT and recurrent thrombotic events.&lt;/li&gt;&lt;li&gt;âž¤ dilute Russell viper venom test (DRVVT)&lt;/li&gt;&lt;li&gt;âž¤ lupus anticoagulant (LA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 19-year-old male presents with purpuric lesions on his lower extremities and abdominal pain. Biopsy of the skin lesion demonstrated immune complexes around small vessels. What is the most likely cause of the vasculitis in this patient, given the laboratory findings and clinical presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granulomatosis with polyangiitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Henoch-SchÃ¶nlein purpura&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Microscopic polyangiitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eosinophilic granulomatosis with polyangiitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Henoch-SchÃ¶nlein purpura&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)Â Henoch-SchÃ¶nlein purpura&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Henoch-SchÃ¶nlein purpura (also called as IgA vasculitis) is characterized by the deposition of IgA immune complexes in small vessels, leading to vasculitis, especially in the skin, joints, and gastrointestinal system. It typically presents with purpuric lesions , especially on the lower extremities, abdominal pain, and arthritis. The production of immune complexes, rather than antineutrophilic cytoplasmic antibodies (ANCA) , is the primary mechanism of vessel damage in IgA vasculitis .&lt;/li&gt;&lt;li&gt;â€¢ Henoch-SchÃ¶nlein purpura (also called as IgA vasculitis)&lt;/li&gt;&lt;li&gt;â€¢ IgA immune complexes&lt;/li&gt;&lt;li&gt;â€¢ purpuric lesions&lt;/li&gt;&lt;li&gt;â€¢ antineutrophilic cytoplasmic antibodies (ANCA)&lt;/li&gt;&lt;li&gt;â€¢ IgA vasculitis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (formerly known as Wegener&#x27;s granulomatosis) is an ANCA-associated vasculitis. It involves the production of antineutrophilic cytoplasmic antibodies (ANCA) , which play a key role in the pathogenesis of the disease, causing inflammation of small to medium-sized vessels. It is not related to immune complex deposition like in IgA vasculitis .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Granulomatosis with polyangiitis:&lt;/li&gt;&lt;li&gt;â€¢ antineutrophilic cytoplasmic antibodies (ANCA)&lt;/li&gt;&lt;li&gt;â€¢ IgA vasculitis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Microscopic polyangiitis: Microscopic polyangiitis is another ANCA-associated vasculitis. It is characterized by the presence of ANCA , which causes damage to small vessels and is not associated with immune complex deposition. This distinguishes it from IgA vasculitis .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Microscopic polyangiitis: Microscopic polyangiitis&lt;/li&gt;&lt;li&gt;â€¢ ANCA&lt;/li&gt;&lt;li&gt;â€¢ IgA vasculitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eosinophilic granulomatosis with polyangiitis: Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) is also an ANCA-associated vasculitis, characterized by asthma, eosinophilia, and vasculitis involving small to medium vessels. Like the other ANCA-associated vasculitides, it does not involve immune complex deposition as the primary mechanism of vessel damage.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eosinophilic granulomatosis with polyangiitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IgA vasculitis (Henoch-SchÃ¶nlein) is caused by immune complex deposition , specifically IgA, and is characterized by purpuric lesions , abdominal pain, and joint swelling. It is distinct from the ANCA-associated vasculitides, which include granulomatosis with polyangiitis , microscopic polyangiitis , and eosinophilic granulomatosis with polyangiitis .&lt;/li&gt;&lt;li&gt;âž¤ IgA vasculitis (Henoch-SchÃ¶nlein)&lt;/li&gt;&lt;li&gt;âž¤ immune complex deposition&lt;/li&gt;&lt;li&gt;âž¤ purpuric lesions&lt;/li&gt;&lt;li&gt;âž¤ granulomatosis with polyangiitis&lt;/li&gt;&lt;li&gt;âž¤ microscopic polyangiitis&lt;/li&gt;&lt;li&gt;âž¤ eosinophilic granulomatosis with polyangiitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with symptoms of hypertension, abdominal pain, and muscle weakness. Laboratory investigations show elevated creatinine levels and hematuria without RBC casts. A biopsy reveals necrotizing vasculitis of small- and medium-sized muscular arteries. Based on these findings, which of the following is not a feature of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary involvement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Negative ANCA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Absence of granulomas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HBV association&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary involvement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pulmonary involvement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The presentation is consistent with polyarteritis nodosa (PAN) , a systemic necrotizing vasculitis involving small- and medium-sized arteries. Typical features include renal involvement (elevated creatinine, hematuria without RBC casts), hypertension, abdominal pain, and muscle weakness. PAN spares the pulmonary vessels, and pulmonary involvement is not a feature of this condition.&lt;/li&gt;&lt;li&gt;â€¢ polyarteritis nodosa (PAN)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Negative ANCA: PAN is typically ANCA-negative, distinguishing it from other vasculitides like microscopic polyangiitis (MPA).&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B&lt;/li&gt;&lt;li&gt;â€¢ Negative ANCA:&lt;/li&gt;&lt;li&gt;â€¢ Option C . Absence of granulomas: PAN does not involve granuloma formation, differentiating it from granulomatosis with polyangiitis (GPA).&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Absence of granulomas:&lt;/li&gt;&lt;li&gt;â€¢ Option D . HBV association: PAN is strongly associated with hepatitis B virus (HBV) infection in approximately 10â€“30% of cases.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D&lt;/li&gt;&lt;li&gt;â€¢ HBV association:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis of small- and medium-sized arteries, characterized by ANCA negativity , absence of granulomas , and HBV association . Pulmonary involvement is not a feature of PAN, which helps differentiate it from other vasculitides.&lt;/li&gt;&lt;li&gt;âž¤ Polyarteritis nodosa (PAN)&lt;/li&gt;&lt;li&gt;âž¤ ANCA negativity&lt;/li&gt;&lt;li&gt;âž¤ absence of granulomas&lt;/li&gt;&lt;li&gt;âž¤ HBV association&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old female presents with a 2-month history of bilateral shoulder and hip pain, along with morning stiffness lasting for over an hour. Laboratory tests reveal an elevated ESR. Which of the following is not typical of this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-cyclic citrullinated peptide (CCP) is negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prompt therapeutic response to low-dose prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid factor is positive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rheumatoid factor is positive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Rheumatoid factor is positive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation suggests polymyalgia rheumatica (PMR) , an inflammatory disorder typically seen in older adults. PMR is characterized by pain and stiffness in the shoulders and hips, elevated ESR or CRP, and a dramatic response to low-dose corticosteroids. Rheumatoid factor positivity is not associated with PMR, making it an atypical finding and indicative of an alternative diagnosis such as rheumatoid arthritis (RA).&lt;/li&gt;&lt;li&gt;â€¢ polymyalgia rheumatica (PMR)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Anti-cyclic citrullinated peptide (CCP) is negative : CCP is not a feature of PMR and is more specific to RA. A negative CCP test is typical in PMR.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Anti-cyclic citrullinated peptide (CCP) is negative&lt;/li&gt;&lt;li&gt;â€¢ Option B . Prompt therapeutic response to low-dose prednisone : A hallmark feature of PMR is its dramatic response to corticosteroids, which often leads to symptom resolution within days.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Prompt therapeutic response to low-dose prednisone&lt;/li&gt;&lt;li&gt;â€¢ Option D . Presence of arthritis : While PMR is primarily periarticular, mild arthritis may be present and is not uncommon in the clinical presentation.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Presence of arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Polymyalgia rheumatica (PMR) is an inflammatory condition affecting the elderly, characterized by proximal muscle stiffness, elevated inflammatory markers, and rapid response to low-dose corticosteroids. Autoimmune markers like RF and CCP are absent, distinguishing PMR from other autoimmune diseases like RA.&lt;/li&gt;&lt;li&gt;âž¤ Polymyalgia rheumatica (PMR)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with progressive muscle weakness and difficulty climbing stairs. He has no skin changes but reports noticeable muscle wasting and weakness, particularly in the quadriceps and forearms. Laboratory tests show elevated muscle enzymes (CPK and aldolase). Given the patient&#x27;s age and presentation, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inclusion body myositis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polymyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune-mediated necrotizing myopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inclusion body myositis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inclusion body myositis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Inclusion body myositis (IBM) is the most common cause of myositis in individuals over 50 years . It is a progressive, idiopathic inflammatory muscle disease that typically presents with muscle weakness and atrophy , most commonly affecting the quadriceps and forearms . The disease is more common in men and presents with characteristic features such as muscle wasting and elevated muscle enzymes . Muscle biopsy typically shows inclusion bodies and rimmed vacuoles, which are pathognomonic for IBM.&lt;/li&gt;&lt;li&gt;â€¢ Inclusion body myositis (IBM)&lt;/li&gt;&lt;li&gt;â€¢ myositis in individuals over 50 years&lt;/li&gt;&lt;li&gt;â€¢ muscle weakness and atrophy&lt;/li&gt;&lt;li&gt;â€¢ quadriceps&lt;/li&gt;&lt;li&gt;â€¢ forearms&lt;/li&gt;&lt;li&gt;â€¢ men&lt;/li&gt;&lt;li&gt;â€¢ muscle wasting&lt;/li&gt;&lt;li&gt;â€¢ elevated muscle enzymes&lt;/li&gt;&lt;li&gt;â€¢ inclusion bodies&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dermatomyositis: Dermatomyositis (DM) is a type of inflammatory myopathy that typically affects younger individuals and is associated with skin involvement , such as a heliotrope rash and Gottron&#x27;s papules . While DM can occur in adults, it is less common in those over 50 years of age and is more likely to occur in women .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dermatomyositis: Dermatomyositis (DM)&lt;/li&gt;&lt;li&gt;â€¢ younger individuals&lt;/li&gt;&lt;li&gt;â€¢ skin involvement&lt;/li&gt;&lt;li&gt;â€¢ heliotrope rash&lt;/li&gt;&lt;li&gt;â€¢ Gottron&#x27;s papules&lt;/li&gt;&lt;li&gt;â€¢ women&lt;/li&gt;&lt;li&gt;â€¢ Option C. Polymyositis: Polymyositis (PM) is another form of inflammatory myopathy that often presents with muscle weakness in the proximal muscles (e.g., hips and shoulders). However, it is less common than IBM in older adults, and the disease tends to present in younger individuals , typically 30-60 years old. It also usually affects women more than men.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Polymyositis: Polymyositis (PM)&lt;/li&gt;&lt;li&gt;â€¢ muscle weakness&lt;/li&gt;&lt;li&gt;â€¢ younger individuals&lt;/li&gt;&lt;li&gt;â€¢ 30-60 years&lt;/li&gt;&lt;li&gt;â€¢ women&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune-mediated necrotizing myopathy: Immune-mediated necrotizing myopathy (IMNM) is a rare form of myopathy that can result from autoimmune diseases or as a consequence of statin use . It tends to cause severe muscle weakness, but it is less common than inclusion body myositis in older individuals.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Immune-mediated necrotizing myopathy: Immune-mediated necrotizing myopathy (IMNM)&lt;/li&gt;&lt;li&gt;â€¢ autoimmune diseases&lt;/li&gt;&lt;li&gt;â€¢ statin use&lt;/li&gt;&lt;li&gt;â€¢ inclusion body myositis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inclusion body myositis (IBM) is the most common form of myositis in individuals over 50, typically presenting with progressive muscle weakness, particularly affecting the quadriceps and forearms , and is characterized by muscle wasting and elevated muscle enzymes&lt;/li&gt;&lt;li&gt;âž¤ Inclusion body myositis (IBM)&lt;/li&gt;&lt;li&gt;âž¤ quadriceps&lt;/li&gt;&lt;li&gt;âž¤ forearms&lt;/li&gt;&lt;li&gt;âž¤ muscle wasting&lt;/li&gt;&lt;li&gt;âž¤ elevated muscle enzymes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old female presents with fatigue. Her iron studies reveal the following: Hb: Normal MCV: Normal RBC protoporphyrin (Âµg/dL): 150 (normal: 30-50) Saturation (%): 15 (normal: 30-50) Marrow iron stores: 0 Serum ferritin (Âµg/L): 10 (normal: 50-200) Based on the findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal iron balance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Negative iron balance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron deficient erythropoiesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Iron deficient erythropoiesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20162246.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Iron deficient erythropoiesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The findings indicate that the patient is in the stage of iron deficient erythropoiesis , where there is depletion of iron stores (marrow iron stores: 0, ferritin: 10 Âµg/L) and a low transferrin saturation (15%). Although hemoglobin and MCV are still normal, the elevated RBC protoporphyrin level reflects iron-deficient heme synthesis. This stage precedes the development of full-blown iron deficiency anemia, where hemoglobin levels become low.&lt;/li&gt;&lt;li&gt;â€¢ iron deficient erythropoiesis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Normal iron balance: The absence of marrow iron stores and low ferritin indicate an abnormal iron balance.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Normal iron balance:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Negative iron balance: This is an earlier stage where iron stores begin to deplete, but RBC protoporphyrin and transferrin saturation remain normal.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Negative iron balance:&lt;/li&gt;&lt;li&gt;â€¢ Option D . Iron deficiency anemia: This is a later stage where hemoglobin levels are low, and microcytosis develops, neither of which is present in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Iron deficiency anemia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Iron deficiency progresses in stages, beginning with negative iron balance (depleting stores), followed by iron deficient erythropoiesis (impaired iron incorporation into RBCs), and culminating in iron deficiency anemia (low Hb and microcytosis). Elevated RBC protoporphyrin and low marrow iron stores signal iron deficient erythropoiesis before anemia develops.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old male with sickle cell anemia presents with frequent episodes of pain and difficulty managing his disease. His physician recommends a monthly intravenous therapy to reduce acute painful episodes by blocking P-selectin , a molecule involved in endothelial cell adhesion. Which of the following medications is being used for this purpose?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Teplizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Voxelotor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crizanlizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ofatumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Crizanlizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Crizanlizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Crizanlizumab is a P-selectin-blocking monoclonal antibody that is used in sickle cell anemia to prevent the adhesive interactions between endothelial cells, platelets, leukocytes, and erythrocytes, which contribute to vaso-occlusion. By blocking P-selectin, Crizanlizumab reduces the frequency of acute painful episodes by approximately 45% , providing relief for patients. This mechanism of action helps reduce the complications of sickle cell disease, such as vaso-occlusive crises, without affecting hemolysis directly.&lt;/li&gt;&lt;li&gt;â€¢ Crizanlizumab&lt;/li&gt;&lt;li&gt;â€¢ P-selectin-blocking monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ Crizanlizumab&lt;/li&gt;&lt;li&gt;â€¢ acute painful episodes&lt;/li&gt;&lt;li&gt;â€¢ 45%&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Teplizumab: Teplizumab is a monoclonal antibody used in the treatment of type 1 diabetes . It does not have a role in the treatment of sickle cell anemia or in blocking P-selectin.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Teplizumab: Teplizumab&lt;/li&gt;&lt;li&gt;â€¢ type 1 diabetes&lt;/li&gt;&lt;li&gt;â€¢ Option B. Voxelotor: Voxelotor works by increasing the oxygen affinity of hemoglobin and stabilizing hemoglobin in its oxygenated form, thereby reducing sickling. It is not a P-selectin blocker, so it does not target the adhesion process between cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Voxelotor: Voxelotor&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ofatumumab: Ofatumumab is a monoclonal antibody used for the treatment of chronic lymphocytic leukemia (CLL) and multiple sclerosis . It is not used in sickle cell anemia and does not block P-selectin.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ofatumumab: Ofatumumab&lt;/li&gt;&lt;li&gt;â€¢ chronic lymphocytic leukemia&lt;/li&gt;&lt;li&gt;â€¢ multiple sclerosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Crizanlizumab is a P-selectin-blocking monoclonal antibody used in sickle cell anemia to reduce acute painful episodes by preventing sickle cellâ€“endothelial adhesion, improving the patient&#x27;s quality of life and reducing complications&lt;/li&gt;&lt;li&gt;âž¤ Crizanlizumab&lt;/li&gt;&lt;li&gt;âž¤ P-selectin-blocking monoclonal antibody&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A newborn presents with severe anemia, and the clinician suspects alpha-thalassemia. Laboratory tests reveal a deletion of all four alpha globin genes. What is the structural composition of the hemoglobin in this newborn?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î±3 Î³1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î± Î³3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ð›½4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î³4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Î³4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Î³4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Deletion of all four alpha globin genes results in Hb Bart&#x27;s hydrops fetalis , a condition in which no alpha chains are produced. In the absence of alpha chains, gamma chains (produced in the fetal stage) form tetramers (Î³4), called Hb Bart&#x27;s. Hb Bart&#x27;s has a very high oxygen affinity and cannot effectively deliver oxygen to tissues, leading to severe hypoxia, hydrops fetalis, and typically, in utero death.&lt;/li&gt;&lt;li&gt;â€¢ Hb Bart&#x27;s hydrops fetalis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Î±3 Î³1 : This combination is not physiologically possible, as alpha and gamma chains form heterotetramers, not uneven combinations like Î±3Î³1.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Î±3 Î³1&lt;/li&gt;&lt;li&gt;â€¢ Option B . Î± Î³3 : While gamma chains are present in the fetal stage, they form tetramers (Î³4) in the absence of alpha chains, not this combination.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Î± Î³3&lt;/li&gt;&lt;li&gt;â€¢ Option C . ð›½4 : Beta tetramers (Hb H) form in alpha-thalassemia with a milder deletion (three alpha genes lost), typically manifesting as Hb H disease, not Hb Bart&#x27;s hydrops fetalis.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ ð›½4&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In alpha-thalassemia with deletion of all four alpha genes, gamma chains form tetramers (Î³4), known as Hb Bart&#x27;s, which is pathognomonic for Hb Bart&#x27;s hydrops fetalis and results in severe anemia and hypoxia.&lt;/li&gt;&lt;li&gt;âž¤ Hb Bart&#x27;s hydrops fetalis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 4-year-old male presents with failure to thrive. He is diagnosed with Imerslund&#x27;s syndrome. What is the defining characteristic of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Selective malabsorption of folate with proteinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Selective malabsorption of cobalamin with folate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Selective malabsorption of cobalamin with proteinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Selective malabsorption of cobalamin with lymphopenia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Selective malabsorption of cobalamin with proteinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Selective malabsorption of cobalamin with proteinuria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Imerslund&#x27;s syndrome (also known as Imerslund-GrÃ¤sbeck syndrome ) is a rare, autosomal recessive disorder characterized by selective malabsorption of cobalamin (vitamin B12) and the presence of proteinuria . This condition typically leads to megaloblastic anemia due to vitamin B12 deficiency and is the most common cause of cobalamin malabsorption in infancy in Western countries. The syndrome is associated with defects in the cobalamin absorption process and renal complications (proteinuria).&lt;/li&gt;&lt;li&gt;â€¢ Imerslund&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ Imerslund-GrÃ¤sbeck syndrome&lt;/li&gt;&lt;li&gt;â€¢ selective malabsorption of cobalamin (vitamin B12)&lt;/li&gt;&lt;li&gt;â€¢ proteinuria&lt;/li&gt;&lt;li&gt;â€¢ megaloblastic anemia&lt;/li&gt;&lt;li&gt;â€¢ cobalamin malabsorption&lt;/li&gt;&lt;li&gt;â€¢ cobalamin absorption process&lt;/li&gt;&lt;li&gt;â€¢ renal complications&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Selective malabsorption of folate with proteinuria: This is not a feature of Imerslund&#x27;s syndrome . While folate malabsorption can occur in certain disorders, Imerslund&#x27;s syndrome specifically involves cobalamin malabsorption , not folate.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Selective malabsorption of folate with proteinuria:&lt;/li&gt;&lt;li&gt;â€¢ Imerslund&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ Imerslund&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ cobalamin malabsorption&lt;/li&gt;&lt;li&gt;â€¢ Option B. Selective malabsorption of cobalamin with folate: While Imerslund&#x27;s syndrome does involve cobalamin malabsorption , it does not involve folate malabsorption as described in this option.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Selective malabsorption of cobalamin with folate:&lt;/li&gt;&lt;li&gt;â€¢ Imerslund&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ cobalamin malabsorption&lt;/li&gt;&lt;li&gt;â€¢ Option D. Selective malabsorption of cobalamin with lymphopenia: Cobalamin malabsorption is the hallmark of Imerslund&#x27;s syndrome and is associated with proteinuria .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Selective malabsorption of cobalamin with lymphopenia: Cobalamin malabsorption&lt;/li&gt;&lt;li&gt;â€¢ Imerslund&#x27;s syndrome&lt;/li&gt;&lt;li&gt;â€¢ proteinuria&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Imerslund&#x27;s syndrome is characterized by selective malabsorption of cobalamin and proteinuria . It causes megaloblastic anemia and is typically diagnosed in infancy.&lt;/li&gt;&lt;li&gt;âž¤ Imerslund&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ selective malabsorption of cobalamin&lt;/li&gt;&lt;li&gt;âž¤ proteinuria&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-year-old child presents with hemoglobinuria after a recent viral infection. Laboratory testing reveals the presence of Donath-Landsteiner antibodies. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Paroxysmal nocturnal hemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;March hemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paroxysmal cold hemoglobinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Warm autoimmune hemolytic anemia (WAIHA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paroxysmal cold hemoglobinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Paroxysmal cold hemoglobinuria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Paroxysmal cold hemoglobinuria (PCH) is a rare form of autoimmune hemolytic anemia (AIHA) , typically seen in children , and often triggered by a viral infection . It is characterized by the presence of Donath-Landsteiner antibodies , which are cold-reactive antibodies that cause hemolysis upon exposure to cold temperatures. In this condition, hemoglobinuria occurs after cold exposure, and the hemolysis typically resolves when the body temperature returns to normal. The presence of Donath-Landsteiner antibodies is diagnostic of this condition.&lt;/li&gt;&lt;li&gt;â€¢ Paroxysmal cold hemoglobinuria (PCH)&lt;/li&gt;&lt;li&gt;â€¢ autoimmune hemolytic anemia (AIHA)&lt;/li&gt;&lt;li&gt;â€¢ children&lt;/li&gt;&lt;li&gt;â€¢ viral infection&lt;/li&gt;&lt;li&gt;â€¢ Donath-Landsteiner antibodies&lt;/li&gt;&lt;li&gt;â€¢ cold-reactive antibodies&lt;/li&gt;&lt;li&gt;â€¢ hemolysis&lt;/li&gt;&lt;li&gt;â€¢ hemoglobinuria&lt;/li&gt;&lt;li&gt;â€¢ Donath-Landsteiner antibodies&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Paroxysmal nocturnal hemoglobinuria (PNH): PNH is characterized by complement-mediated red blood cell lysis due to a defect in glycosylphosphatidylinositol (GPI)-anchored proteins . It is not associated with Donath-Landsteiner antibodies and has a different pathophysiology than paroxysmal cold hemoglobinuria .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Paroxysmal nocturnal hemoglobinuria (PNH): PNH&lt;/li&gt;&lt;li&gt;â€¢ complement-mediated red blood cell lysis&lt;/li&gt;&lt;li&gt;â€¢ glycosylphosphatidylinositol (GPI)-anchored proteins&lt;/li&gt;&lt;li&gt;â€¢ Donath-Landsteiner antibodies&lt;/li&gt;&lt;li&gt;â€¢ paroxysmal cold hemoglobinuria&lt;/li&gt;&lt;li&gt;â€¢ Option B. March hemoglobinuria: March hemoglobinuria occurs after strenuous exercise , especially when there is trauma to the red blood cells (e.g., from running or marching). It is not an autoimmune condition and is unrelated to Donath-Landsteiner antibodies . It results in hemoglobinuria due to physical damage to red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. March hemoglobinuria: March hemoglobinuria&lt;/li&gt;&lt;li&gt;â€¢ strenuous exercise&lt;/li&gt;&lt;li&gt;â€¢ Donath-Landsteiner antibodies&lt;/li&gt;&lt;li&gt;â€¢ hemoglobinuria&lt;/li&gt;&lt;li&gt;â€¢ Option D. Warm autoimmune hemolytic anemia (WAIHA): WAIHA involves warm-reacting antibodies , typically IgG antibodies , which cause hemolysis at normal body temperatures. It is not related to Donath-Landsteiner antibodies , which are cold-reacting antibodies found in PCH .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Warm autoimmune hemolytic anemia (WAIHA): WAIHA&lt;/li&gt;&lt;li&gt;â€¢ warm-reacting antibodies&lt;/li&gt;&lt;li&gt;â€¢ IgG antibodies&lt;/li&gt;&lt;li&gt;â€¢ hemolysis&lt;/li&gt;&lt;li&gt;â€¢ Donath-Landsteiner antibodies&lt;/li&gt;&lt;li&gt;â€¢ PCH&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Donath-Landsteiner antibodies are characteristic of paroxysmal cold hemoglobinuria (PCH) , a condition often triggered by viral infections, leading to hemolysis upon cold exposure. It is an autoimmune hemolytic anemia, predominantly seen in children&lt;/li&gt;&lt;li&gt;âž¤ Donath-Landsteiner antibodies&lt;/li&gt;&lt;li&gt;âž¤ paroxysmal cold hemoglobinuria (PCH)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female, who has been on heparin therapy for 5 days after surgery, presents with thrombocytopenia and new-onset skin lesions at the injection site. Laboratory testing reveals a platelet count drop of 50% from baseline. Which of the following antibodies is implicated in the pathogenesis of the disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platelet factor 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Platelet factor 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Platelet factor 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Platelet factor 4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Platelet factor 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Platelet factor 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is consistent with heparin-induced thrombocytopenia (HIT) , a prothrombotic disorder caused by antibodies directed against complexes of heparin and platelet factor 4 (PF4) . These antibodies activate platelets, leading to thrombocytopenia and an increased risk of thrombosis. The hallmark features of HIT include a &amp;gt;50% drop in platelet count, usually 5â€“10 days after starting heparin, and thrombosis or other complications such as skin necrosis.&lt;/li&gt;&lt;li&gt;â€¢ heparin-induced thrombocytopenia (HIT)&lt;/li&gt;&lt;li&gt;â€¢ heparin and platelet factor 4 (PF4)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A . Platelet factor 1 : This is not involved in the pathogenesis of HIT.&lt;/li&gt;&lt;li&gt;â€¢ Option A&lt;/li&gt;&lt;li&gt;â€¢ Platelet factor 1&lt;/li&gt;&lt;li&gt;â€¢ Option B . Platelet factor 2 : This is incorrect; the implicated factor is platelet factor 4.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Platelet factor 2&lt;/li&gt;&lt;li&gt;â€¢ Option C . Platelet factor 3 : This refers to a phospholipid complex involved in the coagulation cascade but is unrelated to HIT.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ Platelet factor 3&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In heparin-induced thrombocytopenia , antibodies target the heparin-platelet factor 4 complex, leading to platelet activation, thrombocytopenia, and a high risk of thrombosis. Early recognition and discontinuation of heparin are essential to prevent complications.&lt;/li&gt;&lt;li&gt;âž¤ heparin-induced thrombocytopenia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female presents with 2 days of fever and altered mental status. Peripheral smear reveals microangiopathic hemolytic anemia and thrombocytopenia with high serum creatinine. The physician orders a test to evaluate ADAMTS13 activity. What level of activity is diagnostic for the disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt;5%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt;15%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt;10%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt;20%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &lt;10%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;lt;10%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is consistent with thrombotic thrombocytopenic purpura (TTP) , a condition caused by severe deficiency of ADAMTS13 activity. ADAMTS13 is a protease that cleaves large von Willebrand factor (vWF) multimers. When its activity is reduced to &amp;lt;10% , unregulated vWF activity leads to platelet aggregation, thrombocytopenia, microangiopathic hemolytic anemia, and end-organ damage. Testing ADAMTS13 activity confirms the diagnosis of TTP.&lt;/li&gt;&lt;li&gt;â€¢ thrombotic thrombocytopenic purpura (TTP)&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;10%&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;lt;5%: While TTP involves severe ADAMTS13 deficiency, a diagnostic threshold of &amp;lt;10% is standard.&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;lt;5%:&lt;/li&gt;&lt;li&gt;â€¢ Option B. &amp;lt;15%: This threshold is too high and would lead to overdiagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. &amp;lt;15%:&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;lt;20%: This level is also not diagnostic for TTP. It&#x27;s closer to the normal range, but it falls outside the diagnostic criteria for TTP based on ADAMTS13 activity. A patient with this level would likely have other causes for their symptoms investigated.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D. &amp;lt;20%:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thrombotic thrombocytopenic purpura (TTP) is characterized by ADAMTS13 activity levels of &amp;lt;10% , leading to microangiopathic hemolytic anemia and thrombocytopenia. Prompt recognition and initiation of plasma exchange are critical for management.&lt;/li&gt;&lt;li&gt;âž¤ Thrombotic thrombocytopenic purpura (TTP)&lt;/li&gt;&lt;li&gt;âž¤ &amp;lt;10%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old boy presents with purpura on his legs, abdominal pain, and hematuria. His parents report that he had an upper respiratory infection a few days prior. Which of the following statements is not true about the disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Associated with starry sky appearance in renal biopsy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arthritis is common&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PT, aPTT is likely to be normal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucocorticoids can provide symptomatic relief&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Associated with starry sky appearance in renal biopsy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Associated with starry sky appearance in renal biopsy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is consistent with IgA vasculitis (Henoch-SchÃ¶nlein purpura, HSP) , a small-vessel vasculitis commonly seen in children. It is characterized by palpable purpura, abdominal pain, arthralgia/arthritis, and renal involvement (hematuria or proteinuria). Renal biopsy in IgA vasculitis typically shows mesangial IgA deposition , not a \&quot;starry sky\&quot; appearance, which is more characteristic of post-streptococcal glomerulonephritis (PSGN).&lt;/li&gt;&lt;li&gt;â€¢ IgA vasculitis (Henoch-SchÃ¶nlein purpura, HSP)&lt;/li&gt;&lt;li&gt;â€¢ mesangial IgA deposition&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B . Arthritis is common: Arthritis or arthralgia, particularly affecting the knees and ankles, is a frequent symptom of IgA vasculitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Arthritis is common:&lt;/li&gt;&lt;li&gt;â€¢ Option C . PT, aPTT is likely to be normal: Coagulation studies are usually normal in IgA vasculitis, as the condition involves immune-mediated vasculitis rather than a coagulopathy.&lt;/li&gt;&lt;li&gt;â€¢ Option C&lt;/li&gt;&lt;li&gt;â€¢ PT, aPTT is likely to be normal:&lt;/li&gt;&lt;li&gt;â€¢ Option D . Glucocorticoids can provide symptomatic relief: While not curative, glucocorticoids can help alleviate severe abdominal pain or renal involvement in IgA vasculitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Glucocorticoids can provide symptomatic relief:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IgA vasculitis (HSP) is characterized by immune complex deposition in small vessels, with renal biopsy showing mesangial IgA deposition . A \&quot;starry sky\&quot; appearance is not a feature of this disorder, distinguishing it from PSGN.&lt;/li&gt;&lt;li&gt;âž¤ IgA vasculitis (HSP)&lt;/li&gt;&lt;li&gt;âž¤ mesangial IgA deposition&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old male presents with a history of severe mucosal bleeding, joint bleeding, and excessive bleeding after surgery. Laboratory tests show virtually no von Willebrand factor (VWF) protein and factor VIII (FVIII) levels &amp;lt;10%. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 1 VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type 2 VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 3 VWD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type 4 VWD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Type 3 VWD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Type 3 VWD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Type 3 von Willebrand disease (VWD) is the most severe form of VWD . It is characterized by virtually no VWF protein and FVIII levels &amp;lt;10% , which leads to a significant bleeding tendency. This type of VWD is typically autosomal recessive and manifests with severe mucosal bleeding , joint bleeding , and excessive bleeding during surgery. The lack of VWF impairs platelet adhesion to the vascular wall, and the low levels of FVIII contribute to reduced clot formation.&lt;/li&gt;&lt;li&gt;â€¢ Type 3 von Willebrand disease (VWD)&lt;/li&gt;&lt;li&gt;â€¢ VWD&lt;/li&gt;&lt;li&gt;â€¢ virtually no VWF protein&lt;/li&gt;&lt;li&gt;â€¢ FVIII levels &amp;lt;10%&lt;/li&gt;&lt;li&gt;â€¢ autosomal recessive&lt;/li&gt;&lt;li&gt;â€¢ mucosal bleeding&lt;/li&gt;&lt;li&gt;â€¢ joint bleeding&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type 1 VWD: Type 1 VWD is a mild form of the disease where VWF levels are reduced but still detectable. FVIII levels are usually normal or slightly decreased, and the bleeding tendency is less severe when compared to Type 3.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type 1 VWD: Type 1 VWD&lt;/li&gt;&lt;li&gt;â€¢ VWF levels are reduced&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type 2 VWD: Type 2 VWD is characterized by a qualitative defect in VWF rather than a quantitative deficiency. VWF is present, but it is dysfunctional. FVIII levels are usually mildly decreased , and patients may have bleeding, but it is not as severe as in Type 3 VWD .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Type 2 VWD: Type 2 VWD&lt;/li&gt;&lt;li&gt;â€¢ qualitative defect&lt;/li&gt;&lt;li&gt;â€¢ mildly decreased&lt;/li&gt;&lt;li&gt;â€¢ Type 3 VWD&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type 4 VWD: Type 4 VWD is not a recognized subtype of von Willebrand disease . The classification of VWD includes Types 1, 2, and 3 , with Type 3 being the most severe form.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Type 4 VWD: Type 4 VWD&lt;/li&gt;&lt;li&gt;â€¢ von Willebrand disease&lt;/li&gt;&lt;li&gt;â€¢ Types 1, 2, and 3&lt;/li&gt;&lt;li&gt;â€¢ Type 3&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Type 3 VWD is characterized by virtually no VWF protein and FVIII levels &amp;lt;10% , leading to severe bleeding symptoms including mucosal and joint bleeding. It is the most severe form of von Willebrand disease .&lt;/li&gt;&lt;li&gt;âž¤ Type 3 VWD&lt;/li&gt;&lt;li&gt;âž¤ virtually no VWF protein&lt;/li&gt;&lt;li&gt;âž¤ FVIII levels &amp;lt;10%&lt;/li&gt;&lt;li&gt;âž¤ severe bleeding symptoms&lt;/li&gt;&lt;li&gt;âž¤ von Willebrand disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with chronic myelogenous leukemia (CML) shows suboptimal response with imatinib. Genetic testing reveals a T315I mutation. Which of the following is the treatment of choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dasatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nilotinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ponatinib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bosutinib&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ponatinib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ponatinib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Ponatinib is the only tyrosine kinase inhibitor (TKI) that remains active in the setting of the T315I mutation in chronic myelogenous leukemia (CML) . The T315I mutation causes resistance to several earlier TKIs, including imatinib , dasatinib , nilotinib , and bosutinib , but ponatinib has been shown to have activity against this mutation. It is an effective option for patients with the T315I mutation and has demonstrated high response rates, including complete cytogenetic response in 50-70% of patients who had failed two or more TKIs.&lt;/li&gt;&lt;li&gt;â€¢ Ponatinib&lt;/li&gt;&lt;li&gt;â€¢ tyrosine kinase inhibitor (TKI)&lt;/li&gt;&lt;li&gt;â€¢ active&lt;/li&gt;&lt;li&gt;â€¢ T315I mutation&lt;/li&gt;&lt;li&gt;â€¢ chronic myelogenous leukemia (CML)&lt;/li&gt;&lt;li&gt;â€¢ T315I mutation&lt;/li&gt;&lt;li&gt;â€¢ imatinib&lt;/li&gt;&lt;li&gt;â€¢ dasatinib&lt;/li&gt;&lt;li&gt;â€¢ nilotinib&lt;/li&gt;&lt;li&gt;â€¢ bosutinib&lt;/li&gt;&lt;li&gt;â€¢ ponatinib&lt;/li&gt;&lt;li&gt;â€¢ T315I mutation&lt;/li&gt;&lt;li&gt;â€¢ complete cytogenetic response&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dasatinib: Dasatinib is not effective in the presence of the T315I mutation . This mutation confers resistance to dasatinib , along with other first- and second-generation TKIs.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dasatinib: Dasatinib&lt;/li&gt;&lt;li&gt;â€¢ T315I mutation&lt;/li&gt;&lt;li&gt;â€¢ dasatinib&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nilotinib: Nilotinib , like dasatinib , is ineffective against the T315I mutation and therefore not a good treatment option for patients harboring this mutation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nilotinib: Nilotinib&lt;/li&gt;&lt;li&gt;â€¢ dasatinib&lt;/li&gt;&lt;li&gt;â€¢ ineffective&lt;/li&gt;&lt;li&gt;â€¢ T315I mutation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bosutinib: Bosutinib also does not have activity against the T315I mutation and is ineffective in treating CML with this specific mutation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bosutinib: Bosutinib&lt;/li&gt;&lt;li&gt;â€¢ T315I mutation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ponatinib is the only TKI that remains active against the T315I mutation in chronic myelogenous leukemia (CML) , providing an important treatment option for patients who have developed resistance to other TKIs.&lt;/li&gt;&lt;li&gt;âž¤ Ponatinib&lt;/li&gt;&lt;li&gt;âž¤ TKI&lt;/li&gt;&lt;li&gt;âž¤ active&lt;/li&gt;&lt;li&gt;âž¤ T315I mutation&lt;/li&gt;&lt;li&gt;âž¤ chronic myelogenous leukemia (CML)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old child presents with rapidly enlarging lymph nodes and abdominal mass. A biopsy of the node reveals the following. What is the typical doubling time of this aggressive malignancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt;24 h&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;48 h&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;72 h&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;96 h&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &lt;24 h&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20162337.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) &amp;lt;24 h&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The biopsy shows starry sky appearance which is characteristic of Burkittâ€™s lymphoma. Burkittâ€™s lymphoma is one of the fastest-growing non-Hodgkin lymphomas (NHL) , particularly in children. It has a doubling time of less than 24 hours , which means it can rapidly progress and requires aggressive treatment . This rapid growth is a hallmark of the disease, and the tumor often presents with massive lymphadenopathy , abdominal masses , or bowel involvement .&lt;/li&gt;&lt;li&gt;â€¢ The biopsy shows starry sky appearance which is characteristic of Burkittâ€™s lymphoma. Burkittâ€™s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ non-Hodgkin lymphomas (NHL)&lt;/li&gt;&lt;li&gt;â€¢ doubling time of less than 24 hours&lt;/li&gt;&lt;li&gt;â€¢ aggressive treatment&lt;/li&gt;&lt;li&gt;â€¢ massive lymphadenopathy&lt;/li&gt;&lt;li&gt;â€¢ abdominal masses&lt;/li&gt;&lt;li&gt;â€¢ bowel involvement&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 48 h: While Burkittâ€™s lymphoma is a rapidly growing malignancy, its doubling time is usually &amp;lt;24 hours , not 48 hours. A doubling time of 48 hours would indicate a slower-growing tumor.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 48 h:&lt;/li&gt;&lt;li&gt;â€¢ doubling time&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;24 hours&lt;/li&gt;&lt;li&gt;â€¢ Option C. 72 h: A 72-hour doubling time would be considered slower than the rapid progression seen in Burkittâ€™s lymphoma . The tumor grows significantly faster than this in most cases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 72 h:&lt;/li&gt;&lt;li&gt;â€¢ 72-hour doubling time&lt;/li&gt;&lt;li&gt;â€¢ Burkittâ€™s lymphoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. 96 h: A 96-hour doubling time would be considered even slower, which is not characteristic of Burkittâ€™s lymphoma , which is known for its aggressive behavior and extremely rapid growth rate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 96 h:&lt;/li&gt;&lt;li&gt;â€¢ 96-hour doubling time&lt;/li&gt;&lt;li&gt;â€¢ Burkittâ€™s lymphoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Burkittâ€™s lymphoma is one of the most aggressive types of non-Hodgkin lymphoma , with a doubling time of &amp;lt;24 hours . Early diagnosis and prompt treatment are crucial for patient outcomes.&lt;/li&gt;&lt;li&gt;âž¤ Burkittâ€™s lymphoma&lt;/li&gt;&lt;li&gt;âž¤ non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;âž¤ doubling time of &amp;lt;24 hours&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents with splenomegaly and pancytopenia. Peripheral blood smear is shown and bone marrow biopsy reveals monomorphic infiltrate of small B-cells. Which of the following markers is not expressed by these cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD30&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD103&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD25&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD123&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CD30&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20163326.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CD30&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hairy Cell Leukemia (HCL) is a B-cell neoplasm characterized by small lymphocytes with cytoplasmic projections (\&quot;hairy\&quot; cells) on peripheral smear. Patients are usually elderly males and present with massive splenomegaly &amp;amp;/or cytopenias. HCL cells express CD103 , CD25 , and CD123 , among others, but they do not express CD30 . CD30 is typically associated with Hodgkin lymphoma and some T-cell lymphomas, not HCL.&lt;/li&gt;&lt;li&gt;â€¢ CD103&lt;/li&gt;&lt;li&gt;â€¢ CD25&lt;/li&gt;&lt;li&gt;â€¢ CD123&lt;/li&gt;&lt;li&gt;â€¢ CD30&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B . CD103: This is a hallmark marker for HCL and is highly specific for the diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ CD103:&lt;/li&gt;&lt;li&gt;â€¢ Option C. CD25: This marker is commonly expressed in HCL and contributes to the immunophenotypic profile.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ CD25:&lt;/li&gt;&lt;li&gt;â€¢ Option D . CD123: This marker is also expressed in HCL, although less specific than CD103.&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ CD123:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hairy Cell Leukemia can be identified by its characteristic morphology and immunophenotypic markers such as CD103, CD25, and CD123 . It does not express markers like CD30 , which are associated with other hematologic malignancies.&lt;/li&gt;&lt;li&gt;âž¤ CD103, CD25, and CD123&lt;/li&gt;&lt;li&gt;âž¤ CD30&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male with a history of multiple myeloma presents with worsening symptoms of fatigue, bone pain, and renal dysfunction. What is the single most powerful predictor of survival in multiple myeloma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated LDH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-risk gene expression profile&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î²2-microglobulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;De novo plasma cell leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Î²2-microglobulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Î²2-microglobulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In multiple myeloma , Î²2-microglobulin is considered the single most powerful predictor of survival . Elevated levels of Î²2-microglobulin correlate with disease burden and tumor cell proliferation . It is used both in prognostic scoring and as a biomarker to assess the severity of the disease. Î²2-microglobulin is part of the major histocompatibility complex (MHC-I) and is expressed on the surface of all cells, with levels elevated in multiple myeloma due to the increased production of light chains by plasma cells.&lt;/li&gt;&lt;li&gt;â€¢ multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ Î²2-microglobulin&lt;/li&gt;&lt;li&gt;â€¢ single most powerful predictor of survival&lt;/li&gt;&lt;li&gt;â€¢ Î²2-microglobulin&lt;/li&gt;&lt;li&gt;â€¢ disease burden&lt;/li&gt;&lt;li&gt;â€¢ tumor cell proliferation&lt;/li&gt;&lt;li&gt;â€¢ prognostic scoring&lt;/li&gt;&lt;li&gt;â€¢ biomarker&lt;/li&gt;&lt;li&gt;â€¢ Î²2-microglobulin&lt;/li&gt;&lt;li&gt;â€¢ major histocompatibility complex (MHC-I)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated LDH: Lactate dehydrogenase (LDH) can be elevated in multiple myeloma and is associated with disease activity, but it is not as strong a predictor of survival as Î²2-microglobulin . It may indicate tissue damage but is not as specific as Î²2-microglobulin .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated LDH: Lactate dehydrogenase (LDH)&lt;/li&gt;&lt;li&gt;â€¢ not as strong a predictor&lt;/li&gt;&lt;li&gt;â€¢ Î²2-microglobulin&lt;/li&gt;&lt;li&gt;â€¢ Î²2-microglobulin&lt;/li&gt;&lt;li&gt;â€¢ Option B. High-risk gene expression profile: A high-risk gene expression profile can predict poor prognosis in multiple myeloma, but it is generally not as commonly used in routine clinical practice as Î²2-microglobulin . While important in research, it is not the single most powerful predictor .&lt;/li&gt;&lt;li&gt;â€¢ Option B. High-risk gene expression profile:&lt;/li&gt;&lt;li&gt;â€¢ high-risk gene expression profile&lt;/li&gt;&lt;li&gt;â€¢ Î²2-microglobulin&lt;/li&gt;&lt;li&gt;â€¢ single most powerful predictor&lt;/li&gt;&lt;li&gt;â€¢ Option D. De novo plasma cell leukemia: De novo plasma cell leukemia is a high-risk variant of multiple myeloma and is associated with poor prognosis. However, it is not a predictor of survival on its own in the general population of patients with multiple myeloma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. De novo plasma cell leukemia: De novo plasma cell leukemia&lt;/li&gt;&lt;li&gt;â€¢ high-risk variant&lt;/li&gt;&lt;li&gt;â€¢ not a predictor of survival&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Î²2-microglobulin is the most powerful and commonly used predictor of survival in multiple myeloma , providing valuable prognostic information and helping guide treatment decisions.&lt;/li&gt;&lt;li&gt;âž¤ Î²2-microglobulin&lt;/li&gt;&lt;li&gt;âž¤ most powerful&lt;/li&gt;&lt;li&gt;âž¤ predictor of survival&lt;/li&gt;&lt;li&gt;âž¤ multiple myeloma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male with a history of chronic alcohol consumption presents with jaundice and abdominal pain. Laboratory tests show prolonged prothrombin time and serum bilirubin elevation. Which of the following is the correct formula for calculating Maddreyâ€™s discriminant function in alcoholic hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 4.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 4.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Maddrey Discriminant Function (MDF) is used to assess the short-term mortality risk in patients with alcoholic hepatitis . The formula for calculating MDF is:&lt;/li&gt;&lt;li&gt;â€¢ Maddrey Discriminant Function (MDF)&lt;/li&gt;&lt;li&gt;â€¢ short-term mortality risk&lt;/li&gt;&lt;li&gt;â€¢ alcoholic hepatitis&lt;/li&gt;&lt;li&gt;â€¢ MDF&lt;/li&gt;&lt;li&gt;â€¢ MDF = 4.6 Ã— (prolongation of prothrombin time above control in seconds) + serum bilirubin in mg/dL&lt;/li&gt;&lt;li&gt;â€¢ MDF = 4.6 Ã— (prolongation of prothrombin time above control in seconds) + serum bilirubin in mg/dL&lt;/li&gt;&lt;li&gt;â€¢ A MDF score &amp;gt;32 suggests a higher risk of short-term mortality, and patients with a score above this threshold may benefit from more aggressive treatment.&lt;/li&gt;&lt;li&gt;â€¢ MDF score &amp;gt;32&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 2.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]: This is not the correct formula. The correct factor to be used is 4.6 , not 2.6.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 2.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]:&lt;/li&gt;&lt;li&gt;â€¢ correct factor&lt;/li&gt;&lt;li&gt;â€¢ 4.6&lt;/li&gt;&lt;li&gt;â€¢ Option B. 3.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]: This is also incorrect, as the correct factor is 4.6 , not 3.6.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 3.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]:&lt;/li&gt;&lt;li&gt;â€¢ correct factor&lt;/li&gt;&lt;li&gt;â€¢ 4.6&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]: This is incorrect because the correct factor is 4.6 , not 5.6.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]:&lt;/li&gt;&lt;li&gt;â€¢ correct factor&lt;/li&gt;&lt;li&gt;â€¢ 4.6&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Maddrey Discriminant Function (MDF) , calculated as 4.6 Ã— (prolongation of prothrombin time above control in seconds) + serum bilirubin , is used to predict short-term mortality in patients with alcoholic hepatitis .&lt;/li&gt;&lt;li&gt;âž¤ Maddrey Discriminant Function (MDF)&lt;/li&gt;&lt;li&gt;âž¤ 4.6 Ã— (prolongation of prothrombin time above control in seconds) + serum bilirubin&lt;/li&gt;&lt;li&gt;âž¤ short-term mortality&lt;/li&gt;&lt;li&gt;âž¤ alcoholic hepatitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following scenarios is Hyâ€™s Law most commonly used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic Hepatitis B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug-induced liver injury&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Drug-induced liver injury&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Drug-induced liver injury&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hyâ€™s Law is used to predict the risk of severe hepatotoxicity in cases of drug-induced liver injury . It was established by Dr. Hyman Zimmerman in the 1970s, and it describes the increased risk of acute liver failure when jaundice develops in patients taking a new drug . Hy&#x27;s Law specifically predicts that if jaundice occurs during a clinical trial of a drug, the likelihood of severe hepatotoxicity and liver failure increases, with a 10:1 ratio between jaundice and liver failure . This finding is particularly important in the drug development process, as it often leads to the discontinuation of drug approval if severe liver injury is observed.&lt;/li&gt;&lt;li&gt;â€¢ Hyâ€™s Law&lt;/li&gt;&lt;li&gt;â€¢ risk of severe hepatotoxicity&lt;/li&gt;&lt;li&gt;â€¢ drug-induced liver injury&lt;/li&gt;&lt;li&gt;â€¢ Dr. Hyman Zimmerman&lt;/li&gt;&lt;li&gt;â€¢ acute liver failure&lt;/li&gt;&lt;li&gt;â€¢ jaundice&lt;/li&gt;&lt;li&gt;â€¢ new drug&lt;/li&gt;&lt;li&gt;â€¢ jaundice occurs&lt;/li&gt;&lt;li&gt;â€¢ severe hepatotoxicity&lt;/li&gt;&lt;li&gt;â€¢ liver failure&lt;/li&gt;&lt;li&gt;â€¢ 10:1 ratio&lt;/li&gt;&lt;li&gt;â€¢ jaundice and liver failure&lt;/li&gt;&lt;li&gt;â€¢ severe liver injury&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic hepatitis: While alcoholic hepatitis involves liver injury, Hyâ€™s Law is specifically used to predict drug-induced liver injury and is not applicable to alcoholic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alcoholic hepatitis:&lt;/li&gt;&lt;li&gt;â€¢ alcoholic hepatitis&lt;/li&gt;&lt;li&gt;â€¢ Hyâ€™s Law&lt;/li&gt;&lt;li&gt;â€¢ drug-induced liver injury&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic Hepatitis B: Hyâ€™s Law is not relevant to the management or progression of chronic Hepatitis B . It is specific to drug-induced liver injury and the risks associated with jaundice during clinical trials.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Chronic Hepatitis B: Hyâ€™s Law&lt;/li&gt;&lt;li&gt;â€¢ chronic Hepatitis B&lt;/li&gt;&lt;li&gt;â€¢ drug-induced liver injury&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liver carcinoma: Hyâ€™s Law is not used to assess liver carcinoma , which is a cancer and not a condition directly related to drug-induced liver injury. It is a concept used primarily in the context of drug hepatotoxicity .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Liver carcinoma: Hyâ€™s Law&lt;/li&gt;&lt;li&gt;â€¢ liver carcinoma&lt;/li&gt;&lt;li&gt;â€¢ drug hepatotoxicity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hyâ€™s Law is used in the context of drug-induced liver injury and predicts the risk of acute liver failure if jaundice occurs during clinical drug trials. It is a crucial concept in the drug development process, particularly for evaluating the liver toxicity of new medications.&lt;/li&gt;&lt;li&gt;âž¤ Hyâ€™s Law&lt;/li&gt;&lt;li&gt;âž¤ drug-induced liver injury&lt;/li&gt;&lt;li&gt;âž¤ acute liver failure&lt;/li&gt;&lt;li&gt;âž¤ jaundice&lt;/li&gt;&lt;li&gt;âž¤ liver toxicity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male with a history of mild conjugated hyperbilirubinemia presents with dark pigmentation of the liver seen on imaging. Which of the following genes is defective in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ABCCA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SLCO1B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ATP8B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ABCB11&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ABCCA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) ABCCA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Dubin-Johnson syndrome (DJS) is a rare inherited disorder characterized by mild conjugated hyperbilirubinemia , normal liver function, and dark pigmentation in the liver. The defective gene in Dubin-Johnson syndrome is ABCCA , which encodes MRP2 (Multidrug Resistance Protein 2) . This gene defect impairs the excretion of conjugated bilirubin into the bile, leading to the characteristic features of DJS, including dark liver pigmentation and a characteristic urinary coproporphyrin pattern .&lt;/li&gt;&lt;li&gt;â€¢ Dubin-Johnson syndrome (DJS)&lt;/li&gt;&lt;li&gt;â€¢ mild conjugated hyperbilirubinemia&lt;/li&gt;&lt;li&gt;â€¢ dark pigmentation&lt;/li&gt;&lt;li&gt;â€¢ Dubin-Johnson syndrome&lt;/li&gt;&lt;li&gt;â€¢ ABCCA&lt;/li&gt;&lt;li&gt;â€¢ MRP2 (Multidrug Resistance Protein 2)&lt;/li&gt;&lt;li&gt;â€¢ dark liver pigmentation&lt;/li&gt;&lt;li&gt;â€¢ a characteristic urinary coproporphyrin pattern&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. SLCO1B1: SLCO1B1 encodes the OATP1B1 transporter and is associated with other disorders of bile acid transport , such as Rotor syndrome , not Dubin-Johnson syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option B. SLCO1B1: SLCO1B1&lt;/li&gt;&lt;li&gt;â€¢ OATP1B1 transporter&lt;/li&gt;&lt;li&gt;â€¢ bile acid transport&lt;/li&gt;&lt;li&gt;â€¢ Rotor syndrome&lt;/li&gt;&lt;li&gt;â€¢ Dubin-Johnson syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. ATP8B1: ATP8B1 is associated with familial intrahepatic cholestasis type 1 (PFIC1) , a condition that causes severe cholestasis and liver dysfunction beginning in childhood. It is not related to Dubin-Johnson syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option C. ATP8B1: ATP8B1&lt;/li&gt;&lt;li&gt;â€¢ familial intrahepatic cholestasis type 1 (PFIC1)&lt;/li&gt;&lt;li&gt;â€¢ severe cholestasis&lt;/li&gt;&lt;li&gt;â€¢ liver dysfunction&lt;/li&gt;&lt;li&gt;â€¢ Dubin-Johnson syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. ABCB11: ABCB11 encodes the BSEP (Bile Salt Export Pump) and is associated with familial intrahepatic cholestasis type 2 (PFIC2) , which also causes severe cholestasis . This gene is not related to Dubin-Johnson syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option D. ABCB11: ABCB11&lt;/li&gt;&lt;li&gt;â€¢ BSEP (Bile Salt Export Pump)&lt;/li&gt;&lt;li&gt;â€¢ familial intrahepatic cholestasis type 2 (PFIC2)&lt;/li&gt;&lt;li&gt;â€¢ severe cholestasis&lt;/li&gt;&lt;li&gt;â€¢ Dubin-Johnson syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dubin-Johnson syndrome is caused by a defect in the ABCCA gene encoding MRP2 , leading to impaired bilirubin excretion and dark liver pigmentation on imaging.&lt;/li&gt;&lt;li&gt;âž¤ Dubin-Johnson syndrome&lt;/li&gt;&lt;li&gt;âž¤ ABCCA&lt;/li&gt;&lt;li&gt;âž¤ MRP2&lt;/li&gt;&lt;li&gt;âž¤ impaired bilirubin excretion&lt;/li&gt;&lt;li&gt;âž¤ dark liver pigmentation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with cirrhosis presents for evaluation of portal hypertension. Measurement of the hepatic venous pressure gradient (HVPG) is done. What is the threshold for clinically significant portal hypertension with HVPG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 5 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5-10 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt; 10 mmHg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt; 10 mmHg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &gt; 10 mmHg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;gt; 10 mmHg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Portal hypertension is clinically significant when the hepatic venous pressure gradient (HVPG) is â‰¥10 mmHg . This threshold marks the transition from compensated cirrhosis (with HVPG between 5-10 mmHg) to a more advanced stage with a higher risk of complications, including variceal bleeding , ascites , and hepatic encephalopathy . When HVPG exceeds 10 mmHg, it indicates a greater risk of decompensation in patients with cirrhosis.&lt;/li&gt;&lt;li&gt;â€¢ Portal hypertension&lt;/li&gt;&lt;li&gt;â€¢ hepatic venous pressure gradient (HVPG)&lt;/li&gt;&lt;li&gt;â€¢ â‰¥10 mmHg&lt;/li&gt;&lt;li&gt;â€¢ compensated cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ variceal bleeding&lt;/li&gt;&lt;li&gt;â€¢ ascites&lt;/li&gt;&lt;li&gt;â€¢ hepatic encephalopathy&lt;/li&gt;&lt;li&gt;â€¢ decompensation&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;lt; 5 mmHg: An HVPG &amp;lt;5 mmHg is typically considered normal and would not suggest clinically significant portal hypertension. In the absence of other complications, patients with HVPG below this value are usually asymptomatic.&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;lt; 5 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;5 mmHg&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5-10 mmHg: An HVPG in the range of 5-10 mmHg may represent compensated cirrhosis , where the patient may remain asymptomatic for a prolonged period, but this range does not denote clinically significant portal hypertension , which is defined as â‰¥10 mmHg .&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5-10 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ 5-10 mmHg&lt;/li&gt;&lt;li&gt;â€¢ compensated cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ clinically significant portal hypertension&lt;/li&gt;&lt;li&gt;â€¢ â‰¥10 mmHg&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;lt; 10 mmHg: An HVPG &amp;lt;10 mmHg is not considered clinically significant for portal hypertension. â‰¥10 mmHg is the key threshold for identifying patients at higher risk for liver-related complications.&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;lt; 10 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;10 mmHg&lt;/li&gt;&lt;li&gt;â€¢ â‰¥10 mmHg&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Clinically significant portal hypertension is defined as an HVPG of â‰¥10 mmHg , signaling a higher risk of complications in cirrhosis, including variceal bleeding , ascites , and hepatic encephalopathy .&lt;/li&gt;&lt;li&gt;âž¤ Clinically significant portal hypertension&lt;/li&gt;&lt;li&gt;âž¤ HVPG of â‰¥10 mmHg&lt;/li&gt;&lt;li&gt;âž¤ variceal bleeding&lt;/li&gt;&lt;li&gt;âž¤ ascites&lt;/li&gt;&lt;li&gt;âž¤ hepatic encephalopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with dysphagia and chronic reflux symptoms. An endoscopy is done and is shown. Which of the following is the most likely diagnosis based on these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reflux esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Herpes simplex virus esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophilic esophagitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Candida esophagitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eosinophilic esophagitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20163355.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Eosinophilic esophagitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The endoscopic image showing multiple circular rings and a narrowed esophagogastric junction is characteristic of eosinophilic esophagitis (EoE) . The \&quot;corrugated\&quot; appearance of the esophagus, along with impacted grape-like structures at the esophagogastric junction, is typical for this condition. EoE is a chronic, immune-mediated disorder that requires a biopsy showing &amp;gt;15-20 eosinophils per high-power field (HPF) for diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ endoscopic image&lt;/li&gt;&lt;li&gt;â€¢ multiple circular rings&lt;/li&gt;&lt;li&gt;â€¢ narrowed esophagogastric junction&lt;/li&gt;&lt;li&gt;â€¢ eosinophilic esophagitis (EoE)&lt;/li&gt;&lt;li&gt;â€¢ \&quot;corrugated\&quot; appearance&lt;/li&gt;&lt;li&gt;â€¢ impacted grape-like structures&lt;/li&gt;&lt;li&gt;â€¢ EoE&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;15-20 eosinophils per high-power field (HPF)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reflux esophagitis: Reflux esophagitis (or gastroesophageal reflux disease, GERD) often presents with erosions or ulcerations in the esophagus, but it does not typically cause the circular rings and narrowed esophagogastric junction seen in EoE . GERD typically presents with esophageal inflammation due to acid reflux, not eosinophilic infiltration .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reflux esophagitis: Reflux esophagitis&lt;/li&gt;&lt;li&gt;â€¢ erosions&lt;/li&gt;&lt;li&gt;â€¢ ulcerations&lt;/li&gt;&lt;li&gt;â€¢ circular rings&lt;/li&gt;&lt;li&gt;â€¢ narrowed esophagogastric junction&lt;/li&gt;&lt;li&gt;â€¢ EoE&lt;/li&gt;&lt;li&gt;â€¢ esophageal inflammation&lt;/li&gt;&lt;li&gt;â€¢ eosinophilic infiltration&lt;/li&gt;&lt;li&gt;â€¢ Option B. Herpes simplex virus esophagitis: Herpes simplex virus (HSV) esophagitis typically presents with ulcerations and vesicular lesions on endoscopy, not the circular rings seen in EoE . HSV esophagitis is often associated with painful swallowing (odynophagia) and fever .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Herpes simplex virus esophagitis: Herpes simplex virus (HSV) esophagitis&lt;/li&gt;&lt;li&gt;â€¢ ulcerations&lt;/li&gt;&lt;li&gt;â€¢ vesicular lesions&lt;/li&gt;&lt;li&gt;â€¢ circular rings&lt;/li&gt;&lt;li&gt;â€¢ EoE&lt;/li&gt;&lt;li&gt;â€¢ painful swallowing&lt;/li&gt;&lt;li&gt;â€¢ fever&lt;/li&gt;&lt;li&gt;â€¢ Option D. Candida esophagitis: Candida esophagitis presents with white plaques on endoscopy, typically adherent to the esophageal mucosa. This appearance is quite different from the circular rings and narrowed junction seen in EoE . Candida is more common in immunocompromised patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Candida esophagitis: Candida esophagitis&lt;/li&gt;&lt;li&gt;â€¢ white plaques&lt;/li&gt;&lt;li&gt;â€¢ adherent&lt;/li&gt;&lt;li&gt;â€¢ circular rings&lt;/li&gt;&lt;li&gt;â€¢ narrowed junction&lt;/li&gt;&lt;li&gt;â€¢ EoE&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Eosinophilic esophagitis is characterized by multiple circular rings and a narrowed esophagogastric junction , which is a classic endoscopic finding. Diagnosis requires histology showing &amp;gt;15-20 eosinophils per HPF .&lt;/li&gt;&lt;li&gt;âž¤ Eosinophilic esophagitis&lt;/li&gt;&lt;li&gt;âž¤ multiple circular rings&lt;/li&gt;&lt;li&gt;âž¤ narrowed esophagogastric junction&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt;15-20 eosinophils per HPF&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male presents with intermittent chest pain and dysphagia. High resolution manometry is done and shown. What is the most likely diagnosis based on these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Jackhammer esophagus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Achalasia cardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse esophageal spasm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Esophageal carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diffuse esophageal spasm&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20163418.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-31%20164640.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diffuse esophageal spasm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The esophageal pressure topography (or manometry) showing disorganized contractions and spasms in the esophagus, with normal lower esophageal sphincter (LES) pressure , is indicative of diffuse esophageal spasm (DES) . This condition is characterized by uncoordinated, irregular contractions of the esophagus, which can lead to intermittent chest pain and dysphagia . The absence of abnormal LES pressure helps distinguish DES from conditions like achalasia .&lt;/li&gt;&lt;li&gt;â€¢ esophageal pressure topography&lt;/li&gt;&lt;li&gt;â€¢ disorganized contractions&lt;/li&gt;&lt;li&gt;â€¢ spasms&lt;/li&gt;&lt;li&gt;â€¢ normal lower esophageal sphincter (LES) pressure&lt;/li&gt;&lt;li&gt;â€¢ diffuse esophageal spasm (DES)&lt;/li&gt;&lt;li&gt;â€¢ uncoordinated, irregular contractions&lt;/li&gt;&lt;li&gt;â€¢ intermittent chest pain&lt;/li&gt;&lt;li&gt;â€¢ dysphagia&lt;/li&gt;&lt;li&gt;â€¢ abnormal LES pressure&lt;/li&gt;&lt;li&gt;â€¢ achalasia&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Jackhammer esophagus: Jackhammer esophagus is characterized by hypercontractility and excessively high-pressure contractions of the esophagus, typically seen on manometry. This is different from diffuse esophageal spasm , which involves disorganized spasms rather than excessively strong contractions .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Jackhammer esophagus: Jackhammer esophagus&lt;/li&gt;&lt;li&gt;â€¢ hypercontractility&lt;/li&gt;&lt;li&gt;â€¢ excessively high-pressure contractions&lt;/li&gt;&lt;li&gt;â€¢ diffuse esophageal spasm&lt;/li&gt;&lt;li&gt;â€¢ disorganized spasms&lt;/li&gt;&lt;li&gt;â€¢ excessively strong contractions&lt;/li&gt;&lt;li&gt;â€¢ Option B. Achalasia cardia: Achalasia is characterized by impaired relaxation of the LES and absence of peristalsis in the esophagus. On manometry, this shows a high LES pressure and absent or incomplete peristalsis , which is not seen in diffuse esophageal spasm .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Achalasia cardia: Achalasia&lt;/li&gt;&lt;li&gt;â€¢ impaired relaxation of the LES&lt;/li&gt;&lt;li&gt;â€¢ absence of peristalsis&lt;/li&gt;&lt;li&gt;â€¢ high LES pressure&lt;/li&gt;&lt;li&gt;â€¢ absent or incomplete peristalsis&lt;/li&gt;&lt;li&gt;â€¢ diffuse esophageal spasm&lt;/li&gt;&lt;li&gt;â€¢ Option D. Esophageal carcinoma: Esophageal carcinoma typically presents with progressive dysphagia and weight loss . Manometry does not typically show disorganized contractions or spasms . Imaging and biopsy are the primary diagnostic tools for esophageal cancer , not manometry.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Esophageal carcinoma: Esophageal carcinoma&lt;/li&gt;&lt;li&gt;â€¢ progressive dysphagia&lt;/li&gt;&lt;li&gt;â€¢ weight loss&lt;/li&gt;&lt;li&gt;â€¢ disorganized contractions&lt;/li&gt;&lt;li&gt;â€¢ spasms&lt;/li&gt;&lt;li&gt;â€¢ esophageal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diffuse esophageal spasm is characterized by disorganized esophageal contractions with normal LES pressure , leading to symptoms like chest pain and dysphagia , which are typically observed on esophageal pressure topography .&lt;/li&gt;&lt;li&gt;âž¤ Diffuse esophageal spasm&lt;/li&gt;&lt;li&gt;âž¤ disorganized esophageal contractions&lt;/li&gt;&lt;li&gt;âž¤ normal LES pressure&lt;/li&gt;&lt;li&gt;âž¤ chest pain&lt;/li&gt;&lt;li&gt;âž¤ dysphagia&lt;/li&gt;&lt;li&gt;âž¤ esophageal pressure topography&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male with a history of oculocutaneous albinism, granulomatous colitis, platelet dysfunction, and pulmonary fibrosis is diagnosed with a rare genetic disorder. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wiskott-Aldrich syndrome (WAS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hermansky-Pudlak syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune dysregulation polyendocrinopathy, enteropathy X-linked (IPEX)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogen storage disease type B1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hermansky-Pudlak syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hermansky-Pudlak syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder that is characterized by granulomatous colitis , oculocutaneous albinism , platelet dysfunction , and pulmonary fibrosis . It is caused by mutations in one of several genes involved in lysosomal function and organelle trafficking. The syndrome affects multiple organ systems, leading to immunodeficiency , bleeding tendencies due to platelet dysfunction, and progressive pulmonary fibrosis .&lt;/li&gt;&lt;li&gt;â€¢ Hermansky-Pudlak syndrome (HPS)&lt;/li&gt;&lt;li&gt;â€¢ granulomatous colitis&lt;/li&gt;&lt;li&gt;â€¢ oculocutaneous albinism&lt;/li&gt;&lt;li&gt;â€¢ platelet dysfunction&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ immunodeficiency&lt;/li&gt;&lt;li&gt;â€¢ bleeding tendencies&lt;/li&gt;&lt;li&gt;â€¢ progressive pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wiskott-Aldrich syndrome (WAS): Wiskott-Aldrich syndrome is an immunodeficiency disorder associated with eczema , thrombocytopenia , recurrent infections , and autoimmune manifestations , but it does not typically present with granulomatous colitis or pulmonary fibrosis . It is more commonly associated with severe platelet dysfunction and immunodeficiency .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Wiskott-Aldrich syndrome (WAS): Wiskott-Aldrich syndrome&lt;/li&gt;&lt;li&gt;â€¢ eczema&lt;/li&gt;&lt;li&gt;â€¢ thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ recurrent infections&lt;/li&gt;&lt;li&gt;â€¢ autoimmune manifestations&lt;/li&gt;&lt;li&gt;â€¢ granulomatous colitis&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ severe platelet dysfunction&lt;/li&gt;&lt;li&gt;â€¢ immunodeficiency&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune dysregulation polyendocrinopathy, enteropathy X-linked (IPEX): IPEX syndrome is characterized by autoimmune enteropathy (similar to ulcerative colitis ), endocrinopathy (such as type 1 diabetes ), and dermatitis . However, it does not involve the characteristic findings of oculocutaneous albinism or pulmonary fibrosis , which are seen in Hermansky-Pudlak syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option C. Immune dysregulation polyendocrinopathy, enteropathy X-linked (IPEX): IPEX syndrome&lt;/li&gt;&lt;li&gt;â€¢ autoimmune enteropathy&lt;/li&gt;&lt;li&gt;â€¢ ulcerative colitis&lt;/li&gt;&lt;li&gt;â€¢ endocrinopathy&lt;/li&gt;&lt;li&gt;â€¢ type 1 diabetes&lt;/li&gt;&lt;li&gt;â€¢ dermatitis&lt;/li&gt;&lt;li&gt;â€¢ oculocutaneous albinism&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ Hermansky-Pudlak syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycogen storage disease type B1: Glycogen storage disease type B1 (GSD-Ib) is primarily characterized by hypoglycemia , growth retardation , and liver enlargement due to defects in glucose metabolism . It does not present with the combination of granulomatous colitis , pulmonary fibrosis , or oculocutaneous albinism seen in Hermansky-Pudlak syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Glycogen storage disease type B1: Glycogen storage disease type B1 (GSD-Ib)&lt;/li&gt;&lt;li&gt;â€¢ hypoglycemia&lt;/li&gt;&lt;li&gt;â€¢ growth retardation&lt;/li&gt;&lt;li&gt;â€¢ liver enlargement&lt;/li&gt;&lt;li&gt;â€¢ defects in glucose metabolism&lt;/li&gt;&lt;li&gt;â€¢ granulomatous colitis&lt;/li&gt;&lt;li&gt;â€¢ pulmonary fibrosis&lt;/li&gt;&lt;li&gt;â€¢ oculocutaneous albinism&lt;/li&gt;&lt;li&gt;â€¢ Hermansky-Pudlak syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hermansky-Pudlak syndrome is a genetic disorder with characteristic features such as granulomatous colitis , oculocutaneous albinism , platelet dysfunction , and pulmonary fibrosis , which helps distinguish it from other syndromes.&lt;/li&gt;&lt;li&gt;âž¤ Hermansky-Pudlak syndrome&lt;/li&gt;&lt;li&gt;âž¤ granulomatous colitis&lt;/li&gt;&lt;li&gt;âž¤ oculocutaneous albinism&lt;/li&gt;&lt;li&gt;âž¤ platelet dysfunction&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with yellowing of the eyes (scleral icterus) and is concerned about his liver function. His serum bilirubin level is measured. At what serum bilirubin level is scleral icterus typically first noticeable?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 3 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 3 mg/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Scleral icterus occurs when the serum bilirubin level reaches approximately 3 mg/dL (51 Î¼mol/L). The sclerae of the eyes have a particular affinity for bilirubin due to their high elastin content , and jaundice or icterus of the sclera is typically the first noticeable sign when serum bilirubin levels exceed 3 mg/dL .&lt;/li&gt;&lt;li&gt;â€¢ Scleral icterus&lt;/li&gt;&lt;li&gt;â€¢ 3 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ sclerae&lt;/li&gt;&lt;li&gt;â€¢ bilirubin&lt;/li&gt;&lt;li&gt;â€¢ elastin content&lt;/li&gt;&lt;li&gt;â€¢ jaundice&lt;/li&gt;&lt;li&gt;â€¢ icterus&lt;/li&gt;&lt;li&gt;â€¢ serum bilirubin levels exceed 3 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 2 mg/dL: At a serum bilirubin level of 2 mg/dL , jaundice may not yet be evident in the sclera, as scleral icterus typically appears at levels closer to 3 mg/dL .&lt;/li&gt;&lt;li&gt;â€¢ Option A. 2 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ serum bilirubin level of 2 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ 3 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Option C. 4 mg/dL: While scleral icterus may be more noticeable at 4 mg/dL , it is typically detectable at 3 mg/dL , making this option less accurate than the correct answer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 4 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ scleral icterus&lt;/li&gt;&lt;li&gt;â€¢ 4 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ 3 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5 mg/dL: 5 mg/dL is a higher bilirubin level and scleral icterus would definitely be present at this level, but the earliest detectable level for scleral icterus is typically around 3 mg/dL , not 5.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5 mg/dL: 5 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ scleral icterus&lt;/li&gt;&lt;li&gt;â€¢ earliest detectable level&lt;/li&gt;&lt;li&gt;â€¢ scleral icterus&lt;/li&gt;&lt;li&gt;â€¢ 3 mg/dL&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Scleral icterus (yellowing of the eyes) typically occurs when the serum bilirubin level reaches at least 3 mg/dL .&lt;/li&gt;&lt;li&gt;âž¤ Scleral icterus&lt;/li&gt;&lt;li&gt;âž¤ serum bilirubin level reaches at least 3 mg/dL&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male with moderate to severe ulcerative colitis is being considered for biologic therapy. The physician is planning to start the patient on Vedolizumab. What is the mechanism of action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sphingosine-1-phosphate (S1P1) receptor modulator&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recombinant humanized IgG4 antibody against Î±4-integrin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IgG1 monoclonal antibody, blocks the biologic activity of IL-12 and IL-23&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Monoclonal antibody directed against Î±4Î²7-integrin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Monoclonal antibody directed against Î±4Î²7-integrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Monoclonal antibody directed against Î±4Î²7-integrin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Vedolizumab is a monoclonal antibody that targets Î±4Î²7-integrin . It selectively inhibits the migration of lymphocytes into the gut by blocking the interaction of Î±4Î²7-integrin with the MAdCAM-1 receptor on the vascular endothelium of the gut. This gut-selective immunosuppression helps treat inflammatory bowel diseases like ulcerative colitis and Crohn&#x27;s disease , with reduced systemic immunosuppressive effects compared to other biologics.&lt;/li&gt;&lt;li&gt;â€¢ Vedolizumab&lt;/li&gt;&lt;li&gt;â€¢ monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ Î±4Î²7-integrin&lt;/li&gt;&lt;li&gt;â€¢ migration of lymphocytes&lt;/li&gt;&lt;li&gt;â€¢ gut&lt;/li&gt;&lt;li&gt;â€¢ Î±4Î²7-integrin&lt;/li&gt;&lt;li&gt;â€¢ MAdCAM-1&lt;/li&gt;&lt;li&gt;â€¢ gut-selective immunosuppression&lt;/li&gt;&lt;li&gt;â€¢ inflammatory bowel diseases&lt;/li&gt;&lt;li&gt;â€¢ ulcerative colitis&lt;/li&gt;&lt;li&gt;â€¢ Crohn&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sphingosine-1-phosphate (S1P1) receptor modulator: This mechanism is associated with Fingolimod , a drug used in multiple sclerosis and ulcerative colitis , which modulates lymphocyte trafficking by acting on the S1P1 receptor .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sphingosine-1-phosphate (S1P1) receptor modulator:&lt;/li&gt;&lt;li&gt;â€¢ Fingolimod&lt;/li&gt;&lt;li&gt;â€¢ multiple sclerosis&lt;/li&gt;&lt;li&gt;â€¢ ulcerative colitis&lt;/li&gt;&lt;li&gt;â€¢ modulates lymphocyte trafficking&lt;/li&gt;&lt;li&gt;â€¢ S1P1 receptor&lt;/li&gt;&lt;li&gt;â€¢ Option B. Recombinant humanized IgG4 antibody against Î±4-integrin: This mechanism is related to Natalizumab , a humanized IgG4 monoclonal antibody that targets Î±4-integrin and is used in multiple sclerosis and Crohn&#x27;s disease . Unlike Vedolizumab , Natalizumab is not gut-selective and has more systemic effects.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Recombinant humanized IgG4 antibody against Î±4-integrin:&lt;/li&gt;&lt;li&gt;â€¢ Natalizumab&lt;/li&gt;&lt;li&gt;â€¢ humanized IgG4 monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ Î±4-integrin&lt;/li&gt;&lt;li&gt;â€¢ multiple sclerosis&lt;/li&gt;&lt;li&gt;â€¢ Crohn&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ Vedolizumab&lt;/li&gt;&lt;li&gt;â€¢ Natalizumab&lt;/li&gt;&lt;li&gt;â€¢ Option C. IgG1 monoclonal antibody, blocks the biologic activity of IL-12 and IL-23: This mechanism is associated with Ustekinumab , an antibody targeting IL-12 and IL-23 , which is used in the treatment of psoriasis , Crohn&#x27;s disease , and ulcerative colitis . It does not specifically target Î±4Î²7-integrin .&lt;/li&gt;&lt;li&gt;â€¢ Option C. IgG1 monoclonal antibody, blocks the biologic activity of IL-12 and IL-23:&lt;/li&gt;&lt;li&gt;â€¢ Ustekinumab&lt;/li&gt;&lt;li&gt;â€¢ IL-12&lt;/li&gt;&lt;li&gt;â€¢ IL-23&lt;/li&gt;&lt;li&gt;â€¢ psoriasis&lt;/li&gt;&lt;li&gt;â€¢ Crohn&#x27;s disease&lt;/li&gt;&lt;li&gt;â€¢ ulcerative colitis&lt;/li&gt;&lt;li&gt;â€¢ Î±4Î²7-integrin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vedolizumab is a gut-selective biologic that works by inhibiting the Î±4Î²7-integrin interaction, reducing lymphocyte migration into the gut and effectively treating ulcerative colitis and Crohn&#x27;s disease .&lt;/li&gt;&lt;li&gt;âž¤ Vedolizumab&lt;/li&gt;&lt;li&gt;âž¤ gut-selective&lt;/li&gt;&lt;li&gt;âž¤ Î±4Î²7-integrin&lt;/li&gt;&lt;li&gt;âž¤ ulcerative colitis&lt;/li&gt;&lt;li&gt;âž¤ Crohn&#x27;s disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test4" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D   Mission 2.0, Lap 2   19 03 2025   2025 03 19&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D   Mission 2.0, Lap 2   19 03 2025   2025 03 19&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Anil, a 58-year-old man with a history of hypertension, is admitted to the hospital with complaints of chest pain and shortness of breath. He is started on anticoagulants as part of his management. Laboratory monitoring is performed to assess the efficacy and safety of the anticoagulation therapy. Match the following anticoagulants with their corresponding properties: Column A: Unfractionated heparin (UFH) Low-molecular-weight heparin (LMWH) Bivalirudin LMWH and bivalirudin Column B: High bioavailability Dose should be adjusted if creatinine clearance is &amp;lt;30 mL/min Degree of anticoagulation can be monitored using the activated partial thromboplastin time Least likely to trigger type II heparin-induced thrombocytopenia&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-i, B-ii, C-iii, D-iv&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-iii, B-i, C-iv, D-ii&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-iii, B-i, C-ii, D-iv&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-ii, B-iii, C-iv, D-i&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A-iii, B-i, C-iv, D-ii&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A-iii, B-i, C-iv, D-ii&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A-iii. Unfractionated heparin (UFH): Its anticoagulant effect is monitored using activated partial thromboplastin time (aPTT), as UFH primarily inhibits thrombin and activated factor Xa.&lt;/li&gt;&lt;li&gt;â€¢ A-iii. Unfractionated heparin (UFH):&lt;/li&gt;&lt;li&gt;â€¢ B-i. Low-molecular-weight heparin (LMWH): LMWH has high bioavailability and acts predominantly on factor Xa through antithrombin activation.&lt;/li&gt;&lt;li&gt;â€¢ B-i. Low-molecular-weight heparin (LMWH):&lt;/li&gt;&lt;li&gt;â€¢ C-iv. Bivalirudin: A direct thrombin inhibitor, bivalirudin has a low risk of type II heparin-induced thrombocytopenia (HIT).&lt;/li&gt;&lt;li&gt;â€¢ C-iv. Bivalirudin:&lt;/li&gt;&lt;li&gt;â€¢ D-ii. LMWH and bivalirudin: Both require dose adjustments in the presence of renal dysfunction, especially when creatinine clearance (CrCl) is &amp;lt;30 mL/min.&lt;/li&gt;&lt;li&gt;â€¢ D-ii. LMWH and bivalirudin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Understanding the properties of anticoagulants, including their mechanisms of action, monitoring requirements, and side-effect profiles, is critical for optimizing patient care, particularly in renal dysfunction or risk of thrombocytopenia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Suresh, a 52-year-old man from Chennai, presents with progressive exertional dyspnea and lower limb edema. An echocardiogram reveals restrictive cardiomyopathy, and cardiac MRI is shown. Which of the following conditions is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic heart disease (IHD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Amyloidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20140917.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Amyloidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Amyloidosis is a systemic infiltrative disease where amyloid deposits disrupt normal myocardial architecture. On cardiac MRI, circumferential subendocardial LGE is pathognomonic of amyloidosis. This pattern reflects the diffuse infiltration of the myocardium, leading to restrictive physiology. Amyloidosis also commonly presents with signs of heart failure and may be associated with extracardiac manifestations.&lt;/li&gt;&lt;li&gt;â€¢ circumferential subendocardial LGE&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sarcoidosis: Sarcoidosis typically produces patchy myocardial LGE with subendocardial sparing, not circumferential enhancement.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Sarcoidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myocarditis: Myocarditis usually shows focal or patchy LGE in a mid-wall or epicardial distribution, sparing the subendocardium.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myocarditis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic heart disease (IHD): IHD produces LGE in a vascular distribution, often as a transmural or subendocardial patchy scar, not circumferential enhancement.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic heart disease (IHD):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Circumferential subendocardial LGE on cardiac MRI is highly specific for amyloidosis and helps differentiate it from other conditions like sarcoidosis, myocarditis, and ischemic heart disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Ravi, a 62-year-old man from Pune, has a history of chronic stable angina and underwent coronary angiography. The angiogram revealed significant coronary artery disease. Which of the following is not an indication for revascularization with coronary artery bypass grafting (CABG) in chronic stable angina?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LMCA &amp;gt;50% stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Triple vessel disease (&amp;gt;70% stenosis)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Double vessel disease (DVD) with proximal LAD involvement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Controlled angina&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Controlled angina&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Controlled angina&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ CABG is indicated in chronic stable angina when there is:&lt;/li&gt;&lt;li&gt;â€¢ Left main coronary artery (LMCA) stenosis &amp;gt;50%. Triple vessel disease (TVD) with &amp;gt;70% stenosis. Double vessel disease (DVD) involving the proximal left anterior descending (LAD) artery. Persistent angina despite optimal medical management or high-risk findings on non-invasive tests.&lt;/li&gt;&lt;li&gt;â€¢ Left main coronary artery (LMCA) stenosis &amp;gt;50%.&lt;/li&gt;&lt;li&gt;â€¢ Triple vessel disease (TVD) with &amp;gt;70% stenosis.&lt;/li&gt;&lt;li&gt;â€¢ Double vessel disease (DVD) involving the proximal left anterior descending (LAD) artery.&lt;/li&gt;&lt;li&gt;â€¢ Persistent angina despite optimal medical management or high-risk findings on non-invasive tests.&lt;/li&gt;&lt;li&gt;â€¢ Controlled angina, where symptoms are managed effectively with medications, does not warrant invasive revascularization.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. LMCA &amp;gt;50% stenosis: LMCA disease significantly impairs coronary perfusion and is a class I indication for CABG.&lt;/li&gt;&lt;li&gt;â€¢ Option A. LMCA &amp;gt;50% stenosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Triple vessel disease (&amp;gt;70% stenosis): Revascularization is critical in TVD to reduce mortality and improve symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Triple vessel disease (&amp;gt;70% stenosis):&lt;/li&gt;&lt;li&gt;â€¢ Option C. DVD with proximal LAD involvement: Proximal LAD lesions in DVD compromise significant myocardial territory, making CABG necessary.&lt;/li&gt;&lt;li&gt;â€¢ Option C. DVD with proximal LAD involvement:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CABG is reserved for patients with severe coronary artery disease or refractory angina. Controlled angina does not require invasive interventions if symptoms are adequately managed with medications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman presents to the emergency room with chest pain. An ECG is performed to evaluate her symptoms. Which of the following conditions is not associated with ST-elevation on ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute STEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prinzmetal angina&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Takotsubo cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unstable angina&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Unstable angina&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Unstable angina&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Unstable angina does not cause significant or persistent ECG changes such as ST-elevation. It is primarily diagnosed based on clinical history, including chest pain at rest or with minimal exertion, and the absence of biomarkers or ECG findings indicating infarction.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute STEMI: ST-elevation myocardial infarction (STEMI) is defined by ST-elevation on ECG, reflecting transmural myocardial injury.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Acute STEMI:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prinzmetal angina: This condition is caused by coronary vasospasm, leading to transient ST-elevation during episodes of chest pain.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prinzmetal angina:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Takotsubo cardiomyopathy: Also known as \&quot;stress-induced cardiomyopathy,\&quot; it can mimic STEMI with transient ST-elevation due to apical ballooning and myocardial stunning.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Takotsubo cardiomyopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ST-elevation is a hallmark of several conditions, including STEMI, Prinzmetal angina, and Takotsubo cardiomyopathy. However, unstable angina does not typically present with ST-elevation on ECG and is diagnosed based on clinical features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man from Bengaluru presents to the emergency department with acute chest pain and is diagnosed with STEMI. The decision is made to administer thrombolytic therapy. Which of the following drugs is the easiest to administer in this scenario?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reteplase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tenecteplase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alteplase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Streptokinase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tenecteplase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tenecteplase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Tenecteplase is the easiest thrombolytic agent to administer because it is given as a single intravenous bolus over 5 seconds. The dosage (30â€“50 mg) is weight-based, and its simplicity in administration makes it suitable for rapid use in emergency settings without requiring specialized training. Tenecteplase also has minimal adverse reactions and high efficacy.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reteplase: Administered as two boluses 30 minutes apart, making it less convenient than Tenecteplase.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Reteplase:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alteplase: Requires a bolus followed by an infusion, increasing complexity and time for administration.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Alteplase:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Streptokinase: Administered as an infusion over 60 minutes, requiring more time and monitoring.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Streptokinase:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tenecteplase is the thrombolytic agent of choice for ease of administration in acute STEMI, as it is delivered as a single bolus, ensuring rapid treatment initiation in emergency situations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with a history of heart failure and an initial ejection fraction (EF) of 35% undergoes serial follow-ups after optimized medical therapy. Her repeat echocardiogram shows an EF improvement to 48%. According to the current joint consensus classification, heart failure with improving EF is diagnosed if:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;EF &amp;gt;10% improvement&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;EF &amp;gt;5% improvement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;EF &amp;gt;15% improvement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;EF &amp;gt;20% improvement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. EF &gt;10% improvement&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) EF &amp;gt;10% improvement&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Heart failure with improving EF (HFimpEF) is diagnosed when there is an improvement in EF of &amp;gt;10% from a baseline EF &amp;lt;40% . This category highlights patients who were initially diagnosed with heart failure with reduced ejection fraction (HFrEF) and demonstrate significant improvement following medical therapy, reflecting partial recovery of myocardial function.&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;10% from a baseline EF &amp;lt;40%&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. EF &amp;gt;5% improvement: While any improvement is beneficial, a â‰¥10% improvement is required to meet the HFimpEF criteria.&lt;/li&gt;&lt;li&gt;â€¢ Option B. EF &amp;gt;5% improvement:&lt;/li&gt;&lt;li&gt;â€¢ Option C. EF &amp;gt;15% improvement: This threshold is unnecessarily high and not part of the current classification criteria.&lt;/li&gt;&lt;li&gt;â€¢ Option C. EF &amp;gt;15% improvement:&lt;/li&gt;&lt;li&gt;â€¢ Option D. EF &amp;gt;20% improvement: Such an improvement may occur but is not required for the diagnosis of HFimpEF.&lt;/li&gt;&lt;li&gt;â€¢ Option D. EF &amp;gt;20% improvement:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The diagnosis of heart failure with improving EF (HFimpEF) requires &amp;gt;10% improvement in EF from a baseline of &amp;lt;40%. This category emphasizes the potential for myocardial recovery with optimal medical therapy.&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt;10% improvement&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with heart failure with reduced ejection fraction (HFrEF) is being considered for therapy. Which of the following is the first line drug?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ARNI (Sacubitril-Valsartan)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Eplerenone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Torsemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tafamidis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ARNI (Sacubitril-Valsartan)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) ARNI (Sacubitril-Valsartan)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Angiotensin receptor-neprilysin inhibitors (ARNIs), specifically Sacubitril-Valsartan, have demonstrated substantial benefits in HFrEF. Compared to traditional ACE inhibitors or ARBs, ARNIs provide an additional 20% reduction in cardiovascular death and heart failure hospitalization , as shown in the PARADIGM-HF trial. Sacubitril inhibits neprilysin, increasing natriuretic peptides while Valsartan blocks the angiotensin receptor to counteract the renin-angiotensin system.&lt;/li&gt;&lt;li&gt;â€¢ additional 20% reduction in cardiovascular death and heart failure hospitalization&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Eplerenone: A mineralocorticoid receptor antagonist (MRA) that has been used for HFrEF for years but does not offer the same recent and additional benefits as ARNIs.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Eplerenone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Torsemide: A long-acting loop diuretic used for symptom relief in heart failure, but it provides no mortality benefit.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Torsemide:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tafamidis: Used for transthyretin cardiac amyloidosis, not HFrEF.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tafamidis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sacubitril-Valsartan (ARNI) is a revolutionary treatment for HFrEF, providing significant mortality and morbidity benefits compared to traditional therapies. It represents a cornerstone in modern heart failure management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 17-year-old boy presents with exertional dyspnea and syncope. On physical examination, a systolic murmur is heard at the left lower sternal border. Which of the following maneuvers is expected to reduce the intensity and duration of the murmur in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Standing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valsalva&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Squatting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exercise&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Squatting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Squatting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In hypertrophic cardiomyopathy (HCM), the murmur is caused by left ventricular outflow tract (LVOT) obstruction due to septal hypertrophy and systolic anterior motion (SAM) of the mitral valve. Squatting increases venous return and afterload , which enlarges the left ventricular cavity, reducing the obstruction and thereby decreasing the intensity and duration of the murmur.&lt;/li&gt;&lt;li&gt;â€¢ Squatting increases venous return and afterload&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Standing: Reduces venous return and left ventricular cavity size, worsening the obstruction and increasing the murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Standing:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Valsalva: Reduces preload, decreasing LV cavity size, which exacerbates obstruction and intensifies the murmur.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Valsalva:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise: Increases heart rate and contractility, worsening LVOT obstruction and murmur intensity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Exercise:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Maneuvers that increase venous return or afterload (e.g., squatting) alleviate the LVOT obstruction in HCM, reducing murmur intensity, whereas maneuvers that decrease preload or LV cavity size (e.g., standing, Valsalva) exacerbate the obstruction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman with a history of hypertension presents to the emergency room with loss of consciousness, chest pain, and diaphoresis. On examination, she is hemodynamically unstable, and bilateral pulses are unequal. An ECG reveals nonspecific ST-T changes. What is the next best investigation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transesophageal echocardiography (TEE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiac enzymes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;X-ray&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Transesophageal echocardiography (TEE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Transesophageal echocardiography (TEE)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation of chest pain, diaphoresis, and unequal pulses is highly suggestive of aortic dissection . Transesophageal echocardiography (TEE) is the investigation of choice in unstable patients, as it can be performed rapidly at the bedside and provides high sensitivity and specificity for detecting dissection. TEE can identify the intimal flap, true and false lumens, and involvement of the aortic valve or coronary ostia.&lt;/li&gt;&lt;li&gt;â€¢ aortic dissection&lt;/li&gt;&lt;li&gt;â€¢ Transesophageal echocardiography (TEE)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI: While MRI provides excellent imaging of the aorta, it is time-consuming and not suitable for unstable patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cardiac enzymes: These may help in evaluating myocardial infarction but do not confirm or rule out aortic dissection, which is the likely diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cardiac enzymes:&lt;/li&gt;&lt;li&gt;â€¢ Option D. X-ray: Chest X-ray may show mediastinal widening in aortic dissection, but it is nonspecific and insufficient for definitive diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. X-ray:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In suspected aortic dissection, the choice of imaging depends on the patientâ€™s hemodynamic status. TEE is preferred in unstable patients , while CT aortogram is suitable for stable cases. Early diagnosis and management are critical to prevent complications.&lt;/li&gt;&lt;li&gt;âž¤ TEE is preferred in unstable patients&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old man presents with headache and a burning sensation in the head. Physical examination reveals feeble lower limb pulses and elevated blood pressure (190/100 mmHg). A chest X-ray is done and shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic aneurysms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic dissection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coarctation of the aorta&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atrial septal defect (ASD)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Coarctation of the aorta&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20141114.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Coarctation of the aorta&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The combination of hypertension, feeble lower limb pulses, and rib notching on chest X-ray is classic for coarctation of the aorta . Coarctation leads to increased upper body blood pressure and decreased lower body perfusion. Rib notching occurs due to collateral circulation through intercostal arteries compensating for the obstruction in the aorta.&lt;/li&gt;&lt;li&gt;â€¢ coarctation of the aorta&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic aneurysms: Typically present with signs of rupture or dissection, not rib erosion or pulse discrepancies.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aortic aneurysms:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic dissection: Causes chest pain and unequal pulses in the upper and lower limbs but does not cause rib notching or chronic hypertension patterns.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Aortic dissection:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Atrial septal defect (ASD): A pre-tricuspid left-to-right shunt causing right heart failure; it is unrelated to rib notching or systemic hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Atrial septal defect (ASD):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Coarctation of the aorta is characterized by systemic hypertension, reduced lower limb pulses, and rib notching due to collateral formation, making it a key diagnosis in young hypertensive patients with these findings.&lt;/li&gt;&lt;li&gt;âž¤ Coarctation of the aorta&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with episodic palpitations and dizziness. An ECG is done, and it is shown below. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RVH (Right Ventricular Hypertrophy)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;RBBB (Right Bundle Branch Block)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;WPW (Wolff-Parkinson-White syndrome)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ARVC (Arrhythmogenic Right Ventricular Cardiomyopathy)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. WPW (Wolff-Parkinson-White syndrome)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-25%20183738.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) WPW (Wolff-Parkinson-White syndrome)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The ECG findings of tall R waves in V1 , short PR interval , and the presence of delta waves are diagnostic of Wolff-Parkinson-White (WPW) syndrome. WPW is a pre-excitation syndrome caused by an accessory pathway (Bundle of Kent) that bypasses the AV node, leading to a characteristic ECG pattern and episodes of tachyarrhythmia due to reentrant circuits.&lt;/li&gt;&lt;li&gt;â€¢ tall R waves in V1&lt;/li&gt;&lt;li&gt;â€¢ short PR interval&lt;/li&gt;&lt;li&gt;â€¢ delta waves&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. RVH: Tall R waves in V1 can occur in RVH, but it is not associated with a short PR interval or delta waves.&lt;/li&gt;&lt;li&gt;â€¢ Option A. RVH:&lt;/li&gt;&lt;li&gt;â€¢ Option B. RBBB: RBBB shows a widened QRS complex with an rsR&#x27; pattern in V1, not a short PR interval or delta waves.&lt;/li&gt;&lt;li&gt;â€¢ Option B. RBBB:&lt;/li&gt;&lt;li&gt;â€¢ Option D. ARVC: This condition may show epsilon waves and T-wave inversions in the right precordial leads but not the pre-excitation findings seen in WPW.&lt;/li&gt;&lt;li&gt;â€¢ Option D. ARVC:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of short PR interval , delta waves , and tall R waves in V1 is characteristic of WPW syndrome , which can cause symptomatic arrhythmias due to accessory pathway conduction.&lt;/li&gt;&lt;li&gt;âž¤ short PR interval&lt;/li&gt;&lt;li&gt;âž¤ delta waves&lt;/li&gt;&lt;li&gt;âž¤ tall R waves in V1&lt;/li&gt;&lt;li&gt;âž¤ WPW syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents for a routine ECG and is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left ventricular hypertrophy (LVH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Right ventricular hypertrophy (RVH)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right atrial enlargement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left atrial enlargement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Left ventricular hypertrophy (LVH)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-25%20183917.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Left ventricular hypertrophy (LVH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The ECG findings are consistent with Sokolow-Lyon criteria for left ventricular hypertrophy, which include:&lt;/li&gt;&lt;li&gt;â€¢ Sokolow-Lyon criteria&lt;/li&gt;&lt;li&gt;â€¢ SV1 + RV5/6 &amp;gt; 35 mm R in V5/6 &amp;gt; 25 mm R in aVL &amp;gt; 11 mm&lt;/li&gt;&lt;li&gt;â€¢ SV1 + RV5/6 &amp;gt; 35 mm&lt;/li&gt;&lt;li&gt;â€¢ SV1 + RV5/6 &amp;gt; 35 mm&lt;/li&gt;&lt;li&gt;â€¢ R in V5/6 &amp;gt; 25 mm&lt;/li&gt;&lt;li&gt;â€¢ R in V5/6 &amp;gt; 25 mm&lt;/li&gt;&lt;li&gt;â€¢ R in aVL &amp;gt; 11 mm&lt;/li&gt;&lt;li&gt;â€¢ R in aVL &amp;gt; 11 mm&lt;/li&gt;&lt;li&gt;â€¢ Other criteria such as the Cornell voltage criteria (RaVL + SV3 &amp;gt; 28 mm in men or &amp;gt;20 mm in women) may also indicate LVH. These voltage criteria reflect the increased myocardial mass associated with left ventricular hypertrophy.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Right ventricular hypertrophy (RVH): Characterized by a rightward axis, tall R in V1, and deep S in V5/V6, not seen here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Right ventricular hypertrophy (RVH):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right atrial enlargement: Typically shows peaked P waves &amp;gt;2.5 mm in lead II, which are not described here.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Right atrial enlargement:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left atrial enlargement: Indicated by a wide, notched P wave in lead II or a biphasic P wave in V1, absent in this ECG.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left atrial enlargement:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Left ventricular hypertrophy (LVH) is identified on ECG using voltage criteria such as Sokolow-Lyon and Cornell voltage, reflecting increased myocardial mass and often associated with hypertension or valvular heart disease.&lt;/li&gt;&lt;li&gt;âž¤ Left ventricular hypertrophy (LVH)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents to the emergency department with complaints of fatigue and a recent episode of transient loss of consciousness while walking. He denies chest pain or palpitations. On physical examination, his pulse is slow and irregular, with a heart rate of 35/min. An ECG is performed and is shown. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mobitz Type 1 AV Block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complete Heart Block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sinus Bradycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1st Degree AV Block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Complete Heart Block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20152730.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20152749.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Complete Heart Block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The ECG findings of varying PR intervals with fixed and independent PP and RR intervals are diagnostic of Complete Heart Block (CHB) . This indicates a lack of communication between the atria and ventricles, with the ventricles relying on an escape rhythm for contraction. The patient&#x27;s transient loss of consciousness and fatigue are consistent with Stokes-Adams syndrome , which occurs due to inadequate cardiac output during periods of extreme bradycardia or asystole.&lt;/li&gt;&lt;li&gt;â€¢ Complete Heart Block (CHB)&lt;/li&gt;&lt;li&gt;â€¢ Stokes-Adams syndrome&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mobitz Type 1 AV Block: Characterized by progressive prolongation of the PR interval followed by a dropped beat, which is not described here.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mobitz Type 1 AV Block:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sinus Bradycardia: Features a heart rate &amp;lt;60 bpm with regular atrial and ventricular activity; there is no dissociation between the atria and ventricles.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sinus Bradycardia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 1st Degree AV Block: Defined by a prolonged PR interval &amp;gt;200 ms, but the PR interval remains constant, unlike the variation seen in CHB.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 1st Degree AV Block:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Complete Heart Block is diagnosed by atrioventricular dissociation with independent atrial and ventricular rhythms. It requires prompt intervention, such as temporary pacing, to prevent complications like Stokes-Adams attacks.&lt;/li&gt;&lt;li&gt;âž¤ Complete Heart Block&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with a history of hypertension and diabetes is admitted to the emergency room with severe chest pain radiating to his left arm. He is diagnosed with an acute myocardial infarction (AMI), undergoes successful revascularization, and is hospitalized for a week. During his hospital stay, he develops a ventricular tachycardia (VT) on the day of discharge. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Implantable Cardioverter Defibrillator (ICD)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Repeat Coronary Angiogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lignocaine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Implantable Cardioverter Defibrillator (ICD)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Implantable Cardioverter Defibrillator (ICD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Sustained VT occurring more than 48 hours after an acute myocardial infarction (AMI) is classified as late VT and is usually caused by scar-related reentry circuits. In this scenario, the most effective treatment for preventing sudden cardiac death is the implantation of an ICD. Amiodarone may be used as adjunctive therapy, but ICD placement is the definitive treatment.&lt;/li&gt;&lt;li&gt;â€¢ late VT&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Repeat Coronary Angiogram: Indicated only if there are clinical signs of recurrent ischemia, which is not described here.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Repeat Coronary Angiogram:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Amiodarone: Can be used for acute stabilization but is not definitive for long-term prevention of VT.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lignocaine: Is not recommended for long-term management of VT and is less effective compared to ICD therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Lignocaine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ An ICD is the treatment of choice for sustained VT that occurs more than 48 hours after an MI, as it is the most effective strategy to prevent sudden cardiac death in this population.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with palpitations and giddiness for the past 2 hours. On arrival, his blood pressure is 80/60 mmHg. ECG is shown. What is the next step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carotid sinus massage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Electrical Cardioversion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Electrical Cardioversion&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-25%20184220.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20152841.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Electrical Cardioversion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In a patient with hemodynamic instability (evidenced by BP 80/60 mmHg) and AVNRT, immediate synchronized cardioversion is the first-line treatment. Cardioversion restores normal sinus rhythm quickly and is the safest option in unstable patients.&lt;/li&gt;&lt;li&gt;â€¢ hemodynamic instability&lt;/li&gt;&lt;li&gt;â€¢ immediate synchronized cardioversion&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carotid sinus massage: This is an initial maneuver for stable AVNRT, not appropriate in hemodynamically unstable patients.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Carotid sinus massage:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine: Effective in terminating AVNRT, but cardioversion is preferred in unstable patients as it provides immediate and reliable restoration of sinus rhythm.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV metoprolol: Beta-blockers may be used in stable patients for rate control, but they are not first-line in hemodynamically unstable AVNRT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IV metoprolol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with hemodynamically unstable tachyarrhythmias , synchronized cardioversion is the treatment of choice, regardless of the underlying rhythm, to stabilize the patient promptly.&lt;/li&gt;&lt;li&gt;âž¤ hemodynamically unstable tachyarrhythmias&lt;/li&gt;&lt;li&gt;âž¤ synchronized cardioversion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man presents with recurrent episodes of palpitations and occasional dizziness. He is otherwise healthy, with no significant past medical history. During an electrophysiological study, a shortened HV interval is observed on intracardiac ECG. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;WPW syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rheumatic fever&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Infective endocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sinus tachycardia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. WPW syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20152910.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20152926.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) WPW syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The HV interval represents the conduction time between the His bundle and the ventricular myocardium. A shortened HV interval is a hallmark of Wolff-Parkinson-White (WPW) syndrome , where an accessory pathway (the Bundle of Kent) bypasses the AV node, leading to pre-excitation of the ventricles. This results in a shorter conduction time and a characteristic ECG pattern, including a shortened PR interval and delta waves.&lt;/li&gt;&lt;li&gt;â€¢ HV interval&lt;/li&gt;&lt;li&gt;â€¢ shortened HV interval&lt;/li&gt;&lt;li&gt;â€¢ Wolff-Parkinson-White (WPW) syndrome&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rheumatic fever: Primarily affects the heart valves and conduction system, potentially causing AV blocks, but does not typically shorten the HV interval.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Rheumatic fever:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infective endocarditis: Can cause conduction disturbances due to abscess formation near the conduction system but does not lead to a shortened HV interval.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infective endocarditis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sinus tachycardia: Increases heart rate but does not affect the HV interval directly.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sinus tachycardia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A shortened HV interval is diagnostic of pre-excitation syndromes , such as WPW syndrome, due to the presence of an accessory conduction pathway bypassing the normal AV nodal delay.&lt;/li&gt;&lt;li&gt;âž¤ shortened HV interval&lt;/li&gt;&lt;li&gt;âž¤ pre-excitation syndromes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 12-year-old child presents with recurrent episodes of transient weakness on the right side of the body and slurred speech. Angiogram is done and is shown. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Necrotizing arteritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Moyamoya disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fibromuscular dysplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary central nervous system vasculitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Moyamoya disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20152943.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Moyamoya disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Moyamoya disease is a chronic occlusive cerebrovascular disorder primarily involving the distal internal carotid artery and its branches, particularly the middle cerebral artery (MCA) and anterior cerebral artery (ACA). The hallmark \&quot;puff of smoke\&quot; appearance on angiography is caused by the development of a dense collateral network of lenticulostriate arteries. These collateral vessels form in response to arterial occlusion and are prone to rupture or thrombosis, leading to ischemic or hemorrhagic strokes.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necrotizing arteritis: This is associated with systemic vasculitis and does not produce the characteristic collateral pattern seen in Moyamoya disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Necrotizing arteritis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fibromuscular dysplasia: Primarily affects the renal and carotid arteries with a \&quot;string of beads\&quot; appearance on angiography, not a \&quot;puff of smoke.\&quot;&lt;/li&gt;&lt;li&gt;â€¢ Option C. Fibromuscular dysplasia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary central nervous system vasculitis: Affects medium and small cerebral vessels, but does not produce the collateral circulation characteristic of Moyamoya disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Primary central nervous system vasculitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The \&quot;puff of smoke\&quot; appearance on angiography is a pathognomonic feature of Moyamoya disease , a progressive occlusive disorder requiring prompt diagnosis to prevent ischemic and hemorrhagic complications.&lt;/li&gt;&lt;li&gt;âž¤ Moyamoya disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are components of the ABCD2 score for assessing stroke risk after a transient ischemic attack (TIA), except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Creatinine levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Creatinine levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Creatinine levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The ABCD2 score is used to predict the risk of stroke within 2 days following a TIA. It includes:&lt;/li&gt;&lt;li&gt;â€¢ ABCD2 score&lt;/li&gt;&lt;li&gt;â€¢ Age &amp;gt; 60 years (1 point) Blood pressure â‰¥140/90 mmHg at initial evaluation (1 point) Clinical features of TIA (speech disturbance = 1 point, unilateral weakness = 2 points) Duration of TIA symptoms (10â€“59 minutes = 1 point, â‰¥60 minutes = 2 points) Diabetes mellitus (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Age &amp;gt; 60 years (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Age &amp;gt; 60 years (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Blood pressure â‰¥140/90 mmHg at initial evaluation (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Blood pressure â‰¥140/90 mmHg at initial evaluation (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Clinical features of TIA (speech disturbance = 1 point, unilateral weakness = 2 points)&lt;/li&gt;&lt;li&gt;â€¢ Clinical features of TIA (speech disturbance = 1 point, unilateral weakness = 2 points)&lt;/li&gt;&lt;li&gt;â€¢ Duration of TIA symptoms (10â€“59 minutes = 1 point, â‰¥60 minutes = 2 points)&lt;/li&gt;&lt;li&gt;â€¢ Duration of TIA symptoms (10â€“59 minutes = 1 point, â‰¥60 minutes = 2 points)&lt;/li&gt;&lt;li&gt;â€¢ Diabetes mellitus (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Diabetes mellitus (1 point)&lt;/li&gt;&lt;li&gt;â€¢ Creatinine levels are not part of the ABCD2 score.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age: Patients &amp;gt;60 years are assigned 1 point.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Age:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Blood pressure: A BP â‰¥140/90 mmHg is assigned 1 point.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Blood pressure:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diabetes: A history of diabetes adds 1 point.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Diabetes:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The ABCD2 score assesses stroke risk based on age , blood pressure , clinical features , duration of symptoms , and diabetes , but creatinine levels are not included.&lt;/li&gt;&lt;li&gt;âž¤ ABCD2 score&lt;/li&gt;&lt;li&gt;âž¤ age&lt;/li&gt;&lt;li&gt;âž¤ blood pressure&lt;/li&gt;&lt;li&gt;âž¤ clinical features&lt;/li&gt;&lt;li&gt;âž¤ duration of symptoms&lt;/li&gt;&lt;li&gt;âž¤ diabetes&lt;/li&gt;&lt;li&gt;âž¤ creatinine levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of poorly controlled hypertension presents to the emergency department with sudden onset weakness on the right side of his body and slurred speech. A CT scan reveals an intracerebral hemorrhage. What is the most common site?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thalamus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Putamen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pons&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Putamen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Putamen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hypertensive intracerebral hemorrhage (ICH) typically results from the rupture of small penetrating arteries caused by long-standing hypertension. The putamen , a part of the basal ganglia, is the most common site of hypertensive hemorrhage. Hemorrhage in this location often involves the adjacent internal capsule, leading to contralateral hemiparesis as a key clinical sign.&lt;/li&gt;&lt;li&gt;â€¢ putamen&lt;/li&gt;&lt;li&gt;â€¢ contralateral hemiparesis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thalamus: Although a common site, it is less frequently affected than the putamen. Thalamic hemorrhages may cause sensory deficits and gaze disturbances.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thalamus:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellum: Cerebellar hemorrhages are less common and present with ataxia and gait instability.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellum:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pons: Pontine hemorrhages are also less frequent and are typically devastating, causing quadriparesis or coma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pons:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The putamen is the most common site for hypertensive intracerebral hemorrhage, often presenting with contralateral hemiparesis due to involvement of the internal capsule. Early identification and management are critical to improving outcomes.&lt;/li&gt;&lt;li&gt;âž¤ putamen&lt;/li&gt;&lt;li&gt;âž¤ contralateral hemiparesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with headaches and visual disturbances that have worsened over the past few weeks. Neurological examination reveals a left-sided third cranial nerve palsy. An MRI reveals a large berry aneurysm at the bifurcation of the middle cerebral artery. What is the definition of a giant aneurysm based on size?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt;1.5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;gt;2.0 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt;2.5 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt;3.0 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &gt;2.5 cm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;gt;2.5 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Giant aneurysms are defined as aneurysms with a diameter &amp;gt;2.5 cm , accounting for approximately 5% of all intracranial aneurysms. They commonly occur at the terminal internal carotid artery , middle cerebral artery (MCA) bifurcation , and the top of the basilar artery . These aneurysms are associated with:&lt;/li&gt;&lt;li&gt;â€¢ Giant aneurysms&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;2.5 cm&lt;/li&gt;&lt;li&gt;â€¢ terminal internal carotid artery&lt;/li&gt;&lt;li&gt;â€¢ middle cerebral artery (MCA) bifurcation&lt;/li&gt;&lt;li&gt;â€¢ top of the basilar artery&lt;/li&gt;&lt;li&gt;â€¢ A rupture risk of ~6% within the first year, which remains elevated over time. Symptoms due to compression of adjacent brain structures or cranial nerves, even before rupture.&lt;/li&gt;&lt;li&gt;â€¢ A rupture risk of ~6% within the first year, which remains elevated over time.&lt;/li&gt;&lt;li&gt;â€¢ Symptoms due to compression of adjacent brain structures or cranial nerves, even before rupture.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;gt;1.5 cm: Aneurysms of this size are considered large but not classified as giant.&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;gt;1.5 cm:&lt;/li&gt;&lt;li&gt;â€¢ Option B. &amp;gt;2.0 cm: Similar to above, this threshold is used for large aneurysms but not for giant aneurysms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. &amp;gt;2.0 cm:&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;3.0 cm: This size exceeds the threshold for a giant aneurysm but is not the established definition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;3.0 cm:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Giant aneurysms are defined as those with a diameter &amp;gt;2.5 cm , carry significant rupture risks, and often cause symptoms due to compression of nearby structures. Early diagnosis and management are critical.&lt;/li&gt;&lt;li&gt;âž¤ Giant aneurysms&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt;2.5 cm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman with a history of uncontrolled hypertension presents with sudden loss of vision in both eyes. Neurological examination reveals preserved pupillary light reflexes. Despite being blind, the patient insists that her vision is normal. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal ACAs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal MCAs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal PCAs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Any of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bilateral infarction in the distal PCAs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bilateral infarction in the distal PCAs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Antonâ€™s syndrome results from bilateral infarction in the distal posterior cerebral arteries (PCAs) , which supply the primary visual cortex. This condition leads to cortical blindness , characterized by complete loss of vision despite preserved pupillary light reflexes. Patients often exhibit visual anosognosia , meaning they are unaware of or deny their blindness, a hallmark feature of Antonâ€™s syndrome.&lt;/li&gt;&lt;li&gt;â€¢ bilateral infarction in the distal posterior cerebral arteries (PCAs)&lt;/li&gt;&lt;li&gt;â€¢ cortical blindness&lt;/li&gt;&lt;li&gt;â€¢ anosognosia&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bilateral infarction in the distal ACAs: Leads to frontal lobe deficits, including abulia (lack of will) and paraplegia, not cortical blindness.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Bilateral infarction in the distal ACAs:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral infarction in the distal MCAs: Causes significant motor and sensory deficits, but not cortical blindness.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral infarction in the distal MCAs:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Any of the above: Antonâ€™s syndrome specifically requires infarction in the distal PCAs affecting the visual cortex.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Any of the above:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Antonâ€™s syndrome is a rare condition of cortical blindness caused by bilateral PCA infarction , characterized by preserved pupillary light reflexes and denial of blindness (anosognosia). Early recognition is crucial for accurate diagnosis and management.&lt;/li&gt;&lt;li&gt;âž¤ cortical blindness&lt;/li&gt;&lt;li&gt;âž¤ bilateral PCA infarction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with syncope during physical activity, especially while performing dumbbell exercises. On examination, a bruit is noted in the supraclavicular region. What is the most appropriate test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT Angiogram of neck&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vertebral Artery Doppler&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MRI brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treadmill ECG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CT Angiogram of neck&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CT Angiogram of neck&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is suggestive of subclavian steal syndrome, characterized by syncope during upper extremity exertion due to retrograde blood flow in the vertebral artery caused by proximal subclavian artery stenosis or occlusion. A CT angiogram of the neck provides detailed visualization of the subclavian and vertebral arteries, helping confirm the diagnosis by identifying the site and severity of stenosis or occlusion.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vertebral Artery Doppler : can identify reversed vertebral artery flow, supporting the diagnosis of subclavian steal syndrome, but it does not identify the site of subclavian artery stenosis as comprehensively as a CT angiogram.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Vertebral Artery Doppler&lt;/li&gt;&lt;li&gt;â€¢ Option C. MRI brain :  is not indicated as the primary test since the symptoms are due to vascular obstruction rather than a primary brain pathology.&lt;/li&gt;&lt;li&gt;â€¢ Option C. MRI brain&lt;/li&gt;&lt;li&gt;â€¢ Option D. Treadmill ECG : is used for cardiac ischemia evaluation, which is not relevant in this case as the symptoms are localized to arm exertion and vascular compromise.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Treadmill ECG&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CT angiogram of the neck is the investigation of choice for subclavian steal syndrome, providing a detailed assessment of vascular anatomy and identifying the underlying cause of symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man, Mohan, presents to the neurology clinic with complaints of slowed movements, difficulty walking, and a resting tremor in his right hand. His wife mentions that he has trouble maintaining balance and frequently feels unsteady. On examination, he has cogwheel rigidity and a stooped posture. Which of the following is not considered a cardinal motor feature?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rest tremor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradykinesia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Masked facies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postural instability&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Masked facies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Masked facies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient has Parkinsonâ€™s disease. Masked facies (or hypomimia) refers to reduced facial expressivity seen in Parkinsonâ€™s disease but is not classified as a cardinal motor feature . The cardinal motor features of Parkinsonâ€™s disease include:&lt;/li&gt;&lt;li&gt;â€¢ cardinal motor feature&lt;/li&gt;&lt;li&gt;â€¢ Bradykinesia (slowness of movement) Rest tremor (most noticeable at rest) Rigidity (stiffness of muscles) Postural instability (balance difficulties, typically in later stages).&lt;/li&gt;&lt;li&gt;â€¢ Bradykinesia (slowness of movement)&lt;/li&gt;&lt;li&gt;â€¢ Bradykinesia&lt;/li&gt;&lt;li&gt;â€¢ Rest tremor (most noticeable at rest)&lt;/li&gt;&lt;li&gt;â€¢ Rest tremor&lt;/li&gt;&lt;li&gt;â€¢ Rigidity (stiffness of muscles)&lt;/li&gt;&lt;li&gt;â€¢ Rigidity&lt;/li&gt;&lt;li&gt;â€¢ Postural instability (balance difficulties, typically in later stages).&lt;/li&gt;&lt;li&gt;â€¢ Postural instability&lt;/li&gt;&lt;li&gt;â€¢ Masked facies, along with micrographia, reduced eye blinking, drooling, hypophonia, and freezing, are considered additional motor features but not cardinal criteria.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rest tremor: A hallmark symptom of Parkinsonâ€™s disease and one of its cardinal motor features.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rest tremor:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bradykinesia: Essential for diagnosis and a cardinal feature of Parkinsonâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bradykinesia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Postural instability: Often seen in advanced stages and is a cardinal feature of Parkinsonâ€™s disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Postural instability:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The cardinal motor features of Parkinsonâ€™s disease are rest tremor, bradykinesia, rigidity, and postural instability. Masked facies is a common feature but not included in the cardinal criteria.&lt;/li&gt;&lt;li&gt;âž¤ rest tremor, bradykinesia, rigidity, and postural instability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman, diagnosed with Parkinsonâ€™s disease, has been on levodopa therapy for five years. She presents with symptoms of motor fluctuations, including wearing-off effects and dyskinesias. Which of the following factors is LEAST likely associated with an increased risk of levodopa-induced motor complications?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Old patients&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Severe disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Higher doses of levodopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Women&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Old patients&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Old patients&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Levodopa-induced motor complications, such as wearing-off and dyskinesias, are less commonly seen in older patients. They are more frequently observed in younger individuals , likely due to their longer disease duration and greater sensitivity to dopaminergic fluctuations. The other factors, including severe disease, higher doses of levodopa, and female gender, are strongly associated with an increased risk of these complications.&lt;/li&gt;&lt;li&gt;â€¢ younger individuals&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Severe disease: Advanced stages of Parkinsonâ€™s disease increase the likelihood of motor complications due to greater neuronal loss and reduced buffering capacity.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Severe disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Higher doses of levodopa: High doses lead to increased dopaminergic fluctuations, predisposing patients to motor complications.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Higher doses of levodopa:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Women: Women are more prone to developing motor complications, possibly due to differences in dopamine metabolism and pharmacodynamics.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Women:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Levodopa-induced motor complications are more common in younger patients , those with severe disease , higher levodopa doses , and women , while older patients are less likely to experience these issues.&lt;/li&gt;&lt;li&gt;âž¤ younger patients&lt;/li&gt;&lt;li&gt;âž¤ severe disease&lt;/li&gt;&lt;li&gt;âž¤ higher levodopa doses&lt;/li&gt;&lt;li&gt;âž¤ women&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man, with a 10-year history of Parkinsonâ€™s disease, presents with progressive memory impairment, difficulty with daily activities, and confusion over the last few months. On examination, he shows signs of cognitive decline. His current medications include levodopa, Pramipexole, amantadine, trihexyphenidyl, and tolcapone Which of the following drugs should be stopped first to manage his cognitive symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pramipexole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amantadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anticholinergics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tolcapone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anticholinergics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anticholinergics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Anticholinergic medications like trihexyphenidyl are associated with cognitive side effects, especially in elderly patients and those with pre-existing cognitive impairment or dementia. In Parkinsonâ€™s patients who develop dementia, anticholinergics are the first drugs to be stopped, as their risks outweigh their benefits in such cases. The sequence for discontinuing drugs in Parkinsonâ€™s patients with dementia is: anticholinergics â†’ amantadine â†’ dopamine agonists â†’ COMT inhibitors â†’ MAO-B inhibitors, with levodopa being continued at the lowest effective dose.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pramipexole: It is dopamine receptor agonist and can be discontinued after anticholinergics and amantadine, as they have a relatively lower cognitive impact.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pramipexole:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amantadine: Although it can cause cognitive side effects, it is stopped after anticholinergics in patients with Parkinsonâ€™s disease and dementia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amantadine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tolcapone: It is a COMT inhibitor and generally these drugs have minimal cognitive impact. However, LFTs have to be monitored with Tolcapone.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tolcapone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Parkinsonâ€™s disease patients who develop dementia, anticholinergics are the first drugs to be stopped due to their significant impact on cognitive function. Medication adjustments aim to balance motor symptom control with preservation of cognitive abilities.&lt;/li&gt;&lt;li&gt;âž¤ anticholinergics&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old woman, Ananya, presents with a history of recurrent severe headaches accompanied by temporary weakness on one side of her body. Her mother and maternal uncle have similar episodes of hemiparesis associated with migraines. Genetic testing is planned to confirm the diagnosis. Which of the following gene mutations is most likely responsible for familial hemiplegic migraine type 1 (FHM1)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CACNA1A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ATP1A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SCN1A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SCN2A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CACNA1A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CACNA1A&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Familial hemiplegic migraine type 1 (FHM1) is caused by mutations in the CACNA1A gene, which encodes the Cav 2.1 (P/Q)â€“type voltage-gated calcium channel. These channels are critical for neuronal excitability and synaptic transmission. Mutations in CACNA1A alter calcium channel function, predisposing individuals to migraines with aura and hemiparesis.&lt;/li&gt;&lt;li&gt;â€¢ Familial hemiplegic migraine type 1 (FHM1)&lt;/li&gt;&lt;li&gt;â€¢ CACNA1A&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ATP1A2: Mutations in ATP1A2, encoding the Na+-K+ ATPase pump, are associated with FHM type 2 , not type 1. These mutations affect ion homeostasis in neurons and glial cells.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ATP1A2:&lt;/li&gt;&lt;li&gt;â€¢ FHM type 2&lt;/li&gt;&lt;li&gt;â€¢ Option C. SCN1A: Mutations in SCN1A, encoding a neuronal voltage-gated sodium channel, cause FHM type 3 , characterized by similar migraine symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. SCN1A:&lt;/li&gt;&lt;li&gt;â€¢ FHM type 3&lt;/li&gt;&lt;li&gt;â€¢ Option D. SCN2A: While SCN2A mutations are implicated in epilepsy, they are not associated with familial hemiplegic migraine.&lt;/li&gt;&lt;li&gt;â€¢ Option D. SCN2A:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CACNA1A gene mutations are responsible for FHM type 1 , highlighting the role of voltage-gated calcium channels in the pathophysiology of migraines. Other types of FHM involve mutations in ATP1A2 (type 2) and SCN1A (type 3).&lt;/li&gt;&lt;li&gt;âž¤ CACNA1A gene mutations&lt;/li&gt;&lt;li&gt;âž¤ FHM type 1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man, Arjun, presents to the emergency department with severe, unilateral headache centered around his left eye. He describes the pain as excruciating and states that it began suddenly about 30 minutes ago. He also has tearing and redness in the left eye, along with nasal congestion. Which of the following is the treatment of choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral sumatriptan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lidocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen inhalation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oxygen inhalation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oxygen inhalation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ For an acute attack of cluster headache , 100% oxygen inhalation at a flow rate of 12-15 L/min for 15â€“20 minutes is the treatment of choice. Oxygen is highly effective in terminating cluster headache attacks quickly, likely due to its vasoconstrictive and neuromodulatory effects in the trigeminovascular system. It is safe and provides rapid relief in most patients.&lt;/li&gt;&lt;li&gt;â€¢ acute attack of cluster headache&lt;/li&gt;&lt;li&gt;â€¢ 100% oxygen inhalation&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral sumatriptan: While sumatriptan is effective in treating migraines, its oral form is not suitable for cluster headaches due to its slower onset of action. The subcutaneous form of sumatriptan is a second-line option for cluster headache.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Oral sumatriptan:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lidocaine: Intranasal lidocaine can provide some relief but is not the first-line treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lidocaine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Topiramate: This is used as a preventive treatment for cluster headaches, not for acute attacks.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Topiramate:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The treatment of choice for an acute attack of cluster headache is oxygen inhalation , which provides rapid and effective relief. Subcutaneous sumatriptan is a secondary option for patients who do not respond to oxygen.&lt;/li&gt;&lt;li&gt;âž¤ treatment of choice for an acute attack of cluster headache&lt;/li&gt;&lt;li&gt;âž¤ oxygen inhalation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman, presents with severe, recurrent, and sharp stabbing pain on the right side of her face, triggered by activities such as chewing and brushing her teeth. Neurological examination is normal. MRI shows compression of the trigeminal nerve root by a nearby blood vessel. Which of the following blood vessels is most commonly involved in the disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Basilar artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Posterior communicating artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Superior cerebellar artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inferior cerebellar artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Superior cerebellar artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Superior cerebellar artery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical picture is suggestive of trigeminal neuralgia. The superior cerebellar artery (SCA) is the most common vessel responsible for compression of the trigeminal nerve root in trigeminal neuralgia. Vascular compression at the root entry zone leads to demyelination of the nerve, resulting in ectopic discharges and severe pain. In some cases, a tortuous vein or other arteries may also contribute to the condition.&lt;/li&gt;&lt;li&gt;â€¢ superior cerebellar artery (SCA)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Basilar artery: While the basilar artery is a major brainstem artery, it is not commonly implicated in trigeminal nerve compression.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Basilar artery:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Posterior communicating artery: This artery is located in the Circle of Willis and is not typically involved in trigeminal neuralgia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Posterior communicating artery:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inferior cerebellar artery: Although near the trigeminal nerve, this vessel is less commonly involved compared to the superior cerebellar artery.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Inferior cerebellar artery:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The superior cerebellar artery is the most commonly involved blood vessel in trigeminal neuralgia , often causing nerve compression at the root entry zone, which leads to the characteristic paroxysmal facial pain.&lt;/li&gt;&lt;li&gt;âž¤ superior cerebellar artery&lt;/li&gt;&lt;li&gt;âž¤ trigeminal neuralgia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman, Meena, presents with progressive weakness that worsens throughout the day, along with difficulty swallowing and frequent episodes of nasal regurgitation. She also reports episodes of shortness of breath, particularly at night. Examination reveals fatigable weakness and bulbar involvement. Antibody testing is performed to confirm the diagnosis. Which of the following antibodies is most likely associated with the presentation ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-AChR antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-MuSK antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-LRP4 antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-GQ1b antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Anti-MuSK antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Anti-MuSK antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In Myasthenia Gravis (MG) , anti-MuSK (Muscle-Specific Kinase) antibodies are associated with a subtype characterized by prominent bulbar weakness (affecting swallowing and speech) and frequent episodes of respiratory depression. MuSK antibodies disrupt the clustering of acetylcholine receptors (AChRs) at the neuromuscular junction, leading to severe symptoms, particularly in the bulbar and respiratory muscles. These patients often require more aggressive treatment compared to those with anti-AChR antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Myasthenia Gravis (MG)&lt;/li&gt;&lt;li&gt;â€¢ anti-MuSK (Muscle-Specific Kinase) antibodies&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-AChR antibody: Found in most MG cases, but bulbar weakness and respiratory symptoms are less severe compared to MuSK-positive MG.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-AChR antibody:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-LRP4 antibody: Rarely associated with MG; typically presents with milder and more generalized symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-LRP4 antibody:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-GQ1b antibody: Seen in Miller Fisher syndrome and not associated with MG.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti-GQ1b antibody:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-MuSK antibody-positive MG is associated with severe bulbar weakness and a higher risk of respiratory depression , requiring early diagnosis and careful management.&lt;/li&gt;&lt;li&gt;âž¤ Anti-MuSK antibody-positive MG&lt;/li&gt;&lt;li&gt;âž¤ bulbar weakness&lt;/li&gt;&lt;li&gt;âž¤ respiratory depression&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman, Pooja, presents with complaints of fatigable weakness, especially in the proximal muscles and eyelids. Repetitive nerve stimulation (RNS) is planned to confirm the diagnosis. Which of the following statements regarding RNS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-AChE medication should be stopped 6â€“12 h before testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is best to test weak muscles or proximal muscle groups&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;In myasthenic patients, there is a rapid reduction of &amp;gt;10% in the amplitude of the evoked responses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All are true&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All are true&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All are true&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Repetitive nerve stimulation (RNS) is a diagnostic test for myasthenia gravis (MG) that evaluates neuromuscular transmission.&lt;/li&gt;&lt;li&gt;â€¢ Repetitive nerve stimulation (RNS)&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-AChE medication should be stopped 6â€“12 hours before testing to prevent interference with results and provide a true measure of neuromuscular transmission impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-AChE medication should be stopped 6â€“12 hours before testing&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is best to test weak muscles or proximal muscle groups , as these are more likely to exhibit abnormalities in MG.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is best to test weak muscles or proximal muscle groups&lt;/li&gt;&lt;li&gt;â€¢ Option C. In myasthenic patients, there is a rapid reduction of &amp;gt;10% in the amplitude of the evoked responses , reflecting a defect in neuromuscular transmission due to reduced acetylcholine availability at the receptor.&lt;/li&gt;&lt;li&gt;â€¢ Option C. In myasthenic patients, there is a rapid reduction of &amp;gt;10% in the amplitude of the evoked responses&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Repetitive nerve stimulation is a key diagnostic tool for myasthenia gravis and requires appropriate preparation (stopping anti-AChE medication) and testing of weak or proximal muscles. A reduction in amplitude &amp;gt;10% confirms a neuromuscular transmission defect.&lt;/li&gt;&lt;li&gt;âž¤ myasthenia gravis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following hormones uses the JAK/STAT signaling pathway?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BMP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PRL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Activin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. PRL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20130811.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) PRL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Prolactin (PRL) uses the JAK/STAT (Janus kinase/signal transducer and activator of transcription) signaling pathway. Upon binding to its receptor, prolactin activates JAK kinases, which phosphorylate the receptor, allowing STAT proteins to bind and translocate to the nucleus to regulate gene transcription. This pathway is also used by growth hormone (GH) and other cytokine-like hormones.&lt;/li&gt;&lt;li&gt;â€¢ Prolactin (PRL)&lt;/li&gt;&lt;li&gt;â€¢ JAK/STAT (Janus kinase/signal transducer and activator of transcription)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. BMP: Bone morphogenetic proteins (BMP) use the serine/threonine kinase signaling pathway via the SMAD proteins.&lt;/li&gt;&lt;li&gt;â€¢ Option A. BMP:&lt;/li&gt;&lt;li&gt;â€¢ serine/threonine kinase&lt;/li&gt;&lt;li&gt;â€¢ Option C. Activin: Activin also uses the serine/threonine kinase pathway.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Activin:&lt;/li&gt;&lt;li&gt;â€¢ serine/threonine kinase&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulin: Insulin utilizes the Receptor Tyrosine Kinase (RTK) signaling pathway, not JAK/STAT.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulin:&lt;/li&gt;&lt;li&gt;â€¢ Receptor Tyrosine Kinase (RTK)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The JAK/STAT signaling pathway is utilized by hormones like prolactin (PRL) and growth hormone (GH) , enabling the regulation of specific genes critical for their physiological functions.&lt;/li&gt;&lt;li&gt;âž¤ JAK/STAT signaling pathway&lt;/li&gt;&lt;li&gt;âž¤ prolactin (PRL)&lt;/li&gt;&lt;li&gt;âž¤ growth hormone (GH)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 5-year-old boy presents with polyuria, polydipsia, and dehydration. He has increased levels of antidiuretic hormone (ADH), and urine osmolality remains low even after water deprivation and desmopressin test. Some of his family members are affected by this condition. Which type of mutation is most likely responsible for his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;XL, activating arginine vasopressin receptor 2 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;XL, inactivating arginine vasopressin receptor 2 mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AD, activating arginine vasopressin receptor 2 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;AD, inactivating arginine vasopressin receptor 2 mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. XL, inactivating arginine vasopressin receptor 2 mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) XL, inactivating arginine vasopressin receptor 2 mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The boy&#x27;s presentation is consistent with nephrogenic diabetes insipidus (NDI), characterized by polyuria, polydipsia, and an inability to concentrate urine despite high levels of ADH. The condition remains unresponsive to desmopressin (a synthetic ADH analog). Inherited nephrogenic diabetes insipidus is most commonly caused by X-linked (XL) inactivating mutations in the arginine vasopressin receptor 2 (AVPR2) gene, which is located on the X chromosome. This mutation impairs the kidneyâ€™s ability to respond to ADH, leading to the observed symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. XL, activating arginine vasopressin receptor 2 mutation: XL, activating mutations of the AVPR2 gene would cause increased receptor activity, which is inconsistent with the features of nephrogenic diabetes insipidus.&lt;/li&gt;&lt;li&gt;â€¢ Option A. XL, activating arginine vasopressin receptor 2 mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option C. AD, activating arginine vasopressin receptor 2 mutation: AD, activating mutations of the AVPR2 gene would not explain resistance to ADH.&lt;/li&gt;&lt;li&gt;â€¢ Option C. AD, activating arginine vasopressin receptor 2 mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. AD, inactivating arginine vasopressin receptor 2 mutation: AD, inactivating mutations of the AVPR2 gene are rare, and most familial cases of nephrogenic diabetes insipidus are X-linked rather than autosomal dominant.&lt;/li&gt;&lt;li&gt;â€¢ Option D. AD, inactivating arginine vasopressin receptor 2 mutation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nephrogenic diabetes insipidus is most commonly caused by X-linked inactivating mutations in the AVPR2 gene, leading to ADH resistance and impaired urinary concentration.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman, Rina, presents with symptoms of fatigue, and headache. Laboratory tests reveal mild hyperprolactinemia and low cortisol levels. MRI shows a prominent pituitary mass suspicious of lymphocytic hypophysitis. What is the most likely patient population affected?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HIV/AIDS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intracranial metastasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Postpartum women&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postmenopausal women&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Postpartum women&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Postpartum women&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Lymphocytic hypophysitis is an autoimmune inflammatory condition of the pituitary gland that occurs most commonly in postpartum women . It typically presents with symptoms of pituitary dysfunction, including fatigue, headache, hyperprolactinemia, and hypopituitarism. MRI often shows an enlarged pituitary gland that can mimic a pituitary adenoma. The postpartum period is thought to trigger the autoimmune process due to hormonal and immunological changes.&lt;/li&gt;&lt;li&gt;â€¢ Lymphocytic hypophysitis&lt;/li&gt;&lt;li&gt;â€¢ postpartum women&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. HIV/AIDS: While pituitary dysfunction may occur in HIV/AIDS, lymphocytic hypophysitis is not specifically associated with this population.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HIV/AIDS:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intracranial metastasis: Pituitary metastasis may mimic a pituitary mass but is unrelated to lymphocytic hypophysitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Intracranial metastasis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Postmenopausal women: Lymphocytic hypophysitis is rare in postmenopausal women, as it predominantly affects younger, postpartum women.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Postmenopausal women:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lymphocytic hypophysitis most commonly occurs in postpartum women , presenting with a pituitary mass and symptoms of pituitary dysfunction, such as mild hyperprolactinemia and hypopituitarism.&lt;/li&gt;&lt;li&gt;âž¤ Lymphocytic hypophysitis&lt;/li&gt;&lt;li&gt;âž¤ postpartum women&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man, Anil, presents with headaches and progressive visual loss over the past few months. MRI reveals a pituitary adenoma with suprasellar extension compressing the optic chiasm. Which of the following statements is not true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pituitary adenomas frequently extend in a suprasellar direction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Headache is a common feature&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Headache severity correlates with adenoma size or extension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Suprasellar extension can lead to visual loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Headache severity correlates with adenoma size or extension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Headache severity correlates with adenoma size or extension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Headache severity correlates poorly with adenoma size or extension. Even small intrasellar tumors without suprasellar extension can cause headaches due to pressure effects on the sellar diaphragm or surrounding structures. Thus, the size or direction of tumor extension is not a reliable predictor of headache severity.&lt;/li&gt;&lt;li&gt;â€¢ Headache severity correlates poorly with adenoma size or extension.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pituitary adenomas frequently extend in a suprasellar direction: Correct. The dorsal sellar diaphragm offers the least resistance to tumor growth, leading to frequent suprasellar extension.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Pituitary adenomas frequently extend in a suprasellar direction:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Headache is a common feature: Correct. Headaches are often reported in patients with pituitary adenomas, regardless of tumor size.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Headache is a common feature:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Suprasellar extension can lead to visual loss: Correct. Suprasellar extension can compress the optic chiasm, resulting in bitemporal hemianopia or other visual deficits.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Suprasellar extension can lead to visual loss:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While headaches are common in pituitary adenomas , their severity does not reliably correlate with tumor size or extension. Suprasellar growth often leads to visual loss, particularly through optic chiasm compression.&lt;/li&gt;&lt;li&gt;âž¤ headaches are common in pituitary adenomas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man, Ravi, presents with progressive enlargement of his hands and feet, coarsened facial features, and deepening of his voice over the past few years. On examination, he has frontal bossing, an enlarged jaw, and macroglossia. What is the most appropriate screening test for this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum GH levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ACTH reserve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum IGF-1 levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin tolerance test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Serum IGF-1 levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Serum IGF-1 levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Serum IGF-1 levels are the most reliable screening test for acromegaly. IGF-1 (insulin-like growth factor-1) is produced in response to growth hormone (GH) and reflects GH activity over time, providing a stable measure unaffected by the episodic nature of GH secretion. Elevated age-matched serum IGF-1 levels are a hallmark of acromegaly and confirm the need for further diagnostic testing.&lt;/li&gt;&lt;li&gt;â€¢ Serum IGF-1 levels&lt;/li&gt;&lt;li&gt;â€¢ screening test&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum GH levels: GH levels are pulsatile and vary throughout the day, making them unreliable for screening. GH suppression testing after glucose is used for confirmation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Serum GH levels:&lt;/li&gt;&lt;li&gt;â€¢ Option B. ACTH reserve: This is used to evaluate adrenal insufficiency and is unrelated to acromegaly.&lt;/li&gt;&lt;li&gt;â€¢ Option B. ACTH reserve:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulin tolerance test: Used to assess pituitary function or GH deficiency, not for screening acromegaly.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Insulin tolerance test:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The screening test for acromegaly is an age-matched serum IGF-1 level , which provides a stable and accurate measure of GH activity and guides further diagnostic evaluation.&lt;/li&gt;&lt;li&gt;âž¤ screening test for acromegaly&lt;/li&gt;&lt;li&gt;âž¤ age-matched serum IGF-1 level&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old woman, Priya, is diagnosed with diabetes mellitus. She has a strong family history of diabetes, with her father and grandmother diagnosed in their early 20s. Genetic testing reveals a mutation in the HNF1A gene. Which of the following features are characteristic of the disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autosomal dominant inheritance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early onset of hyperglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Impaired insulin secretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Maturity-Onset Diabetes of the Young (MODY) is a monogenic form of diabetes with the following key features:&lt;/li&gt;&lt;li&gt;â€¢ Maturity-Onset Diabetes of the Young (MODY)&lt;/li&gt;&lt;li&gt;â€¢ Autosomal dominant inheritance: MODY is caused by mutations in specific genes involved in insulin secretion, such as HNF1A (most common â€“ MODY 3) , HNF4A , or GCK , and follows an autosomal dominant pattern. Early onset of hyperglycemia: Typically presents before age 25 and sometimes as early as the neonatal period. Impaired insulin secretion: Insulin secretion is impaired, but there is no insulin resistance as seen in type 2 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Autosomal dominant inheritance: MODY is caused by mutations in specific genes involved in insulin secretion, such as HNF1A (most common â€“ MODY 3) , HNF4A , or GCK , and follows an autosomal dominant pattern.&lt;/li&gt;&lt;li&gt;â€¢ Autosomal dominant inheritance:&lt;/li&gt;&lt;li&gt;â€¢ HNF1A (most common â€“ MODY 3)&lt;/li&gt;&lt;li&gt;â€¢ HNF4A&lt;/li&gt;&lt;li&gt;â€¢ GCK&lt;/li&gt;&lt;li&gt;â€¢ Early onset of hyperglycemia: Typically presents before age 25 and sometimes as early as the neonatal period.&lt;/li&gt;&lt;li&gt;â€¢ Early onset of hyperglycemia:&lt;/li&gt;&lt;li&gt;â€¢ Impaired insulin secretion: Insulin secretion is impaired, but there is no insulin resistance as seen in type 2 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Impaired insulin secretion:&lt;/li&gt;&lt;li&gt;â€¢ Key Features of MODY:&lt;/li&gt;&lt;li&gt;â€¢ Key Features of MODY:&lt;/li&gt;&lt;li&gt;â€¢ No insulin resistance : Differentiates MODY from type 2 diabetes. Non-obese patients: Most MODY patients are non-obese, unlike type 2 diabetes. Specific gene mutations: Helps differentiate MODY from other diabetes types. Family history of diabetes in multiple generations: Common due to autosomal dominant inheritance.&lt;/li&gt;&lt;li&gt;â€¢ No insulin resistance : Differentiates MODY from type 2 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ No insulin resistance&lt;/li&gt;&lt;li&gt;â€¢ Non-obese patients: Most MODY patients are non-obese, unlike type 2 diabetes.&lt;/li&gt;&lt;li&gt;â€¢ Non-obese patients:&lt;/li&gt;&lt;li&gt;â€¢ Specific gene mutations: Helps differentiate MODY from other diabetes types.&lt;/li&gt;&lt;li&gt;â€¢ Specific gene mutations:&lt;/li&gt;&lt;li&gt;â€¢ Family history of diabetes in multiple generations: Common due to autosomal dominant inheritance.&lt;/li&gt;&lt;li&gt;â€¢ Family history of diabetes in multiple generations:&lt;/li&gt;&lt;li&gt;â€¢ Each feature (A, B, C) is individually correct, making the most appropriate answer D. All of the above .&lt;/li&gt;&lt;li&gt;â€¢ D. All of the above&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Maturity-Onset Diabetes of the Young (MODY) is characterized by autosomal dominant inheritance , early onset of hyperglycemia , and impaired insulin secretion , making it distinct from type 1 and type 2 diabetes. Genetic testing is essential for diagnosis and tailored management.&lt;/li&gt;&lt;li&gt;âž¤ Maturity-Onset Diabetes of the Young (MODY)&lt;/li&gt;&lt;li&gt;âž¤ autosomal dominant inheritance&lt;/li&gt;&lt;li&gt;âž¤ early onset of hyperglycemia&lt;/li&gt;&lt;li&gt;âž¤ impaired insulin secretion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man has been fasting for 18 hours as part of a religious observance. During the fasting state, which of the following processes is not typically observed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased glycogenolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased glucose uptake in skeletal muscle and fat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased lipolysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased glucose uptake in skeletal muscle and fat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased glucose uptake in skeletal muscle and fat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In the fasting state , low insulin levels and increased glucagon activity shift the bodyâ€™s metabolic focus to maintaining blood glucose levels for essential tissues like the brain:&lt;/li&gt;&lt;li&gt;â€¢ fasting state&lt;/li&gt;&lt;li&gt;â€¢ Increased gluconeogenesis: The liver produces glucose from precursors like amino acids and glycerol to sustain blood glucose levels. Increased glycogenolysis: Stored glycogen in the liver is broken down into glucose to meet immediate energy demands. Increased lipolysis: Fat stores are broken down into free fatty acids and glycerol to provide energy and gluconeogenic substrates.&lt;/li&gt;&lt;li&gt;â€¢ Increased gluconeogenesis: The liver produces glucose from precursors like amino acids and glycerol to sustain blood glucose levels.&lt;/li&gt;&lt;li&gt;â€¢ Increased gluconeogenesis:&lt;/li&gt;&lt;li&gt;â€¢ Increased glycogenolysis: Stored glycogen in the liver is broken down into glucose to meet immediate energy demands.&lt;/li&gt;&lt;li&gt;â€¢ Increased glycogenolysis:&lt;/li&gt;&lt;li&gt;â€¢ Increased lipolysis: Fat stores are broken down into free fatty acids and glycerol to provide energy and gluconeogenic substrates.&lt;/li&gt;&lt;li&gt;â€¢ Increased lipolysis:&lt;/li&gt;&lt;li&gt;â€¢ However, glucose uptake in skeletal muscle and fat is reduced in the fasting state due to low insulin levels, preserving glucose for critical tissues such as the brain and red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ glucose uptake in skeletal muscle and fat is reduced&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased gluconeogenesis: This is a primary mechanism for maintaining blood glucose during fasting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Increased gluconeogenesis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased glycogenolysis: Occurs early in fasting to release glucose from liver glycogen stores.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increased glycogenolysis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased lipolysis: Provides energy and gluconeogenic substrates during prolonged fasting.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Increased lipolysis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the fasting state , the body conserves glucose for essential functions by reducing glucose uptake in skeletal muscle and fat , while promoting gluconeogenesis, glycogenolysis, and lipolysis to maintain blood glucose levels.&lt;/li&gt;&lt;li&gt;âž¤ fasting state&lt;/li&gt;&lt;li&gt;âž¤ glucose uptake in skeletal muscle and fat&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 12-year-old girl, Ananya, with a family history of type 1 diabetes mellitus (T1D), is identified as being at high risk for developing the disease. She has multiple islet cell autoantibodies and impaired glucose tolerance, consistent with stage 2 T1D. Which of the following drugs is approved for delaying the onset of stage 3?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teplizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Golimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Teprotumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Teplizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Teplizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Teplizumab is an Fc receptor-nonbinding anti-CD3 monoclonal antibody that modulates T-cell activity to delay the progression of autoimmune destruction of Î²-cells. A 14-day course of teplizumab has been shown to delay the onset of stage 3 T1D in high-risk individuals (those with multiple autoantibodies and dysglycemia, i.e., stage 2 T1D) by a median of 2.7 years , offering a significant therapeutic advance.&lt;/li&gt;&lt;li&gt;â€¢ Teplizumab&lt;/li&gt;&lt;li&gt;â€¢ anti-CD3 monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ 2.7 years&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rituximab: A monoclonal antibody against CD20 used in autoimmune diseases like rheumatoid arthritis and certain lymphomas, but not approved for delaying T1D.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rituximab:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Golimumab: A TNF-Î± inhibitor used in autoimmune conditions such as rheumatoid arthritis and ulcerative colitis, but not in T1D prevention.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Golimumab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Teprotumumab: An IGF-1R inhibitor used for thyroid eye disease, unrelated to T1D.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Teprotumumab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Teplizumab is the first drug approved to delay the onset of stage 3 type 1 diabetes in individuals at high risk, representing a milestone in preventive treatment for autoimmune diabetes.&lt;/li&gt;&lt;li&gt;âž¤ Teplizumab&lt;/li&gt;&lt;li&gt;âž¤ delay the onset of stage 3 type 1 diabetes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with type 2 diabetes is undergoing routine monitoring of her glycemic control. Due to recent changes in her medication, her physician orders a fructosamine assay instead of an HbA1c test. The fructosamine assay reflects glycemic status for what duration?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 Week&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 Weeks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3 Weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4 Weeks&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 2 Weeks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 2 Weeks&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The fructosamine assay measures glycated proteins, primarily glycated albumin , in the blood. Since the half-life of albumin is approximately 14â€“21 days, the assay reflects the average glycemic status over the prior 2 weeks . This test is particularly useful in situations where short-term glycemic changes need to be assessed, such as after medication adjustments or in conditions affecting red blood cells that impact HbA1c accuracy.&lt;/li&gt;&lt;li&gt;â€¢ fructosamine assay&lt;/li&gt;&lt;li&gt;â€¢ glycated albumin&lt;/li&gt;&lt;li&gt;â€¢ prior 2 weeks&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1 Week: The assay reflects a longer duration due to the albumin half-life.&lt;/li&gt;&lt;li&gt;â€¢ Option A. 1 Week:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 3 Weeks: While close, the test predominantly reflects the prior 2 weeks of glycemia.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 3 Weeks:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 4 Weeks: The test does not capture glycemic control for this long due to albumin turnover.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 4 Weeks:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The fructosamine assay reflects glycemic status over the prior 2 weeks and is particularly useful for short-term monitoring or when HbA1c results may be unreliable.&lt;/li&gt;&lt;li&gt;âž¤ fructosamine assay&lt;/li&gt;&lt;li&gt;âž¤ prior 2 weeks&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man with type 2 diabetes mellitus has uncontrolled sugars. His medical history reveals a family history of medullary thyroid carcinoma and multiple endocrine neoplasia type 2 (MEN 2). Which of the following medications is contraindicated in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Canagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liraglutide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Liraglutide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Liraglutide , a GLP-1 receptor agonist , is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2) . Preclinical studies in rodents demonstrated an increased risk of thyroid C-cell tumors with GLP-1 receptor agonists, prompting the FDA to issue a black box warning for these medications.&lt;/li&gt;&lt;li&gt;â€¢ Liraglutide&lt;/li&gt;&lt;li&gt;â€¢ GLP-1 receptor agonist&lt;/li&gt;&lt;li&gt;â€¢ medullary thyroid carcinoma (MTC)&lt;/li&gt;&lt;li&gt;â€¢ multiple endocrine neoplasia type 2 (MEN 2)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metformin: A first-line medication that lowers glucose through AMP-activated protein kinase activation; it has no association with thyroid tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Metformin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Canagliflozin: An SGLT2 inhibitor, it works by promoting renal glucose excretion and is not linked to thyroid malignancies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Canagliflozin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pioglitazone: A thiazolidinedione that improves insulin sensitivity, unrelated to thyroid cancer risk.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pioglitazone:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ GLP-1 receptor agonists like liraglutide are contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or MEN 2 due to an associated risk of thyroid C-cell tumors.&lt;/li&gt;&lt;li&gt;âž¤ GLP-1 receptor agonists&lt;/li&gt;&lt;li&gt;âž¤ liraglutide&lt;/li&gt;&lt;li&gt;âž¤ medullary thyroid carcinoma (MTC)&lt;/li&gt;&lt;li&gt;âž¤ MEN 2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with type 1 diabetes mellitus presents to the emergency department with nausea, vomiting, and abdominal pain. Lab investigations reveal a glucose level of 400 mg/dL, sodium 125 mmol/L, serum osmolality 300 mOsm/mL, positive urine ketones, and a serum bicarbonate level of 20 mmol/L. Which of the following is unlikely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sodium concentration of 125 mmol/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum osmolality of 300 mOsm/mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urine ketones positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum bicarbonate &amp;gt;18 mmol/L&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum bicarbonate &gt;18 mmol/L&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serum bicarbonate &amp;gt;18 mmol/L&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ In diabetic ketoacidosis (DKA) , serum bicarbonate levels are typically &amp;lt;18 mmol/L , reflecting metabolic acidosis. A bicarbonate level &amp;gt;18 mmol/L would exclude DKA as the diagnosis. This feature helps differentiate DKA from hyperosmolar hyperglycemic state (HHS), where bicarbonate levels are typically normal (&amp;gt;18 mmol/L).&lt;/li&gt;&lt;li&gt;â€¢ diabetic ketoacidosis (DKA)&lt;/li&gt;&lt;li&gt;â€¢ serum bicarbonate levels are typically &amp;lt;18 mmol/L&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sodium concentration of 125 mmol/L: Mild hyponatremia is common in DKA due to hyperglycemia-induced osmotic shifts.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sodium concentration of 125 mmol/L:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serum osmolality of 300 mOsm/mL: This is within the range seen in DKA (300â€“320 mOsm/mL).&lt;/li&gt;&lt;li&gt;â€¢ Option B. Serum osmolality of 300 mOsm/mL:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Urine ketones positive: Positive ketones in urine or serum are a hallmark of DKA, resulting from elevated ketone production due to insulin deficiency.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Urine ketones positive:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Serum bicarbonate &amp;lt;18 mmol/L is a defining feature of DKA , reflecting significant metabolic acidosis. Bicarbonate &amp;gt;18 mmol/L is inconsistent with DKA and may indicate another condition, such as HHS or mild hyperglycemia.&lt;/li&gt;&lt;li&gt;âž¤ Serum bicarbonate &amp;lt;18 mmol/L&lt;/li&gt;&lt;li&gt;âž¤ DKA&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with recurrent kidney stones, fatigue, and abdominal pain. Lab tests reveal hypercalcemia and an elevated parathyroid hormone (PTH) level. Imaging confirms the presence of parathyroid hyperplasia. What is the most common feature of the syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastrinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolactinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal cortical tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Primary hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Primary hyperparathyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation is suggestive of Multiple Endocrine Neoplasia type 1 (MEN1), an autosomal dominant syndrome characterized by the \&quot;3 P&#x27;s\&quot;: parathyroid tumors, pancreatic neuroendocrine tumors, and pituitary tumors. Primary hyperparathyroidism due to parathyroid hyperplasia or adenomas is the most common and earliest manifestation of MEN1.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastrinoma : is a pancreatic neuroendocrine tumor commonly seen in MEN1 but is not the most common feature.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastrinoma&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prolactinoma :  is a pituitary tumor associated with MEN1 but occurs less frequently than primary hyperparathyroidism.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Prolactinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adrenal cortical tumors : can occur in MEN1 but are not a defining or common feature.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adrenal cortical tumors&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Primary hyperparathyroidism is the most common and earliest feature of MEN1, often presenting with hypercalcemia and associated complications such as recurrent kidney stones.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 10-year-old girl presents with tetany, muscle spasms, hyperpigmentation, and shock, following a respiratory infection. There are a couple of members in the family suffering from the same disorder. Which of the following is the first manifestation in this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 1 DM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mucocutaneous candidiasis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal insufficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mucocutaneous candidiasis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mucocutaneous candidiasis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical scenario suggests Autoimmune Polyendocrine Syndrome Type 1 (APS-1), which is characterized by a triad of mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency. Mucocutaneous candidiasis is usually the first manifestation, occurring in childhood due to immune dysfunction targeting fungal pathogens. Hypoparathyroidism and adrenal insufficiency typically develop later.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type 1 DM: is more commonly associated with Autoimmune Polyendocrine Syndrome Type 2 (APS-2) and is not an initial feature of APS-1.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Type 1 DM:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypoparathyroidism: is part of the APS-1 triad but usually develops after mucocutaneous candidiasis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypoparathyroidism:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adrenal insufficiency: occurs later in the disease course of APS-1 and is not typically the first manifestation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Adrenal insufficiency:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Autoimmune Polyendocrine Syndrome Type 1, mucocutaneous candidiasis is the earliest manifestation, followed by hypoparathyroidism and adrenal insufficiency. Early recognition of this progression is crucial for timely diagnosis and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a history of smoking presents with progressive shortness of breath. A pulmonary function test is performed, and the flow-volume loop is analyzed. Which of the following parameters can be directly assessed using the flow-volume loop?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Residual volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Total lung capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Functional residual capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FEV1/FVC&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. FEV1/FVC&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20153700.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) FEV1/FVC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The flow-volume loop provides graphical representation of airflow against lung volume during forced inspiration and expiration. The following parameters can be obtained:&lt;/li&gt;&lt;li&gt;â€¢ flow-volume loop&lt;/li&gt;&lt;li&gt;â€¢ FEV1/FVC: The ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) can be derived, as both parameters are captured during the test. Patterns of obstruction or restriction: The shape of the loop can differentiate between obstructive (e.g., COPD) and restrictive (e.g., pulmonary fibrosis) lung diseases.&lt;/li&gt;&lt;li&gt;â€¢ FEV1/FVC: The ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) can be derived, as both parameters are captured during the test.&lt;/li&gt;&lt;li&gt;â€¢ FEV1/FVC:&lt;/li&gt;&lt;li&gt;â€¢ Patterns of obstruction or restriction: The shape of the loop can differentiate between obstructive (e.g., COPD) and restrictive (e.g., pulmonary fibrosis) lung diseases.&lt;/li&gt;&lt;li&gt;â€¢ Patterns of obstruction or restriction:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Residual volume: Cannot be directly measured from the flow-volume loop. It requires additional tests like body plethysmography or nitrogen washout.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Residual volume:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Total lung capacity: Also requires plethysmography or imaging, as it includes residual volume.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Total lung capacity:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Functional residual capacity: Cannot be measured using the flow-volume loop; it is derived from static lung volume measurements.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Functional residual capacity:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The flow-volume loop is primarily used to assess FEV1/FVC and evaluate patterns of airflow, making it valuable for diagnosing and differentiating obstructive and restrictive lung diseases. Parameters like residual volume and total lung capacity require other testing modalities.&lt;/li&gt;&lt;li&gt;âž¤ flow-volume loop&lt;/li&gt;&lt;li&gt;âž¤ FEV1/FVC&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with a history of smoking and working as a roofer presents with a 5-year history of gradually progressive dyspnea and dry cough. He also reports knee pain and occasional swelling, but no fever or weight loss. Physical examination reveals bilateral end-inspiratory crackles. Pulmonary function testing shows restrictive lung disease with a low DLCO. Chest radiograph suggests bilateral lower zone-predominant lesions. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Emphysema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Asbestosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchogenic Carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Asbestosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20153900.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Asbestosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Asbestosis is a restrictive lung disease caused by chronic inhalation of asbestos fibers. This patient has a significant occupational exposure history (working as a roofer for 40 years), and his clinical presentation includes progressive dyspnea, dry cough, and restrictive spirometry findings (low total lung capacity, FVC, and DLCO). The chest radiograph showing bilateral lower zone-predominant lesions is characteristic of asbestosis, a form of interstitial lung disease caused by asbestos exposure. The presence of crackles on lung auscultation also supports this diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Asbestosis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Emphysema: Emphysema typically presents with an obstructive pattern on spirometry (decreased FEV1/FVC ratio). Although late-stage emphysema can show pseudo-restriction, it does not fit this patientâ€™s restrictive spirometry and occupational exposure history.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Emphysema:&lt;/li&gt;&lt;li&gt;â€¢ obstructive&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumonia: Pneumonia is an acute infection that would likely present with fever, hypoxemia, and more acute symptoms, which this patient does not have.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pneumonia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bronchogenic carcinoma: While bronchogenic carcinoma may cause progressive dyspnea and cough, it typically presents with additional signs like weight loss, clubbing, or hemoptysis. The normal FEV1/FVC ratio and the characteristic restrictive lung pattern on spirometry do not support this diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Bronchogenic carcinoma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Asbestosis is strongly associated with long-term asbestos exposure and presents with a restrictive lung disease pattern, as seen in this patient. The bilateral lower zone-predominant lesions on chest radiograph and the history of occupational exposure are key diagnostic clues.&lt;/li&gt;&lt;li&gt;âž¤ Asbestosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of prostate cancer presents with worsening breathlessness, chest pain, and syncope. On arrival, his heart rate is 125 bpm with a shock index &amp;gt;1. CTPA confirms pulmonary embolism. Cardiac troponin and BNP levels are normal, and an echocardiogram shows reduced right ventricular function. Based on the clinical scenario, which of the following is recommended for in-hospital treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LMWH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bivalirudin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alteplase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. LMWH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) LMWH&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient is diagnosed with intermediate-low risk pulmonary embolism (PE) , likely due to his underlying malignancy (prostate cancer). Low-molecular-weight heparin (LMWH) is the preferred anticoagulant in patients with cancer-associated PE because it is effective, does not require frequent monitoring, and is generally safer in this patient population. It is also the first-line agent for managing PE in intermediate-low risk patients who have no contraindications for anticoagulation.&lt;/li&gt;&lt;li&gt;â€¢ intermediate-low risk pulmonary embolism (PE)&lt;/li&gt;&lt;li&gt;â€¢ Low-molecular-weight heparin (LMWH)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Warfarin: Although warfarin is used for long-term anticoagulation, it requires careful monitoring (INR), has multiple drug interactions, and is not preferred in the acute phase of PE, especially in cancer patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Warfarin:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bivalirudin: A direct thrombin inhibitor used in cases of heparin-induced thrombocytopenia (HIT) . It is not the first choice for managing PE unless there is a contraindication to heparin.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bivalirudin:&lt;/li&gt;&lt;li&gt;â€¢ heparin-induced thrombocytopenia (HIT)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alteplase: Alteplase is a systemic thrombolytic used in high-risk (massive) PE patients with hemodynamic instability, but this patientâ€™s clinical status suggests intermediate-low risk PE, for which thrombolysis is not routinely indicated.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alteplase:&lt;/li&gt;&lt;li&gt;â€¢ Alteplase&lt;/li&gt;&lt;li&gt;â€¢ systemic thrombolytic&lt;/li&gt;&lt;li&gt;â€¢ high-risk (massive) PE&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In intermediate-low risk pulmonary embolism , especially in patients with malignancy, LMWH is the most appropriate in-hospital treatment for managing PE, as it is effective, safe, and does not require stringent monitoring like warfarin. Thrombolytic therapy (alteplase) is typically reserved for high-risk PE patients with hemodynamic instability.&lt;/li&gt;&lt;li&gt;âž¤ intermediate-low risk pulmonary embolism&lt;/li&gt;&lt;li&gt;âž¤ LMWH&lt;/li&gt;&lt;li&gt;âž¤ high-risk PE&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man with a family history of colorectal cancer presents with palpitations and syncope. On arrival, an ECG is performed, and the results are suggestive of right ventricular (RV) strain. Which of the following statements about the ECG findings in pulmonary embolism (PE) is not true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sinus tachycardia is the most common finding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S1Q3T3 is pathognomonic of pulmonary embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T-wave inversion in septal and inferior leads suggests PE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The above ECG shows RV strain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S1Q3T3 is pathognomonic of pulmonary embolism&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-25%20184504.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) S1Q3T3 is pathognomonic of pulmonary embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ S1Q3T3 , which refers to an S wave in lead I , Q wave in lead III , and T wave inversion in lead III , is commonly considered a suggestive sign of pulmonary embolism (PE), but it is not pathognomonic . This pattern can also occur in other conditions that cause acute right ventricular strain , such as acute asthma , COPD exacerbation , or cor pulmonale . Therefore, while it is a classic ECG finding , it is not exclusive to PE.&lt;/li&gt;&lt;li&gt;â€¢ S1Q3T3&lt;/li&gt;&lt;li&gt;â€¢ S wave in lead I&lt;/li&gt;&lt;li&gt;â€¢ Q wave in lead III&lt;/li&gt;&lt;li&gt;â€¢ T wave inversion in lead III&lt;/li&gt;&lt;li&gt;â€¢ suggestive sign&lt;/li&gt;&lt;li&gt;â€¢ pulmonary embolism&lt;/li&gt;&lt;li&gt;â€¢ not pathognomonic&lt;/li&gt;&lt;li&gt;â€¢ acute right ventricular strain&lt;/li&gt;&lt;li&gt;â€¢ acute asthma&lt;/li&gt;&lt;li&gt;â€¢ COPD exacerbation&lt;/li&gt;&lt;li&gt;â€¢ cor pulmonale&lt;/li&gt;&lt;li&gt;â€¢ classic ECG finding&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sinus tachycardia is the most common finding: Sinus tachycardia is indeed the most common and early ECG finding in patients with PE, occurring due to the body&#x27;s response to hypoxia and decreased cardiac output.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Sinus tachycardia is the most common finding:&lt;/li&gt;&lt;li&gt;â€¢ Sinus tachycardia&lt;/li&gt;&lt;li&gt;â€¢ Option C. T-wave inversion in septal and inferior leads suggests PE: T-wave inversion in the septal (V1-V2) and inferior leads (II, III, aVF) can be seen in PE due to right ventricular strain.&lt;/li&gt;&lt;li&gt;â€¢ Option C. T-wave inversion in septal and inferior leads suggests PE:&lt;/li&gt;&lt;li&gt;â€¢ T-wave inversion&lt;/li&gt;&lt;li&gt;â€¢ septal&lt;/li&gt;&lt;li&gt;â€¢ inferior leads&lt;/li&gt;&lt;li&gt;â€¢ Option D. The above ECG shows RV strain: This is a typical finding in PE. Right ventricular strain can be seen on ECG as right axis deviation , T-wave inversion , and ST-segment changes in the right precordial leads (V1-V3), suggesting RV overload.&lt;/li&gt;&lt;li&gt;â€¢ Option D. The above ECG shows RV strain:&lt;/li&gt;&lt;li&gt;â€¢ Right ventricular strain&lt;/li&gt;&lt;li&gt;â€¢ right axis deviation&lt;/li&gt;&lt;li&gt;â€¢ T-wave inversion&lt;/li&gt;&lt;li&gt;â€¢ ST-segment changes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While S1Q3T3 is a classic ECG finding in PE , it is not pathognomonic , as it can also occur in other conditions that cause acute right heart strain. Sinus tachycardia , T-wave inversions , and right ventricular strain are more reliable signs of pulmonary embolism .&lt;/li&gt;&lt;li&gt;âž¤ S1Q3T3&lt;/li&gt;&lt;li&gt;âž¤ ECG finding in PE&lt;/li&gt;&lt;li&gt;âž¤ pathognomonic&lt;/li&gt;&lt;li&gt;âž¤ Sinus tachycardia&lt;/li&gt;&lt;li&gt;âž¤ T-wave inversions&lt;/li&gt;&lt;li&gt;âž¤ right ventricular strain&lt;/li&gt;&lt;li&gt;âž¤ pulmonary embolism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient undergoes right heart catheterization to evaluate for pulmonary hypertension. What is the cutoff for diagnosing pulmonary hypertension based on the mean pulmonary artery pressure (mPAP) measurement?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt;20 mmHg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;gt;25 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt;35 mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt;30 mmHg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &gt;20 mmHg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) &amp;gt;20 mmHg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure (mPAP) greater than 20 mmHg . This is the threshold used to diagnose PH based on right heart catheterization, as per ESC guidelines on pulmonary hypertension (2022). An mPAP above this threshold indicates the presence of pulmonary hypertension, regardless of the underlying cause.&lt;/li&gt;&lt;li&gt;â€¢ Pulmonary hypertension (PH)&lt;/li&gt;&lt;li&gt;â€¢ mean pulmonary artery pressure (mPAP)&lt;/li&gt;&lt;li&gt;â€¢ 20 mmHg&lt;/li&gt;&lt;li&gt;â€¢ ESC guidelines on pulmonary hypertension&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. &amp;gt;25 mmHg: An mPAP of &amp;gt;25 mmHg is used in old definitions of PH but it has been revised in 2018 (WHO).&lt;/li&gt;&lt;li&gt;â€¢ Option B. &amp;gt;25 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;25 mmHg&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;gt;35 mmHg: This is the cut off for diagnosing PH via echocardiogram using RVSP (RV systolic pressure).&lt;/li&gt;&lt;li&gt;â€¢ Option C. &amp;gt;35 mmHg:&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;30 mmHg: Incorrect since the cut off for diagnosing PH is 20mm Hg.&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;30 mmHg:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulmonary hypertension is diagnosed when the mean pulmonary artery pressure (mPAP) exceeds 20 mmHg during right heart catheterization, which is the diagnostic gold standard for assessing pulmonary vascular resistance and pressures.&lt;/li&gt;&lt;li&gt;âž¤ Pulmonary hypertension&lt;/li&gt;&lt;li&gt;âž¤ mean pulmonary artery pressure (mPAP)&lt;/li&gt;&lt;li&gt;âž¤ 20 mmHg&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman with pulmonary hypertension undergoes right heart catheterization and is found to have a positive vasoreactivity test. Which of the following drugs are recommended in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ambrisentan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Epoprostenol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iloprost&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nifedipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nifedipine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Vasoreactivity testing during right heart catheterization involves the administration of inhaled nitric oxide or adenosine to assess the pulmonary artery pressure (PAP) response. A positive vasoreactivity test is defined as a &amp;gt;10 mmHg decrease in mean pulmonary artery pressure (mPAP) leading to a final mPAP &amp;lt;40 mmHg. In patients who show a positive response, the treatment of choice is high-dose long-acting calcium channel blockers (CCBs) , such as nifedipine , diltiazem , or amlodipine . These drugs are indicated for Class II pulmonary hypertension with a positive vasoreactivity test, as they help to improve pulmonary vasodilation and reduce pulmonary pressures.&lt;/li&gt;&lt;li&gt;â€¢ Vasoreactivity testing&lt;/li&gt;&lt;li&gt;â€¢ nitric oxide&lt;/li&gt;&lt;li&gt;â€¢ adenosine&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;10 mmHg decrease&lt;/li&gt;&lt;li&gt;â€¢ high-dose long-acting calcium channel blockers (CCBs)&lt;/li&gt;&lt;li&gt;â€¢ nifedipine&lt;/li&gt;&lt;li&gt;â€¢ diltiazem&lt;/li&gt;&lt;li&gt;â€¢ amlodipine&lt;/li&gt;&lt;li&gt;â€¢ Class II pulmonary hypertension&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ambrisentan: This is an endothelin receptor antagonist (ERA) used for pulmonary arterial hypertension (PAH) , but it is not typically indicated in patients with positive vasoreactivity testing, as these patients may respond well to calcium channel blockers.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ambrisentan:&lt;/li&gt;&lt;li&gt;â€¢ endothelin receptor antagonist (ERA)&lt;/li&gt;&lt;li&gt;â€¢ pulmonary arterial hypertension (PAH)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Epoprostenol: This is a prostacyclin analog used in more advanced or non-vasoreactive cases of pulmonary hypertension, typically when patients do not respond to vasodilators or CCBs.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Epoprostenol:&lt;/li&gt;&lt;li&gt;â€¢ prostacyclin analog&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iloprost: This is another prostacyclin analog used for pulmonary hypertension, typically for more severe forms of PAH, and is not indicated for patients with a positive vasoreactivity test who can benefit from CCBs.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Iloprost:&lt;/li&gt;&lt;li&gt;â€¢ prostacyclin analog&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with Class II pulmonary hypertension who demonstrate a positive vasoreactivity test , high-dose long-acting calcium channel blockers such as nifedipine are recommended, as they can help reduce pulmonary artery pressures and improve symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Class II pulmonary hypertension&lt;/li&gt;&lt;li&gt;âž¤ positive vasoreactivity test&lt;/li&gt;&lt;li&gt;âž¤ high-dose long-acting calcium channel blockers&lt;/li&gt;&lt;li&gt;âž¤ nifedipine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman presents with sudden onset chest pain and syncope. An ECG shows sinus tachycardia, and a CT pulmonary angiogram (CTPA) confirms the diagnosis of pulmonary embolism. A chest radiograph is provided. What is the sign seen on this chest X-ray?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hampton&#x27;s Hump&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Palla sign&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Westermark sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Split pleura sign&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Palla sign&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20154444.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Palla sign&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Palla sign refers to the enlargement of the right descending pulmonary artery , which is sometimes seen in the chest radiograph of patients with pulmonary embolism (PE). This enlargement can mimic a right hilar mass and is often a result of right heart strain or pulmonary artery dilation due to the obstructed pulmonary circulation. Palla sign is an important indicator on chest X-ray when PE is suspected.&lt;/li&gt;&lt;li&gt;â€¢ Palla sign&lt;/li&gt;&lt;li&gt;â€¢ enlargement of the right descending pulmonary artery&lt;/li&gt;&lt;li&gt;â€¢ right heart strain&lt;/li&gt;&lt;li&gt;â€¢ pulmonary artery dilation&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hampton&#x27;s Hump: A wedge-shaped opacity at the lung periphery often seen on X-ray in pulmonary embolism . It represents infarction caused by PE but does not involve the right pulmonary artery.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hampton&#x27;s Hump:&lt;/li&gt;&lt;li&gt;â€¢ wedge-shaped opacity&lt;/li&gt;&lt;li&gt;â€¢ pulmonary embolism&lt;/li&gt;&lt;li&gt;â€¢ Option C. Westermark sign: Refers to a loss of vascular markings or hypoperfusion seen distal to a pulmonary embolism. It suggests a localized area of reduced blood flow but is not directly related to pulmonary artery enlargement.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Westermark sign:&lt;/li&gt;&lt;li&gt;â€¢ loss of vascular markings&lt;/li&gt;&lt;li&gt;â€¢ hypoperfusion&lt;/li&gt;&lt;li&gt;â€¢ Option D. Split pleura sign: Seen in cases of pleural effusion , particularly in conditions like empyema , and is not a sign associated with pulmonary embolism.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Split pleura sign:&lt;/li&gt;&lt;li&gt;â€¢ pleural effusion&lt;/li&gt;&lt;li&gt;â€¢ empyema&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Palla sign , the enlargement of the right descending pulmonary artery , is a key finding in the chest X-ray of patients with pulmonary embolism , indicating right heart strain and pulmonary artery dilation . It can mimic a mass at the right hilum, helping to support the diagnosis of PE.&lt;/li&gt;&lt;li&gt;âž¤ Palla sign&lt;/li&gt;&lt;li&gt;âž¤ enlargement of the right descending pulmonary artery&lt;/li&gt;&lt;li&gt;âž¤ chest X-ray of patients with pulmonary embolism&lt;/li&gt;&lt;li&gt;âž¤ right heart strain&lt;/li&gt;&lt;li&gt;âž¤ pulmonary artery dilation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of COPD is admitted to the hospital with worsening shortness of breath and is placed on high-flow nasal oxygen (HFNO) for acute hypoxemic respiratory failure. His vitals and parameters are as follows: Respiratory rate: 28 breaths/min SpOâ‚‚: 92% FiOâ‚‚: 0.5 What is the calculated ROX index for this patient, and what does it indicate about the likelihood of HFNO success?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;4.6; low likelihood of HFNO success&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;7.2; high likelihood of HFNO success&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3.8; moderate likelihood of HFNO success&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;6.5; high likelihood of HFNO success&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 4.6; low likelihood of HFNO success&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 4.6; low likelihood of HFNO success&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The ROX index is calculated using the formula:&lt;/li&gt;&lt;li&gt;â€¢ ROX index = SpOâ‚‚ / FiOâ‚‚&lt;/li&gt;&lt;li&gt;â€¢ Substituting the given values:&lt;/li&gt;&lt;li&gt;â€¢ ROX index=92/0.528=18428=4.6&lt;/li&gt;&lt;li&gt;â€¢ A ROX index &amp;lt;4.88 at 12 hours of HFNO therapy is associated with a high likelihood of requiring intubation, indicating HFNO is less likely to succeed.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 7.2; high likelihood of HFNO success: This value indicates effective HFNO therapy, which is not consistent with the patient&#x27;s respiratory rate and SpOâ‚‚.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ 7.2; high likelihood of HFNO success:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 3.8; moderate likelihood of HFNO success: A ROX index this low suggests poor HFNO performance but does not match the calculated value.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ 3.8; moderate likelihood of HFNO success:&lt;/li&gt;&lt;li&gt;â€¢ Option D. 6.5; high likelihood of HFNO success: This value is inconsistent with the given parameters and would suggest better oxygenation and ventilatory control than described.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ 6.5; high likelihood of HFNO success:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The ROX index is a critical tool for assessing HFNO effectiveness in patients with hypoxemic respiratory failure. Values &amp;lt;4.88 suggest a need for close monitoring and consideration of intubation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with COPD is admitted with worsening fever, fatigue, and shortness of breath. Chest X-ray reveals left lower lobe consolidation. Despite treatment and resolution of the pneumonia, the patient develops worsening dyspnea and elevated pCO2 on attempts to wean from mechanical ventilation. Which of the following tests would be most appropriate in identifying the cause of weaning failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Muscle Biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ENMG&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoxic response test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;EtCO2 measurements&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. ENMG&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) ENMG&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient is likely experiencing critical illness-related neuromuscular atrophy (CINMA), which is a common cause of weaning failure in critically ill patients, especially those who have been on prolonged mechanical ventilation. ENMG (electroneuromyography) is an important diagnostic tool in this context as it helps identify neuromuscular dysfunction and distinguishes CINMA from other causes of respiratory failure. CINMA results from prolonged immobility, systemic inflammation, and the effects of mechanical ventilation, leading to muscle weakness and impaired respiratory effort.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Muscle Biopsy: Muscle biopsy, though a diagnostic option for certain neuromuscular disorders, is invasive and generally not the first-line test for diagnosing CINMA. Moreover, muscle biopsy results may be non-specific and are not immediately helpful in the acute setting.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Muscle Biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypoxic response test: The hypoxic response test is used to evaluate ventilatory control and is not specific to identifying neuromuscular weakness or CINMA. This test assesses the body&#x27;s response to low oxygen levels, but it is not suitable for identifying weaning failure due to neuromuscular impairment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Hypoxic response test:&lt;/li&gt;&lt;li&gt;â€¢ Option D. EtCO2 measurements: End-tidal CO2 (EtCO2) measurements are useful for monitoring ventilation during mechanical ventilation and assessing gas exchange. However, EtCO2 alone does not provide specific information regarding the cause of weaning failure, especially when the issue is neuromuscular in nature, such as CINMA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. EtCO2 measurements:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with weaning failure after mechanical ventilation, ENMG is a crucial diagnostic tool for identifying critical illness-related neuromuscular atrophy (CINMA), which can impair respiratory muscle function and hinder successful weaning from ventilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old gentleman presents with dry cough and shortness of breath. Spirometry shows an FEV1/FVC ratio of 0.8 with low DLCO. A contrast-enhanced CT (CECT) of the thorax reveals bilateral hilar lymphadenopathy with peribronchial infiltrates in the upper lobes. A small pericardial effusion and mild ascites are noted. Bronchoalveolar lavage (BAL) reveals lymphocytosis with no AFB, CBNAAT, and sterile cultures. Transbronchial needle aspiration from a lymph node shows multiple well-formed non-caseating granulomas. What is the next appropriate investigation for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liver biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transbronchial lung biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;6-minute walking test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Echocardiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Echocardiography&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient&#x27;s presentation with dry cough, shortness of breath, bilateral hilar lymphadenopathy, peribronchial lung infiltrates, and non-caseating granulomas strongly suggests pulmonary sarcoidosis. The presence of pericardial effusion and ascites raises concern for elevated right-sided heart pressures or cardiac involvement, which are common complications of sarcoidosis. The next appropriate step is to perform echocardiography to assess pulmonary pressures, right ventricular function, and potential cardiac involvement, which can be seen in sarcoidosis.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liver biopsy: There is no indication for a liver biopsy in this patient, as there is no clinical or radiologic evidence of liver involvement. The primary focus here is on assessing the cardiac status due to the pericardial effusion and ascites.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liver biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transbronchial lung biopsy: The diagnosis of sarcoidosis has already been established with the transbronchial needle aspiration revealing non-caseating granulomas. A transbronchial lung biopsy is not required in this patient as the diagnosis is confirmed.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Transbronchial lung biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. 6-minute walking test: The 6-minute walking test is used to assess functional capacity in patients with pulmonary diseases but does not provide diagnostic information. It would not help in determining the underlying cause of the pericardial effusion or ascites in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option C. 6-minute walking test:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with confirmed sarcoidosis and signs of possible cardiac involvement (e.g., pericardial effusion, ascites), the next step should be echocardiography to evaluate for cardiac involvement, particularly elevated pulmonary or filling pressures.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male presents with a 6-month history of increasing shortness of breath, persistent dry cough, and fatigue. He has a long history of smoking, smoking a pack per day for 30 years, but he quit 5 years ago. On physical examination, he has mild crackles on auscultation of both lungs, and his oxygen saturation is 91% on room air. High-resolution CT (HRCT) reveals ground-glass opacities with centrilobular nodules prominently in upper lobes. Pulmonary function tests show a mild restrictive pattern with a reduced DLCO. Based on the clinical presentation and imaging findings, which of the following conditions is most likely in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Respiratory bronchiolitis-associated ILD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Desquamative interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Langerhans cell histiocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Usual interstitial pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Respiratory bronchiolitis-associated ILD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Respiratory bronchiolitis-associated ILD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient&#x27;s presentation, including a history of smoking, progressive dyspnea, dry cough, and findings on HRCT such as ground-glass opacities with centrilobular nodules, in upper zones, is most consistent with respiratory bronchiolitis-associated ILD (RB-ILD). RB-ILD is often seen in smokers and manifests with these characteristic imaging features. The condition is associated with mild restrictive lung disease and a reduced DLCO.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Desquamative interstitial pneumonia (DIP): DIP is also a smoking-related ILD, but it typically presents with more diffuse ground-glass opacities in lower zones on imaging and is characterized by the presence of alveolar macrophages. It generally presents with more prominent symptoms and imaging findings than RB-ILD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Desquamative interstitial pneumonia (DIP):&lt;/li&gt;&lt;li&gt;â€¢ ground-glass opacities&lt;/li&gt;&lt;li&gt;â€¢ lower zones&lt;/li&gt;&lt;li&gt;â€¢ Option C. Langerhans cell histiocytosis: Langerhans cell histiocytosis is a smoking-related ILD that typically presents with cystic lesions on imaging, not the centrilobular nodules and ground-glass opacities seen in RB-ILD. It can cause airway inflammation and fibrosis, often seen in smokers.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Langerhans cell histiocytosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Usual interstitial pneumonia (UIP): UIP is commonly associated with idiopathic pulmonary fibrosis (IPF) and is not specifically related to smoking. The HRCT pattern seen in UIP is distinct, with honeycombing and reticulations, which are not seen in this patient&#x27;s imaging.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Usual interstitial pneumonia (UIP):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Respiratory bronchiolitis-associated ILD is a smoking-related interstitial lung disease that presents with ground-glass opacities and centrilobular nodules on imaging. It is important to differentiate it from other smoking-related ILDs, like DIP or Langerhans cell histiocytosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 69-year-old male, with a history of smoking and asbestos exposure between the ages of 30 and 55 years, complains of right-sided chest pain, breathlessness on exertion, and cough. A chest radiograph shows a right pleural effusion associated with nodular pleural thickening. Thoracentesis reveals a bloody-colored pleural effusion. Which of the following statements is false for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thoracoscopy is the preferred diagnostic procedure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thoracentesis may cause spread of the tumor into the chest wall&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tobacco use has played a significant role in the development of mesothelioma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Calretinin and Wilms tumor antigen-1 are two immunohistochemical markers with diagnostic value for mesothelioma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tobacco use has played a significant role in the development of mesothelioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tobacco use has played a significant role in the development of mesothelioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Mesothelioma is primarily associated with asbestos exposure, not tobacco use. This malignancy typically develops 20-25 years after asbestos exposure, which aligns with the patientâ€™s history. Tobacco use is not carcinogenic to the pleura, and therefore does not significantly contribute to the development of mesothelioma.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thoracoscopy is the preferred diagnostic procedure: This is correct. Thoracoscopy is preferred for the diagnosis of mesothelioma, as it allows direct visualization of the pleura and provides tissue for histopathological examination. It is especially helpful for obtaining a definitive diagnosis when cytology from thoracentesis is suspicious but not conclusive.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thoracoscopy is the preferred diagnostic procedure:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thoracentesis may cause spread of the tumor into the chest wall: This is true. Although rare, thoracentesis can result in the spread of malignant cells from the pleura into the chest wall, particularly in cases of pleural malignancy such as mesothelioma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thoracentesis may cause spread of the tumor into the chest wall:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Calretinin and Wilms tumor antigen-1 are two immunohistochemical markers with diagnostic value for mesothelioma: This is correct. Calretinin and Wilms tumor antigen-1 (WT-1) are commonly used immunohistochemical markers that help in the diagnosis of mesothelioma. They help distinguish mesothelioma from other tumors, such as lung adenocarcinoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Calretinin and Wilms tumor antigen-1 are two immunohistochemical markers with diagnostic value for mesothelioma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mesothelioma is strongly linked to asbestos exposure and typically develops many years after exposure. Tobacco use does not contribute significantly to the development of mesothelioma, which distinguishes it from other lung cancers like small-cell or squamous cell carcinoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not used in the management of asthma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Roflumilast&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Benralizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dupilumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Roflumilast&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Roflumilast&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Roflumilast is not used in asthma management. It is primarily indicated for the treatment of chronic obstructive pulmonary disease (COPD), particularly in stage E (severe) COPD where patients have poor response to maximum bronchodilator and steroid therapy. It is a phosphodiesterase-4 (PDE-4) inhibitor that helps reduce inflammation and exacerbations in COPD, but it does not have a role in asthma treatment.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Salbutamol: Salbutamol is a short-acting beta-agonist (SABA) commonly used as a rescue inhaler in asthma for quick relief of bronchospasm. It is part of the standard management for asthma, especially during exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Salbutamol:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Benralizumab: Benralizumab is a monoclonal antibody used in the treatment of severe eosinophilic asthma. It is an IL-5 receptor antagonist that reduces eosinophil levels, helping in the management of asthma that is not controlled by standard therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Benralizumab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dupilumab: Dupilumab is another monoclonal antibody used in the treatment of severe asthma, specifically in patients with eosinophilic asthma or those with a history of allergic asthma. It is an IL-4 receptor antagonist that helps reduce inflammation by blocking both IL-4 and IL-13 signaling.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Dupilumab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Roflumilast is used in COPD management, not asthma. In contrast, biologicals like benralizumab and dupilumab are used for severe eosinophilic asthma, while salbutamol is a standard rescue medication for asthma exacerbations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 69-year-old man with chronic obstructive pulmonary disease (COPD) has been admitted to the hospital three times over the last year for COPD exacerbations. His current SpO2 is 91% on room air. Pulmonary function tests (PFT) show an FEV1 of 45% predicted. Which of the following treatments is most likely to decrease the frequency of his exacerbations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Daily azithromycin 500 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continuous oxygen at 2 L/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nocturnal BiPAP machine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Daily azithromycin 500 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Daily azithromycin 500 mg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Long-term use of azithromycin (500 mg daily) has been shown to reduce the frequency of COPD exacerbations, particularly in patients with frequent exacerbations. Azithromycin has anti-inflammatory properties and inhibits quorum sensing, which can reduce bacterial load and inflammation in the airways, leading to fewer exacerbations. This treatment is especially useful in patients with moderate to severe COPD and frequent exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Continuous oxygen at 2 L/min: While continuous oxygen therapy is essential for COPD patients with chronic hypoxemia, it does not reduce the frequency of exacerbations. Oxygen therapy is primarily used to improve oxygenation and reduce the risk of complications in patients with chronic respiratory failure. The target saturation is typically 88-92% during exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Continuous oxygen at 2 L/min:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nocturnal BiPAP machine: Nocturnal BiPAP (Bilevel Positive Airway Pressure) is indicated for patients with worsening chronic type 2 respiratory failure and respiratory acidosis, usually in severe COPD cases with nocturnal hypoventilation. It is not typically used to reduce the frequency of exacerbations but rather to support ventilation in patients with respiratory acidosis or sleep-disordered breathing.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Nocturnal BiPAP machine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Corticosteroids: While systemic steroids are often used during acute exacerbations of COPD to reduce inflammation and improve recovery, they are not used for long-term prevention of exacerbations. Long-term steroid use has potential side effects and is generally not recommended for reducing exacerbation frequency in COPD patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Corticosteroids:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Long-term treatment with azithromycin can reduce the frequency of COPD exacerbations due to its anti-inflammatory effects and inhibition of bacterial growth. Oxygen therapy and BiPAP are important for managing respiratory failure but do not reduce the frequency of exacerbations, while IV steroids are used for acute exacerbations but not for prevention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old male with a history of episodic wheezing, chest tightness, and persistent symptoms despite high-dose inhaled corticosteroids (ICS), long-acting muscarinic antagonists (LAMA), long-acting beta agonists (LABA), oral steroids, and montelukast, presents with worsening dyspnea on exertion (DOE) and wheeze. Common secondary causes, including CXR, skin precipitins, and food triggers, have been ruled out. Phenotyping shows elevated IgE and FeNO levels (50 ppb). Which of the following is true about his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Good response to anti-IgE therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Poor response to Biologicals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bronchial thermoplasty is an effective option&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Biologicals after treatment optimization&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Good response to anti-IgE therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Good response to anti-IgE therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient likely has severe asthma, given his persistent symptoms despite step 5 GINA treatment (which includes high-dose ICS, LAMA, LABA, and oral steroids). Severe asthma in this case is characterized by type 2 inflammation, as indicated by elevated FeNO and IgE levels. Anti-IgE therapy, such as omalizumab, targets IgE, which plays a key role in allergic inflammation, and is highly effective in patients with elevated IgE levels, providing a good treatment option for this patient.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Poor response to Biologicals: This patient is more likely to respond well to biologicals because of his elevated IgE and FeNO levels, which indicate a type 2 inflammation-driven asthma. Biologicals, especially anti-IgE (like omalizumab), are highly effective in treating this type of asthma, contrary to the suggestion of poor response.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Poor response to Biologicals:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bronchial thermoplasty is an effective option: Bronchial thermoplasty is a treatment option for severe asthma, but it is generally considered when asthma is not well controlled despite optimal pharmacological therapy, and there is no significant type 2 inflammation (e.g., elevated IgE or FeNO). This patient shows evidence of type 2 inflammation, so biological therapy targeting the inflammatory pathway is preferred over bronchial thermoplasty.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bronchial thermoplasty is an effective option:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Biologicals after treatment optimization: While optimizing treatment is important in severe asthma, this patientâ€™s phenotype suggests a strong potential benefit from immediate biological therapy due to the elevated IgE and FeNO levels. Delaying biological therapy after further optimization is not recommended when clear indications are present.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Biologicals after treatment optimization:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with severe asthma and evidence of type 2 inflammation (elevated IgE and FeNO), anti-IgE therapy (such as omalizumab) is a highly effective treatment option and should be considered early in management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient underwent an aortic aneurysm repair and developed a rise in creatinine in the 2 nd post-op week, along with a lacy rash on both lower limbs. The most likely pathology is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contrast-associated acute kidney injury (AKI)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atheroembolic renal disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal vein thrombosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombotic microangiopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Atheroembolic renal disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Atheroembolic renal disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Atheroembolic renal disease occurs when cholesterol crystals from atherosclerotic plaques are embolized into small renal arteries, causing ischemia and acute kidney injury (AKI). This condition can develop after procedures such as aortic aneurysm repair, particularly if there is manipulation of the aorta or large arteries. The gradual rise in creatinine over weeks (typically after D4-7) and the presence of a lacy rash (= livedo reticularis, suggesting cutaneous embolization) are characteristic of atheroembolic disease. This condition is typically associated with a slower progression of renal dysfunction compared to other causes of AKI.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contrast-associated AKI: While contrast-induced nephropathy can cause acute renal injury after the administration of contrast, it typically presents more rapidly, usually within 24-48 hours, following the procedure. It is less likely in this patient given the two-week delay in the rise of creatinine and the associated rash, which points more toward atheroembolic disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Contrast-associated AKI:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal vein thrombosis: Renal vein thrombosis can lead to acute kidney injury, but it typically presents with flank pain, hematuria, and other signs of venous congestion rather than a gradual rise in creatinine. Additionally, the presence of a lacy rash and the timing of this condition following aortic aneurysm repair make renal vein thrombosis less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal vein thrombosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic microangiopathy: Thrombotic microangiopathy (TMA) includes conditions like hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP), which are associated with microvascular thrombi, hemolysis, and thrombocytopenia. TMA often presents with more acute manifestations, including hemolytic anemia, thrombocytopenia, and organ failure, which are not described in this case. The subacute nature of the renal dysfunction and the rash makes TMA less likely.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic microangiopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atheroembolic renal disease is a common cause of subacute renal dysfunction after procedures like aortic aneurysm repair. The condition is characterized by cholesterol embolization into small renal arteries, leading to progressive renal impairment and systemic signs such as a lacy rash due to cutaneous embolization.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with end-stage kidney disease (ESKD) has been undergoing hemodialysis for the past 2 years. What is the major cause of death in patients with end-stage kidney disease like this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebrovascular disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Infectious disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiovascular disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cardiovascular disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cardiovascular disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Cardiovascular disease is the leading cause of death in patients with end-stage kidney disease (ESKD), particularly in those on dialysis. Patients with ESKD have an increased risk of cardiovascular events due to a combination of factors, including hypertension, diabetes, dyslipidemia, and the pro-inflammatory environment created by kidney dysfunction. Cardiovascular mortality and event rates are significantly higher in patients receiving dialysis compared to those who have undergone kidney transplantation, although they remain high in both populations.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cerebrovascular disease: Cerebrovascular disease, while a common cause of morbidity in ESKD, is not the leading cause of death in these patients. Cardiovascular events such as myocardial infarction and heart failure are more commonly fatal.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cerebrovascular disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignancy: Malignancy is an important cause of morbidity and mortality in patients with ESKD, especially in those with prolonged dialysis treatment. However, cardiovascular disease still remains the leading cause of death in these patients.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Malignancy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infectious disease: Infections, particularly related to dialysis access sites and peritoneal dialysis, are common in patients with ESKD. However, infectious diseases are less frequently the primary cause of death compared to cardiovascular events.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Infectious disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiovascular disease is the major cause of death in patients with end-stage kidney disease, highlighting the need for careful management of cardiovascular risk factors in this population.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male undergoing continuous ambulatory peritoneal dialysis (CAPD) for the past 4 months presents with abdominal pain and cloudy effluent for the past 1 day. The CAPD fluid analysis shows a total WBC count of 175 cells/mmÂ³ with 80% neutrophils. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fibrin clot&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Encapsulating peritoneal sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CAPD peritonitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tunnel infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CAPD peritonitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CAPD Peritonitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patientâ€™s presentation of abdominal pain, cloudy effluent, and an elevated WBC count in the peritoneal fluid with a predominance of neutrophils is consistent with CAPD peritonitis. Peritonitis is one of the most common complications of peritoneal dialysis, typically caused by a break in sterile technique during exchanges. Peritonitis is defined by a peritoneal fluid WBC count greater than 100 cells/mmÂ³, with at least 50% being polymorphonuclear neutrophils. The diagnosis is confirmed by these findings, and it requires prompt treatment with intraperitoneal antibiotics.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fibrin clot: A fibrin clot in the peritoneal fluid is typically seen in the context of a sterile reaction to dialysis fluid or after an episode of peritoneal dialysis. It does not cause the significant elevation in neutrophils seen in peritonitis. This is not consistent with the patientâ€™s symptoms or lab findings.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fibrin clot:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Encapsulating Peritoneal Sclerosis (EPS): Encapsulating peritoneal sclerosis is a rare but serious complication of long-term peritoneal dialysis, characterized by the progressive fibrosis of the peritoneum, leading to bowel obstruction and fluid retention. However, it does not present with acute pain, cloudy effluent, or an elevated WBC count. EPS typically develops over months or years and would not present acutely with peritonitis symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Encapsulating Peritoneal Sclerosis (EPS):&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tunnel infection: Tunnel infections are localized infections involving the peritoneal dialysis catheter. While they can present with redness and pain along the catheter tract, they do not typically cause abdominal pain and cloudy effluent. The WBC count in the effluent would not be elevated to the same degree as seen in peritonitis, and the neutrophil count would not be as high.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tunnel infection:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CAPD peritonitis is a common complication in peritoneal dialysis, characterized by abdominal pain, cloudy effluent, and an elevated peritoneal fluid WBC count with predominance of neutrophils. Prompt treatment with antibiotics is required to manage this infection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male with a history of diabetes mellitus presents for routine follow-up. His estimated glomerular filtration rate (eGFR) is calculated at 37 mL/min according to the CKD-EPI formula. Based on this information, which category of chronic kidney disease (CKD) does he fall into?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage 3A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage 3B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage 4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage 5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Stage 3B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Stage 3B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patientâ€™s eGFR of 37 mL/min places him in Stage 3B of chronic kidney disease (CKD). Stage 3 is divided into 2 subcategories:&lt;/li&gt;&lt;li&gt;â€¢ Stage 3A : eGFR between 45-59 mL/min Stage 3B : eGFR between 30-44 mL/min&lt;/li&gt;&lt;li&gt;â€¢ Stage 3A : eGFR between 45-59 mL/min&lt;/li&gt;&lt;li&gt;â€¢ Stage 3A&lt;/li&gt;&lt;li&gt;â€¢ Stage 3B : eGFR between 30-44 mL/min&lt;/li&gt;&lt;li&gt;â€¢ Stage 3B&lt;/li&gt;&lt;li&gt;â€¢ Since his eGFR is 37 mL/min, it fits into Stage 3B. At this stage, the patient has a higher risk of progression to end-stage renal disease (ESRD), and close monitoring is required, including management of underlying conditions such as diabetes, hypertension, and proteinuria.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stage 3A: Stage 3A is characterized by an eGFR between 45-59 mL/min. Since the patientâ€™s eGFR is 37 mL/min, he does not fit into this category.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Stage 3A:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stage 4: Stage 4 CKD is defined by an eGFR between 15-29 mL/min. Since the patientâ€™s eGFR is 37 mL/min, he does not meet the criteria for Stage 4.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stage 4:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stage 5: Stage 5 CKD, also known as end-stage renal disease (ESRD), occurs when the eGFR is less than 15 mL/min. This patientâ€™s eGFR is 37 mL/min, so he does not qualify for Stage 5.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stage 5:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Stage 3B CKD is characterized by an eGFR between 30-44 mL/min, and it carries a higher risk of progression to end-stage renal disease. Close monitoring and management of risk factors are critical at this stage to prevent further deterioration of kidney function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female with a history of rheumatoid arthritis (RA) presents to the clinic with weakness. Which region of the spine is most commonly affected in rheumatoid arthritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cervical spine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thoracic spine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lumbar spine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sacrum&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cervical spine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cervical spine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The cervical spine is the most commonly affected region in rheumatoid arthritis (RA). Specifically, atlantoaxial involvement, which is the instability of the first cervical vertebra (C1) on the second (C2), is a hallmark of cervical spine involvement in RA. This instability can lead to compressive myelopathy and neurologic dysfunction if it progresses. Although neurological symptoms may not be present at first, they can develop with increasing instability. Unlike the spondyloarthropathies, RA rarely affects the thoracic or lumbar spine significantly.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thoracic spine: While the thoracic spine can be affected in rheumatoid arthritis, it is less commonly involved than the cervical spine. RA typically affects the smaller joints in the neck and upper cervical spine more than the thoracic region.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Thoracic spine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lumbar spine: The lumbar spine is rarely involved in rheumatoid arthritis. The lower spine is typically spared in RA, with the main involvement occurring in the peripheral joints and cervical spine.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Lumbar spine:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sacrum: The sacrum is also rarely involved in rheumatoid arthritis. While sacroiliac joint involvement may be seen in spondyloarthropathies, it is not a typical feature of RA.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sacrum:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The cervical spine, especially the atlantoaxial joint, is the most common region affected by rheumatoid arthritis. It can lead to significant complications such as compressive myelopathy due to instability between C1 and C2.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female with a long history of rheumatoid arthritis (RA) presents with unexplained neutropenia and splenomegaly. Further investigation reveals clonal expansion of T-cell large granular lymphocytes. Which of the following statements is not true regarding the condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Develop late in the course of the disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It has a chronic, indolent course&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It leads to neutropenia and splenomegaly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Develop early in the course of the disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Develop late in the course of the disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Develop late in the course of the disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ T-cell large granular lymphocyte leukemia (T-LGL) can occur early in the course of rheumatoid arthritis (RA), unlike other conditions like Feltyâ€™s syndrome, which typically develops later in the course of severe RA. T-LGL is characterized by chronic, indolent clonal growth of large granular lymphocytes (LGLs), leading to neutropenia and splenomegaly. This condition often occurs earlier in the disease course compared to Felty&#x27;s syndrome, which is the main reason option A is incorrect.&lt;/li&gt;&lt;li&gt;â€¢ early&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It has a chronic, indolent course: This is true. T-LGL has a chronic and indolent course, meaning it typically progresses slowly and is not immediately life-threatening. However, its long-term effects, including neutropenia and splenomegaly, require careful monitoring.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It has a chronic, indolent course:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It leads to neutropenia and splenomegaly: This is also correct. T-LGL is associated with neutropenia, which is a reduction in neutrophils, and splenomegaly, which is an enlargement of the spleen. These symptoms are due to the clonal expansion of large granular lymphocytes and can be seen in the patientâ€™s laboratory findings.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It leads to neutropenia and splenomegaly:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Develop early in the course of the disease: This is correct. Unlike Feltyâ€™s syndrome, which often develops later in severe RA, T-LGL can develop early in the course of the disease. This is important to distinguish when evaluating a patient with RA and unexplained hematologic findings.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Develop early in the course of the disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ T-cell large granular lymphocyte leukemia (T-LGL) in rheumatoid arthritis may develop early in the disease and is characterized by a chronic, indolent course, with neutropenia and splenomegaly being common features. It differs from Feltyâ€™s syndrome, which typically appears later in the course of RA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male with sickle cell anemia presents to the clinic for evaluation of new therapy options. The patient has frequent episodes of pain, fatigue, and hemolysis. The physician recommends Voxelotor. What of the following regarding the drug is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreases the affinity of the hemoglobin molecule for O2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreases the P50&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduces polymerization of HbS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Induces high levels of HbF&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Induces high levels of HbF&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Induces high levels of HbF&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Induces high levels of HbF : Incorrect. Voxelotor does not induce fetal hemoglobin ( HbF ). This is the mechanism of hydroxyurea , which increases HbF to reduce sickling.&lt;/li&gt;&lt;li&gt;â€¢ Induces high levels of HbF&lt;/li&gt;&lt;li&gt;â€¢ Voxelotor&lt;/li&gt;&lt;li&gt;â€¢ not&lt;/li&gt;&lt;li&gt;â€¢ HbF&lt;/li&gt;&lt;li&gt;â€¢ hydroxyurea&lt;/li&gt;&lt;li&gt;â€¢ Voxelotor is an oral therapy for sickle cell disease (SCD) that improves hemoglobin levels by preventing sickling of red blood cells.&lt;/li&gt;&lt;li&gt;â€¢ Voxelotor&lt;/li&gt;&lt;li&gt;â€¢ sickle cell disease (SCD)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreases the affinity of the hemoglobin molecule for Oâ‚‚ : Correct. Voxelotor increases hemoglobinâ€™s oxygen affinity, stabilizing the oxygenated form and reducing sickling.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Decreases the affinity of the hemoglobin molecule for Oâ‚‚&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreases the P50 : Correct. By increasing hemoglobin&#x27;s oxygen affinity, Voxelotor lowers the P50 (the partial pressure of oxygen at which hemoglobin is 50% saturated), making it hold onto oxygen more tightly.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Decreases the P50&lt;/li&gt;&lt;li&gt;â€¢ P50&lt;/li&gt;&lt;li&gt;â€¢ Option C. Reduces polymerization of HbS : Correct. The key therapeutic effect of Voxelotor is inhibiting HbS polymerization , which prevents sickling and hemolysis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Reduces polymerization of HbS&lt;/li&gt;&lt;li&gt;â€¢ HbS polymerization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Voxelotor works by increasing hemoglobinâ€™s oxygen affinity, thereby reducing HbS polymerization and improving hemoglobin levels. It does not induce HbF â€” a mechanism specific to hydroxyurea in sickle cell disease management.&lt;/li&gt;&lt;li&gt;âž¤ Voxelotor&lt;/li&gt;&lt;li&gt;âž¤ reducing HbS polymerization&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ HbF&lt;/li&gt;&lt;li&gt;âž¤ hydroxyurea&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old female with a recent history of starting hydralazine for hypertension presents with new-onset fatigue, joint pain, and a butterfly-shaped rash across her cheeks. Laboratory tests reveal a positive antinuclear antibody (ANA) test with a speckled pattern. What is the most likely to be positive this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-histone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti ds-DNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti Sm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti Ro&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anti-histone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Anti-histone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ This patient most likely has drug-induced lupus (DIL), which is commonly associated with the presence of anti-histone antibodies . Drug-induced lupus is characterized by a clinical presentation similar to systemic lupus erythematosus (SLE), but it occurs after exposure to certain drugs like hydralazine, procainamide, and isoniazid. The hallmark of drug-induced lupus is the presence of anti-histone antibodies , which are typically not seen in classic SLE.&lt;/li&gt;&lt;li&gt;â€¢ drug-induced lupus&lt;/li&gt;&lt;li&gt;â€¢ anti-histone antibodies&lt;/li&gt;&lt;li&gt;â€¢ anti-histone antibodies&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti ds-DNA: Anti-dsDNA antibodies are highly specific for systemic lupus erythematosus (SLE) and are seen in about 50% of SLE cases, particularly in patients with kidney involvement. These antibodies are not characteristic of drug-induced lupus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti ds-DNA:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti Sm: Anti-Sm antibodies are specific for SLE and are found in about 30% of patients with the disease. They are not typically associated with drug-induced lupus.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti Sm:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti Ro: Anti-Ro antibodies are associated with autoimmune diseases such as SjÃ¶grenâ€™s syndrome, subacute cutaneous lupus erythematosus (SCLE), and neonatal lupus, but not with drug-induced lupus.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Anti Ro:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-histone antibodies are commonly positive in drug-induced lupus, especially when the patient has a history of taking medications like hydralazine. These antibodies help distinguish drug-induced lupus from other autoimmune diseases, such as SLE, which is more commonly associated with anti-dsDNA and anti-Sm antibodies.&lt;/li&gt;&lt;li&gt;âž¤ Anti-histone antibodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman with systemic lupus erythematosus (SLE) is pregnant and has a history of a previous miscarriage. Her obstetrician orders tests to screen for neonatal lupus in the fetus. Which of the following antibodies is most commonly associated with it?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti RNA polymerase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti Kinetochore&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti Scl-70&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti Ro&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anti Ro&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anti Ro&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Anti-Ro (also known as SS-A ) antibodies are most commonly associated with neonatal lupus . Neonatal lupus can result in a variety of manifestations in the newborn, including congenital heart block and a characteristic rash. The presence of anti-Ro antibodies in the mother can pass to the fetus and cause these complications. This is one of the key antibodies to be monitored during pregnancy in women with systemic lupus erythematosus (SLE) or SjÃ¶grenâ€™s syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Anti-Ro&lt;/li&gt;&lt;li&gt;â€¢ SS-A&lt;/li&gt;&lt;li&gt;â€¢ neonatal lupus&lt;/li&gt;&lt;li&gt;â€¢ anti-Ro antibodies&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti RNA polymerase I: Anti-RNA polymerase I antibodies are associated with nucleolar ANA patterns and are seen in systemic sclerosis, particularly in patients with limited scleroderma (PSS). These antibodies are not typically linked to neonatal lupus.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti RNA polymerase I:&lt;/li&gt;&lt;li&gt;â€¢ nucleolar ANA patterns&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti Kinetochore: Anti-Kinetochore antibodies are associated with a centromere ANA pattern and are seen in CREST syndrome (limited scleroderma). They are not related to neonatal lupus.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti Kinetochore:&lt;/li&gt;&lt;li&gt;â€¢ centromere ANA pattern&lt;/li&gt;&lt;li&gt;â€¢ CREST syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti Scl-70: Anti-Scl-70 antibodies are associated with diffuse systemic sclerosis and are typically linked to fibrosis of the skin and internal organs, such as the lungs. These antibodies are not associated with neonatal lupus.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti Scl-70:&lt;/li&gt;&lt;li&gt;â€¢ diffuse systemic sclerosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-Ro (SS-A) antibodies are associated with neonatal lupus and can lead to severe complications in the fetus, such as congenital heart block and skin rashes. Monitoring these antibodies is important in pregnant women with autoimmune diseases like lupus or SjÃ¶gren&#x27;s syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Anti-Ro (SS-A)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male with a history of chronic low back pain and morning stiffness is diagnosed with ankylosing spondylitis. Which of the following is the most common extraarticular manifestation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inflammatory bowel disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anterior uveitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anterior uveitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anterior uveitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The most common extraarticular manifestation of ankylosing spondylitis is acute anterior uveitis , which affects up to 50% of patients with this condition. Anterior uveitis typically presents with symptoms such as eye pain, photophobia, and redness. The attacks are often unilateral and may recur, sometimes involving the opposite eye. If left untreated, it can lead to cataracts or secondary glaucoma.&lt;/li&gt;&lt;li&gt;â€¢ acute anterior uveitis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heart block: While heart block can occur in ankylosing spondylitis, it is a much less common extraarticular manifestation. Heart block is usually seen in advanced disease, particularly in those with aortic root involvement, but it is not as frequent as anterior uveitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Heart block:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inflammatory bowel disease: Inflammatory bowel disease (IBD) is an extraarticular manifestation of ankylosing spondylitis, but it is less common than anterior uveitis. When it does occur, it is typically seen in the form of Crohn&#x27;s disease or ulcerative colitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Inflammatory bowel disease:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation: Aortic regurgitation can occur in ankylosing spondylitis due to aortitis, but it is a rare manifestation. It is more commonly associated with long-standing disease and can contribute to heart failure if severe.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Aortic regurgitation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anterior uveitis is the most common extraarticular manifestation of ankylosing spondylitis, occurring in up to 50% of patients. It is important for clinicians to monitor for uveitis in these patients, as untreated cases can lead to complications like cataracts and glaucoma.&lt;/li&gt;&lt;li&gt;âž¤ Anterior uveitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old male presents with pain, swelling, and redness in his knee and ankle joints, which developed after an episode of gastroenteritis. Laboratory tests reveal the presence of reactive arthritis. He tests negative for HLA-B27. Which of the following infections is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Shigella&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Yersinia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Campylobacter&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Salmonella&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Campylobacter&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Campylobacter&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ While Shigella , Yersinia , and Salmonella infections are more commonly associated with HLA-B27 positivity in reactive arthritis, Campylobacter-induced reactive arthritis shows little or no association with HLA-B27. Campylobacter is one of the common bacterial triggers of reactive arthritis, but it does not exhibit the same strong HLA-B27 association seen with other pathogens like Shigella and Yersinia.&lt;/li&gt;&lt;li&gt;â€¢ Shigella&lt;/li&gt;&lt;li&gt;â€¢ Yersinia&lt;/li&gt;&lt;li&gt;â€¢ Salmonella&lt;/li&gt;&lt;li&gt;â€¢ Campylobacter-induced reactive arthritis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Shigella: Shigella is one of the pathogens most commonly associated with reactive arthritis, and about 60-85% of patients who develop ReA triggered by Shigella are HLA-B27 positive. This makes Shigella a strong candidate for HLA-B27-associated reactive arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Shigella:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Yersinia: Yersinia, particularly Yersinia enterocolitica , is also frequently associated with reactive arthritis, and like Shigella, a significant proportion of patients with Yersinia-triggered ReA are HLA-B27 positive.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Yersinia:&lt;/li&gt;&lt;li&gt;â€¢ Yersinia enterocolitica&lt;/li&gt;&lt;li&gt;â€¢ Option D. Salmonella: Salmonella infection, particularly Salmonella enteritidis , is another common trigger for reactive arthritis. Although the prevalence of HLA-B27 in Salmonella-associated ReA is lower compared to Shigella or Yersinia, Salmonella still has some association with HLA-B27 in ReA cases.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Salmonella:&lt;/li&gt;&lt;li&gt;â€¢ Salmonella enteritidis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While Shigella , Yersinia , and Salmonella infections have a significant association with HLA-B27 in reactive arthritis, Campylobacter infection shows little or no such association.&lt;/li&gt;&lt;li&gt;âž¤ Shigella&lt;/li&gt;&lt;li&gt;âž¤ Yersinia&lt;/li&gt;&lt;li&gt;âž¤ Salmonella&lt;/li&gt;&lt;li&gt;âž¤ Campylobacter&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with psoriatic arthritis and moderate skin involvement is being considered for oral therapy. He has mild joint involvement and no significant radiographic joint damage or axial involvement. Which of the following oral medications is approved for treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tofacitinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leflunomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Apremilast&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Secukinumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Apremilast&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Apremilast&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Apremilast is an oral phosphodiesterase-4 (PDE-4) inhibitor approved for the treatment of psoriatic arthritis and psoriasis . Apremilast works by inhibiting the enzyme PDE-4, which plays a role in the inflammatory response. It is an effective treatment option for PsA, particularly in patients without significant radiographic joint damage or axial involvement. While it may not be as potent as biologics for PsA, it is favored for its more favorable safety profile.&lt;/li&gt;&lt;li&gt;â€¢ Apremilast&lt;/li&gt;&lt;li&gt;â€¢ psoriatic arthritis&lt;/li&gt;&lt;li&gt;â€¢ psoriasis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tofacitinib: Tofacitinib is an oral Janus kinase (JAK) inhibitor that is approved for the treatment of rheumatoid arthritis , psoriatic arthritis , and ulcerative colitis . It is effective for PsA but works through a different mechanism than apremilast (JAK inhibition vs PDE-4 inhibition).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tofacitinib:&lt;/li&gt;&lt;li&gt;â€¢ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ psoriatic arthritis&lt;/li&gt;&lt;li&gt;â€¢ ulcerative colitis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leflunomide: Leflunomide is an immunosuppressive drug that inhibits pyrimidine synthesis and is used for the treatment of rheumatoid arthritis and psoriatic arthritis . However, it is not a phosphodiesterase-4 inhibitor and is not the correct answer for this specific question.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Leflunomide:&lt;/li&gt;&lt;li&gt;â€¢ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ psoriatic arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Secukinumab: Secukinumab is a biologic agent that targets interleukin-17A (IL-17A) and is used in the treatment of psoriatic arthritis , psoriasis , and ankylosing spondylitis . It is not an oral medication, making it an incorrect answer for this question, which specifically asks about an oral phosphodiesterase-4 inhibitor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Secukinumab:&lt;/li&gt;&lt;li&gt;â€¢ interleukin-17A (IL-17A)&lt;/li&gt;&lt;li&gt;â€¢ psoriatic arthritis&lt;/li&gt;&lt;li&gt;â€¢ psoriasis&lt;/li&gt;&lt;li&gt;â€¢ ankylosing spondylitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Apremilast is the only oral phosphodiesterase-4 inhibitor approved for the treatment of psoriatic arthritis and psoriasis , offering a more favorable safety profile than biologics.&lt;/li&gt;&lt;li&gt;âž¤ Apremilast&lt;/li&gt;&lt;li&gt;âž¤ psoriatic arthritis&lt;/li&gt;&lt;li&gt;âž¤ psoriasis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old female with systemic lupus erythematosus (SLE) presents to the clinic with symptoms of depression and psychosis. On examination, she has no other major systemic involvement. Which of the following is most likely to correlate with her neuropsychiatric symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-dsDNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antiribosomal P&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-Sm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antihistone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Antiribosomal P&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Antiribosomal P&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Anti-ribosomal P antibodies are associated with neuropsychiatric lupus , including depression and psychosis. These antibodies specifically target the ribosomal protein, and their presence in serum has been shown to correlate with neuropsychiatric manifestations of lupus. In some cases, the positive test for anti-ribosomal P can help explain mood disorders or psychosis in patients with lupus.&lt;/li&gt;&lt;li&gt;â€¢ Anti-ribosomal P&lt;/li&gt;&lt;li&gt;â€¢ neuropsychiatric lupus&lt;/li&gt;&lt;li&gt;â€¢ anti-ribosomal P&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-dsDNA: Anti-dsDNA antibodies are strongly associated with systemic lupus erythematosus (SLE) and can correlate with disease activity, especially lupus nephritis. However, anti-dsDNA antibodies are not typically associated with neuropsychiatric symptoms such as depression or psychosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-dsDNA: Anti-dsDNA&lt;/li&gt;&lt;li&gt;â€¢ systemic lupus erythematosus&lt;/li&gt;&lt;li&gt;â€¢ anti-dsDNA&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Sm: Anti-Sm antibodies are specific for SLE but are not specifically linked to neuropsychiatric lupus. They are often present in SLE patients, especially in those of African or Asian descent, but they do not correlate with the neuropsychiatric manifestations of the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-Sm: Anti-Sm&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antihistone: Antihistone antibodies are most often seen in drug-induced lupus rather than in SLE . They are not typically associated with neuropsychiatric symptoms but are more commonly linked to skin rashes, arthralgia, and fever.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Antihistone: Antihistone&lt;/li&gt;&lt;li&gt;â€¢ drug-induced lupus&lt;/li&gt;&lt;li&gt;â€¢ SLE&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-ribosomal P antibodies are associated with neuropsychiatric manifestations, such as depression and psychosis, in systemic lupus erythematosus . Testing for these antibodies can help identify the cause of mood and psychiatric disorders in patients with lupus.&lt;/li&gt;&lt;li&gt;âž¤ Anti-ribosomal P&lt;/li&gt;&lt;li&gt;âž¤ systemic lupus erythematosus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with systemic lupus erythematosus (SLE) is pregnant and has a history of a previous miscarriage with congenital heart block in the fetus. Laboratory tests reveal that she is positive for anti-Ro antibodies. What is the most effective treatment to reduce the chance of heart block in a subsequent fetus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hydroxychloroquine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Voclosporin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hydroxychloroquine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hydroxychloroquine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Hydroxychloroquine has been shown to significantly reduce the risk of congenital heart block in fetuses of mothers with anti-Ro antibodies, particularly in those with a history of a previous infant affected by congenital heart block. Hydroxychloroquine treatment during pregnancy in these cases helps prevent the development of heart block, which can be a life-threatening condition. This therapy is recommended for mothers with anti-Ro antibodies to reduce fetal complications.&lt;/li&gt;&lt;li&gt;â€¢ Hydroxychloroquine&lt;/li&gt;&lt;li&gt;â€¢ congenital heart block&lt;/li&gt;&lt;li&gt;â€¢ anti-Ro&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Azathioprine: Azathioprine is an immunosuppressive medication that is used in the treatment of SLE but has not been shown to specifically reduce the risk of congenital heart block in the fetus. It also has potential teratogenic effects and is generally avoided during pregnancy unless absolutely necessary.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Azathioprine:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cyclophosphamide: Cyclophosphamide is another immunosuppressive drug used in severe SLE, but it is generally avoided in pregnancy due to its teratogenic effects and potential harm to the fetus. It is not effective in reducing the risk of congenital heart block in fetuses with anti-Ro antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cyclophosphamide:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Voclosporin: Voclosporin is an immunosuppressive agent used in lupus nephritis but does not have any evidence supporting its use in preventing congenital heart block in fetuses. Its use in pregnancy is not well-established, and it is not recommended for this indication.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Voclosporin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hydroxychloroquine is the most effective treatment to reduce the risk of congenital heart block in fetuses of mothers with anti-Ro antibodies, especially in those with a history of a previous infant affected by heart block. It is safe during pregnancy and plays a critical role in preventing fetal complications.&lt;/li&gt;&lt;li&gt;âž¤ Hydroxychloroquine&lt;/li&gt;&lt;li&gt;âž¤ anti-Ro&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female presents with Raynaudâ€™s phenomenon and positive anti-centromere antibodies. She has no evidence of skin thickening or fibrosis. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;SSc sine scleroderma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Limited cutaneous SSc&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse cutaneous SSc&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. SSc sine scleroderma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) SSc sine scleroderma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ SSc sine scleroderma is a subset of systemic sclerosis (SSc) in which patients present with Raynaud&#x27;s phenomenon and the characteristic clinical and laboratory features of SSc (such as positive anti-centromere antibodies ) but without detectable skin thickening . This form is considered relatively benign compared to other forms of SSc, where skin thickening is a hallmark feature. The term \&quot;sine scleroderma\&quot; refers to the absence of skin involvement despite systemic features.&lt;/li&gt;&lt;li&gt;â€¢ SSc sine scleroderma&lt;/li&gt;&lt;li&gt;â€¢ systemic sclerosis (SSc)&lt;/li&gt;&lt;li&gt;â€¢ Raynaud&#x27;s phenomenon&lt;/li&gt;&lt;li&gt;â€¢ clinical and laboratory features&lt;/li&gt;&lt;li&gt;â€¢ positive anti-centromere antibodies&lt;/li&gt;&lt;li&gt;â€¢ without detectable skin thickening&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Limited cutaneous SSc: Limited cutaneous systemic sclerosis involves skin thickening that is typically confined to the distal extremities and face. This type of SSc also may involve Raynaudâ€™s phenomenon and autoantibodies such as anti-centromere antibodies , but it is characterized by skin thickening , which is absent in SSc sine scleroderma .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Limited cutaneous SSc:&lt;/li&gt;&lt;li&gt;â€¢ anti-centromere antibodies&lt;/li&gt;&lt;li&gt;â€¢ skin thickening&lt;/li&gt;&lt;li&gt;â€¢ SSc sine scleroderma&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diffuse cutaneous SSc: Diffuse cutaneous systemic sclerosis involves widespread skin thickening and fibrosis, often accompanied by severe organ involvement (e.g., lungs, kidneys). This form of SSc is distinct from SSc sine scleroderma , where no skin thickening is observed.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diffuse cutaneous SSc:&lt;/li&gt;&lt;li&gt;â€¢ SSc sine scleroderma&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above: This option is incorrect because SSc sine scleroderma correctly describes the clinical presentation in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. None of the above:&lt;/li&gt;&lt;li&gt;â€¢ SSc sine scleroderma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SSc sine scleroderma is a form of systemic sclerosis where patients exhibit Raynaud&#x27;s phenomenon and characteristic clinical and laboratory features of scleroderma, but without detectable skin thickening . It is a relatively mild subset of SSc.&lt;/li&gt;&lt;li&gt;âž¤ SSc sine scleroderma&lt;/li&gt;&lt;li&gt;âž¤ Raynaud&#x27;s phenomenon&lt;/li&gt;&lt;li&gt;âž¤ without detectable skin thickening&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old male with asthma and eosinophilia presents with worsening symptoms of sinusitis, peripheral neuropathy, and skin rashes. Peripheral smear reveals eosinophilia. Which of the following is not useful for treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mepolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Benralizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Omalizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Omalizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Omalizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical features suggest eosinophilic granulomatosis with polyangiitis (EGPA), a condition involving eosinophilic-driven inflammation, asthma, and systemic vasculitis. EGPA treatment involves targeting eosinophils or inflammatory mediators like IL-5. Mepolizumab and Benralizumab are effective as they target IL-5 or its receptor, reducing eosinophil counts and disease activity. Omalizumab , an anti-IgE monoclonal antibody, is not effective in treating eosinophilic inflammation in EGPA, as it primarily targets allergic asthma, which does not address the underlying pathology of EGPA.&lt;/li&gt;&lt;li&gt;â€¢ Mepolizumab&lt;/li&gt;&lt;li&gt;â€¢ Benralizumab&lt;/li&gt;&lt;li&gt;â€¢ Omalizumab&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mepolizumab: Approved for EGPA treatment as it directly targets IL-5, reducing eosinophilic inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Mepolizumab:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Benralizumab: Depletes eosinophils by targeting the IL-5 receptor and is effective in managing EGPA symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ Benralizumab:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Rituximab: Although not first-line, it is useful in ANCA-positive EGPA or refractory cases by depleting B cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Rituximab:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ EGPA is primarily managed by targeting eosinophilic inflammation with agents like Mepolizumab and Benralizumab . Omalizumab is not effective, as it does not address the eosinophilic-driven mechanisms of the disease.&lt;/li&gt;&lt;li&gt;âž¤ Mepolizumab&lt;/li&gt;&lt;li&gt;âž¤ Benralizumab&lt;/li&gt;&lt;li&gt;âž¤ Omalizumab&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male presents to the clinic with palpable purpura on his lower extremities. He has no other features. The skin biopsy confirms small-vessel vasculitis. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BehÃ§etâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgA vasculitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic Cutaneous Vasculitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eosinophilic Granulomatosis with Polyangiitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Idiopathic Cutaneous Vasculitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Idiopathic Cutaneous Vasculitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The presentation of isolated palpable purpura on the lower extremities, without systemic involvement, is most consistent with idiopathic cutaneous vasculitis , also known as cutaneous leukocytoclastic vasculitis. It is a small-vessel vasculitis primarily limited to the skin and can occur in response to infections, medications, or as an idiopathic process.&lt;/li&gt;&lt;li&gt;â€¢ idiopathic cutaneous vasculitis&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. BehÃ§etâ€™s disease : BehÃ§etâ€™s involves recurrent oral and genital ulcers, uveitis, and other systemic manifestations, which are absent here.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ BehÃ§etâ€™s disease&lt;/li&gt;&lt;li&gt;â€¢ Option B. IgA vasculitis : While IgA vasculitis (Henoch-SchÃ¶nlein purpura) can present with palpable purpura, it is more common in children and usually involves systemic features such as abdominal pain, arthritis, and renal involvement.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ IgA vasculitis&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eosinophilic granulomatosis with polyangiitis (EGPA) : EGPA is associated with asthma, eosinophilia, and systemic vasculitis, which are not present in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Eosinophilic granulomatosis with polyangiitis (EGPA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Idiopathic cutaneous vasculitis is characterized by isolated palpable purpura limited to the skin, without systemic involvement. It is often self-limited and distinct from systemic vasculitides, which typically present with additional organ-specific symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Idiopathic cutaneous vasculitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female is diagnosed with sarcoidosis after presenting with cough, dyspnea, and fatigue. A chest X-ray reveals is taken and shown. Based on the X-ray findings, what is the most likely stage of her disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage 1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage 4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stage 1&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20140835.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Stage 1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Stage 1 sarcoidosis is characterized by hilar adenopathy alone on chest X-ray, often with involvement of the right paratracheal region . In this case, the X-ray findings of bilateral hilar lymphadenopathy without infiltrates or fibrosis correspond to Stage 1 of the disease, which is typically asymptomatic or mildly symptomatic.&lt;/li&gt;&lt;li&gt;â€¢ Stage 1&lt;/li&gt;&lt;li&gt;â€¢ hilar adenopathy alone&lt;/li&gt;&lt;li&gt;â€¢ right paratracheal region&lt;/li&gt;&lt;li&gt;â€¢ bilateral hilar lymphadenopathy&lt;/li&gt;&lt;li&gt;â€¢ Stage 1&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stage 2: Stage 2 sarcoidosis is characterized by both adenopathy (hilar and/or mediastinal) and pulmonary infiltrates . If the patient had infiltrates in addition to hilar lymphadenopathy, it would indicate Stage 2 rather than Stage 1 .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stage 2: Stage 2&lt;/li&gt;&lt;li&gt;â€¢ adenopathy&lt;/li&gt;&lt;li&gt;â€¢ pulmonary infiltrates&lt;/li&gt;&lt;li&gt;â€¢ Stage 2&lt;/li&gt;&lt;li&gt;â€¢ Stage 1&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stage 3: Stage 3 sarcoidosis is characterized by pulmonary infiltrates alone, without significant hilar adenopathy. This stage typically presents with more extensive lung involvement and can be associated with symptoms like cough and dyspnea.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Stage 3: Stage 3&lt;/li&gt;&lt;li&gt;â€¢ pulmonary infiltrates&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stage 4: Stage 4 represents the end-stage of sarcoidosis, where fibrosis has developed, leading to lung scarring and irreversible damage. This stage is associated with severe respiratory symptoms, including restrictive lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Stage 4: Stage 4&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Stage 1 sarcoidosis is marked by hilar lymphadenopathy without lung infiltrates or fibrosis. The disease typically progresses to Stage 2 and beyond if more severe pulmonary involvement develops.&lt;/li&gt;&lt;li&gt;âž¤ Stage 1&lt;/li&gt;&lt;li&gt;âž¤ hilar lymphadenopathy&lt;/li&gt;&lt;li&gt;âž¤ Stage 2&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female presents with muscle weakness and the lesions shown in the picture. What is the most likely antibody associated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-MDA5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-TIF1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-NXP2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-Mi-2&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anti-Mi-2&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20154953.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anti-Mi-2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The lesions shown are Gottron&#x27;s papules and the patient is likely to be suffering from dermatomyositis. Anti-Mi-2 antibodies are associated with a benign course of dermatomyositis (DM) . Patients with anti-Mi-2 antibodies typically have a more favorable response to treatment, and the disease is less likely to be associated with severe complications like interstitial lung disease (ILD) or cancer , which are seen with other antibodies. These patients generally have classic DM features, including heliotrope rash , Gottron&#x27;s papules , and proximal muscle weakness .&lt;/li&gt;&lt;li&gt;â€¢ The lesions shown are Gottron&#x27;s papules and the patient is likely to be suffering from dermatomyositis. Anti-Mi-2 antibodies&lt;/li&gt;&lt;li&gt;â€¢ benign&lt;/li&gt;&lt;li&gt;â€¢ dermatomyositis (DM)&lt;/li&gt;&lt;li&gt;â€¢ interstitial lung disease (ILD)&lt;/li&gt;&lt;li&gt;â€¢ cancer&lt;/li&gt;&lt;li&gt;â€¢ heliotrope rash&lt;/li&gt;&lt;li&gt;â€¢ Gottron&#x27;s papules&lt;/li&gt;&lt;li&gt;â€¢ proximal muscle weakness&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-MDA5: Anti-MDA5 antibodies are associated with a more severe form of dermatomyositis, often characterized by amyopathic DM , severe palmar rash , digital ulcers , and rapidly progressive interstitial lung disease (ILD) . This form of DM carries a poor prognosis , especially due to the development of ILD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anti-MDA5: Anti-MDA5 antibodies&lt;/li&gt;&lt;li&gt;â€¢ more severe&lt;/li&gt;&lt;li&gt;â€¢ amyopathic DM&lt;/li&gt;&lt;li&gt;â€¢ severe palmar rash&lt;/li&gt;&lt;li&gt;â€¢ digital ulcers&lt;/li&gt;&lt;li&gt;â€¢ rapidly progressive interstitial lung disease (ILD)&lt;/li&gt;&lt;li&gt;â€¢ poor prognosis&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-TIF1 (p155): Anti-TIF1 (also known as anti-p155 ) antibodies are associated with increased risk of cancer in patients with dermatomyositis. These patients may also present with muscle weakness and characteristic skin findings, but the presence of anti-TIF1 antibodies is often a marker of malignancy, which can lead to a more complicated disease course.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anti-TIF1 (p155): Anti-TIF1&lt;/li&gt;&lt;li&gt;â€¢ anti-p155&lt;/li&gt;&lt;li&gt;â€¢ increased risk of cancer&lt;/li&gt;&lt;li&gt;â€¢ muscle weakness&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-NXP2: Anti-NXP2 antibodies are also associated with an increased risk of malignancy in dermatomyositis, similar to anti-TIF1. These patients tend to have muscle weakness and skin findings but also face a higher risk of cancer , making their prognosis less favorable than patients with anti-Mi-2 antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Anti-NXP2: Anti-NXP2 antibodies&lt;/li&gt;&lt;li&gt;â€¢ increased risk of malignancy&lt;/li&gt;&lt;li&gt;â€¢ muscle weakness&lt;/li&gt;&lt;li&gt;â€¢ skin findings&lt;/li&gt;&lt;li&gt;â€¢ cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-Mi-2 antibodies are associated with a benign course of dermatomyositis , with a favorable response to treatment and no significant risk of cancer or severe ILD . This distinguishes them from other antibodies like anti-MDA5 , anti-TIF1 , and anti-NXP2 , which are associated with a more severe disease course .&lt;/li&gt;&lt;li&gt;âž¤ Anti-Mi-2 antibodies&lt;/li&gt;&lt;li&gt;âž¤ benign course&lt;/li&gt;&lt;li&gt;âž¤ dermatomyositis&lt;/li&gt;&lt;li&gt;âž¤ a favorable response to treatment&lt;/li&gt;&lt;li&gt;âž¤ no significant risk of cancer or severe ILD&lt;/li&gt;&lt;li&gt;âž¤ anti-MDA5&lt;/li&gt;&lt;li&gt;âž¤ anti-TIF1&lt;/li&gt;&lt;li&gt;âž¤ anti-NXP2&lt;/li&gt;&lt;li&gt;âž¤ severe disease course&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male presents with severe bleeding and anemia. Peripheral smear is shown below. PT, aPTT and D-dimer are elevated. Which of the following cytogenetic rearrangements is most commonly associated with this disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(9;22)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(8;14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(8;16)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. t(15;17)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-19%20141350.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) t(15;17)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The clinical presentation, along with coagulopathy (elevated PT, aPTT, and D-dimer) and peripheral smear with promyelocytes (with Auer rods = faggot cells) is suggestive of acute promyelocytic leukemia (APL) . APL is characterized by the presence of promyelocytes with Auer rods on peripheral smear and is associated with disseminated intravascular coagulation (DIC), causing severe bleeding. The hallmark cytogenetic abnormality in APL is t(15;17) , which leads to the PML-RARA fusion gene. This translocation disrupts normal retinoic acid receptor (RARA) signaling and differentiation of promyelocytes.&lt;/li&gt;&lt;li&gt;â€¢ acute promyelocytic leukemia (APL)&lt;/li&gt;&lt;li&gt;â€¢ t(15;17)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(9;22): This translocation is associated with chronic myeloid leukemia (CML) and results in the BCR-ABL fusion gene. It is not linked to APL.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ t(9;22):&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(8;14): This is characteristic of Burkitt lymphoma, involving the MYC gene, and is not associated with APL.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ t(8;14):&lt;/li&gt;&lt;li&gt;â€¢ Option D. t(8;16): This translocation is associated with acute monocytic leukemia with t(8;16)(p11;p13) but is unrelated to APL.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ t(8;16):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute promyelocytic leukemia (APL) is strongly associated with the t(15;17) translocation, which leads to the PML-RARA fusion gene. It is commonly complicated by coagulopathy (DIC), and early recognition is critical for initiating appropriate treatment with all-trans retinoic acid (ATRA).&lt;/li&gt;&lt;li&gt;âž¤ Acute promyelocytic leukemia (APL)&lt;/li&gt;&lt;li&gt;âž¤ t(15;17)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old female with mild anemia is suspected of having thalassemia trait based on her clinical presentation. What is the most likely diagnosis based on the hemoglobin fractions and their percentages?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HbA: 60-90 HbF: 10-40 HbA2: 4-6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HbA: 94 HbF: 1-2 HbA2: 4-6&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HbA: 0-5 HbF: 90-100 HbA2: 2-5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HbE: 50-70 HbF: 30-50&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. HbA: 94 HbF: 1-2 HbA2: 4-6&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) HbA: 94 HbF: 1-2 HbA2: 4-6&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The hemoglobin fractions in thalassemia trait are typically characterized by:&lt;/li&gt;&lt;li&gt;â€¢ thalassemia trait&lt;/li&gt;&lt;li&gt;â€¢ HbA : 94% HbF : 1-2% HbA2 : 4-6%&lt;/li&gt;&lt;li&gt;â€¢ HbA : 94%&lt;/li&gt;&lt;li&gt;â€¢ HbA&lt;/li&gt;&lt;li&gt;â€¢ HbF : 1-2%&lt;/li&gt;&lt;li&gt;â€¢ HbF&lt;/li&gt;&lt;li&gt;â€¢ HbA2 : 4-6%&lt;/li&gt;&lt;li&gt;â€¢ HbA2&lt;/li&gt;&lt;li&gt;â€¢ This is a classic pattern seen in thalassemia minor (or thalassemia trait) , where the patient has normal HbA levels (the main adult hemoglobin), a slightly elevated HbA2 , and a very small percentage of HbF (fetal hemoglobin). The patient may have mild anemia, but usually, there are no significant clinical symptoms.&lt;/li&gt;&lt;li&gt;â€¢ thalassemia minor (or thalassemia trait)&lt;/li&gt;&lt;li&gt;â€¢ normal HbA&lt;/li&gt;&lt;li&gt;â€¢ HbA2&lt;/li&gt;&lt;li&gt;â€¢ HbF&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. HbA: 60-90 HbF: 10-40 HbA2: 4-6: This pattern is more typical of thalassemia intermedia (non-transfusion-dependent thalassemia). Patients with thalassemia intermedia may have moderate anemia and varying degrees of symptoms. The HbF percentage is much higher compared to thalassemia trait.&lt;/li&gt;&lt;li&gt;â€¢ Option A. HbA: 60-90 HbF: 10-40 HbA2: 4-6:&lt;/li&gt;&lt;li&gt;â€¢ thalassemia intermedia&lt;/li&gt;&lt;li&gt;â€¢ HbF&lt;/li&gt;&lt;li&gt;â€¢ Option C. HbA: 0-5 HbF: 90-100 HbA2: 2-5: This hemoglobin profile is consistent with thalassemia major (transfusion-dependent thalassemia), which is a more severe form of thalassemia. In this condition, the patient has very little HbA and a very high percentage of HbF . These patients often require regular blood transfusions.&lt;/li&gt;&lt;li&gt;â€¢ Option C. HbA: 0-5 HbF: 90-100 HbA2: 2-5:&lt;/li&gt;&lt;li&gt;â€¢ thalassemia major&lt;/li&gt;&lt;li&gt;â€¢ very little HbA&lt;/li&gt;&lt;li&gt;â€¢ very high percentage of HbF&lt;/li&gt;&lt;li&gt;â€¢ Option D. HbE: 50-70 HbF: 30-50: This pattern is characteristic of HbE-beta thalassemia , where the patient has a mixture of HbE (hemoglobin E) and HbF (fetal hemoglobin). This condition is seen in patients with hemoglobin E mutation and beta-thalassemia , common in Southeast Asia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. HbE: 50-70 HbF: 30-50:&lt;/li&gt;&lt;li&gt;â€¢ HbE-beta thalassemia&lt;/li&gt;&lt;li&gt;â€¢ HbE&lt;/li&gt;&lt;li&gt;â€¢ HbF&lt;/li&gt;&lt;li&gt;â€¢ hemoglobin E&lt;/li&gt;&lt;li&gt;â€¢ beta-thalassemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In thalassemia trait , the most common hemoglobin fractions are HbA: 94% , HbF: 1-2% , and HbA2: 4-6% , with mild anemia but no significant clinical symptoms.&lt;/li&gt;&lt;li&gt;âž¤ thalassemia trait&lt;/li&gt;&lt;li&gt;âž¤ HbA: 94%&lt;/li&gt;&lt;li&gt;âž¤ HbF: 1-2%&lt;/li&gt;&lt;li&gt;âž¤ HbA2: 4-6%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female presents with fatigue, pallor, and glossitis. She has a history of autoimmune gastritis. Laboratory tests reveal elevated methylmalonic acid. Which of the following is not typically associated with the disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastric output of pepsin, and IF is severely reduced&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastric output of hydrochloric acid is severely reduced&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The serum gastrin level is raised&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum pepsinogen I levels are high&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum pepsinogen I levels are high&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serum pepsinogen I levels are high&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The patient is likely to be suffering from pernicious anemia. It is caused by autoimmune gastritis leading to parietal cell destruction , the following is typically observed:&lt;/li&gt;&lt;li&gt;â€¢ autoimmune gastritis&lt;/li&gt;&lt;li&gt;â€¢ parietal cell destruction&lt;/li&gt;&lt;li&gt;â€¢ Severe reduction in gastric output of hydrochloric acid (achlorhydria). Reduction in gastric output of pepsin and intrinsic factor (IF) , both produced by the parietal cells. This leads to B12 deficiency and hence the elevated methylmalonic acid in this patient. Elevated serum gastrin levels due to feedback stimulation from the lack of gastric acid. Low serum pepsinogen I levels due to diminished secretion from the chief cells in the stomach.&lt;/li&gt;&lt;li&gt;â€¢ Severe reduction in gastric output of hydrochloric acid (achlorhydria).&lt;/li&gt;&lt;li&gt;â€¢ Severe reduction&lt;/li&gt;&lt;li&gt;â€¢ hydrochloric acid&lt;/li&gt;&lt;li&gt;â€¢ Reduction in gastric output of pepsin and intrinsic factor (IF) , both produced by the parietal cells. This leads to B12 deficiency and hence the elevated methylmalonic acid in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Reduction&lt;/li&gt;&lt;li&gt;â€¢ pepsin&lt;/li&gt;&lt;li&gt;â€¢ intrinsic factor (IF)&lt;/li&gt;&lt;li&gt;â€¢ Elevated serum gastrin levels due to feedback stimulation from the lack of gastric acid.&lt;/li&gt;&lt;li&gt;â€¢ Elevated serum gastrin&lt;/li&gt;&lt;li&gt;â€¢ feedback stimulation&lt;/li&gt;&lt;li&gt;â€¢ Low serum pepsinogen I levels due to diminished secretion from the chief cells in the stomach.&lt;/li&gt;&lt;li&gt;â€¢ Low serum pepsinogen I levels&lt;/li&gt;&lt;li&gt;â€¢ chief cells&lt;/li&gt;&lt;li&gt;â€¢ Therefore, serum pepsinogen I levels are low , not high, in pernicious anemia, making Option D the correct answer.&lt;/li&gt;&lt;li&gt;â€¢ serum pepsinogen I levels are low&lt;/li&gt;&lt;li&gt;â€¢ Option D&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastric output of pepsin, and IF is severely reduced: This is true in pernicious anemia, as the loss of parietal cells leads to a reduction in both pepsinogen and intrinsic factor (IF) production.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Gastric output of pepsin, and IF is severely reduced:&lt;/li&gt;&lt;li&gt;â€¢ parietal cells&lt;/li&gt;&lt;li&gt;â€¢ pepsinogen&lt;/li&gt;&lt;li&gt;â€¢ intrinsic factor (IF)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gastric output of hydrochloric acid is severely reduced: This is a hallmark of pernicious anemia , caused by damage to the parietal cells that normally produce hydrochloric acid .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Gastric output of hydrochloric acid is severely reduced:&lt;/li&gt;&lt;li&gt;â€¢ pernicious anemia&lt;/li&gt;&lt;li&gt;â€¢ parietal cells&lt;/li&gt;&lt;li&gt;â€¢ hydrochloric acid&lt;/li&gt;&lt;li&gt;â€¢ Option C. The serum gastrin level is raised: In pernicious anemia, the absence of gastric acid (due to parietal cell destruction) leads to increased secretion of gastrin , which is a compensatory response to the lack of acid production.&lt;/li&gt;&lt;li&gt;â€¢ Option C. The serum gastrin level is raised:&lt;/li&gt;&lt;li&gt;â€¢ absence of gastric acid&lt;/li&gt;&lt;li&gt;â€¢ increased secretion of gastrin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In pernicious anemia , serum pepsinogen I levels are low , not high, due to reduced secretion from the chief cells in the stomach, as part of the overall dysfunction of gastric secretions associated with autoimmune gastritis .&lt;/li&gt;&lt;li&gt;âž¤ pernicious anemia&lt;/li&gt;&lt;li&gt;âž¤ serum pepsinogen I levels are low&lt;/li&gt;&lt;li&gt;âž¤ chief cells&lt;/li&gt;&lt;li&gt;âž¤ autoimmune gastritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents with mild anemia. He otherwise has no symptoms, and laboratory tests reveal low serum B12 levels. Which of the following conditions is associated with low serum B12 levels that do not indicate a true B12 deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Liver disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral contraceptives&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myeloproliferative diseases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Oral contraceptives&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Oral contraceptives&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Low serum B12 levels do not always indicate true B12 deficiency. Folate deficiency, TC I (HC) deficiency, oral contraceptives, and multiple myeloma have all been associated with low serum B12 levels that do not indicate B12 deficiency. On the other hand, high serum B12 levels are usually due to raised serum TC I levels and can be due to the presence of liver, renal, or myeloproliferative diseases or to cancer of the breast, colon, or liver.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Liver disease : Liver disease is associated with elevated serum B12 levels due to increased serum transcobalamin I levels.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Liver disease&lt;/li&gt;&lt;li&gt;â€¢ elevated&lt;/li&gt;&lt;li&gt;â€¢ Option C. Renal disease : Renal disease may also lead to elevated serum B12 due to impaired clearance of transcobalamin-bound B12.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Renal disease&lt;/li&gt;&lt;li&gt;â€¢ elevated&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myeloproliferative diseases : Myeloproliferative disorders such as chronic myeloid leukemia often show high serum B12 levels due to increased production of transcobalamin I.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Myeloproliferative diseases&lt;/li&gt;&lt;li&gt;â€¢ high&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Low serum B12 levels can occur in conditions that do not reflect true B12 deficiency, such as oral contraceptive use. Conversely, elevated B12 levels are often due to increased transcobalamin I production in conditions like liver disease, renal disease, and myeloproliferative disorders.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old male with suspected dengue fever presents to the emergency department with thrombocytopenia. An intern collects a blood sample using an EDTA tube for a platelet count. The result shows 20,000 platelets/cumm and the peripheral blood smear is shown to have platelet clumping. What is the next best step in managing this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Send a sample again in EDTA tube&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Confirm thrombocytopenia and start treatment accordingly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Send a sample again in sodium citrate tube&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Send a sample again in clot accelerator (red) tube&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Send a sample again in sodium citrate tube&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Send a sample again in sodium citrate tube&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The presence of platelet clumping on the peripheral smear in a patient with thrombocytopenia suggests the possibility of pseudothrombocytopenia . This is an artifact that can occur when platelets agglutinate in EDTA (the anticoagulant used in the EDTA tube), which reduces calcium levels and leads to platelet aggregation . To confirm the platelet count and rule out pseudothrombocytopenia , a new sample should be collected in a sodium citrate tube (blue top), which is not as likely to cause platelet clumping.&lt;/li&gt;&lt;li&gt;â€¢ platelet clumping&lt;/li&gt;&lt;li&gt;â€¢ thrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ pseudothrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ platelets agglutinate in EDTA&lt;/li&gt;&lt;li&gt;â€¢ platelet aggregation&lt;/li&gt;&lt;li&gt;â€¢ pseudothrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ new sample&lt;/li&gt;&lt;li&gt;â€¢ sodium citrate tube&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Send a sample again in EDTA tube: Sending another sample in the EDTA tube would likely yield the same result due to the potential for pseudothrombocytopenia caused by platelet clumping. This is not the appropriate next step.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Send a sample again in EDTA tube:&lt;/li&gt;&lt;li&gt;â€¢ EDTA tube&lt;/li&gt;&lt;li&gt;â€¢ pseudothrombocytopenia&lt;/li&gt;&lt;li&gt;â€¢ Option B. Confirm thrombocytopenia and start treatment accordingly: While thrombocytopenia is common in dengue fever , in this case, the result could be a false low due to platelet clumping in the EDTA tube. Treatment for dengue thrombocytopenia should only be initiated after confirming that the low platelet count is accurate.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Confirm thrombocytopenia and start treatment accordingly:&lt;/li&gt;&lt;li&gt;â€¢ dengue fever&lt;/li&gt;&lt;li&gt;â€¢ false low&lt;/li&gt;&lt;li&gt;â€¢ platelet clumping&lt;/li&gt;&lt;li&gt;â€¢ dengue&lt;/li&gt;&lt;li&gt;â€¢ Option  D. Send a sample again in clot accelerator (red) tube: A clot accelerator (red) tube is used to collect serum for tests like serum chemistries or serological assays . It is not suitable for platelet counts, as it does not contain anticoagulant, and a clotted sample would not provide an accurate platelet count.&lt;/li&gt;&lt;li&gt;â€¢ Option  D. Send a sample again in clot accelerator (red) tube:&lt;/li&gt;&lt;li&gt;â€¢ clot accelerator (red) tube&lt;/li&gt;&lt;li&gt;â€¢ serum chemistries&lt;/li&gt;&lt;li&gt;â€¢ serological assays&lt;/li&gt;&lt;li&gt;â€¢ clotted sample&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ If pseudothrombocytopenia is suspected due to platelet clumping in an EDTA sample, the next best step is to send a new sample in a sodium citrate tube (blue top) or use a fresh unanticoagulated blood smear to confirm the true platelet count.&lt;/li&gt;&lt;li&gt;âž¤ pseudothrombocytopenia&lt;/li&gt;&lt;li&gt;âž¤ sodium citrate tube&lt;/li&gt;&lt;li&gt;âž¤ fresh unanticoagulated blood smear&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female is diagnosed with immune thrombocytopenic purpura (ITP) and is being evaluated for treatment options. Which of the following is not typically used in the treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prednisone at 1 mg/kg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;4-day course of dexamethasone, 40 mg/d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rh0 (D) immune globulin in Rh-negative patients&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IVIgG at 1â€“2 g/kg total, given over 1â€“5 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rh0 (D) immune globulin in Rh-negative patients&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Rh0 (D) immune globulin in Rh-negative patients&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Rh0 (D) immune globulin (WinRho SDF) is used in the treatment of immune thrombocytopenic purpura (ITP) , but it is only given to Rh-positive patients, not Rh-negative patients. The mechanism of action involves antibody-coated cells â€œsaturatingâ€ the Fc receptors on macrophages, thus inhibiting platelet destruction. In Rh-negative patients , administering Rh0 (D) immune globulin is not appropriate as it is not effective in this group.&lt;/li&gt;&lt;li&gt;â€¢ Rh0 (D) immune globulin&lt;/li&gt;&lt;li&gt;â€¢ immune thrombocytopenic purpura (ITP)&lt;/li&gt;&lt;li&gt;â€¢ Rh-positive&lt;/li&gt;&lt;li&gt;â€¢ Rh-negative&lt;/li&gt;&lt;li&gt;â€¢ Fc receptors&lt;/li&gt;&lt;li&gt;â€¢ Rh-negative patients&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prednisone at 1 mg/kg: Prednisone is a first-line treatment for ITP. It is a corticosteroid used to suppress the immune response and increase platelet count. The standard dose is typically 1 mg/kg daily.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Prednisone at 1 mg/kg: Prednisone&lt;/li&gt;&lt;li&gt;â€¢ 1 mg/kg&lt;/li&gt;&lt;li&gt;â€¢ Option B. 4-day course of dexamethasone, 40 mg/d: A 4-day course of dexamethasone is also an effective treatment for ITP. It is used in higher doses, typically 40 mg/day for 4 days, and can provide rapid platelet count improvement in patients with ITP.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 4-day course of dexamethasone, 40 mg/d:&lt;/li&gt;&lt;li&gt;â€¢ 4-day course of dexamethasone&lt;/li&gt;&lt;li&gt;â€¢ 40 mg/day&lt;/li&gt;&lt;li&gt;â€¢ Option D. IVIgG at 1â€“2 g/kg total, given over 1â€“5 days: IVIgG (intravenous immunoglobulin) is another treatment used in ITP. It works by blocking the Fc receptor system and increasing platelet survival. It is often given as 1-2 g/kg over 1-5 days, especially in cases that require urgent treatment or for postsplenectomy patients.&lt;/li&gt;&lt;li&gt;â€¢ Option D. IVIgG at 1â€“2 g/kg total, given over 1â€“5 days: IVIgG&lt;/li&gt;&lt;li&gt;â€¢ Fc receptor system&lt;/li&gt;&lt;li&gt;â€¢ 1-2 g/kg&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rh0 (D) immune globulin is used only in Rh-positive patients with ITP , not Rh-negative patients. Other treatments like prednisone , dexamethasone , and IVIgG are commonly used for ITP management.&lt;/li&gt;&lt;li&gt;âž¤ Rh0 (D) immune globulin&lt;/li&gt;&lt;li&gt;âž¤ Rh-positive&lt;/li&gt;&lt;li&gt;âž¤ ITP&lt;/li&gt;&lt;li&gt;âž¤ Rh-negative&lt;/li&gt;&lt;li&gt;âž¤ prednisone&lt;/li&gt;&lt;li&gt;âž¤ dexamethasone&lt;/li&gt;&lt;li&gt;âž¤ IVIgG&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;35-year-old female with thrombotic thrombocytopenic purpura (TTP) is being treated for an ADAMTS13 activity level &amp;lt;10% and is showing clinical symptoms such as microangiopathic hemolytic anemia and thrombocytopenia. Which of the following treatments, known for targeting von Willebrand factor (vWF), is most beneficial in reducing the mortality and burden of care in these patients?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ibritumomab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Caplacizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tiuxetan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ofatumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Caplacizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Caplacizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Caplacizumab is an anti-von Willebrand factor (vWF) nanobody that has been shown to decrease mortality and the burden of care in patients with thrombotic thrombocytopenic purpura (TTP) . It works by preventing the interaction of vWF with platelets, thereby reducing platelet aggregation and microthrombus formation, which are central to the pathophysiology of TTP. Caplacizumab is used in combination with plasma exchange and steroids for patients with TTP who have ADAMTS13 activity &amp;lt;10% .&lt;/li&gt;&lt;li&gt;â€¢ Caplacizumab&lt;/li&gt;&lt;li&gt;â€¢ anti-von Willebrand factor (vWF) nanobody&lt;/li&gt;&lt;li&gt;â€¢ mortality&lt;/li&gt;&lt;li&gt;â€¢ burden of care&lt;/li&gt;&lt;li&gt;â€¢ thrombotic thrombocytopenic purpura (TTP)&lt;/li&gt;&lt;li&gt;â€¢ vWF&lt;/li&gt;&lt;li&gt;â€¢ plasma exchange&lt;/li&gt;&lt;li&gt;â€¢ steroids&lt;/li&gt;&lt;li&gt;â€¢ TTP&lt;/li&gt;&lt;li&gt;â€¢ ADAMTS13 activity &amp;lt;10%&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ibritumomab: Ibritumomab is a monoclonal antibody used for radioimmunotherapy in certain types of non-Hodgkin lymphoma and chronic lymphocytic leukemia . It does not have a role in the treatment of TTP .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Ibritumomab: Ibritumomab&lt;/li&gt;&lt;li&gt;â€¢ monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ radioimmunotherapy&lt;/li&gt;&lt;li&gt;â€¢ non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ chronic lymphocytic leukemia&lt;/li&gt;&lt;li&gt;â€¢ TTP&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tiuxetan: Tiuxetan is used as part of radioimmunotherapy for hematologic malignancies but does not target vWF or have any application in TTP treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Tiuxetan: Tiuxetan&lt;/li&gt;&lt;li&gt;â€¢ radioimmunotherapy&lt;/li&gt;&lt;li&gt;â€¢ hematologic malignancies&lt;/li&gt;&lt;li&gt;â€¢ vWF&lt;/li&gt;&lt;li&gt;â€¢ TTP&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ofatumumab: Ofatumumab is another monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and multiple sclerosis but does not play a role in treating TTP .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ofatumumab: Ofatumumab&lt;/li&gt;&lt;li&gt;â€¢ monoclonal antibody&lt;/li&gt;&lt;li&gt;â€¢ chronic lymphocytic leukemia (CLL)&lt;/li&gt;&lt;li&gt;â€¢ multiple sclerosis&lt;/li&gt;&lt;li&gt;â€¢ TTP&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Caplacizumab , an anti-vWF nanobody , is an important therapeutic agent in TTP , helping to reduce platelet aggregation and improving patient outcomes, particularly in those with ADAMTS13 &amp;lt;10% .&lt;/li&gt;&lt;li&gt;âž¤ Caplacizumab&lt;/li&gt;&lt;li&gt;âž¤ anti-vWF nanobody&lt;/li&gt;&lt;li&gt;âž¤ TTP&lt;/li&gt;&lt;li&gt;âž¤ platelet aggregation&lt;/li&gt;&lt;li&gt;âž¤ ADAMTS13 &amp;lt;10%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male presents with severe mucosal bleeding, including epistaxis and gum bleeding, without any previous history of bleeding disorders. He has a monoclonal gammopathy identified during workup for anemia. Which of the following is most commonly associated with this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congenital VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;WaldenstrÃ¶mâ€™s macroglobulinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Monoclonal gammopathies of undetermined significance (MGUS)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple myeloma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Monoclonal gammopathies of undetermined significance (MGUS)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Monoclonal gammopathies of undetermined significance (MGUS)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Von Willebrand disease (VWD) is an inherited bleeding disorder, but acquired von Willebrand syndrome (VWS) is commonly seen in monoclonal gammopathies of undetermined significance (MGUS) , multiple myeloma , and WaldenstrÃ¶mâ€™s macroglobulinemia . In patients with MGUS, acquired VWS typically manifests as severe mucosal bleeding , which may include symptoms like epistaxis and gingival bleeding . This bleeding tendency is due to the interference with von Willebrand factor (vWF) function caused by the underlying monoclonal protein. MGUS is the most common condition associated with acquired VWS, particularly in elderly patients .&lt;/li&gt;&lt;li&gt;â€¢ Von Willebrand disease (VWD)&lt;/li&gt;&lt;li&gt;â€¢ acquired von Willebrand syndrome (VWS)&lt;/li&gt;&lt;li&gt;â€¢ monoclonal gammopathies of undetermined significance (MGUS)&lt;/li&gt;&lt;li&gt;â€¢ multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ WaldenstrÃ¶mâ€™s macroglobulinemia&lt;/li&gt;&lt;li&gt;â€¢ acquired VWS&lt;/li&gt;&lt;li&gt;â€¢ severe mucosal bleeding&lt;/li&gt;&lt;li&gt;â€¢ epistaxis&lt;/li&gt;&lt;li&gt;â€¢ gingival bleeding&lt;/li&gt;&lt;li&gt;â€¢ MGUS&lt;/li&gt;&lt;li&gt;â€¢ elderly patients&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congenital VWD: Congenital VWD is inherited and is characterized by a deficiency or dysfunction of von Willebrand factor (vWF). However, it is not typically associated with monoclonal gammopathies, which are the underlying cause of acquired VWS .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Congenital VWD: Congenital VWD&lt;/li&gt;&lt;li&gt;â€¢ acquired VWS&lt;/li&gt;&lt;li&gt;â€¢ Option B. WaldenstrÃ¶mâ€™s macroglobulinemia: While WaldenstrÃ¶mâ€™s macroglobulinemia (a lymphoproliferative disorder) can be associated with acquired VWS , MGUS is more commonly linked to the development of acquired VWS, particularly in elderly patients. WaldenstrÃ¶mâ€™s may still be considered in this context but is less common than MGUS for causing acquired VWS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. WaldenstrÃ¶mâ€™s macroglobulinemia:&lt;/li&gt;&lt;li&gt;â€¢ WaldenstrÃ¶mâ€™s macroglobulinemia&lt;/li&gt;&lt;li&gt;â€¢ acquired VWS&lt;/li&gt;&lt;li&gt;â€¢ MGUS&lt;/li&gt;&lt;li&gt;â€¢ WaldenstrÃ¶mâ€™s&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple myeloma: Multiple myeloma is also associated with acquired VWS , but MGUS is more frequently seen as the underlying cause of this bleeding disorder.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Multiple myeloma: Multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ acquired VWS&lt;/li&gt;&lt;li&gt;â€¢ MGUS&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acquired von Willebrand syndrome is most commonly associated with monoclonal gammopathies of undetermined significance (MGUS) , particularly in elderly patients who present with new-onset mucosal bleeding .&lt;/li&gt;&lt;li&gt;âž¤ Acquired von Willebrand syndrome&lt;/li&gt;&lt;li&gt;âž¤ monoclonal gammopathies of undetermined significance (MGUS)&lt;/li&gt;&lt;li&gt;âž¤ new-onset mucosal bleeding&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 3-year-old child with Down syndrome is diagnosed with acute myeloid leukemia (AML), specifically the acute megakaryocytic subtype. What is the most likely mutation associated with this form of leukemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CEBPA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ETV6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GATA1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;GATA2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. GATA1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) GATA1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Down syndrome-associated AML in children, particularly those under 4 years old , is typically of the acute megakaryocytic subtype. This form of leukemia is most commonly associated with mutations in the GATA1 gene , which is involved in hematopoiesis , particularly megakaryocyte differentiation. The mutation in GATA1 leads to an increased risk of leukemia in children with Down syndrome , specifically in those with trisomy 21 .&lt;/li&gt;&lt;li&gt;â€¢ Down syndrome-associated AML&lt;/li&gt;&lt;li&gt;â€¢ 4 years old&lt;/li&gt;&lt;li&gt;â€¢ acute megakaryocytic&lt;/li&gt;&lt;li&gt;â€¢ GATA1 gene&lt;/li&gt;&lt;li&gt;â€¢ hematopoiesis&lt;/li&gt;&lt;li&gt;â€¢ GATA1&lt;/li&gt;&lt;li&gt;â€¢ Down syndrome&lt;/li&gt;&lt;li&gt;â€¢ trisomy 21&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. CEBPA: CEBPA mutations are typically associated with AML in adults and are not commonly seen in Down syndrome-associated AML , which is more specifically linked to GATA1 mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CEBPA: CEBPA&lt;/li&gt;&lt;li&gt;â€¢ AML&lt;/li&gt;&lt;li&gt;â€¢ Down syndrome-associated AML&lt;/li&gt;&lt;li&gt;â€¢ GATA1&lt;/li&gt;&lt;li&gt;â€¢ Option B. ETV6: ETV6 mutations are associated with various forms of leukemia, including acute lymphoblastic leukemia (ALL) and AML in both adults and children, but they are not the hallmark of Down syndrome-associated AML .&lt;/li&gt;&lt;li&gt;â€¢ Option B. ETV6: ETV6&lt;/li&gt;&lt;li&gt;â€¢ acute lymphoblastic leukemia (ALL)&lt;/li&gt;&lt;li&gt;â€¢ AML&lt;/li&gt;&lt;li&gt;â€¢ Down syndrome-associated AML&lt;/li&gt;&lt;li&gt;â€¢ Option D. GATA2: While GATA2 mutations are associated with certain forms of leukemia, such as monosomy 7 -associated AML , they are not the primary mutation in Down syndrome-associated AML , which is more closely associated with GATA1 mutations.&lt;/li&gt;&lt;li&gt;â€¢ Option D. GATA2:&lt;/li&gt;&lt;li&gt;â€¢ GATA2&lt;/li&gt;&lt;li&gt;â€¢ monosomy 7&lt;/li&gt;&lt;li&gt;â€¢ AML&lt;/li&gt;&lt;li&gt;â€¢ Down syndrome-associated AML&lt;/li&gt;&lt;li&gt;â€¢ GATA1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ GATA1 mutations are the hallmark of Down syndrome-associated AML , particularly in young children, and this mutation is strongly linked with the acute megakaryocytic subtype of the disease.&lt;/li&gt;&lt;li&gt;âž¤ GATA1 mutations&lt;/li&gt;&lt;li&gt;âž¤ Down syndrome-associated AML&lt;/li&gt;&lt;li&gt;âž¤ acute megakaryocytic&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male is diagnosed with acute myeloid leukemia (AML) and is evaluated for cytogenetic abnormalities. Which of the following cytogenetic rearrangements is considered a poor prognostic factor in AML?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(8;21)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(6;9)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;inv(16)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. t(6;9)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) t(6;9)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The t(6;9) translocation is considered a poor prognostic factor in acute myeloid leukemia (AML) . This translocation is associated with a very poor prognosis in AML patients, with outcomes significantly worse than those with other more favorable cytogenetic abnormalities. Other genetic abnormalities associated with poor prognosis include TP53 mutations , complex karyotypes , and chromosomal abnormalities like inv(3) and -7 .&lt;/li&gt;&lt;li&gt;â€¢ t(6;9)&lt;/li&gt;&lt;li&gt;â€¢ poor prognostic factor&lt;/li&gt;&lt;li&gt;â€¢ acute myeloid leukemia (AML)&lt;/li&gt;&lt;li&gt;â€¢ very poor prognosis&lt;/li&gt;&lt;li&gt;â€¢ TP53 mutations&lt;/li&gt;&lt;li&gt;â€¢ complex karyotypes&lt;/li&gt;&lt;li&gt;â€¢ chromosomal abnormalities like inv(3)&lt;/li&gt;&lt;li&gt;â€¢ -7&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(15;17): The t(15;17) translocation, which leads to the formation of the PML-RARA fusion gene, is a hallmark of acute promyelocytic leukemia (APL) . This cytogenetic abnormality is associated with a very good prognosis , with high cure rates (approximately 85% cured) when treated with all-trans retinoic acid (ATRA) and chemotherapy .&lt;/li&gt;&lt;li&gt;â€¢ Option A. t(15;17):&lt;/li&gt;&lt;li&gt;â€¢ t(15;17)&lt;/li&gt;&lt;li&gt;â€¢ PML-RARA&lt;/li&gt;&lt;li&gt;â€¢ acute promyelocytic leukemia (APL)&lt;/li&gt;&lt;li&gt;â€¢ very good prognosis&lt;/li&gt;&lt;li&gt;â€¢ high cure rates&lt;/li&gt;&lt;li&gt;â€¢ 85%&lt;/li&gt;&lt;li&gt;â€¢ all-trans retinoic acid (ATRA)&lt;/li&gt;&lt;li&gt;â€¢ chemotherapy&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(8;21): The t(8;21) translocation is associated with a good prognosis in AML . Patients with this translocation tend to have a better outcome , with about 55% cured with appropriate treatment.&lt;/li&gt;&lt;li&gt;â€¢ Option B. t(8;21):&lt;/li&gt;&lt;li&gt;â€¢ t(8;21)&lt;/li&gt;&lt;li&gt;â€¢ AML&lt;/li&gt;&lt;li&gt;â€¢ better outcome&lt;/li&gt;&lt;li&gt;â€¢ 55%&lt;/li&gt;&lt;li&gt;â€¢ Option D. inv (16): The inv (16) translocation is another favorable prognostic factor in AML. It is commonly seen in the core-binding factor AML subtype and is associated with a good prognosis , with around 55% of patients cured.&lt;/li&gt;&lt;li&gt;â€¢ Option D. inv (16):&lt;/li&gt;&lt;li&gt;â€¢ inv (16)&lt;/li&gt;&lt;li&gt;â€¢ core-binding factor AML&lt;/li&gt;&lt;li&gt;â€¢ good prognosis&lt;/li&gt;&lt;li&gt;â€¢ 55%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ t(6;9) is a poor prognostic factor in AML , associated with worse survival rates and a more aggressive disease course, whereas other cytogenetic abnormalities like t(15;17) , t(8;21) , and inv(16) generally predict better outcomes.&lt;/li&gt;&lt;li&gt;âž¤ t(6;9)&lt;/li&gt;&lt;li&gt;âž¤ poor prognostic factor&lt;/li&gt;&lt;li&gt;âž¤ AML&lt;/li&gt;&lt;li&gt;âž¤ t(15;17)&lt;/li&gt;&lt;li&gt;âž¤ t(8;21)&lt;/li&gt;&lt;li&gt;âž¤ inv(16)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents with splenomegaly and recurrent infections. Laboratory tests reveal the presence of lymphoplasmacytic lymphoma and splenic marginal zone lymphoma. Which of the following viruses is most commonly associated with the development of these lymphomas?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatitis A virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatitis B virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatitis C virus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatitis E virus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hepatitis C virus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hepatitis C virus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Chronic hepatitis C virus (HCV) infection has been strongly associated with the development of both lymphoplasmacytic lymphoma and splenic marginal zone lymphoma (MZL). The chronic immune activation caused by HCV infection is believed to contribute to the pathogenesis of these B-cell lymphomas . The association between HCV and these lymphomas highlights the importance of early detection and management of HCV in patients at risk for lymphoproliferative disorders .&lt;/li&gt;&lt;li&gt;â€¢ Chronic hepatitis C virus (HCV)&lt;/li&gt;&lt;li&gt;â€¢ lymphoplasmacytic lymphoma&lt;/li&gt;&lt;li&gt;â€¢ splenic marginal zone lymphoma&lt;/li&gt;&lt;li&gt;â€¢ B-cell lymphomas&lt;/li&gt;&lt;li&gt;â€¢ lymphoproliferative disorders&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hepatitis A virus: Hepatitis A virus (HAV) is an acute viral infection and is not typically associated with lymphoplasmacytic lymphoma or splenic marginal zone lymphoma . HAV does not have a known association with chronic immune stimulation leading to B-cell lymphomas.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Hepatitis A virus: Hepatitis A virus (HAV)&lt;/li&gt;&lt;li&gt;â€¢ lymphoplasmacytic lymphoma&lt;/li&gt;&lt;li&gt;â€¢ splenic marginal zone lymphoma&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatitis B virus: While hepatitis B virus (HBV) can lead to liver cirrhosis and increase the risk of hepatocellular carcinoma , it is not primarily associated with lymphoplasmacytic lymphoma or splenic marginal zone lymphoma . However, HBV may increase the risk of non-Hodgkin lymphoma more generally, but this is less specific than the association with HCV .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hepatitis B virus:&lt;/li&gt;&lt;li&gt;â€¢ hepatitis B virus (HBV)&lt;/li&gt;&lt;li&gt;â€¢ hepatocellular carcinoma&lt;/li&gt;&lt;li&gt;â€¢ not primarily associated&lt;/li&gt;&lt;li&gt;â€¢ lymphoplasmacytic lymphoma&lt;/li&gt;&lt;li&gt;â€¢ splenic marginal zone lymphoma&lt;/li&gt;&lt;li&gt;â€¢ HBV&lt;/li&gt;&lt;li&gt;â€¢ non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;â€¢ HCV&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hepatitis E virus: Hepatitis E virus (HEV) is generally associated with acute hepatitis , particularly in pregnant women, and does not have a known association with the development of lymphoplasmacytic lymphoma or splenic marginal zone lymphoma .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hepatitis E virus: Hepatitis E virus (HEV)&lt;/li&gt;&lt;li&gt;â€¢ acute hepatitis&lt;/li&gt;&lt;li&gt;â€¢ lymphoplasmacytic lymphoma&lt;/li&gt;&lt;li&gt;â€¢ splenic marginal zone lymphoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic hepatitis C virus infection is associated with an increased risk of lymphoplasmacytic lymphoma and splenic marginal zone lymphoma , making HCV a critical factor in the pathogenesis of these B-cell lymphomas .&lt;/li&gt;&lt;li&gt;âž¤ Chronic hepatitis C virus infection&lt;/li&gt;&lt;li&gt;âž¤ lymphoplasmacytic lymphoma&lt;/li&gt;&lt;li&gt;âž¤ splenic marginal zone lymphoma&lt;/li&gt;&lt;li&gt;âž¤ B-cell lymphomas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with painless lymphadenopathy. Biopsy is done and is shown. Which of the following markers is not typically expressed by these cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BCL2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD20&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD30&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD45&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CD30&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20155138.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CD30&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The biopsy findings show popcorn-like Reed-Sternberg cells characteristic of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) . Unlike classical Hodgkin lymphoma (CHL), NLPHL expresses CD20 and CD45 , markers of B cells, and is negative for CD30 and CD15 . Additionally, BCL2 may be variably expressed in the reactive lymphocytes or tumor cells.&lt;/li&gt;&lt;li&gt;â€¢ popcorn-like Reed-Sternberg cells&lt;/li&gt;&lt;li&gt;â€¢ Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)&lt;/li&gt;&lt;li&gt;â€¢ CD20&lt;/li&gt;&lt;li&gt;â€¢ CD45&lt;/li&gt;&lt;li&gt;â€¢ CD30&lt;/li&gt;&lt;li&gt;â€¢ CD15&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. BCL2: This marker may be variably expressed, especially in the reactive lymphocytes surrounding the tumor cells, and is not a distinguishing feature.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ BCL2:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CD20: CD20 is a key B-cell marker, strongly expressed by tumor cells in NLPHL.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ CD20:&lt;/li&gt;&lt;li&gt;â€¢ Option D. CD45: CD45 is a pan-leukocyte marker, typically expressed in NLPHL but absent in classical Hodgkin lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ CD45:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nodular Lymphocyte-Predominant Hodgkin Lymphoma is distinguished from classical Hodgkin lymphoma by its expression of CD20 and CD45 and lack of CD30 and CD15 , reflecting its B-cell lineage.&lt;/li&gt;&lt;li&gt;âž¤ CD20 and CD45&lt;/li&gt;&lt;li&gt;âž¤ CD30 and CD15&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with hyperviscosity syndrome, anemia, and elevated IgM levels. Genetic testing reveals a MYD88 L265P mutation. In which of the following conditions is this mutation commonly found?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Marginal zone lymphomas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple myeloma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;WaldenstrÃ¶mâ€™s macroglobulinemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgM-secreting myeloma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. WaldenstrÃ¶mâ€™s macroglobulinemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) WaldenstrÃ¶mâ€™s macroglobulinemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The MYD88 L265P mutation is a somatic mutation found in over 90% of patients with WaldenstrÃ¶mâ€™s macroglobulinemia (WM) , as well as the majority of IgM monoclonal gammopathy of undetermined significance (MGUS) . This mutation is considered a hallmark of WM and plays a significant role in distinguishing it from other IgM-secreting disorders . The presence of this mutation is useful in confirming the diagnosis of WM and helps differentiate it from conditions like marginal zone lymphoma (MZL) and IgM-secreting myeloma , which have overlapping clinical features.&lt;/li&gt;&lt;li&gt;â€¢ MYD88 L265P mutation&lt;/li&gt;&lt;li&gt;â€¢ somatic mutation&lt;/li&gt;&lt;li&gt;â€¢ over 90% of patients with WaldenstrÃ¶mâ€™s macroglobulinemia (WM)&lt;/li&gt;&lt;li&gt;â€¢ IgM monoclonal gammopathy of undetermined significance (MGUS)&lt;/li&gt;&lt;li&gt;â€¢ WM&lt;/li&gt;&lt;li&gt;â€¢ IgM-secreting disorders&lt;/li&gt;&lt;li&gt;â€¢ WM&lt;/li&gt;&lt;li&gt;â€¢ marginal zone lymphoma&lt;/li&gt;&lt;li&gt;â€¢ IgM-secreting myeloma&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Marginal zone lymphomas: MYD88 L265P is not a characteristic mutation for marginal zone lymphomas (MZLs) , though it can be found in a subset of these lymphomas. MYD88 mutations are more specific to WaldenstrÃ¶mâ€™s macroglobulinemia and IgM MGUS .&lt;/li&gt;&lt;li&gt;â€¢ Option A. Marginal zone lymphomas: MYD88 L265P&lt;/li&gt;&lt;li&gt;â€¢ marginal zone lymphomas (MZLs)&lt;/li&gt;&lt;li&gt;â€¢ MYD88 mutations&lt;/li&gt;&lt;li&gt;â€¢ WaldenstrÃ¶mâ€™s macroglobulinemia&lt;/li&gt;&lt;li&gt;â€¢ IgM MGUS&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple myeloma: Multiple myeloma is not associated with MYD88 L265P mutations . It is more commonly associated with mutations affecting other genes, such as KRAS , TP53 , and IGH .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Multiple myeloma: Multiple myeloma&lt;/li&gt;&lt;li&gt;â€¢ MYD88 L265P mutations&lt;/li&gt;&lt;li&gt;â€¢ KRAS&lt;/li&gt;&lt;li&gt;â€¢ TP53&lt;/li&gt;&lt;li&gt;â€¢ IGH&lt;/li&gt;&lt;li&gt;â€¢ Option D. IgM-secreting myeloma: While IgM-secreting myeloma may show overlap with WaldenstrÃ¶mâ€™s macroglobulinemia , MYD88 L265P mutations are not a prominent feature in IgM-secreting myeloma . This mutation is more characteristic of WM and IgM MGUS .&lt;/li&gt;&lt;li&gt;â€¢ Option D. IgM-secreting myeloma:&lt;/li&gt;&lt;li&gt;â€¢ IgM-secreting myeloma&lt;/li&gt;&lt;li&gt;â€¢ WaldenstrÃ¶mâ€™s macroglobulinemia&lt;/li&gt;&lt;li&gt;â€¢ MYD88 L265P mutations&lt;/li&gt;&lt;li&gt;â€¢ IgM-secreting myeloma&lt;/li&gt;&lt;li&gt;â€¢ WM&lt;/li&gt;&lt;li&gt;â€¢ IgM MGUS&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The MYD88 L265P mutation is found in &amp;gt;90% of patients with WaldenstrÃ¶mâ€™s macroglobulinemia (WM) and is an important diagnostic marker to differentiate WM from other IgM-producing disorders , such as marginal zone lymphomas and IgM-secreting myeloma .&lt;/li&gt;&lt;li&gt;âž¤ MYD88 L265P mutation&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt;90% of patients with WaldenstrÃ¶mâ€™s macroglobulinemia (WM)&lt;/li&gt;&lt;li&gt;âž¤ IgM-producing disorders&lt;/li&gt;&lt;li&gt;âž¤ marginal zone lymphomas&lt;/li&gt;&lt;li&gt;âž¤ IgM-secreting myeloma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old male presents with jaundice, fatigue, and a history of chronic alcohol consumption. Which of the following is not a feature of alcoholic hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AST and ALT elevations often exceed 400 IU/L&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AST/ALT ratio of &amp;gt;2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum bilirubin &amp;gt;3 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Steatosis and inflammation in liver biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. AST and ALT elevations often exceed 400 IU/L&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) AST and ALT elevations often exceed 400 IU/L&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Alcoholic hepatitis typically presents with modest elevations in AST and ALT levels , generally not exceeding 300 IU/L . An AST/ALT ratio of &amp;gt;2 is a classic feature due to pyridoxine deficiency associated with chronic alcohol use. Severe cases often show elevated bilirubin levels (&amp;gt;3 mg/dL) , and liver biopsy confirms the presence of steatosis and inflammation , hallmark features of alcoholic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ modest elevations in AST and ALT levels&lt;/li&gt;&lt;li&gt;â€¢ 300 IU/L&lt;/li&gt;&lt;li&gt;â€¢ AST/ALT ratio of &amp;gt;2&lt;/li&gt;&lt;li&gt;â€¢ elevated bilirubin levels (&amp;gt;3 mg/dL)&lt;/li&gt;&lt;li&gt;â€¢ steatosis and inflammation&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. AST/ALT ratio of &amp;gt;2: This is a diagnostic feature of alcoholic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B.&lt;/li&gt;&lt;li&gt;â€¢ AST/ALT ratio of &amp;gt;2:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Serum bilirubin &amp;gt;3 mg/dL: This indicates significant liver dysfunction in alcoholic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Serum bilirubin &amp;gt;3 mg/dL:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Steatosis and inflammation in liver biopsy: These are histological findings consistent with alcoholic hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Steatosis and inflammation in liver biopsy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alcoholic hepatitis is characterized by modest elevations in AST and ALT levels , with an AST/ALT ratio &amp;gt;2 , hyperbilirubinemia, and characteristic histological findings such as steatosis and inflammation . AST and ALT levels exceeding 400 IU/L are more typical of other liver conditions, such as acute viral or ischemic hepatitis.&lt;/li&gt;&lt;li&gt;âž¤ modest elevations in AST and ALT levels&lt;/li&gt;&lt;li&gt;âž¤ AST/ALT ratio &amp;gt;2&lt;/li&gt;&lt;li&gt;âž¤ steatosis and inflammation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents to the emergency department after accidentally ingesting a drug. She is evaluated for liver toxicity. The Rumack-Matthew nomogram is used to assess the risk of hepatotoxicity. Which of the following is the nomogram specifically used for?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetaminophen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alcoholic liver injury&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acetaminophen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20155244.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acetaminophen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Rumack-Matthew nomogram is used to assess the toxicity risk of acetaminophen overdose . It helps determine whether N-acetylcysteine (NAC) , the antidote, should be administered based on the time of ingestion and the serum acetaminophen level . The nomogram helps predict the likelihood of liver injury and can guide treatment decisions in patients with acetaminophen toxicity .&lt;/li&gt;&lt;li&gt;â€¢ Rumack-Matthew nomogram&lt;/li&gt;&lt;li&gt;â€¢ toxicity risk&lt;/li&gt;&lt;li&gt;â€¢ acetaminophen overdose&lt;/li&gt;&lt;li&gt;â€¢ N-acetylcysteine (NAC)&lt;/li&gt;&lt;li&gt;â€¢ time of ingestion&lt;/li&gt;&lt;li&gt;â€¢ serum acetaminophen level&lt;/li&gt;&lt;li&gt;â€¢ liver injury&lt;/li&gt;&lt;li&gt;â€¢ acetaminophen toxicity&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Isoniazid: While isoniazid overdose can cause liver toxicity , the Rumack-Matthew nomogram is specific to acetaminophen toxicity, not isoniazid. Isoniazid toxicity management involves other clinical measures and does not rely on this nomogram.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Isoniazid:&lt;/li&gt;&lt;li&gt;â€¢ isoniazid&lt;/li&gt;&lt;li&gt;â€¢ liver toxicity&lt;/li&gt;&lt;li&gt;â€¢ Rumack-Matthew nomogram&lt;/li&gt;&lt;li&gt;â€¢ acetaminophen&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amiodarone: Amiodarone toxicity, including liver injury , is a recognized concern but is not associated with the use of the Rumack-Matthew nomogram . This nomogram is not used in cases of amiodarone overdose .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amiodarone: Amiodarone&lt;/li&gt;&lt;li&gt;â€¢ liver injury&lt;/li&gt;&lt;li&gt;â€¢ Rumack-Matthew nomogram&lt;/li&gt;&lt;li&gt;â€¢ amiodarone overdose&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alcoholic liver injury: Alcoholic liver injury results from chronic or acute alcohol consumption but is not related to the Rumack-Matthew nomogram , which is specific to acetaminophen toxicity.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alcoholic liver injury: Alcoholic liver injury&lt;/li&gt;&lt;li&gt;â€¢ Rumack-Matthew nomogram&lt;/li&gt;&lt;li&gt;â€¢ acetaminophen&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Rumack-Matthew nomogram is used to assess acetaminophen toxicity , guiding treatment decisions, particularly the use of N-acetylcysteine (NAC) for overdose management.&lt;/li&gt;&lt;li&gt;âž¤ Rumack-Matthew nomogram&lt;/li&gt;&lt;li&gt;âž¤ acetaminophen toxicity&lt;/li&gt;&lt;li&gt;âž¤ N-acetylcysteine (NAC)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with cirrhosis presents with worsening fatigue, abdominal distension, and jaundice. His clinical and laboratory findings are as follows: Total bilirubin: 3.5 mg/dL Serum albumin: 2.5 g/dL INR: 1.8 Ascites: Controlled with diuretics Encephalopathy: Grade 1 Using the Child-Pugh scoring system, which of the following classifications does his score fall under?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Child-Pugh class A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Child-Pugh class B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Child-Pugh class C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Child-Pugh class D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Child-Pugh class B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Child-Pugh class B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The Child-Pugh score is calculated using five parameters: bilirubin, albumin, INR, ascites, and encephalopathy . Each parameter is scored from 1 to 3 points based on severity.&lt;/li&gt;&lt;li&gt;â€¢ bilirubin, albumin, INR, ascites, and encephalopathy&lt;/li&gt;&lt;li&gt;â€¢ For this patient:&lt;/li&gt;&lt;li&gt;â€¢ Bilirubin of 3.5 mg/dL: 3 points Albumin of 2.5 g/dL: 2 points INR of 1.8: 2 points Ascites (controlled with diuretics): 2 points Encephalopathy (Grade 1): 1 point&lt;/li&gt;&lt;li&gt;â€¢ Bilirubin of 3.5 mg/dL: 3 points&lt;/li&gt;&lt;li&gt;â€¢ 3 points&lt;/li&gt;&lt;li&gt;â€¢ Albumin of 2.5 g/dL: 2 points&lt;/li&gt;&lt;li&gt;â€¢ 2 points&lt;/li&gt;&lt;li&gt;â€¢ INR of 1.8: 2 points&lt;/li&gt;&lt;li&gt;â€¢ 2 points&lt;/li&gt;&lt;li&gt;â€¢ Ascites (controlled with diuretics): 2 points&lt;/li&gt;&lt;li&gt;â€¢ 2 points&lt;/li&gt;&lt;li&gt;â€¢ Encephalopathy (Grade 1): 1 point&lt;/li&gt;&lt;li&gt;â€¢ 1 point&lt;/li&gt;&lt;li&gt;â€¢ Total score = 3 + 2 + 2 + 2 + 1 = 8 points&lt;/li&gt;&lt;li&gt;â€¢ 8 points&lt;/li&gt;&lt;li&gt;â€¢ A score of 7â€“9 corresponds to Child-Pugh class B .&lt;/li&gt;&lt;li&gt;â€¢ 7â€“9&lt;/li&gt;&lt;li&gt;â€¢ Child-Pugh class B&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Child-Pugh class A is for scores of 5â€“6 .&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Child-Pugh class A&lt;/li&gt;&lt;li&gt;â€¢ 5â€“6&lt;/li&gt;&lt;li&gt;â€¢ Option C. Child-Pugh class C is for scores of 10â€“15 .&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Child-Pugh class C&lt;/li&gt;&lt;li&gt;â€¢ 10â€“15&lt;/li&gt;&lt;li&gt;â€¢ Option D. Child-Pugh class D does not exist in the Child-Pugh classification system.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Child-Pugh class D&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The Child-Pugh score assesses liver function in cirrhotic patients and stratifies them into Class A, B, or C based on a total score from five clinical and laboratory parameters.&lt;/li&gt;&lt;li&gt;âž¤ Child-Pugh score&lt;/li&gt;&lt;li&gt;âž¤ Class A, B, or C&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male post-renal transplant is being treated with tacrolimus for immunosuppression. Which of the following statements is incorrect about tacrolimus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tacrolimus is more potent than Cyclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neurotoxicity is more severe in Tacrolimus-treated patients&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tacrolimus frequently causes gingival hyperplasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tacrolimus does not cause Hirsutism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tacrolimus frequently causes gingival hyperplasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tacrolimus frequently causes gingival hyperplasia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Tacrolimus is a more potent immunosuppressive agent than cyclosporine , but it is associated with greater toxicity . One of the key differences between the two is that gingival hyperplasia is not a common side effect of tacrolimus . Gingival hyperplasia is more commonly seen with cyclosporine use. In contrast, tacrolimus can cause other adverse effects like neurotoxicity , nephrotoxicity , and diabetes mellitus , but gingival hyperplasia is not typically one of them.&lt;/li&gt;&lt;li&gt;â€¢ Tacrolimus&lt;/li&gt;&lt;li&gt;â€¢ cyclosporine&lt;/li&gt;&lt;li&gt;â€¢ greater toxicity&lt;/li&gt;&lt;li&gt;â€¢ gingival hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ tacrolimus&lt;/li&gt;&lt;li&gt;â€¢ cyclosporine&lt;/li&gt;&lt;li&gt;â€¢ tacrolimus&lt;/li&gt;&lt;li&gt;â€¢ neurotoxicity&lt;/li&gt;&lt;li&gt;â€¢ nephrotoxicity&lt;/li&gt;&lt;li&gt;â€¢ diabetes mellitus&lt;/li&gt;&lt;li&gt;â€¢ gingival hyperplasia&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tacrolimus is more potent than Cyclosporine: This is true. Tacrolimus is generally more potent than cyclosporine in terms of immunosuppressive effects, which allows for lower doses to be used.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Tacrolimus is more potent than Cyclosporine:&lt;/li&gt;&lt;li&gt;â€¢ Tacrolimus&lt;/li&gt;&lt;li&gt;â€¢ cyclosporine&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neurotoxicity is more severe in Tacrolimus-treated patients: This is true. Neurotoxicity (including symptoms like tremors , seizures , and psychosis ) is more pronounced in tacrolimus treatment, making it one of the more severe side effects associated with this drug.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Neurotoxicity is more severe in Tacrolimus-treated patients:&lt;/li&gt;&lt;li&gt;â€¢ Neurotoxicity&lt;/li&gt;&lt;li&gt;â€¢ tremors&lt;/li&gt;&lt;li&gt;â€¢ seizures&lt;/li&gt;&lt;li&gt;â€¢ psychosis&lt;/li&gt;&lt;li&gt;â€¢ tacrolimus&lt;/li&gt;&lt;li&gt;â€¢ more severe side effects&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tacrolimus does not cause Hirsutism: This is true. Hirsutism , or excessive hair growth, is a known side effect of cyclosporine , but it is not commonly associated with tacrolimus use.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tacrolimus does not cause Hirsutism:&lt;/li&gt;&lt;li&gt;â€¢ Hirsutism&lt;/li&gt;&lt;li&gt;â€¢ cyclosporine&lt;/li&gt;&lt;li&gt;â€¢ tacrolimus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tacrolimus is more potent than cyclosporine and associated with greater neurotoxicity. However, it does not commonly cause gingival hyperplasia or hirsutism , which are more frequently seen with cyclosporine .&lt;/li&gt;&lt;li&gt;âž¤ Tacrolimus&lt;/li&gt;&lt;li&gt;âž¤ cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ gingival hyperplasia&lt;/li&gt;&lt;li&gt;âž¤ hirsutism&lt;/li&gt;&lt;li&gt;âž¤ cyclosporine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male with cirrhosis presents with ascites that is not responding to initial diuretic therapy. After confirming compliance with low-sodium diet and medications, the physician considers escalating the diuretic dose. What is the maximum daily dose of spironolactone and furosemide that can be safely used in the management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone 200 mg/d, furosemide 40 mg/d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spironolactone 300 mg/d, furosemide 80 mg/d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spironolactone 400 mg/d, furosemide 160 mg/d&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spironolactone 500 mg/d, furosemide 200 mg/d&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Spironolactone 400 mg/d, furosemide 160 mg/d&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Spironolactone 400 mg/d, furosemide 160 mg/d&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The maximum dose of diuretics for ascites in cirrhosis is spironolactone 400 mg/day and furosemide 160 mg/day . This combination is used to manage refractory ascites if compliance with a low-sodium diet is confirmed and if ascitic fluid is not being mobilized adequately. If ascites persists despite these maximum doses, it is considered refractory ascites , and alternative treatments, such as large volume paracentesis (LVP) or transjugular intrahepatic portosystemic shunt (TIPS) , should be considered.&lt;/li&gt;&lt;li&gt;â€¢ ascites&lt;/li&gt;&lt;li&gt;â€¢ cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ spironolactone 400 mg/day&lt;/li&gt;&lt;li&gt;â€¢ furosemide 160 mg/day&lt;/li&gt;&lt;li&gt;â€¢ refractory ascites&lt;/li&gt;&lt;li&gt;â€¢ low-sodium diet&lt;/li&gt;&lt;li&gt;â€¢ refractory ascites&lt;/li&gt;&lt;li&gt;â€¢ large volume paracentesis (LVP)&lt;/li&gt;&lt;li&gt;â€¢ transjugular intrahepatic portosystemic shunt (TIPS)&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spironolactone 200 mg/d, furosemide 40 mg/d: These doses are lower than the maximum recommended doses . While they may be used for initial management, they are not sufficient for managing refractory ascites.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Spironolactone 200 mg/d, furosemide 40 mg/d:&lt;/li&gt;&lt;li&gt;â€¢ maximum recommended doses&lt;/li&gt;&lt;li&gt;â€¢ Option B. Spironolactone 300 mg/d, furosemide 80 mg/d: These doses are still below the maximum daily doses and would not be considered appropriate for cases of refractory ascites , where higher doses are necessary for optimal fluid mobilization.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Spironolactone 300 mg/d, furosemide 80 mg/d:&lt;/li&gt;&lt;li&gt;â€¢ maximum daily doses&lt;/li&gt;&lt;li&gt;â€¢ refractory ascites&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spironolactone 500 mg/d, furosemide 200 mg/d: These doses exceed the recommended maximum doses . While doses above the recommended maximum may occasionally be used in very specific clinical settings, they increase the risk of adverse effects such as electrolyte imbalances , kidney dysfunction , and hepatorenal syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Spironolactone 500 mg/d, furosemide 200 mg/d:&lt;/li&gt;&lt;li&gt;â€¢ recommended maximum doses&lt;/li&gt;&lt;li&gt;â€¢ electrolyte imbalances&lt;/li&gt;&lt;li&gt;â€¢ kidney dysfunction&lt;/li&gt;&lt;li&gt;â€¢ hepatorenal syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The maximum recommended doses for diuretics in the management of ascites are spironolactone 400 mg/day and furosemide 160 mg/day . If ascites remains refractory despite these doses, alternative treatments should be considered.&lt;/li&gt;&lt;li&gt;âž¤ maximum recommended doses&lt;/li&gt;&lt;li&gt;âž¤ ascites&lt;/li&gt;&lt;li&gt;âž¤ spironolactone 400 mg/day&lt;/li&gt;&lt;li&gt;âž¤ furosemide 160 mg/day&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old asymptomatic individual undergoes colorectal cancer screening. Which of the following is the recommended screening interval for the multitargeted stool DNA test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Annually&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Every 3 years&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Every 5 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Every 10 years&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Every 3 years&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Every 3 years&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ For asymptomatic individuals â‰¥45 years old, the multitargeted stool DNA test (which detects genetic changes and blood in the stool) is recommended to be performed every 3 years as part of colorectal cancer screening . This test is used as an alternative to other screening methods and is considered highly effective for early detection of colorectal cancer or advanced precancerous polyps.&lt;/li&gt;&lt;li&gt;â€¢ asymptomatic individuals â‰¥45 years&lt;/li&gt;&lt;li&gt;â€¢ multitargeted stool DNA test&lt;/li&gt;&lt;li&gt;â€¢ every 3 years&lt;/li&gt;&lt;li&gt;â€¢ colorectal cancer screening&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Annually: The multitargeted stool DNA test is not recommended to be performed annually . Screening intervals are set at every 3 years , not annually, for this test.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Annually:&lt;/li&gt;&lt;li&gt;â€¢ multitargeted stool DNA test&lt;/li&gt;&lt;li&gt;â€¢ annually&lt;/li&gt;&lt;li&gt;â€¢ every 3 years&lt;/li&gt;&lt;li&gt;â€¢ Option C. Every 5 years: The screening interval for the multitargeted stool DNA test is every 3 years , not every 5 years.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Every 5 years:&lt;/li&gt;&lt;li&gt;â€¢ multitargeted stool DNA test&lt;/li&gt;&lt;li&gt;â€¢ every 3 years&lt;/li&gt;&lt;li&gt;â€¢ Option D. Every 10 years: The multitargeted stool DNA test has a shorter interval of every 3 years . A colonoscopy , however, is recommended every 10 years for colorectal cancer screening.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Every 10 years:&lt;/li&gt;&lt;li&gt;â€¢ multitargeted stool DNA test&lt;/li&gt;&lt;li&gt;â€¢ shorter interval&lt;/li&gt;&lt;li&gt;â€¢ every 3 years&lt;/li&gt;&lt;li&gt;â€¢ colonoscopy&lt;/li&gt;&lt;li&gt;â€¢ 10 years&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For asymptomatic individuals â‰¥45 years old , the multitargeted stool DNA test is done every 3 years as part of routine colorectal cancer screening .&lt;/li&gt;&lt;li&gt;âž¤ asymptomatic individuals â‰¥45 years old&lt;/li&gt;&lt;li&gt;âž¤ multitargeted stool DNA test&lt;/li&gt;&lt;li&gt;âž¤ 3 years&lt;/li&gt;&lt;li&gt;âž¤ colorectal cancer screening&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with dysphagia and diagnosed with Plummer Vinson Syndrome. What is the feature of the disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proximal esophageal webs and iron-deficiency anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Proximal esophageal webs and B12 deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Distal esophageal webs and iron-deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Distal esophageal webs and B12 deficiency anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Proximal esophageal webs and iron-deficiency anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Proximal esophageal webs and iron-deficiency anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The combination of proximal esophageal webs , dysphagia and iron-deficiency anemia is characteristic of Plummer-Vinson syndrome , also known as Paterson-Kelly Brown syndrome . This condition typically affects middle-aged women and presents with dysphagia due to the presence of esophageal webs, along with iron-deficiency anemia . This syndrome is associated with an increased risk of esophageal cancer , especially in the setting of chronic untreated iron deficiency.&lt;/li&gt;&lt;li&gt;â€¢ proximal esophageal webs&lt;/li&gt;&lt;li&gt;â€¢ dysphagia&lt;/li&gt;&lt;li&gt;â€¢ iron-deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ Plummer-Vinson syndrome&lt;/li&gt;&lt;li&gt;â€¢ Paterson-Kelly Brown syndrome&lt;/li&gt;&lt;li&gt;â€¢ middle-aged women&lt;/li&gt;&lt;li&gt;â€¢ dysphagia&lt;/li&gt;&lt;li&gt;â€¢ iron-deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ esophageal cancer&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Proximal esophageal webs and B12 deficiency anemia: While B12 deficiency anemia can cause symptoms such as fatigue and neurological deficits, it is not typically associated with proximal esophageal webs . This combination is not seen in Paterson-Kelly syndrome .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Proximal esophageal webs and B12 deficiency anemia:&lt;/li&gt;&lt;li&gt;â€¢ B12 deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ proximal esophageal webs&lt;/li&gt;&lt;li&gt;â€¢ Paterson-Kelly syndrome&lt;/li&gt;&lt;li&gt;â€¢ Option C. Distal esophageal webs and iron-deficiency anemia: Distal esophageal webs are more commonly seen in ** Schatzki rings**, which are associated with gastroesophageal reflux disease (GERD) and not iron-deficiency anemia . The esophageal webs in Paterson-Kelly syndrome are typically proximal , not distal.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Distal esophageal webs and iron-deficiency anemia: Distal esophageal webs&lt;/li&gt;&lt;li&gt;â€¢ gastroesophageal reflux disease (GERD)&lt;/li&gt;&lt;li&gt;â€¢ not iron-deficiency anemia&lt;/li&gt;&lt;li&gt;â€¢ Paterson-Kelly syndrome&lt;/li&gt;&lt;li&gt;â€¢ proximal&lt;/li&gt;&lt;li&gt;â€¢ Option D. Distal esophageal webs and B12 deficiency anemia: This combination is not typically associated with any specific syndrome and is not seen in Paterson-Kelly syndrome . B12 deficiency is more commonly associated with pernicious anemia or other conditions related to malabsorption .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Distal esophageal webs and B12 deficiency anemia:&lt;/li&gt;&lt;li&gt;â€¢ Paterson-Kelly syndrome&lt;/li&gt;&lt;li&gt;â€¢ B12 deficiency&lt;/li&gt;&lt;li&gt;â€¢ pernicious anemia&lt;/li&gt;&lt;li&gt;â€¢ malabsorption&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Paterson-Kelly syndrome (Plummer-Vinson syndrome) is defined by the presence of proximal esophageal webs and iron-deficiency anemia , often in middle-aged women, and it increases the risk of esophageal cancer .&lt;/li&gt;&lt;li&gt;âž¤ Paterson-Kelly syndrome (Plummer-Vinson syndrome)&lt;/li&gt;&lt;li&gt;âž¤ proximal esophageal webs&lt;/li&gt;&lt;li&gt;âž¤ iron-deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ esophageal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old male presents with unintentional weight loss and is concerned about his health. After a detailed assessment, he reveals a loss of 5% of his body weight over the past 8 months. How is this weight loss classified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt;2% of oneâ€™s body weight over a period of 6â€“12 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;gt;3% of oneâ€™s body weight over a period of 6â€“12 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt;5% of oneâ€™s body weight over a period of 6â€“12 months&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt;10% of oneâ€™s body weight over a period of 6â€“12 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &gt;5% of oneâ€™s body weight over a period of 6â€“12 months&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;gt;5% of oneâ€™s body weight over a period of 6â€“12 months&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Clinically important weight loss is typically defined as a loss of &amp;gt;5% of oneâ€™s body weight over a period of 6â€“12 months . This level of weight loss is often considered significant and warrants further investigation to rule out underlying medical conditions, such as malignancies , endocrine disorders , or gastrointestinal diseases .&lt;/li&gt;&lt;li&gt;â€¢ loss of &amp;gt;5%&lt;/li&gt;&lt;li&gt;â€¢ body weight over a period of 6â€“12 months&lt;/li&gt;&lt;li&gt;â€¢ significant&lt;/li&gt;&lt;li&gt;â€¢ malignancies&lt;/li&gt;&lt;li&gt;â€¢ endocrine disorders&lt;/li&gt;&lt;li&gt;â€¢ gastrointestinal diseases&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;gt;2% of oneâ€™s body weight over a period of 6â€“12 months: A 2% weight loss does not typically reach the threshold for clinically significant weight loss. It would be considered mild and usually not a cause for concern unless accompanied by other symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;gt;2% of oneâ€™s body weight over a period of 6â€“12 months:&lt;/li&gt;&lt;li&gt;â€¢ 2% weight loss&lt;/li&gt;&lt;li&gt;â€¢ mild&lt;/li&gt;&lt;li&gt;â€¢ Option B. &amp;gt;3% of oneâ€™s body weight over a period of 6â€“12 months: While 3% weight loss can be noteworthy, it does not meet the commonly accepted definition for clinically significant weight loss, which is generally considered to be &amp;gt;5% .&lt;/li&gt;&lt;li&gt;â€¢ Option B. &amp;gt;3% of oneâ€™s body weight over a period of 6â€“12 months:&lt;/li&gt;&lt;li&gt;â€¢ 3% weight loss&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;5%&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;10% of oneâ€™s body weight over a period of 6â€“12 months: A 10% weight loss is more extreme and may indicate severe malnutrition or a serious medical condition. Although important, the general clinical threshold for significant weight loss is &amp;gt;5% over 6â€“12 months , and &amp;gt;10% would be classified as severe, but not the general definition for clinical importance.&lt;/li&gt;&lt;li&gt;â€¢ Option D. &amp;gt;10% of oneâ€™s body weight over a period of 6â€“12 months:&lt;/li&gt;&lt;li&gt;â€¢ 10% weight loss&lt;/li&gt;&lt;li&gt;â€¢ malnutrition&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;5%&lt;/li&gt;&lt;li&gt;â€¢ 6â€“12 months&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;10%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Clinically significant weight loss is typically defined as a loss of &amp;gt;5% of oneâ€™s body weight over a 6â€“12-month period , which requires further clinical evaluation to identify any underlying causes.&lt;/li&gt;&lt;li&gt;âž¤ Clinically significant weight loss&lt;/li&gt;&lt;li&gt;âž¤ loss of &amp;gt;5% of oneâ€™s body weight&lt;/li&gt;&lt;li&gt;âž¤ 6â€“12-month period&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male presents with ascites. His serum albumin is 3.5 g/dL, and his ascitic fluid albumin is 1.8 g/dL. Based on these findings, which of the following is the most likely cause of his ascites?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peritoneal carcinomatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nephrotic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cirrhosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-18%20162012.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ The serum ascites albumin gradient (SAAG) is calculated by subtracting the ascitic fluid albumin from the serum albumin . The gradient is used to determine whether the ascites is due to portal hypertension or other causes.&lt;/li&gt;&lt;li&gt;â€¢ serum ascites albumin gradient (SAAG)&lt;/li&gt;&lt;li&gt;â€¢ ascitic fluid albumin&lt;/li&gt;&lt;li&gt;â€¢ serum albumin&lt;/li&gt;&lt;li&gt;â€¢ portal hypertension&lt;/li&gt;&lt;li&gt;â€¢ SAAG = Serum albumin â€“ Ascitic fluid albumin In this case, SAAG = 3.5 g/dL â€“ 1.8 g/dL = 1.7 g/dL , which is &amp;gt;1.1 g/dL , indicating ascites due to portal hypertension . Cirrhosis is the most common cause of ascites due to portal hypertension , and this pattern is typically seen in cirrhosis-related ascites.&lt;/li&gt;&lt;li&gt;â€¢ SAAG = Serum albumin â€“ Ascitic fluid albumin&lt;/li&gt;&lt;li&gt;â€¢ SAAG = Serum albumin â€“ Ascitic fluid albumin&lt;/li&gt;&lt;li&gt;â€¢ In this case, SAAG = 3.5 g/dL â€“ 1.8 g/dL = 1.7 g/dL , which is &amp;gt;1.1 g/dL , indicating ascites due to portal hypertension .&lt;/li&gt;&lt;li&gt;â€¢ SAAG = 3.5 g/dL â€“ 1.8 g/dL = 1.7 g/dL&lt;/li&gt;&lt;li&gt;â€¢ &amp;gt;1.1 g/dL&lt;/li&gt;&lt;li&gt;â€¢ portal hypertension&lt;/li&gt;&lt;li&gt;â€¢ Cirrhosis is the most common cause of ascites due to portal hypertension , and this pattern is typically seen in cirrhosis-related ascites.&lt;/li&gt;&lt;li&gt;â€¢ Cirrhosis&lt;/li&gt;&lt;li&gt;â€¢ portal hypertension&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peritoneal carcinomatosis: In cases of peritoneal carcinomatosis , the ascitic fluid albumin level is usually higher than in cirrhosis, and the SAAG is typically &amp;lt;1.1 g/dL (indicative of non-portal hypertension-related ascites).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Peritoneal carcinomatosis:&lt;/li&gt;&lt;li&gt;â€¢ peritoneal carcinomatosis&lt;/li&gt;&lt;li&gt;â€¢ higher&lt;/li&gt;&lt;li&gt;â€¢ SAAG&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;1.1 g/dL&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nephrotic syndrome: In nephrotic syndrome , ascites can occur due to hypoalbuminemia and fluid retention . However, the SAAG in nephrotic syndrome is typically &amp;lt;1.1 g/dL , and ascitic fluid albumin would be low , but not as low as seen in cirrhosis. The protein content of ascitic fluid would generally be low due to loss of protein in urine .&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nephrotic syndrome:&lt;/li&gt;&lt;li&gt;â€¢ nephrotic syndrome&lt;/li&gt;&lt;li&gt;â€¢ hypoalbuminemia&lt;/li&gt;&lt;li&gt;â€¢ fluid retention&lt;/li&gt;&lt;li&gt;â€¢ SAAG&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;1.1 g/dL&lt;/li&gt;&lt;li&gt;â€¢ low&lt;/li&gt;&lt;li&gt;â€¢ protein content&lt;/li&gt;&lt;li&gt;â€¢ low&lt;/li&gt;&lt;li&gt;â€¢ loss of protein in urine&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tuberculosis: Ascites due to tuberculosis generally has a low SAAG (&amp;lt;1.1 g/dL) , and the ascitic fluid albumin level would be lower than in cirrhosis, but it would be associated with other features of TB , such as fever, weight loss , and a positive culture or PCR for Mycobacterium tuberculosis .&lt;/li&gt;&lt;li&gt;â€¢ Option D. Tuberculosis: Ascites due to tuberculosis&lt;/li&gt;&lt;li&gt;â€¢ low SAAG (&amp;lt;1.1 g/dL)&lt;/li&gt;&lt;li&gt;â€¢ lower&lt;/li&gt;&lt;li&gt;â€¢ other features of TB&lt;/li&gt;&lt;li&gt;â€¢ fever, weight loss&lt;/li&gt;&lt;li&gt;â€¢ positive culture&lt;/li&gt;&lt;li&gt;â€¢ PCR&lt;/li&gt;&lt;li&gt;â€¢ Mycobacterium tuberculosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A SAAG &amp;gt;1.1 g/dL , with low ascitic fluid albumin (as in this case), suggests portal hypertension , making cirrhosis the most likely cause of ascites.&lt;/li&gt;&lt;li&gt;âž¤ SAAG &amp;gt;1.1 g/dL&lt;/li&gt;&lt;li&gt;âž¤ low ascitic fluid albumin&lt;/li&gt;&lt;li&gt;âž¤ portal hypertension&lt;/li&gt;&lt;li&gt;âž¤ cirrhosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child is diagnosed with inflammatory bowel disease (IBD). What is the definition of very early onset IBD (VEOIBD)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IBD in patients &amp;lt;2 years old&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IBD in patients &amp;lt;4 years old&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IBD in patients &amp;lt;6 years old&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IBD in patients &amp;lt;10 years old&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IBD in patients &lt;6 years old&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)Â  IBD in patients &amp;lt;6 years old&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Very-early-onset IBD (VEOIBD) is defined as IBD in patients &amp;lt;6 years old . This category of IBD typically affects children who have a strong family history of IBD and involves a more severe disease course. It mainly affects the colon and is often resistant to standard medications . In some cases, these patients may develop complications such as growth retardation or intestinal failure .&lt;/li&gt;&lt;li&gt;â€¢ Very-early-onset IBD (VEOIBD)&lt;/li&gt;&lt;li&gt;â€¢ IBD in patients &amp;lt;6 years old&lt;/li&gt;&lt;li&gt;â€¢ strong family history of IBD&lt;/li&gt;&lt;li&gt;â€¢ colon&lt;/li&gt;&lt;li&gt;â€¢ resistant to standard medications&lt;/li&gt;&lt;li&gt;â€¢ growth retardation&lt;/li&gt;&lt;li&gt;â€¢ intestinal failure&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A. IBD in patients &amp;lt;2 years old: IBD in patients &amp;lt;2 years old is classified as infantile IBD , a more severe form that presents in early infancy and also affects the colon . It is even more resistant to standard treatments than VEOIBD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. IBD in patients &amp;lt;2 years old: IBD in patients &amp;lt;2 years old&lt;/li&gt;&lt;li&gt;â€¢ infantile IBD&lt;/li&gt;&lt;li&gt;â€¢ colon&lt;/li&gt;&lt;li&gt;â€¢ Option B. IBD in patients &amp;lt;4 years old: While this answer seems close, the correct age range for very-early-onset IBD is &amp;lt;6 years old , not &amp;lt;4 years old .&lt;/li&gt;&lt;li&gt;â€¢ Option B. IBD in patients &amp;lt;4 years old:&lt;/li&gt;&lt;li&gt;â€¢ very-early-onset IBD&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;6 years old&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;4 years old&lt;/li&gt;&lt;li&gt;â€¢ Option D. IBD in patients &amp;lt;10 years old: IBD in patients &amp;lt;10 years old is categorized as early-onset IBD (EOIBD) , which includes patients with IBD before the age of 10 but after 6 years old . This category does not include the very-early-onset cases, which are specifically defined as &amp;lt;6 years old .&lt;/li&gt;&lt;li&gt;â€¢ Option D. IBD in patients &amp;lt;10 years old: IBD in patients &amp;lt;10 years old&lt;/li&gt;&lt;li&gt;â€¢ early-onset IBD (EOIBD)&lt;/li&gt;&lt;li&gt;â€¢ IBD&lt;/li&gt;&lt;li&gt;â€¢ 6 years old&lt;/li&gt;&lt;li&gt;â€¢ very-early-onset&lt;/li&gt;&lt;li&gt;â€¢ &amp;lt;6 years old&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Very-early-onset IBD (VEOIBD) is defined as IBD in patients &amp;lt;6 years old and is associated with more severe disease, often affecting the colon and being resistant to standard treatment.&lt;/li&gt;&lt;li&gt;âž¤ Very-early-onset IBD (VEOIBD)&lt;/li&gt;&lt;li&gt;âž¤ IBD in patients &amp;lt;6 years old&lt;/li&gt;&lt;li&gt;âž¤ colon&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test5" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D Part 1   Mission 2.0 (Inicet)   16 09 2024   2024 09 16&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D Part 1   Mission 2.0 (Inicet)   16 09 2024   2024 09 16&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                75 Questions | 300 Total Marks | 85 min Duration | ~68.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 45-year-old asymptomatic male presents with a grade II diastolic murmur on routine physical exam. He has no other symptoms and physical examinations showed no abnormalities. ECG and chest X-ray are normal . What is the next best step for evaluation of his murmur?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac computed tomography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No further workup required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Echocardiogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-113011.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Echocardiogram&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Vishal, a 67-year-old owner of a wildly successful chain of fastfood restaurants. He complains of shortness of breath with exertion, lower extremity edema, and awakening at night feeling acutely short of breath. You wish to assess his volume status, and know that jugular venous pulse (JVP) assessment is the single most important bedside measurement to aid in this. Which of the following is true regarding the measurement?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Measurement of the elevation of the top of the jugular venous pulsation and the sternal inflection point (angle of Louis) will provide a highly accurate measurement of central venous pressure.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;If done properly, the angle of inclination matters little to the measurement of JVP.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;In normal patients, the JVP rises with inspiration due to the augmented volume loading of the right heart.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Venous pulsations above the clavicle in the sitting position are abnormal.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Venous pulsations above the clavicle in the sitting position are abnormal.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man who presents to your emergency department appearing quite ill. His family says he has not had his normal energy for the last 6 months, and they noted he appeared confused and lethargic for the last day or two. As you take a history from the family, you palpate the patientâ€™s radial pulse and notice a regular beat-to-beat variability of pulse amplitude although his rhythm is regular. Indeed, as you later take his blood pressure, you note that only every other phase I (systolic) Korotkoff sound is audible as the cuff pressure is slowly lowered, and that this is independent of the respiratory cycle. Based on this, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial fibrillation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe left ventricular dysfunction&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Severe left ventricular dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Severe left ventricular dysfunction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are working in the emergency department when a 65-year-old woman with a history of recently diagnosed lymphoma who has not started treatment or undergone staging yet. On presentation, she is markedly diaphoretic and dyspneic. SBP 70mm Hg on palpation, heart rate is 110 beats/min, and her radial pulse becomes difficult to palpate on inspiration. ECG of the patient is shown below. What pathology is present and accountable for her shock state?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute anterior myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myocardial amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pericardial effusion with tamponade&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pericardial effusion with tamponade&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-113430.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pericardial effusion with tamponade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are performing a right heart catheterization in a 45-year-old man with suspected pulmonary hypertension. You do indeed note elevated pulmonary arterial pressures, with a mean pulmonary arterial pressure of 45 mmHg. The patient is not hypoxemic. However, you also note the following oxygen saturations from each cardiac chamber: Superior vena cavaâ€”61% Inferior vena cavaâ€”65% Right atriumâ€”85% Right ventricleâ€”84% Pulmonary arteryâ€”84% You suspect which of the following based on this data?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial septal defect with left-to-right shunting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ventricular septal defect with left-to-right shunting&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventricular septal defect with right-to-left shunting&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atrial septal defect with left-to-right shunting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Atrial septal defect with left-to-right shunting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing Mr. Johnson who is a 24-year-old previously healthy marathon runner. He is in for his employer-required physical examination. ECG is shown below. Whatâ€™s the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;First-degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mobitz type I, second-degree heart block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mobitz type II, second-degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type III heart block&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mobitz type I, second-degree heart block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-113753.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mobitz type I, second-degree heart block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old woman with a history of hypertension, chronic obstructive pulmonary disease, diabetes mellitus, and osteoporosis presents to the emergency department after a fall at home followed immediately by intense left hip pain. She was found by a neighbor after several hours. The patient cannot remember if she lost consciousness. She is exquisitely tender to palpation over the left hip, and her leg is shortened and externally rotated. Her mucous membranes are dry and her skin tents easily. Blood pressure is 170/80 and her heart rate is 130 beats/min. She is dyspneic and wheezing. ECG taken and shown below. What is the most appropriate first step for her tachycardia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adenosine 6 mg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Direct current cardioversion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol 5 mg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pain control and IV hydration&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pain control and IV hydration&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-113931.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pain control and IV hydration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old man, recently diagnosed with multiple myeloma after presenting with fatigue from anemia and lower back pain. Further evaluation found malignant bone lesions in his thoracic and lumbar spine. He was started on multi-agent treatment 6 weeks ago and comes in for follow-up. He has been feeling well with decreased pain and denies any new side effects from treatment. He wants to know if his disease is responding to the current therapy. Which test would be the most helpful in assessing his response to treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complete blood count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluorodeoxyglucose-positron emission tomography scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Flow cytometry&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Monoclonal immunoglobulin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Monoclonal immunoglobulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Monoclonal immunoglobulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 69-year-old woman with metastatic thyroid cancer. Her cancer is progressing now after three different therapies. Her oncologist recommends that she join a clinical trial. After searching on the Internet, she finds a trial that she is eligible for and sounds interesting. The trial is testing a new drug, drug x. The main end point of the trial is to determine the maximally tolerated dose of drug x. What phase of drug development is drug x currently in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phase I&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phase II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phase III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phase IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Phase I&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Phase I&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man with a 40 pack-year smoking history. He finally quit last year when he started to develop shortness of breath. His shortness of breath has continued to progress to the point where he is short of breath even at rest. He did not want to go to the doctor, but his daughter finally convinced him to go to the emergency room. There CT imaging revealed a 3-cm left-sided peripheral nodule with three ipsilateral enlarged lymph nodes and a larger left pleural effusion. Lung cancer is suspected, so biopsy of the lung nodule is obtained. What is the next best step in management and why?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Await pathology results because if the patient has a KRAS mutation, targeted treatments can be offered.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Await pathology results because if the patient has an EGFR mutation, targeted treatments can be offered.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Consult medical oncology for emergent chemotherapy while hospitalized.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Consult radiation oncology for emergent radiation therapy while hospitalized.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Await pathology results because if the patient has an EGFR mutation, targeted treatments can be offered.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Await pathology results because if the patient has an EGFR mutation, targeted treatments can be offered.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old woman returns to your clinic after being â€œlost to follow-upâ€ for 3 years. She reports that she was diagnosed with left-sided, stage I, estrogen/progesterone receptorâ€“ positive breast cancer 3 years ago. She was then treated with surgery, radiation, and adjuvant hormonal therapy. She did not receive chemotherapy. She reports that she has been doing well, without any symptoms currently. Her last mammogram was 15 months ago. Her CA 27-29 level was 40 U/mL at the time of diagnosis. Which of the following tests would be recommended for her now?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT chest, abdomen, pelvis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mammogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum chemistry studies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mammogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mammogram&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are caring for a 17-year-old boy after repair of muscular ventricular septal defect; he is postoperative day number 1 and doing well. The nurse pages you that he suddenly had a rise in heart rate. Given your clinical savvy and knowledge gleaned from hours of study, you suspect junctional ectopic tachycardia (JET). All of the statements regarding JET are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoproterenol administration may induce JET.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is due to reentry within the atrioventricular node (AV).&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is more common in children.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It may commonly be seen after cardiac surgery or ablation procedures in the AV node.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. It is due to reentry within the atrioventricular node (AV).&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) It is due to reentry within the atrioventricular node (AV).&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 86-year-old man with long-standing heart failure. He presents with the acute onset of palpitations, weakness, dizziness, and dyspnea. On arrival, his skin is cool and clammy, and he is sleepy. He will arouse to a loud voice, but he is not oriented and quickly becomes obtunded. His heart rate is irregularly irregular at 160 beats/min and his blood pressure is 50/30. STAT 12-lead electrocardiogram confirms atrial fibrillation with rapid ventricular response. Which of the following is the most reasonable next therapeutic step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;200-J QRS-synchronous shock&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenosine 6 mg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Digoxin 500 mcg IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Metoprolol 5 mg IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 200-J QRS-synchronous shock&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) 200-J QRS-synchronous shock&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old man with known sickle cell anemia is admitted to the intensive care unit with diffuse body pain, shortness of breath, fever, and cough. He started having a bone pain crisis 1 day ago and tried to treat it at home with oral hydration. On examination, his blood pressure and heart rate are elevated, and he is in obvious pain and respiratory discomfort. His room air SaO2 is 83% and increases to 91% on a nonrebreather oxygen face mask. His chest radiograph shows bilateral diffuse alveolar infiltrates. This is his third similar episode in the last 12 months. All of the statements regarding his condition are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic therapy with oral hydroxyurea should be considered.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;He is having sickle cell acute chest syndrome.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;He should receive daily sildenafil.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hematocrit should be maintained&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. He should receive daily sildenafil.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) He should receive daily sildenafil.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Anbu, 58 years old male is admitted with an anterior myocardial infarction after watching India losing in a cricket World cup final again. He undergoes timely revascularization with a stent to the left anterior descending artery. In the intensive care unit afterward, you notice frequent premature ventricular contractions but no ventricular tachycardia. You draw a set of electrolytes that finds a potassium of 3.2 mEq/L (normal 3.5â€“5.1) and magnesium of 1.1 mEq/L (normal 1.3â€“3.1). All of the following are indicated in this setting EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV lidocaine.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Magnesium repletion.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Potassium repletion.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV lidocaine.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV lidocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old post-menopausal woman is seen for onset of severe dyspnea over the last few weeks. She reports no preceding chest pain, cough, sputum, or fever, although she does report leg swelling. Physical examination is notable for a blood pressure of 145/78 mmHg and heart rate of 123 beats/min. Exophthalmos is present as well as bilateral inspiratory crackles approximately occupying one-third of the lower chest with neck vein distention. She has a third heart sound with no murmur. Bilateral lower extremity edema is also present with warm extremities and a fine hand tremor. Which of the following is the most likely pathophysiologic explanation for her heart failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anemia with high-output state&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic systemic hypertension with resultant left ventricular hypertrophy and non-systolic heart failure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myocardial infarction with depressed left ventricular systolic function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thyrotoxicosis with high-output state&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Thyrotoxicosis with high-output state&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Thyrotoxicosis with high-output state.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyrotoxicosis can cause high-output heart failure. Recognizing the signs and symptoms of thyrotoxicosis is crucial for prompt diagnosis and management.&lt;/li&gt;&lt;li&gt;âž¤ Thyrotoxicosis can cause high-output heart failure.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the signs and symptoms of thyrotoxicosis is crucial for prompt diagnosis and management.&lt;/li&gt;&lt;li&gt;âž¤ In patients presenting with heart failure, consider a broad differential diagnosis, including less common causes like thyrotoxicosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old man returns to the acute care clinic complaining of 1 day of worsening malaise, weakness, abdominal pain, and discolored dark urine. He was at the clinic yesterday where he was diagnosed with a possible staphylococcal skin carbuncle and treated with empiric trimethoprim/sulfamethoxazole. His physical examination is notable for mild jaundice, normal vital signs, and no focal findings other than the carbuncle in his left axilla. His complete blood count shows that his hemoglobin has fallen from 13 to 8 g/dL and his bilirubin has gone from normal to 3.0 mg/dL. His urine dipstick is positive for bilirubin. A peripheral blood smear is obtained and shown below. Which of the following is the most likely cause of his new anemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucose 6-phosphate dehydrogenase deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic-uremic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron-deficiency anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glucose 6-phosphate dehydrogenase deficiency&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-114307.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glucose 6-phosphate dehydrogenase deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;On yearly labs done to follow a 40-year-old patient with a history of iron-deficiency anemia, you notice the development of new thrombocytosis with a platelet count of 750 Ã— 109/L. All of the following statements regarding thrombocytosis are true EXCEPT&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron-deficiency anemia can cause thrombocytosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients with essential thrombosis have a similar survival compared with the general population.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The incidence of thrombosis in this patient is no higher than age-matched controls.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment with aspirin should be started immediately.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Treatment with aspirin should be started immediately.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Treatment with aspirin should be started immediately.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man presents to the emergency department with shortness of breath. He is found to have an elevated serum B-type natriuretic peptide (BNP). In addition to heart failure, all of the following may also cause an elevation in BNP EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Advanced age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Female gender&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary embolism with right heart strain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Obesity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Obesity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing Mr. Whaley in the clinic today. He is a 67-year-old man with no past medical history. He has symptoms of heart failure with orthopnea and limited exercise tolerance. On a 12-lead electrocardiogram he has both PR prolongation and multifocal premature ventricular contractions. Echocardiogram shows dilated left ventricular size and reduced function. Endomyocardial biopsy is shown below. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac sarcoidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chagas disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lyme myocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tuberculous myocarditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cardiac sarcoidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-114924.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cardiac sarcoidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old man presents to your office requesting to be taken off of his antiepileptic drugs. He was in an automobile accident at the age of 12, resulting in significant head trauma. He was in a medically induced coma for 6 weeks and had intracranial edema with generalized tonic-clonic seizures at that time. These persisted for several years afterward. The last seizure he is aware of occurred at the age of 18 and was generalized. He continues to take valproic acid 1000 mg bid. On physical examination, he demonstrates normal cognition and affect. He has ongoing focal weakness involving his left lower extremity with spasticity. You refer him for a sleep-deprived electroencephalogram, which shows no evidence of focal abnormalities. Which of the following factors is of greatest concern regarding his risk of recurrent seizures?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Focal defect on neurologic examination&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Generalized seizure disorder&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Head trauma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Seizure within the last 7 years&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Focal defect on neurologic examination&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Focal defect on neurologic examination:&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60 years old male, presents to you in the emergency department with acute-onset dysarthria and confusion. You make the diagnosis of stroke clinically. What is the next appropriate step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin 81 mg by mouth&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT of the brain&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Heparin IV drip&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tissue plasminogen activator&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CT of the brain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CT of the brain&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65 years old male, is in the clinic after recent discharge for an ischemic stroke. He was prescribed aspirin as a secondary prevention measure. How long does the platelet antiaggregating effect of aspirin last?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;12 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;1 day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;6 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;8 days&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 8 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old woman with 1 year of progressive memory loss. She has had difficulties with executive functioning especially over the last 6 months. You note that she has an ataxic gait and her family mentions that she has had worsening urinary incontinence as well. Neuroimaging reveals enlarged lateral ventricles (hydrocephalus) with little or no cortical atrophy. Which of the following is the most effective method of diagnosis of the likely etiology of her dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brain biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cisternography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Close observation after lumbar puncture and removal of 30â€“50 cc of cerebrospinal fluid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Electroencephalogram&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Close observation after lumbar puncture and removal of 30â€“50 cc of cerebrospinal fluid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Close observation after lumbar puncture and removal of 30â€“50 cc of cerebrospinal fluid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old man presents with symptoms of tremor and a generalized feeling of slowing down. His tremor bothers him most on his left side. His past medical history is significant for depression, hypertension, and hyperlipidemia. He is taking fluoxetine 40 mg daily, lisinopril 40 mg daily, and atorvastatin 20 mg daily. On physical examination, he has a resting tremor with presence of cogwheel rigidity. When observing his gait, you note slow, shuffling steps with difficulty maneuvering to turn around. His facial features show decreased range of emotion and appears somewhat flat. Eye movements are full. Mental status examination shows normal mentation. You suspect Parkinson disease. Which of the following is the first choice of therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Levodopa-carbidopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rotigotine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Selegiline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Any of the above can be used&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Any of the above can be used&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Any of the above can be used&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The initial treatment for Parkinson&#x27;s disease should be tailored to the individual patient, considering various factors such as age, disease severity, comorbidities, and patient preferences. All three options (levodopa-carbidopa, dopamine agonists, and MAO-B inhibitors) are potential first-line therapies&lt;/li&gt;&lt;li&gt;âž¤ The initial treatment for Parkinson&#x27;s disease should be tailored to the individual patient, considering various factors such as age, disease severity, comorbidities, and patient preferences.&lt;/li&gt;&lt;li&gt;âž¤ All three options (levodopa-carbidopa, dopamine agonists, and MAO-B inhibitors) are potential first-line therapies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a patient with a clinical syndrome suggesting Huntington disease (HD). He is inquiring about genetic testing. Which of the following is true regarding the genetic basis of HD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HD is sporadic and not genetically based.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HD is caused by an autosomal dominant mutation in the aTTR gene.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HD is caused by an increase in polyglutamine repeats in the huntingtin gene.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HD is caused by mutations in the CFTR gene&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HD is caused by an increase in polyglutamine repeats in the huntingtin gene.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Huntington&#x27;s disease is an autosomal dominant neurodegenerative disorder caused by an expanded CAG repeat in the HTT gene, leading to an abnormal polyglutamine tract in the huntingtin protein. Genetic testing can confirm the diagnosis in individuals with suspected HD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Strokes can be divided into hemorrhagic and ischemic types with subtypes within those types. Which subtype of stroke has the strongest association with cognitive impairment and vascular dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemorrhagic stroke, subarachnoid subtype&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemorrhagic stroke, subdural subtype&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ischemic stroke, large vessel subtype&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic stroke, small vessel subtype&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ischemic stroke, small vessel subtype&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ischemic stroke, small vessel subtype&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Small vessel ischemic strokes (lacunar strokes) are strongly associated with the development of vascular dementia due to their cumulative effect on subcortical structures, leading to cognitive impairment over time.&lt;/li&gt;&lt;li&gt;âž¤ Small vessel ischemic strokes&lt;/li&gt;&lt;li&gt;âž¤ vascular dementia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents with fatigue, dark urine in the morning, and shortness of breath. She has a history of recurrent venous thrombosis. Her labs show hemoglobin of 8.5 g/dL, elevated lactate dehydrogenase (LDH), and low haptoglobin. Given the likely diagnosis, which of the following flow cytometry findings will be seen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Absence of CD55 and CD59 on red blood cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased CD19 and CD20 on lymphocytes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased CD4/CD8 ratio on T cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased expression of CD5 on B cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Absence of CD55 and CD59 on red blood cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Absence of CD55 and CD59 on red blood cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In PNH , flow cytometry will reveal the absence of CD55 and CD59 on red blood cells, confirming the diagnosis of this hemolytic disorder.&lt;/li&gt;&lt;li&gt;âž¤ PNH&lt;/li&gt;&lt;li&gt;âž¤ absence of CD55 and CD59&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman with a long-standing history of asthma, comes to the emergency department complaining of shortness of breath typical of her asthma exacerbations after visiting a friendâ€™s who had seven cats in the house. On examination, she has diffuse bilateral polyphonic wheezes and is using accessory muscles to breathe. Her initial arterial blood gas on room air shows a pH of 7.34, PaCO2 of 32 mmHg, and PaO2 of 48 mmHg. After placing her on 40% oxygen by face mask, a repeat PaO2 is 200 mmHg and PaCO2 is 32 mmHg. The most likely cause of her initial hypoxemia was:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alveolar hypoventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diffusion defect&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Shunt&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ventilation-perfusion mismatch&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ventilation-perfusion mismatch&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ventilation-perfusion mismatch&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common cause of hypoxemia in asthma is V/Q mismatch. V/Q mismatch responds well to supplemental oxygen, as demonstrated by the significant improvement in PaO2 in this patient. Recognizing the underlying mechanism of hypoxemia is crucial for appropriate management of respiratory conditions.&lt;/li&gt;&lt;li&gt;âž¤ The most common cause of hypoxemia in asthma is V/Q mismatch.&lt;/li&gt;&lt;li&gt;âž¤ V/Q mismatch responds well to supplemental oxygen, as demonstrated by the significant improvement in PaO2 in this patient.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the underlying mechanism of hypoxemia is crucial for appropriate management of respiratory conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old quarry worker presents for evaluation because of an abnormal chest radiograph that was obtained by his primary care physician to investigate a chronic cough. The radiograph shows poorly defined upper lobe nodules, as well as enlarged hilar lymph nodes with eggshell calcifications. A purified protein derivative (PPD) was placed by the primary care physician, and it is positive in your office 2 days later. Which of the following is likely true about this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;False-positive PPDs are common in patients exposed to silicate dust.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The patient likely has active pulmonary tuberculosis (TB) and needs to be isolated immediately.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The patient likely has latent TB and given the possibility of underlying silicosis he should be treated for a longer period of time.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The patient needs an urgent surgical biopsy to exclude active TB and diagnose the cause of the lung disease.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. The patient likely has latent TB and given the possibility of underlying silicosis he should be treated for a longer period of time.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) The patient likely has latent TB and given the possibility of underlying silicosis he should be treated for a longer period of time.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Silicosis increases the risk of developing active TB. A positive PPD in a patient with silicosis warrants careful evaluation for active TB and consideration for prolonged LTBI treatment. Management should involve both pulmonologists and infectious disease specialists.&lt;/li&gt;&lt;li&gt;âž¤ Silicosis increases the risk of developing active TB.&lt;/li&gt;&lt;li&gt;âž¤ A positive PPD in a patient with silicosis warrants careful evaluation for active TB and consideration for prolonged LTBI treatment.&lt;/li&gt;&lt;li&gt;âž¤ Management should involve both pulmonologists and infectious disease specialists.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man with a long history of cigarette smoking comes to see you for a 4-month history of progressive shortness of breath and dyspnea on exertion. The symptoms have been indolent, with no recent worsening. He denies fever, chest pain, or hemoptysis. He has a daily cough of 3â€“6 tablespoons of yellow phlegm. The patient says he has not seen a physician for over 10 years. Physical examination is notable for normal vital signs, a prolonged expiratory phase, scattered rhonchi, elevated jugular venous pulsation, and moderate pedal edema. Hematocrit is 49%. Which of the following therapies is most likely to prolong his survival?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atenolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enalapril&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;LTOT (Long-term oxygen therapy)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. LTOT (Long-term oxygen therapy)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) LTOT (Long-term oxygen therapy)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LTOT is the only therapy proven to improve survival in patients with COPD and chronic hypoxemia. Other medications like bronchodilators and inhaled corticosteroids can improve symptoms and quality of life but do not directly impact survival.&lt;/li&gt;&lt;li&gt;âž¤ LTOT is the only therapy proven to improve survival in patients with COPD and chronic hypoxemia.&lt;/li&gt;&lt;li&gt;âž¤ Other medications like bronchodilators and inhaled corticosteroids can improve symptoms and quality of life but do not directly impact survival.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 37-year-old female presents with several months of dry cough, with worsening dyspnea on exertion. She is a non-smoker. In addition to her respiratory complaints, she notes worsening fatigue, intermittent low-grade fevers, and aches in her thighs and lower back. She has a history of Raynaud syndrome in the past and also notes severe dry skin with cracking on the sides of her thumbs and index fingers over the last month that she attributes to doing the dishes more frequently at home. Chest CT reveals diffuse subpleural, symmetric, ground glass, and reticular opacities with perhaps some early traction bronchiectasis at the bases. Which of the following would most likely yield the correct diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoscopy with bronchoalveolar lavage and transbronchial biopsies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Purified protein derivative skin testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serologies for anti-synthetase antibodies including Jo-1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum precipitins against common environmental exposures such as thermophilic bacteria and bird antigens&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Serologies for anti-synthetase antibodies including Jo-1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Serologies for anti-synthetase antibodies including Jo-1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Antisynthetase syndrome is a rare but important cause of interstitial lung disease. Recognizing the constellation of symptoms and findings (ILD, Raynaud&#x27;s phenomenon, mechanic&#x27;s hands, myalgias) can lead to early diagnosis and treatment. Serologic testing for anti-synthetase antibodies, including anti-Jo-1, is crucial in confirming the diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ Antisynthetase syndrome is a rare but important cause of interstitial lung disease.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the constellation of symptoms and findings (ILD, Raynaud&#x27;s phenomenon, mechanic&#x27;s hands, myalgias) can lead to early diagnosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ Serologic testing for anti-synthetase antibodies, including anti-Jo-1, is crucial in confirming the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man is evaluated for dyspnea on exertion that has progressively worsened over a period of 10 months. He has a 50 pack-year history of tobacco, quitting 10 years ago. On physical examination, has a resting oxygen saturation of 94%. After ambulation of 100 m, his oxygen saturation drops to 84%. His lung examination shows diffuse end-inspiratory crackles throughout both lungs. His total lung capacity is 72% predicted, residual volume is 68% predicted, and diffusing capacity is 60% predicted. The chest CT is shown below. Serologic workup for autoimmune disease is unremarkable, and thorough history yields no exposures that would lead to these findings. Given the likely diagnosis, What is the expected finding on surgical pathology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Desquamative interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loosely organized granulomatous inflammation and fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nonspecific interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Usual interstitial pneumonia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Usual interstitial pneumonia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-115316.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Usual interstitial pneumonia (UIP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Idiopathic pulmonary fibrosis is a chronic, progressive lung disease with a poor prognosis. The diagnosis of IPF is based on a combination of clinical features, pulmonary function tests, and imaging findings suggestive of UIP. Surgical lung biopsy is often needed to confirm the diagnosis and exclude other interstitial lung diseases. UIP on biopsy is the hallmark of IPF.&lt;/li&gt;&lt;li&gt;âž¤ Idiopathic pulmonary fibrosis is a chronic, progressive lung disease with a poor prognosis.&lt;/li&gt;&lt;li&gt;âž¤ The diagnosis of IPF is based on a combination of clinical features, pulmonary function tests, and imaging findings suggestive of UIP.&lt;/li&gt;&lt;li&gt;âž¤ Surgical lung biopsy is often needed to confirm the diagnosis and exclude other interstitial lung diseases.&lt;/li&gt;&lt;li&gt;âž¤ UIP on biopsy is the hallmark of IPF.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with a body mass index of 32 has recently been diagnosed with obstructive sleep apnea with an apnea-hypopnea index of 13 per hour. He does not have a history of snoring. He presents to the clinic for follow-up because he has tried wearing continuous positive airway pressure (CPAP) at home but has not felt comfortable with it. He asks if there are other potential treatment options for his sleep apnea. Which of the following would be a possible alternative therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bariatric surgery.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;An oral appliance.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Supplementation oxygen.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Upper airway neurostimulation is the preferred treatment of mild sleep apnea in patients who have failed CPAP therapy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. An oral appliance.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) An oral appliance.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The choice of OSA treatment depends on the severity of the condition (AHI) and the patient&#x27;s individual preferences and tolerance to different therapies. In mild OSA, oral appliances are a good alternative for patients who cannot tolerate CPAP. For moderate to severe OSA, other options like upper airway neurostimulation or, in specific cases, bariatric surgery may be considered.&lt;/li&gt;&lt;li&gt;âž¤ The choice of OSA treatment depends on the severity of the condition (AHI) and the patient&#x27;s individual preferences and tolerance to different therapies.&lt;/li&gt;&lt;li&gt;âž¤ In mild OSA, oral appliances are a good alternative for patients who cannot tolerate CPAP.&lt;/li&gt;&lt;li&gt;âž¤ For moderate to severe OSA, other options like upper airway neurostimulation or, in specific cases, bariatric surgery may be considered.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with progressive shortness of breath and chest discomfort. He worked in shipbuilding for 30 years and retired 10 years ago. Gives a history of significant weight loss around 5-6kg in a span of 6 months. His chest X-ray shows pleural thickening and a right-sided pleural effusion. A CT scan reveals pleural plaques. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Idiopathic pulmonary fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchogenic carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mesothelioma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Silicosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mesothelioma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mesothelioma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mesothelioma is strongly associated with asbestos exposure and typically presents with pleural thickening , pleural effusions , and pleural plaques on imaging. This distinguishes it from other pulmonary diseases caused by occupational exposures.&lt;/li&gt;&lt;li&gt;âž¤ Mesothelioma&lt;/li&gt;&lt;li&gt;âž¤ asbestos exposure&lt;/li&gt;&lt;li&gt;âž¤ pleural thickening&lt;/li&gt;&lt;li&gt;âž¤ pleural effusions&lt;/li&gt;&lt;li&gt;âž¤ pleural plaques&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man has a history of splenectomy following trauma at the age of 20. He received appropriate vaccinations immediately after his trauma but has not had any medical care for more than 10 years. He is homeless. He presents to the emergency department with a fever of 102.3Â°F (39.1Â°C), blood pressure of 70/40, heart rate of 130 beats/min respiratory rate of 30 breaths/min, and oxygen saturation of 95% on room air. What is the best initial antibiotic therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftriaxone and vancomycin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ceftriaxone, ampicillin, and vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftriaxone, vancomycin, and amphotericin B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clindamycin, gentamicin, and vancomycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ceftriaxone and vancomycin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Ceftriaxone and vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In asplenic patients with suspected sepsis , empiric antibiotic therapy should target encapsulated organisms . Ceftriaxone and vancomycin provide broad-spectrum coverage for these pathogens, including resistant Gram-positive organisms.&lt;/li&gt;&lt;li&gt;âž¤ sepsis&lt;/li&gt;&lt;li&gt;âž¤ encapsulated organisms&lt;/li&gt;&lt;li&gt;âž¤ Ceftriaxone and vancomycin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old male with a past medical history of alcoholic cirrhosis presented with 3 days of right calf pain, chills, fevers, malaise, and a bullous rash on the right lower extremity after a meal of crab cakes and oysters as shown in image below. He presents to the emergency department with a fever of 39.1Â°C (102.3Â°F), blood pressure of 85/50, heart rate of 130 beats/min, respiratory rate of 30 breaths/min, and oxygen saturation of 95% on room air. What antibiotics should you initiate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Doxycycline and ceftriaxone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Moxifloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trimethoprim/sulfamethoxazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Doxycycline and ceftriaxone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-115858.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Doxycycline and ceftriaxone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with cirrhosis who present with sepsis after consuming shellfish, consider Vibrio vulnificus infection. Empiric therapy should include doxycycline and ceftriaxone for optimal coverage.&lt;/li&gt;&lt;li&gt;âž¤ cirrhosis&lt;/li&gt;&lt;li&gt;âž¤ Vibrio vulnificus&lt;/li&gt;&lt;li&gt;âž¤ doxycycline&lt;/li&gt;&lt;li&gt;âž¤ ceftriaxone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman is traveling to Kenya for a safari. She has no past medical history and is not taking any other medications. All of the following may be recommended for prophylaxis against malaria for this patient EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atovaquone-proguanil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloroquine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mefloquine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chloroquine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chloroquine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For travelers to chloroquine-resistant regions such as Kenya, options for malaria prophylaxis include atovaquone-proguanil , doxycycline , or mefloquine . Chloroquine is ineffective due to widespread resistance in these areas.&lt;/li&gt;&lt;li&gt;âž¤ chloroquine-resistant regions&lt;/li&gt;&lt;li&gt;âž¤ atovaquone-proguanil&lt;/li&gt;&lt;li&gt;âž¤ doxycycline&lt;/li&gt;&lt;li&gt;âž¤ mefloquine&lt;/li&gt;&lt;li&gt;âž¤ Chloroquine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old woman presents with 3 days of fever and 1 day of severe pain in her left knee to the point where she can no longer stand. She has no past medical history. She is not sexually active. On examination, her temperature is 38.3Â°C. Her heart rate is 100 beats/min, with blood pressure of 128/75 mm/Hg. Her left knee is tender, with erythema and a palpable effusion. Her cardiac, lung, and abdominal examinations are all normal. Which of the following should you do?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Draw blood cultures and perform joint aspiration.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Draw blood cultures, perform an x-ray of the left knee, and initiate vancomycin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Draw blood cultures, perform joint aspiration, and initiate vancomycin.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate vancomycin and perform an x-ray of the left knee.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Draw blood cultures, perform joint aspiration, and initiate vancomycin.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Draw blood cultures, perform joint aspiration, and initiate vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with a swollen, erythematous, and painful joint with fever, the priority is to perform joint aspiration to confirm septic arthritis and initiate empiric antibiotics like vancomycin to cover likely pathogens such as Staphylococcus aureus . Blood cultures should also be drawn to assess for bacteremia.&lt;/li&gt;&lt;li&gt;âž¤ perform joint aspiration&lt;/li&gt;&lt;li&gt;âž¤ septic arthritis&lt;/li&gt;&lt;li&gt;âž¤ vancomycin&lt;/li&gt;&lt;li&gt;âž¤ Staphylococcus aureus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 82-year-old woman with dementia has been living in a nursing home for 5 years. She was seen by her primary care provider for evaluation of diarrhea 4 weeks ago. At that time, a stool sample was positive by polymerase chain reaction (PCR) confirms the diagnosis, and she was treated with oral metronidazole with some improvement in her symptoms. However, she has had five loose bowel movements per day starting 4 days ago and now has abdominal tenderness. Stool PCR remains positive. Colonoscopy was done and the image is shown below. Which of the following is the most appropriate therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fecal microbiota transplantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral metronidazole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral nitazoxanide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral vancomycin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Oral vancomycin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-120301.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Oral vancomycin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For recurrent Clostridioides difficile infection , oral vancomycin is the treatment of choice, especially after metronidazole failure. In cases of multiple recurrences, fecal microbiota transplantation may be considered.&lt;/li&gt;&lt;li&gt;âž¤ recurrent Clostridioides difficile infection&lt;/li&gt;&lt;li&gt;âž¤ oral vancomycin&lt;/li&gt;&lt;li&gt;âž¤ fecal microbiota transplantation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old female college student with no past medical history presents with 3 days of fever, headache, and agitation. On presentation to the emergency department, she experiences a seizure. On examination, she has a blood pressure of 120/70, heart rate of 90 beats/min, and respiratory rate of 16 breaths/min. Her temperature is 38.3Â°C. She does not respond verbally to any questions or follow any commands. Her strength is intact in her upper and lower extremities and her reflexes are normal. Examination of her cerebrospinal fluid demonstrates a white blood cell count of 15 cells/Î¼L, a red blood cell count of 500 cells/Î¼L, glucose of 60, and protein of 100. While awaiting further tests, what treatment could you initiate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftriaxone IV and vancomycin IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ampicillin IV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acyclovir IV&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ganciclovir IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acyclovir IV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acyclovir IV&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with suspected HSV encephalitis , which is suggested by CSF findings of lymphocytic pleocytosis, elevated RBCs, and altered mental status, early initiation of IV acyclovir is critical while awaiting confirmatory testing like PCR.&lt;/li&gt;&lt;li&gt;âž¤ HSV encephalitis&lt;/li&gt;&lt;li&gt;âž¤ IV acyclovir&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old woman with a recently worsening tremor. She notes that it predominantly affects her hands and is worse with action such as trying to eat. It is not present at rest. It is improved by drinking 1â€“2 beers. She has no other symptoms. On examination, her resting heart rate is 52 beats/min with normal vital signs otherwise. Which of the following is the best initial therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilateral hand botulinum toxin injections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;L-dopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primidone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Primidone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Primidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with essential tremor who also have bradycardia , primidone is a better choice for initial therapy than propranolol, as it avoids the risk of worsening the bradycardia.&lt;/li&gt;&lt;li&gt;âž¤ essential tremor&lt;/li&gt;&lt;li&gt;âž¤ bradycardia&lt;/li&gt;&lt;li&gt;âž¤ primidone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman came to the emergency department with fever and sore throat. On examination, she has extensive submandibular and cervical swelling present. Patientâ€™s oral cavity is shown below. A rapid strep test is negative. The patient is at risk for which of the following complications of this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Epidural abscess&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Meningitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myocarditis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Myocarditis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-120629.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Myocarditis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diphtheria presents with a pseudomembrane in the throat and can lead to serious complications like myocarditis due to the systemic effects of the diphtheria toxin. Prompt recognition and treatment with diphtheria antitoxin and antibiotics are essential.&lt;/li&gt;&lt;li&gt;âž¤ Diphtheria&lt;/li&gt;&lt;li&gt;âž¤ pseudomembrane&lt;/li&gt;&lt;li&gt;âž¤ myocarditis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old woman presents for neurologic evaluation after experiencing a severe burn on the palm of her right hand. She had placed her hand onto the hot surface of a smooth electric range. She did not feel the burn when it occurred and only when she picked her hand up did she notice the burn. After that, it was discovered that the patient unknowingly has bilateral loss of pain and temperature sensation in both hands. However, she does have touch and vibratory sense. Mapping of her loss of sensation shows decreased pain sensation in the nape of her neck, shoulders, and upper arms as well in a cape-like distribution. Deep tendon reflexes are absent at the biceps and triceps, and there is visible muscle wasting of the right biceps and shoulder musculature. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arteriovenous malformation of the spine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neoplastic spinal cord compression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute combined degeneration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Syringomyelia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Syringomyelia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Syringomyelia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Syringomyelia is a condition characterized by a fluid-filled cavity within the spinal cord, causing a cape-like distribution of sensory loss and muscle weakness/atrophy. It&#x27;s important to recognize the classic presentation of syringomyelia and differentiate it from other spinal cord disorders. MRI is the imaging modality of choice for diagnosing syringomyelia.&lt;/li&gt;&lt;li&gt;âž¤ Syringomyelia is a condition characterized by a fluid-filled cavity within the spinal cord, causing a cape-like distribution of sensory loss and muscle weakness/atrophy.&lt;/li&gt;&lt;li&gt;âž¤ It&#x27;s important to recognize the classic presentation of syringomyelia and differentiate it from other spinal cord disorders.&lt;/li&gt;&lt;li&gt;âž¤ MRI is the imaging modality of choice for diagnosing syringomyelia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 23-year-old woman who is 3 months pregnant and is sexually active. She has been experiencing dysuria and vaginal discharge. Gram stain of her vaginal discharge is shown in the image below. She has no known medication allergies. Which of the following is the most reasonable medical regimen for the treatment of her infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftriaxone 250 mg IM once&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ceftriaxone 250 mg IM and azithromycin 1 g orally once&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ceftriaxone 250 mg IM once and doxycycline 100 mg orally twice daily for 7 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ciprofloxacin 500 mg twice daily for 10 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ceftriaxone 250 mg IM and azithromycin 1 g orally once&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-120747.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ceftriaxone 250 mg IM and azithromycin 1 g orally once&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In pregnant women with Neisseria gonorrhoeae infection, the treatment regimen should include Ceftriaxone and Azithromycin , which are both safe in pregnancy and cover the risk of co-infection with Chlamydia trachomatis .&lt;/li&gt;&lt;li&gt;âž¤ Neisseria gonorrhoeae&lt;/li&gt;&lt;li&gt;âž¤ Ceftriaxone&lt;/li&gt;&lt;li&gt;âž¤ Azithromycin&lt;/li&gt;&lt;li&gt;âž¤ Chlamydia trachomatis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of hypertension, diabetes, and chronic low back pain presents to the clinic for follow-up. His physical examination is unremarkable with no edema or jugular venous distension. Recent laboratory testing shows a decreased glomerular filtration rate of 55 mL/min/1.73 m2. His hemoglobin A1c is 5.4%. He is currently on metformin, naproxen, and hydrochlorothiazide. What medication change could help slow his progression of chronic kidney disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Discontinue metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Discontinue Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Substitute lisinopril for hydrochlorothiazide&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Substitute lisinopril for hydrochlorothiazide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Substitute lisinopril for hydrochlorothiazide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors or ARBs are essential in slowing CKD progression in patients with hypertension and/or diabetes.&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors or ARBs are essential in slowing CKD progression in patients with hypertension and/or diabetes.&lt;/li&gt;&lt;li&gt;âž¤ In this case, substituting lisinopril for hydrochlorothiazide would provide better blood pressure control and renal protection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man presents with rapidly progressive weakness over 2 days, including difficulty standing and lifting his arms. He also reports tingling in his hands and feet and sharp pains in his shoulders and spine. His blood pressure has dropped from 138/82 to 92/50, and he has absent deep tendon reflexes in the lower extremities. Which of the following features would most commonly accompany this patientâ€™s history?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A diagnosis of â€œwalking pneumoniaâ€ that was treated with azithromycin 2 weeks prior to presentation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;An acute diarrheal illness 2 weeks prior to presentation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of a massive mediastinal lymphadenopathy on chest radiograph&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Presence of a monoclonal gammopathy of unknown significance on laboratory testing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. An acute diarrheal illness 2 weeks prior to presentation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) An acute diarrheal illness 2 weeks prior to presentation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Guillain-BarrÃ© syndrome (GBS) often follows an acute diarrheal illness and presents with rapidly progressive weakness, areflexia, and autonomic dysfunction. Early recognition and management are crucial to prevent respiratory failure.&lt;/li&gt;&lt;li&gt;âž¤ Guillain-BarrÃ© syndrome (GBS)&lt;/li&gt;&lt;li&gt;âž¤ acute diarrheal illness&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 33-year-old previously healthy woman presents to the emergency department with malaise, confusion, and fever of 37.8Â°C (100.1Â°F). She had no preceding diarrheal illness. CT of the head is unremarkable. She is found to have platelets of 13,000/cu, hemoglobin of 9.0 g/dL, and creatinine of 2.3 mg/dL. Urinalysis shows pH 5.0, protein 1+, and 11 red blood cells/high-powered field. Which of the following laboratory findings would be expected with her diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ADAMSTS13 &amp;lt;10%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-glomerular basement membrane antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased lactate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Positive direct Coombs test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ADAMSTS13 &lt;10%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) ADAMSTS13 &amp;lt;10%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TTP is a medical emergency characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction. A low ADAMTS13 level (&amp;lt;10%) is a key diagnostic finding in TTP. Prompt recognition and treatment with plasma exchange are crucial to improve outcomes.&lt;/li&gt;&lt;li&gt;âž¤ TTP is a medical emergency characterized by microangiopathic hemolytic anemia, thrombocytopenia, and organ dysfunction.&lt;/li&gt;&lt;li&gt;âž¤ A low ADAMTS13 level (&amp;lt;10%) is a key diagnostic finding in TTP.&lt;/li&gt;&lt;li&gt;âž¤ Prompt recognition and treatment with plasma exchange are crucial to improve outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications used to treat multiple sclerosis is highly effective and targets CD20 on the surface of mature B cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fingolimod&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interferon beta&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Natalizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ocrelizumab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ocrelizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ocrelizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ocrelizumab is a highly effective disease-modifying therapy for multiple sclerosis that targets CD20 on B cells, leading to B cell depletion and a reduction in disease activity. It is important to understand the different mechanisms of action of various MS medications to make informed treatment decisions.&lt;/li&gt;&lt;li&gt;âž¤ Ocrelizumab is a highly effective disease-modifying therapy for multiple sclerosis that targets CD20 on B cells, leading to B cell depletion and a reduction in disease activity.&lt;/li&gt;&lt;li&gt;âž¤ It is important to understand the different mechanisms of action of various MS medications to make informed treatment decisions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man is evaluated for severe headaches that have occurred several times over the last 5â€“7 years. He describes the headache as occurring behind his left eye and coming on suddenly. The headaches have a stabbing quality and are associated with tearing of his eye and nasal congestion. He says the pain is a â€œ12â€ out of 10 when it occurs, and he finds that he cannot even sit still due to pain. The headaches last about 20 minutes and then subside. He says that the headaches always seem to occur around 5 AM, but he can go months without having any headache at all. He has a difficult time identifying a trigger for the headaches. Which of the following is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cluster headache&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paroxysmal hemicrania&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Short-lasting unilateral neuralgiform headaches with conjunctival injection and tearing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cluster headache&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cluster headache&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cluster headaches are a rare but debilitating primary headache disorder. They present with severe, unilateral, stabbing pain around the eye or temple, often with autonomic symptoms. Recognizing the characteristic features is essential for prompt diagnosis and management.&lt;/li&gt;&lt;li&gt;âž¤ Cluster headaches are a rare but debilitating primary headache disorder.&lt;/li&gt;&lt;li&gt;âž¤ They present with severe, unilateral, stabbing pain around the eye or temple, often with autonomic symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the characteristic features is essential for prompt diagnosis and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 21-year-old male college student presents with profound fatigue, foot spasms, cramps, and sustained muscle contractions. Laboratory evaluation reveals hypokalemia (2.8 mEq/L), hypochloremia (90 mEq/L), and metabolic alkalosis (bicarbonate of 30 mmol/L), with normal sodium and magnesium levels. Urine chloride is elevated, and diuretic abuse is ruled out. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bulimia nervosa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuretic abuse&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gitelman syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liddle syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gitelman syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gitelman syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gitelman syndrome presents with hypokalemia , hypochloremic metabolic alkalosis , normal or elevated urine chloride, and muscle cramps due to defective reabsorption in the distal convoluted tubule. It is an inherited disorder often diagnosed in young adults with chronic electrolyte disturbances.&lt;/li&gt;&lt;li&gt;âž¤ Gitelman syndrome&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ hypochloremic metabolic alkalosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old woman presents to the emergency room with malaise, confusion, and headache. Blood pressure is found to be 220/105. Physical examination is notable for skin thickening of the arms and legs, facial telangiectasias, and decreased oral aperture. Laboratory studies show a creatinine of 3.5 mg/dL, hemoglobin of 7.0 g/dL, platelets of 75,000/dL, lactate dehydrogenase of 700. What is the appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eculizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Captopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Captopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Scleroderma renal crisis is a medical emergency requiring prompt recognition and treatment. ACE inhibitors are the cornerstone of treatment for SRC. Early diagnosis and aggressive blood pressure control are crucial to improve outcomes.&lt;/li&gt;&lt;li&gt;âž¤ Scleroderma renal crisis is a medical emergency requiring prompt recognition and treatment.&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors are the cornerstone of treatment for SRC.&lt;/li&gt;&lt;li&gt;âž¤ Early diagnosis and aggressive blood pressure control are crucial to improve outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old woman with a history of colon cancer treated with resection and chemotherapy 2 years earlier is admitted to the hospital after routine lab work at her primary care physicianâ€™s office showed a blood urea nitrogen of 65 mg/dL and a creatinine of 4.5 mg/dL. She reports mild fatigue and recent lower back pain, but otherwise feels well. She does admit to recent nonsteroidal anti-inflammatory drug (NSAID) use but has not taken more than the recommended quantity. Aside from stopping the NSAID and avoidance of nephrotoxins, which of the following studies should be the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT of the abdomen/pelvis with oral contrast&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Postvoid residual volume of bladder&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Retrograde urography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ultrasound of the abdomen/kidney&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ultrasound of the abdomen/kidney&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ultrasound of the abdomen/kidney&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with acute kidney injury (AKI) , particularly those with a history of malignancy, an ultrasound is the preferred initial study to evaluate for obstructive causes of renal impairment. This modality is non-invasive, safe, and does not expose the kidneys to further nephrotoxins.&lt;/li&gt;&lt;li&gt;âž¤ acute kidney injury (AKI)&lt;/li&gt;&lt;li&gt;âž¤ ultrasound&lt;/li&gt;&lt;li&gt;âž¤ obstructive causes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman with a history of chronic hepatitis C presents with fatigue, edema, and dark urine. Laboratory studies reveal hematuria, proteinuria, and reduced serum complement levels. A renal biopsy is performed. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Membranoproliferative glomerulonephritis (MPGN)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Minimal change disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Focal segmental glomerulosclerosis (FSGS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Membranoproliferative glomerulonephritis (MPGN)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-114642.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Â Membranoproliferative glomerulonephritis (MPGN)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Membranoproliferative glomerulonephritis (MPGN) is associated with chronic hepatitis C and presents with proteinuria , hematuria , low complement levels , and characteristic tram-track changes on renal biopsy.&lt;/li&gt;&lt;li&gt;âž¤ Membranoproliferative glomerulonephritis (MPGN)&lt;/li&gt;&lt;li&gt;âž¤ chronic hepatitis C&lt;/li&gt;&lt;li&gt;âž¤ proteinuria&lt;/li&gt;&lt;li&gt;âž¤ hematuria&lt;/li&gt;&lt;li&gt;âž¤ low complement levels&lt;/li&gt;&lt;li&gt;âž¤ tram-track&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old male with known chronic alcohol use, presents with two episodes of hematemesis. He recently sustained a fall and injured his knee. He has been taking ibuprofen several times a day for the last week for pain control. His initial hemoglobin is 10 g/dL. He receives 2 L of IV fluid and undergoes an urgent upper endoscopy. All of the following are true about his risk of rebleeding without intervention EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A clean-based ulcer is associated with a low risk (3â€“5%) of rebleeding.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adherent clots covering the ulcer base have a 90% risk of rebleeding.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Flat pigmented spots covering the ulcer base have a 10% risk of rebleeding.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;When a fibrin plug is seen protruding from a vessel wall in the base of an ulcer, (so-called sentinel clot or visible vessel), the risk of rebleeding from the ulcer is 40%.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Adherent clots covering the ulcer base have a 90% risk of rebleeding.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Â Adherent clots covering the ulcer base have a 90% risk of rebleeding.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The risk of rebleeding in peptic ulcers varies based on endoscopic findings, with clean-based ulcers having the lowest risk and visible vessels having a moderate risk. Adherent clots typically have a lower rebleeding risk (20-30%) than visible vessels and benefit from therapeutic intervention to reduce the risk further.&lt;/li&gt;&lt;li&gt;âž¤ rebleeding&lt;/li&gt;&lt;li&gt;âž¤ Adherent clots&lt;/li&gt;&lt;li&gt;âž¤ lower rebleeding risk&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old man with a long history of abdominal pain, heartburn, and dyspepsia has an esophagogastroduodenoscopy to evaluate for peptic ulcer disease. No gastric or duodenal ulcers are found, but there are tongues of reddish mucosa extending proximally from the gastroesophageal junction into the esophagus. Biopsies of these areas demonstrate columnar metaplasia. All of the following statements regarding this diagnosis are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Finding high-grade dysplasia mandates further intervention.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-dose proton pump inhibitor therapy will likely cause regression of the mucosal abnormalities.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The incidence of these lesions has increased in the era of potent acid suppression.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The patient has a high risk of coexisting cancer.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. High-dose proton pump inhibitor therapy will likely cause regression of the mucosal abnormalities.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Â High-dose proton pump inhibitor therapy will likely cause regression of the mucosal abnormalities.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Barrett&#x27;s esophagus is a condition where columnar metaplasia replaces the normal squamous epithelium in the esophagus due to chronic GERD. While PPIs help control symptoms, they do not reverse metaplasia. The presence of high-grade dysplasia mandates further intervention due to the high risk of progression to esophageal adenocarcinoma.&lt;/li&gt;&lt;li&gt;âž¤ Barrett&#x27;s esophagus&lt;/li&gt;&lt;li&gt;âž¤ columnar metaplasia&lt;/li&gt;&lt;li&gt;âž¤ PPIs&lt;/li&gt;&lt;li&gt;âž¤ high-grade dysplasia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old woman who presents with recurrent episodes of chest discomfort at rest. She denies exertional dyspnea and reports that occasionally her pain is relieved with antacids. She works as a health care consultant and has frequent stressful battles with doctors and hospitals. An exercise cardiac stress test does not reveal any evidence of inducible ischemia. She has a barium swallow shown below. You suspect that she has diffuse esophageal spasm. Which of the following findings on esophageal manometry would support that diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contractions in the distal esophagus with short latency relative to the time of the pharyngeal contraction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertensive peristalsis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Impaired lower esophageal sphincter (LES) contraction and absent peristalsis with substantial fluid pressurization of the esophageal body&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Impaired LES contraction and absent peristalsis with no fluid pressurization of the esophageal body&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Contractions in the distal esophagus with short latency relative to the time of the pharyngeal contraction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-114730.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Â Contractions in the distal esophagus with short latency relative to the time of the pharyngeal contraction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diffuse esophageal spasm is diagnosed with esophageal manometry , which reveals simultaneous or premature contractions in the distal esophagus. These uncoordinated contractions can cause chest pain that mimics cardiac ischemia, as well as dysphagia.&lt;/li&gt;&lt;li&gt;âž¤ Diffuse esophageal spasm&lt;/li&gt;&lt;li&gt;âž¤ esophageal manometry&lt;/li&gt;&lt;li&gt;âž¤ simultaneous or premature contractions&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old woman is evaluated by her primary care physician for diffuse, crampy abdominal pain. She reports that she has had abdominal pain for the last several years, but it is getting worse and is now associated with intermittent diarrhea without flatulence. This does not wake her at night. Stools do not float and are not hard to flush. She has not noted any worsening with specific foods, but she does have occasional rashes on her lower legs. She has lost about 6 kg over the last year. She is otherwise healthy and takes no medications. Which of the following is the most appropriate recommendation at this point?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased dietary fiber intake&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Measurement of antiendomysial antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Measurement of 24-hour fecal fat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Referral to gastroenterologist for endoscopy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Measurement of antiendomysial antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Â Measurement of antiendomysial antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a young patient with abdominal pain , diarrhea , weight loss , and rashes suggestive of dermatitis herpetiformis , the initial step is to test for celiac disease using antiendomysial or anti-tissue transglutaminase antibodies .&lt;/li&gt;&lt;li&gt;âž¤ abdominal pain&lt;/li&gt;&lt;li&gt;âž¤ diarrhea&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;li&gt;âž¤ rashes&lt;/li&gt;&lt;li&gt;âž¤ dermatitis herpetiformis&lt;/li&gt;&lt;li&gt;âž¤ celiac disease&lt;/li&gt;&lt;li&gt;âž¤ antiendomysial or anti-tissue transglutaminase antibodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old female develops acute diverticulitis and requires hospitalization for IV antibiotics. She has a CT scan that does not show evidence of abscess perforation, stricture, or fistula, and she improves in about a week. Which of the following should be undertaken to prevent further symptomatic disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Annual colonoscopy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Avoidance of nuts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Daily mesalamine therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiation of a high-fiber diet&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Initiation of a high-fiber diet&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Â Initiation of a high-fiber diet&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To reduce the risk of recurrent diverticulitis , patients should adopt a high-fiber diet , which can help improve colonic motility and decrease the likelihood of diverticula becoming inflamed. Avoidance of nuts and seeds is no longer recommended&lt;/li&gt;&lt;li&gt;âž¤ diverticulitis&lt;/li&gt;&lt;li&gt;âž¤ high-fiber diet&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman who was previously incarcerated has an area of induration that measures 15 mm 72 hours after a skin test with tuberculin purified protein derivative (PPD). A positive PPD skin test for Mycobacterium tuberculosis represents which type of immune reaction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytotoxic reaction of antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Delayed-type hypersensitivity reaction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immediate-type hypersensitivity reaction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune complex formation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Delayed-type hypersensitivity reaction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Â Delayed-type hypersensitivity reaction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A positive PPD skin test for Mycobacterium tuberculosis represents a Type IV delayed-type hypersensitivity reaction, involving T-cell mediated immunity and typically appearing 48-72 hours after the test.&lt;/li&gt;&lt;li&gt;âž¤ PPD skin test&lt;/li&gt;&lt;li&gt;âž¤ Mycobacterium tuberculosis&lt;/li&gt;&lt;li&gt;âž¤ Type IV delayed-type hypersensitivity&lt;/li&gt;&lt;li&gt;âž¤ T-cell mediated immunity&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents to the clinic with intermittent flushing, diarrhea, headaches, and a new skin rash of several monthsâ€™ duration. He has noticed that his symptoms of diarrhea and flushing tend to worsen if he takes ibuprofen to treat his headaches. On examination, he has a palpable spleen and cervical lymphadenopathy. Serum tryptase is elevated at 35 ng/mL. His skin rash is shown below. A diagnostic skin biopsy is performed. What histological findings are most likely to be noted on the skin biopsy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Interface dermatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multifocal dense infiltrates of mast cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neutrophilic dermal infiltrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Noncaseating granulomas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Multifocal dense infiltrates of mast cells&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-114757.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Â Multifocal dense infiltrates of mast cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Systemic mastocytosis is a rare disorder characterized by the abnormal proliferation and accumulation of mast cells. It can present with a variety of symptoms, including flushing, diarrhea, headaches, and skin rash.&lt;/li&gt;&lt;li&gt;âž¤ Systemic mastocytosis is a rare disorder characterized by the abnormal proliferation and accumulation of mast cells.&lt;/li&gt;&lt;li&gt;âž¤ It can present with a variety of symptoms, including flushing, diarrhea, headaches, and skin rash.&lt;/li&gt;&lt;li&gt;âž¤ Elevated serum tryptase levels and the presence of multifocal dense infiltrates of mast cells on skin biopsy are key diagnostic features.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with a history of psoriasis presents to the clinic for a follow-up appointment. He has been treated with infliximab about a year. Since his last infusion of infliximab, he has been experiencing aching in his muscles and joints and a new facial rash. On examination you note a raised erythematous malar rash, but there is no synovitis in any joints and there is no weakness on neurologic examination. Laboratory testing shows a positive anti-nuclear antibody at a titer of 1:320. Which specific autoantibody is most likely to be present?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-Î²-2-glycoprotein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-cyclic citrullinated protein antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-dsDNA antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-histone antibodies&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Anti-histone antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Anti-histone antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Drug-induced lupus erythematosus is a potential complication of certain medications, including TNF inhibitors like infliximab. It typically presents with muscle and joint aches, skin rash, and a positive ANA. Anti-histone antibodies are highly specific for DILE and are the most likely autoantibody to be present in this case.&lt;/li&gt;&lt;li&gt;âž¤ Drug-induced lupus erythematosus is a potential complication of certain medications, including TNF inhibitors like infliximab.&lt;/li&gt;&lt;li&gt;âž¤ It typically presents with muscle and joint aches, skin rash, and a positive ANA.&lt;/li&gt;&lt;li&gt;âž¤ Anti-histone antibodies are highly specific for DILE and are the most likely autoantibody to be present in this case.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old woman with depression and chronic migraine headaches reports several years of dry mouth and dry eyes. Her primary complaint is that she can no longer eat her favorite crackers, although she does report photosensitivity and eye burning on further questioning. She has no other associated symptoms. Examination shows dry, erythematous, sticky oral mucosa. All of the following tests are likely to be positive in this patient EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;La/SS-B antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ro/SS-A antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schirmer I test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scl-70 antibody&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Scl-70 antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Scl-70 antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SjÃ¶gren&#x27;s syndrome is an autoimmune disease that causes dryness of the eyes and mouth. It can be associated with other symptoms like fatigue, joint pain, and skin rash. The diagnosis is based on clinical features, autoantibody testing (anti-Ro/SS-A, anti-La/SS-B), and objective measures of dryness (Schirmer&#x27;s test). Scl-70 antibody is not associated with SjÃ¶gren&#x27;s syndrome and is more specific for scleroderma.&lt;/li&gt;&lt;li&gt;âž¤ SjÃ¶gren&#x27;s syndrome is an autoimmune disease that causes dryness of the eyes and mouth.&lt;/li&gt;&lt;li&gt;âž¤ It can be associated with other symptoms like fatigue, joint pain, and skin rash.&lt;/li&gt;&lt;li&gt;âž¤ The diagnosis is based on clinical features, autoantibody testing (anti-Ro/SS-A, anti-La/SS-B), and objective measures of dryness (Schirmer&#x27;s test).&lt;/li&gt;&lt;li&gt;âž¤ Scl-70 antibody is not associated with SjÃ¶gren&#x27;s syndrome and is more specific for scleroderma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with primary SjÃ¶gren syndrome that was diagnosed 6 years ago and treated with tear replacement for symptomatic relief notes continued parotid swelling for the last 3 months. She has also noted enlarging posterior cervical lymph nodes. Evaluation shows leukopenia and low C4 complement levels. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic pancreatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HIV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Â Lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with primary SjÃ¶gren syndrome have an increased risk of developing non-Hodgkin lymphoma , particularly when they exhibit persistent parotid gland swelling, lymphadenopathy, and immune changes such as leukopenia and low complement levels . Close monitoring for signs of lymphoma is essential in these patients.&lt;/li&gt;&lt;li&gt;âž¤ primary SjÃ¶gren syndrome&lt;/li&gt;&lt;li&gt;âž¤ non-Hodgkin lymphoma&lt;/li&gt;&lt;li&gt;âž¤ leukopenia&lt;/li&gt;&lt;li&gt;âž¤ low complement levels&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man presents with pain and swelling in his right knee and left ankle. He also reports dysuria and eye redness that began two weeks ago. He recently had an episode of urethritis but did not seek treatment. There is no history of trauma. Examination reveals conjunctival injection and tenderness of the affected joints. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gonococcal arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reactive arthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Septic arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reactive arthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Â Reactive arthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Reactive arthritis is a post-infectious autoimmune syndrome often triggered by Chlamydia urethritis and presents with the triad of arthritis, urethritis , and conjunctivitis . It is crucial to recognize the association with prior infections to guide appropriate management.&lt;/li&gt;&lt;li&gt;âž¤ Reactive arthritis&lt;/li&gt;&lt;li&gt;âž¤ post-infectious autoimmune syndrome&lt;/li&gt;&lt;li&gt;âž¤ Chlamydia urethritis&lt;/li&gt;&lt;li&gt;âž¤ arthritis, urethritis&lt;/li&gt;&lt;li&gt;âž¤ conjunctivitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old man is evaluated for 1 year of recurrent episodes of bilateral ear swelling. The ear is painful during these events, and the right ear has become floppy. He is otherwise healthy and reports no illicit habits. He works in an office, and his only sport is cricket on sundays. On examination, the left ear has a beefy red color and the pinna is tender and swollen; the earlobe appears minimally swollen but is neither red nor tender. Which of the following is the most likely explanation for this finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BehÃ§et syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cogan syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemoglobinopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Relapsing polychondritis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Relapsing polychondritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Â Relapsing polychondritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Relapsing polychondritis is a rare inflammatory disease that primarily affects cartilage. Recurrent episodes of painful ear swelling with potential cartilage damage are characteristic features. The diagnosis is often clinical, but biopsy may be needed in some cases. Treatment typically involves corticosteroids and other immunosuppressive medications.&lt;/li&gt;&lt;li&gt;âž¤ Relapsing polychondritis is a rare inflammatory disease that primarily affects cartilage.&lt;/li&gt;&lt;li&gt;âž¤ Recurrent episodes of painful ear swelling with potential cartilage damage are characteristic features.&lt;/li&gt;&lt;li&gt;âž¤ The diagnosis is often clinical, but biopsy may be needed in some cases.&lt;/li&gt;&lt;li&gt;âž¤ Treatment typically involves corticosteroids and other immunosuppressive medications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman presents to the clinic with right thumb and wrist pain that has worsened over several weeks. She has pain when she pinches her thumb against her other fingers. Her only other history is that she is a new mother with an 8-week-old infant at home. On physical examination, she has mild swelling and tenderness over the radial styloid process, and pain is elicited when she places her thumb in her palm and grasps it with her fingers. A Phalen maneuver is negative. Which condition is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carpal tunnel syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;De Quervain tenosynovitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gouty arthritis of the 1st MCP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Palmar fasciitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. De Quervain tenosynovitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Â De Quervain tenosynovitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ De Quervain tenosynovitis is a common overuse injury that can occur in new mothers. Recognizing the characteristic symptoms and physical exam findings is crucial for prompt diagnosis and management. Treatment options include rest, splinting, NSAIDs, corticosteroid injections, and in severe cases, surgery.&lt;/li&gt;&lt;li&gt;âž¤ De Quervain tenosynovitis is a common overuse injury that can occur in new mothers.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the characteristic symptoms and physical exam findings is crucial for prompt diagnosis and management.&lt;/li&gt;&lt;li&gt;âž¤ Treatment options include rest, splinting, NSAIDs, corticosteroid injections, and in severe cases, surgery.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man reports to his primary care physician that his wife has noted coarsening of his facial features over several years. In addition, he reports low libido and decreased energy. Physical examination shows frontal bossing and enlarged hands. An MRI confirms that he has a pituitary mass. Which of the following screening tests should be ordered to diagnose the cause of the mass?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;24-Hour urinary free cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adrenocorticotropic hormone assay&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Growth hormone level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum insulin-like growth factor-1 (IGF-1) level&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum insulin-like growth factor-1 (IGF-1) level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serum insulin-like growth factor-1 (IGF-1) level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with clinical features of acromegaly and a pituitary mass , the screening test of choice is serum IGF-1 , as it provides a more accurate reflection of growth hormone activity than a direct GH measurement.&lt;/li&gt;&lt;li&gt;âž¤ acromegaly&lt;/li&gt;&lt;li&gt;âž¤ pituitary mass&lt;/li&gt;&lt;li&gt;âž¤ serum IGF-1&lt;/li&gt;&lt;li&gt;âž¤ growth hormone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man has a pituitary adenoma on imaging that has extended directly superiorly and is compressing his optic chiasm. Which of the following visual field deficits is most likely present?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilateral inferior visual field deficits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral superior visual field deficits&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bitemporal hemianopia with superior defect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bitemporal hemianopia with inferior defect&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bitemporal hemianopia with superior defect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Compression of the optic chiasm by a pituitary adenoma commonly leads to bitemporal hemianopia , a visual field defect affecting the temporal visual fields of both eyes due to damage to the crossing fibers from the nasal retinas.&lt;/li&gt;&lt;li&gt;âž¤ optic chiasm&lt;/li&gt;&lt;li&gt;âž¤ pituitary adenoma&lt;/li&gt;&lt;li&gt;âž¤ bitemporal hemianopia&lt;/li&gt;&lt;li&gt;âž¤ temporal visual fields&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old woman is evaluated for anxiety, palpitations, and diarrhea and found to have Graves disease. Before she begins therapy for her thyroid condition, she has an episode of acute chest pain and presents to the emergency department. Although a CT angiogram is ordered, the radiologist calls to notify the treating physician that this is potentially dangerous. Which of the following best explains the radiologistâ€™s concern?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iodinated contrast exposure in patients with Graves disease may exacerbate hyperthyroidism.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary embolism is exceedingly rare in Graves disease.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radiation exposure in patients with hyperthyroidism is associated with increased risk of subsequent malignancy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tachycardia with Graves disease limits the image quality of CT angiography and will not allow accurate assessment of pulmonary embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Iodinated contrast exposure in patients with Graves disease may exacerbate hyperthyroidism.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Â Iodinated contrast exposure in patients with Graves disease may exacerbate hyperthyroidism.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with Graves disease , exposure to iodinated contrast during procedures like CT angiography can exacerbate hyperthyroidism, potentially leading to thyroid storm . Careful consideration and alternative imaging methods may be necessary.&lt;/li&gt;&lt;li&gt;âž¤ Graves disease&lt;/li&gt;&lt;li&gt;âž¤ iodinated contrast&lt;/li&gt;&lt;li&gt;âž¤ thyroid storm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with a history of medullary thyroid carcinoma presents with episodic palpitations, sweating, and severe hypertension that occurs unpredictably. Her father also had thyroid cancer and passed away from a sudden hypertensive crisis. Genetic testing shows a RET proto-oncogene mutation. Laboratory studies reveal elevated plasma normetanephrines and an adrenal mass on imaging. Which of the following additional findings is most likely in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parathyroid hyperplasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pituitary adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperinsulinemia from an insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal cell carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Parathyroid hyperplasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Parathyroid hyperplasia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MEN 2A is characterized by medullary thyroid carcinoma , pheochromocytoma , and parathyroid hyperplasia , and is associated with RET proto-oncogene mutations . Family history and clinical findings guide the diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ MEN 2A&lt;/li&gt;&lt;li&gt;âž¤ medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ parathyroid hyperplasia&lt;/li&gt;&lt;li&gt;âž¤ RET proto-oncogene mutations&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man presents to the emergency department with numbness and weakness in his legs and feet. On examination, you find that he is numb to the knees and has marked weakness in ankle dorsiflexion and plantar flexion. Two years ago, he developed diabetes, and last year, he was admitted when found to be profoundly hypothyroid. On examination, he has hepatosplenomegaly and appears to have a dark tan despite having no sun exposure recently. Which of the following tests will likely help make his diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-nuclear antibody titer measurement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antithymoglobulin antibody titer measurement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blood cultures&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum protein electrophoresis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum protein electrophoresis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serum protein electrophoresis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ POEMS syndrome is characterized by polyneuropathy , organomegaly , endocrinopathy , monoclonal gammopathy , and skin changes . Serum protein electrophoresis (SPEP) is essential for identifying the monoclonal protein that underlies this condition.&lt;/li&gt;&lt;li&gt;âž¤ POEMS syndrome&lt;/li&gt;&lt;li&gt;âž¤ polyneuropathy&lt;/li&gt;&lt;li&gt;âž¤ organomegaly&lt;/li&gt;&lt;li&gt;âž¤ endocrinopathy&lt;/li&gt;&lt;li&gt;âž¤ monoclonal gammopathy&lt;/li&gt;&lt;li&gt;âž¤ skin changes&lt;/li&gt;&lt;li&gt;âž¤ Serum protein electrophoresis (SPEP)&lt;/li&gt;&lt;li&gt;âž¤ monoclonal protein&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman presents to the clinic to discuss contraception options. She has a history of mild hypertension that is well controlled on amlodipine 5 mg daily. She smokes about one pack of cigarettes per day. Her family history is notable for ovarian cancer in her grandmother and a stroke in her father. Which of the following is an absolute contraindication for oral contraceptives?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age &amp;gt;35 combined with cigarette use&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Family history of ovarian cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Family history of stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Age &gt;35 combined with cigarette use&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Â Age &amp;gt;35 combined with cigarette use&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Combined oral contraceptives (COCs) are absolutely contraindicated in women who are older than 35 and who smoke due to the increased risk of thromboembolism , myocardial infarction , and stroke .&lt;/li&gt;&lt;li&gt;âž¤ Combined oral contraceptives (COCs)&lt;/li&gt;&lt;li&gt;âž¤ absolutely contraindicated&lt;/li&gt;&lt;li&gt;âž¤ older than 35&lt;/li&gt;&lt;li&gt;âž¤ thromboembolism&lt;/li&gt;&lt;li&gt;âž¤ myocardial infarction&lt;/li&gt;&lt;li&gt;âž¤ stroke&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man comes to the clinic for his yearly visit. He complains of pain in his feet and ankles bilaterally that has been present for over a year. His past medical history is significant for long-standing hypertension treated with lisinopril and type 2 diabetes mellitus (hemoglobin A1c 10.3%). He lives alone and does not have any family that checks on him routinely. He works in a factory, frequently standing for most of the day, and recently the pain has limited his work capacity. He feels the pain in his feet has become debilitating and he is hoping for some relief to be able to return to work. Which of the following medications would be best for him?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amitriptyline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Doxepin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Duloxetine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nortriptyline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Duloxetine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Â Duloxetine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Duloxetine is an effective and well-tolerated treatment for diabetic peripheral neuropathy in older adults, with fewer side effects than tricyclic antidepressants. It provides both pain relief and mood stabilization, making it a preferred option in patients like this one with neuropathic pain .&lt;/li&gt;&lt;li&gt;âž¤ Duloxetine&lt;/li&gt;&lt;li&gt;âž¤ diabetic peripheral neuropathy&lt;/li&gt;&lt;li&gt;âž¤ neuropathic pain&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old man with a history of hypertension treated with hydrochlorothiazide and metoprolol tartrate. He presents to your clinic with a complaint of fatigue over the past few weeks. On examination, the only notable finding is a heart rate of 40 beats/min. Electrocardiogram (ECG) shows sinus bradycardia with normal PR interval. Laboratory studies show no abnormalities including normal thyroid studies and hemoglobin. The next most reasonable step would be which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dual-chamber pacemaker implantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exercise ECG test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start theophylline 100 mg daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stop metoprolol tartrate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Stop metoprolol tartrate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Stop metoprolol tartrate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Beta-blockers are a common cause of bradycardia. In a patient with symptomatic bradycardia and a history of beta-blocker use, discontinuing the medication is the most reasonable initial step. If symptoms persist after medication discontinuation, further evaluation and consideration of pacemaker implantation may be necessary.&lt;/li&gt;&lt;li&gt;âž¤ Beta-blockers are a common cause of bradycardia.&lt;/li&gt;&lt;li&gt;âž¤ In a patient with symptomatic bradycardia and a history of beta-blocker use, discontinuing the medication is the most reasonable initial step.&lt;/li&gt;&lt;li&gt;âž¤ If symptoms persist after medication discontinuation, further evaluation and consideration of pacemaker implantation may be necessary.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 85 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test6" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D Part 2   Mission 2.0 (Inicet)   18 09 2024   2024 09 18&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D Part 2   Mission 2.0 (Inicet)   18 09 2024   2024 09 18&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                75 Questions | 300 Total Marks | 85 min Duration | ~68.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;You are seeing a 65-year-old man with a history of progressive systolic heart failure and hypotension in the cardiac care unit. Echocardiogram shows a severe reduction in left ventricular function and you clinically make the diagnosis of cardiogenic shock. You wish to start a medication that will increase the inotropic state of his heart. Which intracellular ion will increase as a result of this medication and will be responsible for increasing myocardial contractility?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phosphorus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Potassium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Calcium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Calcium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cardiogenic shock, increasing intracellular calcium is a key mechanism for improving cardiac contractility. Medications like dobutamine and milrinone work by increasing calcium levels within cardiac myocytes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding blood pressure measurements?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systolic pressure increases and diastolic pressure decreases when measured in more distal arteries.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Systolic leg blood pressures are usually as much as 20 mmHg lower than arm blood pressures.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The concept of â€œwhite coat hypertensionâ€ (blood pressures measured in office or hospital settings significantly higher than in nonclinical settings) has been shown to be a myth.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Using a blood pressure cuff that is too small will result in a marked underestimation of the true blood pressure.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Systolic pressure increases and diastolic pressure decreases when measured in more distal arteries.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Systolic pressure increases and diastolic pressure decreases when measured in more distal arteries.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Blood pressure measurements can be influenced by various factors, including the site of measurement and the size of the blood pressure cuff. Systolic pressure tends to increase, and diastolic pressure tends to decrease in more distal arteries. White coat hypertension is a real phenomenon that can affect blood pressure readings. It&#x27;s important to use the correct cuff size to obtain accurate blood pressure measurements.&lt;/li&gt;&lt;li&gt;âž¤ Blood pressure measurements can be influenced by various factors, including the site of measurement and the size of the blood pressure cuff.&lt;/li&gt;&lt;li&gt;âž¤ Systolic pressure tends to increase, and diastolic pressure tends to decrease in more distal arteries.&lt;/li&gt;&lt;li&gt;âž¤ White coat hypertension is a real phenomenon that can affect blood pressure readings.&lt;/li&gt;&lt;li&gt;âž¤ It&#x27;s important to use the correct cuff size to obtain accurate blood pressure measurements.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man presents to the emergency department with crushing substernal chest pain. You suspect myocardial ischemia based on the history. Which of the following is true regarding the electrocardiogram in myocardial ischemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;In acute transmural myocardial ischemia, Q waves typically precede ST-segment elevation by 4â€“6 hours.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subendocardial ischemia alone results in ST-segment elevation in the leads corresponding to the anatomic area of ischemia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transmural posterior wall ischemia can result in ST depressions in leads V1â€“V3.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transmural ST-segment elevation in leads II, III, and aVF indicate acute transmural ischemia in the anterior wall.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transmural posterior wall ischemia can result in ST depressions in leads V1â€“V3.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Transmural posterior wall ischemia can result in ST depressions in leads V1â€“V3.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ST-segment elevation is a hallmark of acute transmural myocardial ischemia. Subendocardial ischemia typically results in ST-segment depression. Posterior wall ischemia can manifest as ST-segment depression in the anterior leads (V1-V3). It&#x27;s important to recognize the ECG changes associated with myocardial ischemia to facilitate prompt diagnosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ ST-segment elevation is a hallmark of acute transmural myocardial ischemia.&lt;/li&gt;&lt;li&gt;âž¤ Subendocardial ischemia typically results in ST-segment depression.&lt;/li&gt;&lt;li&gt;âž¤ Posterior wall ischemia can manifest as ST-segment depression in the anterior leads (V1-V3).&lt;/li&gt;&lt;li&gt;âž¤ It&#x27;s important to recognize the ECG changes associated with myocardial ischemia to facilitate prompt diagnosis and treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 53-year-old man complaining of occasional, pressure like chest discomfort. The discomfort seems to worsen when he exerts himself, and he has to stop when climbing stairs to allow it to dissipate. You suspect coronary artery disease, and he is not amenable to any invasive testing such as coronary angiography. Which non-invasive test given here has the highest sensitivity currently for detecting stenosis in major coronary arteries?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac magnetic resonance perfusion scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary CT angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dobutamine echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Single-photon emission computed tomography myocardial perfusion imaging&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Coronary CT angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-094123.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Coronary CT angiography&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When a patient is not amenable to invasive coronary angiography, CCTA is the non-invasive test with the highest sensitivity for detecting significant coronary artery stenosis.&lt;/li&gt;&lt;li&gt;âž¤ CCTA can help guide further management decisions, such as the need for revascularization or medical therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most common mechanism of cardiac arrhythmia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased cellular coupling&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enhanced automaticity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Early after depolarizations&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reentry&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Reentry&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Reentry is the most frequent mechanism underlying cardiac arrhythmias. Understanding the different mechanisms of arrhythmias is crucial for their diagnosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ Reentry is the most frequent mechanism underlying cardiac arrhythmias.&lt;/li&gt;&lt;li&gt;âž¤ Understanding the different mechanisms of arrhythmias is crucial for their diagnosis and treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman with systemic lupus erythematosus (SLE) complicated by nephropathy, hemolytic anemia, and pleuritis. Her disease is well controlled on therapy. She recently discovered that she is pregnant and presents today for prenatal counselling. She specifically is concerned about the effect her disease may have on the infant. You tell her that the most common cardiac complication in children born to mothers with SLE is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Libman-Sacks endocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dilated cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atrioventricular block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Coronary artery disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atrioventricular block&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Atrioventricular block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For mothers with SLE, particularly those with anti-Ro (SSA) antibodies, the most concerning cardiac complication for their infants is the risk of atrioventricular block, making it crucial for healthcare providers to monitor for this condition during prenatal consultations and after birth.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a retired electrician in your clinic, Mr. Surish. He is a 72-year-old with no past medical history other than well-treated hypertension and presents today with complaints of occasional palpitations. You obtain a 12-lead electrocardiogram, which serendipitously occurs during one of his events. You note a rapid heart rate of 160 beats/min, a narrow QRS complex, and P waves with an abnormal axis occurring before every QRS. You astutely diagnose an atrial tachycardia. Which of the following is true about atrial tachycardia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial tachycardia can occur in the absence of structural heart disease.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial tachycardia is the most common etiology of supraventricular tachycardia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atrial tachycardia occurs most often in people younger than age 50.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fibrosis in atrial tissue is preventative against atrial tachycardia by preventing reentrant circuits.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Atrial tachycardia can occur in the absence of structural heart disease.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Atrial tachycardia can occur in the absence of structural heart disease.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atrial tachycardia can occur without structural heart disease, and it is important to assess any individual presenting with palpitations for potential causes that may not involve underlying heart pathology.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The clinical consequences of atrial fibrillation are attributable to which of the following pathophysiologic mechanisms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Loss of atrial contraction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Predisposition to thrombus formation in the left atrial appendage with potential embolization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rapid ventricular rate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The clinical consequences of atrial fibrillation are multifactorial and include decreased cardiac output due to loss of atrial contraction, increased risk of thromboembolic events, and symptoms related to rapid ventricular rate.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are caring for Ms. Sarma, a 22-year-old woman with rheumatic mitral stenosis. She presents to your office with worsening dyspnea and you note that she is in atrial fibrillation. She is unclear when exactly her symptoms started. You calculate her CHA2DS2-VASc score as only 1. Which of the following represents the appropriate approach to stroke prevention?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arrange for immediate cardioversion to sinus rhythm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Initiate amiodarone orally and 1 week later arrange electrical cardioversion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Initiate apixaban 5 mg twice daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate warfarin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Initiate warfarin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â D) Initiate warfarin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with atrial fibrillation and mitral stenosis, oral anticoagulation is recommended for stroke prevention, even if their CHA2DS2-VASc score is low. Warfarin is a traditional and effective option, but DOACs may also be considered after careful evaluation. The choice between warfarin and DOACs should be individualized based on the patient&#x27;s specific risk factors, bleeding risk, and preferences. Shared decision-making is crucial.&lt;/li&gt;&lt;li&gt;âž¤ In patients with atrial fibrillation and mitral stenosis, oral anticoagulation is recommended for stroke prevention, even if their CHA2DS2-VASc score is low.&lt;/li&gt;&lt;li&gt;âž¤ Warfarin is a traditional and effective option, but DOACs may also be considered after careful evaluation.&lt;/li&gt;&lt;li&gt;âž¤ The choice between warfarin and DOACs should be individualized based on the patient&#x27;s specific risk factors, bleeding risk, and preferences. Shared decision-making is crucial.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a history of myocardial infarction and congestive heart failure is comfortable at rest. However, when walking to his car, he develops dyspnea, fatigue, and sometimes palpitations. He must rest for several minutes before these symptoms resolve. Which of the following is his New York Heart Association classification?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Class III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Class III&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This patient&#x27;s symptoms with less than ordinary activity (walking to the car) but relief at rest align with NYHA Class III , indicating marked limitation of activity but comfort at rest.&lt;/li&gt;&lt;li&gt;âž¤ NYHA Class III&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;From a pathophysiologic perspective, all of the following are upregulated in heart failure with reduced ejection fraction EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Angiotensin II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;B-type natriuretic peptide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Calcium uptake into the sarcoplasmic reticulum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Norepinephrine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Calcium uptake into the sarcoplasmic reticulum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Calcium uptake into the sarcoplasmic reticulum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In heart failure with reduced ejection fraction, compensatory mechanisms like the RAAS and sympathetic nervous system are upregulated, but calcium handling in the sarcoplasmic reticulum is impaired, leading to reduced myocardial function. Thus, calcium uptake into the sarcoplasmic reticulum is not upregulated in HFrEF.&lt;/li&gt;&lt;li&gt;âž¤ calcium uptake into the sarcoplasmic reticulum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing Mr. Ataley who is a 54-year-old man with dyspnea. After careful physical examination, you suspect cor pulmonale and pulmonary hypertension. Which of the following tests is required to definitively confirm the diagnosis of pulmonary hypertension and rule out left heart disease as causal?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B-type natriuretic peptide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Electrocardiogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right heart catheterization&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transthoracic echocardiogram&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right heart catheterization&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Right heart catheterization&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Right heart catheterization is essential for definitively diagnosing pulmonary hypertension and distinguishing it from left heart disease, making it the most appropriate test for confirming the diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ definitively diagnosing pulmonary hypertension&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 84-year-old woman with well controlled diabetes and a history of multiple myeloma who presents with acute headache and undergoes CT scan with IV contrast, which shows no acute intracranial abnormalities. While her admission creatinine was 2.1, on post-admission day 2 it is 2.6 and rises to 3.6 on the next day. She is not dehydrated, she has not received any other nephrotoxic agents, and a diagnosis of contrast-induced nephropathy is made. All of the following are risk factors for contrast-induced nephropathy EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age &amp;gt;80 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low-contrast dose&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Paraproteinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Low-contrast dose&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â C) Low-contrast dose&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CIN is a serious complication of contrast administration. Recognizing the risk factors for CIN allows for appropriate preventive measures, such as adequate hydration and minimizing contrast dose when possible. Paraproteinemia, associated with conditions like multiple myeloma, is a risk factor for CIN.&lt;/li&gt;&lt;li&gt;âž¤ CIN is a serious complication of contrast administration.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the risk factors for CIN allows for appropriate preventive measures, such as adequate hydration and minimizing contrast dose when possible.&lt;/li&gt;&lt;li&gt;âž¤ Paraproteinemia, associated with conditions like multiple myeloma, is a risk factor for CIN.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a young man with seizures. As you work to classify the type and etiology of seizure, you know all of the following statements are true, EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Focal seizures originate within networks limited to one brain region.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Generalized seizures arise within and rapidly engage networks distributed across both cerebral hemispheres.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Focal seizures are not usually associated with structural abnormalities of the brain.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Focal seizures can evolve into generalized seizures.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Focal seizures are not usually associated with structural abnormalities of the brain.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Focal seizures are not usually associated with structural abnormalities of the brain.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Focal seizures are commonly associated with structural abnormalities in the brain. Understanding the different types of seizures and their underlying mechanisms is crucial for proper diagnosis and management.&lt;/li&gt;&lt;li&gt;âž¤ Focal seizures are commonly associated with structural abnormalities in the brain.&lt;/li&gt;&lt;li&gt;âž¤ Understanding the different types of seizures and their underlying mechanisms is crucial for proper diagnosis and management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male with a history of diabetes and hypertension presents with sudden onset right-sided weakness and facial droop. Which of the following is LEAST likely to be a contributing risk factor for his current presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-density lipoprotein cholesterol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low-density lipoprotein cholesterol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. High-density lipoprotein cholesterol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) High-density lipoprotein cholesterol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ High-density lipoprotein cholesterol is a protective factor against stroke, while diabetes, hypertension, and high LDL cholesterol are significant risk factors. Recognizing and managing these risk factors is crucial in preventing stroke.&lt;/li&gt;&lt;li&gt;âž¤ High-density lipoprotein cholesterol is a protective factor against stroke, while diabetes, hypertension, and high LDL cholesterol are significant risk factors.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing and managing these risk factors is crucial in preventing stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are called emergently by a nurse into an emergency department room where Mr. Freeman is a 75-yearold patient who had presented with a headache. He has just returned from head CT where an intracranial hemorrhage was found. On return from CT, he is obtunded and gurgling with arterial oxygenation saturation of 90%. He has minimal response to painful stimuli. Blood pressure is 150/90. What is the next best action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bedside craniotomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV hypertonic saline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intubation and mechanical ventilation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Labetalol IV for blood pressure control&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intubation and mechanical ventilation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intubation and mechanical ventilation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with impaired consciousness and signs of poor oxygenation, securing the airway with intubation and mechanical ventilation is the immediate priority, especially in the setting of an intracranial hemorrhage where neurologic deterioration can lead to airway compromise and aspiration.Top of Form&lt;/li&gt;&lt;li&gt;âž¤ intubation and mechanical ventilation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;While most cases of vascular dementia are sporadic and largely due to environmental/acquired risk factors, some are genetic. The most prevalent is cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. This disorder is due to a mutation in which of the following genes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CFTR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dystrophin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NOTCH3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Titin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. NOTCH3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) NOTCH3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CADASIL is the most common genetic cause of vascular dementia and is due to mutations in the NOTCH3 gene . This condition results in recurrent strokes, cognitive impairment, and other neurological symptoms due to small vessel disease in the brain.&lt;/li&gt;&lt;li&gt;âž¤ CADASIL&lt;/li&gt;&lt;li&gt;âž¤ NOTCH3 gene&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 70 years old male, in the clinic today. He presents with rest tremor, occasional rigidity, generalized bradykinesia, and gait dysfunction with frequent falls. You would expect degeneration of which neuron subtype within the brain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dopaminergic neurons in the substantia nigra&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GABAergic neurons in the putamen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serotonergic neurons in the cortex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serotonergic neurons in the substantia nigra&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Dopaminergic neurons in the substantia nigra&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Dopaminergic neurons in the substantia nigra&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease is characterized by the degeneration of dopaminergic neurons in the substantia nigra , leading to the hallmark motor symptoms of the disease, such as tremor, rigidity, bradykinesia, and postural instability.&lt;/li&gt;&lt;li&gt;âž¤ dopaminergic neurons&lt;/li&gt;&lt;li&gt;âž¤ substantia nigra&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;24-year-old with unilateral facial weakness, you diagnose a simple Bellâ€™s palsy without any other neurologic deficits. Laboratory studies including an erythrocyte sedimentation rate, Lyme titer, and angiotensin-converting enzyme level are normal. Chest x-ray is normal. Which of the following is the next most reasonable therapeutic step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Ig infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Focused muscle electrical stimulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;L-dopa therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisone 60 mg daily for 5 days and then tapered over 5 days&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prednisone 60 mg daily for 5 days and then tapered over 5 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prednisone 60 mg daily for 5 days and then tapered over 5 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For acute Bell&#x27;s palsy , oral corticosteroids (prednisone) initiated early are the most effective treatment to reduce nerve inflammation and improve recovery. Other interventions like IVIg or electrical stimulation are not appropriate for this condition.&lt;/li&gt;&lt;li&gt;âž¤ acute Bell&#x27;s palsy&lt;/li&gt;&lt;li&gt;âž¤ oral corticosteroids (prednisone)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 71-year-old man, for changes in mental status and cognition. His wife reports that he has slowly been worsening over the last year or two. He has frequent visual hallucinations, sleeps heavily during the daytime but not well at night, and has delusions of persecution. He was noted to have some parkinsonian features previously and was started on L-dopa, but quickly developed a hallucinatory delirium requiring cessation of L-dopa. He does not have orthostatic hypotension or syncope. Which of the following diseases best fits his dementia syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Delirium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dementia with Lewy bodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple systems atrophy with parkinsonism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dementia with Lewy bodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dementia with Lewy bodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dementia with Lewy bodies is a common cause of dementia, often presenting with visual hallucinations, fluctuating cognition, and parkinsonism. Patients with DLB are highly sensitive to antipsychotic medications and dopamine agonists, which can worsen their symptoms. Recognizing the clinical features of DLB is crucial for accurate diagnosis and appropriate management, avoiding medications that can exacerbate their condition.&lt;/li&gt;&lt;li&gt;âž¤ Dementia with Lewy bodies is a common cause of dementia, often presenting with visual hallucinations, fluctuating cognition, and parkinsonism.&lt;/li&gt;&lt;li&gt;âž¤ Patients with DLB are highly sensitive to antipsychotic medications and dopamine agonists, which can worsen their symptoms.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the clinical features of DLB is crucial for accurate diagnosis and appropriate management, avoiding medications that can exacerbate their condition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents to the emergency department with a sudden, severe headache described as the \&quot;worst headache of her life.\&quot; She also reports nausea, neck stiffness, and photophobia. A non-contrast CT scan of the head reveals hyperdensity in the basal cisterns and along the sulci. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Migraine with aura&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subarachnoid haemorrhage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tension headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic stroke&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Subarachnoid haemorrhage&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-100222.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Subarachnoid hemorrhage&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A sudden, severe headache (\&quot;worst headache of life\&quot;) with CT evidence of hyperdensity in the basal cisterns is most indicative of a subarachnoid hemorrhage , often caused by a ruptured aneurysm.&lt;/li&gt;&lt;li&gt;âž¤ sudden, severe headache&lt;/li&gt;&lt;li&gt;âž¤ CT evidence of hyperdensity&lt;/li&gt;&lt;li&gt;âž¤ subarachnoid hemorrhage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with recurrent episodes of optic neuritis and longitudinally extensive transverse myelitis. Her symptoms include vision loss in one eye and weakness in her legs. Laboratory testing reveals a positive autoantibody. Which of the following is the most likely target of the autoantibody found in 70% of patients with this clinical diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aquaporin-4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclic citrullinated peptides&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Double-stranded DNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myeloperoxidase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Aquaporin-4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Aquaporin-4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In neuromyelitis optica (NMO) , the autoantibodies commonly target aquaporin-4 , leading to recurrent episodes of optic neuritis and transverse myelitis. Detecting these antibodies helps confirm the diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ neuromyelitis optica (NMO)&lt;/li&gt;&lt;li&gt;âž¤ aquaporin-4&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman is seen for complaints of weakness for the last month. She notes this to be particularly worse in the late afternoon and evening. Initially, she attributed the weakness to stress from her job, but she feels that the weakness is worsening despite taking several days off work. She also is now noticing some occasional double vision, and her husband has noticed that her voice sounds weak. The patient denies pain. On physical examination, you note the appearance of mild ptosis and a nasal, breathy tone to her voice. Which of the following tests would be most sensitive and specific for making a diagnosis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetylcholine receptor antibodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Edrophonium test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Muscle-specific kinase antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repetitive nerve stimulation test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acetylcholine receptor antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acetylcholine receptor antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with suspected myasthenia gravis , testing for acetylcholine receptor antibodies is the most sensitive and specific method to confirm the diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ myasthenia gravis&lt;/li&gt;&lt;li&gt;âž¤ acetylcholine receptor antibodies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mr. Rollins is brought to the emergency department on Saturday night. His wife reports that he came home from a late business meeting with altered mental status and ataxia. He was completely normal this afternoon when she visited him at work. On examination, you note that he is moderately somnolent but awakens with voice. He has a bilateral ataxia, which is symmetric. He denies vertigo. Which of the following tests is most likely to discover the etiology of his neurologic abnormalities?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood ethanol level&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Brain MRI focusing on fine cuts through the cerebellum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dix-Hallpike test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lumbar puncture with polymerase chain reaction for varicella zoster&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Blood ethanol level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Blood ethanol level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For patients presenting with acute altered mental status and ataxia, alcohol intoxication is a common and easily reversible cause. A blood ethanol level is a simple and effective diagnostic test in this clinical scenario.&lt;/li&gt;&lt;li&gt;âž¤ alcohol intoxication&lt;/li&gt;&lt;li&gt;âž¤ blood ethanol level&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man presents complaining of weakness. He has a difficult time pinpointing an onset. He believes he first noticed weakness in his right foot and leg about 6 months ago. He reports that he frequently trips over his toes and drags his foot. He also gets frequent cramps when he stretches in bed in the mornings. The weakness is progressing to involve both legs now. On examination, you note tongue fasciculations. Deep tendon reflexes are 3+ at the knees and ankles. Strength is 4â€“ at the extensors and flexors of the right foot and 4+ at the left foot. Hand grip strength is also 4+. Which of the following is the suspected pathologic lesion(s)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Demyelinating plaques&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Loss of anterior horn cells in the spinal cord and degeneration of CST&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loss of large pyramidal cells in the precentral gyrus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphocytic infiltrate of spinal roots and nerves&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Loss of anterior horn cells in the spinal cord and degeneration of CST&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Loss of anterior horn cells in the spinal cord and degeneration of CST&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ALS involves degeneration of both upper motor neurons (corticospinal tracts) and lower motor neurons (anterior horn cells), leading to a combination of muscle weakness, hyperreflexia, fasciculations, and atrophy, as seen in this patient.&lt;/li&gt;&lt;li&gt;âž¤ ALS&lt;/li&gt;&lt;li&gt;âž¤ upper motor neurons&lt;/li&gt;&lt;li&gt;âž¤ lower motor neurons&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You have developed a new screening test for disease X. When you compare your test to the gold standard test, you find that you are correctly able to identify 8 of 10 people who have the disease. You next test a population of 50 people without the disease and you identify 3 positive results on your test. Which of the following is true regarding your test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The sensitivity is 20%.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The sensitivity is 94%.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The specificity is 6%.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The specificity is 94%&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. The specificity is 94%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) The specificity is 94%.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sensitivity: True positive rate Specificity: True negative rate&lt;/li&gt;&lt;li&gt;âž¤ Sensitivity: True positive rate&lt;/li&gt;&lt;li&gt;âž¤ Sensitivity:&lt;/li&gt;&lt;li&gt;âž¤ Specificity: True negative rate&lt;/li&gt;&lt;li&gt;âž¤ Specificity:&lt;/li&gt;&lt;li&gt;âž¤ In this case, the new test has a high specificity (94%), meaning it&#x27;s good at correctly identifying people who don&#x27;t have the disease. It has a moderate sensitivity (80%), indicating it might miss some people who actually have the disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 21-year-old man is treated with induction chemotherapy for acute lymphoblastic leukemia. His initial white blood cell count prior to treatment was 156,000/Î¼L. All of the following are expected complications during his treatment EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute kidney injury&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypercalcemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperphosphatemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypercalcemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypercalcemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tumor lysis syndrome is a potentially life-threatening complication of chemotherapy in patients with high tumor burden. It&#x27;s essential to monitor for and manage electrolyte abnormalities and acute kidney injury that may occur due to TLS.&lt;/li&gt;&lt;li&gt;âž¤ Tumor lysis syndrome is a potentially life-threatening complication of chemotherapy in patients with high tumor burden.&lt;/li&gt;&lt;li&gt;âž¤ It&#x27;s essential to monitor for and manage electrolyte abnormalities and acute kidney injury that may occur due to TLS.&lt;/li&gt;&lt;li&gt;âž¤ Hypercalcemia is not a typical complication in this setting.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;As an oncologist, you are considering treatment options for your patients with lung cancer, including small-molecule therapy targeting the epidermal growth factor receptor (EGFR). Which of the following patients is most likely to have an EGFR mutation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A 23-year-old man with a hamartoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A 33-year-old woman with a carcinoid tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A 45-year-old woman who has never smoked with an adenocarcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A 56-year-old man with a 100 pack-year history of tobacco use with small-cell lung carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. A 45-year-old woman who has never smoked with an adenocarcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) A 45-year-old woman who has never smoked with an adenocarcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ EGFR mutations are important biomarkers in lung cancer, particularly in non-small cell lung cancer (NSCLC). They are more commonly found in never-smokers or light smokers, women, and individuals of Asian ethnicity. Targeted therapies against EGFR mutations have revolutionized the treatment of NSCLC in patients with these mutations.&lt;/li&gt;&lt;li&gt;âž¤ EGFR mutations are important biomarkers in lung cancer, particularly in non-small cell lung cancer (NSCLC).&lt;/li&gt;&lt;li&gt;âž¤ They are more commonly found in never-smokers or light smokers, women, and individuals of Asian ethnicity.&lt;/li&gt;&lt;li&gt;âž¤ Targeted therapies against EGFR mutations have revolutionized the treatment of NSCLC in patients with these mutations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 18-year-old boy comes into the hospital with severe pain in his bilateral hips, arms, and diffuse body aches. He has had similar episodes but has not required hospitalization. He is not on any medications. He plays soccer part of the year but has not been playing recently and has not had any trauma. On initial labs, his comprehensive metabolic panel is normal except for a total bilirubin of 1.5 mg/dL. Complete blood count is notable for microcytic anemia. His peripheral smear is shown below. Given the likely diagnosis, which explanation fits with this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A somatic mutation that causes deranged messenger RNA splicing of the globin gene.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated carbon monoxide levels.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mutation in the Î²- globin gene that changes the sixth amino acid from glutamic acid to valine.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;One of the four Î±- globin loci is deleted&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Mutation in the Î²- globin gene that changes the sixth amino acid from glutamic acid to valine.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-101346.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Mutation in the Î²-globin gene that changes the sixth amino acid from glutamic acid to valine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of microcytic anemia, recurrent pain crises, and hemolysis in an adolescent with a likely hemoglobinopathy points to sickle cell disease , which is caused by a mutation in the Î²-globin gene leading to the production of abnormal hemoglobin S.&lt;/li&gt;&lt;li&gt;âž¤ microcytic anemia, recurrent pain crises, and hemolysis&lt;/li&gt;&lt;li&gt;âž¤ sickle cell disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman is referred to your clinic for evaluation of anemia that was found on a life insurance screening examination. She reports being healthy, takes no medications other than a multivitamin with iron, and only admits some recent fatigue on exertion in the past 6â€“9 months. She menstruates regularly with 3- to 4-day menses that have not changed in years. She eats a normal omnivorous diet, smokes one pack of cigarettes per day, and does not use illicit drugs. The results of her complete blood count reveal a white blood cell count of 4.0/Î¼L, platelet count of 235,000/Î¼L, and hemoglobin of 8 g/dL with a mean corpuscular volume of 105.Peripheral smear is shown below. She has normal renal and liver function. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute myeloblastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron-deficiency anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pernicious anemia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pernicious anemia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-101457.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pernicious anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The elevated MCV and clinical presentation are most consistent with pernicious anemia , a common cause of B12 deficiency , which leads to megaloblastic anemia despite normal dietary intake due to impaired absorption of B12.&lt;/li&gt;&lt;li&gt;âž¤ pernicious anemia&lt;/li&gt;&lt;li&gt;âž¤ B12 deficiency&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman comes to the clinic with fatigue, intermittent fevers, and night sweats for the past 2 weeks. She denies any recent travel or sick contacts. Her physical examination reveals pale conjunctiva but is otherwise normal. Her vital signs are notable only for a temperature of 38.0Â°C (100.4Â°F). The metabolic panel is normal, but her complete blood count reveals a white blood cell count of 900/Î¼L, hemoglobin of 8.0g/dL, and a platelet count of 98,000/ Î¼L. Which of the following is the least likely cause of her current symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acquired aplastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myelodysplastic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myelofibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Parvovirus infection&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Parvovirus infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Parvovirus infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In this case of pancytopenia with fatigue, fever, and night sweats, parvovirus infection is the least likely cause, as it typically causes isolated anemia rather than pancytopenia. Bone marrow disorders like aplastic anemia , myelodysplastic syndrome , and myelofibrosis are more likely.&lt;/li&gt;&lt;li&gt;âž¤ parvovirus infection&lt;/li&gt;&lt;li&gt;âž¤ aplastic anemia&lt;/li&gt;&lt;li&gt;âž¤ myelodysplastic syndrome&lt;/li&gt;&lt;li&gt;âž¤ myelofibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old-man comes in for follow-up after a recent hospitalization for a car accident in which he was rear-ended. He suffered no injuries and was released from the emergency room after a full examination and monitoring. On labs done in the emergency room, he was noted to have an elevated white blood cell count to 95 Ã— 109/L, predominantly lymphocytes. You do a peripheral smear is shown below. Which of the following is the best next step of action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Admission to the hospital for high-dose induction chemotherapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Flow cytometry&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Flow cytometry&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/whatsapp-image-2024-09-17-at-41635-pm.jpeg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Flow cytometry&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with an elevated white blood cell count and predominantly lymphocytes, especially in an elderly patient, chronic lymphocytic leukemia (CLL) should be suspected. Flow cytometry is the most appropriate next step to confirm the diagnosis before determining the need for treatment or observation.&lt;/li&gt;&lt;li&gt;âž¤ chronic lymphocytic leukemia (CLL)&lt;/li&gt;&lt;li&gt;âž¤ Flow cytometry&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old female is evaluated by her primary care physician for worsening dyspnea on exertion. She has a history of rheumatoid arthritis (RA) treated with anti-tumor necrosis factor alpha therapy, which has controlled her joint manifestations. Which of the following additional findings suggest that her dyspnea may be related to RA-associated interstitial lung disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A total lung capacity of 55% predicted with a diffusing capacity for carbon dioxide (DLCO) of 50% predicted&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A total lung capacity of 55% predicted and a DLCO of 90% predicted&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A total lung capacity of 90% predicted with a normal DLCO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A total lung capacity of 120% predicted with a DLCO of 60% predicted&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. A total lung capacity of 55% predicted with a diffusing capacity for carbon dioxide (DLCO) of 50% predicted&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) A total lung capacity of 55% predicted with a diffusing capacity for carbon dioxide (DLCO) of 50% predicted&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with RA-associated interstitial lung disease , pulmonary function tests typically show a restrictive pattern (reduced TLC) with a reduced DLCO , reflecting impaired gas exchange due to lung fibrosis.&lt;/li&gt;&lt;li&gt;âž¤ RA-associated interstitial lung disease&lt;/li&gt;&lt;li&gt;âž¤ restrictive pattern&lt;/li&gt;&lt;li&gt;âž¤ reduced DLCO&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old male with cystic fibrosis has had an increase in the number of respiratory exacerbations over the last year, despite good compliance with airway clearance techniques and treatment with several rounds of antibiotics for chronic pseudomonas colonization. On examination in your office he has scattered wheezes over his anterior lung fields, as well as bibasilar crackles with rhonchi. CT of the chest reveals extensive upper lobe bronchiectasis with mucus plugging as well as scattered areas of bronchiolitis. In addition to repeat sputum cultures to look for new bacterial and atypical mycobacterial infections, which of the following tests would be indicated at this time?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arterial blood gas analysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchoscopy with bronchoalveolar lavage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CT angiogram to look for pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum IgE level&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum IgE level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serum IgE levels.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with cystic fibrosis who present with worsening respiratory symptoms and bronchiectasis, especially with mucus plugging , it&#x27;s important to consider allergic bronchopulmonary aspergillosis (ABPA) . A serum IgE level is the next best test to evaluate for this condition.&lt;/li&gt;&lt;li&gt;âž¤ cystic fibrosis&lt;/li&gt;&lt;li&gt;âž¤ mucus plugging&lt;/li&gt;&lt;li&gt;âž¤ allergic bronchopulmonary aspergillosis (ABPA)&lt;/li&gt;&lt;li&gt;âž¤ serum IgE level&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year old male with known cystic fibrosis (CF) presents to the clinic with worsening cough, sputum production, and shortness of breath over the last 3 weeks. Prior to this episode he has been doing fairly well, and has been compliant with his airway clearance regimen, which includes hypertonic saline nebulizers, inhaled dornase, and twice daily use of a flutter valve to aid with expectoration of sputum. You suspect that he has an acute CF exacerbation. Which of the following would be the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhaled tobramycin to cover for likely Pseudomonas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV ceftazidime and tobramycin to cover likely Pseudomonas infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV vancomycin and ceftriaxone to cover both methicillin-resistant Staphylococcus aureus infection as well as possible community-acquired pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral azithromycin, ethambutol, and rifampin to cover likely atypical mycobacterial infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IV ceftazidime and tobramycin to cover likely Pseudomonas infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) IV ceftazidime and tobramycin to cover likely Pseudomonas infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with cystic fibrosis experiencing an acute exacerbation, empiric therapy should cover Pseudomonas aeruginosa , typically with a combination of IV antibiotics like ceftazidime and tobramycin .&lt;/li&gt;&lt;li&gt;âž¤ cystic fibrosis&lt;/li&gt;&lt;li&gt;âž¤ Pseudomonas aeruginosa&lt;/li&gt;&lt;li&gt;âž¤ IV antibiotics&lt;/li&gt;&lt;li&gt;âž¤ ceftazidime and tobramycin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old presents to the clinic with 6 months of intermittent cough and sputum production, and worsening dyspnea on exertion. He has been treated at an urgent care center twice in the last year for bronchitis. He smokes about 1 pack of cigarettes per day and has done so for the last 20 years. Pulmonary function testing reveals an FEV1/ FVC ratio of 50%, with an FEV1 of 45% predicted. CT of the chest reveals pan-acinar emphysema with slightly worse disease in the lower lobes. What would be the next step in management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Careful environmental history to better understand possible exposure risk to airway irritants and toxins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Genetic testing for cystic fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sputum culture to rule out atypical mycobacterial infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Testing for alpha-1 antitrypsin levels&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Testing for alpha-1 antitrypsin levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Testing for alpha-1 antitrypsin levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a relatively young smoker with pan-acinar emphysema in the lower lobes, testing for alpha-1 antitrypsin deficiency (AATD) is crucial to confirm the diagnosis, as it is a common cause of early-onset emphysema in these patients.&lt;/li&gt;&lt;li&gt;âž¤ pan-acinar emphysema&lt;/li&gt;&lt;li&gt;âž¤ alpha-1 antitrypsin deficiency (AATD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with mild amyotrophic lateral sclerosis is followed by a pulmonologist for respiratory dysfunction associated with his neuromuscular disease. Which of the following symptoms in addition to PaCO2 â‰¥45 mmHg would necessitate therapy with noninvasive positive pressure ventilation for hypoventilation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Orthopnea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Poor-quality sleep&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dyspnea in activities of daily living&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ALS patients with elevated PaCO2 and symptoms like orthopnea, poor sleep quality , and dyspnea , noninvasive positive pressure ventilation (NIPPV) is indicated to support respiratory function and prevent further respiratory decline.&lt;/li&gt;&lt;li&gt;âž¤ PaCO2&lt;/li&gt;&lt;li&gt;âž¤ orthopnea, poor sleep quality&lt;/li&gt;&lt;li&gt;âž¤ dyspnea&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old male presents with worsening cough and exertional dyspnea over the last 2 months. He currently smokes 1.5 packs of cigarettes per day and has done so for 30 years. His pulmonary function tests show a normal FEV1/FVC ratio, a total lung capacity that is 75% of predicted, and a diffusing capacity that is 60% of predicted. High-resolution CT of the chest shows diffuse centrilobular nodules and scattered ground-glass opacities. Which of the following treatments would be most likely effective for his interstitial lung disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nintedanib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoking cessation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Smoking cessation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Smoking cessation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with smoking-related interstitial lung disease like RB-ILD , smoking cessation is the primary and most effective treatment. Continuing to smoke can exacerbate lung damage, whereas quitting can halt disease progression and improve symptoms.&lt;/li&gt;&lt;li&gt;âž¤ smoking-related interstitial lung disease&lt;/li&gt;&lt;li&gt;âž¤ RB-ILD&lt;/li&gt;&lt;li&gt;âž¤ smoking cessation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old man with a history of pulmonary tuberculosis (TB) presents with fatigue, nausea, and low blood pressure. He has been on anti-tuberculosis therapy (ATT) for 4 months. On examination, he is hypotensive with hyperpigmented skin. Lab tests show hyponatremia and hyperkalemia. What is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid-induced hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rifampin-induced nephrotoxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyrazinamide-induced gout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal hemorrhage due to miliary tuberculosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Adrenal hemorrhage due to miliary tuberculosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Adrenal hemorrhage due to miliary tuberculosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Miliary tuberculosis can lead to adrenal hemorrhage and subsequent adrenal insufficiency, which presents with hypotension , electrolyte imbalances (hyponatremia, hyperkalemia), and fatigue . Recognizing these signs is crucial in patients on anti-tuberculosis therapy .&lt;/li&gt;&lt;li&gt;âž¤ Miliary tuberculosis&lt;/li&gt;&lt;li&gt;âž¤ adrenal hemorrhage&lt;/li&gt;&lt;li&gt;âž¤ hypotension&lt;/li&gt;&lt;li&gt;âž¤ electrolyte imbalances&lt;/li&gt;&lt;li&gt;âž¤ fatigue&lt;/li&gt;&lt;li&gt;âž¤ anti-tuberculosis therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man was admitted to the intensive care unit with a large intracranial bleed following a motorcycle accident. On initial CT scan, there was midline shift and evidence of uncal herniation. At the scene of the accident, the patient was initially minimally responsive but has been totally unresponsive to all stimuli since admission. The patient was intubated by emergency medical services en route to the hospital. He has now been admitted for 24 hours. You believe the patient is brain dead. Which of the following contributes to the diagnosis of brain death?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Absence of pupillary light reflex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apnea Test positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loss of oculovestibular reflexes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above are criteria for assessment of brain death&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above are criteria for assessment of brain death&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above are criteria for assessment of brain death&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The diagnosis of brain death requires the absence of all brainstem reflexes (including pupillary light reflex and oculovestibular reflex), and a positive apnea test , confirming the irreversible loss of brain function.&lt;/li&gt;&lt;li&gt;âž¤ brain death&lt;/li&gt;&lt;li&gt;âž¤ apnea test&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old woman with relapsed acute myelogenous leukemia has undergone a myeloablative allogeneic stem cell transplantation. She has been profoundly neutropenic for 21 days and has had a persistent fever for the past 7 days. Today, she has appeared septic with hypotension, tachycardia, and a new oxygen requirement. A nurse calls you to evaluate a new rash. On examination, the patient looks ill. She is tachypneic and is rigoring. Skin examination reveals a few scattered areas of hemorrhagic vesicles, the largest measuring 3 cm in diameter, on the hands and legs. Image is shown below. What is the most likely causative organism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neisseria meningitidis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pseudomonas aeruginosa&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rickettsia rickettsia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Staphylococcus aureus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pseudomonas aeruginosa&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-103536.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pseudomonas aeruginosa&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ecthyma gangrenosum is a cutaneous manifestation of invasive infection, most commonly caused by Pseudomonas aeruginosa. It is often seen in immunocompromised patients with prolonged neutropenia. Recognizing the characteristic skin lesions and the associated clinical context is crucial for prompt diagnosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ Ecthyma gangrenosum is a cutaneous manifestation of invasive infection, most commonly caused by Pseudomonas aeruginosa.&lt;/li&gt;&lt;li&gt;âž¤ It is often seen in immunocompromised patients with prolonged neutropenia.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the characteristic skin lesions and the associated clinical context is crucial for prompt diagnosis and treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man has chronic obstructive pulmonary disease and presents to your office for routine follow-up. He has no complaints currently and feels well. His most recent FEV1 was 55% predicted, and he is not on oxygen. He received one dose of pneumococcal vaccine 7 years previously. He is asking whether he should receive another dose of pneumococcal vaccine. According to the guidelines of the Centers for Disease Control and Prevention, what is your recommendation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;He does not require further vaccination unless his FEV1 drops below 50% predicted.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;He does not require further vaccination until he reaches age 65.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;He should be revaccinated today.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;He should be revaccinated 10 years after his initial vaccine.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. He should be revaccinated today.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) He should be revaccinated today.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Adults with chronic lung disease, including COPD, should receive two pneumococcal vaccines: PCV13 and PPSV23. Revaccination with PPSV23 is recommended 5 years after the first PPSV23 dose.&lt;/li&gt;&lt;li&gt;âž¤ Adults with chronic lung disease, including COPD, should receive two pneumococcal vaccines: PCV13 and PPSV23.&lt;/li&gt;&lt;li&gt;âž¤ Revaccination with PPSV23 is recommended 5 years after the first PPSV23 dose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You admit a patient with severe community-acquired pneumonia who requires intubation and mechanical ventilation. She has decreased breath sounds and dullness to percussion halfway up her right lung. Chest x-ray and ultrasound confirm the presence of a large pleural effusion. You perform a diagnostic thoracentesis, but fluid remains. All of the following are indications for complete drainage of the pleural fluid EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pleural fluid pH &amp;lt;7&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleural fluid glucose &amp;lt;2.2 mmol/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pleural fluid protein &amp;gt;5 g/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural fluid lactate dehydrogenase concentration &amp;gt;1000 units/L&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pleural fluid protein &gt;5 g/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pleural fluid protein &amp;gt; 5 g/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with severe pneumonia and a large pleural effusion, certain pleural fluid findings (low pH, low glucose, high LDH) are indicative of empyema and necessitate complete drainage. A high pleural fluid protein level alone is not an absolute indication for complete drainage. Further investigation and clinical correlation are necessary to determine the appropriate management.&lt;/li&gt;&lt;li&gt;âž¤ In a patient with severe pneumonia and a large pleural effusion, certain pleural fluid findings (low pH, low glucose, high LDH) are indicative of empyema and necessitate complete drainage.&lt;/li&gt;&lt;li&gt;âž¤ A high pleural fluid protein level alone is not an absolute indication for complete drainage. Further investigation and clinical correlation are necessary to determine the appropriate management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman with a past medical history of hypertension presents to her primary care doctor prior to a 2-week long mission trip her church is taking to Guatemala. You provide her with extensive pretravel counseling and treatment. You could provide her with all of the following guidance and prophylaxis regarding the prevention of travelerâ€™s diarrhea EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avoid raw vegetables, salads, and unpeeled fruit.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Take bismuth subsalicylate.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Take ciprofloxacin.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Take probiotics.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Take ciprofloxacin.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Take ciprofloxacin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Traveler&#x27;s diarrhea prevention primarily focuses on dietary and hygiene practices, such as avoiding contaminated food and water. Bismuth subsalicylate and probiotics can be considered for prophylaxis in some cases. Antibiotics like ciprofloxacin are reserved for the treatment of traveler&#x27;s diarrhea if it occurs, not for routine prophylaxis.&lt;/li&gt;&lt;li&gt;âž¤ Traveler&#x27;s diarrhea prevention primarily focuses on dietary and hygiene practices, such as avoiding contaminated food and water.&lt;/li&gt;&lt;li&gt;âž¤ Bismuth subsalicylate and probiotics can be considered for prophylaxis in some cases.&lt;/li&gt;&lt;li&gt;âž¤ Antibiotics like ciprofloxacin are reserved for the treatment of traveler&#x27;s diarrhea if it occurs, not for routine prophylaxis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following tests is the most sensitive to make the appropriate diagnosis in a woman seen at a sexually transmitted disease clinic with profuse, yellow, and purulent, homogenous vaginal discharge with vulvar irritation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Culture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enzyme-linked immunosorbent assay testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gram stain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nucleic acid amplification test&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nucleic acid amplification test&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Nucleic acid amplification test&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NAAT is the preferred diagnostic test for most STIs due to its high sensitivity and specificity.&lt;/li&gt;&lt;li&gt;âž¤ NAAT is the preferred diagnostic test for most STIs due to its high sensitivity and specificity.&lt;/li&gt;&lt;li&gt;âž¤ In a patient presenting with purulent vaginal discharge and vulvar irritation, NAAT should be performed to rule out Chlamydia trachomatis and Neisseria gonorrhoeae infection.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old woman has recurrent urinary tract infections. She is placed on suppressive antibiotic therapy by her primary physician. One year later, she is complaining of progressive dyspnea, and a chest radiograph shows development of pulmonary fibrosis. Which antibiotic could explain development of this complication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cefaclor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cephalexin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciprofloxacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nitrofurantoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Nitrofurantoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Nitrofurantoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nitrofurantoin, although effective for urinary tract infections, carries a risk of pulmonary toxicity, including fibrosis, especially with long-term use. Monitor patients on long-term nitrofurantoin for respiratory symptoms and consider alternative antibiotics if pulmonary complications develop.&lt;/li&gt;&lt;li&gt;âž¤ Nitrofurantoin, although effective for urinary tract infections, carries a risk of pulmonary toxicity, including fibrosis, especially with long-term use.&lt;/li&gt;&lt;li&gt;âž¤ Monitor patients on long-term nitrofurantoin for respiratory symptoms and consider alternative antibiotics if pulmonary complications develop.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman with a history of developmental delay who lives in a group home is brought to the hospital for weakness starting in the head and descending to her legs. She has symmetric cranial nerve palsies, inability to move, and decreased breathing. Deep tendon reflexes are normal. On examination, she is taking only shallow respirations, and you note flaccid muscle tone throughout. There was no preceding fever, cough, coryza, rash, or new medications. She was recently given amoxicillin-clavulanate for sinusitis. She had been eating many foods created with prepared meats. Which of the following is the most likely cause of her presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Botulinum toxicity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Guillain-BarrÃ© syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypokalemic periodic paralysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tetanus toxicity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Botulinum toxicity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Botulinum toxicity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Botulism is a medical emergency that requires prompt recognition and treatment with antitoxin. The classic presentation is descending flaccid paralysis with cranial nerve involvement and potential respiratory failure. A history of consuming improperly canned or preserved food is a crucial clue to the diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ Botulism is a medical emergency that requires prompt recognition and treatment with antitoxin.&lt;/li&gt;&lt;li&gt;âž¤ The classic presentation is descending flaccid paralysis with cranial nerve involvement and potential respiratory failure.&lt;/li&gt;&lt;li&gt;âž¤ A history of consuming improperly canned or preserved food is a crucial clue to the diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old patient with prerenal azotemia secondary to dehydration. His creatinine was initially 3.6 mg/dL on admission, but it has improved today to 2.1 mg/dL. He complains of mild lower back pain, and you prescribe naproxen to be taken intermittently. By what mechanism might this drug further impair his renal function?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Afferent arteriolar vasoconstriction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Afferent arteriolar vasodilatation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Efferent arteriolar vasoconstriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proximal tubular toxicity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Afferent arteriolar vasoconstriction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Afferent arteriolar vasoconstriction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NSAIDs , such as naproxen, can impair renal function by causing afferent arteriolar vasoconstriction , reducing renal perfusion, particularly in patients with conditions like prerenal azotemia .&lt;/li&gt;&lt;li&gt;âž¤ NSAIDs&lt;/li&gt;&lt;li&gt;âž¤ afferent arteriolar vasoconstriction&lt;/li&gt;&lt;li&gt;âž¤ prerenal azotemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old woman with chronic kidney disease is maintained on daily peritoneal dialysis. Her past medical history is notable for hypertension and atrial fibrillation. Her medications include losartan and warfarin. Two days ago she developed a lesion on her abdominal wall, which is shown below. All of the following statements regarding her condition are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral calcium supplement may be a risk factor.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pathologically, there is vascular occlusion.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudomonas co-infection is typical.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe hyperparathyroidism may not be present.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pseudomonas co-infection is typical.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-104635.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pseudomonas co-infection is typical&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Calciphylaxis is a serious condition involving vascular calcification and skin necrosis in patients with end-stage renal disease . Secondary infections are common, but Pseudomonas is not typically involved. Risk factors include hypercalcemia, hyperphosphatemia, and imbalances in calcium-phosphate metabolism.&lt;/li&gt;&lt;li&gt;âž¤ Calciphylaxis&lt;/li&gt;&lt;li&gt;âž¤ end-stage renal disease&lt;/li&gt;&lt;li&gt;âž¤ Pseudomonas&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old obese female with a 5-year history of mild hypertension controlled by a thiazide diuretic is evaluated for proteinuria noted on a urine dipstick during a routine visit. Physical examination shows mild pedal edema and laboratory tests reveal serum creatinine of 1.2 mg/dL and proteinuria of 5.9 g/dL. A renal biopsy was taken and shown below. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Focal segmental sclerosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertensive nephrosclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Minimal change (nil) disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Membranous glomerulopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Focal segmental sclerosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-104751.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Focal segmental sclerosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Focal segmental glomerulosclerosis (FSGS) is a common cause of nephrotic syndrome in adults, particularly in obese individuals. It is characterized by nephrotic-range proteinuria and segmental scarring of the glomeruli on renal biopsy.&lt;/li&gt;&lt;li&gt;âž¤ Focal segmental glomerulosclerosis (FSGS)&lt;/li&gt;&lt;li&gt;âž¤ nephrotic-range proteinuria&lt;/li&gt;&lt;li&gt;âž¤ segmental scarring of the glomeruli&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a history of SjÃ¶gren syndrome has the following laboratory findings: plasma sodium 139 mEq/L, chloride 112 mEq/L, bicarbonate 15 mEq/L, and potassium 3.0 mEq/L. Urine studies show a pH of 6.0, sodium of 15 mEq/L, potassium of 10 mEq/L, and chloride of 12 mEq/L. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type I RTA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type II RTA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type III RTA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Type I RTA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Type I RTA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Type I (distal) RTA is associated with conditions like SjÃ¶gren syndrome and presents with a non-anion gap metabolic acidosis , hypokalemia , and an inappropriately high urine pH (&amp;gt;5.5) despite systemic acidosis. This impaired excretion of H+ leads to chronic acidosis and electrolyte abnormalities.&lt;/li&gt;&lt;li&gt;âž¤ Type I (distal) RTA&lt;/li&gt;&lt;li&gt;âž¤ SjÃ¶gren syndrome&lt;/li&gt;&lt;li&gt;âž¤ non-anion gap metabolic acidosis&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ inappropriately high urine pH (&amp;gt;5.5)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman who is in the 30th week of her second pregnancy has been followed closely because of mild hypertension. Her first pregnancy was complicated by preeclampsia. She now complains of worsening fatigue over the last day. Her blood pressure is 140/90, and she has a heart rate of 84 beats/min and room air oxygen saturation of 95%. Fetal monitoring shows no distress. Laboratory studies are notable for a hemoglobin of 6 g/dL (10 g/ dL 1 week ago) and platelet count of 80,000/dL (180,000/ dL 1 week ago). A peripheral blood smear shows schistocytes. All of the following statements are true about her condition EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucocorticoids are effective in reducing morbidity and mortality.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Her liver function enzymes are likely elevated.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Preeclampsia predisposes to the condition.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal failure is common.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glucocorticoids are effective in reducing morbidity and mortality.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glucocorticoids are effective in reducing morbidity and mortality&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HELLP syndrome is a serious complication of pregnancy involving hemolysis, elevated liver enzymes, and low platelets . Treatment involves urgent delivery, as continuing the pregnancy increases maternal and fetal risks. Glucocorticoids are not effective for reducing morbidity and mortality in HELLP syndrome, making this option incorrect&lt;/li&gt;&lt;li&gt;âž¤ HELLP syndrome&lt;/li&gt;&lt;li&gt;âž¤ hemolysis, elevated liver enzymes, and low platelets&lt;/li&gt;&lt;li&gt;âž¤ not effective&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a history of recurrent calcium oxalate kidney stones presents to your clinic for follow-up. He is interested in learning about interventions to prevent future stone formation. He has been advised on dietary modifications in the past but is unsure which strategies are most effective. Which of the following interventions has been shown to decrease the recurrence of calcium oxalate renal stones?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A diet with abundant spinach and rhubarb&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low-calcium diet (400 mg/day)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thiazide diuretics&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Thiazide diuretics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Thiazide diuretics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thiazide diuretics are effective in preventing the recurrence of calcium oxalate kidney stones by reducing urinary calcium excretion. Dietary calcium should not be excessively restricted, and oxalate-rich foods like spinach and rhubarb should be limited.&lt;/li&gt;&lt;li&gt;âž¤ Thiazide diuretics&lt;/li&gt;&lt;li&gt;âž¤ calcium oxalate kidney stones&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old HIV-positive man presents with sudden-onset flank pain, hematuria, and dysuria. He has been on antiretroviral therapy for several years. His drugs include Abacavir, Lamivudine, Indinavir and Rosuvastatin. Which of the following is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium oxalate stones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Uric acid stones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Indinavir-induced nephrolithiasis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Struvite stones&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Indinavir-induced nephrolithiasis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Indinavir-induced nephrolithiasis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Indinavir , a protease inhibitor, can cause radiolucent nephrolithiasis due to drug crystallization in the urinary tract. Patients on indinavir who develop flank pain and hematuria should be evaluated for this type of kidney stone.&lt;/li&gt;&lt;li&gt;âž¤ Indinavir&lt;/li&gt;&lt;li&gt;âž¤ radiolucent nephrolithiasis&lt;/li&gt;&lt;li&gt;âž¤ indinavir&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a known history of autosomal dominant polycystic kidney disease (ADPKD) presents with sudden-onset, severe right-sided flank pain. He denies fever, dysuria, or hematuria. His blood pressure is 145/95 mmHg, and his creatinine is stable at 1.5 mg/dL. Urinalysis shows trace blood but no signs of infection. What is the most likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyelonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nephrolithiasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyst rupture&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal artery thrombosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cyst rupture&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cyst rupture&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with ADPKD can experience sudden flank pain due to cyst rupture , which may be accompanied by mild hematuria. This diagnosis should be considered when pain occurs without signs of infection or significant changes in renal function.&lt;/li&gt;&lt;li&gt;âž¤ ADPKD&lt;/li&gt;&lt;li&gt;âž¤ cyst rupture&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old female wishes to undergo a screening colonoscopy for colon cancer. She has no family history of colon cancer and currently has no symptoms referable to the gastrointestinal tract. Which of the following statements is true about colonoscopy as a screening test for colon cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Barium enema is as sensitive as colonoscopy for detecting colitis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colonoscopy remains the gold standard for imaging the colonic mucosa.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CT colonography has replaced traditional colonoscopy for many younger patients because of its ability to detect serrated polyps with greater sensitivity.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Flexible sigmoidoscopy would be as effective as colonoscopy for detecting colon cancer in this patient&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Colonoscopy remains the gold standard for imaging the colonic mucosa.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Colonoscopy remains the gold standard for imaging the colonic mucosa.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Colonoscopy is the gold standard for screening and diagnosing colorectal cancer due to its high sensitivity and the ability to remove polyps during the procedure. Other imaging modalities like CT colonography and flexible sigmoidoscopy have their roles but are not as comprehensive as colonoscopy for detecting all colorectal neoplasia.&lt;/li&gt;&lt;li&gt;âž¤ Colonoscopy is the gold standard for screening and diagnosing colorectal cancer due to its high sensitivity and the ability to remove polyps during the procedure.&lt;/li&gt;&lt;li&gt;âž¤ Other imaging modalities like CT colonography and flexible sigmoidoscopy have their roles but are not as comprehensive as colonoscopy for detecting all colorectal neoplasia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old man is evaluated in the emergency department for chest pain that developed at a restaurant after swallowing a piece of steak. He reports intermittent episodes of meat getting stuck in his lower chest over the past 3 years, but none as severe as this event. He denies food regurgitation outside of these episodes or heartburn symptoms. He is able to swallow liquids without difficulty and has not had any weight loss. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Achalasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenocarcinoma of the esophagus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plummer-Vinson syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Schatzki ring&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Schatzki ring&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Schatzki ring&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Schatzki ring is a common cause of intermittent dysphagia to solids, often triggered by poorly chewed meat. Recognizing the typical presentation can lead to timely diagnosis and appropriate management, such as endoscopic dilation.&lt;/li&gt;&lt;li&gt;âž¤ Schatzki ring is a common cause of intermittent dysphagia to solids, often triggered by poorly chewed meat.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the typical presentation can lead to timely diagnosis and appropriate management, such as endoscopic dilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man presents with progressive dysphagia over a 2-month period. He has noted that food has been getting stuck more frequently in the last 2 weeks. He has a history of intermittent gastroesophageal reflux disease for which he takes over-the-counter antacids every few weeks. He has a history of eczema as a child but is not currently requiring treatment. He undergoes an esophagogastroduodenoscopy, which is shown below along with the biopsy. Which of the following is the most appropriate first step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elimination diet&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV methylprednisolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mepolizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trial of a proton pump inhibitor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Trial of a proton pump inhibitor&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-110419.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Trial of a proton pump inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The management of EoE should be individualized, and a trial of PPI is often a reasonable first step in patients with a history of GERD. If symptoms persist, further evaluation and EoE-specific therapies can be considered.&lt;/li&gt;&lt;li&gt;âž¤ The management of EoE should be individualized, and a trial of PPI is often a reasonable first step in patients with a history of GERD.&lt;/li&gt;&lt;li&gt;âž¤ If symptoms persist, further evaluation and EoE-specific therapies can be considered.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with peptic ulcer disease experiences transient improvement with Helicobacter pylori eradication. However, 3 months later, symptoms recur despite acid-suppressing therapy. He does not take nonsteroidal anti-inflammatory drugs. Stool analysis for H. pylori antigen is negative. Upper gastrointestinal (GI) endoscopy reveals prominent gastric folds together with the persistent ulceration in the duodenal bulb previously detected and the beginning of a new ulceration 4 cm proximal to the initial ulcer. Fasting gastrin levels are elevated, and basal acid secretion is 15 mEq/h. What is the best test to perform to make the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No additional testing is necessary.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood sampling for gastrin levels following a meal.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blood sampling for gastrin levels following secretin administration.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Endoscopic ultrasonography of the pancreas.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Blood sampling for gastrin levels following secretin administration.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Blood sampling for gastrin levels following secretin administration.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Zollinger-Ellison syndrome should be suspected in patients with recurrent or refractory peptic ulcers, especially with elevated gastrin levels. The secretin stimulation test is the gold standard for diagnosing ZES. Early diagnosis and treatment are essential to prevent complications and improve outcomes.&lt;/li&gt;&lt;li&gt;âž¤ Zollinger-Ellison syndrome should be suspected in patients with recurrent or refractory peptic ulcers, especially with elevated gastrin levels.&lt;/li&gt;&lt;li&gt;âž¤ The secretin stimulation test is the gold standard for diagnosing ZES.&lt;/li&gt;&lt;li&gt;âž¤ Early diagnosis and treatment are essential to prevent complications and improve outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man is evaluated by a gastroenterologist for diarrhea that has been present for approximately 1 month. He reports stools that float and are difficult to flush down the toilet; these can occur at any time of day or night but seem worsened by fatty meals. In addition, he reports pain in many joints lasting days to weeks and not relieved by ibuprofen. His wife notes that the patient has had difficulty with memory for the last few months. He has lost 16kg and reports intermittent low-grade fevers. He takes no medications and is otherwise healthy. Endoscopy is recommended. Which of the following is the most likely finding on small bowel biopsy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dilated lymphatics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flat villi with crypt hyperplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mononuclear cell infiltrate in the lamina propria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Periodic acidâ€“Schiff-positive macrophages containing small bacilli&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Periodic acidâ€“Schiff-positive macrophages containing small bacilli&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â D) Periodic acidâ€“Schiff-positive macrophages containing small bacilli&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Whipple&#x27;s disease is a rare systemic infection caused by Tropheryma whipplei. It presents with a combination of malabsorption, arthralgias, and neurological symptoms. The diagnosis is confirmed by identifying PAS-positive macrophages containing bacilli in a small bowel biopsy. Early diagnosis and treatment with antibiotics are essential for a good outcome.&lt;/li&gt;&lt;li&gt;âž¤ Whipple&#x27;s disease is a rare systemic infection caused by Tropheryma whipplei.&lt;/li&gt;&lt;li&gt;âž¤ It presents with a combination of malabsorption, arthralgias, and neurological symptoms.&lt;/li&gt;&lt;li&gt;âž¤ The diagnosis is confirmed by identifying PAS-positive macrophages containing bacilli in a small bowel biopsy.&lt;/li&gt;&lt;li&gt;âž¤ Early diagnosis and treatment with antibiotics are essential for a good outcome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old male from Mexico was found to be purified protein derivativeâ€“positive on routine health screening prior to beginning a new job in a hospital. He was started on isoniazid for treatment of latent tuberculosis. Three months into his treatment course he develops numbness and tingling in his bilateral feet. On laboratory assessment his liver function tests are normal. He reports taking his isoniazid faithfully but does not remember being told to take any additional medications along with the isoniazid. Which of the following is the likely cause of his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Niacin deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thiamine deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin A toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin B6 deficiency&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vitamin B6 deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Vitamin B6 deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Isoniazid can cause vitamin B6 deficiency, leading to peripheral neuropathy. It is crucial to supplement patients on isoniazid with pyridoxine (vitamin B6) to prevent this complication. Recognizing the symptoms of vitamin B6 deficiency and promptly initiating supplementation can help prevent long-term neurological damage&lt;/li&gt;&lt;li&gt;âž¤ Isoniazid can cause vitamin B6 deficiency, leading to peripheral neuropathy.&lt;/li&gt;&lt;li&gt;âž¤ It is crucial to supplement patients on isoniazid with pyridoxine (vitamin B6) to prevent this complication.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the symptoms of vitamin B6 deficiency and promptly initiating supplementation can help prevent long-term neurological damage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old man presents with episodic abdominal pain and stress-induced edema of the lips, tongue, and occasionally the larynx. He has no history of allergies or new medications. What is the most likely deficiency in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C1 esterase inhibitor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;C5A (complement cascade)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclooxygenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgE&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. C1 esterase inhibitor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) C1 esterase inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hereditary angioedema is caused by a deficiency or dysfunction of C1 esterase inhibitor , leading to episodes of non-allergic, non-IgE mediated angioedema that can affect the skin, gastrointestinal tract, and airways.&lt;/li&gt;&lt;li&gt;âž¤ Hereditary angioedema&lt;/li&gt;&lt;li&gt;âž¤ C1 esterase inhibitor&lt;/li&gt;&lt;li&gt;âž¤ non-allergic, non-IgE mediated angioedema&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man is admitted to the intensive care unit with hypoxemia. His partner tells the intensive care team that he has been coughing up blood for the last 2 days in increasing amounts. On laboratory studies his creatinine is markedly elevated. He is ultimately diagnosed with Goodpasture syndrome. What is the immune mechanism leading to organ damage in Goodpasture syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibody-dependent cellular cytotoxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complement-activating autoantibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inactivating autoantibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulating autoantibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Complement-activating autoantibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â B) Â Complement-activating autoantibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Goodpasture syndrome is an autoimmune disease in which complement-activating autoantibodies target the basement membranes of the kidneys and lungs, leading to glomerulonephritis and pulmonary hemorrhage .&lt;/li&gt;&lt;li&gt;âž¤ Goodpasture syndrome&lt;/li&gt;&lt;li&gt;âž¤ complement-activating autoantibodies&lt;/li&gt;&lt;li&gt;âž¤ basement membranes&lt;/li&gt;&lt;li&gt;âž¤ glomerulonephritis&lt;/li&gt;&lt;li&gt;âž¤ pulmonary hemorrhage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman with long-standing diagnosis of systemic lupus erythematosus is evaluated by her rheumatologist as routine follow-up. A new cardiac murmur is heard, and an echocardiogram is ordered. She is feeling well and has no fevers, weight loss, or pre-existing cardiac disease. A vegetation on the mitral valve is demonstrated. Which of the following statements is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood cultures are unlikely to be positive.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucocorticoid therapy has been proven to lead to improvement in this condition.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pericarditis is frequently present concomitantly.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The lesion has a low risk of embolization.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Blood cultures are unlikely to be positive.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Blood cultures are unlikely to be positive.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Libman-Sacks endocarditis is associated with SLE and characterized by sterile vegetations on cardiac valves, most commonly the mitral valve. Blood cultures are typically negative , and there is a risk of embolization from these vegetations.&lt;/li&gt;&lt;li&gt;âž¤ Libman-Sacks endocarditis&lt;/li&gt;&lt;li&gt;âž¤ SLE&lt;/li&gt;&lt;li&gt;âž¤ sterile vegetations&lt;/li&gt;&lt;li&gt;âž¤ negative&lt;/li&gt;&lt;li&gt;âž¤ embolization&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman with a history of SjÃ¶grenâ€™s syndrome presents for prenatal care. She is 22 weeks pregnant, and routine fetal heart monitoring reveals bradycardia. Testing confirms the presence of anti-Ro (SSA) antibodies. Which of the following conditions is most likely to affect the newborn?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neonatal lupus rash&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neonatal congenital hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neonatal congenital heart block&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neonatal polycythemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neonatal congenital heart block&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neonatal congenital heart block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In mothers with autoimmune conditions like SjÃ¶grenâ€™s syndrome or SLE who test positive for anti-Ro (SSA) antibodies , there is an increased risk of the fetus developing congenital heart block (CHB) , which can lead to fetal bradycardia and may require close fetal monitoring.&lt;/li&gt;&lt;li&gt;âž¤ SjÃ¶grenâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ SLE&lt;/li&gt;&lt;li&gt;âž¤ anti-Ro (SSA) antibodies&lt;/li&gt;&lt;li&gt;âž¤ congenital heart block (CHB)&lt;/li&gt;&lt;li&gt;âž¤ fetal bradycardia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman presents with progressive proximal muscle weakness over the past few months. She also reports a red, scaly rash over her knuckles and a purple discoloration of her eyelids. Physical exam reveals symmetrical muscle weakness in her shoulders and hips. Laboratory tests show elevated creatine kinase. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polymyalgia rheumatic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dermatomyositis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Â Dermatomyositis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dermatomyositis is characterized by proximal muscle weakness and distinctive skin findings such as Gottron&#x27;s papules and heliotrope rash . Elevated creatine kinase confirms muscle involvement, distinguishing it from other autoimmune diseases.&lt;/li&gt;&lt;li&gt;âž¤ Dermatomyositis&lt;/li&gt;&lt;li&gt;âž¤ proximal muscle weakness&lt;/li&gt;&lt;li&gt;âž¤ Gottron&#x27;s papules&lt;/li&gt;&lt;li&gt;âž¤ heliotrope rash&lt;/li&gt;&lt;li&gt;âž¤ creatine kinase&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old woman is evaluated for weakness. She has had several weeks of difficulty brushing her teeth and combing her hair. She has also noted a rash on her face. Examination is notable for a heliotrope rash and proximal muscle weakness. Serum CPK is elevated, and she is diagnosed with dermatomyositis. After evaluation, she is found to have anti-Jo-1 antibodies. She is also likely to have which of the following additional findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inflammatory bowel disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interstitial lung disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary biliary cirrhosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Interstitial lung disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â C) Â Interstitial lung disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with dermatomyositis and anti-Jo-1 antibodies are at an increased risk for interstitial lung disease , which requires careful monitoring and management alongside their muscle disease.&lt;/li&gt;&lt;li&gt;âž¤ dermatomyositis&lt;/li&gt;&lt;li&gt;âž¤ anti-Jo-1 antibodies&lt;/li&gt;&lt;li&gt;âž¤ interstitial lung disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old man who presented to you with unexplained pancreatitis 2 weeks ago. Imaging of his pancreas showed diffuse pancreatic enlargement. He denies any alcohol intake and did not have any gallstones on imaging. Interestingly, on examination, he also has marked lacrimal gland and submandibular gland enlargement. Biopsy of his submandibular gland is shown below. The cells pictured in the figure stain strongly positive for IgG4, CD19, and CD138. Which of the following is the appropriate therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thalidomide and dexamethasone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cytomegalovirus immunoglobulin and ganciclovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Systemic chemotherapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prednisone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-111558.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prednisone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IgG4-related disease is a multisystem autoimmune disorder characterized by IgG4-positive plasma cell infiltration , often affecting the pancreas, salivary glands, and other organs. The treatment of choice is corticosteroids , such as prednisone , which can lead to remission in most cases.&lt;/li&gt;&lt;li&gt;âž¤ IgG4-related disease&lt;/li&gt;&lt;li&gt;âž¤ IgG4-positive plasma cell infiltration&lt;/li&gt;&lt;li&gt;âž¤ corticosteroids&lt;/li&gt;&lt;li&gt;âž¤ prednisone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Production of which of the following hormones would be most impaired by lesions that affect the pituitary stalk or hypothalamus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adrenocorticotrophic hormone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Growth hormone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxytocin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prolactin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oxytocin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oxytocin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lesions affecting the pituitary stalk primarily impair the release of posterior pituitary hormones (oxytocin and ADH) due to disruption of their transport and storage. Anterior pituitary hormones can still be produced to some extent, and prolactin levels would actually increase due to the loss of dopamine inhibition.&lt;/li&gt;&lt;li&gt;âž¤ Lesions affecting the pituitary stalk primarily impair the release of posterior pituitary hormones (oxytocin and ADH) due to disruption of their transport and storage.&lt;/li&gt;&lt;li&gt;âž¤ Anterior pituitary hormones can still be produced to some extent, and prolactin levels would actually increase due to the loss of dopamine inhibition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with new-onset headaches. Brain MRI reveals a pituitary lesion. Which of the following laboratory findings is MOST likely associated with a non-functioning pituitary adenoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated free T4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated luteinizing hormone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated morning cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated prolactin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Elevated prolactin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Elevated prolactin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Non-functioning pituitary adenomas can cause hormonal imbalances through mass effect and compression of the pituitary stalk.&lt;/li&gt;&lt;li&gt;âž¤ Elevated prolactin levels due to the \&quot;stalk effect\&quot; are a common and characteristic finding in non-functioning pituitary adenomas.&lt;/li&gt;&lt;li&gt;âž¤ Recognizing the potential for hormonal dysfunction in patients with pituitary lesions is crucial, prompting appropriate laboratory investigations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old mother of three presents to her primary care office with complaints of fatigue. She feels that her energy level has been low for the past 3 months. She was previously healthy and taking no medications. She does report that she has gained about 6 Kg weight and has severe constipation, for which she has been taking a number of laxatives. Her thyroid-stimulating hormone level is elevated at 25 mU/L. Free T4 is low. She is wondering why she has hypothyroidism. Which of the following tests is most likely to diagnose the etiology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antithyroid peroxidase antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antithyroglobulin antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radioiodine uptake scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum thyroglobulin level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Antithyroid peroxidase antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Antithyroid peroxidase antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Antithyroid peroxidase antibody is the most useful test to diagnose Hashimoto&#x27;s thyroiditis, the most common cause of hypothyroidism.&lt;/li&gt;&lt;li&gt;âž¤ Antithyroid peroxidase antibody is the most useful test to diagnose Hashimoto&#x27;s thyroiditis, the most common cause of hypothyroidism.&lt;/li&gt;&lt;li&gt;âž¤ Other tests may be helpful in certain situations, but TPO antibody is the initial test of choice in most cases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old man presents to the clinic reporting ankle swelling. On examination, his blood pressure is elevated at 162/86, and he has bilateral ankle edema. There are no other abnormalities on physical examination. Laboratory studies show a potassium of 2.9 and normal creatinine. Which of the following studies is recommended next?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AM cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT of adrenals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Plasma renin and aldosterone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thyroid-stimulating hormone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Plasma renin and aldosterone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Plasma renin and aldosterone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with hypertension, hypokalemia, and normal renal function, primary hyperaldosteronism should be strongly suspected. The plasma renin and aldosterone test is the initial diagnostic test of choice to confirm the diagnosis. If the test is positive, further imaging (e.g., CT of adrenals) may be needed to identify the underlying cause&lt;/li&gt;&lt;li&gt;âž¤ In a patient with hypertension, hypokalemia, and normal renal function, primary hyperaldosteronism should be strongly suspected.&lt;/li&gt;&lt;li&gt;âž¤ The plasma renin and aldosterone test is the initial diagnostic test of choice to confirm the diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ If the test is positive, further imaging (e.g., CT of adrenals) may be needed to identify the underlying cause&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents to the clinic with fatigue, hair loss, and constipation. She has a history of type 1 diabetes mellitus that is well controlled on insulin and celiac disease, which she manages with a gluten-free diet. On physical examination she has dry skin but no other obvious abnormalities. On laboratory studies, her thyroid-stimulating hormone level is 85 mU/L and thyroid peroxidase antibodies are elevated. What is her underlying syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;APS-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;APS-2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. APS-2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â B) Â APS-2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of autoimmune thyroid disease and type 1 diabetes in a young woman is highly suggestive of APS-2. Patients with APS-2 should be monitored for other autoimmune conditions, including Addison&#x27;s disease, as early detection and treatment can improve outcomes.&lt;/li&gt;&lt;li&gt;âž¤ The combination of autoimmune thyroid disease and type 1 diabetes in a young woman is highly suggestive of APS-2.&lt;/li&gt;&lt;li&gt;âž¤ Patients with APS-2 should be monitored for other autoimmune conditions, including Addison&#x27;s disease, as early detection and treatment can improve outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An infant is noted to have ambiguous genitalia at birth. The baby has fused labia with clitoral enlargement. The karyotype is 46 XX. The baby has increased levels of 17-hydroxyprogesterone on laboratory studies. Which of the following biochemical abnormalities may be seen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypernatremia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyponatremia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hyponatremia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hyponatremia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Congenital adrenal hyperplasia is a group of inherited disorders affecting adrenal hormone production. 21-hydroxylase deficiency is the most common form and can present with ambiguous genitalia in females and salt-wasting crisis in both sexes. Hyponatremia, hyperkalemia, and hypoglycemia are the characteristic biochemical abnormalities in 21-hydroxylase deficiency&lt;/li&gt;&lt;li&gt;âž¤ Congenital adrenal hyperplasia is a group of inherited disorders affecting adrenal hormone production.&lt;/li&gt;&lt;li&gt;âž¤ 21-hydroxylase deficiency is the most common form and can present with ambiguous genitalia in females and salt-wasting crisis in both sexes.&lt;/li&gt;&lt;li&gt;âž¤ Hyponatremia, hyperkalemia, and hypoglycemia are the characteristic biochemical abnormalities in 21-hydroxylase deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man comes to the clinic with his spouse complaining of erectile dysfunction. He has a 10-year history of moderately controlled diabetes mellitus and uses insulin. Over the last year, despite intact libido, he has been unable to attain or sustain an erection when attempting sexual intercourse with his wife. He reports that over this time he no longer awakes with an erection as he did previously. Serum chemistries are normal, hemoglobin A1c is 5.8%, and serum testosterone is normal for his age. Which class of drug is most likely to improve his ability to achieve and maintain erection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;5Î±-Reductase inhibitor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Androgen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Corticosteroid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phosphodiesterase-5 inhibitor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phosphodiesterase-5 inhibitor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. Â D) Phosphodiesterase-5 inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with ED and risk factors for vascular disease (age, diabetes), PDE5 inhibitors are the most appropriate first-line treatment, especially when testosterone levels are normal. Other treatment options may be considered if PDE5 inhibitors are ineffective or contraindicated.&lt;/li&gt;&lt;li&gt;âž¤ In a patient with ED and risk factors for vascular disease (age, diabetes), PDE5 inhibitors are the most appropriate first-line treatment, especially when testosterone levels are normal.&lt;/li&gt;&lt;li&gt;âž¤ Other treatment options may be considered if PDE5 inhibitors are ineffective or contraindicated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 85 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test7" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D Part 1 (Mission Neet Pg)   11 08 2023   2023 08 11&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D Part 1 (Mission Neet Pg)   11 08 2023   2023 08 11&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                74 Questions | 296 Total Marks | 84 min Duration | ~68.11 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Production of which of the following hormones would be most impaired by lesions that affect the pituitary stalk or hypothalamus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ACTH.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Growth hormone.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ADH.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prolactin.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ADH.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. ADH.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man reports coarsening of his facial features over several years. In addition, he reports low libido and decreased energy. Physical examination shows frontal bossing and enlarged hands. Which of the following screening tests should be ordered?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;24-Hour UFC.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S. ACTH.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fasting GH levels.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;S. IGF-1.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. S. IGF-1.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. S. IGF-1.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents to the ER with severe headache and vidual disturbances. Head CT revealed a 3cm sellar mass as well as intralesional hyperdensities. On examination, T - 37.5Â°C, HR 100/min, BP 90/60 mmHg and RR 22 breaths/min. Labs - Na: 132 mEq/L, K: 4.2 mEq/L &amp;amp; Cr: 0.8 mg/dL. What is the next best step in her management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer hydrocortisone.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Assessment of TFT &amp;amp; ADH.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Refer for MRI with pituitary protocol.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Refer for neurosurgical consultation.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Administer hydrocortisone.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Administer hydrocortisone.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not seen in MEN1?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Posterior pituitary tumors.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Forgut carcinoids.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Parathyroid hyperplasia.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Angiofibromas.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Posterior pituitary tumors.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Posterior pituitary tumors.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old man presents to the ER after he was found to be confused by his friend at home. He is alert but disoriented. His friend relays that he was recently fired from his job and has been at home for the last week drinking too much lately. He is afebrile, PR 68/min, BP 140/86 mmHg &amp;amp; has moist mucous membranes with normal CRT and skin turgor. S. Na is 126 mEq/L &amp;amp; CBG is 120 mg/dL. UOSM is 75 mOsm/kg. What is the next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer loop diuretic.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluid restriction.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV normal saline.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tolvaptan.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV normal saline.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. IV normal saline.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old woman with a AD and amyloidosis presents to the ER with confusion and lethargy. Her vitals are stable and on examination, she is somnolent but easily arousable, with dry mucous membranes. S. Na is 156 mEq /L with CBG is 140 mg/dL. UOSM is 225 &amp;amp; with a SOSM is 335. IV NS is administered and over the next 12 hours, she voids 1.5 L and repeat S. Na is 154 mEq/L and UOSM is 255 mOsm/kg. dDAVP is administered and UOSM increases to 290 mOsm/kg. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CDI.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;GI free water loss.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lack of access to free water.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;NDI.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. NDI.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. NDI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is false with regards to Klinefelterâ€™s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Androgen supplementation is useful.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients are at increased risk for breast tumors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduced plasma estrogen.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most cases are diagnosed after puberty.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduced plasma estrogen.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Reduced plasma estrogen.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly man who is a known case of RA is admitted to the hospital after a car accident. CT scan reveals a splenic laceration and emergent splenectomy was performed. In the ICU his BP is 70/50 with an increase only to 82/52 after a bolus of 2 L of NS. Repeat CT scan of the chest, abdomen, and pelvis shows no hemorrhage. Which of the following is the next most appropriate step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administer hydrocortisone.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer vancomycin and Pip-Tazo.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insert IABP.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urgent exploratory laparotomy.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Administer hydrocortisone.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Administer hydrocortisone.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has neurosurgery for a pituitary tumor that requires resection of the gland. Which of the following functions of the adrenal gland will be preserved postoperatively?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Morning peak of plasma cortisol level.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Release of cortisol in response to stress.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium retention in response to hypovolemia.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sodium retention in response to hypovolemia.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Sodium retention in response to hypovolemia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient was suspected to have pheochromocytoma was started on labetalol. He has a PMH of depression for which he is taking Sertraline. 24-hour urine total metanephrines are elevated (1.5 x ULN). Which of the following is the next most appropriate step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hold labetalol for 1 week and repeat testing.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hold sertraline for 1 week and repeat testing.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Refer immediately for surgical evaluation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Measure 24-hour urine VMA.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hold labetalol for 1 week and repeat testing.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Hold labetalol for 1 week and repeat testing.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is true regarding management of pheochromocytoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î²Bs are C/I in pheochromocytoma.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salt and fluid intake should be restricted.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV phentolamine is indicated for HTN crisis.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgery is rarely required.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV phentolamine is indicated for HTN crisis.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. IV phentolamine is indicated for HTN crisis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 21-year-old woman with a history of type 1 DM is brought to the ER with nausea, vomiting, lethargy, and dehydration. She is confused and not responding to commands. Her BP is 80/40, and HR 112 beats/min. S. Na 126 mEq/L, S. K 4.3 mEq/L, S. Mg 1.2 mEq/L, BUN 76 mg/dL, S. cr 2.2 mg/dL, S. HCO3 10 mEq/L, and S. Cl 88 mEq/L. Serum glucose is 720 mg/dL. All the followingare appropriate management steps EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;3% Nacl.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arterial blood gas.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV insulin + IV potassium.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IVF bolus.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. 3% Nacl.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. 3% Nacl.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A morbidly obese diabetic woman was on MF but could not achieve glycemic control. She has had a previous osteoporotic fracture and the patient does not want to take injections. Which of the following would be suitable to reduce her glucose levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sitagliptin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pioglitazone.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Canagliflozin.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Semaglutide.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Semaglutide.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Semaglutide.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;27-year-old female develops eye pain and reduced visual acuity following the initiation of treatment for her recently diagnosed Grave&#x27;s disease. Which one of the following treatments is likely to have been started?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RAIA.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thyroidectomy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PTU.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbimazole.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. RAIA.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. RAIA.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT associated with pseudohypoparathyroidism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Low calcium.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low PTH.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Short 4th and 5th metacarpals.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Short Stature.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Low PTH.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Low PTH.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following is associated with APS type 1, except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Addison disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic mucocutaneous Candidiasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Autosomal recessive inheritance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Primary hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Primary hyperparathyroidism.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients with metabolic syndrome are at higher risk for all of the following EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NAFLD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;OSA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alzheimerâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Alzheimerâ€™s disease.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the recommended daily intake of Ca and vitamin D?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;500 mg calcium, 400 IU vitamin D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;500 mg calcium, 1000 IU vitamin D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1200 mg calcium, 400 IU vitamin D&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1200 mg calcium, 2000 IU vitamin D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 1200 mg calcium, 400 IU vitamin D&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. 1200 mg calcium, 400 IU vitamin D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are risk factors for an osteoporotic fracture in a woman except&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early menopause&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;History of cigarette smoking&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low body weight&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Low calcium intake&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. History of cigarette smoking&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. History of cigarette smoking.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents to the clinic with right groin pain that has worsened over the last 6 months. X ray is shown. Which of the following is the underlying cause of the pain?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Avascular necrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fracture of the femoral neck&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paget disease and secondary osteoarthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trochanteric bursitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paget disease and secondary osteoarthritis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/picture6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Paget disease and secondary osteoarthritis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;26-year-old guy presented with unconsciousness. Relatives say that he went to a party last night and did not pick their calls since then. ABG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cocaine intoxication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MDMA intoxication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alcohol intoxication&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Beer Potomania&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alcohol intoxication&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/screenshot-2023-08-11-143624.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Alcohol intoxication.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old obese man was admitted with respiratory failure after pneumonia in the ICU. With time he became more septic and went into septic shock, along with AKI. It was decided that he will need RRT soon and you were asked to get a dialysis catheter. Which of the following statement is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Femoral site is associated with increased risk of infections than jugular vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subclavian vein is preferred due to least complication&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right jugular vein is preferred over left jugular vein&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The catheter diameter ideally should be about half of the vein diameter&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right jugular vein is preferred over left jugular vein&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Right jugular vein is preferred over left jugular vein.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is true regarding acute interstitial nephritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eosinophilia is noted in approximately 25% of patients with AIN.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antibiotics are implicated in 60% of cases of drug-induced AIN.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;40% of patients taking NSAIDs typically develop nephrotoxicity.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal Ultrasound is diagnostic for AIN.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Eosinophilia is noted in approximately 25% of patients with AIN.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Eosinophilia is noted in approximately 25% of patients with AIN.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 20-year-old man who complains of edema and frothy urine for 2 months. Labs reveal a normal serum creatinine and 4+ protein in urine without blood or bacteria. He undergoes a kidney biopsy, which is normal on light microscopy. Which is the best treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 11-year-old develops sore throat, fever to 103 F, tender lymphadenopathy, and tonsillar exudate. Which is the 1 st line drug that helps to prevent PSGN ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Penicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clindamycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythromycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. None&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.Â  None&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In patients with chronic kidney disease, below which degree of renal function does one begin to be at significant risk for 25-hydroxy vitamin D deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;eGFR &amp;lt;10 mL/min/1.73m2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;eGFR &amp;lt;20 mL/min/1.73m2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;eGFR &amp;lt;30 mL/min/1.73m2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;eGFR &amp;lt;40 mL/min/1.73m2&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. eGFR &lt;30 mL/min/1.73m2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with ESRD due to Ig A nephropathy received deceased donor kidney transplant two weeks ago. She underwent an allograft kidney biopsy due to high creatinine. Biopsy is as below. What should be the best management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obtain donor specific antibodies (DSA).&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obtain serum BK PCR.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start IVIG+ steroid+ PlasmapheresisÂ± Rituximab.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start thymoglobulin + steroid.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Start IVIG+ steroid+ PlasmapheresisÂ± Rituximab.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/picture5.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Start IVIG+ steroid+ Plasmapheresis+_ Rituximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old girl comes to the urologist for a follow-up visit after a UTI. She was diagnosed with B/L grade 4 VUR at the age of four, following frequent UTIs and an episode of pyelonephritis. The patient has been on Abx prophylaxis but had several breakthrough UTIs. Her abdomen is soft and there is no tenderness on palpation. Her BUN is 15 mg/dL and Cr is 1.5 mg/dL. Today a MCU shows left-sided grade 3 VUR and right-sided grade 4 VUR, with no residual postvoid contrast. Which of the following is the best next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B/L ureteral reimplant.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continue Abx prophylaxis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repeat MCU.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DMSA scan.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. B/L ureteral reimplant.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with a history of GPA successfully treated with oral CYC presents for evaluation of hematuria. He is asymptomatic and urine protein is 200 mg in 24 hours and he has a stable creatinine of 1.4 mg/dL. ANCA titres are unchanged from baseline. CT scan shows no kidney masses, cysts, or stones. Which one of the following is the next best step in managing this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Kidney biopsy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Follow up in 6 months with a repeat urinalysis and 24-hour urine protein.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start corticosteroids and reassess in 2 weeks.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cystoscopy.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cystoscopy.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Cystoscopy.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman with SLE presents for evaluation. Recent renal Bx showed MGN, and CS were begun. Proteinuria only minimally improved, and Cr stabilized at 1.7. Currently her complaint is B/L flank pain. Urinalysis shows no crystals, 4+ proteinuria, and hematuria. Current Cr is 3.0. Which of the following is the most appropriate initial Rx?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cyclophosphamide.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heparin.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous pulse corticosteroids.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydroxychloroquine.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Heparin.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Heparin.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are reviewing a 33-year-old man who has recently been diagnosed with adult polycystic kidney disease in the renal clinic. You proceed to examine his cardiovascular system. Which other feature are you most likely to find on examination?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dilated cardiomyopathy.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic stenosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Renal bruit secondary to renal artery stenosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitral valve prolapses.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mitral valve prolapses.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Mital valve prolapse.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 17-year-old female undergoes an uneventful arthroscopic knee surgery on his right knee because of a ligament tear after playing football. The surgery takes a little longer than expected. The next day he has urine like â€œCoca-Cola.â€ The patientâ€™s current Cr is 1.7 mg/dL (preop Cr was normal). Exam shows a swollen, tender right leg. Vital are normal. Urine shows dark brown urine with trace protein, 4+ heme, 0 to 2 white blood cells, 0 to 2 red blood cells (RBCs). Which one of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glomerulonephritis after streptococcal infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pigment-induced nephropathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute obstruction caused by a kidney stone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pigment-induced nephropathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Pigment-induced nephropathy.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with severe PAD is hospitalized for chest pain and undergoes CAG. His serum creatinine is unchanged 3 days post-procedure, but from day 4 slowly rises to a peak of 2.4 mg/dL. Urinalysis demonstrates no proteinuria or red blood cells, and a few granular casts are present. Serum complement is low. Which one of the following is likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AIN&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CIN&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atheroembolic disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PIGN&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atheroembolic disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Atheroembolic disease.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements regarding the condition are true EXCEPT? â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral calcium supplement may be a risk factor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Warfarin is a risk factor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pathologically, there is vascular occlusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pseudomonas co-infection is typical&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pseudomonas co-infection is typical&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pseudomonas co-infection is typical.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man has a MI complicated by shock. He recovers well from the MI, but several days later, his renal function deteriorates. One week after his MI, he is oliguric and BUN and Cr are 53 mg/dL and 3.9 mg/dL, respectively. Urinalysis shows multiple granular casts. When measuring the FeNa is likely value is: â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt; 2%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 1%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt; 35%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 50%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &gt; 2%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. &amp;gt;2%.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following fluid or electrolyte abnormalities can be seen in some patients after the relief of B/L renal obstruction?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypermagnesemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypernatremia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypervolemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypernatremia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hypernatremia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents to the ER with epistaxis. On examination, she has a low-grade fever and appears confused and jaundiced. UPT is negative. Blood results from the laboratory: Hb 8.5 g/dl, Platelets 8000/ml, WBC 4500/ml, MCV 92 fl, Na+ 138 mmol/l, K+4.9 mmol/l, Urea 102 mg/dl, Creatinine 3.1 mg/dl, Clotting studies are normal. What is the most appropriate Rx?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platelet transfusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IVIg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PEX&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV MPS 1g&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PEX&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. PEX.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;â€˜Fr&#x27; in catheter means&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inner Radius&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Outer Diameter&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inner Circumference&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Outer Circumference&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Outer Circumference&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Outer Circumference.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements regarding anaphylaxis is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;History of atopy is a risk factor for anaphylaxis to penicillin therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Onset of anaphylaxis is within seconds to minutes of antigen exposure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV glucocorticoids are NOT effective for acute anaphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Failure to use epi within 20 minutes of symptoms is a risk factor for death&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. History of atopy is a risk factor for anaphylaxis to penicillin therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. History of atopy is a risk factor for anaphylaxis to penicillin therapy.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old woman is brought to ER after getting discharged from recent hospitalization because of right flank and abdominal pain for the past 24 hours. She also has fever and nausea. She has DM2 and on MF. Her temperature is 38.8Â°C (101.8Â°F), PR is 92/min, RR 14/min, CBG 127 mg/dL, and BP is 130/82 mm Hg. Urinalysis shows 40-50 s/hpf. Which of the following is the most appropriate Rx for this patient&#x27;s condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Meropenem&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Levofloxacin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Meropenem&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Meropenem.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the immune mechanism leading to organ damage in Goodpasture syndrome? â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibody-dependent cellular cytotoxicity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complement-activating autoantibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inactivating autoantibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulating autoantibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Antibody-dependent cellular cytotoxicity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Antibody-dependent cellular cytotoxicity.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most likely mechanism of gentamicin related AKI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute tubular necrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic injury&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute tubular necrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Acute tubular necrosis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are predisposing factors for SLE EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C3 deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Female sex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HLA-DR alleles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TREX1 mutations&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. C3 deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. C3 deficiency.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman with SLE presents with a new cardiac murmur. She has no other symptoms. Echo shows a vegetation on the MV. Which of the following statements is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Blood cultures are unlikely to be positive.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucocorticoid therapy has NOT been proven to be effective.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pericarditis is frequently present concomitantly.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The lesion has a high risk of embolization.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pericarditis is frequently present concomitantly.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Pericarditis is frequently present concomitantly.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man is evaluated for SOB on exertion and dry cough that have worsened over the course of 6 months. He has a H/o CAD, AF and CABG. He has clubbing and his vitals are stable. PFT: FEV1 65%, FVC 67%, FEV1/FVC 74%, TLC 68% and DLCO 62%. Which test is most likely to determine the etiology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoscopy with transbronchial lung biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HRCT chest&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PET CT of whole body&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HRCT chest&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. HRCT chest&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Physician looked at a patientâ€™s CXR and made a diagnosis. His room air SaO2 is 88% &amp;amp; paO2 is 54 mm Hg. Which of the following will improve survival?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LAMA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary rehabilitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Supplemental O2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhaled Corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Supplemental O2&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/picture3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Supplemental O2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old man with CF comes to the ER because of a 1-week H/o worsening, productive cough. Temperature is 39Â° C (102Â° F), PR 98/min, RR 21/min, and BP is 129/76 mm Hg. His BMI is 17.5. On examination B/L crackles are heard in the lower lung fields. Chest CT scan shows prominent bronchiectasis. Which of the following antibiotics is the most appropriate next step in therapy of the patient&#x27;s infection?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ampicillin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefuroxime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Piperacillin-Tazobactum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ceftriaxone + Metronidazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Piperacillin-Tazobactum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Piperacillin- Tazonactum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man presents with persistent, productive cough with clear sputum for the past 3 months. He also reports feeling SOB when using the stairs. He is a retired coal miner. His vitals are stable, and examination reveals reduced breath sounds in all lung fields. PFT revealed a FEV1: FVC ratio of 60% and reduced DLCO. Which of the following findings is likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diffuse B/L infiltrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apical Cavitary lesion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperinflation with diaphragmatic flattening&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mass lesion with mediastinal adenopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hyperinflation with diaphragmatic flattening&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hyperinflation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;35-year-old woman presents with fever and pain in knees and ankles. Her BMI is 21, temperature is 37.8Â°C (100.1Â°F), PR 95/min, BP 125/83 mm Hg, RR 14/min, and SpO2 99% on RA. On exam, she has B/L parotid swelling, and she has lesion shown in the picture below. Laboratory studies are normal except for a slightly increased calcium level. What is the most appropriate Rx?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allopurinol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plasma Exchange&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Corticosteroids&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/picture2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Corticosteroids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A farmer tried to commit suicide and he has invested about 2 glasses of paraquat. What is the primary system affected in paraquat toxicity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dermatologic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neurologic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pulmonary&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following statements regarding aPL is true:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;aPL are generally directed against phospholipids.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Those who have LA will have elevated PTT that corrects with mixing studies.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Majority of the patients with SLE and aPL develop APS.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ÃŸ2 glycoprotein I is central to pathogenesis of APS.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. ÃŸ2 glycoprotein I is central to pathogenesis of APS.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;FeNO in bronchial asthma is related to -&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoconstriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mucus hypersecretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophilic inflammation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Airway hyperreactivity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eosinophilic inflammation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Eosinophilic inflammation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman without PMH presents for evaluation of 3 months of progressive SOB on exertion. She undergoes PFTs, which reveal a DLCO of 45% predicted. Her spirometry and TLC are WNL. Which of the following diseases could the PFT findings NOT support?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Motor Neuron Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary HTN&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Motor Neuron Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Motor Neuton Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with a 10-year H/o untreated RA presents to your clinic with worsening joint pain and malaise over the last 6 months. On exam she has massive splenomegaly. Lab studies show neutropenia, elevated CRP, and anemia. What is the most important differential?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute myeloid leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic lymphocytic leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Essential thrombocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;T-cell LGL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. T-cell LGL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. T- Cell LGL.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following situations would NIV considered to be contraindicated? â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AECOPD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ARDS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AMI (Acute Myocardial Infacrction)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Post-extubation.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. AMI (Acute Myocardial Infacrction)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Acute Myocardial Infacrction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following treatments have supporting evidence for efficacy in early ARDS EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early use of paralytic agents&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluid restriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucocorticoids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prone positioning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glucocorticoids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Glucocorticoids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients with rheumatoid arthritis are at higher risk for all the following EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Colorectal cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary artery disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoandrogenism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Colorectal cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with a BMI of 32 has recently been diagnosed with OSA (AHI = 13). He does not have a history of snoring. He is unwilling for CPAP. Which of the following would be a possible alternative therapy? â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bariatric surgery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Supplementation oxygen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral appliance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Uvulopalatopharyngoplasty&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oral appliance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Oral appliance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following agents have been shown to have disease modifying activity in patients with RA EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leflunomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Naproxen&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Naproxen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Indications of chest drain in a parapneumonic effusion are all except: â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Loculated pleural fluid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleural fluid pH &amp;lt; 7 .2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pleural fluid glucose &amp;lt; 60 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural fluid LDH &amp;gt; 1000&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pleural fluid LDH &gt; 1000&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Pleural&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a diagnosis of dcSSc presents with malignant HTN, oliguria, hemolysis, and renal failure. Which of the following is the recommended Rx?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Captopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Captopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old smoker is presented with SOB on exertion. Resting SpO2 is 94% which reduces to 85% on after walking to 100m. Exam reveals B/L end-inspiratory crackles. The chest CT is shown. Serologic workup for autoimmune disease is unremarkable. What is the next therapeutic option?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nintedanib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nintedanib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Nintedanib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A soldier operating in Siachen glacier presents with numbness of his legs. Incorrect regarding the image given?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rewarming is the treatment of choice.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Analgesics are contraindicated.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombolytics can be used.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amputation in severe cases.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Analgesics are contraindicated.&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/picture1_YQmOAbt.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Analgesics are contraindicated.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following conditions is more common in patients with dcSSC than in lcSSc?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Esophageal involvement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PAH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Raynaud phenomenon&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pulmonary fibrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Pulmonary fibrosis.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with primary SjÃ¶gren syndrome notes continued parotid swelling for the last 3 months with enlarging posterior cervical lymph nodes. Evaluation shows leukopenia and low C4 levels. What is the most likely diagnosis? â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic pancreatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HIV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are effective in treating PsA except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secukinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ustekinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rituximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Rituximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following features are not typically seen in a patient with AOSD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Maculopapular rash&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rheumatoid factor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pyrexia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High ferritin level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Rheumatoid factor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Rheumatoid factor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A stale potato curry causes severe gastroenteritis in a picnic group. A 36-year-old man recovers from the diarrhoea, but 2 weeks later develops arthritis in his right knee and severe left-sided Achilles tendinitis. What is the most likely organism implicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C. jejuni&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S. flexneri&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;H. pylori&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C. difficile&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S. flexneri&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. S. flexneri&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is required for the diagnosis of BehÃ§et syndrome? â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Uveitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pathergy test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Recurrent oral ulceration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Recurrent genital ulceration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Recurrent oral ulceration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Recurrent oral ulceration.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with H/o MI complained of shoulder and thigh pain while on statins. Statins were discontinued since his CPK was elevated to 8x ULN. But patientâ€™s pain continued and CPK is now 12x ULN. What is the next best test to establish a diagnosis? â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti HMG CoA reductase&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ANA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-Jo-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti SRP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anti HMG CoA reductase&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Anti HMG CoA reductase&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following conditions are manifestations of IgG4RD EXCEPT&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autoimmune pancreatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Crescentic glomerulonephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphoplasmacytic aortitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Orbital pseudotumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Crescentic glomerulonephritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Crescentic glomerulonephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following Rx are efficacious in treating OA symptoms EXCEPT - â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acetaminophen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucocorticoid intra-articular injections&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucosamine-chondroitin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Naproxen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glucosamine-chondroitin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Glucosamine-chondroitin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is incorrect with regards to allopurinol in gout? â€‹â€‹â€‹â€‹â€‹â€‹â€‹&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allopurinol should not be used with Colchicine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allopurinol dosing should be adjusted for renal function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allopurinol dosing should be titrated to a S. UA &amp;lt; 6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allopurinol hypersensitivity is associated with HLA B5801&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Allopurinol should not be used with Colchicine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Allopurinol should not be used with Colchicine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following therapies are recommended as part of the treatment plan for fibromyalgia EXCEPT&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exercise and yoga&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Milnacipran&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Opioid analgesics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pregabalin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Opioid analgesics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Opioid analgesics.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 84 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test8" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D Part 1, Mission 3.0 (Early Intern Batch)   07 06 2025   2025 06 07&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D Part 1, Mission 3.0 (Early Intern Batch)   07 06 2025   2025 06 07&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;An elderly male with coronary artery disease, heart failure (LVEF 30%), and hypertension presents without new symptoms. BP is 108/56 mmHg, HR is 88/min, SpO2 9 is 98%. ECG is shown below. His ECG was normal ECG six months ago. Which treatment is most indicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic anticoagulation with warfarin or NOAC&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Flecainide 600 mg as needed&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aspirin 325 mg daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amiodarone 400 mg daily&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Systemic anticoagulation with warfarin or NOAC&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_OVo7fyJ.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Systemic anticoagulation with warfarin or NOAC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ High CHAâ‚‚DSâ‚‚-VASc scores in AF prioritize anticoagulation over rhythm control in stable patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 6-month-old infant with poor weight gain and cyanotic spells has a harsh systolic murmur at the left upper sternal border. Echocardiogram confirms a congenital defect. Which is not a feature of this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tricuspid atresia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Right ventricular hypertrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right ventricular outflow obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Overriding aorta&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tricuspid atresia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Tricuspid atresia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TOF includes VSD, pulmonary stenosis, overriding aorta, and RV hypertrophy; tricuspid atresia is unrelated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man with prior MI and reduced LV function has sudden dizziness. ECG shows regular wide-complex tachycardia at 170/min. Which finding suggests SVT with aberrancy over VT?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No R wave in lead aVR&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AV dissociation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Monomorphic R wave in V1â€“V6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Structural heart disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. No R wave in lead aVR&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) No R wave in lead Avr&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In wide-complex tachycardia, no R wave in aVR supports SVT with aberrancy, but VT is more common in structural heart disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A middle-aged woman with a thoracic aortic aneurysm on CT has a bifid uvula, hypertelorism, and corkscrew carotid arteries on neck CT. MRI is shown below. Which gene mutation is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fibrillin-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;STK11 gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CFTR gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TGF-Î² receptor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. TGF-Î² receptor&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_EARXrGY.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) TGF-Î² receptor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Loeys-Dietz syndrome, due to TGF-Î² receptor mutations, requires vigilance for vascular complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with metastatic adenocarcinoma has sudden dyspnea, BP 70/30 mmHg, HR 142/min, distended JVP, clear lungs, and faint heart sounds. ECG is shown below. Which parameter is decreased?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left atrial pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left ventricular end diastolic volume&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Jugular venous pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intrapericardial pressure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Left ventricular end diastolic volume&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wFJcgQ7.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Left ventricular end diastolic volume&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiac tamponade reduces LVEDV due to restricted filling, requiring urgent pericardiocentesis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man post-tamponade stabilization has brief palpitations. ECG reveals atrial premature contractions (APCs). He is stable with mild discomfort. What is accurate about his rhythm?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stress testing for ischemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echocardiography for structural disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reassure, no further testing&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Reassure, no further testing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Reassure, no further testing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Benign APCs in stable patients require reassurance, not further workup.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old baseball player has right arm pain after overhead throwing, described as tight and aching. Pain is reproduced with arm abduction and external rotation. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cervical epidural abscess&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coarctation of the aorta&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thoracic outlet syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Thoracic outlet syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Thoracic outlet syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TOS is suspected in athletes with positional arm symptoms; arterial TOS mimics claudication.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with suspected pulmonary hypertension has oxygen saturations: SVC 61%, IVC 65%, right atrium 85%, right ventricle 84%, pulmonary artery 84%. What explains these findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aorta to IVC shunt&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial septal defect with left-to-right shunt&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;VSD with right-to-left shunt&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Patent ductus arteriosus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Atrial septal defect with left-to-right shunt&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Atrial septal defect with left-to-right shunt&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Right atrial oxygen step-up suggests ASD with left-to-right shunting, guiding management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with cardiomyopathy and ICD has three ICD shocks in 15 minutes, then a fourth an hour later. He feels sore but okay. He takes metoprolol, lisinopril, aspirin, eplerenone. What is the Next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clinic visit next day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urgent electrolyte tests&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left heart catheterization next week&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Emergency hospital transport&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Emergency hospital transport&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Emergency hospital transport&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ICD storm is a medical emergency requiring immediate hospital evaluation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man with hypertension and diabetes has dyspnea, orthopnea, and leg swelling. Exam shows elevated JVP and S4. Echocardiogram shows EF 55%, enlarged left atrium, suggesting HFpEF. Which treatment reduces mortality?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Angiotensin receptor blockers&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Phosphodiesterase-5 inhibitors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium-potassium-ATPase inhibitors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. None of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) None of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HFpEF lacks mortality-reducing therapies; focus on symptom and comorbidity management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old runner with palpitations has stress and high coffee intake. ECG shows sinus rhythm with two early wide QRS complexes. Which statement about PVCs is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;QRS pattern may indicate structural heart disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dominant R wave in V1 indicates RV origin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PVCs in ischemia are unrelated to VT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple PVC morphologies are benign&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. QRS pattern may indicate structural heart disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) QRS pattern may indicate structural heart disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PVC QRS morphology helps differentiate benign from pathological cases, guiding further evaluation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man post-anterior MI and PCI has palpitations. Labs: potassium 3.2 mEq/L, magnesium 1.1 mEq/L. ECG is shown below. Which is not recommended?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Replenish magnesium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start IV lidocaine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Replenish potassium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Begin metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Start IV lidocaine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_seuVi3W.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Start IV lidocaine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Post-MI PVCs are managed with electrolyte correction and beta-blockers, not routine lidocaine.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old with hypertension and CAD is evaluated for heart failure. Besides dyspnea and fatigue, which symptom can indicate heart failure?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right upper abdominal pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early satiety&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nocturia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HF presents with non-cardiac symptoms like RUQ pain, satiety issues, and nocturia, requiring holistic assessment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In HFrEF, which is not typically increased?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;B-type natriuretic peptide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Norepinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Angiotensin II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Calcium reuptake into sarcoplasmic reticulum&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Calcium reuptake into sarcoplasmic reticulum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Calcium reuptake into sarcoplasmic reticulum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HFrEF involves neurohormonal activation, but calcium reuptake is impaired, worsening systolic function.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old man with palpitations is stable with minimal symptoms. ECG is shown below. Which statement about management is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Electrical cardioversion has no role&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Catheter ablation is highly successful&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rate control is easier than in AF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anticoagulation is unnecessary&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Catheter ablation is highly successful&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uIDw8iz.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Catheter ablation is highly successful&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Catheter ablation is preferred for typical atrial flutter due to high efficacy; anticoagulation mirrors AF. Image Cue : ECG with sawtooth flutter waves.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 19-year-old with acute heart failure has reduced LV function. Biopsy confirms viral myocarditis. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thymoglobulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lisinopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oseltamivir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lisinopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Lisinopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Viral myocarditis is treated with heart failure therapies like ACE inhibitors; avoid anti-inflammatories/antivirals.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man has palpitations during stressful singing. ECG is shown below. Echo/MRI are normal. What is the arrhythmia source?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertrophic cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Right ventricular outflow tract VT&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arrhythmogenic RV cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scar-mediated VT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Right ventricular outflow tract VT&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_aiRLh2e.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Right ventricular outflow tract VT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ RVOT VT is benign, stress-triggered, with LBBB and inferior axis in healthy individuals.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman has lightheadedness and tachycardia (HR 135 bpm) upon standing post-viral infection. BP is stable. What is a reasonable treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fludrocortisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Compression stockings&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium chloride tablets&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Any of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Any of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Any of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ POTS is managed with volume expansion and mechanical support to reduce symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with pulmonary embolism has BP 127/83 mmHg, SpO2 97%, exertional dyspnea. Echocardiogram shows dilated, hypokinetic RV. Troponin/BNP elevated. What is his risk category regarding the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Massive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Submassive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Saddle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Catastrophic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Submassive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Submassive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Submassive PE involves RV dysfunction/biomarkers with normal BP, guiding risk-based therapy. Image Cue : Echocardiogram showing dilated, hypokinetic RV.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which statement about inpatient VTE prevention is not true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mechanical prophylaxis for bleeding risk patients&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;VTE is often clinically silent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Protocols improve prophylaxis rates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Routine VTE prophylaxis is not essential&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Routine VTE prophylaxis is not essential&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Routine VTE prophylaxis is not essential&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Routine VTE prophylaxis is critical in hospitals; mechanical options are used when anticoagulation is contraindicated.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue : None (guideline-based).&lt;/li&gt;&lt;li&gt;âž¤ Image Cue&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman with ischemic cardiomyopathy (EF 35%), NYHA class II, on lisinopril, carvedilol, spironolactone, has stable vitals. Which drug adds mortality benefit?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aliskiren&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. None of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) None of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Optimal HFrEF therapy includes ACEi, beta-blockers, MRAs; additional drugs have specific indications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with chest pressure has ECG shows with 2 mm ST depression in V2â€“V3. Which statement about ischemia ECG findings is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Q waves precede ST elevation in transmural MI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ST depression is more reliable for localization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subendocardial ischemia causes ST elevation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ST depression in V1â€“V3 indicates posterior MI&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. ST depression in V1â€“V3 indicates posterior MI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) ST depression in V1â€“V3 indicates posterior MI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ST depression in V1â€“V3 suggests posterior MI, requiring posterior leads for confirmation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with orthopnea, nocturnal cough, and leg swelling has suspected heart failure. Echocardiogram shows the presence of HF. Which statement about orthopnea is accurate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;No improvement with posture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Can occur in abdominal obesity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Due to blood moving to gut/limbs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Earlier than exertional dyspnea&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Can occur in abdominal obesity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Can occur in abdominal obesity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Orthopnea occurs in HF and obesity, relieved by upright posture, due to central fluid shifts.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old with leg aching has dilated, tortuous veins. Which is not a conservative treatment for varicose veins?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Compression stockings&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Leg elevation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Avoid prolonged standing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Daily aspirin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Daily aspirin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Daily aspirin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Varicose vein treatment is mechanical; aspirin is not indicated.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old non-smoker is tired while gardening. Vitals, labs, CXR, ECG normal. Echocardiogram normal. Treadmill ECG shows peak HR 96 bpm, no ST changes. What explains his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HFpEF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal aging&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chronotropic incompetence&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chronotropic incompetence&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Chronotropic incompetence&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronotropic incompetence causes exercise intolerance with blunted HR response, diagnosed via stress testing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man, 7 days post-angiography presents with nausea, abdominal pain, oliguria, fever (38.3Â°C), livedo reticularis, creatinine 2.7 mg/dL (baseline 1.1), eosinophilia. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contrast-induced nephropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Churg-Strauss syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypereosinophilic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atheroembolic renal disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Atheroembolic renal disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Atheroembolic renal disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Atheroembolic renal disease is a delayed post-procedural complication with systemic signs, unlike contrast nephropathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which physical sign is not expected in chronic aortic regurgitation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bounding peripheral pulse&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pistol-shot sound over femoral artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nailbed flushing/paling with pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Systolic ejection murmur to neck&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Systolic ejection murmur to neck&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Systolic ejection murmur to neck&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ AR causes peripheral signs from wide pulse pressure; systolic murmurs to neck indicate aortic stenosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman with chemotherapy-induced cardiomyopathy (EF 15%), NYHA IIIâ€“IV, VOâ‚‚ 9 mL/kg/min, ineligible for transplant, is on maximal therapy. Echocardiogram confirms severe LV dysfunction. What is the Next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Milrinone infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stem cell therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Palliative care only&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;LVAD evaluation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. LVAD evaluation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) LVAD evaluation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ LVAD is viable for end-stage HF in non-transplant candidates, improving survival.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 19-year-old woman collapses jogging, pulseless. ECG is shown below. What caused her cardiac arrest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial flutter&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AF with pre-excitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AVNRT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Torsades de pointes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. AF with pre-excitation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vuZGhGV.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) AF with pre-excitation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ AF with pre-excitation (WPW) causes irregular wide-complex tachycardia, risking sudden cardiac arrest.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue : ECG with irregular wide QRS, varying morphology.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man with reduced energy and confusion has a regular pulse with alternating strength. BP shows alternating Korotkoff sounds. Echocardiogram is shown below. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiac tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe LV dysfunction&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Severe LV dysfunction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Severe LV dysfunction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulsus alternans is a hallmark of severe LV dysfunction, prompting HF evaluation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;https://media.cerebellumacademy.com/media/public/question_media/question/video/82894/WhatsApp_Video_2025-06-07_at_13.06.41.mp4&quot;}, {&quot;text&quot;: &quot;A 67-year-old man with a 45-year smoking history, diagnosed with COPD (FEVâ‚ 44% predicted), presents post-hospitalization for dyspnea and sputum. He has chronic cough and quit smoking 18 months ago. SpOâ‚‚ is 92% on room air. Which therapy best reduces future COPD exacerbation risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azithromycin 250 mg thrice weekly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continuous home oxygen therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nocturnal BiPAP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Roflumilast 500 Î¼g daily&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Roflumilast 500 Î¼g daily&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Roflumilast 500 Î¼g daily&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Roflumilast is effective for reducing exacerbations in severe COPD with chronic bronchitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man collapses, found in ventricular fibrillation, achieves ROSC after defibrillation. ECG shows anterior ST elevation, and angioplasty reveals LAD occlusion. In ICU, he is intubated, on norepinephrine, unresponsive with absent reflexes and myoclonus. Which is true about targeted temperature management (TTM)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brain imaging is required before TTM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothermia can cause thrombotic risk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TTM at 33-36Â°C for 24 hours is beneficial&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TTM is not indicated due to poor prognosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. TTM at 33-36Â°C for 24 hours is beneficial&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) TTM at 33-36Â°C for 24 hours is beneficial&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TTM at 32â€“34Â°C is indicated for comatose post-arrest patients to enhance neurological recovery.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman with recurrent productive cough, breathlessness, and recent joint stiffness presents with fatigue and dry eyes. Auscultation reveals rhonchi and basal crackles. HRCT shows lower lobe bronchiectasis and interstitial markings. Which test is most likely to identify the cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CFTR genetic testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nasal mucosal biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid factor, anti-Ro/La&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sputum TB culture&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rheumatoid factor, anti-Ro/La&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Rheumatoid factor, anti-Ro/La&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Autoimmune serologies are key in bronchiectasis with systemic symptoms like joint pain and dry eyes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman with poorly controlled asthma dies in the ED from respiratory failure despite treatment. Postmortem lung exam is performed. Which pathological feature is not typically found?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eosinophilic/T-cell mucosal infiltration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inflammatory infiltrates in alveolar spaces&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mucus plugging of bronchial lumens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subepithelial fibrosis, thickened basement membrane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inflammatory infiltrates in alveolar spaces&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inflammatory infiltrates in alveolar spaces&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Asthma affects airways, not alveoli, unlike alveolar-centric diseases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man in ICU post-accident has intracerebral hemorrhage with midline shift. Intubated, unresponsive, with absent reflexes and no spontaneous breaths on apnea test (temp 37Â°C, stable BP, no sedatives). Which is essential for brain death diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Absent pupillary reflex&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;No spontaneous breathing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Absent oculovestibular reflexes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brain death requires coma, absent brainstem reflexes, and apnea, confirmed clinically.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man in ICU for respiratory failure is intubated. Ventilator mode is changed to patient-initiated breaths with preset pressure, flow-cycled, no mandatory breaths. Ventilator settings are reviewed. Which mode is this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Time-triggered, pressure-limited, time-cycled&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fixed tidal volume for all breaths&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Baseline ventilation with pressure-supported breaths&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Patient-triggered, pressure-limited, flow-cycled&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Patient-triggered, pressure-limited, flow-cycled&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Patient-triggered, pressure-limited, flow-cycled&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PSV is a weaning mode, patient-driven, with pressure support and flow-cycling.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old ex-smoker (55 pack-years) presents with dyspnea, needing 3 L/min oxygen on ambulation (SpOâ‚‚ 83%). Exam shows bibasilar crackles. PFT = TLC 70%, RV 66%, DLCO 58%. HRCT is shown. What is the likely biopsy pattern?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nonspecific interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Usual interstitial pneumonia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Desquamative interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Granulomas with fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Usual interstitial pneumonia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Xgr1Hqp.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Usual interstitial pneumonia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IPF presents with UIP on biopsy, characterized by basal fibrosis and honeycombing.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue : HRCT with basilar reticulation, honeycombing.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with severe COPD (FEVâ‚ 40%) presents with 5-day worsening dyspnea, purulent sputum. ABG: pH 7.28, PaCOâ‚‚ 76 mmHg, PaOâ‚‚ 52 mmHg. CXR shows no infiltrates. Which treatment most reduces mortality?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inhaled bronchodilators&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Systemic corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Noninvasive positive-pressure ventilation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Early intubation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Noninvasive positive-pressure ventilation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Noninvasive positive-pressure ventilation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NIPPV is the cornerstone for reducing mortality in hypercapnic COPD exacerbations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with asthma (SABA use 1â€“2 times/month) now uses SABA 2â€“3 times/week due to spring allergies. Exam shows end-expiratory wheezing. What is the next management step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start inhaled corticosteroid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Order chest X-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prescribe leukotriene antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Perform PFTs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Start inhaled corticosteroid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Start inhaled corticosteroid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ICS is the preferred step-up therapy for mild persistent asthma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with 3-month dyspnea, dry cough, and low-grade fever works at a pet store cleaning bird enclosures. SpOâ‚‚ drops to 89% on walking. HRCT is shown below. Biopsy reveals lymphocytes, plasma cells, noncaseating granulomas. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspergillosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypersensitivity pneumonitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Collagen vascular disease ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypersensitivity pneumonitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xx5R4aD.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypersensitivity pneumonitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HP is diagnosed by exposure, CT, and granulomas; antigen avoidance is key.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with ALS has PaCOâ‚‚ 46 mmHg, orthopnea, fatigue, and trouble clearing secretions. Which additional finding supports initiating NIPPV?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Orthopnea&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Copious secretions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Altered Mental Status&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Orthopnea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Orthopnea&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NIPPV is indicated in ALS with hypercapnia and symptoms like orthopnea or impaired cough.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which PFT pattern best matches myasthenia gravis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased TLC, reduced VC, low FEVâ‚/FVC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reduced TLC, reduced RV/VC, high FEVâ‚/FVC, normal MIP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduced TLC, increased RV, normal FEVâ‚/FVC, low MIP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal TLC, RV, FEVâ‚/FVC, normal MIP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduced TLC, increased RV, normal FEVâ‚/FVC, low MIP&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reduced TLC, increased RV, normal FEVâ‚/FVC, low MIP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myasthenia gravis shows restrictive PFTs with low MIP, normal FEVâ‚/FVC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about shock physiology is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypotension enhances sympathetic outflow, reduces vagal tone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitochondrial injury reduces ATP, increases lactate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Proinflammatory pathways contribute to multiorgan dysfunction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypotension reduces sympathetic activity, promotes vagal stimulation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hypotension reduces sympathetic activity, promotes vagal stimulation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hypotension reduces sympathetic activity, promotes vagal stimulation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Shock triggers sympathetic activation, not vagal dominance, to maintain perfusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old smoker presents with dyspnea. CXR is done and it is shown. Which of the following reports supports the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated TLC, decreased VC, decreased FEVâ‚/FVC&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased TLC, VC, RV, increased FEVâ‚/FVC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased TLC, increased RV, normal FEVâ‚/FVC, low MIP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal TLC, RV, FEVâ‚/FVC, normal MIP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Elevated TLC, decreased VC, decreased FEVâ‚/FVC&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_y5s9mG3.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Elevated TLC, decreased VC, decreased FEVâ‚/FVC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ COPD shows obstructive PFTs with hyperinflation and reduced VC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman, 5 years post-lung transplant for cystic fibrosis, has dyspnea and FEVâ‚ drop from 82% to 64% predicted. No infection signs. Which finding suggests bronchiolitis obliterans syndrome (BOS)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Air trapping on expiratory HRCT&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Segmental bronchus narrowing near anastomosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphocytes around vessels on biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspergillus in BAL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Air trapping on expiratory HRCT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Air trapping on expiratory HRCT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ BOS is diagnosed by FEVâ‚ decline and CT air trapping in lung transplant patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman with wheezing during workouts and cat exposure has allergic rhinitis, eczema. PFTs is shown below. Which statement is true regarding the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoprovocation needed for diagnosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Asthma mortality has risen recently&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Severity remains stable over time&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Single genetic cause dominates&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Severity remains stable over time&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JA9OKYT.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Severity remains stable over time&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Asthma severity is generally stable; atopy is the primary risk factor.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 53-year-old woman with chronic green sputum cough, hemoptysis, sinus infections has coarse bilateral crackles. PFTs: FEVâ‚ 52%, FEVâ‚/FVC 54%. Sputum grows Pseudomonas. What is the next test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-resolution CT&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bronchoscopy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sweat chloride testing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. High-resolution CT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) High-resolution CT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HRCT is diagnostic for bronchiectasis in chronic productive cough.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old woman in ICU for bilateral pneumonia has SpOâ‚‚ 58% on room air, 80% on nonrebreather. Intubated, on AC mode (tidal volume 6 mL/kg, FiOâ‚‚ 100%, PEEP 12 cm Hâ‚‚O). ABG: pH 7.21, PaCOâ‚‚ 31 mmHg, PaOâ‚‚ 52 mmHg. CXR is shown. What causes persistent hypoxemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alveolar shunting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;V/Q mismatch&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mixed shunt/hypoventilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alveolar shunting&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0cPCYMu.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alveolar shunting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Shunt causes refractory hypoxemia in pneumonia/ARDS, unresponsive to high FiOâ‚‚.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman with 3-month dyspnea, dry cough, fever, working with birds, has SpOâ‚‚ drop to 89% on walking. HRCT shows ground-glass, nodules. Biopsy shows lymphocytes, granulomas. What is the treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glucocorticoids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glucocorticoids plus antigen avoidance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Azathioprine and corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Glucocorticoids plus antigen avoidance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Glucocorticoids plus antigen avoidance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HP requires antigen avoidance and short-term corticosteroids for optimal outcomes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old woman with chronic liver disease, admitted for urosepsis, becomes unresponsive with leftward eye deviation. CT head is normal. Vitals: HR 82, BP 130/88, RR 17, SpOâ‚‚ 95%. What explains this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left frontal lobe seizure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left pontine stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right frontal lobe seizure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left uncal herniation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right frontal lobe seizure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Right frontal lobe seizure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Conjugate eye deviation suggests frontal lobe seizure, treated with anticonvulsants.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man, 2 years post-kidney transplant, has a seizure, headache, and cortical blindness. On tacrolimus, BP 158/92, normal labs. MRI FLAIR is shown below. What is the cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Posterior circulation infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;JC virus encephalopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Posterior reversible encephalopathy syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute tacrolimus toxicity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Posterior reversible encephalopathy syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_z5UIPNI.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Posterior reversible encephalopathy syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PRES, linked to calcineurin inhibitors, presents with seizures and occipital edema, reversible with management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old woman with asthma, fatigue, fever, and left foot weakness has peroneal nerve palsy. Which cause is most likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peroneal nerve entrapment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cortical stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Churg Strauss syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Compressive neuropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Churg Strauss syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Churg Strauss syndrome (EGPA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ EGPA should be suspected in asthma with mononeuritis and systemic symptoms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which best describes coma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Awake but unresponsive to stimuli&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psychiatric mutism/immobility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unconscious, eyes closed, unarousable&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Irreversible brain damage&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Unconscious, eyes closed, unarousable&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Unconscious, eyes closed, unarousable&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Coma is distinct from vegetative state and catatonia, potentially reversible.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman post-subarachnoid hemorrhage (SAH) with coiling develops lethargy, hyponatremia (Na 124 mEq/L), high urine output, and volume depletion. CT is unchanged. What explains her hyponatremia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebral salt wasting (CSW)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SIADH with fluid restriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypervolemic hyponatremia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nimodipine-induced sodium loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cerebral salt wasting (CSW)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cerebral salt wasting (CSW)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CSW in SAH causes hypovolemic hyponatremia, treated with saline.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman with fever, pleuritic pain, and dyspnea post-smoking resumption is intubated for hypoxemic failure. CXR is shown. BAL shows 40% eosinophils. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV methylprednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Surgical lung biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Continue antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oseltamivir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV methylprednisolone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Dg8phuC.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV methylprednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute eosinophilic pneumonia requires corticosteroids based on BAL eosinophilia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old woman with alcohol use disorder has fever, confusion, and right lower lobe pneumonia. Vitals: Temp 39.4Â°C, HR 108, BP 102/60, RR 26, SpOâ‚‚ 89%. Labs: WBC 21,800, creatinine 1.5 (baseline 0.9). What is her clinical status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Septic shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SIRS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mild infection&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sepsis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sepsis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sepsis is defined by infection plus organ dysfunction, assessed by SOFA score.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is a contraindication to Noninvasive ventilation (NIV)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heart failure with respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute MI with chest pain&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Post-extubation COPD support&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;COPD exacerbation, pH 7.30&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute MI with chest pain&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acute MI with chest pain&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NIV is contraindicated in unstable cardiac conditions like acute MI.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 73-year-old man with 25-year construction work, 60 pack-year smoking, and COPD has right pleural effusion. CXR is shown below. Thoracentesis: exudative, 70% lymphocytes. What is true about the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brief exposure causes disease after long latency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Smoking increases risk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pleural fluid cytology is diagnostic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Deaths from metastatic spread&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Brief exposure causes disease after long latency&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vg0C4CU.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Brief exposure causes disease after long latency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mesothelioma has long latency from asbestos; biopsy is needed for diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man with moderate COPD (FEVâ‚ 62%) uses tiotropium, occasional salbutamol, no recent exacerbations, smokes 10 cigarettes/day. He walks briskly without dyspnea. What is the most important next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start ICS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add LABA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary rehabilitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoking cessation counseling&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Smoking cessation counseling&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Smoking cessation counselling&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Smoking cessation is critical in COPD to halt disease progression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman post-SAH coiling becomes drowsy with left weakness on day 8. CT shows no new bleed. On nimodipine, what is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Norepinephrine, consider angioplasty&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperventilate, give mannitol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Place ventriculostomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrict free water&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Norepinephrine, consider angioplasty&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Norepinephrine, consider angioplasty&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vasospasm post-SAH requires vasopressors and potential angioplasty.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman at 32 weeks pregnant presents with fatigue and abdominal discomfort. BP is 145/95 mmHg. Labs: Hb 7 g/dL, platelets 85,000/ÂµL, elevated liver enzymes. Peripheral smear is shown. Which statement about her condition is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glucocorticoids reduce morbidity/mortality&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liver enzymes are elevated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Preeclampsia history increases risk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal dysfunction is common&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Glucocorticoids reduce morbidity/mortality&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fLd4Ftw.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Glucocorticoids reduce morbidity/mortality&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HELLP syndrome requires prompt delivery, not glucocorticoids, for management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old man with fatigue, foot cramps, and muscle spasms has worsening symptoms post-exertion. BP 110/70 mmHg. Labs: Kâº 2.7 mEq/L, HCOâ‚ƒâ» 31 mmol/L, normal MgÂ²âº, high urine chloride, negative diuretic screen. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bulimia nervosa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuretic abuse&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gitelman syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liddle syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gitelman syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gitelman syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gitelman syndrome presents with hypokalemic alkalosis in normotensive young adults.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with stage 5 CKD (eGFR 11 mL/min/1.73 mÂ²) due to diabetic nephropathy has dyspnea and leg swelling despite diuretics. Exam shows elevated JVP, pedal edema. Chest X-ray suggests fluid overload. What is the indication for hemodialysis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Managed acidosis with bicarbonate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluid overload despite diuretics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;BUN &amp;gt;90 mg/dL without symptoms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;eGFR &amp;lt;15 mL/min/1.73 mÂ² without signs&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fluid overload despite diuretics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fluid overload despite diuretics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Refractory fluid overload is a key indication for dialysis in CKD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman with ESRD from hypertension and diabetes on hemodialysis for 6 months has anemia, hyperparathyroidism, and LVH. What is the likely cause of death?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dementia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Major bleeding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myocardial infarction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Worsening uremia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Myocardial infarction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Myocardial infarction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiovascular events dominate mortality in ESRD patients.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with septic shock and AKI has urine output &amp;lt;100 mL/24h despite fluids. Labs show acidosis, rising creatinine. Renal ultrasound is normal. Which statement about dialysis in AKI is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemodialysis uses convection/diffusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-intensity CRRT has no survival benefit&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intermittent hemodialysis preferred in cerebral edema&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Peritoneal dialysis usable in select AKI&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intermittent hemodialysis preferred in cerebral edema&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intermittent hemodialysis preferred in cerebral edema&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CRRT is preferred over intermittent hemodialysis in AKI with cerebral edema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man with stage 5 CKD will start hemodialysis. He asks about the safest, most durable vascular access. Which statement is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AV grafts have better patency than fistulas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fistulas preferred over grafts&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nontunneled catheters have lower infection risk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subclavian vein preferred for tunneled catheters&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fistulas preferred over grafts&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fistulas preferred over grafts&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ AV fistulas are the preferred hemodialysis access for durability and safety.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman with membranous nephropathy presents with leg swelling, frothy urine, and flank pain has 4+ proteinuria, mild hematuria. Ultrasound shows enlarged left kidney. What is the best imaging to confirm?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT renal veins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Contrast venography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MR venography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Doppler ultrasound&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. MR venography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) MR venography&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MR venography is the preferred non-invasive test for renal vein thrombosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man with stage 4 CKD (Hb 9.6 g/dL, ferritin 150 ng/mL) has fatigue. Kidney biopsy confirms hypertensive nephrosclerosis. Which statement about erythropoietin in CKD is false?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Target Hb 100â€“115 g/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Improves cardiovascular outcomes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increases stroke risk in diabetics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;May accelerate dialysis need&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Improves cardiovascular outcomes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Improves cardiovascular outcomes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ESAs manage CKD anemia but lack cardiovascular benefit.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue : Biopsy showing hypertensive nephrosclerosis.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with CKD (eGFR 52) will undergo surgery. Which procedure has the highest AKI risk?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hernia repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cataract surgery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary artery bypass grafting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cholecystectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Coronary artery bypass grafting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Coronary artery bypass grafting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CABG poses the highest postoperative AKI risk due to multiple mechanisms.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which nephron segment reabsorbs the most filtered NaCl?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cortical collecting duct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Distal convoluted tubule&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thick ascending limb&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proximal convoluted tubule&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Proximal convoluted tubule&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Proximal convoluted tubule&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PCT is the primary site for NaCl reabsorption in the nephron.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with 4.1 g/day proteinuria has normal renal function. Renal biopsy is done and it is shown. Which is not a typical secondary cause of the disroder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hepatitis C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NSAIDs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tuberculosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5DVUaUE.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Tuberculosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TB is not a secondary cause of membranous nephropathy, unlike infections, drugs, or cancers.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with ESRD is evaluated for kidney transplant. What is not part of expanded criteria donor (ECD) definitions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Donor &amp;gt;60 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Donor &amp;gt;50 with hypertension, Cr &amp;gt;1.5 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Donor &amp;gt;50 with hypertension, CVA death&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Donor-specific antibodies in recipient&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Donor-specific antibodies in recipient&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Donor-specific antibodies in recipient&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DSA in recipients is a transplant contraindication, not an ECD criterion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with septic shock has AKI (Cr 3.2 mg/dL, oliguria). Urinalysis shows the finding below. Ultrasound of the abdomen is normal. Which agent improves outcomes in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low-dose dopamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Endothelin antagonists&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. None of the above&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LjZkTF2.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) None of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ATI in AKI requires supportive care, not specific pharmacologic agents.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with cervical cancer history has new kidney dysfunction (Cr 4.2 mg/dL, BUN 70 mg/dL), fatigue, and flank pain. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Postvoid residual volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT abdomen with contrast&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Retrograde pyelography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Renal ultrasound&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Renal ultrasound&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Renal ultrasound&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Renal ultrasound screens for obstruction in AKI with malignancy history.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old man 3 months post-renal transplant on tacrolimus, prednisone, and another immunosuppressant has diarrhea. Transplant biopsy is normal. Which drug, inhibiting purine synthesis, likely causes this?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mycophenolate mofetil&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sirolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Belatacept&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mycophenolate mofetil&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mycophenolate mofetil&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mycophenolate causes diarrhea in transplant patients via purine synthesis inhibition.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old man with Cr 1.5 mg/dL, no urinary symptoms, and childhood UTIs has small, asymmetric kidneys on ultrasound. What is the cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allergic interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgG4-related nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reflux nephropathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SjÃ¶gren syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reflux nephropathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reflux nephropathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Reflux nephropathy from childhood UTIs leads to scarred, small kidneys.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman with ADPKD has no neurological symptoms but worries about intracranial aneurysms. Kidney ultrasound confirms cysts. Which statement is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypertension increases aneurysm rupture risk&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aneurysms rarely cause hemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Family history doesnâ€™t impact risk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aneurysm size unrelated to rupture&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypertension increases aneurysm rupture risk&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypertension increases aneurysm rupture risk&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypertension is a modifiable risk for aneurysm rupture in ADPKD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old obese woman with hypertension has 5.4 g/day proteinuria, Cr 1.1 mg/dL, no hematuria. Renal biopsy is done and it is shown below. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Minimal change disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertensive nephrosclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Focal segmental glomerulosclerosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Membranous nephropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Focal segmental glomerulosclerosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_n8Cof99.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Focal segmental glomerulosclerosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ FSGS is a common cause of nephrotic proteinuria in obesity/hypertension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman with confusion, fever, Hb 8.8 g/dL, platelets 15,000/ÂµL, Cr 2.6 mg/dL, and hematuria has no recent diarrhea. What finding is consistent with her diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Schistocytes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-GBM antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Positive Coombs test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spherocytes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Schistocytes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Schistocytes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TTP is diagnosed by schistocytes and low ADAMTS13 activity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old man with type 1 diabetes has 3.2 g/day proteinuria, Cr 1.1 mg/dL. Fundus exam is shown. What is characteristic of kidney involvement due to the disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RBC casts&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased kidney size&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetic retinopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rapid ESRD within 2 years&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diabetic retinopathy&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_78TXrpc.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diabetic retinopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diabetic nephropathy in type 1 diabetes strongly correlates with retinopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old woman presents with painful ear swelling sparing the earlobes, hoarseness, and blurred vision. Exam findings are shown. Which disorders are most commonly associated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Giant cell arteritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Granulomatosis with polyangiitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;B and C&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. B and C&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ODLbEz8.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) B and C&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Relapsing polychondritis often coexists with GPA and RA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man has digital clubbing. Which condition is not associated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic obstructive pulmonary disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyanotic congenital heart disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cystic fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatocellular carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chronic obstructive pulmonary disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chronic obstructive pulmonary disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Clubbing absence in COPD prompts further investigation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old boy with fever, joint pain post-sore throat has swollen knees/ankles and a soft systolic murmur . What is the most common presentation of his diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chorea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythema marginatum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Polyarthritis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Polyarthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Polyarthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Polyarthritis dominates ARF presentation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old man with sudden pain/swelling in the left first MTP joint, on thiazide for hypertension, has erythematous, tender joint. Arthrocentesis shows the following. What is the metabolic derangement?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute bacterial infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyaline cartilage degeneration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inorganic pyrophosphate increase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Uric acid overproduction&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Uric acid overproduction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-06-07%20at%2014.48.24.jpeg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Uric acid overproduction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gout stems from uric acid dysregulation, confirmed by crystal analysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old woman presents with symmetrical joint pain and morning stiffness &amp;gt;1 hour. Her joints are shown in the image below. She also has subcutaneous nodules. Which joint is most commonly involved in established disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Distal interphalangeal joint&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hip&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Knee&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Wrist&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Wrist&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_8IqIlt9.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Wrist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Wrist involvement is hallmark in RA.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man in ICU with hemoptysis, dyspnea has Cr 5.2 mg/dL, pulmonary infiltrates, hematuria. Anti-GBM antibodies confirm Goodpasture syndrome. What is the immune mechanism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibody-dependent cytotoxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complement-activating autoantibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inactivating autoantibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;T-cellâ€“mediated cytotoxicity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Complement-activating autoantibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Complement-activating autoantibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Complement activation drives Goodpasture syndrome damage.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with 6-year primary SjÃ¶gren syndrome has 3-month parotid swelling, cervical lymphadenopathy, weight loss. Labs: leukopenia, low C4. Likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyloidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic pancreatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HIV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lymphoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lymphoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lymphoma risk rises in SjÃ¶gren with parotid swelling, low C4.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man with knee swelling, dactylitis post-diarrhea has dysuria. Works in childcare with similar GI cases. Likely causative organism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Campylobacter jejuni&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clostridium difficile&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Escherichia coli&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Shigella flexneri&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Shigella flexneri&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Shigella flexneri&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Shigella is a key cause of post-diarrheal reactive arthritis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old man with lower back stiffness improving with activity, morning stiffness &amp;gt; 1 hour Xray is shown. What percentage of patients with this condition are HLA-B27 positive?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;10%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;30%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;80%&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 80%&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ENOPj1x.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 80%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ High HLA-B27 positivity in AS aids diagnosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with dry mouth, eye irritation needs water to eat, has photosensitivity. Exam: dry oral mucosa, no Raynaudâ€™s. Which test is least likely positive?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;La/SS-B antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ro/SS-A antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Schirmer I test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scl-70 antibody&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Scl-70 antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Scl-70 antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Scl-70 is specific to systemic sclerosis, not SjÃ¶gren.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man with proximal muscle pain/weakness post-statin (stopped 3 weeks ago) has CK 12x ULN. What test confirms diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-HMG-CoA reductase antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-nuclear antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-Jo-1 antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antiâ€“signal recognition particle antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anti-HMG-CoA reductase antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Anti-HMG-CoA reductase antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-HMG-CoA confirms statin-induced IMNM.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old woman with systemic sclerosis, diffuse skin thickening has headache, confusion, leg swelling, BP 220/110 mmHg, Cr rise, schistocytes. Initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Captopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Captopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Captopril is critical for SRC management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with SLE, recurrent miscarriages has antiphospholipid antibodies. Which statement about antiphospholipid syndrome is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Causes false-positive syphilis tests&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lupus anticoagulant prolongs aPTT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Targets negatively charged phospholipids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most lupus patients with antibodies develop thrombosis/loss&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Most lupus patients with antibodies develop thrombosis/loss&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Most lupus patients with antibodies develop thrombosis/loss&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Few SLE patients with antiphospholipid antibodies develop APS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old man with drug use history has bilateral parotid enlargement, dry mouth, no eye/joint symptoms. Ro/SS-A, La/SS-B negative. Likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HIV infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgG4-related disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary SjÃ¶gren syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. HIV infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) HIV infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HIV mimics sicca with parotid enlargement, negative serology.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 41-year-old man with chronic psoriasis has wrist/knee pain, erosive changes on X-ray. Which medication is least effective for skin/joint symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secukinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ustekinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rituximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Rituximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rituximab is not used in PsA, unlike other biologics.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman with prior incarceration has 15 mm induration 72 hours post-tuberculin skin test. This reaction represents which immune response?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytotoxic antibody-mediated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Delayed-type hypersensitivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immediate hypersensitivity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune complexâ€“mediated&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Delayed-type hypersensitivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Delayed-type hypersensitivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PPD elicits DTH, indicating TB sensitization.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with pulmonary sarcoidosis has palpitations, fatigue. ECG shows PVCs, echo mild LV dysfunction. Which cardiac manifestations are due to sarcoidosis granulomas?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Coronary artery disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Decreased ejection fraction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary dissection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Decreased ejection fraction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Decreased ejection fraction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiac sarcoidosis causes arrhythmias, heart failure via granulomas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man with right elbow pain after pulling luggage has tenderness over lateral epicondyle, pain with wrist extension. Most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NSAIDs and rest&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. NSAIDs and rest&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) NSAIDs and rest&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tennis elbow managed with NSAIDs, rest, injections.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with skin lesions as shown in the image. She also has dry cough. CXR is done and it is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acne vulgaris&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute cutaneous lupus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Erythema nodosum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lupus pernio&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lupus pernio&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_nG1SegQ.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Lupus pernio&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lupus pernio is a sarcoidosis-specific facial rash.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with psoriasis, joint aches post-infliximab has a rash as shown below. ANA 1:320. Which autoantibody is likely present?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-CCP antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-dsDNA antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti-histone antibodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-thyroid peroxidase antibodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti-histone antibodies&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_a1Nwdjb.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti-histone antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-histone antibodies hallmark DIL from TNF inhibitors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test9" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D Part 2 (Mission Neet Pg)   10 11 2023   2023 11 10&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D Part 2 (Mission Neet Pg)   10 11 2023   2023 11 10&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                75 Questions | 300 Total Marks | 85 min Duration | ~68.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;In MI, which of the following markers is most likely to be increased in the first few minutes after the onset of CP and back to baseline within 12 hours?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CK MB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;H - FABP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IMA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trop I&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IMA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. IMA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with CAD and HTN is in the ICU recovering from a partial colectomy. On POD3 she is developed confusion. Her temperature is 37Â°C (98.4Â°F), BP is 88/60 mm Hg, PR is 118/min/regular, and RR is 28/min. Her PCWP is 20 mm Hg. Her ECG is unchanged, and cardiac enzyme levels are normal. What is the most likely cause of this patient&#x27;s shock?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Addisonian crisis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anaphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiogenic shock&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Septic shock&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardiogenic shock&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Cardiogenic shock&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman was admitted with AECOPD. After initial treatment with salbutamol and CS, her RR has normalized, and her SpO2 is now 88%â€“92% but PR is still 110/min. She no longer reports dyspnea or cough. Which of the following is most likely to be seen in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AFL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MAT&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;VT&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. MAT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. MAT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Ebsteinâ€™s anomaly presented with arrhythmia. What is the long-term management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;RFA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AV nodal ablation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. RFA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. RFA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with DM2 and HTN presents for an annual check-up. His current medications are MF and telmisartan. His temperature is 37.2Â°C (98.7Â°F), HR is 82/min, BP is 146/84 mm Hg, and 6. RR is 18/min. Laboratory tests show: HbA1C: 7.5%, TC: 225 mg/dL, LDL-C: 165 mg/dL, HDL-C 30 mg/dL, TG: 150 mg/dL. Which of the following targets is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Target LDL cholesterol &amp;lt; 100 mg/dL and BP &amp;lt;130/80 mm Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Target LDL cholesterol &amp;lt; 70 mg/dL and BP &amp;lt;130/80 mm Hg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Target LDL cholesterol &amp;lt; 100 mg/dL and A1C &amp;lt; 9%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Target total cholesterol &amp;lt; 70 mg/dL and hemoglobin A1c &amp;lt; 8%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Target LDL cholesterol &lt; 100 mg/dL and BP &lt;130/80 mm Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Target LDL cholesterol &amp;lt; 100 mg/dL and BP &amp;lt;130/80 mm Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;54-year-old man comes to the clinic because of intermittent CP. He describes the pain as vague sense of nausea and chest tightness. The episodes last 1-2 minutes occur randomly. He does not exercise and has a significant smoking history. He is moderately obese and is in no apparent distress. His BP is 152/88 mm Hg. Her ECG, lytes and biomarkers are normal. Which of the following is the most appropriate next step in diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stress Myocardial perfusion imaging&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac CTA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stress ECG&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CAG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Stress ECG&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Stress ECG&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old presents to his physician because of increasing SOB, palpitations, and CP with exertion over the past 2 months. Cardiac examination reveals a widely split S2 that narrows with inspiration, and a systolic crescendo-decrescendo murmur best heard at the LLSB. Which of the following would most likely lead to a decrease in the intensity of the murmur?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Squatting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valsalva&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Squatting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Squatting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a history of HTN, DM2, and DLP is brought to the ER because of reports of palpitations and dizziness. ECG is ordered and shown in the image. His temperature is 36.8Â°C, PR is 106/min, RR is 18/min, BPis 84/46 mm Hg, and SpO2 is 92% on room air. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Synchronized DCC&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Synchronized DCC&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture1_EgG7iTH.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Synchronized DCC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man presents for a MHC. His BP is 148/96 mm Hg and has LUTS. The exam is normal except for an enlarged, smooth prostate. Laboratory studies done were normal. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Check BP after 3 months&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chlorthalidone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Telmisartan + Amlodipine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prazosin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Prazosin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with a history of DLP, HTN and aortic sclerosis presents to the ER with CP. The CP is like angina attacks in his past. He took 3 NTG tablets with some relief. In the ER he is given ASA, metoprolol, and morphine and is placed on nasal O2 &amp;amp; ECG monitoring. On exam the patient is diaphoretic and appears to be uncomfortable. His vitals are stable and cardiac enzymes were normal. An ECG on admission is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;STEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NSTEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stable Angina&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unstable Angina&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Unstable Angina&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture2_ozgNJlq.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Unstable Angina&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man presented 2 days ago to the ER with chest pain and was diagnosed/treated for Anterior MI. On the morning of his second hospital day, his PR is 60/min, RR is 16/min, BP is 124/76 mm Hg, temperature is 36.7Â°C (98Â°F), and SpO2 is 99% on room air. A routine ECG is obtained and shown. What is the most appropriate Rx?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Carotid massage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Permanent pacemaker&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Atropine IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Permanent pacemaker&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture3_ElrPRkP.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Permanent pacemaker&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient collapsed and was brought to the casualty with no proper history. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Check for responsiveness&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secure airway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Shock: 300J&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Check for carotid pulse&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Check for responsiveness&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Check for responsiveness&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the strongest predictor of cardiovascular disease incidence and subsequent mortality due to CVD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TC/HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;hsCRP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. LDL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. LDL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 51-year-old male presents recurrent CP 4 days after a STEMI. The CP radiates to the trapezius and worse with deep inspiration. The pain woke him from sleep and has improved slightly after getting up out of bed. His CTn levels were unchanged, and ECG was showed new ST elevations in inferior and lateral leads. What is the likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Recurrent MI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early Pericarditis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dresslerâ€™s Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe GERD due to aspirin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Early Pericarditis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Early Pericarditis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man post MI had the following lab values LDL -127mg/dl, HDL -32 mg/dl, TGL -270mg/dl. Which of the following must be his treatment plan?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rosuvastatin 40mg + Fenofibrate 162mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atorvastatin 80mg + Fenofibrate 105mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atorvastatin 80mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rosuvastatin 10mg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atorvastatin 80mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Atorvastatin 80mg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presented with CP and was noted to have 2 mm of ST segment elevation in his inferior leads. He has a SBP of 84 mm Hg and a HR at 124 beats/min. On examination, he seems less alert, his JVP is elevated, and his lungs are clear. Which of the following is the best treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Normal Saline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV NTG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV Normal Saline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. IV Normal Saline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old gentleman is brought into your ER after a syncope. The monitor showed a HR of 190 bpm with a BP of 85/50mmHg. His SpO2 is 98% (on NRBM). ECG shows a regular WCT with no apparent P waves. Regarding the JVP waveform, which of these features would you expect to see?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Giant v waves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannon a waves&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prominent x descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Slow y descent&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cannon a waves&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Cannon a waves&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following fits into the picture of Papillary muscle rupture, Cardiac tamponade, VSD and RV infarction in order? RA = 21 mm Hg, RV = 60/22 mm Hg, PCWP = 20 mm Hg, CI = 1.7 L/min/m2, Pu.aO2 sat = 70% RA = 12 mm Hg, RV = 60/30 mm Hg, PCWP = 10 mm Hg, CI = 1.7 L/min/m2, Pu.aO2 sat = 95% RA = 15 mm Hg, RV = 60/30 mm Hg, PCWP = 6 mm Hg, CI = 1.7 L/min/m2, Pu.aO2 sat = 70% RA = 12 mm Hg, RV = 50/20 mm Hg, PCWP = 40 mm Hg, CI = 1.6 L/min/m2, Pu.aO2 sat = 75%&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DACB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DABC&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CBDA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;BCAD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. DABC&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. DABC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which among the following according to the latest guidelines is NOT an indication to IE prophylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prior IE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MVP with severe MR&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unrepaired CyCHD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac transplant with valvulopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MVP with severe MR&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. MVP with severe MR&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a past medical history of coronary artery disease develops a myocardial infarction. He got treated in CCU and before he is discharged, he undergoes echocardiography, which reveals a left ventricular ejection fraction of 35% to 40%. He is asymptomatic. Repeat Echo after 3 months shows the same findings. What is this patientâ€™s heart failure stage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Stage B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Stage&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following medications may induce an episode of atrial fibrillation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flecainide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lidocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Adenosine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Adenosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old male with a history of Brugada syndrome presents for new patient evaluation. He reports having had 2 prior episodes of syncope last summer, once while playing basketball and once after swimming. He has no history of cardiac arrest. He is adopted and does not know his biological family history. An ECG in the office shows a right bundle branch block pattern with 2 mm coved ST-segment elevations in the anterior precordial leads. Which of the following treatments would reduce this patientâ€™s risk of sudden cardiac death (SCD)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ICD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Quinidine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ICD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. ICD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 33-year-old female presents to her physician with complaints of palpitations. An ECG is taken during an episode and provided below. She is otherwise stable. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Synchronized DCC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Valsalva&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Valsalva&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture4_1pnOkjc.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Valsalva&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old woman comes to the ER complaining of fatigue 2 days and an episode of hemoptysis. She has a H/o AF and OA â€“ on naproxen and warfarin. Her BP is 60/40 mm Hg and labs showed â€“ INR 5.1 and Hct 12.6%. She received IV vitamin K, 4 U PRBCs and 4U FFP. 8h later, she begins to complain of SOB. Vitals T - 39Â°C, RR 35/min, SpO2 84% on RA, and BP 100/52 mm Hg. Exam revealed B/L crackles and the patient was intubated for respiratory failure. CXR is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anaphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TACO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TRALI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspiration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. TRALI&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture5_bvj4lQD.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. TRALI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 19-year-old presented with C/o tender, painful skin lesions in his axilla. He reports multiple similar episodes in the past. Current report â€“ positive cultures for Serratia marcescens. All the following statements are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Infections with coagulase positive organisms are typical&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prophylactic use of TMP/SMX is effective&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diagnosed by Dihydrorhodamine (DHR) 123 test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Usually transmitted by XLR inheritance&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Infections with coagulase positive organisms are typical&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture6_iVqqdSS.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Infections with coagulase positive organisms are typical.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the expected MCV in CBC based on the PS image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 80 fL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;80-100 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt; 100 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 120 fL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &lt; 80 fL&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture7.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. &amp;lt; 80 fL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are incorrect regarding CUP except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tumor markers are non-specific.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Most are squamous cell cancers.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Most common genomic alteration is KRAS mutation.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CK7 -/CK20 â€“ is the typical profile of CRCs.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tumor markers are non-specific.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is characteristic of tumor suppressor genes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;The mutant allele is often inherited through the germ line&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;The somatic mutation does not contribute to cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The inherited form of the mutant allele does not commonly have a tissue preference&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The mutant allele acts in a dominant fashion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. The mutant allele is often inherited through the germ line&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. The mutant allele is often inherited through the germ line&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a hallmark of cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immune evasion &amp;amp; avoiding immune mediated destruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Escaping growth inhibitory signals&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Energy from oxidative phosphorylation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tumor promoting inflammation.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Energy from oxidative phosphorylation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Energy from oxidative phosphorylation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old man with HL was treated successfully with the ABVD regimen Which of the following drugs used in the Rx of this patient is cell cycle specific?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alkylating agents&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antimetabolites&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plant alkaloids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Plant alkaloids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Plant alkaloids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient was about to receive cisplatin for chemotherapy. What are the drugs that can be offered to prevent/reduce chemotherapy induced nausea and vomiting?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granisetron, Aprepitant and dexamethasone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metoclopramide, dexamethasone and domperidone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prochlorperazine, granisetron and domperidone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Promethazine, doxylamine and metoclopramide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Granisetron, Aprepitant and dexamethasone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Granisetron, Aprepitant and dexamethasone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following would be important for prevention of the CTLS EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of allopurinol 300 mg/m2 daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administration of IV fluids at a minimum of 3000 mL/m2 daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alkalinization of the urine by administration of NaHCO3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Frequent monitoring of serum chemistries every 4 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alkalinization of the urine by administration of NaHCO3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Alkalinization of the urine by administration of NaHCO3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;CSI is primarily used in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oligodendroglioma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Piloctic astrocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mixed oligoastrocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Medulloblastoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Medulloblastoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D.Â Medulloblastoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is most likely to be the major underlying cause of the anemia in a patient with chronic HFrEF?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â†‘ RBC destruction 2Â° to deposition of complement on the RBC membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â†‘ Blood loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â†“ Life of RBCs because of maladaptive changes to the RBC membrane&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;â†“ Intestinal absorption of Fe secondary to â†‘ circulating hepcidin levels&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. â†“ Intestinal absorption of Fe secondary to â†‘ circulating hepcidin levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. â†“ Intestinal absorption of Fe secondary to â†‘ circulating hepcidin levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 39-year-old male presents with vague abdominal pain and ED to the emergency department (ED). He also complains of fatigue and light pink urine. Labs - Hb 8.1 g/dl, â†‘ retics, â†“ haptoglobin, â†‘ LDH and bilirubin. The loss of which cell surface proteins during FCx would most likely be responsible for the hemoglobinuria in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD22 and CD29&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD55 and CD59&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD2 and CD4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CD4 and CD8&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CD55 and CD59&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. CD55 and CD59&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old was admitted for a infected wound for which he received vancomycin. He developed several bruises on his arms and legs with no obvious signs of trauma. His PT/PTT are within normal limits, HBV/HCV are negative, WBC 6.5 x 103 uL, HGB, 14.2 g/dL, and platelets 18,000/uL. In previous laboratory examinations, all laboratory levels were found to be within normal limits. Based on the patient&#x27;s clinic presentation which of the following is the most likely explanation of the patient&#x27;s findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Formation of drug-dependent antibodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inherited platelet disorder&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic thrombocytopenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombotic thrombocytopenic purpura (TTP)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Formation of drug-dependent antibodies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Formation of drug-dependent antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old woman presents two years after Rx and remission of cHL with painful right cervical lymphadenopathy. A FDG-PET scan shows hypermetabolic lesions in the right infraclavicular, B/L hilar, para-aortic, and inguinal lymph nodes. What regimen would be frontline therapy for this recurrent disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ICE salvage&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Repeat ABVD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brentuximab Vedotin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bendamustine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ICE salvage&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. ICE salvage&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old woman presents with painless cervical LAN. Her WBC count is 5000 cells/ÂµL, ANC 2500/ÂµL, ALC 1900/ÂµL, platelets 220,000/ÂµL and Hb is 13.9 g/dL. She has B/L cervical, axillary, and inguinal LAN. BMAx demonstrates normal trilineage hematopoiesis. Fcx of axillary LN Bx showed a population of neoplastic lymphoid cells is identified which is positive for CD5, CD19, CD20 (dim), and CD23, and negative for CD10 and CD38. CCND1 stain by IHC is negative. There are no cytogenetic abnormalities identified. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Small lymphocytic lymphoma (SLL)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic lymphocytic leukemia (CLL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Monoclonal B Lymphocytosis (MBL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mantle cell lymphoma (MCL)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Small lymphocytic lymphoma (SLL)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Small lymphocytic lymphoma (SLL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is usually the first to be affected in a disoriented patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Location&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Name&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Time&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Time&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Time&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following statements regarding astrocytes are true EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;They actively phagocytose synapses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;They exert effects on the life of synapses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;They make up â‰¥ 90% of all CNS cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;They participate in the dynamic regulation of local vascular tone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. They make up â‰¥ 90% of all CNS cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. They make up â‰¥ 90% of all CNS cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following factors is of greatest concern regarding the risk of recurrent Sz?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Focal defect on neurologic examination&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Generalized Sz disorder&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Head trauma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Seizure within the last 7 years&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Focal defect on neurologic examination&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Focal defect on neurologic examination&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old man with a H/o Sz disorder presents with GCSE. He had been having persistent Sz activity for 20 minutes when EMS was activated. He was given lorazepam 8 mg IV and on arrival in the ER 20 minutes later, he threw another Sz. Vitals - temperature is 39.2Â°C (102.5Â°F), BP 182/92, HR 158 beats/min, RR 38 breaths/min, and SpO2 95%. Which of the following is the next step in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fosphenytoin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Midazolam&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thiopentone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isoflurane&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fosphenytoin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Fosphenytoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old male presents to the ER with the acute onset of ataxia. Neurological examination shows loss of pain and temperature sensation from the face on the left side and loss of pain and temperature sensation from the right half of the body. He also has dysarthria, dysphagia, and diminished gag reflex with ptosis, miosis, and anhidrosis on the left. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lateral pontine syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medial medullary syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lateral medullary syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Weber syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lateral medullary syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Lateral medullary syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old F1 driver complains of neck pain following a race. 3 days later he presents with left sided facial numbness as well as numbness across the right upper and lower limb. On exam - the left pupil is much smaller than the right and there is a partial ptosis on the left. Eye movements are normal. Power, coordination, and reflexes are all normal. What is the gold standard brain-imaging method used in order to establish the primary diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carotid artery doppler&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;EEG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CT angiogram of head &amp;amp; neck&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. CT angiogram of head &amp; neck&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. CT angiogram of head &amp;amp; neck&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;This patient was presented with diplopia. Identify the injured nerve based on the test given in the picture:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Trochlear Nerve&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Occulomotor Nerve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Abducens Nerve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Facial Nerve with Abducens Nerve&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Trochlear Nerve&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture8.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Trochlear Nerve&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient comes to ER with headache describing it as worst headache in his life. Initial NCCT is shows SAH. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;DSA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lumbar puncture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MRI brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;V-P shunt&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. DSA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. DSA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old man is investigated for progressive cognitive impairment. Which one of the following features is most suggestive of Lewy body dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disinhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Emotional lability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neuroleptic sensitivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary incontinence&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neuroleptic sensitivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Neuroleptic sensitivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old male presents to your clinic with a 6-month history of left-sided daily headaches located in the frontal and retro-orbital area. He denies any pain-free periods. The headaches are of moderate 5/10 severity with unpredictable exacerbations of severe pain going up to 9/10 severity. He describes to you what sounds to you like left-sided conjunctival injection and lacrimation often occurring alongside the headaches. Which of the following is most likely to aid you in making a diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High flow 100% oxygen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lumbar puncture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Trial of Indomethacin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MRI Brain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Trial of Indomethacin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Trial of Indomethacin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman presents with a tremor. Which one of the following features would suggest a diagnosis of essential tremor rather than Parkinson&#x27;s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Difficulty in initiating movement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tremor is worse following alcohol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unilateral symptoms&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tremor is worse when the arms are outstretched&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tremor is worse when the arms are outstretched&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Tremor is worse when the arms are outstretched&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;This is the MRI of a patient who had a history of multiple falls. Identify the sign that is not associated with the diagnosis:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Downgaze palsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Slowed movements&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Predominant bladder bowel disturbance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Square wave jerks&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Predominant bladder bowel disturbance&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture9.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Predominant bladder bowel disturbance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In wernikes encephalopathy, the earliest clinical feature to recover is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Opthalmoparesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Confusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Memory loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Opthalmoparesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Opthalmoparesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;PNS characterized by anti YO antibodies are characterised by â€“&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebellar Degeneration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stiff Person syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Optic Neuritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Retinopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cerebellar Degeneration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Cerebellar Degeneration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient came with complaints of high-grade fever and altered sensorium. He was diagnosed to be suffering from meningococcal meningitis. Which of the following is the most appropriate empirical treatment option?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ceftriaxone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cefotetan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Penicillin G&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cefoxitin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ceftriaxone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ceftriaxone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female presents to her physician with blurred vision in the left eye which developed gradually over the past week. Past medical history is significant for an episode of left face, arm, and leg weakness with imbalance lasting two weeks, which occurred three years ago. Eye examination revealed swelling of the optic disk &amp;amp; decreased pupillary constriction to light. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Recurrent strokes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ophthalmoplegic migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Devicâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Multiple sclerosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Multiple sclerosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The Miller-Fisher variant of GBS presents as a triad of which symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Distal weakness, sensory loss, ataxia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Distal weakness, ophthalmoplegia, areflexia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ophthalmoplegia, areflexia, ataxia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cervical myelitis, optic neuritis, ataxia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ophthalmoplegia, areflexia, ataxia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Ophthalmoplegia, areflexia, ataxia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not a risk factor for peptic ulcer disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Eating spicy foods&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Smoking&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Zollinger-Ellison syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Infection with Helicobacter pylori&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Eating spicy foods&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Eating spicy foods&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following regarding non-invasive testing for H. pylori is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;There is no reliable non-invasive method to detect H. pylori&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False negative UBT reports occur with use of NSAIDs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serology offer the greatest sensitivity for diagnosis of infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exposure to low-dose radiation is a limitation to UBT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Exposure to low-dose radiation is a limitation to UBT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Exposure to low-dose radiation is a limitation to UBT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are treatment options for IBS â€“ D except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prucalopride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alosetron&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loperamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cholestyramine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prucalopride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Prucalopride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old female develops acute diverticulitis and hospitalized for IV antibiotics. Her CT scan does not show evidence of abscess perforation, stricture, or fistula, and she improves in about a week. Which of the following should be advised at discharge?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Annual colonoscopy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Initiation of a high-fiber diet&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subtotal colectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Daily mesalamine therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Initiation of a high-fiber diet&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Initiation of a high-fiber diet&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old man presents with 1 month of diarrhea. He states that he has 8 to 10 loose bowel movements a day. He has lost 6 kgs during this time. Vital signs and physical examination are normal. Serum lab studies are normal. A 24-hour stool collection reveals 500g of stool with a measured stool osmolality of 200 mOsm/Land a calculated stool osmolality of 210 mOsm/L. Based on these findings, which of the following is the most likely cause of his diarrhea?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Celiac sprue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic pancreatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lactase deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;VIP tumor&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. VIP tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. VIP tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a 5-year history of UC presents with acute abdominal pain. Workup reveals fever and leukocytosis. Plain film is shown below. What is the next management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Methyprednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subtotal colectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV Methyprednisolone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture10.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. IV Methyprednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old woman underwent a hip surgery and on POD2 she complains of increasing abdominal discomfort and distension. On physical examination, she is afebrile with a BP 140/80, HR 110 bpm, RR 16 and SpO2 100% on 2 L O2. She has a distended tympanic abdomen with absent bowel sounds. There is no rebound tenderness. Xray is shown. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acalculous cholecystitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colonic pseudo-obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Small bowel ileus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intestinal perforation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Small bowel ileus&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/picture11.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Small bowel ileus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are reviewing a serology report of a patient in a routine MHC â€“ HBSAg: Negative Anti HBS: Negative Anti HBC: Positive HBEAg: Negative Anti HBE: Negative. All of the following are true except.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Window period&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Late acute infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occult HBV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HBV in the remote past&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Late acute infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Late acute infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is incorrect with regards to DILI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Direct toxic hepatitis is usually clinically indistinguishable from viral hepatitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Idiosyncratic reactions are unpredictable and is NOT dose dependent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;The occurrence of jaundice in a phase 3 clinical trial is predictive of severe hepatotoxicity in post-marketing surveillance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;The incidence of DILI is the same in patients with CLD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Direct toxic hepatitis is usually clinically indistinguishable from viral hepatitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Direct toxic hepatitis is usually clinically indistinguishable from viral hepatitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman is evaluated for fatigue, malaise, arthralgias, and a 10-lb weight loss over the past 6â€“8 weeks. She has no PMH. On exam, vitals are stable and she has hepatomegaly, jaundice and mild joint swelling. Labs â€“ AST 542 IU/L, ALT is 657 IU/L, ALP 102 IU/L, TB 5.3 mg/dL, DB is 4.8 mg/dL. Which of the following tests would be LEAST likely to be positive in this diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ANA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;RF&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AMA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypergammaglobulinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. AMA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. AMA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following statements are true regarding NAFLD Rx EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bariatric surgery is safe in patients with NAFLD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin E is helpful in reducing steatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Statins may worsen inflammation in NAFLD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;There are no therapies approved by FDA for NAFLD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Statins may worsen inflammation in NAFLD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Statins may worsen inflammation in NAFLD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old cirrhotic presents with increasing confusion and increasing ascites. Diagnostic paracentesis is performed that yields reveal clear fluid with 800 WBCs/ Î¼ L (40% PMNs). Which of the following is the most indicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ampicillin + ceftriaxone + vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Large volume paracenetesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Piperacillin â€“ Tazobactum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lactulose&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Piperacillin â€“ Tazobactum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Piperacillin â€“ Tazobactum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man with HBV related cirrhosis has ascites requiring frequent LVP. All of the following are true regarding treatment of ascites EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluid restriction &amp;lt; 2 L daily&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Furosemide + spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Na restriction &amp;lt; 2 g daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TIPS has no survival benefit compared to LVP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fluid restriction &lt; 2 L daily&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Fluid restriction &amp;lt; 2 L daily&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old alcoholic with ascites and jaundice presents with acute UGI bleed. All the following are appropriate treatment options EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endoscopic variceal ligation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TIPS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Management of HRS includes all except â€“&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Volume expansion with IV albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuresis with furosemide + spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Midodrine and octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Referral to liver transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Diuresis with furosemide + spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. Diuresis with furosemide + spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Indications for cholecystectomy in gallstone disease are all except -&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anomalous pancreatic ductal drainage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gallbladder polyp of 11 mm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gallstone of 18 mm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Porcelain gallbladder&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gallstone of 18 mm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Gallstone of 18 mm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old woman presents with a 1-week history of RUQ pain, intermittent fever, and nausea. Labs â€“ elevated TB, ALP and mild transaminitis. USG â€“ normal. MRCP reveals a beaded appearance of her intrahepatic and extrahepatic bile ducts due to multiple discrete strictures. Which of the following lab tests would be most helpful?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti HCV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Procalcitonin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum IgG-4 levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum triglycerides&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Serum IgG-4 levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Serum IgG-4 levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following regarding pancreatic enzyme secretion is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ach inhibits pancreatic enzyme secretion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;All pancreatic enzymes are secreted as zymogens&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CCK receptors are NOT seen on acinar cells&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Enterokinase found in the duodenal mucosa activates trypsinogen&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ach inhibits pancreatic enzyme secretion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Ach inhibits pancreatic enzyme secretion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are accepted diagnostic criteria for acute pancreatitis EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Confirmatory findings of acute pancreatitis on cross-sectional imaging&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PaO2 &amp;lt; 60&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â‰¥ 3x elevation in serum lipase and/or amylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Typical abdominal pain in the epigastrium that may radiate to the back&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. PaO2 &lt; 60&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B. PaO2 &amp;lt; 60&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman with CF is diagnosed with chronic pancreatitis. All of the following complications may be seen EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin A deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancreatic carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Niacin deficiency&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Niacin deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Niacin deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 85 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test10" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine E&amp;amp;D Part 2, Mission 3.0 (Early Intern Batch)   13 06 2025   2025 06 13&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine E&amp;amp;D Part 2, Mission 3.0 (Early Intern Batch)   13 06 2025   2025 06 13&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 72-year-old man presents with lethargy and hypothermia (34.8Â°C) during winter, found unresponsive by neighbours. His clinical appearance is shown in the image below. Chest X-ray reveals left lower lobe pneumonia, and labs show a TSH of 92 mU/L. What is the most appropriate initial pharmacologic treatment alongside antibiotics?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypotonic saline + Piperacillin Tazobactum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Saline + Intravenous hydrocortisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous levothyroxine + hydrocortisone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oral prednisone + Oral Amoxicillin-clavulanate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Intravenous levothyroxine + hydrocortisone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_HcJ7L3P.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Intravenous levothyroxine + hydrocortisone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myxedema coma requires IV levothyroxine and hydrocortisone as initial treatment, alongside antibiotics for coexisting infections like pneumonia. Hypothermia and unresponsiveness necessitate urgent hormone replacement in a critical care setting. Avoid hypotonic fluids to prevent complications like cerebral edema.&lt;/li&gt;&lt;li&gt;âž¤ Myxedema coma requires IV levothyroxine and hydrocortisone as initial treatment, alongside antibiotics for coexisting infections like pneumonia.&lt;/li&gt;&lt;li&gt;âž¤ Hypothermia and unresponsiveness necessitate urgent hormone replacement in a critical care setting.&lt;/li&gt;&lt;li&gt;âž¤ Avoid hypotonic fluids to prevent complications like cerebral edema.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A newborn girl presents with ambiguous genitalia, fused labia, and clitoromegaly. She develops severe vomiting by day 10. Karyotyping shows 46XX and she has high 17-hydroxyprogesterone levels. What is the expected electrolyte abnormality?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypernatremia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyponatremia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Hyponatremia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Hyponatremia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Salt-wasting CAH presents with hyponatremia in newborns.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man presents with altered mental status, dystonia, and new-onset ascites. He had unexplained hepatitis two years ago. Labs show elevated liver enzymes and anemia, and slit-lamp exam reveals the finding below. What is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cholestyramine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;D-penicillamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Liver transplantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trientine&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Trientine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_0sK809R.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Trientine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Trientine is the first-line chelator for symptomatic Wilson disease.&lt;/li&gt;&lt;li&gt;âž¤ Trientine is the first-line chelator for symptomatic Wilson disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with chronic fatigue and vision changes. She is diagnosed with diabetic retinopathy. Which complication is most likely to be a microvascular issue associated with her diabetes mellitus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cheiroarthropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gastroparesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Macular edema&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Peripheral arterial disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Macular edema&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Macular edema&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Macular edema is a key microvascular complication of diabetic retinopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man presents with infertility after two years of unsuccessful attempts to conceive. His appearance is shown below. On examination he has small firm testes with sparse body hair. Labs show low testosterone. What finding is most consistent with his likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal estrogen levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low follicle-stimulating hormone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased plasma estrogen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal luteinizing hormone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased plasma estrogen&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_NgxdX8o.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased plasma estrogen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Klinefelter syndrome features increased estrogen, causing gynecomastia.&lt;/li&gt;&lt;li&gt;âž¤ Klinefelter syndrome features increased estrogen, causing gynecomastia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with persistent headaches and reduced peripheral vision. MRI reveals the following. What is the most likely visual field defect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilateral inferior visual field loss&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral central scotomas&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bitemporal hemianopia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right homonymous hemianopia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bitemporal hemianopia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tiy0QE2.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bitemporal hemianopia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bitemporal hemianopia is the hallmark of pituitary macroadenoma compression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old woman presents with 8 months of amenorrhea, hot flashes, and night sweats after two years of irregular menses. Laboratory tests are ordered to evaluate her hormonal status. What is the typical hormonal pattern in menopause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Decreased FSH, increased estradiol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased FSH, decreased estradiol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Decreased LH, decreased estradiol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased LH, increased estradiol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Increased FSH, decreased estradiol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Increased FSH, decreased estradiol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Menopause is characterized by high FSH and low estradiol.&lt;/li&gt;&lt;li&gt;âž¤ Menopause is characterized by high FSH and low estradiol.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents with headache and loss of libido. His appearance is shown. MRI reveals a pituitary mass. What is the most appropriate screening test for the suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;24-hour urinary cortisol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum insulin-like growth factor-1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Random growth hormone level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum prolactin level&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Serum insulin-like growth factor-1&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_P24cWHc.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Serum insulin-like growth factor-1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Serum IGF-1 is the screening test for acromegaly.&lt;/li&gt;&lt;li&gt;âž¤ Serum IGF-1 is the screening test for acromegaly.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old woman presents with newly diagnosed hypothyroidism and a history of coronary artery disease. She reports cold extremities and fatigue. What is the primary cardiovascular consequence of her hypothyroidism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased stroke volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Enhanced myocardial contractility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduced stroke volume&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased skin blood flow&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduced stroke volume&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reduced stroke volume&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypothyroidism reduces stroke volume, impacting cardiac output.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old woman presents with sudden severe abdominal pain, nausea, and vomiting during her menstrual period. She reports dark urine and leg weakness. CT abdomen is normal. What is most likely elevated during this acute episode?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum copper&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Urine porphyrins&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fibrinogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alpha-1 antitrypsin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Urine porphyrins&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Urine porphyrins&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Urine porphyrins are diagnostic for AIP during acute episodes.&lt;/li&gt;&lt;li&gt;âž¤ Urine porphyrins are diagnostic for AIP during acute episodes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man presents for a routine health check with no symptoms but a family history of cirrhosis. He has some lumps in the legs as shown below. Labs show LDL cholesterol of 392 mg/dL. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Familial defective apoB-100&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Familial hepatic lipase deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Familial hypercholesterolemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lipoprotein lipase deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Familial hypercholesterolemia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_UsE5MvA.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Familial hypercholesterolemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Familial hypercholesterolemia presents with high LDL and tendon xanthomas.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man presents with frequent nighttime urination, difficulty initiating urination, and a weak urinary stream. He has hypertension treated with hydrochlorothiazide and consumes alcohol at night. Examination shows an enlarged, smooth prostate with normal PSA. What is the most appropriate initial intervention?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase fluid intake at bedtime&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Take hydrochlorothiazide at night&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduce evening alcohol consumption&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start immediate prostate surgery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduce evening alcohol consumption&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reduce evening alcohol consumption&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Reducing evening alcohol is a key initial step for BPH-related nocturia.&lt;/li&gt;&lt;li&gt;âž¤ Reducing evening alcohol is a key initial step for BPH-related nocturia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman presents with irregular menstrual periods and heavy uterine bleeding for over a week. She has a BMI of 33 kg/mÂ², mild hirsutism and elevated serum testosterone. What is the most effective treatment for her current bleeding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clomiphene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Letrozole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Progesterone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Progesterone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Progesterone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Progesterone effectively controls heavy bleeding in PCOS.&lt;/li&gt;&lt;li&gt;âž¤ Progesterone effectively controls heavy bleeding in PCOS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old woman presents with visual disturbances and severe headache one day after vaginal delivery. She becomes unresponsive with a blood pressure of 70/30 mmHg and glucose of 48 mg/dL. What is the most appropriate immediate treatment for her hypotension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous thyroxine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous hydrocortisone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous antibiotics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Red blood cell transfusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous hydrocortisone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intravenous hydrocortisone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IV hydrocortisone is critical for patients presenting with pituitary apoplexy and adrenal crisis.&lt;/li&gt;&lt;li&gt;âž¤ IV hydrocortisone is critical for patients presenting with pituitary apoplexy and adrenal crisis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 21-year-old woman presents with recurrent joint dislocations, easy bruising, and mild scoliosis. She has the following features as shown in the image. Which feature is not typically associated with this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congenital hip dislocation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lens dislocation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Skin hyperextensibility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Premature tooth loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Lens dislocation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-06-13%20115149.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Lens dislocation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lens dislocation is associated with Marfan syndrome, not EDS.&lt;/li&gt;&lt;li&gt;âž¤ Lens dislocation is associated with Marfan syndrome, not EDS.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old transgender woman presents for routine care. She is on hormone therapy and asks about health risks specific to her transgender status. Which condition is most disproportionately elevated among transgender individuals?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiovascular disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Suicide attempts&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Substance abuse disorder&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Suicide attempts&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Suicide attempts&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Suicide attempts are a major health concern in transgender individuals, requiring robust mental health support.&lt;/li&gt;&lt;li&gt;âž¤ Suicide attempts are a major health concern in transgender individuals, requiring robust mental health support.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 21-year-old man presents with obesity since childhood, mild intellectual disability, short stature, and underdeveloped genitalia. He has small hands and feet and exhibits food-seeking behavior. His appearance is shown. Labs show low testosterone. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bardet-Biedl syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cushing syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insulinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prader-Willi syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prader-Willi syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_hOfwXmn.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prader-Willi syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Prader-Willi syndrome presents with hyperphagia and hypogonadism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old man presents with decreased sexual interest, erectile dysfunction, and fatigue. Labs show a total testosterone level of 195 ng/dL. Which symptom is most likely to improve with testosterone replacement therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cognitive function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Physical mobility&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fatigue&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Erectile function&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Erectile function&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Erectile function&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Testosterone therapy primarily improves erectile function in hypogonadism.&lt;/li&gt;&lt;li&gt;âž¤ Testosterone therapy primarily improves erectile function in hypogonadism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man presents with sudden right thigh pain and leg weakness. He has poorly controlled type 2 diabetes (HbA1c 10%) and no sensory loss. MRI of the lumbar spine is normal, and hip flexion power is 4/5. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Distal symmetric polyneuropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Herniated lumbar disc&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetic amyotrophy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Meralgia paresthetica&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diabetic amyotrophy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diabetic amyotrophy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diabetic amyotrophy presents with proximal pain and weakness in poorly controlled diabetes.&lt;/li&gt;&lt;li&gt;âž¤ Diabetic amyotrophy presents with proximal pain and weakness in poorly controlled diabetes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man presents with recurrent blistering lesions on the back of his hands, worsened by sunlight and alcohol. Examination shows hypopigmented scars and thickened skin. Urinary porphyrin levels are elevated. What is the most appropriate long-term treatment to prevent recurrence?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hydroxychloroquine 200 mg twice daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phlebotomy every 1â€“2 weeks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Topical corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Phlebotomy every 1â€“2 weeks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Phlebotomy every 1â€“2 weeks&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Phlebotomy is the first-line treatment for PCT to prevent recurrence.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old woman presents for an annual checkup with well-controlled hypertension on amlodipine. Examination reveals a firm 1.5 cm nodule in the right thyroid lobe, with normal TSH levels. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fine-needle aspiration biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Radionuclide thyroid scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diagnostic thyroid ultrasound&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repeat TSH measurement&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diagnostic thyroid ultrasound&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diagnostic thyroid ultrasound&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyroid ultrasound is the first step for evaluating palpable nodules with normal TSH.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 32-year-old man presents with type 1 diabetes mellitus requiring basal insulin therapy. Which insulin preparation has the longest duration of action to provide steady glucose control?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Insulin aspart&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulin glargine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Insulin lispro&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neutral Protamine Hagedorn (NPH)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Insulin glargine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Insulin glargine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Insulin glargine provides the longest-acting basal coverage for diabetes.&lt;/li&gt;&lt;li&gt;âž¤ Insulin glargine provides the longest-acting basal coverage for diabetes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman presents for a routine checkup. She asks about health conditions that disproportionately affect women. Which condition is notably more common as a cause of death in women than in men?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiovascular disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Suicide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Alzheimerâ€™s disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Alzheimerâ€™s disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alzheimerâ€™s disease is a leading cause of death in women due to longevity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man presents with bilateral ankle swelling and elevated blood pressure (164/90 mmHg). Labs reveal hypokalemia (Kâº 2.8 mmol/L) and normal creatinine. Examination shows pitting edema. What is the most appropriate initial investigation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT scan of the adrenal glands&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thyroid-stimulating hormone level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urine metanephrines&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plasma renin and aldosterone levels&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Plasma renin and aldosterone levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Plasma renin and aldosterone levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Plasma renin and aldosterone levels screen for primary hyperaldosteronism in hypokalemic hypertension.&lt;/li&gt;&lt;li&gt;âž¤ Plasma renin and aldosterone levels screen for primary hyperaldosteronism in hypokalemic hypertension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old man presents with delayed puberty and short stature. He received cranial radiation at age 8 for medulloblastoma. Examination shows prepubertal features. What is the most common hormonal abnormality in radiation-induced hypopituitarism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid-stimulating hormone deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adrenocorticotropic hormone deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Growth hormone deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Gonadotropin deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Growth hormone deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Growth hormone deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Growth hormone deficiency is the most common issue in radiation-induced hypopituitarism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man presents with fatigue, low libido, joint pain, and upper abdominal discomfort. He has type 2 diabetes, hyperlipidemia, hepatomegaly, testicular atrophy, and grayish skin discoloration. What is the most appropriate initial diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum ceruloplasmin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hepatic ultrasound&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HFE gene mutation testing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hepatitis B surface antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HFE gene mutation testing&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HFE gene mutation testing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ HFE gene testing confirms hemochromatosis in multisystem iron overload.&lt;/li&gt;&lt;li&gt;âž¤ HFE gene testing confirms hemochromatosis in multisystem iron overload.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman presents with osteoporosis and is started on denosumab to prevent bone loss. What molecule does denosumab directly inhibit to reduce bone resorption?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Insulin-like growth factor-1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parathyroid hormone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;RANK ligand&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. RANK ligand&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) RANK ligand&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Denosumab targets RANKL to treat osteoporosis by reducing bone resorption.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old woman presents with multiple long bone fractures since childhood, blue sclerae, yellowish teeth, and mild limb deformities. She is diagnosed with osteogenesis imperfecta. What is the most accurate statement about this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bone biopsy is required for diagnosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type I procollagen mutation is common&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bone mineral density is increased&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fractures increase after puberty&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Type I procollagen mutation is common&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Type I procollagen mutation is common&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ OI is caused by type I procollagen mutations and diagnosed clinically.&lt;/li&gt;&lt;li&gt;âž¤ OI is caused by type I procollagen mutations and diagnosed clinically.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man presents with muscle cramps and fatigue. Labs reveal low magnesium levels. Which condition is least likely to cause his hypomagnesemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic diarrhea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ethanol use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin D deficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypothyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Hypothyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypothyroidism does not cause hypomagnesemia, unlike diarrhea or ethanol use.&lt;/li&gt;&lt;li&gt;âž¤ Hypothyroidism does not cause hypomagnesemia, unlike diarrhea or ethanol use.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents with normal bone mass on densitometry and a serum 25-hydroxy-vitamin D level of 42 ng/mL. She is postmenopausal and asks about preventive measures for bone health. What is the recommended daily calcium intake for her?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;500 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;800 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1000 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1200 mg&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. 1200 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) 1200 mg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Postmenopausal women need 1200 mg daily calcium to prevent bone loss.&lt;/li&gt;&lt;li&gt;âž¤ Postmenopausal women need 1200 mg daily calcium to prevent bone loss.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 39-year-old woman presents with recurrent episodes of bilateral optic neuritis and transverse myelitis. MRI of the spine reveals longitudinally extensive lesions spanning four vertebral segments. Which autoantibody is most likely to be positive?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Double-stranded DNA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Myeloperoxidase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aquaporin-4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;tRNA synthetase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aquaporin-4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Aquaporin-4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-aquaporin-4 antibodies are diagnostic for NMOSD with optic neuritis and extensive myelitis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old man presents for a routine check-up and admits to drinking 3â€“4 alcoholic drinks daily on weekdays and over 10 on weekends. He reports occasional hangovers and one blackout but denies missing work or legal issues. Which laboratory marker best detects chronic heavy alcohol use?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AST:ALT ratio &amp;gt;2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbohydrate-deficient transferrin &amp;gt;2.6%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mean corpuscular volume &amp;gt;91 Î¼mÂ³&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum uric acid &amp;gt;7 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Carbohydrate-deficient transferrin &gt;2.6%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Carbohydrate-deficient transferrin &amp;gt;2.6%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CDT is the best marker for detecting chronic heavy alcohol use.&lt;/li&gt;&lt;li&gt;âž¤ CDT is the best marker for detecting chronic heavy alcohol use.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman presents with fatigue, muscle stiffness, and cramping for several months, along with weight gain and cold intolerance. Examination shows the finding below and serum creatine kinase is eight times the upper limit of normal. Which endocrine disorder is most likely causing her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary hyperaldosteronism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypothyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypothyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hypothyroidism presents with myopathy, elevated CK, and delayed reflexes.&lt;/li&gt;&lt;li&gt;âž¤ Hypothyroidism presents with myopathy, elevated CK, and delayed reflexes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;https://media.cerebellumacademy.com/media/public/question_media/question/video/84384/WhatsApp_Video_2025-06-13_at_12.09.06.mp4&quot;}, {&quot;text&quot;: &quot;A 55-year-old man presents with 7 months of progressive leg weakness, initially with tripping and foot drop, now with hand weakness and morning cramps. Examination reveals hyperreflexia in the legs, and extensor plantar reflexes. His tongue appearance is shown. What is the primary pathologic finding in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Demyelination of peripheral nerves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Autoantibody infiltration of motor endplates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Degeneration of corticospinal tracts and anterior horn cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inflammation of spinal roots&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Degeneration of corticospinal tracts and anterior horn cells&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Degeneration of corticospinal tracts and anterior horn cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ALS involves combined UMN and LMN degeneration, affecting corticospinal tracts and anterior horn cells.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;https://media.cerebellumacademy.com/media/public/question_media/question/video/84385/Tongue_fasciculations.mp4&quot;}, {&quot;text&quot;: &quot;A 5-year-old boy presents with delayed speech, poor eye contact, and repetitive hand movements. He is diagnosed with autism spectrum disorder. Which statement about the genetic basis of this condition is incorrect?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Most cases are caused by a single gene mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Monozygotic twins have higher concordance than dizygotic twins&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Risk genes often affect synaptic function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;First-degree relatives have increased risk&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Most cases are caused by a single gene mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Most cases are caused by a single gene mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ASD is polygenic, not monogenic, with high heritability.&lt;/li&gt;&lt;li&gt;âž¤ ASD is polygenic, not monogenic, with high heritability.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old man presents within 12 hours of left-sided hemiparesis and facial droop. Non-contrast CT brain shows no hemorrhage and CT angiography is negative for a large vessel occlusion. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dipyridamole&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ticagrelor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Aspirin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Aspirin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aspirin is the only antiplatelet proven for acute ischemic stroke within 48 hours.&lt;/li&gt;&lt;li&gt;âž¤ Aspirin is the only antiplatelet proven for acute ischemic stroke within 48 hours.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman presents with Parkinsonâ€™s disease and disabling hand tremors despite optimal levodopa therapy. She has no dementia or frequent falls. Which feature makes her a suitable candidate for deep brain stimulation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Severe gait freezing unresponsive to levodopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Moderate dementia affecting daily function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Severe tremor unresponsive to medications&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postural instability from orthostatic hypotension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Severe tremor unresponsive to medications&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Severe tremor unresponsive to medications&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ DBS is ideal for PD patients with severe, medication-resistant tremor without dementia.&lt;/li&gt;&lt;li&gt;âž¤ DBS is ideal for PD patients with severe, medication-resistant tremor without dementia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man presents with ongoing generalized tonic-clonic seizures for over 25 minutes despite receiving 8 mg IV lorazepam. He is intubated, with a fever of 39Â°C and heart rate of 150 bpm. Seizures recur after paralytic effects fade. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Re-dose neuromuscular blockade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer fosphenytoin 20 mg/kg IV&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start pentobarbital infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Initiate isoflurane anesthesia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Administer fosphenytoin 20 mg/kg IV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Administer fosphenytoin 20 mg/kg IV&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fosphenytoin is second-line for GCSE after benzodiazepines fail.&lt;/li&gt;&lt;li&gt;âž¤ Fosphenytoin is second-line for GCSE after benzodiazepines fail.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old man presents with recurrent migraines with aura, mood disturbances, and cognitive decline. His father had strokes and memory loss in his 40s. MRI is done and it is shown below. Which gene mutation is most likely responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CFTR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NOTCH3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dystrophin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transthyretin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. NOTCH3&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_95apcbZ.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) NOTCH3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NOTCH3 mutations cause CADASIL, presenting with early strokes and dementia.&lt;/li&gt;&lt;li&gt;âž¤ NOTCH3 mutations cause CADASIL, presenting with early strokes and dementia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 9-year-old girl presents with frequent episodes of staring blankly for several seconds, often with rapid blinking or chewing motions. These occur multiple times daily, especially when tired. Which finding is atypical for her?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rapid blinking&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lip smacking&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Postictal confusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Clonic hand movements&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Postictal confusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Postictal confusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Absence seizures lack postictal confusion, distinguishing them from other seizures. Image Cue : EEG with 3 Hz spike-and-wave pattern.&lt;/li&gt;&lt;li&gt;âž¤ Absence seizures lack postictal confusion, distinguishing them from other seizures. Image Cue : EEG with 3 Hz spike-and-wave pattern.&lt;/li&gt;&lt;li&gt;âž¤ Image Cue&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old woman presents with primary progressive multiple sclerosis and multiple relapses despite interferon Î² therapy. Her neurologist considers a monoclonal antibody that can be effective. Which agent is most appropriate?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dimethyl fumarate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fingolimod&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Natalizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ocrelizumab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Ocrelizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Ocrelizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ocrelizumab targets CD20 for effective MS management in refractory RRMS and PPMS cases.&lt;/li&gt;&lt;li&gt;âž¤ Ocrelizumab targets CD20 for effective MS management in refractory RRMS and PPMS cases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 33-year-old woman presents with 9 months of persistent fatigue, unrefreshing sleep, and difficulty concentrating. Extensive evaluation is unrevealing, leading to a diagnosis of chronic fatigue syndrome. Which intervention is most likely to improve her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acyclovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cognitive behavioral therapy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gabapentin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Venlafaxine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cognitive behavioral therapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cognitive behavioral therapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CBT is the most effective intervention for chronic fatigue syndrome.&lt;/li&gt;&lt;li&gt;âž¤ CBT is the most effective intervention for chronic fatigue syndrome.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man presents with stage 5 chronic kidney disease and is scheduled for an MRI with contrast. His nephrologist is concerned about a skin complication. What is the strongest risk factor for this complication?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Advanced age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diabetes mellitus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;eGFR &amp;lt; 30&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. eGFR &lt; 30&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) eGFR &amp;lt; 30&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ GFR &amp;lt;30 is the primary risk factor for NSF with gadolinium.&lt;/li&gt;&lt;li&gt;âž¤ GFR &amp;lt;30 is the primary risk factor for NSF with gadolinium.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man presents with personality changes, social inappropriateness, and memory decline over the past year. He made lewd comments at a family event and was aggressive at a club meeting. Mini-Mental State Examination score is 21/30, with brisk reflexes and a positive glabellar reflex. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dementia with Lewy bodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Frontotemporal dementia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Progressive supranuclear palsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Frontotemporal dementia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Frontotemporal dementia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ FTD presents with early behavioral changes and executive dysfunction.&lt;/li&gt;&lt;li&gt;âž¤ FTD presents with early behavioral changes and executive dysfunction.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old man presents with progressive weakness, stumbling due to left foot weakness, and difficulty gripping objects. His clinical findings are shown below. Family history reveals similar symptoms. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acid maltase deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Becker muscular dystrophy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myotonic dystrophy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Duchenne muscular dystrophy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Myotonic dystrophy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Myotonic dystrophy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myotonic dystrophy features myotonia, distal weakness, and hatchet facies.&lt;/li&gt;&lt;li&gt;âž¤ Myotonic dystrophy features myotonia, distal weakness, and hatchet facies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;https://media.cerebellumacademy.com/media/public/question_media/question/video/84396/mcqs_45.mp4&quot;}, {&quot;text&quot;: &quot;A 61-year-old man presents with rapidly progressive memory loss, myoclonus, ataxia, and visual disturbances over weeks. MRI is shown. What is the nature of the causative agent for his disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bacterial pathogen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DNA virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transmissible protein&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Environmental toxin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transmissible protein&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7P8Hq8L.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Transmissible protein&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CJD is caused by prions, transmissible proteins without nucleic acids.&lt;/li&gt;&lt;li&gt;âž¤ CJD is caused by prions, transmissible proteins without nucleic acids.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old woman presents with a burn on her right palm that she did not feel initially. Examination shows bilateral loss of pain and temperature sensation in a cape-like distribution over her neck and arms, with preserved touch and vibration. Reflexes are absent at biceps and triceps, with shoulder muscle wasting. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arteriovenous malformation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neoplastic spinal cord compression&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute combined degeneration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Syringomyelia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Syringomyelia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Syringomyelia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Syringomyelia presents with cape-like dissociated sensory loss and upper limb areflexia.&lt;/li&gt;&lt;li&gt;âž¤ Syringomyelia presents with cape-like dissociated sensory loss and upper limb areflexia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old woman presents with chest tightness, dizziness, and intense fear while shopping, resolving after 30 minutes. She is exhausted, with a heart rate of 110 bpm and respiratory alkalosis (pH = 7.51, PaCOâ‚‚ = 29 mmHg, A-a gradient = 9 mmHg). ECG shows sinus tachycardia. Her SpO2 and D-dimer levels are normal. What is the most appropriate next step for her suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start alprazolam immediately&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Reassure and monitor for recurrence&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Begin fluoxetine 10 mg daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Order CT pulmonary angiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Reassure and monitor for recurrence&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Reassure and monitor for recurrence&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old woman presents with recurrent headaches and seeks to differentiate migraines from tension-type headaches. Which symptom makes tension-type headache less likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilateral pain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pressing quality&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vomiting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mild intensity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vomiting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vomiting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vomiting is a migraine feature, not seen in tension-type headaches.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man presents 2.5 hours after sudden left hemiplegia and aphasia. NIHSS score is 18. CT shows no hemorrhage and CT angiography shows right M1 MCA occlusion. He has a history of recent ischemic stroke (3 weeks ago) and atrial fibrillation on apixaban. BP is 170/100 mmHg. What is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV alteplase alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV alteplase + mechanical thrombectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Defer thrombolysis, proceed with EVT only&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hold thrombolysis and EVT, start heparin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Defer thrombolysis, proceed with EVT only&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Defer thrombolysis, proceed with EVT only&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Apixaban and recent stroke contraindicate thrombolysis; EVT is preferred in eligible patients. ASPECTS of 6 suggests caution but does not rule out EVT within time windows. Rapid imaging (CTA) confirms LVO for EVT decision.&lt;/li&gt;&lt;li&gt;âž¤ Apixaban and recent stroke contraindicate thrombolysis; EVT is preferred in eligible patients.&lt;/li&gt;&lt;li&gt;âž¤ ASPECTS of 6 suggests caution but does not rule out EVT within time windows.&lt;/li&gt;&lt;li&gt;âž¤ Rapid imaging (CTA) confirms LVO for EVT decision.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman presents 2 hours after left facial droop and arm weakness (NIHSS 8). CT shows no hemorrhage, ASPECTS = 9. BP is 190/110 mmHg, and she has a history of recent TIA (10 days ago) and hypertension. What is the most appropriate initial step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV alteplase after Labetalol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mechanical thrombectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV alteplase without BP adjustment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defer both, start antihypertensives&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV alteplase after Labetalol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV alteplase after Labetalol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ BP must be controlled (&amp;lt;180/105 mmHg) before alteplase in hypertension. Recent TIA is a relative contraindication; assess risk-benefit. Rapid imaging and BP management are critical.&lt;/li&gt;&lt;li&gt;âž¤ BP must be controlled (&amp;lt;180/105 mmHg) before alteplase in hypertension.&lt;/li&gt;&lt;li&gt;âž¤ Recent TIA is a relative contraindication; assess risk-benefit.&lt;/li&gt;&lt;li&gt;âž¤ Rapid imaging and BP management are critical.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman presents with worsening weakness in the late afternoon, double vision, and a nasal voice. Examination shows the following finding (shown below). Which diagnostic test is most sensitive and specific for her suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Edrophonium test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acetylcholine receptor antibodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Muscle-specific kinase antibodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repetitive nerve stimulation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acetylcholine receptor antibodies&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TBJfIE8.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acetylcholine receptor antibodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ AChR antibodies are the most reliable test for myasthenia gravis.&lt;/li&gt;&lt;li&gt;âž¤ AChR antibodies are the most reliable test for myasthenia gravis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old man presents with heavy alcohol use and acute alcoholic hepatitis. On day 3 of admission, he develops agitation, tremors, fever (38.5Â°C), and disorientation. What is the most appropriate next step in managing this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start IV normal saline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administer IV diazepam 10â€“20 mg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Obtain urgent head CT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Begin broad-spectrum antibiotics&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Administer IV diazepam 10â€“20 mg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Administer IV diazepam 10â€“20 mg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IV diazepam is first-line for delirium tremens to control severe withdrawal.&lt;/li&gt;&lt;li&gt;âž¤ IV diazepam is first-line for delirium tremens to control severe withdrawal.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old woman presents with progressive visual disturbance and left leg weakness for 6 weeks, with reduced color vision in the right eye. She had eye pain 4 months ago. Examination shows spasticity, hyperreflexia, and optic disc swelling. Which investigation supports the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated CSF protein &amp;gt;100 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;T2-weighted MRI hyperintense lesions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T1-weighted MRI mass lesion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CSF polymorphonuclear cells&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. T2-weighted MRI hyperintense lesions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) T2-weighted MRI hyperintense lesions&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ T2 MRI lesions are diagnostic for MS with clinical correlation.&lt;/li&gt;&lt;li&gt;âž¤ T2 MRI lesions are diagnostic for MS with clinical correlation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old woman presents with pain radiating down her right arm and finger numbness in a dermatomal pattern, suggesting radiculopathy. Which condition is least likely to cause her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Herniated cervical disc&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diabetic radiculopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin B6 toxicity&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Vitamin B6 toxicity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Vitamin B6 toxicity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Vitamin B6 toxicity causes polyneuropathy, not radiculopathy.&lt;/li&gt;&lt;li&gt;âž¤ Vitamin B6 toxicity causes polyneuropathy, not radiculopathy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man presents with diabetes, dilated cardiomyopathy, and atrial fibrillation confirmed by ECG. He lives in a remote area with limited lab access. What is the most appropriate therapy to prevent stroke?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apixaban&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Electrical cardioversion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Apixaban&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Apixaban&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Apixaban is preferred for atrial fibrillation stroke prevention in remote settings.&lt;/li&gt;&lt;li&gt;âž¤ Apixaban is preferred for atrial fibrillation stroke prevention in remote settings.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman presents with short episodes of stabbing pain over her left cheek, triggered by chewing or touch, lasting about a minute. Examination shows pain with light facial touch but is otherwise normal. What is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brain MRI immediately&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carbamazepine 100 mg daily&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Microvascular decompression surgery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Temporal artery biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Carbamazepine 100 mg daily&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Carbamazepine 100 mg daily&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Carbamazepine is first-line for trigeminal neuralgia, started at low dose.&lt;/li&gt;&lt;li&gt;âž¤ Carbamazepine is first-line for trigeminal neuralgia, started at low dose.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 49-year-old woman presents with blurred vision, balance issues, and leg tingling, suggesting a demyelinating disorder. She also had the following finding one year ago. Which diagnostic study will be most helpful?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT head without contrast&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MRI brain and spinal cord&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Electroencephalogram&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carotid Doppler ultrasound&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MRI brain and spinal cord&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) MRI brain and spinal cord&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MRI is the first-line imaging for suspected demyelinating disorders.&lt;/li&gt;&lt;li&gt;âž¤ MRI is the first-line imaging for suspected demyelinating disorders.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;https://media.cerebellumacademy.com/media/public/question_media/question/video/84409/MCQs_58.mp4&quot;}, {&quot;text&quot;: &quot;A 62-year-old man presents with progressive movement difficulty, bradykinesia, cogwheel rigidity, and right-sided resting tremor. Which environmental factor is associated with reduced risk of his suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pesticide exposure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cigarette smoking&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Head trauma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Industrial solvent exposure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cigarette smoking&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cigarette smoking&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cigarette smoking is linked to lower Parkinsonâ€™s disease risk.&lt;/li&gt;&lt;li&gt;âž¤ Cigarette smoking is linked to lower Parkinsonâ€™s disease risk.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman presents with numbness, tingling, and burning in her feet and hands in a glove-and-stocking pattern due to poorly controlled type 2 diabetes for 15 years. Nerve conduction studies show reduced amplitude. Which statement about her diagnosis is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It is a rare cause of neuropathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tight glucose control reverses it fully&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diabetic nephropathy increases risk&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Autonomic symptoms appear late&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diabetic nephropathy increases risk&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diabetic nephropathy increases risk&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Diabetic nephropathy heightens neuropathy risk, glucose control prevents progression.&lt;/li&gt;&lt;li&gt;âž¤ Diabetic nephropathy heightens neuropathy risk, glucose control prevents progression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman is recovering from left knee arthroplasty. On POD#3, she develops progressive abdominal distension and bloating. She is passing minimal flatus, denies vomiting, and has no fever. Vitals: T 37Â°C, BP 138/82 mmHg, HR 108/min. On exam: her abdomen is markedly distended, tympanic, and non-tender; bowel sounds are absent. Abdominal Xray is shown. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acalculous cholecystitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Colonic pseudo-obstruction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perforated duodenal ulcer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Small bowel obstruction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Colonic pseudo-obstruction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_s6Dwi6n.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Colonic pseudo-obstruction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Elderly postoperative patients with painless, progressive colonic dilation and absent bowel sounds likely have Ogilvie syndrome. Prompt diagnosis and supportive management are crucial to avoid ischemic complications.&lt;/li&gt;&lt;li&gt;âž¤ Elderly postoperative patients with painless, progressive colonic dilation and absent bowel sounds likely have Ogilvie syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Prompt diagnosis and supportive management are crucial to avoid ischemic complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old man with a 4-year history of Crohn disease is evaluated for persistent symptoms. He was initially managed with budesonide and later required multiple prednisone tapers during flares. Over the past 4 months, he has been hospitalized twice for worsening abdominal pain and fever, requiring IV steroids and antibiotics. He denies perianal disease and is currently off steroids but remains symptomatic. What is the next best step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Begin IV cyclosporine A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Start regular azathioprine + infliximab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Use infliximab infusions only during flares&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start maintenance prednisone for 3 months&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Start regular azathioprine + infliximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_RaVTt6e.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Start regular azathioprine + infliximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Moderate to severe Crohnâ€™s with steroid dependence should transition to immunomodulators Â± biologics, not long-term steroids or on-demand biologics.&lt;/li&gt;&lt;li&gt;âž¤ Moderate to severe Crohnâ€™s with steroid dependence should transition to immunomodulators Â± biologics, not long-term steroids or on-demand biologics.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents with sudden, severe upper abdominal pain radiating to the back. He has known gallstones, no alcohol use. He is tachycardic, mildly distended, and tender in the epigastrium. Which of the following is not a diagnostic criterion for the suspected diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Confirmatory imaging changes&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Partial pressure of oxygen (PaOâ‚‚) &amp;lt;60 mmHg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum lipase or amylase elevated â‰¥3Ã— upper limit of normal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Severe epigastric pain radiating to the back&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Partial pressure of oxygen (PaOâ‚‚) &lt;60 mmHg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Partial pressure of oxygen (PaOâ‚‚) &amp;lt;60 mmHg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute pancreatitis diagnosis requires two of: clinical pain, high enzymes, or characteristic imaging. Hypoxemia is a severity marker, not a diagnostic feature.&lt;/li&gt;&lt;li&gt;âž¤ Acute pancreatitis diagnosis requires two of: clinical pain, high enzymes, or characteristic imaging.&lt;/li&gt;&lt;li&gt;âž¤ Hypoxemia is a severity marker, not a diagnostic feature.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old woman presents with upper abdominal pain, heartburn, and recent black, tarry stools. She takes no medications. Exam shows epigastric tenderness; stool occult blood is positive. Endoscopy reveals a 2.2 cm bleeding duodenal ulcer; biopsy confirms Helicobacter pylori. What is the most appropriate initial treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pantoprazole, amoxicillin, clarithromycin, metronidazole for 14 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Omeprazole, bismuth subsalicylate, tetracycline, metronidazole for 14 days&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lansoprazole, amoxicillin, clarithromycin for 14 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pantoprazole, amoxicillin for 14 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Omeprazole, bismuth subsalicylate, tetracycline, metronidazole for 14 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Omeprazole, bismuth subsalicylate, tetracycline, metronidazole for 14 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Bismuth Quadruple Therapy : First-line for H. pylori in high/unknown clarithromycin resistance (ACG 2017, Maastricht V), ideal for bleeding ulcers (eradication &amp;gt;90%). Bleeding Ulcer : Requires initial IV PPI (e.g., pantoprazole 80 mg bolus, 8 mg/h for 72 hours), then oral high-dose PPI (e.g., omeprazole 40 mg BID) for 4-8 weeks. Resistance : Clarithromycin-based regimens are suboptimal in high-resistance areas; bismuth-based therapy is preferred. Follow-Up : Confirm eradication with urea breath test or fecal antigen test 4-8 weeks post-treatment.&lt;/li&gt;&lt;li&gt;âž¤ Bismuth Quadruple Therapy : First-line for H. pylori in high/unknown clarithromycin resistance (ACG 2017, Maastricht V), ideal for bleeding ulcers (eradication &amp;gt;90%).&lt;/li&gt;&lt;li&gt;âž¤ Bismuth Quadruple Therapy&lt;/li&gt;&lt;li&gt;âž¤ Bleeding Ulcer : Requires initial IV PPI (e.g., pantoprazole 80 mg bolus, 8 mg/h for 72 hours), then oral high-dose PPI (e.g., omeprazole 40 mg BID) for 4-8 weeks.&lt;/li&gt;&lt;li&gt;âž¤ Bleeding Ulcer&lt;/li&gt;&lt;li&gt;âž¤ Resistance : Clarithromycin-based regimens are suboptimal in high-resistance areas; bismuth-based therapy is preferred.&lt;/li&gt;&lt;li&gt;âž¤ Resistance&lt;/li&gt;&lt;li&gt;âž¤ Follow-Up : Confirm eradication with urea breath test or fecal antigen test 4-8 weeks post-treatment.&lt;/li&gt;&lt;li&gt;âž¤ Follow-Up&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 57-year-old man reports 3 weeks of profuse, watery diarrhea (7â€“9 episodes daily) and an 8 kg unintentional weight loss. He denies fever, blood in stool, or recent travel. Exam is unremarkable. A 24-hour stool collection yields 520 g of stool. Stool osmolality: measured 205 mOsm/kg, calculated 215 mOsm/kg. His diarrhea persists despite fasting. What is the most likely underlying mechanism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic pancreatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lactase deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vasoactive intestinal peptide (VIP) tumor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Whipple disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Vasoactive intestinal peptide (VIP) tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Vasoactive intestinal peptide (VIP) tumor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Always rule out reversible causes such as pelvic floor or incontinence disorders before diagnosing psychiatric disease in elderly with social withdrawal and hygiene issues.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old man with chronic alcohol use presents after 2 days of worsening abdominal pain and vomiting following a heavy drinking episode. He has not eaten for 24 hours and feels dizzy when standing. On exam: tachycardic, appears dehydrated, epigastric and right upper quadrant tenderness with a clinical finding shown below. Which of the following is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Abdominal X-ray will show pancreatic calcification&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT scan will show necrotizing pancreatitis with intra-abdominal bleeding&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Endoscopic ultrasound will show a pancreatic mass&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;RUQ ultrasound will reveal acute cholecystitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CT scan will show necrotizing pancreatitis with intra-abdominal bleeding&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_LN1AJhn.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CT scan will show necrotizing pancreatitis with intra-abdominal bleeding&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Grey Turner sign in acute abdominal pain following alcohol binge points toward hemorrhagic necrotizing pancreatitis, confirmed on CT scan.&lt;/li&gt;&lt;li&gt;âž¤ Grey Turner sign in acute abdominal pain following alcohol binge points toward hemorrhagic necrotizing pancreatitis, confirmed on CT scan.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man presents with 5 months of progressive dysphagia to both liquids and solids. He describes food â€œstickingâ€ in the chest and frequent regurgitation of undigested food 30â€“60 minutes after meals. Heâ€™s lost 8 kg and recently had aspiration pneumonia. Barium swallow revelas the following finding shown in the image. What is the most likely underlying pathophysiology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diffuse spasm of esophageal smooth muscle&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infection with Trypanosoma cruzi&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Autoimmune degeneration of myenteric plexus ganglion cells&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenocarcinoma of the distal esophagus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Autoimmune degeneration of myenteric plexus ganglion cells&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MDL8p2e.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Autoimmune degeneration of myenteric plexus ganglion cells&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Primary achalasia is due to autoimmune destruction of myenteric inhibitory neurons, confirmed by â€œbird-beakâ€ sign on barium swallow.&lt;/li&gt;&lt;li&gt;âž¤ Primary achalasia is due to autoimmune destruction of myenteric inhibitory neurons, confirmed by â€œbird-beakâ€ sign on barium swallow.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 33-year-old man with a history of atopic dermatitis presents with 6 weeks of progressive dysphagia, especially to solid foods like bread and meat. He reports that food sometimes becomes lodged mid-chest and requires repeated sips of water to clear. Endoscopic appearance is shown. What is the most appropriate initial management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elimination diet&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Trial of proton pump inhibitor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Topical corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV methylprednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Trial of proton pump inhibitor&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_rQKu9q4.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Trial of proton pump inhibitor&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ First-line for EoE is a PPI trial; classic endoscopic findings include rings and furrows.&lt;/li&gt;&lt;li&gt;âž¤ First-line for EoE is a PPI trial; classic endoscopic findings include rings and furrows.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old man with chronic alcohol dependence is admitted for confusion and agitation after being found disoriented and wandering outdoors. He is being treated with IV dextrose for hypoglycemia and lorazepam for withdrawal. Exam: awake but disoriented, horizontal nystagmus, impaired coordination, wide-based gait, and reduced sensation in legs. He has paranoid delusions. What is the most likely cause of his current symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Niacin deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thiamine deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Undertreated alcohol withdrawal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyponatremia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Thiamine deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Thiamine deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Classic Wernicke-Korsakoff syndrome in alcoholicsâ€”always give thiamine before glucose to prevent neurologic injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with decompensated cirrhosis (due to chronic HBV + alcohol) presents with recurrent tense ascites, requiring frequent paracenteses. He is currently not on diuretics. Renal function and serum sodium is normal. Which is not appropriate in initial medical management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start furosemide 40 mg daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Restrict fluid intake to &amp;lt;2 L/day&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Begin sodium restriction to &amp;lt;2 g/day&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start spironolactone 100 mg daily&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Restrict fluid intake to &lt;2 L/day&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Restrict fluid intake to &amp;lt;2 L/day&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Do not restrict fluids in cirrhotic ascites unless there is significant hyponatremia.&lt;/li&gt;&lt;li&gt;âž¤ Do not restrict fluids in cirrhotic ascites unless there is significant hyponatremia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 38-year-old woman with a 3-year history of ulcerative colitis presents with 2 weeks of severe abdominal pain, &amp;gt;10 bloody stools/day, fever, and tachycardia. On exam: diffuse abdominal tenderness, mild distension, and guarding. Laboratory studies reveal anemia, leukocytosis, and elevated CRP. Abdominal Xray is shown. What is the first line treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV methylprednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urgent Surgery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Infliximab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV methylprednisolone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Bc781b5.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV methylprednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objectives:&lt;/li&gt;&lt;li&gt;âž¤ ASUC : &amp;gt;6 bloody stools/day, systemic signs (fever, tachycardia), and lab abnormalities. Toxic megacolon indicated by colonic dilatation. First-Line : IV methylprednisolone for rapid control of ASUC/toxic megacolon. Management : Hospitalize, give IV fluids, antibiotics if infection suspected. Assess steroid response in 3-5 days. Escalation : Infliximab or cyclosporine if steroids fail; surgery for refractory cases.&lt;/li&gt;&lt;li&gt;âž¤ ASUC : &amp;gt;6 bloody stools/day, systemic signs (fever, tachycardia), and lab abnormalities. Toxic megacolon indicated by colonic dilatation.&lt;/li&gt;&lt;li&gt;âž¤ ASUC&lt;/li&gt;&lt;li&gt;âž¤ First-Line : IV methylprednisolone for rapid control of ASUC/toxic megacolon.&lt;/li&gt;&lt;li&gt;âž¤ First-Line&lt;/li&gt;&lt;li&gt;âž¤ Management : Hospitalize, give IV fluids, antibiotics if infection suspected. Assess steroid response in 3-5 days.&lt;/li&gt;&lt;li&gt;âž¤ Management&lt;/li&gt;&lt;li&gt;âž¤ Escalation : Infliximab or cyclosporine if steroids fail; surgery for refractory cases.&lt;/li&gt;&lt;li&gt;âž¤ Escalation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old man presents with repeated episodes of hematemesis and melena. He has a history of chronic hepatitis B. On exam, he is hypotensive, tachycardic, and has a distended abdomen with shifting dullness. Upper GI endoscopic appearance is shown below. What is the next best step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Immediate variceal band ligation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV proton pump inhibitor infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start prophylactic nonselective beta-blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Emergency transjugular intrahepatic portosystemic shunt (TIPS)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Immediate variceal band ligation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dM7UedG.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Immediate variceal band ligation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute esophageal variceal bleeding requires urgent endoscopic therapy, typically band ligation.&lt;/li&gt;&lt;li&gt;âž¤ Acute esophageal variceal bleeding requires urgent endoscopic therapy, typically band ligation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man presents with jaundice, pruritus, and dark urine. He reports pale stools and 8 kg weight loss over 3 months. On exam: painless jaundice, palpable gallbladder, and mild epigastric tenderness. Laboratory studies show elevated conjugated bilirubin, high ALP, mild transaminase elevation, and CA 19-9 of 425 U/mL (normal 0-37). What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ultrasound of the abdomen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ERCP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CECT abdomen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MRCP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CECT abdomen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) CECT abdomen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ USG is often the initial imaging for undifferentiated jaundice to assess biliary obstruction or liver pathology. USG is less sensitive for pancreatic masses. In suspected pancreatic cancer (painless jaundice, weight loss, Courvoisierâ€™s sign, elevated CA 19-9), CECT abdomen is the first-line imaging for diagnosis and staging.&lt;/li&gt;&lt;li&gt;âž¤ USG is often the initial imaging for undifferentiated jaundice to assess biliary obstruction or liver pathology. USG is less sensitive for pancreatic masses.&lt;/li&gt;&lt;li&gt;âž¤ In suspected pancreatic cancer (painless jaundice, weight loss, Courvoisierâ€™s sign, elevated CA 19-9), CECT abdomen is the first-line imaging for diagnosis and staging.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 53-year-old woman is admitted for confusion, asterixis, and drowsiness. She has a history of cirrhosis due to MASH and was recently started on furosemide for edema. On exam- jaundice, ascites, bilateral pitting edema. She also has the finding shown in the video below. Serum ammonia is elevated, serum sodium is 127 mmol/L and serum potassium is 3.0 mmol/L. What is the most likely precipitating factor for her current condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Initiation of furosemide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Spontaneous bacterial peritonitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;GI bleeding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypovolemia due to vomiting&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Initiation of furosemide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Initiation of furosemide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cirrhotics, initiation or escalation of diuretics often precipitates hepatic encephalopathy by inducing hypokalemia and hyponatremia.&lt;/li&gt;&lt;li&gt;âž¤ In cirrhotics, initiation or escalation of diuretics often precipitates hepatic encephalopathy by inducing hypokalemia and hyponatremia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;https://media.cerebellumacademy.com/media/public/question_media/question/video/84425/Asterixis.mp4&quot;}, {&quot;text&quot;: &quot;A 28-year-old man presents with 4 weeks of watery diarrhea, abdominal bloating, and weight loss. He has no recent travel. Exam: mild pallor, glossitis, and a rash as shown in the image below. Labs: hemoglobin 10.4 g/dL (MCV 105 fL), platelets normal, iron low, folate low, tissue transglutaminase IgA positive. What is the most likely cause of his skin findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pellagra due to niacin deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dermatitis herpetiformis due to celiac disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron deficiency anemia due to hookworm infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Psoriasis due to chronic malabsorption&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dermatitis herpetiformis due to celiac disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JFaEfNx.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dermatitis herpetiformis due to celiac disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dermatitis herpetiformis is the pathognomonic skin manifestation of celiac disease and resolves with a gluten-free diet.&lt;/li&gt;&lt;li&gt;âž¤ Dermatitis herpetiformis is the pathognomonic skin manifestation of celiac disease and resolves with a gluten-free diet.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman is admitted with acute upper abdominal pain, fever, and hypotension. She is known to have gallstones but no prior episodes. Exam: T 38.9Â°C, BP 84/58 mmHg, HR 122/min, jaundiced, right upper quadrant tenderness with a positive Murphyâ€™s sign. Labs: ALT 130 U/L, AST 145 U/L, ALP 210 U/L, total bilirubin 4.8 mg/dL, WBC 21,000/Î¼L. Abdominal ultrasound shows a dilated common bile duct with an echogenic material. What is the next best step in her management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRCP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ERCP&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repeat USG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urgent laparotomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. ERCP&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) ERCP&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute Cholangitis is diagnosed by Charcotâ€™s triad (fever, jaundice, right upper quadrant pain) plus lab/imaging evidence. Severe if organ dysfunction (e.g., hypotension). ERCP for urgent biliary decompression in severe cholangitis due to choledocholithiasis. Initiate IV antibiotics (e.g., ceftriaxone + metronidazole), fluids, and stabilize before ERCP. Cholecystectomy post-ERCP to prevent recurrent gallstone complications.&lt;/li&gt;&lt;li&gt;âž¤ Acute Cholangitis is diagnosed by Charcotâ€™s triad (fever, jaundice, right upper quadrant pain) plus lab/imaging evidence.&lt;/li&gt;&lt;li&gt;âž¤ Severe if organ dysfunction (e.g., hypotension).&lt;/li&gt;&lt;li&gt;âž¤ ERCP for urgent biliary decompression in severe cholangitis due to choledocholithiasis. Initiate IV antibiotics (e.g., ceftriaxone + metronidazole), fluids, and stabilize before ERCP.&lt;/li&gt;&lt;li&gt;âž¤ Cholecystectomy post-ERCP to prevent recurrent gallstone complications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man presents with worsening fatigue, pruritus, and jaundice. On exam, he has scleral icterus, hepatomegaly, and excoriations over his arms. Labs: ALP 515 U/L, total bilirubin 7.8 mg/dL, AST 92 U/L, ALT 75 U/L. MRCP is done and shown below. Which of the following is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AMA testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ANA and SMA testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Colonoscopy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Screen for HBV and HCV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Colonoscopy&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_uLJLXZ1.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Colonoscopy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PSC is suspected with cholestatic liver tests (elevated ALP, bilirubin) and MRCP showing biliary strictures/dilatations. Colonoscopyis used to screen for IBD (especially UC), present in ~70-80% of PSC patients. PSC patients require lifelong colorectal cancer surveillance due to increased risk. Ursodeoxycholic acid may be considered; ERCP and stenting can be done for dominant strictures; monitor for cholangiocarcinoma.&lt;/li&gt;&lt;li&gt;âž¤ PSC is suspected with cholestatic liver tests (elevated ALP, bilirubin) and MRCP showing biliary strictures/dilatations.&lt;/li&gt;&lt;li&gt;âž¤ Colonoscopyis used to screen for IBD (especially UC), present in ~70-80% of PSC patients.&lt;/li&gt;&lt;li&gt;âž¤ PSC patients require lifelong colorectal cancer surveillance due to increased risk.&lt;/li&gt;&lt;li&gt;âž¤ Ursodeoxycholic acid may be considered; ERCP and stenting can be done for dominant strictures; monitor for cholangiocarcinoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 29-year-old woman presents with a 2-month history of fatigue, vague RUQ discomfort, and mild jaundice. She has no history of alcohol use. Labs: AST 195 U/L, ALT 228 U/L, ALP 96 U/L, total bilirubin 3.2 mg/dL, ANA positive, anti-smooth muscle antibody positive, and elevated IgG. Virals erologies are negative. What is the first line management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ursodeocycholic acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sofosbuvir + Velpatasvir&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Prednisolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Prednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ AIH can be suspected with elevated transaminases, positive ANA/anti-smooth muscle antibody, elevated IgG, and negative viral serologies. Prednisolone is the first line to induce remission, often combined with azathioprine for maintenance.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 37-year-old man presents with 6 weeks of jaundice and pruritus. Labs: total bilirubin 9.1 mg/dL, ALP 430 U/L, ALT 66 U/L, AST 75 U/L. Patient denies any drug use in the last several months. Examination shows the finding shown in the image below. Ultrasound of the abdomen is normal. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRCP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AMA testing&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ANA and SMA testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. AMA testing&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ssLqWcn.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) AMA testing&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PBC is suspected with cholestatic liver tests (elevated ALP, bilirubin), pruritus, xanthelasma, and normal ultrasound. AMA testing to confirm PBC. Can give Ursodeoxycholic acid if PBC is confirmed.&lt;/li&gt;&lt;li&gt;âž¤ PBC is suspected with cholestatic liver tests (elevated ALP, bilirubin), pruritus, xanthelasma, and normal ultrasound.&lt;/li&gt;&lt;li&gt;âž¤ AMA testing to confirm PBC.&lt;/li&gt;&lt;li&gt;âž¤ Can give Ursodeoxycholic acid if PBC is confirmed.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman presents with new-onset ascites and abdominal distension. On exam: no jaundice or hepatomegaly. Paracentesis reveals the following: Albumin = 3.1 g/dL, total protein = 3.2 g/dL. Serum albumin is 3.5 g/dL. Which of the following best explains her findings?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Portal hypertension due to cirrhosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peritoneal carcinomatosis due to metastatic disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nephrotic syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Peritoneal carcinomatosis due to metastatic disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Peritoneal carcinomatosis due to metastatic disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SAAG &amp;lt;1.1 g/dL indicates non-portal hypertension causes (e.g., malignancy, infection); SAAG â‰¥1.1 g/dL suggests portal hypertension (e.g., cirrhosis).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with malaise, nausea, and jaundice. Labs: ALT 890 U/L, AST 776 U/L, total bilirubin = 6.3 mg/dL. Serology: HBsAg negative, anti-HBc IgM positive, anti-HBs negative. What is the most likely explanation for this pattern?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Resolved hepatitis B infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Window Period&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic hepatitis B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vaccinated against hepatitis B&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Window Period&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Window Period&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-HBc IgM alone positive = window period of acute hepatitis B.&lt;/li&gt;&lt;li&gt;âž¤ Anti-HBc IgM alone positive = window period of acute hepatitis B.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 44-year-old man with chronic hepatitis B presents for evaluation. Serology: HBsAg positive, HBeAg negative, anti-HBc positive, HBV DNA undetectable, ALT normal. What is the best management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Start tenofovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Observe and monitoring&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start pegylated interferon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immediate liver biopsy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Observe and monitoring&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Observe and monitoring&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Inactive carrier state requires monitoring, not immediate therapy.&lt;/li&gt;&lt;li&gt;âž¤ Inactive carrier state requires monitoring, not immediate therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 12-year-old boy presents with recurrent episodes of severe limb pain, especially after physical exertion or exposure to cold. He has scleral icterus, mild splenomegaly, and a history of anemia. Labs: Hemoglobin 8.4 g/dL, MCV 76 fL, indirect bilirubin elevated, LDH elevated. Peripheral smear is shown. What is the most likely reason for his disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Frameshift mutation in the Î±-globin gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Substitution of valine for glutamic acid at position 6 in Î²-globin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Deletion of one Î²-globin gene&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Point mutation causing loss of heme synthesis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Substitution of valine for glutamic acid at position 6 in Î²-globin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_HQTSXTA.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Substitution of valine for glutamic acid at position 6 in Î²-globin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell disease results from a specific Î²-globin point mutation (Gluâ†’Val, position 6).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old man develops sudden dark urine, jaundice, and anemia after taking cotrimoxazole for a skin infection. Labs: Hemoglobin 8 g/dL (previous 13), indirect bilirubin 3.2 mg/dL, reticulocytosis. Peripheral smear is shown. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;G6PD deficiency&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hereditary spherocytosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Warm autoimmune hemolytic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î²-thalassemia trait&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. G6PD deficiency&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_2Cm2u3t.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) G6PD deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ G6PD deficiency causes bite cells and hemolysis after oxidative stress (drugs, infection, fava beans).&lt;/li&gt;&lt;li&gt;âž¤ G6PD deficiency causes bite cells and hemolysis after oxidative stress (drugs, infection, fava beans).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 61-year-old man presents for a routine checkup. He has a history of smoking 1.5 packs per day for 30 years and quit smoking 7 years ago. He is asymptomatic and wants to reduce his risk of dying from lung cancer. Which of the following is the most appropriate recommendation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Annual chest x-ray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Annual low-dose CT scan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Genetic screening for lung cancer risk&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Daily vitamin E supplementation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Annual low-dose CT scan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_z4gQRmI.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Annual low-dose CT scan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Annual low-dose CT is the evidence-based screening method for reducing lung cancer mortality in patients with a significant smoking history.&lt;/li&gt;&lt;li&gt;âž¤ Annual low-dose CT is the evidence-based screening method for reducing lung cancer mortality in patients with a significant smoking history.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old woman presents to clinic after completing 6 weeks of treatment for newly diagnosed multiple myeloma. She was initially diagnosed after presenting with fatigue, hypercalcemia, and lytic lesions in her lumbar spine. Her symptoms have improved with therapy, and she now asks how her response to treatment can be monitored going forward. Which of the following is the best method to assess treatment response?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Complete blood count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FDG-PET scan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum lactate dehydrogenase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum monoclonal immunoglobulin level&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum monoclonal immunoglobulin level&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_b6fmHvi.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Serum monoclonal immunoglobulin level&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In multiple myeloma, serum monoclonal immunoglobulin levels are the most reliable way to assess treatment response and disease progression.&lt;/li&gt;&lt;li&gt;âž¤ In multiple myeloma, serum monoclonal immunoglobulin levels are the most reliable way to assess treatment response and disease progression.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 20-year-old competitive swimmer presents with sudden-onset fatigue and left upper abdominal pain. Two days ago, she was treated for presumed gonorrhea with intramuscular ceftriaxone and oral azithromycin. Examination shows mild tachycardia and a palpable spleen. Labs reveal: Hemoglobin: 5.2 g/dL, WBC and platelets: Normal. Peripheral smear is shown below. Which of the following tests is most likely to confirm the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ADAMTS-13 activity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Direct antiglobulin (Coombs) test&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;G6PD enzyme assay&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemoglobin electrophoresis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Direct antiglobulin (Coombs) test&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_zBMmwUX.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xV2YRNn.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Direct antiglobulin (Coombs) test&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ AIHA is diagnosed with the direct antiglobulin test, especially in the setting of recent drug exposure and presence of spherocytes on smear.&lt;/li&gt;&lt;li&gt;âž¤ AIHA is diagnosed with the direct antiglobulin test, especially in the setting of recent drug exposure and presence of spherocytes on smear.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old fitness trainer presents with increasing fatigue over 3 months. He has no past medical history and follows a strict vegan diet, avoiding iron supplements and fortified foods. Exam is unremarkable. Labs: Hemoglobin: 10.4 g/dL, MCV: 72 fL, Serum iron: 27 Î¼g/dL, Ferritin: 12 Î¼g/L, TIBC: 420 Î¼g/dL. What is the most appropriate next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin B12 supplementation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Iron supplementation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Folic acid supplementation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment of underlying inflammation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Iron supplementation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Iron supplementation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oral iron is first-line therapy for dietary iron deficiency anemia.&lt;/li&gt;&lt;li&gt;âž¤ Oral iron is first-line therapy for dietary iron deficiency anemia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old man presents with fatigue, bruising, and intermittent fevers for the past 3 weeks. Examination reveals pallor, petechiae on the lower limbs, and mild hepatosplenomegaly. CBC shows pancytopenia. Peripheral smear reveals blasts. Bone marrow biopsy confirms acute lymphoblastic leukemia (ALL). CNS examination is pending. Which of the following statements is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BCR-ABL1 of Ph-like ALL has increasing frequency with age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients with Down syndrome are at increased risk of developing AML but not ALL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lumbar puncture is an essential diagnostic measure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most adult ALLs are of T-cell origin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lumbar puncture is an essential diagnostic measure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_kW9HkRB.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Lumbar puncture is an essential diagnostic measure&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CNS involvement is common in ALL and should always be evaluated with lumbar puncture to guide therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man comes to the emergency department with sudden-onset drooping of the right eyelid and blurred vision. He reports several months of right shoulder and arm pain as well. He has a long history of smoking and COPD. On examination, he has right-sided ptosis and miosis, but full extraocular movements. The right hand shows wasting of the intrinsic muscles. Chest auscultation is clear. Which of the following findings is most likely responsible for his symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metastatic lesions in the midbrain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Paraneoplastic syndrome with antibodies to voltage-gated calcium channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right apical pleural thickening with a mass-like density&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Superior vena cava obstruction from mediastinal lymphadenopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right apical pleural thickening with a mass-like density&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DG1JoAo.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Right apical pleural thickening with a mass-like density&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pancoast tumors should be suspected in smokers presenting with shoulder pain, Horner syndrome, and hand muscle wasting. Chest imaging often shows right apical pleural thickening or a mass.&lt;/li&gt;&lt;li&gt;âž¤ Pancoast tumors should be suspected in smokers presenting with shoulder pain, Horner syndrome, and hand muscle wasting. Chest imaging often shows right apical pleural thickening or a mass.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old man with a newly diagnosed high-grade colon carcinoma is undergoing molecular profiling of the tumor. The oncology team discusses common genetic alterations that drive tumorigenesis and aid treatment planning. Which of the following is least likely to be found as a driver mutation in cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aneuploidy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Epigenetic modifications&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Indels in oncogenes&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Point mutations in oncogenes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Indels in oncogenes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_XMuVCme.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Indels in oncogenes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Oncogenes are most often activated by specific point mutations, while tumor suppressor genes undergo loss-of-function through indels, deletions, or epigenetic silencing.&lt;/li&gt;&lt;li&gt;âž¤ Oncogenes are most often activated by specific point mutations, while tumor suppressor genes undergo loss-of-function through indels, deletions, or epigenetic silencing.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old man came to your OPD for a routine MHC. He is a non-smoker, drinks occasionally, and has no major medical history. Exam revelas a palpable spleen and BP of 142/88 mmHg. Labs: Hemoglobin: 19.8 g/dL, Hematocrit: 58%, WBC: 14,800/Î¼L, Platelets: 460,000/Î¼L, SpOâ‚‚: 96% on room air. What is the recommended first line treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydroxyurea&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Imatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phlebotomy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Phlebotomy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Phlebotomy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Phlebotomy is first-line therapy in low-risk PV to control hematocrit and reduce thrombosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old retired teacher is evaluated after routine blood tests reveal a high total protein. He feels well and reports no symptoms. Labs: creatinine 1.0 mg/dL, calcium 9.8 mg/dL, albumin 4.1 g/dL, hemoglobin 12.8 g/dL. Further testing shows serum monoclonal IgG (3.1 g/dL) and bone marrow with 15% clonal plasma cells. What is the next best step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Begin dexamethasone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Begin lenalidomide plus dexamethasone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Perform a PET-CT scan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Annual labs and monitoring only&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Perform a PET-CT scan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_5Gx8LJr.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Perform a PET-CT scan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Imaging (PET-CT or MRI) is essential to distinguish smoldering from active myeloma before treatment or observation.&lt;/li&gt;&lt;li&gt;âž¤ Imaging (PET-CT or MRI) is essential to distinguish smoldering from active myeloma before treatment or observation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old man receiving unfractionated heparin for pulmonary embolism develops a platelet drop from 160,000/Î¼L to 85,000/Î¼L on day 6 of treatment. He has no bleeding but complains of mild right leg pain and swelling. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Continue heparin and wait for antibody test results&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stop heparin and withhold all anticoagulation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stop heparin and start Argatroban&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stop heparin and start enoxaparin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Stop heparin and start Argatroban&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4Km2XMp.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Stop heparin and start argatroban&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When HIT is suspected, stop all heparin and switch to a non-heparin anticoagulant such as argatroban immediately.&lt;/li&gt;&lt;li&gt;âž¤ When HIT is suspected, stop all heparin and switch to a non-heparin anticoagulant such as argatroban immediately.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following risk factors is associated with both adenocarcinoma and squamous cell carcinoma of the esophagus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Barrett esophagus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic gastroesophageal reflux disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cigarette smoking&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lye ingestion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cigarette smoking&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_7dAZOqW.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Cigarette smoking&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cigarette smoking increases the risk of both squamous cell and adenocarcinoma of the esophagus and is a key modifiable risk factor for esophageal cancer.&lt;/li&gt;&lt;li&gt;âž¤ Cigarette smoking increases the risk of both squamous cell and adenocarcinoma of the esophagus and is a key modifiable risk factor for esophageal cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 63-year-old man undergoing chemotherapy with paclitaxel and carboplatin for stage IIIB lung adenocarcinoma presents with a fever of 38.3Â°C. There is erythema near the catheter reported by ICU staff nurse (shown in the image below). Blood cultures are negative at 48 hours, neutrophil count is 1550/Î¼L. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Removal of catheter&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Treatment with ceftazidime and vancomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Treatment with topical antibiotics at the catheter site&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Treatment with vancomycin alone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Treatment with vancomycin alone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_OQUKVEs.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_MKkIYCk.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Treatment with vancomycin alone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In non-neutropenic patients with a tunneled catheter and localized exit-site infection, vancomycin alone is appropriate initial therapy.&lt;/li&gt;&lt;li&gt;âž¤ In non-neutropenic patients with a tunneled catheter and localized exit-site infection, vancomycin alone is appropriate initial therapy.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 64-year-old man presents with 3 weeks of progressive fatigue, gingival bleeding, and easy bruising. Exam reveals pallor, splenomegaly, and scattered ecchymoses. Labs: pancytopenia, elevated D-dimer, and prolonged PT and aPTT. Peripheral smear is shown. Which of the following agents is most specific to the initial management of this patientâ€™s disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acyclovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Daunorubicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tretinoin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Tretinoin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_d508Fc8.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Tretinoin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In APL tretinoin is the key, disease-specific treatment.&lt;/li&gt;&lt;li&gt;âž¤ In APL tretinoin is the key, disease-specific treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 56-year-old woman undergoes a haplo-identical bone marrow transplant for poor-risk acute myeloid leukemia. Which of the following is most likely to occur within the first 30 days after bone marrow transplantation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspergillus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Candida&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytomegalovirus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Encapsulated bacteria&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Candida&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KlXOWUE.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_4q6L61r.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Candida&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the early phase postâ€“bone marrow transplant (first 30 days), patients are most vulnerable to infections like Candida due to neutropenia and mucosal injury.&lt;/li&gt;&lt;li&gt;âž¤ In the early phase postâ€“bone marrow transplant (first 30 days), patients are most vulnerable to infections like Candida due to neutropenia and mucosal injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old man is admitted for induction chemotherapy for newly diagnosed acute lymphoblastic leukemia. Which of the following is not routinely recommended in the prevention of tumor lysis syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of allopurinol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Avoidance urinary alkalinization&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Frequent monitoring of serum chemistries&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prophylactic hemodialysis prior to chemotherapy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prophylactic hemodialysis prior to chemotherapy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_tYZwQTL.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Prophylactic hemodialysis prior to chemotherapy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Routine TLS prophylaxis includes hydration, uric acid control, and electrolyte monitoring. Prophylactic dialysis is not indicated unless renal failure is already present.&lt;/li&gt;&lt;li&gt;âž¤ Routine TLS prophylaxis includes hydration, uric acid control, and electrolyte monitoring. Prophylactic dialysis is not indicated unless renal failure is already present.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most significant risk factor for cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Family history&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tobacco&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Age&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_Cibanr6.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Age&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test11" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine Neet Pg Revision E&amp;amp;D   30 11 2023   2023 11 30&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine Neet Pg Revision E&amp;amp;D   30 11 2023   2023 11 30&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;MDR tuberculosis shows resistance to which of the following drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid, rifampicin, and fluoroquinolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluoroquinolones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isoniazid and rifampicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isoniazid, rifampicin, and kanamycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Isoniazid and rifampicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Isoniazid and rifampicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is not seen in MEN 2B syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Megacolon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Parathyroid adenoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mucosal neuroma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Marfanoid habitus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Parathyroid adenoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Parathyroid adenoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ parathyroid adenomas are not part of the MEN 2B syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The cerebrospinal fluid (CSF) specimen of a patient is shown below along with the microscopy. The report shows mononuclear cytosis, elevated proteins, and low sugars. Which of the following is the likely etiology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tuberculous meningitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aseptic meningitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bacterial meningitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chemical meningitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Tuberculous meningitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture1_n0UdHQm.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Tuberculous meningitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ tuberculous meningitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with Ebsteinâ€™s anomaly presented with arrhythmia. What is the long-term management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radiofrequency Ablation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AV nodal ablation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Verapamil&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Radiofrequency Ablation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Radiofrequency Ablation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Radiofrequency ablation (RFA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dL and the presence of ketone bodies. What is the next best step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous fluids with S.C. long-acting insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous fluids with S.C. regular insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous insulin I.V. long-acting insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous fluids with I.V. regular insulin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Intravenous fluids with I.V. regular insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Intravenous fluids with I.V. regular insulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ IV fluids&lt;/li&gt;&lt;li&gt;âž¤ IV regular insulin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;patient with retro-positive status was started on 2nd line highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD4+ T cell count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Viral load&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;p24 antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Viral serotype&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Viral load&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Viral load&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Viral load&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following would most likely lead to a decrease in the intensity of the murmur in a patient with hypertrophic cardiomyopathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Squatting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valsalva&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Squatting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Squatting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ increase preload or afterload&lt;/li&gt;&lt;li&gt;âž¤ squatting&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a history of hypertension, type 2 diabetes mellitus, and dyslipidemia is brought to the ER because of reports of palpitations and dizziness. The ECG is shown in the image. His temperature is 36.8Â°C, pulse rate is 106/min, respiratory rate is 18/min, blood pressure is 84/46 mm Hg, and SpO2 is 92% on room air. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DC shock&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. DC shock&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture2_RfyvqT3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) DC shock&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ hemodynamically unstable&lt;/li&gt;&lt;li&gt;âž¤ synchronized direct current (DC) cardioversion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the best drug for acute management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flunarizine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sumatriptan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sumatriptan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Sumatriptan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ acute management&lt;/li&gt;&lt;li&gt;âž¤ sumatriptan&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with a history of dyslipidemia, hypertension, and aortic sclerosis presents to the emergency department with chest pain. He took 3 NTG tablets with no relief. His vitals are stable, and cardiac enzymes were normal. An ECG on admission is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;STEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NSTEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stable Angina&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unstable Angina&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Unstable Angina&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture3_FxCJbsX.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Unstable Angina&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Unstable angina&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A hypertensive patient who is non-compliant with medication presents to you with sudden onset breathlessness. A chest X-ray was done, which is shown below. How will you manage this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous nitroglycerin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nebulization with salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxygen and antibiotics&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous nitroglycerin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture1_baZ6yz3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Intravenous nitroglycerin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ intravenous nitroglycerin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient collapsed and was brought to the casualty with no proper history. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Check for responsiveness&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secure airway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Shock: 300J&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Check for carotid pulse&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Check for responsiveness&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Check for responsiveness&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Basic Life Support (BLS)&lt;/li&gt;&lt;li&gt;âž¤ check for responsiveness&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the strongest predictor of cardiovascular disease incidence and subsequent mortality due to CVD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TC/HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;hsCRP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. LDL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) LDL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Elevated LDL levels&lt;/li&gt;&lt;li&gt;âž¤ cardiovascular disease incidence&lt;/li&gt;&lt;li&gt;âž¤ primary&lt;/li&gt;&lt;li&gt;âž¤ secondary&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on antidepressants presented to you with hypotension. An ECG was done, which showed wide QRS complexes and right axis deviation. How will you manage this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antiarrhythmics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV NaHCO3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IV NaHCO3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) IV NaHCO3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ tricyclic antidepressant toxicity&lt;/li&gt;&lt;li&gt;âž¤ wide QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ intravenous sodium bicarbonate (NaHCO3)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents to you with fever, night sweats, ptosis, and bilateral facial nerve palsy. Investigations showed leukocytosis and bilateral hilar lymphadenopathy. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypersensitive pneumonitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sarcoidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sarcoidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Sarcoidosis&lt;/li&gt;&lt;li&gt;âž¤ bilateral hilar lymphadenopathy&lt;/li&gt;&lt;li&gt;âž¤ fever&lt;/li&gt;&lt;li&gt;âž¤ night sweats&lt;/li&gt;&lt;li&gt;âž¤ facial nerve palsy&lt;/li&gt;&lt;li&gt;âž¤ granulomatous disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presented with chest pain and was noted to have 2 mm of ST-segment elevation in his inferior leads. He has a systolic blood pressure (SBP) of 84 mm Hg and a heart rate (HR) of 124 beats/min. On examination, he is disoriented, jugular venous pressure (JVP) is elevated, and his lungs are clear. Which of the following is the best treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Normal Saline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Nitroglycerin (NTG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV Normal Saline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV Normal Saline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ right ventricular infarction (RVMI)&lt;/li&gt;&lt;li&gt;âž¤ hypotension&lt;/li&gt;&lt;li&gt;âž¤ clear lungs&lt;/li&gt;&lt;li&gt;âž¤ IV normal saline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old gentleman is brought into your ER after a syncope. The monitor showed a heart rate of 190 bpm with a blood pressure of 85/50 mmHg. His SpO2 is 98% (on NRPBM). The ECG shows a regular wide complex tachycardia (WCT) with no apparent P waves. With regard to the jugular venous pressure (JVP) waveform, which of these features would you expect to see?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Giant v waves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannon a waves&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prominent x descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Slow y descent&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cannon a waves&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cannon a waves&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ventricular tachycardia with AV dissociation , you would expect to see cannon a waves on the JVP waveform, resulting from the atria contracting against closed AV valves due to the lack of synchronization between atrial and ventricular contractions.&lt;/li&gt;&lt;li&gt;âž¤ ventricular tachycardia&lt;/li&gt;&lt;li&gt;âž¤ AV dissociation&lt;/li&gt;&lt;li&gt;âž¤ cannon a waves&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient with infertility presents with galactorrhea. Evaluation reveals a 7mm prolactinoma. She is worried about her chances of conception. What is the appropriate drug in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cabergoline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bromocriptine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pegvisomant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cabergoline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bromocriptine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ prolactinoma&lt;/li&gt;&lt;li&gt;âž¤ trying to conceive&lt;/li&gt;&lt;li&gt;âž¤ bromocriptine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which among the following, according to the latest guidelines, is NOT an indication for infective endocarditis (IE) prophylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prior Infective Endocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral Valve Prolapse with severe MR&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unrepaired Cyanotic Congenital Heart Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac transplant with valvulopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mitral Valve Prolapse with severe MR&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mitral Valve Prolapse with severe MR&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ According to the latest guidelines, mitral valve prolapse with severe mitral regurgitation is not an indication for infective endocarditis prophylaxis, while other high-risk conditions such as prior IE, unrepaired cyanotic congenital heart disease, and cardiac transplant with valvulopathy are .&lt;/li&gt;&lt;li&gt;âž¤ mitral valve prolapse with severe mitral regurgitation&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ are&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a past medical history of coronary artery disease develops an MI. He got treated in CCU and before he is discharged, he undergoes echocardiography, which reveals a left ventricular ejection fraction of 35% to 40%. He is asymptomatic. What is this patientâ€™s heart failure stage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Stage B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Stage B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ structural heart disease&lt;/li&gt;&lt;li&gt;âž¤ no symptoms&lt;/li&gt;&lt;li&gt;âž¤ Stage B&lt;/li&gt;&lt;li&gt;âž¤ ACC/AHA heart failure stages&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Laboratory investigations of a patient being evaluated for jaundice show elevated bilirubin and alkaline phosphatase (ALP) levels. Levels of the remaining liver enzymes are normal. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obstructive jaundice&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatic jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prehepatic jaundice&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Obstructive jaundice&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Obstructive jaundice&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Obstructive jaundice&lt;/li&gt;&lt;li&gt;âž¤ bilirubin&lt;/li&gt;&lt;li&gt;âž¤ alkaline phosphatase&lt;/li&gt;&lt;li&gt;âž¤ biliary obstruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman presents with fever, arthralgia, ulcers, and fatigue for the past six months, along with new-onset hematuria. Urine examination reveals RBC casts and proteinuria. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Poststreptococcal glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lupus nephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lupus nephritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lupus nephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of systemic lupus erythematosus (SLE) symptoms and renal involvement (hematuria, RBC casts, and proteinuria) makes lupus nephritis the most likely diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ systemic lupus erythematosus (SLE) symptoms&lt;/li&gt;&lt;li&gt;âž¤ renal involvement&lt;/li&gt;&lt;li&gt;âž¤ lupus nephritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 11-year-old child who weighs 26 kg with a history of streptococcal pharyngitis presents with fever and arthralgia. There is no past history of rheumatic heart disease, carditis, or valvular disease. How often is benzathine penicillin recommended for the prophylaxis of rheumatic heart disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;600000 IU once in 3 weeks for 5 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;600000 IU once in 3 weeks for 10 years&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1200000 IU once in 3 weeks for 10 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1200000 IU once in 3 weeks for life&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 600000 IU once in 3 weeks for 10 years&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 600000 IU once in 3 weeks for 10 years&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ 27 kg&lt;/li&gt;&lt;li&gt;âž¤ no history of carditis&lt;/li&gt;&lt;li&gt;âž¤ 600000 IU&lt;/li&gt;&lt;li&gt;âž¤ benzathine penicillin&lt;/li&gt;&lt;li&gt;âž¤ 21 years of age&lt;/li&gt;&lt;li&gt;âž¤ 10 years&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A man on diuretics presents with weakness. An ECG was done which showed flat T waves and prominent U waves. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypomagnesemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypernatremia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypokalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypokalemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of flat T waves and prominent U waves on an ECG in a patient taking diuretics strongly suggests hypokalemia .&lt;/li&gt;&lt;li&gt;âž¤ flat T waves&lt;/li&gt;&lt;li&gt;âž¤ prominent U waves&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A male patient presents to the emergency department. The arterial blood gas (ABG) report is as follows: pH = 7.2 pCO2 = 81 mm Hg HCO3- = 40 meq/L Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute on chronic respiratory acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute on chronic respiratory acidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute on chronic respiratory acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ elevated pCO2&lt;/li&gt;&lt;li&gt;âž¤ elevated HCO3-&lt;/li&gt;&lt;li&gt;âž¤ low pH&lt;/li&gt;&lt;li&gt;âž¤ acute on chronic respiratory acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with fever, jaundice, and malaise. Based on the following serology reports, what is the most incorrect diagnosis? Anti-HBc : Positive HBsAg : Negative Anti-HBs : Negative HBeAg : Negative&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic HBV infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Remote HBV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occult HBV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Window Period&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chronic HBV infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chronic HBV infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Chronic HBV infection&lt;/li&gt;&lt;li&gt;âž¤ HBsAg&lt;/li&gt;&lt;li&gt;âž¤ HBsAg is negative&lt;/li&gt;&lt;li&gt;âž¤ not possible&lt;/li&gt;&lt;li&gt;âž¤ incorrect diagnosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child presents to the emergency department with a history of ingestion of 10-20 ferrous sulfate tablets. Arterial blood gas reveals acidosis. Which of the following can be used in the management of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Whole Bowel Irrigation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Activated Charcoal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dimercaprol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Penicillamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Whole Bowel Irrigation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Whole Bowel Irrigation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ iron intoxication&lt;/li&gt;&lt;li&gt;âž¤ Whole Bowel Irrigation&lt;/li&gt;&lt;li&gt;âž¤ Activated charcoal&lt;/li&gt;&lt;li&gt;âž¤ Dimercaprol&lt;/li&gt;&lt;li&gt;âž¤ Penicillamine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male patient presented to the hospital with palpitations. Physical examination showed a diastolic murmur in the left 3rd intercostal space. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tricuspid regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aortic regurgitation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aortic regurgitation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ diastolic murmur&lt;/li&gt;&lt;li&gt;âž¤ left 3rd intercostal space&lt;/li&gt;&lt;li&gt;âž¤ aortic regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly male patient was brought by his son because he was not using his left arm for day-to-day functioning. He has an unkempt appearance on the left side of his body and has a history of bumping into door frames while walking through them. The evaluation performed is shown in the image (clock drawing). Where does a lesion in the brain cause this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right parietotemporal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left parietal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right parietal&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right premotor cortex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right parietal&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Right parietal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Left-sided hemineglect&lt;/li&gt;&lt;li&gt;âž¤ right parietal lobe&lt;/li&gt;&lt;li&gt;âž¤ non-dominant hemisphere&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A person with dyspnea has a slight limitation in physical activity. Doing ordinary activities causes symptoms, but he is asymptomatic at rest. Which class of the New York Heart Association (NYHA) classification does he belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Class II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A patient who has slight limitations in physical activity but is asymptomatic at rest falls under NYHA Class II . Ordinary activities, such as walking or climbing stairs, result in symptoms.&lt;/li&gt;&lt;li&gt;âž¤ slight limitations in physical activity&lt;/li&gt;&lt;li&gt;âž¤ asymptomatic at rest&lt;/li&gt;&lt;li&gt;âž¤ NYHA Class II&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with headache and bitemporal hemianopia. Hormonal evaluation was normal. Which of the following is a likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gonadotroph adenoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mammotroph adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Corticotroph adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Somatotroph adenoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gonadotroph adenoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gonadotroph adenoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ normal hormonal evaluation&lt;/li&gt;&lt;li&gt;âž¤ headache&lt;/li&gt;&lt;li&gt;âž¤ bitemporal hemianopia&lt;/li&gt;&lt;li&gt;âž¤ gonadotroph adenoma&lt;/li&gt;&lt;li&gt;âž¤ non-functioning pituitary adenoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman presents with prolonged menstrual bleeding. Her investigations showed normal platelet count, PT, and aPTT, while bleeding time was increased. Ristocetin test was normal. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bernard-Soulier syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glanzmann thrombasthenia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Haemophilia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Von Willebrand disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glanzmann thrombasthenia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glanzmann thrombasthenia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ prolonged menstrual bleeding&lt;/li&gt;&lt;li&gt;âž¤ increased bleeding time&lt;/li&gt;&lt;li&gt;âž¤ normal Ristocetin test&lt;/li&gt;&lt;li&gt;âž¤ Glanzmann thrombasthenia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with chronic pain in his hands, knees, and hips, which is aggravated by activities such as climbing stairs. He reports increased hand pain when writing or typing. He also experiences morning stiffness in his joints, lasting around 30 minutes. An X-ray of his knee shows narrowed joint space with osteophytes. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bone tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteoporosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Osteoarthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Osteoarthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of chronic joint pain , morning stiffness lasting less than 1 hour , and X-ray findings of narrowed joint space with osteophytes is most consistent with osteoarthritis , a common non-inflammatory degenerative joint disease.&lt;/li&gt;&lt;li&gt;âž¤ chronic joint pain&lt;/li&gt;&lt;li&gt;âž¤ morning stiffness lasting less than 1 hour&lt;/li&gt;&lt;li&gt;âž¤ X-ray findings&lt;/li&gt;&lt;li&gt;âž¤ narrowed joint space with osteophytes&lt;/li&gt;&lt;li&gt;âž¤ osteoarthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with frequent urination, nocturia, and enuresis. A 24-hour urine volume was measured to be 7 liters, and the urine osmolarity was 260 mOsm/L. An ADH assay was performed, with a result of 0.8 pg/ml. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nephrogenic DI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mannitol infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary polydipsia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Central DI&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Central DI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Central Diabetes Insipidus (DI)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with low ADH levels , polyuria , and dilute urine , the most likely diagnosis is Central Diabetes Insipidus (DI) , where there is a deficiency of ADH leading to the inability of the kidneys to concentrate urine.&lt;/li&gt;&lt;li&gt;âž¤ low ADH levels&lt;/li&gt;&lt;li&gt;âž¤ polyuria&lt;/li&gt;&lt;li&gt;âž¤ dilute urine&lt;/li&gt;&lt;li&gt;âž¤ Central Diabetes Insipidus (DI)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is confirmatory to ensure that a central line is in the jugular vein?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ETCO2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blood color&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chest X-ray&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Chest X-ray&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most confirmatory method to ensure that a central line is placed correctly in the jugular vein or other central venous locations is a chest X-ray , which helps visualize the position of the catheter tip and detect any complications.&lt;/li&gt;&lt;li&gt;âž¤ jugular vein&lt;/li&gt;&lt;li&gt;âž¤ chest X-ray&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old medical student with a 2-month history of palpitations, sweating, restlessness, and complains of sweaty palms. Which of the following will help in diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid receptor antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Thyroglobulin Antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ultrasensitive thyrotropin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-thyroid peroxidase antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ultrasensitive thyrotropin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ultrasensitive thyrotropin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient presenting with symptoms suggestive of thyrotoxicosis , the most appropriate first step is to measure TSH with an ultrasensitive thyrotropin test to confirm the diagnosis before moving on to other investigations.&lt;/li&gt;&lt;li&gt;âž¤ thyrotoxicosis&lt;/li&gt;&lt;li&gt;âž¤ TSH&lt;/li&gt;&lt;li&gt;âž¤ ultrasensitive thyrotropin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman who recently received a kidney transplant 2 months ago developed a high-grade fever, dyspnea, and a hacking cough. Chest X-ray reveals bilateral interstitial infiltrates. Urine examination shows â€œowl eyeâ€ appearance of cells. Which of the following agents is most likely responsible for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Influenza virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory syncytial virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytomegalovirus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenovirus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cytomegalovirus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cytomegalovirus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ \&quot;owl eye\&quot; inclusions&lt;/li&gt;&lt;li&gt;âž¤ Cytomegalovirus (CMV)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old presents with chest pain, dyspnea that worsens when lying down and is relieved when sitting upright. On examination, heart sounds are muffled and the lungs are clear. A chest X-ray is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute Pulmonary edema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute MI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac Tamponade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cardiac Tamponade&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture5.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cardiac Tamponade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of dyspnea, chest pain relieved by sitting upright , muffled heart sounds , and X-ray findings (likely showing an enlarged heart silhouette) strongly suggests cardiac tamponade . This is a medical emergency that requires prompt diagnosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ dyspnea, chest pain relieved by sitting upright&lt;/li&gt;&lt;li&gt;âž¤ muffled heart sounds&lt;/li&gt;&lt;li&gt;âž¤ cardiac tamponade&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is a known case of hypertension is on multiple anti-hypertensive drugs. His ECG is shown below. Which drug is responsible for the following ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Spironolactone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone can lead to hyperkalemia , which manifests on ECG with tall T waves , widened QRS complexes , and potential absent P waves . This is the most likely cause of the ECG changes in this hypertensive patient on multiple antihypertensive medications.&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone&lt;/li&gt;&lt;li&gt;âž¤ hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ tall T waves&lt;/li&gt;&lt;li&gt;âž¤ widened QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ absent P waves&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A morbidly obese diabetic woman was on Metformin but could not achieve glycemic control. She has had a previous osteoporotic fracture and has a history of pancreatitis. The patient does not want to take injections. Which of the following would be suitable to reduce her glucose levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Semaglutide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ morbidly obese&lt;/li&gt;&lt;li&gt;âž¤ osteoporosis&lt;/li&gt;&lt;li&gt;âž¤ pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 31-year-old woman with rheumatoid arthritis (RA) gets pregnant. She is currently on hydroxychloroquine and sulfasalazine, but her disease is progressively worsening at 32 weeks of gestation. Which drug can she be started on?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leflunomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NSAIDs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Certolizumab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Certolizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Certolizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For pregnant women with rheumatoid arthritis , Certolizumab is the safest TNF-alpha inhibitor that can be used throughout pregnancy, particularly in the later stages, because it does not cross the placenta.&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ Certolizumab&lt;/li&gt;&lt;li&gt;âž¤ TNF-alpha inhibitor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman is referred for evaluation due to a 5-year history of Raynaud phenomenon and thickening of the skin over her fingers. Routine laboratory tests are within normal limits. DLCO (diffusing capacity of the lungs for carbon monoxide) is 44% of normal, with normal lung volumes. What is the likely diagnosis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic obstructive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interstitial Lung Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrictive lung disease secondary to pleural disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pulmonary hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ systemic sclerosis&lt;/li&gt;&lt;li&gt;âž¤ pulmonary arterial hypertension (PAH)&lt;/li&gt;&lt;li&gt;âž¤ reduced DLCO&lt;/li&gt;&lt;li&gt;âž¤ normal lung volumes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female patient with chronic hepatitis B who is HBeAg negative is evaluated for treatment. ALT is normal and HBV DNA is 800 IU/mL. Which of the following would you recommend for treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peg-interferon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lamivudine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adefovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Observation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Observation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ chronic hepatitis B&lt;/li&gt;&lt;li&gt;âž¤ HBeAg negative&lt;/li&gt;&lt;li&gt;âž¤ HBV DNA &amp;lt; 2000 IU/mL&lt;/li&gt;&lt;li&gt;âž¤ normal ALT&lt;/li&gt;&lt;li&gt;âž¤ observation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is likely with ascitic fluid protein 1.9 g/dL and a SAAG (Serum-Ascites Albumin Gradient) of 1.4?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic cirrhosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peritoneal malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Veno-occlusive disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alcoholic cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alcoholic cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ SAAG â‰¥ 1.1 g/dL&lt;/li&gt;&lt;li&gt;âž¤ ascitic fluid protein &amp;lt; 2.5 g/dL&lt;/li&gt;&lt;li&gt;âž¤ portal hypertension&lt;/li&gt;&lt;li&gt;âž¤ alcoholic cirrhosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old pilot presents to a neurologist with rapidly progressive dementia, myoclonus, ataxia, and visual disturbances. EEG showed periodic complexes. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Creutzfeldt-Jakob Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Whipple disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vascular dementia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Creutzfeldt-Jakob Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Creutzfeldt-Jakob Disease (CJD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ rapidly progressive dementia&lt;/li&gt;&lt;li&gt;âž¤ myoclonus&lt;/li&gt;&lt;li&gt;âž¤ ataxia&lt;/li&gt;&lt;li&gt;âž¤ periodic complexes&lt;/li&gt;&lt;li&gt;âž¤ Creutzfeldt-Jakob Disease (CJD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female with a history of recurrent headaches presented for further evaluation. Laboratory tests revealed normal hemoglobin and WBC counts, with an elevated platelet count. Bone marrow evaluation showed increased megakaryocytes and a JAK2 mutation. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Essential thrombocytosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polycythemia vera&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic myelogenous leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary myelofibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Essential thrombocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Essential thrombocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ elevated platelet count&lt;/li&gt;&lt;li&gt;âž¤ normal hemoglobin and WBC counts&lt;/li&gt;&lt;li&gt;âž¤ increased megakaryocytes&lt;/li&gt;&lt;li&gt;âž¤ JAK2 mutation&lt;/li&gt;&lt;li&gt;âž¤ Essential Thrombocytosis (ET)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man is evaluated for shortness of breath on exertion and dry cough that have worsened over the course of 6 months. He has clubbing, and his vitals are stable. Pulmonary function tests (PFT) reveal: FEV1: 65% FVC: 67% FEV1/FVC: 74% TLC: 68% DLCO: 62% Which test is most likely to determine the etiology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoscopy with transbronchial lung biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HRCT chest&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PET CT of whole body&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HRCT chest&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HRCT chest&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ progressive dyspnea&lt;/li&gt;&lt;li&gt;âž¤ cough&lt;/li&gt;&lt;li&gt;âž¤ restrictive lung disease&lt;/li&gt;&lt;li&gt;âž¤ HRCT of the chest&lt;/li&gt;&lt;li&gt;âž¤ interstitial lung diseases&lt;/li&gt;&lt;li&gt;âž¤ idiopathic pulmonary fibrosis (IPF)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A physician reviewed a patientâ€™s chest X-ray and diagnosed COPD. The patientâ€™s room air SaO2 is 88% and paO2 is 54 mm Hg. Which of the following will improve survival?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LAMA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary rehabilitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Supplemental O2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhaled Corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Supplemental O2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Supplemental O2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with COPD and significant hypoxemia , the intervention that has been shown to improve survival is long-term supplemental oxygen therapy .&lt;/li&gt;&lt;li&gt;âž¤ COPD&lt;/li&gt;&lt;li&gt;âž¤ hypoxemia&lt;/li&gt;&lt;li&gt;âž¤ improve survival&lt;/li&gt;&lt;li&gt;âž¤ long-term supplemental oxygen therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is brought to the OPD by his wife who reports that he has difficulty expressing emotions. On examination, resting tremors and rigidity are present. Which part of the brain among the following options is primarily affected in this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Basal Ganglia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Substantia Nigra&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hippocampus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Substantia Nigra&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Substantia Nigra&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ substantia nigra&lt;/li&gt;&lt;li&gt;âž¤ resting tremors&lt;/li&gt;&lt;li&gt;âž¤ rigidity&lt;/li&gt;&lt;li&gt;âž¤ bradykinesia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with sensory loss and weakness of limbs for 3 months. He also has angular stomatitis. On examination, there is loss of proprioception and vibration sensations, UMN-type weakness of the lower limbs, and absent ankle reflexes. What is the probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyotrophic Lateral Sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple Sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intramedullary tumour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subacute combined degeneration of the cord&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Subacute combined degeneration of the cord&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Subacute combined degeneration of the cord&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Subacute combined degeneration of the cord&lt;/li&gt;&lt;li&gt;âž¤ vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;âž¤ loss of proprioception&lt;/li&gt;&lt;li&gt;âž¤ vibration sensation&lt;/li&gt;&lt;li&gt;âž¤ UMN-type weakness&lt;/li&gt;&lt;li&gt;âž¤ absent reflexes&lt;/li&gt;&lt;li&gt;âž¤ angular stomatitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a long history of alcoholism presents with acute pain and swelling of the left great toe. Synovial fluid analysis shows raised leucocytes. Investigation shows normal serum uric acid levels. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute Gout&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Septic Arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudogout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reactive Arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute Gout&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute Gout&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Acute gout&lt;/li&gt;&lt;li&gt;âž¤ acute pain and swelling of the great toe&lt;/li&gt;&lt;li&gt;âž¤ serum uric acid levels are normal&lt;/li&gt;&lt;li&gt;âž¤ serum uric acid&lt;/li&gt;&lt;li&gt;âž¤ 30-40% of acute gout&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A farmer tried to commit suicide by ingesting about 2 glasses of paraquat. What is the primary system affected in paraquat toxicity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dermatologic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neurologic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pulmonary&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ paraquat poisoning&lt;/li&gt;&lt;li&gt;âž¤ pulmonary system&lt;/li&gt;&lt;li&gt;âž¤ acute lung injury&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female presents with complaints of chest pain, palpitation, and shortness of breath. On auscultation, a mid-diastolic murmur is heard, and on examination, a prominent &#x27;a&#x27; wave on the JVP is noted. What is the most appropriate diagnosis among the following options?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitral Stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tricuspid Stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tricuspid Regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitral Regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tricuspid Stenosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tricuspid Stenosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ mid-diastolic murmur&lt;/li&gt;&lt;li&gt;âž¤ prominent &#x27;a&#x27; wave&lt;/li&gt;&lt;li&gt;âž¤ tricuspid stenosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presented to the OPD with complaints of early morning backache and stiffness that improves with exercise and persistent red eyes. On examination, lung expansion was less than 3 cm. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pagetâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ankylosing Spondylitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Healed Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteopetrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ankylosing Spondylitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ankylosing Spondylitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Ankylosing Spondylitis&lt;/li&gt;&lt;li&gt;âž¤ morning back pain&lt;/li&gt;&lt;li&gt;âž¤ stiffness that improves with exercise&lt;/li&gt;&lt;li&gt;âž¤ reduced chest expansion&lt;/li&gt;&lt;li&gt;âž¤ extra-articular manifestations&lt;/li&gt;&lt;li&gt;âž¤ anterior uveitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;FeNO in bronchial asthma is related to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoconstriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mucus hypersecretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophilic inflammation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Airway hyperreactivity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eosinophilic inflammation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Eosinophilic inflammation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In bronchial asthma , FeNO is primarily used to assess eosinophilic inflammation , which is associated with TH2-type inflammation. Elevated FeNO levels can help in guiding the use of biologic therapies for asthma.&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ FeNO&lt;/li&gt;&lt;li&gt;âž¤ eosinophilic inflammation&lt;/li&gt;&lt;li&gt;âž¤ TH2-type&lt;/li&gt;&lt;li&gt;âž¤ biologic therapies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with severe restlessness and tremors to the emergency department. She has a history of bronchial asthma. On examination, a swollen neck is observed, and her blood pressure and heart rate are elevated. An ECG shows atrial fibrillation. Which of the following drugs can be given in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Esmolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diltiazem&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diltiazem&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ thyrotoxicosis-induced atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ diltiazem&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient undergoing hemodialysis for hyperkalemia and raised urea levels develops drowsiness, has a seizure, and becomes hypotensive during the procedure. What can be given for treatment in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mannitol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethacrynic Acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bumetanide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mannitol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mannitol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Dialysis disequilibrium syndrome&lt;/li&gt;&lt;li&gt;âž¤ hemodialysis&lt;/li&gt;&lt;li&gt;âž¤ cerebral edema&lt;/li&gt;&lt;li&gt;âž¤ Mannitol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following situations would Non-Invasive Ventilation (NIV) be considered contraindicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AECOPD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ARDS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute MI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Post-extubation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute MI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute MI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: NIV is contraindicated in patients with hemodynamically unstable acute myocardial infarction (MI)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following improves survival in ARDS (Acute Respiratory Distress Syndrome)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early use of paralytic agents&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluid restriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low tidal volume&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prone positioning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Low tidal volume&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Low tidal volume&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ARDS&lt;/li&gt;&lt;li&gt;âž¤ low tidal volume ventilation (LTVV)&lt;/li&gt;&lt;li&gt;âž¤ survival&lt;/li&gt;&lt;li&gt;âž¤ Prone positioning&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with a BMI of 32 has recently been diagnosed with OSA (AHI = 13). He does not have a history of snoring. He is unwilling for CPAP. Which of the following would be a possible alternative therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bariatric surgery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Supplementation oxygen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oral appliance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Uvulopalatopharyngoplasty&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oral appliance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Oral appliance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ oral appliance&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Indications for a chest drain in a parapneumonic effusion include all of the following except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Loculated pleural fluid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleural fluid pH &amp;lt; 7.2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pleural fluid glucose &amp;lt; 60 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural fluid LDH &amp;gt; 1000&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pleural fluid LDH &gt; 1000&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pleural fluid LDH &amp;gt; 1000&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ chest drainage&lt;/li&gt;&lt;li&gt;âž¤ parapneumonic effusion&lt;/li&gt;&lt;li&gt;âž¤ loculated fluid&lt;/li&gt;&lt;li&gt;âž¤ pleural fluid pH &amp;lt; 7.2&lt;/li&gt;&lt;li&gt;âž¤ glucose &amp;lt; 60 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ LDH &amp;gt; 1000&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old smoker presents with shortness of breath (SOB) on exertion. Resting SpO2 is 94%, which reduces to 85% after walking 100 meters. Examination reveals bilateral end-inspiratory crackles. The chest CT (shown) reveals honeycombing and a pattern consistent with pulmonary fibrosis. A serologic workup for autoimmune disease is unremarkable. What is the next therapeutic option?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nintedanib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nintedanib&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture7.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nintedanib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ idiopathic pulmonary fibrosis (IPF)&lt;/li&gt;&lt;li&gt;âž¤ progressive fibrosis&lt;/li&gt;&lt;li&gt;âž¤ nintedanib&lt;/li&gt;&lt;li&gt;âž¤ immunosuppressants&lt;/li&gt;&lt;li&gt;âž¤ steroids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A soldier operating in the Siachen Glacier presents with numbness of his legs. Based on the image provided, which of the following statements is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rewarming is the treatment of choice&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Analgesics are contraindicated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombolytics cannot be used&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amputation is not required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rewarming is the treatment of choice&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture8.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Rewarming is the treatment of choice&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of frostbite , like that seen in the image, rewarming is the immediate treatment of choice. Pain management is important, and in severe cases, other interventions such as thrombolytics or, in extreme situations, amputation may be considered.&lt;/li&gt;&lt;li&gt;âž¤ frostbite&lt;/li&gt;&lt;li&gt;âž¤ rewarming&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old man with Hodgkin lymphoma (HL) was treated successfully with the ABVD regimen. Which of the following drugs used in the treatment of this patient is cell cycle specific?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alkylating agents&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antimetabolites&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plant alkaloids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Plant alkaloids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Plant alkaloids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Plant alkaloids , like vinblastine , are cell cycle-specific agents used in the treatment of Hodgkin lymphoma as part of the ABVD regimen, and they primarily affect cells during the M phase (mitosis) of the cell cycle.&lt;/li&gt;&lt;li&gt;âž¤ Plant alkaloids&lt;/li&gt;&lt;li&gt;âž¤ vinblastine&lt;/li&gt;&lt;li&gt;âž¤ M phase (mitosis)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old male presents to the ER with the acute onset of ataxia. Neurological examination shows loss of pain and temperature sensation from the face on the left side and loss of pain and temperature sensation from the right half of the body. He also has dysarthria, dysphagia, and diminished gag reflex with ptosis, miosis, and anhidrosis on the left. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lateral pontine syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medial medullary syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lateral medullary syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Locked In Syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lateral medullary syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lateral medullary syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ crossed sensory loss&lt;/li&gt;&lt;li&gt;âž¤ dysarthria&lt;/li&gt;&lt;li&gt;âž¤ dysphagia&lt;/li&gt;&lt;li&gt;âž¤ Hornerâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ lateral medullary syndrome (Wallenberg syndrome)&lt;/li&gt;&lt;li&gt;âž¤ posterior inferior cerebellar artery (PICA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with severe peripheral arterial disease (PAD) is hospitalized for chest pain and undergoes coronary angiography (CAG). His serum creatinine is unchanged 3 days post-procedure, but from day 4, it slowly rises to a peak of 2.4 mg/dL. Urinalysis shows no proteinuria or red blood cells, and a few granular casts are present. Serum complement is low. Which one of the following is likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis (AIN)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Contrast-induced nephropathy (CIN)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atheroembolic disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Post-infectious glomerulonephritis (PIGN)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Atheroembolic disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Atheroembolic disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Atheroembolic disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient comes to the ER with a headache, describing it as the worst headache of his life. Initial NCCT (non-contrast CT) shows subarachnoid hemorrhage (SAH). What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT Angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lumbar puncture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MRI brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;V-P shunt&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CT Angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CT Angiography&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with confirmed SAH on non-contrast CT , the next step is CT Angiography (CTA) to identify the cause, typically a ruptured aneurysm , for further therapeutic intervention.&lt;/li&gt;&lt;li&gt;âž¤ confirmed SAH&lt;/li&gt;&lt;li&gt;âž¤ non-contrast CT&lt;/li&gt;&lt;li&gt;âž¤ CT Angiography (CTA)&lt;/li&gt;&lt;li&gt;âž¤ aneurysm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old man is investigated for progressive cognitive impairment. Which one of the following features is most suggestive of Lewy body dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disinhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Emotional lability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neuroleptic sensitivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary incontinence&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neuroleptic sensitivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neuroleptic sensitivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Neuroleptic sensitivity&lt;/li&gt;&lt;li&gt;âž¤ Lewy body dementia (LBD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In Wernicke&#x27;s encephalopathy, the earliest clinical feature to recover is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ophthalmoparesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Confusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Memory loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ophthalmoparesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ophthalmoparesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Wernicke&#x27;s encephalopathy&lt;/li&gt;&lt;li&gt;âž¤ ophthalmoparesis&lt;/li&gt;&lt;li&gt;âž¤ earliest clinical feature&lt;/li&gt;&lt;li&gt;âž¤ thiamine therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are accepted diagnostic criteria for acute pancreatitis except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Confirmatory findings of acute pancreatitis on cross-sectional imaging&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PaO2 &amp;lt; 60 mm Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â‰¥ 3x elevation in serum lipase and/or amylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Typical abdominal pain in the epigastrium that may radiate to the back&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. PaO2 &lt; 60 mm Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) PaO2 &amp;lt; 60 mm Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ acute pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ abdominal pain&lt;/li&gt;&lt;li&gt;âž¤ elevated enzymes (amylase or lipase)&lt;/li&gt;&lt;li&gt;âž¤ imaging findings&lt;/li&gt;&lt;li&gt;âž¤ PaO2 &amp;lt; 60 mm Hg&lt;/li&gt;&lt;li&gt;âž¤ Ranson&#x27;s criteria&lt;/li&gt;&lt;li&gt;âž¤ prognosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Paraneoplastic neurological syndromes (PNS) characterized by anti-Yo antibodies are associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebellar Degeneration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stiff Person Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Optic Neuritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Retinopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cerebellar Degeneration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cerebellar Degeneration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Anti-Yo antibodies&lt;/li&gt;&lt;li&gt;âž¤ paraneoplastic cerebellar degeneration&lt;/li&gt;&lt;li&gt;âž¤ gynecological cancers&lt;/li&gt;&lt;li&gt;âž¤ ovarian&lt;/li&gt;&lt;li&gt;âž¤ breast cancer&lt;/li&gt;&lt;li&gt;âž¤ progressive cerebellar ataxia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 20-year-old man who complains of edema and frothy urine for 2 months. Labs reveal normal serum creatinine and 4+ protein in urine without blood or bacteria. He undergoes a kidney biopsy, which is normal on light microscopy. What is the best treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prednisolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ nephrotic syndrome&lt;/li&gt;&lt;li&gt;âž¤ normal kidney biopsy&lt;/li&gt;&lt;li&gt;âž¤ minimal change disease (MCD)&lt;/li&gt;&lt;li&gt;âž¤ prednisolone&lt;/li&gt;&lt;li&gt;âž¤ MCD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the expected MCV in the CBC based on the peripheral smear (PS) image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 80 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 60 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;80-100 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 100 fL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. &gt; 100 fL&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture9.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) &amp;gt; 100 fL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ hypersegmented neutrophils&lt;/li&gt;&lt;li&gt;âž¤ macrocytes&lt;/li&gt;&lt;li&gt;âž¤ peripheral smear&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ MCV&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt; 100 fL&lt;/li&gt;&lt;li&gt;âž¤ vitamin B12&lt;/li&gt;&lt;li&gt;âž¤ folate deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man has an MI complicated by shock. He recovers well from the MI, but several days later, his renal function deteriorates. One week after his MI, he becomes oliguric with BUN of 53 mg/dL and creatinine of 3.9 mg/dL. What is the likely value of FeNa?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt; 2%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 1%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt; 35%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 50%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &gt; 2%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) &amp;gt; 2%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ acute tubular necrosis (ATN)&lt;/li&gt;&lt;li&gt;âž¤ FeNa&lt;/li&gt;&lt;li&gt;âž¤ greater than 2%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most likely mechanism of gentamicin-related AKI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute tubular necrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic injury&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute tubular necrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acute tubular necrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most likely mechanism of gentamicin-related acute kidney injury is acute tubular necrosis (ATN) , resulting from direct toxic damage to the proximal tubular cells of the kidney.&lt;/li&gt;&lt;li&gt;âž¤ gentamicin-related acute kidney injury&lt;/li&gt;&lt;li&gt;âž¤ acute tubular necrosis (ATN)&lt;/li&gt;&lt;li&gt;âž¤ toxic damage to the proximal tubular cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following would be important for the prevention of tumor lysis syndrome (TLS) EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of allopurinol 300 mg/mÂ² daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administration of IV fluids at a minimum of 3000 mL/mÂ² daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alkalinization of the urine by administration of NaHCO3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Frequent monitoring of serum chemistries every 4 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alkalinization of the urine by administration of NaHCO3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Alkalinization of the urine by administration of NaHCO3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While hydration , allopurinol , and frequent serum monitoring are critical in tumor lysis syndrome (TLS) prevention, urine alkalinization is not recommended because it increases the risk of kidney complications, such as calcium phosphate precipitation .&lt;/li&gt;&lt;li&gt;âž¤ hydration&lt;/li&gt;&lt;li&gt;âž¤ allopurinol&lt;/li&gt;&lt;li&gt;âž¤ frequent serum monitoring&lt;/li&gt;&lt;li&gt;âž¤ tumor lysis syndrome (TLS)&lt;/li&gt;&lt;li&gt;âž¤ urine alkalinization&lt;/li&gt;&lt;li&gt;âž¤ not recommended&lt;/li&gt;&lt;li&gt;âž¤ calcium phosphate precipitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old woman comes to the ER complaining of bleeding due to Warfarin. She received IV vitamin K, 4 U PRBCs, and 4 U FFP. Eight hours later, she begins to complain of SOB. Her vitals are T - 39Â°C, RR 35/min, SpO2 84% on room air, and BP 100/52 mm Hg. Exam reveals bilateral crackles, and the patient was intubated for respiratory failure. A chest X-ray (CXR) is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anaphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TACO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TRALI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspiration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. TRALI&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture10.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) TRALI (Transfusion-Related Acute Lung Injury)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: TRALI&lt;/li&gt;&lt;li&gt;âž¤ acute respiratory distress&lt;/li&gt;&lt;li&gt;âž¤ hypoxemia&lt;/li&gt;&lt;li&gt;âž¤ bilateral pulmonary infiltrates&lt;/li&gt;&lt;li&gt;âž¤ 6 hours&lt;/li&gt;&lt;li&gt;âž¤ FFP&lt;/li&gt;&lt;li&gt;âž¤ PRBCs&lt;/li&gt;&lt;li&gt;âž¤ TACO&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following regarding non-invasive testing for H. pylori is true?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;There is no reliable non-invasive method to detect H. pylori&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;False negative UBT reports occur with the use of NSAIDs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serology offers the greatest sensitivity for diagnosis of infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Exposure to low-dose radiation is a limitation to UBT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Exposure to low-dose radiation is a limitation to UBT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Exposure to low-dose radiation is a limitation to UBT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Urea Breath Test (UBT)&lt;/li&gt;&lt;li&gt;âž¤ carbon-14 (C-14)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a 5-year history of ulcerative colitis (UC) presents with acute abdominal pain, fever, and leukocytosis. A plain film is shown below. What is the next management step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Methylprednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subtotal colectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV Methylprednisolone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/30/picture11.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV Methylprednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ ulcerative colitis flare-ups&lt;/li&gt;&lt;li&gt;âž¤ toxic megacolon&lt;/li&gt;&lt;li&gt;âž¤ IV Methylprednisolone&lt;/li&gt;&lt;li&gt;âž¤ subtotal colectomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the immune mechanism leading to organ damage in Goodpasture syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibody-dependent cellular cytotoxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complement-activating autoantibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inactivating autoantibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulating autoantibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Complement-activating autoantibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Complement-activating autoantibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ immune mechanism&lt;/li&gt;&lt;li&gt;âž¤ Goodpasture syndrome&lt;/li&gt;&lt;li&gt;âž¤ complement-activating autoantibodies&lt;/li&gt;&lt;li&gt;âž¤ basement membrane&lt;/li&gt;&lt;li&gt;âž¤ glomerulonephritis&lt;/li&gt;&lt;li&gt;âž¤ pulmonary hemorrhage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients with rheumatoid arthritis (RA) are at higher risk for all of the following EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Colorectal Cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary Artery Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoandrogenism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Colorectal Cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Colorectal Cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ coronary artery disease&lt;/li&gt;&lt;li&gt;âž¤ hypoandrogenism&lt;/li&gt;&lt;li&gt;âž¤ lymphoma&lt;/li&gt;&lt;li&gt;âž¤ no clear evidence&lt;/li&gt;&lt;li&gt;âž¤ colorectal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old alcoholic with ascites and jaundice presents with an acute upper gastrointestinal (UGI) bleed. All of the following are appropriate treatment options EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endoscopic variceal ligation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TIPS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ endoscopic variceal ligation&lt;/li&gt;&lt;li&gt;âž¤ octreotide&lt;/li&gt;&lt;li&gt;âž¤ TIPS&lt;/li&gt;&lt;li&gt;âž¤ Propranolol&lt;/li&gt;&lt;li&gt;âž¤ prevention&lt;/li&gt;&lt;li&gt;âž¤ not appropriate&lt;/li&gt;&lt;li&gt;âž¤ acute management&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a diagnosis of diffuse cutaneous scleroderma presents with malignant hypertension, oliguria, hemolysis, and renal failure. Which of the following is the recommended treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Captopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Captopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Captopril&lt;/li&gt;&lt;li&gt;âž¤ first-line treatment&lt;/li&gt;&lt;li&gt;âž¤ scleroderma renal crisis&lt;/li&gt;&lt;li&gt;âž¤ renin-angiotensin system&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements are true regarding MAFLD (Metabolic dysfunction-associated fatty liver disease) treatment EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bariatric surgery is safe in patients with MAFLD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin E is helpful in reducing steatosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Statins may worsen inflammation in MAFLD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Resmetirom is the only FDA-approved drug in MAFLD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Statins may worsen inflammation in MAFLD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Statins are safe and do not worsen inflammation in patients with MAFLD.&lt;/li&gt;&lt;li&gt;â€¢ They are commonly prescribed for dyslipidemia, a frequent comorbidity in MAFLD, and studies confirm that statins do not exacerbate liver inflammation.&lt;/li&gt;&lt;li&gt;â€¢ Moreover, statins help reduce cardiovascular risk, which is significantly increased in patients with MAFLD.&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Other Options:&lt;/li&gt;&lt;li&gt;â€¢ Option A) Bariatric surgery is safe in patients with MAFLD - It improves insulin sensitivity, weight, and liver histology.&lt;/li&gt;&lt;li&gt;â€¢ Option A) Bariatric surgery is safe in patients with MAFLD&lt;/li&gt;&lt;li&gt;â€¢ Option B) Vitamin E is helpful in reducing steatosis - Especially beneficial in non-diabetic patients with biopsy-proven MASH.&lt;/li&gt;&lt;li&gt;â€¢ Option B) Vitamin E is helpful in reducing steatosis&lt;/li&gt;&lt;li&gt;â€¢ Option D) Resmetirom is the only FDA-approved drug in MAFLD - Resmetirom (a selective thyroid hormone receptor-Î² agonist) is the first FDA-approved therapy for MASH with fibrosis, a subset of MAFLD.&lt;/li&gt;&lt;li&gt;â€¢ Option D) Resmetirom is the only FDA-approved drug in MAFLD&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Statins do not worsen liver inflammation in MAFLD and are considered safe and beneficial for cardiovascular risk management.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are effective in treating Psoriatic arthritis except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secukinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ustekinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rituximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Rituximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Rituximab&lt;/li&gt;&lt;li&gt;âž¤ not effective&lt;/li&gt;&lt;li&gt;âž¤ psoriatic arthritis&lt;/li&gt;&lt;li&gt;âž¤ TNF-alpha&lt;/li&gt;&lt;li&gt;âž¤ IL-17&lt;/li&gt;&lt;li&gt;âž¤ IL-12/23&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A stale potato curry causes severe gastroenteritis in a picnic group. A 36-year-old man recovers from the diarrhea, but 2 weeks later develops arthritis in his right knee and severe left-sided Achilles tendinitis. What is the most likely organism implicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C. jejuni&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S. flexneri&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;H. pylori&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C. difficile&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S. flexneri&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) S. flexneri&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: S. flexneri&lt;/li&gt;&lt;li&gt;âž¤ reactive arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man with HBV-related cirrhosis has ascites requiring frequent large volume paracentesis (LVP). All of the following are true regarding treatment of ascites EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fluid restriction &amp;lt; 2 L daily&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Furosemide + spironolactone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Na restriction &amp;lt; 2 g daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TIPS has no survival benefit compared to LVP&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fluid restriction &lt; 2 L daily&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Fluid restriction &amp;lt; 2 L daily&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sodium restriction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is incorrect with regards to allopurinol in gout?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allopurinol should not be used with Colchicine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allopurinol dosing should be adjusted for renal function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allopurinol dosing should be titrated to a S. UA &amp;lt; 6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allopurinol hypersensitivity is associated with HLA B5801&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Allopurinol should not be used with Colchicine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Allopurinol should not be used with Colchicine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ \&quot;Allopurinol should not be used with Colchicine,\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Colchicine&lt;/li&gt;&lt;li&gt;âž¤ Allopurinol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Management of Hepatorenal Syndrome includes all EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Volume expansion with IV albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuresis with furosemide + spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Midodrine and octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Referral to liver transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Diuresis with furosemide + spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Diuresis with furosemide + spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ hepatorenal syndrome&lt;/li&gt;&lt;li&gt;âž¤ diuretics&lt;/li&gt;&lt;li&gt;âž¤ furosemide and spironolactone&lt;/li&gt;&lt;li&gt;âž¤ contraindicated&lt;/li&gt;&lt;li&gt;âž¤ volume expansion with IV albumin&lt;/li&gt;&lt;li&gt;âž¤ vasoactive agents&lt;/li&gt;&lt;li&gt;âž¤ midodrine and octreotide&lt;/li&gt;&lt;li&gt;âž¤ liver transplantation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are reviewing a serology report of a patient in a routine medical health check-up (MHC): HBSAg : Negative Anti-HBS : Negative Anti-HBC : Positive HBEAg : Negative Anti-HBE : Negative All of the following are true except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Window period&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Late acute infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occult HBV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HBV in the remote past&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Late acute infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Late acute infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ occult HBV infection&lt;/li&gt;&lt;li&gt;âž¤ remote past HBV infection&lt;/li&gt;&lt;li&gt;âž¤ late acute infection&lt;/li&gt;&lt;li&gt;âž¤ Anti-HBS&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 34-year-old woman is evaluated for fatigue, malaise, arthralgias, and a 10-lb weight loss over the past 6â€“8 weeks. She has no past medical history. On exam, her vitals are stable, and she has hepatomegaly, jaundice, and mild joint swelling. Laboratory tests show: AST: 542 IU/L ALT: 657 IU/L ALP: 102 IU/L Total bilirubin: 5.3 mg/dL Direct bilirubin: 4.8 mg/dL Which of the following tests would be LEAST likely to be seen in this diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antinuclear Antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Rheumatoid Factor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Antimitochondrial Antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypergammaglobulinemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Antimitochondrial Antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Antimitochondrial Antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ autoimmune hepatitis&lt;/li&gt;&lt;li&gt;âž¤ Antimitochondrial Antibody (AMA)&lt;/li&gt;&lt;li&gt;âž¤ primary biliary cholangitis (PBC)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman with cystic fibrosis (CF) is diagnosed with chronic pancreatitis. All of the following complications may be seen EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin B12 deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin A deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pancreatic carcinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Niacin deficiency&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Niacin deficiency&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Niacin deficiency&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with chronic pancreatitis due to cystic fibrosis, deficiencies of fat-soluble vitamins (like A and B12) are common, and there is an increased risk of pancreatic carcinoma , but niacin deficiency is not a typical complication.&lt;/li&gt;&lt;li&gt;âž¤ pancreatic carcinoma&lt;/li&gt;&lt;li&gt;âž¤ niacin deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is false with regards to Klinefelterâ€™s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Androgen supplementation is useful&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients are at increased risk for breast tumors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduced plasma estrogen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most cases are diagnosed after puberty&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduced plasma estrogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reduced plasma estrogen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ \&quot;Reduced plasma estrogen\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Klinefelter&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ increased estrogen levels&lt;/li&gt;&lt;li&gt;âž¤ testicular failure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has neurosurgery for a pituitary tumor that requires resection of the gland. Which of the following functions of the adrenal gland will be preserved postoperatively?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Morning peak of plasma cortisol level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Release of cortisol in response to stress&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium retention in response to hypovolemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Synthesis of adrenal sex steroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sodium retention in response to hypovolemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Sodium retention in response to hypovolemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ sodium&lt;/li&gt;&lt;li&gt;âž¤ hypovolemia&lt;/li&gt;&lt;li&gt;âž¤ renin-angiotensin-aldosterone system (RAAS)&lt;/li&gt;&lt;li&gt;âž¤ ACTH&lt;/li&gt;&lt;li&gt;âž¤ ACTH&lt;/li&gt;&lt;li&gt;âž¤ cortisol production&lt;/li&gt;&lt;li&gt;âž¤ adrenal androgen synthesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is true regarding the management of pheochromocytoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î²-blockers are contraindicated in pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salt and fluid intake should be restricted&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV phentolamine is indicated for hypertensive crisis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgery is rarely required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV phentolamine is indicated for hypertensive crisis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IV phentolamine is indicated for hypertensive crisis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ IV phentolamine&lt;/li&gt;&lt;li&gt;âž¤ hypertensive crisis&lt;/li&gt;&lt;li&gt;âž¤ after alpha-blockade&lt;/li&gt;&lt;li&gt;âž¤ definitive treatment&lt;/li&gt;&lt;li&gt;âž¤ salt and fluid restriction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old female develops eye pain and reduced visual acuity following the initiation of treatment for her recently diagnosed Graves&#x27; disease. Which one of the following treatments is likely to have been started?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radioactive Iodine Ablation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thyroidectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbimazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Radioactive Iodine Ablation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Radioactive Iodine Ablation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Radioactive iodine ablation&lt;/li&gt;&lt;li&gt;âž¤ Graves&#x27; orbitopathy&lt;/li&gt;&lt;li&gt;âž¤ Graves&#x27; disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is the characteristic pattern seen in Brown-Sequard syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contralateral loss of joint sense and position&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Contralateral loss of pain sensation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ipsilateral loss of complete sensory functions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Contralateral motor function loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Contralateral loss of pain sensation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Contralateral loss of pain sensation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brown-Sequard syndrome&lt;/li&gt;&lt;li&gt;âž¤ contralateral loss of pain and temperature sensation&lt;/li&gt;&lt;li&gt;âž¤ spinothalamic tract&lt;/li&gt;&lt;li&gt;âž¤ ipsilateral loss of motor function and proprioception&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with thalassemia has a history of multiple blood transfusions, iron overload, and cardiac arrhythmia. She has now come for a blood transfusion and during the process, complains of backache and looks very anxious. What would you do next?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stop the blood transfusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continue the transfusion but do an ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stop the transfusion and wait for the patient to become normal to start it again&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Do a clerical check and get an ECG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stop the blood transfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Stop the blood transfusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ suspected acute transfusion reaction&lt;/li&gt;&lt;li&gt;âž¤ backache&lt;/li&gt;&lt;li&gt;âž¤ anxiety&lt;/li&gt;&lt;li&gt;âž¤ immediate step&lt;/li&gt;&lt;li&gt;âž¤ stop the transfusion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has recurrent optic neuritis of both eyes with extensive transverse myelitis. Visual acuity in the right eye is 6/60 and visual acuity in the left eye 6/18. The patient showed a partial response to steroids. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neuromyelitis optica&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute combined degeneration of spinal cord&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neurosyphilis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Neuromyelitis optica&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Neuromyelitis optica&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective: Neuromyelitis optica (NMO)&lt;/li&gt;&lt;li&gt;âž¤ recurrent bilateral optic neuritis&lt;/li&gt;&lt;li&gt;âž¤ extensive transverse myelitis&lt;/li&gt;&lt;li&gt;âž¤ multiple sclerosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old man with a diagnosis of acute myeloid leukemia with a blood type O negative blood group presents to the transplant clinic to discuss proceeding with an allogeneic stem cell transplant. Which of the following would be an optimal donor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;His identical twin brother&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Umbilical cord transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;An HLA identical matched unrelated donor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;His HLA identical 50-year-old brother&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. His HLA identical 50-year-old brother&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) His HLA identical 50-year-old brother&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ optimal donor&lt;/li&gt;&lt;li&gt;âž¤ HLA identical sibling&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test12" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine Test (The Champion Batch Hyderabad)   15 01 2025   2025 01 15&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine Test (The Champion Batch Hyderabad)   15 01 2025   2025 01 15&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following findings are seen in patients with stable angina?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â†‘TropI â†‘Myoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â†‘CKMB, Normal Trop I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â†‘Myoglobin, Normal CK-MB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal cardiac enzymes&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Normal cardiac enzymes&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Normal cardiac enzymes&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Stable angina is associated with normal cardiac enzymes because there is no myocardial injury or necrosis in this condition.&lt;/li&gt;&lt;li&gt;âž¤ normal cardiac enzymes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old medical student with a 2-month history of palpitations, sweating, and restlessness. He also complains of sweaty palms. His appearance is as shown in the picture. Which among the following will help in the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid receptor antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Thyroglobulin Antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ultrasensitive thyrotropin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-thyroid peroxidase antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thyroid receptor antibody&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Thyroid receptor antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyroid receptor antibodies (TRAb) are the most specific test for diagnosing Graves&#x27; disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the maximum predicted heart rate in a 45-year-old gentleman on exercise tolerance test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;165/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;175/min&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;185/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;195/min&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 175/min&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) 175/min&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The maximum predicted heart rate during exercise is calculated as 220 minus the person&#x27;s age . For a 45-year-old, the MHR is 175 beats per minute .&lt;/li&gt;&lt;li&gt;âž¤ maximum predicted heart rate&lt;/li&gt;&lt;li&gt;âž¤ 220 minus the person&#x27;s age&lt;/li&gt;&lt;li&gt;âž¤ 175 beats per minute&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For each statement, match the corresponding anti-coagulant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-1, B-ii,C-iii, D-iv&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-iii, B-i, C-iv, D-ii&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-iii, B-i, C-ii, D-iv&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-ii, B-iii, C-iv, D-i&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A-iii, B-i, C-iv, D-ii&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/image_fnpUY5H.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A-iii, B-i, C-iv, D-ii&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key properties and clinical uses of common anticoagulants:&lt;/li&gt;&lt;li&gt;âž¤ UFH: Requires monitoring with aPTT, safe in renal failure. LMWH: High bioavailability, dose adjustment needed in renal impairment. Bivalirudin: Least likely to cause HIT. Dose adjustment is critical for LMWH and Bivalirudin in renal failure.&lt;/li&gt;&lt;li&gt;âž¤ UFH: Requires monitoring with aPTT, safe in renal failure.&lt;/li&gt;&lt;li&gt;âž¤ UFH:&lt;/li&gt;&lt;li&gt;âž¤ LMWH: High bioavailability, dose adjustment needed in renal impairment.&lt;/li&gt;&lt;li&gt;âž¤ LMWH:&lt;/li&gt;&lt;li&gt;âž¤ Bivalirudin: Least likely to cause HIT.&lt;/li&gt;&lt;li&gt;âž¤ Bivalirudin:&lt;/li&gt;&lt;li&gt;âž¤ Dose adjustment is critical for LMWH and Bivalirudin in renal failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old man presents for a routine check-up, feeling well overall. Cardiac examination reveals a mid-to-late systolic murmur best heard at the apex. On further examination, the murmur becomes more pronounced when the patient stands up and decreases when he squats. The abdomen is soft and nontender, and the remainder of the physical exam is normal. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic valve regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic valve stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary valve stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitral valve prolapse&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mitral valve prolapse&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mitral valve prolapse&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In mitral valve prolapse, the murmurâ€™s intensity is increased by standing (due to reduced blood volume) and decreased by squatting (due to increased venous return), which helps distinguish it from other valvular diseases.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An old man has recurrent fainting episodes. His ECG shows p-wave at 75/min, QRS complexes are at 35 bpm. The clinical diagnosis is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Electrical alternans&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Atrial tachycardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;First degree AV block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stokes Adams Syndrome&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Stokes Adams Syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Stokes Adams Syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Production of which of the following hormones would be most impaired by lesions that affect the pituitary stalk or hypothalamus?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ACTH.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Growth hormone.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ADH.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prolactin.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. ADH.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. ADH.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old asymptomatic male presents with a grade II diastolic murmur on routine physical exam. He has no other symptoms and physical examinations showed no abnormalities. ECG and chest X-ray are normal . What is the next best step for evaluation of his murmur?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac computed tomography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Echocardiogram&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No further workup required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Echocardiogram&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/16/screenshot-2024-09-16-113011.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Echocardiogram&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 65-year-old man with a history of progressive systolic heart failure and hypotension in the cardiac care unit. Echocardiogram shows a severe reduction in left ventricular function and you clinically make the diagnosis of cardiogenic shock. You wish to start a medication that will increase the inotropic state of his heart. Which intracellular ion will increase as a result of this medication and will be responsible for increasing myocardial contractility?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Phosphorus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Potassium&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Calcium&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Calcium&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cardiogenic shock, increasing intracellular calcium is a key mechanism for improving cardiac contractility. Medications like dobutamine and milrinone work by increasing calcium levels within cardiac myocytes.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;MDR tuberculosis shows resistance to which of the following drugs?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Isoniazid, rifampicin, and fluoroquinolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluoroquinolones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Isoniazid and rifampicin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Isoniazid, rifampicin, and kanamycin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Isoniazid and rifampicin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Isoniazid and rifampicin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ MDR TB is defined as resistance to isoniazid (H) and rifampicin (R) , the two key first-line drugs used in tuberculosis treatment.&lt;/li&gt;&lt;li&gt;âž¤ isoniazid (H)&lt;/li&gt;&lt;li&gt;âž¤ rifampicin (R)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In MI, which of the following markers is most likely to be increased in the first few minutes after the onset of CP and back to baseline within 12 hours?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CK MB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;H - FABP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IMA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Trop I&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IMA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. IMA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 76-year-old man with peripheral artery disease (PAD) and persistent claudication despite exercise and optimal medical therapy (aspirin, statin, enalapril). What is the most appropriate additional treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cilostazol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Clopidogrel&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Evolocumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pentoxifylline&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cilostazol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clopidogrel : Dual antiplatelet therapy is not routinely recommended for PAD.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Clopidogrel&lt;/li&gt;&lt;li&gt;â€¢ Option C. Evolocumab : PCSK9 inhibitors are for patients with high LDL cholesterol despite statin therapy.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Evolocumab&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pentoxifylline : Not proven effective for claudication.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pentoxifylline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with peripheral artery disease and intermittent claudication, cilostazol is recommended to improve limb symptoms in addition to smoking cessation, aspirin, statin therapy, and supervised exercise.&lt;/li&gt;&lt;li&gt;âž¤ Cilostazol is contraindicated in patients with heart failure.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with normal blood pressure and no significant medical history has a lipid profile showing total cholesterol of 241 mg/dL, HDL of 49 mg/dL, LDL of 116 mg/dL, and triglycerides of 128 mg/dL. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Begin high-intensity statin therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Begin high-intensity statin therapy and ezetimibe&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Calculate 10-year risk for ASCVD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repeat lipid profile while fasting&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Calculate 10-year risk for ASCVD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Begin high-intensity statin therapy and Option B. Begin high-intensity statin therapy and ezetimibe : Starting statin therapy (with or without ezetimibe) is premature without assessing risk.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Begin high-intensity statin therapy&lt;/li&gt;&lt;li&gt;â€¢ Option B. Begin high-intensity statin therapy and ezetimibe&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat lipid profile while fasting : While fasting lipid profile is preferred, the non-fasting results do not warrant immediate repeat testing before risk assessment.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repeat lipid profile while fasting&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Cardiovascular risk scores can be used to assess a patient&#x27;s future risk for major cardiovascular events and to identify preventive interventions.&lt;/li&gt;&lt;li&gt;âž¤ The American College of Cardiology/American Heart Association Pooled Cohort Equations are commonly used to calculate the 10-year risk for atherosclerotic cardiovascular disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 67-year-old woman with stable heart failure with reduced ejection fraction (HFrEF) is on maximum doses of lisinopril, among other medications. Which treatment is most appropriate to further reduce HF hospitalizations and mortality?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Add ivabradine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increase carvedilol dosage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Switch lisinopril to valsartan-sacubitril&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Switch lisinopril to valsartan-sacubitril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin: While it can reduce HF hospitalizations, it does not improve mortality.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Digoxin:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ivabradine: Used for patients with HFrEF in sinus rhythm and a high heart rate despite beta-blocker therapy. Not applicable here.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ivabradine:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increasing carvedilol: Might not be tolerated well and has not shown the same mortality benefit as valsartan-sacubitril.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increasing carvedilol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Valsartan-sacubitril significantly reduces heart failure hospitalizations and mortality in patients with symptomatic heart failure with reduced ejection fraction and is recommended in preference to an ACE inhibitor or angiotensin receptor blocker.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with a recent type B aortic dissection presents with abdominal pain and lower limb ischemia with diminished femoral and popliteal pulses. What is the most appropriate next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Add intravenous enalaprilat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increase nitroprusside infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repair the descending aorta&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Switch nitroprusside to amlodipine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Repair the descending aorta&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Repair the descending aorta&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enalaprilat: Although used for blood pressure control, it doesn&#x27;t address the underlying issue of malperfusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Enalaprilat:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increasing nitroprusside: May help with blood pressure control but doesn&#x27;t solve the urgent need for revascularization.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Increasing nitroprusside:&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Switching to amlodipine: Not appropriate in an acute setting requiring immediate intervention.&lt;/li&gt;&lt;li&gt;â€¢ Option D.  Switching to amlodipine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the signs of complicated type B aortic dissection (malperfusion syndromes) and the need for immediate surgical/endovascular repair.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with a history of hypertension and hyperlipidemia presents with acute chest pain radiating to the left arm and jaw. ECG is shown. Which coronary artery is most likely occluded?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left anterior descending (LAD) artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left circumflex (LCx) artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right coronary artery (RCA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left main coronary artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right coronary artery (RCA)&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/05/screenshot-2024-10-05-174647.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left anterior descending (LAD) artery : Occlusion of the LAD artery typically causes ST-segment elevation in anterior leads.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left anterior descending (LAD) artery&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left circumflex (LCx) artery : Occlusion of the LCx artery typically causes ST-segment elevation in lateral leads.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Left circumflex (LCx) artery&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left main coronary artery : Occlusion of the left main coronary artery typically causes widespread ST-segment elevation.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Left main coronary artery&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the ECG findings of an inferior myocardial infarction and its association with RCA occlusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man with history of hypertension and stroke has been diagnosed with mildly symptomatic paroxysmal AF. He is currently taking rivaroxaban and metoprolol. What is the most appropriate treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left atrial appendage occlusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pacemaker implantation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rhythm control&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No additional therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rhythm control&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left atrial appendage occlusion: Indicated for stroke prevention in non-valvular AF but not the primary treatment for rhythm control.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Left atrial appendage occlusion:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pacemaker implantation: Not indicated for paroxysmal AF without symptomatic bradycardia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Pacemaker implantation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No additional therapy: Early rhythm control is recommended for this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No additional therapy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with recently diagnosed atrial fibrillation and concomitant cardiovascular conditions, early rhythm control (antiarrhythmic drugs or ablation) reduces the primary composite end point of cardiovascular death, stroke, or hospitalization for heart failure or acute coronary syndrome compared with usual care.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with complaints of heat intolerance, weight loss, and palpitations. Physical examination reveals tachycardia, tremor, and exophthalmos. Which of the following statements is most likely true regarding the hormone responsible for her symptoms?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It binds to an intracellular receptor and acts as a transcription factor.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is stored in vesicles and released by exocytosis.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It utilizes cyclic AMP (cAMP) as a second messenger.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;It is derived from cholesterol.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. It binds to an intracellular receptor and acts as a transcription factor.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) It binds to an intracellular receptor and acts as a transcription factor.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is stored in vesicles and released by exocytosis: This mechanism is characteristic of Group II hormones, such as peptide hormones and catecholamines.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It is stored in vesicles and released by exocytosis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. It utilizes cyclic AMP (cAMP) as a second messenger: While cAMP is a common second messenger, it is primarily used by Group II hormones that bind to cell surface receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option C. It utilizes cyclic AMP (cAMP) as a second messenger:&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is derived from cholesterol: This is true for steroid hormones, which are also Group I hormones. However, thyroid hormones are derived from tyrosine and iodine, not cholesterol.&lt;/li&gt;&lt;li&gt;â€¢ Option D. It is derived from cholesterol:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyroid hormones, like thyroxine (T4), bind to intracellular receptors and act as transcription factors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A neonate presents with seizures, microcephaly, and developmental delay. Brain imaging reveals abnormalities in the white matter. Genetic testing confirms a mutation in the SLC2A1 gene. What is the treatment of choice?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ketogenic diet&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valproate d&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lamotrigine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Ketogenic diet&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-091146.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Ketogenic diet&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prednisolone: This is a corticosteroid used to treat inflammation and autoimmune conditions. It is not effective in GLUT1 deficiency syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Prednisolone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Valproate and Option D. Lamotrigine: These are anti-seizure medications that are generally ineffective in controlling seizures associated with GLUT1 deficiency syndrome.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Valproate&lt;/li&gt;&lt;li&gt;â€¢ Option D. Lamotrigine:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ GLUT1 deficiency syndrome, caused by SLC2A1 gene mutation, is best treated with a ketogenic diet to bypass glucose transport issues.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following preparations of insulin has the longest time to onset and the longest duration of action?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aspart&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glargine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NPH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Regular&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glargine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-123019.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/14/screenshot-2024-08-14-123213.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glargine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspart: This is a rapid-acting insulin analog with a quick onset (15-30 minutes) and short duration (3-5 hours).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aspart:&lt;/li&gt;&lt;li&gt;â€¢ Option C. NPH: This is an intermediate-acting insulin with a slower onset (1-2 hours) and moderate duration (12-18 hours).&lt;/li&gt;&lt;li&gt;â€¢ Option C. NPH:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Regular: This is a short-acting insulin with a relatively quick onset (30-60 minutes) and shorter duration (5-8 hours).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Regular:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Glargine is a long-acting insulin analog with a slow onset (1-2 hours) and prolonged duration (20-24 hours).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following laboratory values is typically seen in hyperglycemic hyperosmolar state (HHS) and not in diabetic ketoacidosis (DKA)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Arterial pH &amp;gt;7.3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated plasma ketones&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Osmolality &amp;lt;320 mOsm/mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sodium &amp;lt;135 mEq/L&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Arterial pH &gt;7.3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Arterial pH &amp;gt;7.3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated plasma ketones: This is a hallmark of DKA, not HHS.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated plasma ketones:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osmolality &amp;lt;320 mOsm/mL: Hyperosmolarity can occur in both DKA and HHS but DKA patients tend to have a serum osmolality of &amp;lt; 320 mOsm/L. HHS patients typically have a serum osmolality of &amp;gt; 320 mOsm/L (due to extreme hyperglycemia).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osmolality &amp;lt;320 mOsm/mL:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sodium &amp;lt;135 mEq/L: Hyponatremia (low sodium) can occur in both DKA and HHS but it is less pronounced and it is often normal in HHS (in view of severe dehydration and water loss).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Sodium &amp;lt;135 mEq/L:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In HHS, the arterial pH is typically normal or near normal (&amp;gt;7.3) due to the absence of significant ketoacidosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has neurosurgery for a pituitary tumor that requires resection of the gland. Which of the following functions of the adrenal gland will be preserved in this patient immediately post-op?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Morning peak of plasma cortisol level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Release of cortisol in response to stress&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium retention in response to hypovolemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Release of DHEA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sodium retention in response to hypovolemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Sodium retention in response to hypovolemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Morning peak of plasma cortisol level: This is regulated by ACTH from the pituitary and would be impaired after pituitary resection.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Morning peak of plasma cortisol level:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Release of cortisol in response to stress: This is also regulated by ACTH and would be impaired after pituitary resection.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Release of cortisol in response to stress:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Release of DHEA: This is also regulated by ACTH and would be impaired after pituitary resection.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Release of DHEA:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Aldosterone production and function, which regulate sodium retention in response to hypovolemia, are controlled by the renin-angiotensin-aldosterone system (RAAS) and not dependent on the pituitary gland. Therefore, this function will be preserved postoperatively.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old male with uncontrolled hypertension presents with sudden left-sided weakness and difficulty speaking. He has right-sided hemiparesis and aphasia. An urgent non-contrast head CT scan is shown. What is this finding indicative of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperdense middle cerebral artery (MCA) sign&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stripe sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Radial band sign&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eye-of-the-tiger sign&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hyperdense middle cerebral artery (MCA) sign&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/21/screenshot-2024-08-21-111854.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stripe sign: Thin line of contrast enhancement within a hyperdense vessel, indicating partial occlusion.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stripe sign:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radial band sign: Linear bands of differing density in white matter, seen in multiple sclerosis.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Radial band sign:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eye-of-the-tiger sign: Hypointense globus pallidus with central hyperintensity on MRI, seen in PKAN.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Eye-of-the-tiger sign:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the hyperdense MCA sign on NCCT as an early indicator of acute ischemic stroke.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old man with uncontrolled hypertension presents unconscious with sudden severe headache, vomiting, pinpoint pupils, and a GCS of 6. CT shows a hemorrhage. What is the most likely site of the bleed?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Putamen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pons&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thalamus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pons&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Putamen: Putaminal hemorrhages usually present with contralateral hemiparesis, hemisensory loss, and homonymous hemianopia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Putamen:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellum: Cerebellar hemorrhages often present with ataxia and may not cause pinpoint pupils or rapid coma.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellum:&lt;/li&gt;&lt;li&gt;â€¢ Option D.Thalamus: Thalamic hemorrhages usually present with sensory loss, hemiparesis, and upgaze palsy.&lt;/li&gt;&lt;li&gt;â€¢ Option D.Thalamus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the characteristic features of pontine hemorrhage, a life-threatening condition often associated with hypertension, requiring immediate medical attention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which type of aphasia is characterized by fluent speech, but impaired comprehension and repetition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Broca&#x27;s aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Wernicke&#x27;s aphasia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Global aphasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Conduction aphasia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Wernicke&#x27;s aphasia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Broca&#x27;s aphasia: Broca&#x27;s aphasia is non-fluent with effortful speech, but relatively preserved comprehension.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Broca&#x27;s aphasia:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Global aphasia: Global aphasia is a severe impairment of both production and comprehension of language.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Global aphasia:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Conduction aphasia: Conduction aphasia is characterized by fluent speech, relatively good comprehension, but impaired repetition.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Conduction aphasia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Differentiate Wernicke&#x27;s aphasia from other types by its characteristic fluent but nonsensical speech and impaired comprehension.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old woman presents with increasing forgetfulness, misplacing items, forgetting appointments, depressed mood, and a lack of interest in activities. What is NOT suggestive of cortical dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Forgetfulness&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Depressed mood&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fluent speech&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Difficulty naming objects&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Depressed mood&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ While forgetfulness , fluent speech with anomia (difficulty naming objects), and executive dysfunction are common in cortical dementia, depressed mood is more characteristic of subcortical dementias or primary mood disorders.&lt;/li&gt;&lt;li&gt;â€¢ forgetfulness&lt;/li&gt;&lt;li&gt;â€¢ fluent speech&lt;/li&gt;&lt;li&gt;â€¢ anomia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Differentiate between cortical and subcortical dementia presentations, noting that depressed mood is not a hallmark of cortical dementia.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Familial hemiplegic migraine type 1 is caused due to mutation in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CACNA1A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ATP1A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SCN1A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SCN2A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CACNA1A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with progressive weakness in his right arm and leg, difficulty climbing stairs, and smaller, less legible handwriting. Exam reveals increased tone and brisk reflexes in the right extremities, along with a positive Babinski sign. Which of the following is the most likely impairment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Upper motor neuron (UMN) lesions&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lower motor neuron (LMN) lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neuromuscular junction (NMJ) lesions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Upper motor neuron (UMN) lesions&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lower motor neuron (LMN) lesions: LMN lesions present with weakness, decreased reflexes, atrophy, and fasciculations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Lower motor neuron (LMN) lesions:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neuromuscular junction (NMJ) lesions: NMJ lesions (e.g., myasthenia gravis) cause fatigable weakness and typically have normal reflexes.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Neuromuscular junction (NMJ) lesions:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myopathy: Myopathies cause weakness with normal reflexes and tone, affecting proximal muscles.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Myopathy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Recognize the clinical features that distinguish UMN lesions from other neuromuscular disorders.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with a 30-pack-year smoking history presents with chronic cough and shortness of breath. Spirometry shows an FEV1/FVC ratio of 0.60. What does this finding suggest?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Restrictive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obstructive lung disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Normal lung function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interstitial lung disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Obstructive lung disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ A reduced FEV1/FVC ratio (typically &amp;lt; 0.70) is a hallmark of obstructive lung diseases, where airflow is limited, such as COPD and asthma.&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Other options&lt;/li&gt;&lt;li&gt;â€¢ Option A. Restrictive lung disease: Characterized by reduced lung volumes with a normal or increased FEV1/FVC ratio.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Restrictive lung disease:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal lung function: Normal PFTs would show a normal FEV1/FVC ratio.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Normal lung function:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Interstitial lung disease: A type of restrictive lung disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Interstitial lung disease:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A reduced FEV1/FVC ratio (&amp;lt; 0.70) on spirometry is indicative of obstructive lung disease, commonly seen in conditions like COPD and asthma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with a history of deep vein thrombosis (DVT) six months ago. She is concerned about her risk of recurrence. Which of the following factors is the strongest predictor of recurrent venous thromboembolism (VTE)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor V Leiden mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral contraceptive use&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Active malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prior history of DVT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prior history of DVT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prior history of DVT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor V Leiden mutation: While a significant risk factor for VTE, it is not the strongest predictor of recurrence compared to a prior VTE event.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Factor V Leiden mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral contraceptive use: This is a transient risk factor that decreases after discontinuation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Oral contraceptive use:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Active malignancy: Increases VTE risk but is less predictive of recurrence than a prior VTE.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Active malignancy:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A prior history of venous thromboembolism (VTE) is the strongest predictor of recurrent events.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old banker with a history of DVT presents with progressive dyspnea, chest tightness, and syncope. PFTs are normal, but DLCO is reduced. ECHO shows elevated Right Ventricular Systolic Pressure (RVSP). What is the next BEST step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI angiogram of the thorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CT pulmonary angiogram (CTPA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start prostacyclin therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CT pulmonary angiogram (CTPA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI angiogram of the thorax: While useful for some vascular imaging, not as sensitive or readily available as CTPA for CTEPH.&lt;/li&gt;&lt;li&gt;â€¢ Option A. MRI angiogram of the thorax:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary angiography: This assesses coronary arteries, not pulmonary circulation.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Coronary angiography:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start prostacyclin therapy: This is a treatment option for PAH, but not the initial step in diagnosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Start prostacyclin therapy:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ CTPA is the primary imaging modality for diagnosing chronic thromboembolic pulmonary hypertension (CTEPH).&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 48-year-old man with a history of asthma presents to the clinic with worsening wheezing, cough, and shortness of breath. Which of the following is the LEAST likely trigger for his current exacerbation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Exposure to cat dander&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recent URI with rhinovirus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Using beta-blocker for hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Consuming large amounts of alcohol&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Consuming large amounts of alcohol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Options A. Exposure to cat dander: Animal dander is a common allergen and a well-known trigger for asthma exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Options A. Exposure to cat dander:&lt;/li&gt;&lt;li&gt;â€¢ Options B. Recent URI with rhinovirus: Viral respiratory infections are among the most common triggers of asthma exacerbations.&lt;/li&gt;&lt;li&gt;â€¢ Options B. Recent URI with rhinovirus:&lt;/li&gt;&lt;li&gt;â€¢ Options C. Using a beta-blocker for hypertension: Beta-blockers can worsen asthma symptoms due to their bronchoconstrictive effects by blocking beta-2 receptors in the airways.&lt;/li&gt;&lt;li&gt;â€¢ Options C. Using a beta-blocker for hypertension:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Alcohol consumption is not a direct trigger for bronchoconstriction and airway inflammation in asthma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old male with a history of atrial fibrillation presents with progressive dyspnea and a dry cough over the past three months. He has been on amiodarone therapy for the past year. High-resolution CT of the chest reveals findings consistent with interstitial lung disease (ILD). All of the following medications are known to cause ILD except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bleomycin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cisplatin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cisplatin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Amiodarone: Known to cause ILD, particularly with long-term use.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A. Amiodarone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Methotrexate: Associated with ILD in patients, particularly those with rheumatoid arthritis.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ B. Methotrexate:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Bleomycin: A chemotherapeutic agent well known for its potential to cause ILD&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C. Bleomycin:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective :&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone, methotrexate, and bleomycin are known to cause drug-induced interstitial lung disease (ILD), while cisplatin is not typically associated with ILD; its primary toxicities are nephrotoxicity and ototoxicity.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presents with dyspnea and pleuritic chest pain. A chest X-ray reveals a pleural effusion. Diagnostic thoracentesis is performed, and pleural fluid analysis shows the following: pleural fluid protein/serum protein ratio of 0.7. How would this pleural effusion be classified?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transudative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Exudative&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malignant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hemorrhagic&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Exudative&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Exudative&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Transudative : Transudative effusions do not meet Light&#x27;s criteria for exudative effusions and are typically due to systemic factors such as heart failure or cirrhosis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Transudative&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malignant : While malignancy can cause exudative effusions, this classification is based on Light&#x27;s criteria, not etiology.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Malignant&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemorrhagic : Refers to the presence of blood in the pleural fluid, which is a descriptive term rather than a classification based on Light&#x27;s criteria.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hemorrhagic&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A pleural effusion is classified as exudative if one or more of Light&#x27;s criteria are met, such as a pleural fluid protein/serum protein ratio &amp;gt; 0.5. In this case, the pleural fluid protein/serum protein ratio is 0.7, classifying it as exudative.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;According to the berlin definition, moderate ARDS is characterized by all, except: (NEET PG 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;PaO2/FiO2 ratio 200-300 mm/Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral interstitial infiltrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Symptom onset within a week&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No cardiac failure on echocardiography&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. PaO2/FiO2 ratio 200-300 mm/Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. PaO2/FiO2 ratio 200-300 mm/Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral interstitial infiltrates: This is correct and consistent with all classifications of ARDS, which require bilateral opacities on imaging, either from chest radiographs or CT, indicative of pulmonary edema not fully explained by cardiac failure or fluid overload.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bilateral interstitial infiltrates:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Symptom onset within a week: True for the Berlin definition, which stipulates that ARDS must occur within 7 days of a known clinical insult or new or worsening respiratory symptoms.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Symptom onset within a week:&lt;/li&gt;&lt;li&gt;â€¢ Option D. No cardiac failure on echocardiography: Also true according to the Berlin definition, as the pulmonary edema should not be fully explained by cardiac failure or fluid overload, thus necessitating the exclusion of cardiac failure through echocardiography.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No cardiac failure on echocardiography:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ 2012 Berlin Definition:&lt;/li&gt;&lt;li&gt;âž¤ 2012 Berlin Definition:&lt;/li&gt;&lt;li&gt;âž¤ Onset within 7 days after a known clinical insult or new or worsening respiratory symptoms B/L opacities (Alveolar/Interstitial that are \&quot;consistent with pulmonary edema\&quot; on chest radiographs or chest CT) Minimum PEEP setting or CPAP, 5 cm of water.&lt;/li&gt;&lt;li&gt;âž¤ Onset within 7 days after a known clinical insult or new or worsening respiratory symptoms&lt;/li&gt;&lt;li&gt;âž¤ Onset within 7 days&lt;/li&gt;&lt;li&gt;âž¤ B/L opacities (Alveolar/Interstitial that are \&quot;consistent with pulmonary edema\&quot; on chest radiographs or chest CT)&lt;/li&gt;&lt;li&gt;âž¤ \&quot;consistent with pulmonary edema\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Minimum PEEP setting or CPAP, 5 cm of water.&lt;/li&gt;&lt;li&gt;âž¤ PaO 2 : FiO 2 assessed on invasive mechanical ventilation (CPAP criterion used for the diagnosis of mild ARDS).&lt;/li&gt;&lt;li&gt;âž¤ Categorization of ARDS severity (on the basis of FiO 2 ):&lt;/li&gt;&lt;li&gt;âž¤ Categorization of ARDS severity (on the basis of FiO 2 ):&lt;/li&gt;&lt;li&gt;âž¤ Mild: 200-300 Moderate: 100-200 Severe: &amp;lt;100&lt;/li&gt;&lt;li&gt;âž¤ Mild: 200-300&lt;/li&gt;&lt;li&gt;âž¤ Moderate: 100-200&lt;/li&gt;&lt;li&gt;âž¤ Severe: &amp;lt;100&lt;/li&gt;&lt;li&gt;âž¤ In resource limited settings Kigali Modifications was proposed (2016):&lt;/li&gt;&lt;li&gt;âž¤ Kigali Modifications&lt;/li&gt;&lt;li&gt;âž¤ Bilateral opacities could be documented by either ultrasonography or chest radiograph . Oxygenation criteria: pulse oximetry oxygen saturation (SpO 2 )/FiO 2 ratio â‰¤ 315 without the requirement for PEEP.&lt;/li&gt;&lt;li&gt;âž¤ Bilateral opacities could be documented by either ultrasonography or chest radiograph .&lt;/li&gt;&lt;li&gt;âž¤ Oxygenation criteria: pulse oximetry oxygen saturation (SpO 2 )/FiO 2 ratio â‰¤ 315 without the requirement for PEEP.&lt;/li&gt;&lt;li&gt;âž¤ (SpO 2 )/FiO 2 ratio â‰¤ 315 without the requirement for PEEP.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference - Harrison/Respiratory Failure/Chap 301&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are features of the MOANS criteria except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mask seal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neck mobility&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Neck mobility&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Neck mobility&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mask seal: Difficulty in achieving a proper mask seal due to facial hair, facial injuries, etc., is a feature of MOANS.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mask seal:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Obesity: Obesity is a factor in the MOANS criteria that can complicate bag-mask ventilation due to increased airway obstruction and difficulty in ventilation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Obesity:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Age: Age over 55 can affect airway anatomy and lung compliance, making ventilation more challenging.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Age:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neck mobility is part of the LEMON criteria for assessing difficult intubation, not the MOANS criteria for predicting difficult bag-mask ventilation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old female patient is on mechanical ventilation and is being weaned off. Which mode of ventilation is best in this situation ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IMV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SIMV&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AC&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PSV&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. PSV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) PSV&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. IMV: Intermittent Mandatory Ventilation provides a set number of mandatory breaths per minute with no support to patient-initiated breaths, which is not ideal for weaning.&lt;/li&gt;&lt;li&gt;â€¢ Option A. IMV:&lt;/li&gt;&lt;li&gt;â€¢ Option B. SIMV: Synchronized Intermittent Mandatory Ventilation provides a set number of mandatory breaths per minute with synchronized support to patient-initiated breaths, but it may still provide more support than necessary for a weaning patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. SIMV:&lt;/li&gt;&lt;li&gt;â€¢ Option C. AC: Assist Control Ventilation provides a set number of mandatory breaths per minute with full support to any additional breaths initiated by the patient, which is ideal to support respiratory failure but not during weaning.&lt;/li&gt;&lt;li&gt;â€¢ Option C. AC:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pressure Support Ventilation (PSV) is the most suitable mode for weaning a patient off mechanical ventilation as it provides partial support to patient-initiated breaths, facilitating gradual assumption of breathing effort by the patient.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient with long-standing type 2 diabetes presents with fatigue, pruritus, and elevated creatinine. Renal ultrasound shows bilaterally small kidneys measuring 7 cm in length. Which of the following laboratory findings would best support a diagnosis of CKD rather than acute kidney injury (AKI)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated serum creatinine kinase (CK)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypercalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated parathyroid hormone (PTH)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated parathyroid hormone (PTH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Elevated parathyroid hormone (PTH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated serum creatinine kinase (CK) : Elevated CK is primarily seen in muscle damage, not CKD.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated serum creatinine kinase (CK)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypercalcemia : CKD often leads to hypocalcemia (low calcium) due to impaired vitamin D metabolism, not hypercalcemia.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Hypercalcemia&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypokalemia : Hypokalemia is not a primary feature of CKD, although it can occur in later stages due to medication use or other factors.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Hypokalemia&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CKD is characterized by a gradual decline in kidney function over months or years, while AKI is a sudden onset of kidney dysfunction. Elevated parathyroid hormone (PTH) is a key laboratory marker for CKD due to secondary hyperparathyroidism caused by impaired vitamin D metabolism and phosphate retention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In CKD, the remaining nephrons undergo hyperfiltration and hypertrophy to compensate for lost renal mass. Which of the following is a long-term consequence of these adaptations?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Improved renal function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glomerulosclerosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased renal blood flow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decreased intrarenal pressure&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glomerulosclerosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glomerulosclerosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Improved renal function: Hyperfiltration and hypertrophy only temporarily maintain GFR and eventually lead to decline.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Improved renal function:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased renal blood flow: While blood flow initially increases, it eventually decreases as nephrons are lost.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Increased renal blood flow:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased intrarenal pressure: Intrarenal pressure actually increases due to hyperfiltration, contributing to damage&lt;/li&gt;&lt;li&gt;â€¢ Option D. Decreased intrarenal pressure:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand that while hyperfiltration and hypertrophy are initially compensatory mechanisms in chronic kidney disease (CKD), they ultimately lead to glomerulosclerosis and progressive decline in renal function. Recognizing this pathophysiological process highlights the importance of early intervention and management to slow down the progression of CKD.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is NOT a cause of hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diuretic excess&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mineralocorticoid deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebral salt wasting syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Syndrome of inappropriate antidiuretic hormone secretion (SIADH)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diuretic excess, Option B. Mineralocorticoid deficiency, and Option C. Cerebral salt wasting syndrome are all causes of hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Diuretic excess, Option B. Mineralocorticoid deficiency, and Option C. Cerebral salt wasting syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ To understand the different types of hyponatremia and their associated urine sodium levels. Hypovolemic hyponatremia with a urine sodium level greater than 20 mEq/L is caused by renal sodium loss (e.g., diuretics, mineralocorticoid deficiency) or extrarenal sodium loss (e.g., cerebral salt wasting). SIADH is euvolemic hyponatremia with high urine sodium due to excessive water retention.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with the following laboratory values: Which of the following best describes the patientâ€™s acidâ€“base status?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis plus metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anion gap metabolic acidosis plus normal anion gap metabolic acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal anion gap metabolic acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anion gap metabolic acidosis plus normal anion gap metabolic acidosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-01-16%20130956.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anion gap metabolic acidosis plus normal anion gap metabolic acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anion gap metabolic acidosis: Does not account for the extra bicarbonate drop.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Anion gap metabolic acidosis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anion gap metabolic acidosis plus metabolic alkalosis: Would typically yield a higher bicarbonate, often with Î”â€“Î” &amp;gt; 2.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Anion gap metabolic acidosis plus metabolic alkalosis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal anion gap metabolic acidosis: The elevated AG of 18 rules out a pure normal AG acidosis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Normal anion gap metabolic acidosis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When you see a low bicarbonate and an elevated anion gap, use the Deltaâ€“Delta Ratio. A ratio &amp;lt;1 suggests coexisting anion gap and normal anion gap metabolic acidosis. Top of Form&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements about ambulatory blood pressure monitoring (ABPM) is FALSE?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;It measures BP every 15-30 minutes during the day and every 15-60 minutes at night.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It provides a more comprehensive assessment of BP than isolated clinic readings.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;It is less reliable than home BP monitoring for predicting target organ damage.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;An attenuated nocturnal BP dip is associated with increased cardiovascular risk.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. It is less reliable than home BP monitoring for predicting target organ damage.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) It is less reliable than home BP monitoring for predicting target organ damage.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. It measures BP every 15-30 minutes during the day and every 15-60 minutes at night : ABPM takes frequent BP readings throughout the day and night, providing a more complete picture than clinic readings.&lt;/li&gt;&lt;li&gt;â€¢ Option A. It measures BP every 15-30 minutes during the day and every 15-60 minutes at night&lt;/li&gt;&lt;li&gt;â€¢ Option B. It provides a more comprehensive assessment of BP than isolated clinic readings : ABPM captures BP variations throughout the day, unlike isolated clinic readings.&lt;/li&gt;&lt;li&gt;â€¢ Option B. It provides a more comprehensive assessment of BP than isolated clinic readings&lt;/li&gt;&lt;li&gt;â€¢ Option D. An attenuated nocturnal BP dip is associated with increased cardiovascular risk : Less pronounced or absent nocturnal BP dips are linked to higher cardiovascular risk. ABPM helps identify these patterns.&lt;/li&gt;&lt;li&gt;â€¢ Option D. An attenuated nocturnal BP dip is associated with increased cardiovascular risk&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ ABPM is a valuable tool for diagnosing and managing hypertension because it provides a more complete and accurate assessment of blood pressure patterns than other methods.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old male with a history of alcohol abuse presents with sudden onset of severe pain, redness, and swelling in his left big toe. What is the MOST LIKELY diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Gouty arthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudogout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Gouty arthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Gouty arthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid arthritis : This is an autoimmune condition that typically affects multiple joints symmetrically (both sides of the body). It tends to develop gradually and doesn&#x27;t usually cause sudden, severe pain in a single joint like gout does.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Rheumatoid arthritis&lt;/li&gt;&lt;li&gt;â€¢ Option C. Pseudogout: While similar to gout in terms of causing acute joint pain, pseudogout more commonly affects the knee rather than the big toe. Also, it&#x27;s not as strongly associated with alcohol use as gout.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Pseudogout:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Osteoarthritis: This is a degenerative joint disease that usually develops slowly over time. It can affect the big toe, but the onset is typically more gradual and less severe than the sudden pain seen in gout.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Osteoarthritis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gouty arthritis is a common inflammatory arthritis associated with alcohol use. It typically presents with sudden, severe pain, redness, and swelling in the big toe (podagra). Recognizing the classic presentation and risk factors can help guide appropriate diagnosis and treatment&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male presents with a 6-month history of photosensitivity, malar rash, and recurrent episodes of mucositis. He also reports headaches, seizures, and difficulty concentrating. Anti-nuclear antibody (ANA) testing is positive, and anti-dsDNA antibodies are present. A kidney biopsy reveals signs of lupus nephritis. A mutation analysis of which of the following genes is most likely to be informative, regarding the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TLR7&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IRF5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TREX1&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TNFSF4&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. TREX1&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) TREX1&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. TLR7: Gain-of-function mutations in TLR7 are associated with SLE, but they typically lead to adult-onset disease with a milder phenotype, not the early-onset and severe neuropsychiatric manifestations seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option A. TLR7:&lt;/li&gt;&lt;li&gt;â€¢ Option B. IRF5: Variants in IRF5 increase susceptibility to SLE, but they are not typically associated with monogenic forms or severe neuropsychiatric presentations.&lt;/li&gt;&lt;li&gt;â€¢ Option B. IRF5:&lt;/li&gt;&lt;li&gt;â€¢ Option D. TNFSF4: Mutations in TNFSF4 are linked to an increased risk of SLE, but they do not usually cause the specific combination of early-onset, neuropsychiatric symptoms, and lupus nephritis seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. TNFSF4:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Monogenic lupus: A small percentage of SLE cases are caused by single gene mutations, with TREX1 being one of the most well-characterized. Patients with monogenic lupus often present with early-onset disease and may have more severe manifestations, including neuropsychiatric involvement. Identifying a TREX1 mutation can confirm the diagnosis of monogenic lupus and has implications for prognosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ Monogenic lupus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;During a temporal artery biopsy for suspected giant cell arteritis, which of the following factors is MOST important for improving diagnostic yield?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obtaining a biopsy sample from the most tender area of the artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Using a large bore needle for biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Obtaining a biopsy segment of at least 3-5 cm in length&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Performing the biopsy under general anesthesia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Obtaining a biopsy segment of at least 3-5 cm in length&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Obtaining a biopsy segment of at least 3-5 cm in length&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obtaining a biopsy sample from the most tender area of the artery: While tenderness might indicate inflammation, a longer segment is more important for sampling.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Obtaining a biopsy sample from the most tender area of the artery:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Using a large bore needle for biopsy: The needle size is less relevant than the length of the biopsy specimen.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Using a large bore needle for biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Performing the biopsy under general anesthesia: General anesthesia is not typically required.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Performing the biopsy under general anesthesia:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Adequate biopsy length is essential for accurate diagnosis of GCA. While other factors like tenderness or imaging findings can guide the biopsy site, the length of the specimen is the most critical determinant of diagnostic yield.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old woman presents with progressive muscle weakness, difficulty swallowing, and a persistent skin rash. She reports feeling tired and experiencing muscle aches. Physical examination reveals erythematous papules and plaques over the knuckles and elbows. Additionally, she has a purplish rash on her eyelids and periorbital edema. On examination patient&#x27;s hands showing erythematous papules and plaques over the knuckles (as shown in the image below): Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Systemic lupus erythematosus (SLE)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Psoriasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Scleroderma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dermatomyositis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/30/screenshot-2024-07-30-120241.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dermatomyositis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic lupus erythematosus (SLE): While SLE can present with muscle weakness and skin rash, the pattern of skin involvement and presence of Gottron sign are more characteristic of dermatomyositis.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Systemic lupus erythematosus (SLE):&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psoriasis: Psoriasis typically presents with well-demarcated, silvery plaques on extensor surfaces, not the violaceous rash seen in this patient.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Psoriasis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Scleroderma: Scleroderma is characterized by skin thickening and fibrosis, not the muscle weakness and specific rash seen in this case.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Scleroderma:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Recognize the key clinical features of dermatomyositis, including Gottron&#x27;s papules and heliotrope rash, as these are important for early diagnosis and prompt initiation of treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which cancer site had the highest incidence rate among males in 2021?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lung&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prostate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Colorectal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pancreas&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Prostate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Prostate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lung: While lung cancer is the leading cause of cancer deaths, it does not have the highest number of new cases (incidence) among males (12%).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Lung:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Colorectal: Colorectal cancer is the third most common (8%) cancer in men, but its incidence rate is lower than that of prostate cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Colorectal:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreas: Pancreatic cancer is less common than prostate cancer, with a lower incidence rate.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pancreas:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Prostate cancer screening and early detection are crucial for men&#x27;s health.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents to the emergency department with severe pain in his lower back and legs. He reports that he has experienced similar pain episodes in the past, usually during times of stress or dehydration. He also mentions that he had a recent upper respiratory infection. On examination, he appears to be in distress due to pain, his temperature is 37.8Â°C (100Â°F), and his sclerae are icteric. Laboratory tests reveal a hemoglobin level of 8 g/dL, reticulocyte count of 12%, and elevated bilirubin. Peripheral blood smear shows sickle-shaped red blood cells. Which of the following is the most likely mutation responsible for the condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Non-sense mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Conservative missense mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Non-conservative missense mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Frameshift mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Non-conservative missense mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-sense mutation : This type of mutation introduces a premature stop codon, leading to truncated proteins. It is not the cause of sickle cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Non-sense mutation&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conservative missense mutation : This type of mutation changes an amino acid to another with similar properties, which usually does not significantly affect protein function. Sickle cell disease is caused by a non-conservative missense mutation.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Conservative missense mutation&lt;/li&gt;&lt;li&gt;â€¢ Option D. Frameshift mutation : This type of mutation is caused by insertions or deletions that shift the reading frame of the genetic code, resulting in a completely different amino acid sequence downstream. It is not the cause of sickle cell disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Frameshift mutation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell disease is caused by a non-conservative missense mutation in the HBB gene, leading to the substitution of glutamic acid with valine at the sixth position of the beta-globin chain. This mutation alters the properties of hemoglobin, causing red blood cells to assume a sickle shape under low oxygen conditions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In the context of cancer development, which of the following statements best differentiates proto-oncogenes from tumor suppressor genes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Proto-oncogenes causes cancer by gain of function mutations, while tumor suppressor genes cause cancer due to loss of function mutations.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Proto-oncogenes are typically inactivated in cancer, while tumor suppressor genes are overactivated.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Proto-oncogenes are exclusively found in malignant tumors, while tumor suppressor genes are found in benign tumors.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Proto-oncogenes encode for growth factors, while tumor suppressor genes encode for growth factor receptors.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Proto-oncogenes causes cancer by gain of function mutations, while tumor suppressor genes cause cancer due to loss of function mutations.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B . Proto-oncogenes are not typically inactivated in cancer; they are activated or overexpressed. Tumor suppressor genes are often inactivated or under expressed in cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B&lt;/li&gt;&lt;li&gt;â€¢ Option C. Both proto-oncogenes and tumor suppressor genes can be involved in both malignant and benign tumors.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Proto-oncogenes and tumor suppressor genes can encode a variety of proteins, not limited to growth factors and growth factor receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ Proto-oncogenes and tumor suppressor genes are two key classes of genes involved in cancer development. Proto-oncogenes promote cell growth and proliferation and can lead to cancer when mutated to gain function. Tumor suppressor genes normally inhibit cell growth, and their inactivation or loss of function can contribute to cancer development.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with mantle cell lymphoma (MCL). Which of the following genetic alterations is MOST likely associated with this malignancy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CDKN2A (p16INK4A) mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CDKN1B (p27) mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CCND1 amplification&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TP53 mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CCND1 amplification&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. CDKN2A (p16INK4A) mutation: While CDKN2A mutations can be seen in various cancers, they are more commonly associated with melanoma and other solid tumors. In mantle cell lymphoma, CDKN2A deletions are associated with poor prognosis but are not the primary driver of the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option A. CDKN2A (p16INK4A) mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDKN1B (p27) mutation: Mutations in CDKN1B are associated with MEN4 syndrome (multiple endocrine neoplasia type 4) and can be seen in other cancers, but not typically in mantle cell lymphoma.&lt;/li&gt;&lt;li&gt;â€¢ Option B. CDKN1B (p27) mutation:&lt;/li&gt;&lt;li&gt;â€¢ Option D. TP53 mutation: TP53 is a tumor suppressor gene, and mutations are found in various cancers. While TP53 mutations can occur in MCL and are associated with a worse prognosis, they are not the primary genetic alteration driving the disease.&lt;/li&gt;&lt;li&gt;â€¢ Option D. TP53 mutation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ CCND1 amplification is a hallmark of mantle cell lymphoma.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old patient presents with painless hematuria and flank pain. Imaging reveals a renal mass with characteristic features of clear cell renal cell carcinoma (RCC). Which of the following genetic alterations is MOST likely involved in the pathogenesis of this tumor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mutation in BRCA1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amplification of HER2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Loss of function mutation in VHL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Activation of KRAS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Loss of function mutation in VHL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mutation in BRCA1: BRCA1 is a tumor suppressor gene primarily associated with breast and ovarian cancers. While it can be involved in other cancers, it&#x27;s not the primary driver of clear cell renal cell carcinoma (RCC).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Mutation in BRCA1:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amplification of HER2: HER2 amplification is a key feature of certain breast cancers and some other malignancies, but not clear cell RCC.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Amplification of HER2:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activation of KRAS: KRAS is an oncogene involved in various cancers, including some types of lung and colon cancer. It is not the hallmark of clear cell RCC.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Activation of KRAS:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The VHL gene plays a crucial role in oxygen sensing and regulation of blood vessel growth. When VHL is inactivated, it leads to the stabilization and activation of hypoxia-inducible factor (HIF), which promotes angiogenesis (new blood vessel formation) and tumor growth. This is why VHL loss-of-function mutations are so strongly linked to clear cell RCC.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 58-year-old woman with metastatic pancreatic cancer is undergoing chemotherapy. Her oncologist is considering adding an antimetabolite that not only disrupts DNA synthesis but also has an inhibitory effect on RNA reductase to further hinder cancer cell growth. Which of the following medications would BEST fit this description?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fludarabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;6-Mercaptopurine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gemcitabine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5-Fluorouracil (5-FU)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gemcitabine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gemcitabine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fludarabine : Fludarabine primarily acts by incorporating into DNA and inhibiting DNA polymerase and other enzymes involved in DNA synthesis and repair. It does not have a known mechanism of action involving RNA reductase inhibition.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Fludarabine&lt;/li&gt;&lt;li&gt;â€¢ Option B. 6-Mercaptopurine : This purine analog inhibits purine synthesis, indirectly affecting both DNA and RNA synthesis. However, its primary target is not RNA reductase.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 6-Mercaptopurine&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5-Fluorouracil (5-FU) : 5-FU acts by inhibiting thymidylate synthase, an enzyme crucial for DNA synthesis. It does not directly inhibit RNA reductase.&lt;/li&gt;&lt;li&gt;â€¢ Option D. 5-Fluorouracil (5-FU)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Gemcitabine&#x27;s dual mechanism of action, targeting both DNA and RNA synthesis, makes it a valuable chemotherapeutic option for various cancers, including pancreatic cancer.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is about to start a chemotherapy regimen containing high-dose cyclophosphamide (&amp;gt;1500mg/mÂ²). Which antiemetic regimen is MOST appropriate for preventing CINV in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dexamethasone alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5HT3 antagonist alone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dexamethasone + 5HT3 antagonist&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Dexamethasone + 5HT3 antagonist + NK1 receptor antagonist&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Dexamethasone + 5HT3 antagonist + NK1 receptor antagonist&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Dexamethasone + 5HT3 antagonist + NK1 receptor antagonist&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dexamethasone alone: While dexamethasone has antiemetic properties, it is not sufficient on its own to prevent CINV in high-risk regimens like those involving high-dose cyclophosphamide.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Dexamethasone alone:&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5HT3 antagonist alone: 5HT3 antagonists are effective antiemetics, but they are not potent enough to control CINV in high-risk settings when used alone.&lt;/li&gt;&lt;li&gt;â€¢ Option B. 5HT3 antagonist alone:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dexamethasone + 5HT3 antagonist: This combination provides better control than either drug alone, but it may still be inadequate for high-risk chemotherapy. The addition of an NK1 receptor antagonist further enhances antiemetic efficacy in these cases.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Dexamethasone + 5HT3 antagonist:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ High-risk emetogenic chemotherapy requires a triple-drug antiemetic regimen to effectively prevent CINV.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old man with acute myeloid leukemia (AML) undergoing chemotherapy presents to the emergency department with a 2-day history of fever, right lower quadrant abdominal pain, and watery diarrhea. His absolute neutrophil count (ANC) is 300/ÂµL. Abdominal CT scan reveals cecal wall thickening. Which of the following is the MOST likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Appendicitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diverticulitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neutropenic enterocolitis (typhlitis)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic colitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neutropenic enterocolitis (typhlitis)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neutropenic enterocolitis (typhlitis)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Appendicitis: While appendicitis can present with similar symptoms, it is less likely in this patient with neutropenia and cecal wall thickening.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Appendicitis:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diverticulitis: Diverticulitis typically affects the left colon and is less common in younger individuals.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Diverticulitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic colitis: Ischemic colitis is more common in older individuals with cardiovascular risk factors. It usually presents with bloody diarrhea and is less likely in the context of neutropenia.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Ischemic colitis:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective:&lt;/li&gt;&lt;li&gt;â€¢ Neutropenic enterocolitis is a life-threatening complication that can occur in patients with severe neutropenia. Early recognition and prompt treatment are essential.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with a history of squamous cell lung cancer presents with fatigue, constipation, and confusion. Her laboratory tests reveal a serum calcium level of 13 mg/dL. Which of the following is the MOST Common mechanism underlying her hypercalcemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased bone resorption mediated by parathyroid hormone-related protein (PTHrP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ectopic production of 1,25-dihydroxyvitamin D (1,25 DHCC)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Osteolytic bone metastases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Increased bone resorption mediated by parathyroid hormone-related protein (PTHrP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Increased bone resorption mediated by parathyroid hormone-related protein (PTHrP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ectopic production of 1,25-dihydroxyvitamin D (1,25 DHCC): This mechanism is more commonly seen in lymphomas and some other solid tumors, not as frequently in squamous cell lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Ectopic production of 1,25-dihydroxyvitamin D (1,25 DHCC):&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osteolytic bone metastases: While possible, it is less frequent than PTHrP production as the cause of hypercalcemia in squamous cell lung cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Osteolytic bone metastases:&lt;/li&gt;&lt;li&gt;â€¢ Option D. All of the above: Although all three mechanisms can contribute to hypercalcemia in SCC, PTHrP-mediated bone resorption is the most prevalent.&lt;/li&gt;&lt;li&gt;â€¢ Option D. All of the above:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ PTHrP-mediated bone resorption is the predominant mechanism of hypercalcemia in squamous cell lung cancer and certain other malignancies.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old woman presents to the clinic with a 2-month history of progressive memory loss, confusion, and episodes of hallucinations. Her family also reports a change in her behavior, describing her as increasingly irritable and sometimes displaying inappropriate emotional responses. She was recently diagnosed with lung cancer. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cortical encephalitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Limbic encephalitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellar encephalitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Brainstem encephalitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Limbic encephalitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Limbic encephalitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cortical encephalitis: Would involve more widespread cerebral cortex symptoms, including significant changes in cognition, motor, and sensory functions but might not specifically target memory and emotional regulation as in limbic encephalitis.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Cortical encephalitis:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Cerebellar encephalitis: Would primarily affect coordination, gait, and balance due to inflammation of the cerebellum, and would be less likely to cause the memory and behavioral symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option C.&lt;/li&gt;&lt;li&gt;â€¢ Cerebellar encephalitis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Brainstem encephalitis: Would involve symptoms related to the functions of the brainstem, including vital functions, cranial nerve functions, and coordination, rather than primarily memory and behavior.&lt;/li&gt;&lt;li&gt;â€¢ Option D.&lt;/li&gt;&lt;li&gt;â€¢ Brainstem encephalitis:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Limbic encephalitis presents with progressive memory loss, confusion, behavioral changes, and sometimes hallucinations due to the involvement of the limbic system. It can be associated with lung cancer as a paraneoplastic syndrome, where the immune system&#x27;s response to the cancer also affects the nervous system.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old woman with a history of cervical cancer is being considered for targeted radionuclide therapy using an alpha-emitting radiopharmaceutical. The discussion focuses on the ionizing power of alpha particles in targeting residual microscopic disease. Which statement best describes the ionizing power of alpha particles in this therapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Low ionizing power for deep tissue penetration and targeting distant metastases.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High ionizing power causing dense ionization with limited penetration, ideal for localized disease.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extremely high ionizing power causing widespread damage beyond targeted cells, high toxicity risk.&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Similar ionizing power to beta particles but with longer range, suitable for larger tumors.&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. High ionizing power causing dense ionization with limited penetration, ideal for localized disease.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) High ionizing power causing dense ionization with limited penetration, ideal for localized disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Alpha particles actually have low penetration in tissue, not deep tissue penetration, which limits their use to more localized or superficial treatments rather than targeting distant metastases.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ A.&lt;/li&gt;&lt;li&gt;â€¢ Option C. While alpha particles have a high ionizing power, they do not cause widespread damage beyond targeted cells due to their limited penetration range. The risk of toxicity is more related to their potential to cause significant damage within a short range, which is why they need to be precisely targeted.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ C.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Alpha particles have a much higher ionizing power compared to beta particles but a much shorter range in tissue. Beta particles can penetrate deeper into tissue, making them suitable for larger tumors, whereas alpha particles are more effective for localized treatment due to their short range.&lt;/li&gt;&lt;li&gt;â€¢ Option&lt;/li&gt;&lt;li&gt;â€¢ D.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Alpha-emitting radiopharmaceuticals are utilized in targeted radionuclide therapy for their high ionizing power, which allows for dense ionization and significant DNA damage within cancer cells. Their limited penetration depth makes them ideal for treating localized microscopic disease while minimizing collateral damage to surrounding healthy tissue.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A radiation oncologist is planning a course of radiotherapy for a patient with a large, solid tumor. The oncologist is concerned about the presence of hypoxic regions within the tumor, as these areas are known to be relatively resistant to radiation. To enhance the effectiveness of the treatment, the oncologist decides to fractionate the radiation dose, delivering it in multiple smaller doses over several weeks. Which of the following, oncologist primarily leveraging by using fractionated radiotherapy to target hypoxic tumor cells?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Re-assortment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Re-oxygenation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Repair&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Repopulation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Re-oxygenation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Re-assortment: This refers to the redistribution of tumor cells into more radiosensitive phases of the cell cycle after radiation. While this can contribute to overall tumor cell killing, it&#x27;s not the primary mechanism for overcoming hypoxia.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Re-assortment:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Repair: This process allows normal tissues to recover between radiation fractions, reducing toxicity. However, it&#x27;s not directly related to addressing hypoxia in tumor cells.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Repair:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repopulation: This refers to the accelerated growth of both normal and tumor cells between fractions. While it can benefit normal tissue repair, it can also lead to tumor regrowth and is not specifically aimed at hypoxic cells.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Repopulation:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Re-oxygenation is a critical factor in the success of fractionated radiotherapy. By allowing time between doses for hypoxic tumor cells to become oxygenated, it increases their radiosensitivity and improves the overall effectiveness of the treatment.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old postmenopausal woman with a family history of breast cancer is concerned about her risk of developing the disease. Her past medical history is significant for fibroadenoma and alcohol use. Which of the following factors most significantly increases her risk for breast cancer?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Family history of breast cancer&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Past history of fibroadenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Advanced age&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Moderate alcohol consumption&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Advanced age&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Advanced age&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Family history of breast cancer: Although a family history of breast cancer is an important risk factor, especially if the cancer occurred in a first-degree relative or involved high-risk genes like BRCA1 or BRCA2, the overall risk increases with age regardless of family history.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Family history of breast cancer:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Past history of fibroadenoma : Fibroadenomas are benign breast tumors and are not considered a significant risk factor for developing breast cancer. They are common in younger women and do not significantly increase the risk of breast cancer.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Past history of fibroadenoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Moderate alcohol consumption : While alcohol consumption is associated with an increased risk of breast cancer, the risk level is generally lower compared to the risk associated with advancing age. The risk increases with the amount of alcohol consumed, but age remains a more significant factor.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Moderate alcohol consumption&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Advanced age is a significant risk factor for breast cancer, with most cases diagnosed in women aged 50 years and older. The risk increases with age due to factors such as cumulative exposure to estrogen and the increased likelihood of genetic mutations over time.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old female presents with fatigue and pallor. Her reticulocyte count is 5%, hemoglobin is 9 g/dL, and hematocrit is 28%. What is her corrected reticulocyte count?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2.5%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3.0%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;5.0%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;10.0%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 3.0%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 3.0%.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most common cause of death in adult patients with sickle cell disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute chest syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sepsis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary hypertension&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute chest syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute chest syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stroke: While stroke is a significant cause of morbidity and mortality in children with sickle cell disease (SCD), it is less common in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Stroke:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sepsis: Sepsis is a major concern in SCD patients of all ages due to functional asplenia (decreased spleen function). However, acute chest syndrome remains the leading cause of death in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Sepsis:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary hypertension: Pulmonary hypertension is a serious complication of SCD, contributing to morbidity and mortality. However, it is not as frequent a cause of death as acute chest syndrome in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Pulmonary hypertension:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Early recognition and aggressive management of acute chest syndrome are crucial in preventing mortality in sickle cell disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with blood type A requires a blood transfusion. Which of the following blood types could they safely receive?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A and AB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A and O&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A, B, and AB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Only A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A and O&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A and O&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. A and AB: Type AB blood contains B antigens, which would react with the recipient&#x27;s anti-B antibodies, leading to a transfusion reaction.&lt;/li&gt;&lt;li&gt;â€¢ Option A. A and AB:&lt;/li&gt;&lt;li&gt;â€¢ Option C. A, B, and AB: Type B blood would also react with the recipient&#x27;s anti-B antibodies.&lt;/li&gt;&lt;li&gt;â€¢ Option C. A, B, and AB:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Only A: While type A blood is compatible, type O is also safe for transfusion to a person with type A blood.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Only A:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Understanding ABO compatibility is crucial for safe blood transfusions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents to the clinic with a two-week history of easy bruising and pinprick red spots on her lower legs. She denies any recent injuries or medication use. On examination, she has multiple petechiae on her skin and mucous membranes. Blood investigations except low platelet count, imagings turned out to be normal. What&#x27;s the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aplastic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immune thrombocytopenia (ITP)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Myelodysplastic syndrome (MDS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombotic microangiopathy (TMA)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Immune thrombocytopenia (ITP)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Immune thrombocytopenia (ITP)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aplastic anemia : While it can cause thrombocytopenia, it also affects other cell lines (red blood cells and white blood cells).&lt;/li&gt;&lt;li&gt;â€¢ Option A. Aplastic anemia&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myelodysplastic syndrome (MDS) : MDS can cause thrombocytopenia, but it is more common in older adults and often presents with other cytopenias.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Myelodysplastic syndrome (MDS)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic microangiopathy (TMA) : TMA causes thrombocytopenia through a different mechanism (platelet consumption in microvascular thrombi).&lt;/li&gt;&lt;li&gt;â€¢ Option D. Thrombotic microangiopathy (TMA)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ ITP is a diagnosis of exclusion, meaning other causes of thrombocytopenia need to be ruled out.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the PRIMARY agonist responsible for platelet aggregation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thromboxane A2 (TxA2)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Adenosine Diphosphate (ADP)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Fibrinogen&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Fibrinogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Fibrinogen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thromboxane A2 (TxA2) : TxA2 is a potent platelet activator and vasoconstrictor, but it does not directly mediate platelet aggregation.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Thromboxane A2 (TxA2)&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine Diphosphate (ADP) : ADP is a weak platelet activator that promotes platelet aggregation by binding to P2Y12 and P2Y1 receptors.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Adenosine Diphosphate (ADP)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thrombin : Thrombin is a powerful platelet activator and promotes aggregation through protease-activated receptors (PARs).&lt;/li&gt;&lt;li&gt;â€¢ Option C. Thrombin&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Fibrinogen is the primary agonist responsible for platelet aggregation by cross-linking activated platelets through GP IIb/IIIa receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the maximum storage duration for PRBCs at 2-6Â°C?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;21 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;35 days&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;42 days&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;56 days&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 42 days&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 42 days&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old woman presents with pancytopenia and a bone marrow biopsy revealing trilineage dysplasia. Cytogenetic analysis shows a normal karyotype. Which of the following would be the most appropriate next step in the workup?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Repeat bone marrow biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Molecular testing for gene mutations&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Start treatment with erythropoietin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transfuse packed red blood cells and platelets&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Molecular testing for gene mutations&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Molecular testing for gene mutations&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Repeat bone marrow biopsy: Repeat bone marrow biopsy is not necessary if the initial biopsy is diagnostic.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Repeat bone marrow biopsy:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start treatment with erythropoietin: Erythropoietin is used to treat anemia in MDS, but it is not a diagnostic test.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Start treatment with erythropoietin:&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transfuse packed red blood cells and platelets: Transfusion support may be needed, but it is not the next step in the diagnostic workup.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Transfuse packed red blood cells and platelets:&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Molecular testing for gene mutations is essential for the accurate diagnosis and management of MDS, especially in cases with a normal karyotype.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old woman presents with painless cervical lymphadenopathy and pruritus. Excisional biopsy of a lymph node reveals Reed-Sternberg (RS) cells positive for CD15 and CD30. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Classical Hodgkin Lymphoma (CHL)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse large B-cell lymphoma (DLBCL)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Follicular lymphoma (FL)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Classical Hodgkin Lymphoma (CHL)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Classical Hodgkin Lymphoma (CHL)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) : This subtype is characterized by \&quot;popcorn\&quot; cells, which are negative for CD15 and CD30.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diffuse large B-cell lymphoma (DLBCL) and Option D. Follicular lymphoma (FL) : These are non-Hodgkin lymphomas with different histopathological features.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Diffuse large B-cell lymphoma (DLBCL)&lt;/li&gt;&lt;li&gt;â€¢ Option D. Follicular lymphoma (FL)&lt;/li&gt;&lt;li&gt;â€¢ Educational objective :&lt;/li&gt;&lt;li&gt;â€¢ Educational objective&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ CHL is diagnosed based on the presence of classic RS cells positive for CD15 and CD30.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;According to the Advanced Trauma Life Support (ATLS) definition, massive transfusion is defined as:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transfusion of &amp;gt;5 units of packed red blood cells (PRBCs) in 24 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Transfusion of &amp;gt;10 units of PRBCs in 24 hours&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transfusion of any amount of PRBCs in a patient with hemorrhagic shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transfusion of PRBCs, platelets, and plasma in a 1:1:1 ratio&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Transfusion of &gt;10 units of PRBCs in 24 hours&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Transfusion of &amp;gt;10 units of PRBCs in 24 hours&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following patterns of liver function tests (LFTs) is most consistent with acute viral hepatitis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated ALT, normal AST&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Elevated AST, normal ALT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ALT and AST&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Elevated alkaline phosphatase, normal ALT and AST&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Elevated ALT and AST&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Elevated ALT, normal AST : While elevated ALT is characteristic of hepatocellular injury, normal AST levels would be less typical in acute viral hepatitis where both enzymes are usually elevated.&lt;/li&gt;&lt;li&gt;â€¢ Option A.&lt;/li&gt;&lt;li&gt;â€¢ Elevated ALT, normal AST&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT : While elevated AST can indicate hepatocellular injury, normal ALT levels would be less consistent with acute viral hepatitis.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Elevated AST, normal ALT&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST : This pattern is more suggestive of cholestatic liver disease rather than acute viral hepatitis, as alkaline phosphatase levels are typically elevated in cholestasis.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Elevated alkaline phosphatase, normal ALT and AST&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In acute viral hepatitis, both ALT and AST levels are typically elevated, reflecting hepatocellular injury.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following clinical features is most indicative of advanced cirrhosis with portal hypertension?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Easy bruising&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Spider nevi&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Caput medusae&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Caput medusae&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/20/screenshot-2024-08-20-140329.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Caput medusae&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Jaundice: Jaundice is a sign of liver dysfunction but is not specific to portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Jaundice:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Easy bruising: Easy bruising can indicate liver dysfunction due to decreased production of clotting factors but, like jaundice, is not specific to portal hypertension.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Easy bruising:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spider nevi: Spider nevi are associated with liver disease but are less specific for portal hypertension compared to caput medusae.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Spider nevi:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Caput medusae is a clinical feature indicative of portal hypertension in the setting of advanced cirrhosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old male presents with dysphagia, regurgitation of undigested food, halitosis and history of recurrent aspiration pneumonia. Upper endoscopy reveals a pathology in the upper esophagus. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Achalasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Esophageal stricture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Zenker&#x27;s diverticulum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Barrett&#x27;s esophagus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Zenker&#x27;s diverticulum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Achalasia: Achalasia is characterized by the failure of the lower esophageal sphincter to relax and by aperistalsis of the esophagus, leading to dysphagia and regurgitation, but it does not involve the formation of a diverticulum.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Achalasia:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture : An esophageal stricture typically presents with progressive dysphagia, particularly for solid foods, and is usually caused by chronic gastroesophageal reflux disease (GERD), radiation, or ingestion of caustic substances, but it does not cause a diverticulum.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Esophageal stricture&lt;/li&gt;&lt;li&gt;â€¢ Option D. Barrett&#x27;s esophagus: It is a condition where the lining of the esophagus is replaced by tissue similar to the lining of the intestine, usually as a result of chronic GERD. It is associated with an increased risk of esophageal adenocarcinoma but does not present with a diverticulum or the specific symptoms described.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Barrett&#x27;s esophagus:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Zenker&#x27;s diverticulum is characterized by dysphagia, regurgitation of undigested food, halitosis, and the presence of a pulsion diverticulum just above the upper esophageal sphincter.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 78-year-old woman presents with exertional dyspnea, and chest pain. Echo was done and showed severe aortic stenosis, He has hypertension, chronic kidney disease (stage G4), hyperlipidemia, severe COPD, and atrial fibrillation. What is the most appropriate next step in treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Balloon aortic valvuloplasty&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continued medical therapy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Surgical aortic valve replacement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Transcatheter aortic valve implantation (TAVI)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Transcatheter aortic valve implantation (TAVI)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Transcatheter aortic valve implantation is recommended in preference to surgical aortic valve replacement for symptomatic patients with severe aortic stenosis who are older than 80 years or younger patients with a life expectancy less than 10 years.&lt;/li&gt;&lt;li&gt;âž¤ Transcatheter aortic valve implantation is recommended for symptomatic patients of any age with severe aortic stenosis and a high or prohibitive surgical risk if predicted post procedure survival is more than 12 months with an acceptable quality of life.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old asymptomatic man is found to have a patent ductus arteriosus (PDA) with left- atrial and ventricular enlargement on echocardiogram. The estimated right ventricular systolic pressure is 30 mmHg and RV is normal in size. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Indomethacin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PDA device closure&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serial echocardiographic monitoring&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PDA device closure&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI : While it can provide detailed information, echocardiography is sufficient to confirm the diagnosis and indication for closure.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac MRI&lt;/li&gt;&lt;li&gt;â€¢ Option B. Indomethacin : Used to close PDA in premature infants, not effective in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Indomethacin&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serial echocardiographic monitoring : Not recommended when closure is already indicated due to left heart enlargement.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Serial echocardiographic monitoring&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ PDA closure is indicated in patients with left-sided cardiac chamber enlargement even in the absence of symptoms, as long as PA systolic pressure is &amp;lt; 50% of systemic.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old non-smoker presents with dyspnea, chest pain, and pulsus paradoxus. Echocardiogram shows a large pericardial effusion and a right atrial mass. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Atrial myxoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bronchogenic carcinoma with cardiac metastasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardiac angiosarcoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Papillary fibroelastoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cardiac angiosarcoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation&lt;/li&gt;&lt;li&gt;â€¢ :&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial myxoma : More common in the left atrium, less likely to cause bloody effusion.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Atrial myxoma&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchogenic carcinoma : Less likely in a non-smoker, and presentation is not typical.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Bronchogenic carcinoma&lt;/li&gt;&lt;li&gt;â€¢ Option D. Papillary fibroelastoma : Usually found on heart valves, not associated with pericardial effusion.&lt;/li&gt;&lt;li&gt;â€¢ Option D. Papillary fibroelastoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cardiac angiosarcomas are rare malignant cardiac tumors that typically arise within the right atrium and are commonly associated with sanguinous pericardial effusion.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 75-year-old man with a history of bioprosthetic aortic valve replacement presents with intermittent fever and dyspnea 3 years after the procedure. TTE is normal. What is the most appropriate diagnostic test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac CT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiac MRI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Transesophageal echocardiography (TEE)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;No further testing&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Transesophageal echocardiography (TEE)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac CT : Less sensitive than TEE for detecting vegetations.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Cardiac CT&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac MRI : Not the first-line imaging modality for PVE.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Cardiac MRI&lt;/li&gt;&lt;li&gt;â€¢ Option D. No further testing : Inappropriate given the suspicion for PVE.&lt;/li&gt;&lt;li&gt;â€¢ Option D. No further testing&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective&lt;/li&gt;&lt;li&gt;âž¤ :&lt;/li&gt;&lt;li&gt;âž¤ In patients with suspected infective endocarditis, transthoracic echocardiography is recommended as the initial imaging choice in most clinical situations.&lt;/li&gt;&lt;li&gt;âž¤ TEE is the preferred imaging modality to evaluate for PVE when TTE is inconclusive or if complications have developed or are clinically suspected or if intracardiac device leads are present, transesophageal echocardiography is recommended.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 28-year-old African American male presents with nephrotic syndrome and progressive renal failure. Renal biopsy reveals focal segmental glomerulosclerosis (FSGS). Which of the following genetic polymorphisms is most likely associated with his condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;NPHS1 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NPHS2 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TRPC6 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;APOL1 polymorphism&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. APOL1 polymorphism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) APOL1 polymorphism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;amp; B. NPHS1 and NPHS2: Mutations are associated with congenital nephrotic syndrome, not FSGS in adults.&lt;/li&gt;&lt;li&gt;â€¢ Option A. &amp;amp; B. NPHS1 and NPHS2:&lt;/li&gt;&lt;li&gt;â€¢ Option C. TRPC6 mutations: Can cause FSGS, but they are less common than APOL1 variants in African Americans.&lt;/li&gt;&lt;li&gt;â€¢ Option C. TRPC6 mutations:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ APOL1 gene variants are a significant risk factor for focal segmental glomerulosclerosis (FSGS) and other forms of non-diabetic kidney disease in individuals of African descent.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 35-year-old woman presents with weight loss, heat intolerance, and palpitations. Her TSH is normal, and free T4 is elevated. Which of the following is the most likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Graves&#x27; disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Toxic multinodular goiter&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute thyroiditis (de Quervain&#x27;s thyroiditis)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TSH-secreting pituitary adenoma&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. TSH-secreting pituitary adenoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) TSH-secreting pituitary adenoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Option A. Graves&#x27; disease: TSH would be suppressed as it is a primary hyperthyroidism. RAIU will show diffuse increase in uptake of Iodine.&lt;/li&gt;&lt;li&gt;â€¢ Option A. Graves&#x27; disease:&lt;/li&gt;&lt;li&gt;â€¢ Option B. Toxic multinodular goiter: TSH would be suppressed as it is a primary hyperthyroidism. RAIU will show patchy multi-focal increased uptake of Iodine.&lt;/li&gt;&lt;li&gt;â€¢ Option B. Toxic multinodular goiter:&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subacute thyroiditis (de Quervain&#x27;s thyroiditis): TSH would be suppressed as it is a primary hyperthyroidism. RAIU will show decreased uptake.&lt;/li&gt;&lt;li&gt;â€¢ Option C. Subacute thyroiditis (de Quervain&#x27;s thyroiditis):&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A TSH-secreting pituitary adenoma is indicated by the combination of normal TSH and elevated free T4, consistent with central hyperthyroidism.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman with chronic kidney disease presents with muscle cramps and tingling in her fingers. Her serum calcium is 7.7 mg/dL (normal: 8.5-10.5 mg/dL) and serum albumin is 3.0 g/dL (normal range: 3.5-5.0 g/dL). What is her corrected calcium level?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;8.0 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;8.3 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;8.5 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;9.0 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 8.5 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 8.5 mg/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Explanation:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â€¢ Explanation:&lt;/li&gt;&lt;li&gt;â€¢ Corrected calcium is calculated using the following formula:&lt;/li&gt;&lt;li&gt;â€¢ Corrected calcium (mg/dL) = Measured calcium (mg/dL) + 0.8 x (4.0 - Albumin [g/dL])&lt;/li&gt;&lt;li&gt;â€¢ In this case:&lt;/li&gt;&lt;li&gt;â€¢ Corrected calcium = 7.5 + 0.8 x (4.0 - 3.0) = 7.7 + 0.8 = 8.5 mg/dL&lt;/li&gt;&lt;li&gt;â€¢ Therefore, the patient&#x27;s corrected calcium level is 8.5 mg/dL, which is within the normal range.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ To calculate the corrected calcium level in patients with low serum albumin, use the formula:&lt;/li&gt;&lt;li&gt;âž¤ Corrected calcium (mg/dL) = Measured calcium (mg/dL) + 0.8 x (4.0 - Albumin [g/dL])&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the cardiac biomarkers is the earliest to rise in myocardial injury?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Myoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ischemia modified albumin (IMA)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Troponin I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Troponin T&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ischemia modified albumin (IMA)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/28/picture108.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ischemia modified albumin (IMA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman presented with complaints of recurrent anxiety, headaches, hypertension, and palpitation. Patient has had similar episodes in the past. Laboratory studies revealed an elevated urinary metanephrines. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Renal artery stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Addisonâ€™s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pheochromocytoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/06/med1.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pheochromocytoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old patient presented with chronic projectile vomiting and weight loss. What is the likely metabolic abnormality that can be seen?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypokalemic hypochloremic metabolic alkalosis with hyponatremia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypokalemic hypochloremic metabolic alkalosis with hypernatremia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypokalemic hypochloremic metabolic alkalosis with hypercalcemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypokalemic hypochloremic metabolic acidosis with hyponatremia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypokalemic hypochloremic metabolic alkalosis with hyponatremia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypokalemic hypochloremic metabolic alkalosis with hyponatremia.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old hypertensive patient presents with fluctuating blood pressure readings, a double apical impulse, bilateral basal crepitations, and difficulty in ascertaining the heart rate due to an irregularly irregular rhythm. No murmurs were detected on auscultation. Based on these findings, what is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Left atrial myxoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cor pulmonale&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Left ventricular hypertrophy&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Left ventricular hypertrophy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the context of a hypertensive patient presenting with symptoms including an irregularly irregular rhythm and a double apical impulse, left ventricular hypertrophy is a possible underlying cause, especially considering the patient&#x27;s hypertension. LVH can lead to changes in the heart&#x27;s structure and function that may cause or be associated with arrhythmias like atrial fibrillation and complications such as heart failure, indicated by basal crepitations.&lt;/li&gt;&lt;li&gt;âž¤ In the context of a hypertensive patient presenting with symptoms including an irregularly irregular rhythm and a double apical impulse, left ventricular hypertrophy is a possible underlying cause, especially considering the patient&#x27;s hypertension.&lt;/li&gt;&lt;li&gt;âž¤ LVH can lead to changes in the heart&#x27;s structure and function that may cause or be associated with arrhythmias like atrial fibrillation and complications such as heart failure, indicated by basal crepitations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old medical student develops extreme shortness of breath and develops blue fingertips and bilateral crackles after trekking in Ladakh. What is the probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹â€‹ Frost bite&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹â€‹â€‹ Acute interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹â€‹â€‹ Non-cardiogenic pulmonary oedema&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. â€‹â€‹â€‹â€‹â€‹ Non-cardiogenic pulmonary oedema&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Non cardiogenic pulmonary oedema&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a young individual with acute respiratory distress and bilateral crackles following rapid ascent to high altitude, consider High Altitude Pulmonary Edema (HAPE), which is non-cardiogenic in nature. It is important to distinguish HAPE from other forms of pulmonary edema and respiratory conditions like pneumonia, which have different treatments and implications.&lt;/li&gt;&lt;li&gt;âž¤ In a young individual with acute respiratory distress and bilateral crackles following rapid ascent to high altitude, consider High Altitude Pulmonary Edema (HAPE), which is non-cardiogenic in nature.&lt;/li&gt;&lt;li&gt;âž¤ It is important to distinguish HAPE from other forms of pulmonary edema and respiratory conditions like pneumonia, which have different treatments and implications.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An alcoholic developed intractable vomiting for 2 days with loose motions. Since he had decreased food intake and altered sensorium, he was brought to the hospital, where the fluid loss and dyselectrolytemia was aggressively corrected with fluid infusion. Post treatment, the patient started having quadriplegia and mutism. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â€‹â€‹â€‹â€‹ Osmotic demyelination syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Syndrome of inappropriate ADH production&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brain stem infarct â€‹â€‹â€‹â€‹&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute disseminated encephalomyelitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. â€‹â€‹â€‹â€‹ Osmotic demyelination syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The rapid correction of hyponatremia, particularly in individuals who are malnourished or chronically ill (such as those with chronic alcoholism), can lead to osmotic demyelination syndrome. This is characterized by neurological symptoms that can develop days after the overly rapid correction of sodium levels. Care must be taken to correct sodium slowly in at-risk patients to prevent this serious complication.&lt;/li&gt;&lt;li&gt;âž¤ The rapid correction of hyponatremia, particularly in individuals who are malnourished or chronically ill (such as those with chronic alcoholism), can lead to osmotic demyelination syndrome.&lt;/li&gt;&lt;li&gt;âž¤ This is characterized by neurological symptoms that can develop days after the overly rapid correction of sodium levels.&lt;/li&gt;&lt;li&gt;âž¤ Care must be taken to correct sodium slowly in at-risk patients to prevent this serious complication.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old man complains of double vision and difficulty speaking and breathing daily in the evening. Examination shows the following appearance. His peripheral muscle tone and deep tendon reflexes were normal. What is the most likely cause?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibodies to acetylcholine receptors&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antibodies to presynaptic calcium channels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Demyelination of the central nervous system&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Demyelination of the peripheral nervous system&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Antibodies to acetylcholine receptors&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/12/screenshot-2024-06-12-173300.JPG&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Antibodies to acetylcholine receptors&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Myasthenia gravis is an autoimmune disease caused by antibodies against acetylcholine receptors.&lt;/li&gt;&lt;li&gt;âž¤ Myasthenia gravis is an autoimmune disease caused by antibodies against acetylcholine receptors.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 15-year-old boy presents with leg swelling, recurrent canker sores, and painful genital ulcers. Examination reveals evidence of deep vein thrombosis but no urethritis or conjunctivitis. What is the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polymyalgia rheumatica&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Behcet syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Drug-induced lupus erythematous&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Behcet syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Behcet syndrome is characterized by recurrent oral and genital ulcers, deep vein thrombosis, and inflammation throughout the body.&lt;/li&gt;&lt;li&gt;âž¤ Behcet syndrome is characterized by recurrent oral and genital ulcers, deep vein thrombosis, and inflammation throughout the body.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 42-year-old woman with severe muscle and joint pain, morning stiffness, and tingling in her lower limbs has normal ESR and TSH. Physical exam reveals muscular tenderness. What is the most appropriate pharmacotherapy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin B12&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amitriptyline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Amitriptyline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amitriptyline is used for fibromyalgia&lt;/li&gt;&lt;li&gt;âž¤ Amitriptyline is used for fibromyalgia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Thrombosis of posterior inferior cerebellar artery causes? (NEET PG 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lateral medullary syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Weber syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Medial medullary syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Millard Gubler syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lateral medullary syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163123.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-164951.jpg&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-163156.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Lateral Medullary syndrome.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Image showing arteries involved in brainstem syndromes lateral vs medial brainstem.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference - Harrison 21E/Chap 426/Neurology/stroke&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old female patient is brought to the ER in a state of unconsciousness. Her BP is 70/50 mm of Hg and her ECG is shown below. What is the next best step in the management of her condition? (NEET PG 2019)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV verapamil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV adenosine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Carotid massage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Synchronized cardioversion&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Synchronized cardioversion&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/screenshot-2024-10-01-144116.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-110009.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D. Synchronized cardioversion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient came to the hospital with complaints of lethargy, increased sleep, and weight gain. Investigations revealed low plasma TSH concentration. However, on the administration of TRH, the TSH levels increased. Which of the following conditions is likely in this patient? (NEET PG 2020)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperthyroidism due to disease in the pituitary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypothyroidism due to disease in the pituitary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypothyroidism due to disease in the hypothalamus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperthyroidism due to disease in the hypothalamus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypothyroidism due to disease in the hypothalamus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C. Hypothyroidism due to disease in the hypothalamus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When evaluating a patient with hypothyroid symptoms and low TSH that responds to TRH administration, consider hypothalamic dysfunction as a probable cause. This is indicative of secondary hypothyroidism due to a lack of TRH production, affecting the pituitaryâ€™s secretion of TSH in the absence of exogenous stimulation.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference - Harrison/Hypothyroidism/Chap 383&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 37-year-old woman presents with headaches for 6 months. She has been taking analgesics regularly. The headache recently increased in severity for 3 days but was reduced on stopping the analgesic. What is the likely diagnosis? (NEET PG 2021)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Medication overuse headache&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tension headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic migraine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cluster headache&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Medication overuse headache&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A. Medication overuse headache&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medication overuse headache is characterized by the worsening of headaches due to frequent use of headache medications, and improvement upon cessation of the medication. This phenomenon highlights the importance of managing headache disorders with appropriate treatments and avoiding overuse of analgesics.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dL and the presence of ketone bodies. What is the next best step in management? (Neet pg 2022)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous fluids with S.C. long-acting insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous fluids with S.C. regular insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous insulin I.V. long-acting insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous fluids with I.V. regular insulin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Intravenous fluids with I.V. regular insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Intravenous fluids with I.V. regular insulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In the management of diabetic ketoacidosis (DKA), the initial steps involve aggressive IV fluid resuscitation followed by IV regular insulin to rapidly lower blood glucose and resolve ketosis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 54-year-old female presented with shortness of breath. On examination, she had bibasal crackles and S3. Echocardiogram revealed poor cardiac contractility with an EF of 33%. Which of the following drugs can reduce mortality? (NEET PG 2024)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bisoprolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pindolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Labetalol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Bisoprolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Bisoprolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The key beta-blockers that reduce mortality in heart failure with reduced ejection fraction (HF-REF) are bisoprolol, metoprolol, and carvedilol.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Definition of PUO includes all of the following except? (AIIMS MAY 2017)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fever persisting for more than 3 weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Immunocompromised status should be ruled out&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Undiagnosed after one week of investigation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Temperature more than 38.3Â° C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Undiagnosed after one week of investigation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Undiagnosed after one week of investigation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Criteria for diagnosis of PUO:&lt;/li&gt;&lt;li&gt;âž¤ Criteria for diagnosis of PUO:&lt;/li&gt;&lt;li&gt;âž¤ Fever &amp;gt; 38.3 degrees C (101Â° F) on 2 occasions. Duration &amp;gt; 3 weeks. Not immunocompromised state. Diagnosis not certain after history, physical examination and routine and obligatory investigations.&lt;/li&gt;&lt;li&gt;âž¤ Fever &amp;gt; 38.3 degrees C (101Â° F) on 2 occasions.&lt;/li&gt;&lt;li&gt;âž¤ Duration &amp;gt; 3 weeks.&lt;/li&gt;&lt;li&gt;âž¤ Not immunocompromised state.&lt;/li&gt;&lt;li&gt;âž¤ Diagnosis not certain after history, physical examination and routine and obligatory investigations.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Management of hyperkalemia includes all except : (AIIMS NOV 2017)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium gluconate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Insulin drip&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Salbutamol nebulisation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Magnesium sulphate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Magnesium sulphate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Magnesium sulphate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Management of hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ Management of hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ Calcium gluconate- reduces plasma K+ concentration by redistribution in cells rapidly Insulin- lowers plasma K+ concentration by moving potassium intracellular, insulin dose used â€“ 10units of IV regular insulin f/b 50ml of 50%dextrose Salbutamol Cation exchange resins, diuretics, dialysis.&lt;/li&gt;&lt;li&gt;âž¤ Calcium gluconate- reduces plasma K+ concentration by redistribution in cells rapidly&lt;/li&gt;&lt;li&gt;âž¤ Insulin- lowers plasma K+ concentration by moving potassium intracellular, insulin dose used â€“ 10units of IV regular insulin f/b 50ml of 50%dextrose&lt;/li&gt;&lt;li&gt;âž¤ Salbutamol&lt;/li&gt;&lt;li&gt;âž¤ Cation exchange resins, diuretics, dialysis.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 18-year-old girl with the diagnosis of acute promyelocytic leukemia was treated medically. She developed fever and tachypnea and a chest X-ray showed pulmonary infiltrates. What drug should she be given next? (AIIMS MAY 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cytarabine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Dexamethasone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Doxorubicin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Dexamethasone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Dexamethasone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dexamethasone is used to manage differentiation syndrome in patients with acute promyelocytic leukemia, characterized by symptoms like fever, tachypnea, and pulmonary infiltrates following treatment with specific leukemia drugs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference - Harrison/Oncology/Acute leukemia/chap100-743&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Disappearance of loud S1 in mitral stenosis occurs in all except: (AIIMS NOV 2018)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;First degree of heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;AR&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Calcified valve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mild MS&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mild MS&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mild MS.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In mitral stenosis, a loud S1 is typically present unless there is an associated condition that affects the mobility or timing of the mitral valve leaflet closure, such as calcification, regurgitation in other valves, or disturbances in electrical conduction that affect heart rhythm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 16-year-old who is taking antiepileptics, has had a seizure-free period of 6 months. She has no family history of epilepsy. Her EEG is now normal and she has a normal neurological exam and intelligence. What would be your advice? (AIIMS MAY 2019)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stop the treatment and follow up&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continue treatment for another 2 years&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gradually taper the drug and stop treatment&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Continue lifelong treatment with antiepileptics&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Continue treatment for another 2 years&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Continue treatment for another 2 years&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-epileptics once initiated must be continued for a minimum period of 2 years . Decision to stop AED is considered if, seizure free &amp;gt; 2 years with normal MRI, EEG, seizure type .&lt;/li&gt;&lt;li&gt;âž¤ must be continued for a minimum period of 2 years&lt;/li&gt;&lt;li&gt;âž¤ seizure free &amp;gt; 2 years with normal MRI, EEG, seizure&lt;/li&gt;&lt;li&gt;âž¤ type&lt;/li&gt;&lt;li&gt;âž¤ Recurrences occur in the first 3 months of discontinuing AED.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;&lt;strong&gt;References:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;â†³ Reference - Harrison principles of internal Medicine 21st edition Pg. 12076&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The ECG of a patient who presented to the ER is as given below. The patient was already given a carotid massage and IV Adenosine but the BP is currently 60/30 mm Hg. What is the next best step of management? (AIIMS NOV 2019)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Repeat Inj. adenosine 6 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Synchronized cardioversion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inj. amiodarone 300 mg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DC cardioversion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Synchronized cardioversion&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm97.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/screenshot-2024-09-11-112319.png&quot;, &quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm118.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of hemodynamically unstable tachyarrhythmias where initial pharmacological interventions fail, synchronized cardioversion should be promptly employed to stabilize the patient. This technique is crucial for preventing progression to more severe complications such as cardiac arrest.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the drug of choice for hairy cell leukemia? (AIIMS MAY 2020)&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cladribine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vemurafenib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Interferon-alpha&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cladribine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)Â Cladribine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cladribine remains the first-line treatment for hairy cell leukemia due to its high efficacy in inducing remissions.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test13" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine Test (The Champion Batch Hyderabad)   15 12 2024   2024 12 15&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine Test (The Champion Batch Hyderabad)   15 12 2024   2024 12 15&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                150 Questions | 600 Total Marks | 160 min Duration | ~64.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;A 23-year-old medical student with a 2-month history of palpitations, sweating, and restlessness. He also complains of sweaty palms. His appearance is as shown in the picture. Which among the following will help in the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid receptor antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Thyroglobulin Antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Elevated ultrasensitive thyrotropin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-thyroid peroxidase antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Thyroid receptor antibody&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture1.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Thyroid receptor antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Thyroid receptor antibodies (TRAb) are the most specific test for diagnosing Graves&#x27; disease.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Among the given options, the murmur shown in the image is associated with?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic Regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral Regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral Stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aortic Stenosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mitral Regurgitation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture2.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mitral Regurgitation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A pansystolic murmur extending from S1 to S2 is characteristic of mitral regurgitation .&lt;/li&gt;&lt;li&gt;âž¤ pansystolic murmur&lt;/li&gt;&lt;li&gt;âž¤ S1 to S2&lt;/li&gt;&lt;li&gt;âž¤ mitral regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with hypertension is on multiple antihypertensive drugs. His ECG is shown in the image. Which drug is responsible for the following ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hydrochlorothiazide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Spironolactone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture3.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone can cause hyperkalemia , leading to ECG changes like tall T waves , wide QRS complexes , and absent P waves .&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone&lt;/li&gt;&lt;li&gt;âž¤ hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ tall T waves&lt;/li&gt;&lt;li&gt;âž¤ wide QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ absent P waves&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old woman presents with a progressive decline in daily activity. She gives a history of staring into space with frequent visual hallucinations. Pathology reveals Lewy bodies in neurons. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Parkinsonâ€™s Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prionâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Huntingtonâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alzheimerâ€™s Disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Parkinsonâ€™s Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Parkinsonâ€™s Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of Lewy bodies and symptoms like visual hallucinations and progressive cognitive decline point to a diagnosis of Parkinsonâ€™s disease .&lt;/li&gt;&lt;li&gt;âž¤ Lewy bodies&lt;/li&gt;&lt;li&gt;âž¤ visual hallucinations&lt;/li&gt;&lt;li&gt;âž¤ progressive cognitive decline&lt;/li&gt;&lt;li&gt;âž¤ Parkinsonâ€™s disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dL and the presence of ketone bodies. What is the next best step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous fluids with S.C. long-acting insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous fluids with S.C. regular insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intravenous insulin I.V. long-acting insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intravenous fluids with I.V. regular insulin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Intravenous fluids with I.V. regular insulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Intravenous fluids with I.V. regular insulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The management of diabetic ketoacidosis (DKA) includes IV fluids and IV regular insulin , which is the gold standard for rapidly controlling blood glucose levels and resolving ketosis.&lt;/li&gt;&lt;li&gt;âž¤ diabetic ketoacidosis (DKA)&lt;/li&gt;&lt;li&gt;âž¤ IV fluids&lt;/li&gt;&lt;li&gt;âž¤ IV regular insulin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with retro-positive status was started on 2nd line highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD4+ T cell count&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Viral load&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;p24 antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Viral serotype&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Viral load&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Viral load&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Viral load is the best marker for monitoring the efficacy of antiretroviral therapy (HAART) in patients with HIV, aiming to reduce it to undetectable levels to prevent disease progression and transmission.&lt;/li&gt;&lt;li&gt;âž¤ Viral load&lt;/li&gt;&lt;li&gt;âž¤ antiretroviral therapy (HAART)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following would most likely lead to a decrease in the intensity of the murmur in a patient with hypertrophic cardiomyopathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Squatting&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Valsalva&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Squatting&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Squatting&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Squatting increases preload and afterload, leading to a decrease in the intensity of the murmur in patients with hypertrophic cardiomyopathy (HCM) by reducing left ventricular outflow tract obstruction.&lt;/li&gt;&lt;li&gt;âž¤ Squatting&lt;/li&gt;&lt;li&gt;âž¤ decrease in the intensity of the murmur&lt;/li&gt;&lt;li&gt;âž¤ hypertrophic cardiomyopathy (HCM)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old man with a history of HTN, DM2, and DLP is brought to the ER because of reports of palpitations and dizziness. An ECG is ordered and shown in the image. His temperature is 36.8Â°C, PR is 106/min, RR is 18/min, BP is 84/46 mm Hg, and SpO2 is 92% on room air. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Heparin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DC shock&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. DC shock&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) DC shock&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with hemodynamically unstable atrial fibrillation , DC cardioversion is the immediate and most appropriate treatment to restore normal rhythm and stabilize the patient.&lt;/li&gt;&lt;li&gt;âž¤ hemodynamically unstable atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ DC cardioversion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the best drug for acute management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flunarizine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sumatriptan&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sumatriptan&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sumatriptan&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For acute migraine management , sumatriptan is the drug of choice, as it provides rapid relief of symptoms such as headache, nausea, and sensitivity to light and sound.&lt;/li&gt;&lt;li&gt;âž¤ acute migraine management&lt;/li&gt;&lt;li&gt;âž¤ sumatriptan&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man with a history of dyslipidemia, hypertension, and aortic sclerosis presents to the emergency department with chest pain. He took 3 nitroglycerin (NTG) tablets with no relief. His vitals are stable, and cardiac enzymes were normal. An ECG on admission is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;STEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;NSTEMI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stable Angina&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Unstable Angina&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Unstable Angina&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture5.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Unstable Angina&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Unstable angina is a type of acute coronary syndrome where chest pain occurs without elevated cardiac enzymes or ST-segment elevation on ECG. This diagnosis is made when patients present with persistent chest pain despite normal initial tests, as seen in this case.&lt;/li&gt;&lt;li&gt;âž¤ Unstable angina&lt;/li&gt;&lt;li&gt;âž¤ acute coronary syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a long history of alcoholism presents with acute pain and swelling of the left great toe. Synovial fluid analysis shows raised leucocytes. Investigation shows normal serum uric acid levels. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute Gout.&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Septic Arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pseudogout&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reactive Arthritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Acute Gout.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Acute Gout&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Acute gout should be strongly suspected in a patient with acute pain and swelling of the great toe (podagra), even if serum uric acid levels are normal at the time of presentation. This is because serum uric acid can be normal in up to 30-40% of acute gout cases.&lt;/li&gt;&lt;li&gt;âž¤ Acute gout&lt;/li&gt;&lt;li&gt;âž¤ acute pain and swelling of the great toe&lt;/li&gt;&lt;li&gt;âž¤ serum uric acid levels are normal&lt;/li&gt;&lt;li&gt;âž¤ serum uric acid&lt;/li&gt;&lt;li&gt;âž¤ 30-40% of acute gout&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A farmer tried to commit suicide by ingesting about 2 glasses of paraquat. What is the primary system affected in paraquat toxicity?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dermatologic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neurologic&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pulmonary&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pulmonary&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In paraquat poisoning , the pulmonary system is the primary system affected, with acute lung injury and eventual pulmonary fibrosis being the most critical complications.&lt;/li&gt;&lt;li&gt;âž¤ paraquat poisoning&lt;/li&gt;&lt;li&gt;âž¤ pulmonary system&lt;/li&gt;&lt;li&gt;âž¤ acute lung injury&lt;/li&gt;&lt;li&gt;âž¤ pulmonary fibrosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A hypertensive patient who is non-compliant with medication presents to you with sudden onset breathlessness. A chest X-ray was done, which is shown below. How will you manage this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Intravenous salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous nitroglycerin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nebulization with salbutamol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Oxygen and antibiotics&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous nitroglycerin&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture6.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intravenous nitroglycerin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Intravenous nitroglycerin is the first-line treatment for acute pulmonary edema secondary to hypertensive emergency , as it helps reduce both preload and afterload, alleviating the heartâ€™s workload and reducing pulmonary congestion.&lt;/li&gt;&lt;li&gt;âž¤ Intravenous nitroglycerin&lt;/li&gt;&lt;li&gt;âž¤ acute pulmonary edema&lt;/li&gt;&lt;li&gt;âž¤ hypertensive emergency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female presents with complaints of chest pain, palpitation, and shortness of breath. On auscultation, a mid-diastolic murmur is heard, and on examination, a prominent &#x27;a&#x27; wave on the JVP is noted. What is the most appropriate diagnosis among the following options?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mitral Stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tricuspid Stenosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tricuspid Regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mitral Regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tricuspid Stenosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Tricuspid Stenosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A mid-diastolic murmur heard at the left sternal border, combined with a prominent &#x27;a&#x27; wave in the JVP, is most consistent with tricuspid stenosis , which causes elevated right atrial pressure and a characteristic JVP waveform.&lt;/li&gt;&lt;li&gt;âž¤ mid-diastolic murmur&lt;/li&gt;&lt;li&gt;âž¤ prominent &#x27;a&#x27; wave&lt;/li&gt;&lt;li&gt;âž¤ tricuspid stenosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient collapsed and was brought to the casualty with no proper history. What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Check for responsiveness&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secure airway&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Shock: 300J&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Check for carotid pulse&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Check for responsiveness&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Check for responsiveness&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The first step in managing an unresponsive patient in Basic Life Support (BLS) is to check for responsiveness . This will guide subsequent actions such as checking for breathing and pulse, initiating CPR, and using defibrillation if necessary.&lt;/li&gt;&lt;li&gt;âž¤ Basic Life Support (BLS)&lt;/li&gt;&lt;li&gt;âž¤ check for responsiveness&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old man presented to the OPD with complaints of early morning backache and stiffness that improves with exercise and persistent red eyes. On examination, lung expansion was less than 3 cm. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pagetâ€™s Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ankylosing Spondylitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Healed Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteopetrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ankylosing Spondylitis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ankylosing Spondylitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Ankylosing Spondylitis should be strongly suspected in young patients with morning back pain , stiffness that improves with exercise , reduced chest expansion , and extra-articular manifestations like anterior uveitis .&lt;/li&gt;&lt;li&gt;âž¤ Ankylosing Spondylitis&lt;/li&gt;&lt;li&gt;âž¤ morning back pain&lt;/li&gt;&lt;li&gt;âž¤ stiffness that improves with exercise&lt;/li&gt;&lt;li&gt;âž¤ reduced chest expansion&lt;/li&gt;&lt;li&gt;âž¤ extra-articular manifestations&lt;/li&gt;&lt;li&gt;âž¤ anterior uveitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the strongest predictor of cardiovascular disease incidence and subsequent mortality due to CVD?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;TC/HDL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;LDL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;hsCRP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HDL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. LDL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) LDL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Elevated LDL levels are the strongest predictor of cardiovascular disease incidence and subsequent mortality due to CVD, making LDL the primary target for therapy in both primary and secondary prevention of cardiovascular events.&lt;/li&gt;&lt;li&gt;âž¤ Elevated LDL levels&lt;/li&gt;&lt;li&gt;âž¤ cardiovascular disease incidence&lt;/li&gt;&lt;li&gt;âž¤ primary&lt;/li&gt;&lt;li&gt;âž¤ secondary&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;FeNO in bronchial asthma is related to:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoconstriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mucus hypersecretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophilic inflammation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Airway hyperreactivity&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eosinophilic inflammation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Eosinophilic inflammation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In bronchial asthma , FeNO is primarily used to assess eosinophilic inflammation , which is associated with TH2-type inflammation. Elevated FeNO levels can help in guiding the use of biologic therapies for asthma.&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ FeNO&lt;/li&gt;&lt;li&gt;âž¤ eosinophilic inflammation&lt;/li&gt;&lt;li&gt;âž¤ TH2-type&lt;/li&gt;&lt;li&gt;âž¤ biologic therapies&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient on antidepressants presented to you with hypotension. An ECG was done, which showed wide QRS complexes and right axis deviation. How will you manage this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antiarrhythmics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV NaHCO3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IV NaHCO3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) IV NaHCO3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of tricyclic antidepressant toxicity with wide QRS complexes , intravenous sodium bicarbonate (NaHCO3) is the treatment of choice, as it helps reverse the sodium channel blockade and prevents further cardiac arrhythmias.&lt;/li&gt;&lt;li&gt;âž¤ tricyclic antidepressant toxicity&lt;/li&gt;&lt;li&gt;âž¤ wide QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ intravenous sodium bicarbonate (NaHCO3)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with severe restlessness and tremors to the emergency department. She has a history of bronchial asthma. On examination, a swollen neck is observed, and her blood pressure and heart rate are elevated. An ECG shows atrial fibrillation. Which of the following drugs can be given in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Esmolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diltiazem&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diltiazem&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with thyrotoxicosis-induced atrial fibrillation and a history of bronchial asthma , diltiazem is the safest choice to control the heart rate without exacerbating bronchospasm.&lt;/li&gt;&lt;li&gt;âž¤ thyrotoxicosis-induced atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ diltiazem&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient undergoing hemodialysis for hyperkalemia and raised urea levels develops drowsiness, has a seizure, and becomes hypotensive during the procedure. What can be given for treatment in this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mannitol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nesiritide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ethacrynic Acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bumetanide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Mannitol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Mannitol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Dialysis disequilibrium syndrome can occur during hemodialysis , especially in patients with high urea levels, causing cerebral edema . Mannitol is the treatment of choice to reduce cerebral swelling in this condition.&lt;/li&gt;&lt;li&gt;âž¤ Dialysis disequilibrium syndrome&lt;/li&gt;&lt;li&gt;âž¤ hemodialysis&lt;/li&gt;&lt;li&gt;âž¤ cerebral edema&lt;/li&gt;&lt;li&gt;âž¤ Mannitol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents to you with fever, night sweats, ptosis, and bilateral facial nerve palsy. Investigations showed leukocytosis and bilateral hilar lymphadenopathy. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sarcoidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypersensitive pneumonitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Sarcoidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Sarcoidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sarcoidosis is the most likely diagnosis in patients with bilateral hilar lymphadenopathy , fever , night sweats , and facial nerve palsy , a pattern commonly seen in this granulomatous disease .&lt;/li&gt;&lt;li&gt;âž¤ Sarcoidosis&lt;/li&gt;&lt;li&gt;âž¤ bilateral hilar lymphadenopathy&lt;/li&gt;&lt;li&gt;âž¤ fever&lt;/li&gt;&lt;li&gt;âž¤ night sweats&lt;/li&gt;&lt;li&gt;âž¤ facial nerve palsy&lt;/li&gt;&lt;li&gt;âž¤ granulomatous disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following situations would Non-Invasive Ventilation (NIV) be considered contraindicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;AECOPD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ARDS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute MI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Post-extubation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute MI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute MI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ NIV is contraindicated in patients with hemodynamically unstable acute myocardial infarction (MI) because it can exacerbate cardiac dysfunction. In cases of respiratory failure associated with AECOPD, ARDS (mild/moderate), or post-extubation, NIV can be beneficial.&lt;/li&gt;&lt;li&gt;âž¤ NIV is contraindicated in patients with hemodynamically unstable acute myocardial infarction (MI)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old man presented with chest pain and was noted to have 2 mm of ST-segment elevation in his inferior leads. He has a systolic blood pressure (SBP) of 84 mm Hg and a heart rate (HR) of 124 beats/min. On examination, he is disoriented, jugular venous pressure (JVP) is elevated, and his lungs are clear. Which of the following is the best treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Normal Saline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Nitroglycerin (NTG)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Metoprolol&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV Normal Saline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV Normal Saline&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of right ventricular infarction (RVMI) associated with hypotension and clear lungs , the best initial treatment is IV normal saline to optimize preload and improve cardiac output.&lt;/li&gt;&lt;li&gt;âž¤ right ventricular infarction (RVMI)&lt;/li&gt;&lt;li&gt;âž¤ hypotension&lt;/li&gt;&lt;li&gt;âž¤ clear lungs&lt;/li&gt;&lt;li&gt;âž¤ IV normal saline&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following improves survival in ARDS (Acute Respiratory Distress Syndrome)?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Early use of paralytic agents&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fluid restriction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Low tidal volume&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prone positioning&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Low tidal volume&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Low tidal volume&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ARDS , low tidal volume ventilation (LTVV) is a key intervention that improves survival by reducing ventilator-induced lung injury. Prone positioning is also beneficial, particularly in severe ARDS, but LTVV is the most established intervention for improving survival.&lt;/li&gt;&lt;li&gt;âž¤ ARDS&lt;/li&gt;&lt;li&gt;âž¤ low tidal volume ventilation (LTVV)&lt;/li&gt;&lt;li&gt;âž¤ survival&lt;/li&gt;&lt;li&gt;âž¤ Prone positioning&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old gentleman is brought into your ER after a syncope. The monitor showed a heart rate of 190 bpm with a blood pressure of 85/50 mmHg. His SpO2 is 98% (on NRPBM). The ECG shows a regular wide complex tachycardia (WCT) with no apparent P waves. With regard to the jugular venous pressure (JVP) waveform, which of these features would you expect to see?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Giant v waves&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannon a waves&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prominent x descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Slow y descent&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cannon a waves&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cannon a waves&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ventricular tachycardia with AV dissociation , you would expect to see cannon a waves on the JVP waveform, resulting from the atria contracting against closed AV valves due to the lack of synchronization between atrial and ventricular contractions.&lt;/li&gt;&lt;li&gt;âž¤ ventricular tachycardia&lt;/li&gt;&lt;li&gt;âž¤ AV dissociation&lt;/li&gt;&lt;li&gt;âž¤ cannon a waves&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Indications for a chest drain in a parapneumonic effusion include all of the following except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Loculated pleural fluid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleural fluid pH &amp;lt; 7.2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pleural fluid glucose &amp;lt; 60 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural fluid LDH &amp;gt; 1000&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Pleural fluid LDH &gt; 1000&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Pleural fluid LDH &amp;gt; 1000&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Indications for chest drainage in parapneumonic effusion include loculated fluid , pleural fluid pH &amp;lt; 7.2 , and glucose &amp;lt; 60 mg/dL . Elevated LDH &amp;gt; 1000 alone is not a sufficient indication for drainage without additional signs of complication.&lt;/li&gt;&lt;li&gt;âž¤ chest drainage&lt;/li&gt;&lt;li&gt;âž¤ parapneumonic effusion&lt;/li&gt;&lt;li&gt;âž¤ loculated fluid&lt;/li&gt;&lt;li&gt;âž¤ pleural fluid pH &amp;lt; 7.2&lt;/li&gt;&lt;li&gt;âž¤ glucose &amp;lt; 60 mg/dL&lt;/li&gt;&lt;li&gt;âž¤ LDH &amp;gt; 1000&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female patient with infertility presents with galactorrhea. Evaluation reveals a 7mm prolactinoma. She is worried about her chances of conception. What is the appropriate drug in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cabergoline&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bromocriptine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pegvisomant&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cabergoline&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Bromocriptine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For women with a prolactinoma who are trying to conceive , bromocriptine is the preferred treatment due to its well-established safety and efficacy in restoring fertility.&lt;/li&gt;&lt;li&gt;âž¤ prolactinoma&lt;/li&gt;&lt;li&gt;âž¤ trying to conceive&lt;/li&gt;&lt;li&gt;âž¤ bromocriptine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 62-year-old smoker presents with shortness of breath (SOB) on exertion. Resting SpO2 is 94%, which reduces to 85% after walking 100 meters. Examination reveals bilateral end-inspiratory crackles. The chest CT (shown) reveals honeycombing and a pattern consistent with pulmonary fibrosis. A serologic workup for autoimmune disease is unremarkable. What is the next therapeutic option?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Azathioprine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Nintedanib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Nintedanib&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102511.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Nintedanib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For idiopathic pulmonary fibrosis (IPF) , which is characterized by progressive fibrosis of the lungs, nintedanib is an appropriate therapeutic option as it helps to slow the progression of the disease. Other options like immunosuppressants or steroids are not effective in IPF and may be harmful.&lt;/li&gt;&lt;li&gt;âž¤ idiopathic pulmonary fibrosis (IPF)&lt;/li&gt;&lt;li&gt;âž¤ progressive fibrosis&lt;/li&gt;&lt;li&gt;âž¤ nintedanib&lt;/li&gt;&lt;li&gt;âž¤ immunosuppressants&lt;/li&gt;&lt;li&gt;âž¤ steroids&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which among the following, according to the latest guidelines, is NOT an indication for infective endocarditis (IE) prophylaxis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prior Infective Endocarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mitral Valve Prolapse with severe MR&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Unrepaired Cyanotic Congenital Heart Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac transplant with valvulopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mitral Valve Prolapse with severe MR&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mitral Valve Prolapse with severe MR&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ According to the latest guidelines, mitral valve prolapse with severe mitral regurgitation is not an indication for infective endocarditis prophylaxis, while other high-risk conditions such as prior IE, unrepaired cyanotic congenital heart disease, and cardiac transplant with valvulopathy are .&lt;/li&gt;&lt;li&gt;âž¤ mitral valve prolapse with severe mitral regurgitation&lt;/li&gt;&lt;li&gt;âž¤ not&lt;/li&gt;&lt;li&gt;âž¤ are&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 68-year-old man with a past medical history of coronary artery disease develops an MI. He got treated in CCU and before he is discharged, he undergoes echocardiography, which reveals a left ventricular ejection fraction of 35% to 40%. He is asymptomatic. What is this patientâ€™s heart failure stage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stage A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stage B&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stage C&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stage D&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Stage B&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Stage B&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ This patient, with structural heart disease but no symptoms , fits into Stage B heart failure according to the ACC/AHA heart failure stages .&lt;/li&gt;&lt;li&gt;âž¤ structural heart disease&lt;/li&gt;&lt;li&gt;âž¤ no symptoms&lt;/li&gt;&lt;li&gt;âž¤ Stage B&lt;/li&gt;&lt;li&gt;âž¤ ACC/AHA heart failure stages&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A soldier operating in the Siachen Glacier presents with numbness of his legs. Based on the image provided, which of the following statements is correct?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rewarming is the treatment of choice&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Analgesics are contraindicated&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thrombolytics cannot be used&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Amputation is not required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Rewarming is the treatment of choice&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102531.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Rewarming is the treatment of choice&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of frostbite , like that seen in the image, rewarming is the immediate treatment of choice. Pain management is important, and in severe cases, other interventions such as thrombolytics or, in extreme situations, amputation may be considered.&lt;/li&gt;&lt;li&gt;âž¤ frostbite&lt;/li&gt;&lt;li&gt;âž¤ rewarming&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Laboratory investigations of a patient being evaluated for jaundice show elevated bilirubin and alkaline phosphatase (ALP) levels. Levels of the remaining liver enzymes are normal. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Obstructive jaundice&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemolytic jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hepatic jaundice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prehepatic jaundice&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Obstructive jaundice&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Obstructive jaundice&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Obstructive jaundice is characterized by elevated bilirubin and alkaline phosphatase (ALP) levels, while other liver enzymes (such as AST and ALT) remain normal, indicating a biliary obstruction as the likely cause.&lt;/li&gt;&lt;li&gt;âž¤ Obstructive jaundice&lt;/li&gt;&lt;li&gt;âž¤ bilirubin&lt;/li&gt;&lt;li&gt;âž¤ alkaline phosphatase&lt;/li&gt;&lt;li&gt;âž¤ biliary obstruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 46-year-old male presents to the ER with the acute onset of ataxia. Neurological examination shows loss of pain and temperature sensation from the face on the left side and loss of pain and temperature sensation from the right half of the body. He also has dysarthria, dysphagia, and diminished gag reflex with ptosis, miosis, and anhidrosis on the left. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lateral pontine syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medial medullary syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lateral medullary syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Locked in Syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lateral medullary syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lateral medullary syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The patientâ€™s symptoms of crossed sensory loss , dysarthria , dysphagia , and Hornerâ€™s syndrome are characteristic of lateral medullary syndrome (Wallenberg syndrome) , most often due to posterior inferior cerebellar artery (PICA) infarction.&lt;/li&gt;&lt;li&gt;âž¤ crossed sensory loss&lt;/li&gt;&lt;li&gt;âž¤ dysarthria&lt;/li&gt;&lt;li&gt;âž¤ dysphagia&lt;/li&gt;&lt;li&gt;âž¤ Hornerâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ lateral medullary syndrome (Wallenberg syndrome)&lt;/li&gt;&lt;li&gt;âž¤ posterior inferior cerebellar artery (PICA)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman presents with fever, arthralgia, ulcers, and fatigue for the past six months, along with new-onset hematuria. Urine examination reveals RBC casts and proteinuria. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Poststreptococcal glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lupus nephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IgA nephropathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lupus nephritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lupus nephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of systemic lupus erythematosus (SLE) symptoms and renal involvement (hematuria, RBC casts, and proteinuria) makes lupus nephritis the most likely diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ systemic lupus erythematosus (SLE) symptoms&lt;/li&gt;&lt;li&gt;âž¤ renal involvement&lt;/li&gt;&lt;li&gt;âž¤ lupus nephritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient comes to the ER with a headache, describing it as the worst headache of his life. Initial NCCT (non-contrast CT) shows subarachnoid hemorrhage (SAH). What is the next step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT Angiography&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lumbar puncture&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MRI brain&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;V-P shunt&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CT Angiography&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) CT Angiography&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with confirmed SAH on non-contrast CT , the next step is CT Angiography (CTA) to identify the cause, typically a ruptured aneurysm , for further therapeutic intervention.&lt;/li&gt;&lt;li&gt;âž¤ confirmed SAH&lt;/li&gt;&lt;li&gt;âž¤ non-contrast CT&lt;/li&gt;&lt;li&gt;âž¤ CT Angiography (CTA)&lt;/li&gt;&lt;li&gt;âž¤ aneurysm&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 80-year-old man is investigated for progressive cognitive impairment. Which one of the following features is most suggestive of Lewy body dementia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Disinhibition&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Emotional lability&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neuroleptic sensitivity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Urinary incontinence&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neuroleptic sensitivity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neuroleptic sensitivity&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neuroleptic sensitivity is a key feature of Lewy body dementia (LBD) . Patients with LBD are at risk of experiencing severe adverse reactions to antipsychotic medications, making this a distinguishing clinical feature of the disease.&lt;/li&gt;&lt;li&gt;âž¤ Neuroleptic sensitivity&lt;/li&gt;&lt;li&gt;âž¤ Lewy body dementia (LBD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An 11-year-old child who weighs 26 kg with a history of streptococcal pharyngitis presents with fever and arthralgia. There is no past history of rheumatic heart disease, carditis, or valvular disease. How often is benzathine penicillin recommended for the prophylaxis of rheumatic heart disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;600000 IU once in 3 weeks for 5 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;600000 IU once in 3 weeks for 10 years&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1200000 IU once in 3 weeks for 10 years&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;1200000 IU once in 3 weeks for life&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 600000 IU once in 3 weeks for 10 years&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 600000 IU once in 3 weeks for 10 years&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a child under 27 kg with no history of carditis , 600000 IU of benzathine penicillin every 3 weeks is the recommended dose, and the duration should continue until 21 years of age or for 10 years from the time of diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ 27 kg&lt;/li&gt;&lt;li&gt;âž¤ no history of carditis&lt;/li&gt;&lt;li&gt;âž¤ 600000 IU&lt;/li&gt;&lt;li&gt;âž¤ benzathine penicillin&lt;/li&gt;&lt;li&gt;âž¤ 21 years of age&lt;/li&gt;&lt;li&gt;âž¤ 10 years&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In Wernicke&#x27;s encephalopathy, the earliest clinical feature to recover is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ataxia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ophthalmoparesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Confusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Memory loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ophthalmoparesis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Ophthalmoparesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Wernicke&#x27;s encephalopathy , ophthalmoparesis is the earliest clinical feature to recover following thiamine therapy .&lt;/li&gt;&lt;li&gt;âž¤ Wernicke&#x27;s encephalopathy&lt;/li&gt;&lt;li&gt;âž¤ ophthalmoparesis&lt;/li&gt;&lt;li&gt;âž¤ earliest clinical feature&lt;/li&gt;&lt;li&gt;âž¤ thiamine therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A man on diuretics presents with weakness. An ECG was done which showed flat T waves and prominent U waves. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypokalemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperkalemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypomagnesemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypernatremia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Hypokalemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Hypokalemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of flat T waves and prominent U waves on an ECG in a patient taking diuretics strongly suggests hypokalemia .&lt;/li&gt;&lt;li&gt;âž¤ flat T waves&lt;/li&gt;&lt;li&gt;âž¤ prominent U waves&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are accepted diagnostic criteria for acute pancreatitis except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Confirmatory findings of acute pancreatitis on cross-sectional imaging&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PaO2 &amp;lt; 60 mm Hg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â‰¥ 3x elevation in serum lipase and/or amylase&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Typical abdominal pain in the epigastrium that may radiate to the back&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. PaO2 &lt; 60 mm Hg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) PaO2 &amp;lt; 60 mm Hg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For diagnosing acute pancreatitis , the accepted criteria are abdominal pain , elevated enzymes (amylase or lipase) , and imaging findings . A PaO2 &amp;lt; 60 mm Hg is part of the Ranson&#x27;s criteria used for prognosis , not for diagnosis.&lt;/li&gt;&lt;li&gt;âž¤ acute pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ abdominal pain&lt;/li&gt;&lt;li&gt;âž¤ elevated enzymes (amylase or lipase)&lt;/li&gt;&lt;li&gt;âž¤ imaging findings&lt;/li&gt;&lt;li&gt;âž¤ PaO2 &amp;lt; 60 mm Hg&lt;/li&gt;&lt;li&gt;âž¤ Ranson&#x27;s criteria&lt;/li&gt;&lt;li&gt;âž¤ prognosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A male patient presents to the emergency department. The arterial blood gas (ABG) report is as follows: pH = 7.2 pCO2 = 81 mm Hg HCO3- = 40 meq/L Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic respiratory acidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute on chronic respiratory acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute respiratory acidosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute on chronic respiratory acidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute on chronic respiratory acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of elevated pCO2 , elevated HCO3- , and a low pH suggests acute on chronic respiratory acidosis , commonly seen in patients with chronic respiratory conditions experiencing an acute exacerbation.&lt;/li&gt;&lt;li&gt;âž¤ elevated pCO2&lt;/li&gt;&lt;li&gt;âž¤ elevated HCO3-&lt;/li&gt;&lt;li&gt;âž¤ low pH&lt;/li&gt;&lt;li&gt;âž¤ acute on chronic respiratory acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Paraneoplastic neurological syndromes (PNS) characterized by anti-Yo antibodies are associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cerebellar Degeneration&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stiff Person Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Optic Neuritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Retinopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Cerebellar Degeneration&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Cerebellar Degeneration&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Anti-Yo antibodies are most commonly associated with paraneoplastic cerebellar degeneration , particularly in patients with gynecological cancers like ovarian and breast cancer . This condition is characterized by progressive cerebellar ataxia and other cerebellar signs.&lt;/li&gt;&lt;li&gt;âž¤ Anti-Yo antibodies&lt;/li&gt;&lt;li&gt;âž¤ paraneoplastic cerebellar degeneration&lt;/li&gt;&lt;li&gt;âž¤ gynecological cancers&lt;/li&gt;&lt;li&gt;âž¤ ovarian&lt;/li&gt;&lt;li&gt;âž¤ breast cancer&lt;/li&gt;&lt;li&gt;âž¤ progressive cerebellar ataxia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient present with fever, jaundice, and malaise. Based on the following serology reports, what is the most incorrect diagnosis? Anti-HBc: Positive HBsAg: Negative Anti-HBs: Negative HBeAg: Negative&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chronic HBV infection&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Remote HBV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occult HBV infection&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Window Period&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Chronic HBV infection&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Chronic HBV infection&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Chronic HBV infection requires the persistence of HBsAg for more than 6 months. In this case, since HBsAg is negative , chronic infection is not possible , making it the most incorrect diagnosis .&lt;/li&gt;&lt;li&gt;âž¤ Chronic HBV infection&lt;/li&gt;&lt;li&gt;âž¤ HBsAg&lt;/li&gt;&lt;li&gt;âž¤ HBsAg is negative&lt;/li&gt;&lt;li&gt;âž¤ not possible&lt;/li&gt;&lt;li&gt;âž¤ incorrect diagnosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;You are seeing a 20-year-old man who complains of edema and frothy urine for 2 months. Labs reveal normal serum creatinine and 4+ protein in urine without blood or bacteria. He undergoes a kidney biopsy, which is normal on light microscopy. What is the best treatment for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Tacrolimus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cyclophosphamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Prednisolone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Prednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a young adult presenting with nephrotic syndrome and a normal kidney biopsy on light microscopy, minimal change disease (MCD) is the most likely diagnosis. The best initial treatment is prednisolone , as most cases of MCD respond rapidly to corticosteroid therapy.&lt;/li&gt;&lt;li&gt;âž¤ nephrotic syndrome&lt;/li&gt;&lt;li&gt;âž¤ normal kidney biopsy&lt;/li&gt;&lt;li&gt;âž¤ minimal change disease (MCD)&lt;/li&gt;&lt;li&gt;âž¤ prednisolone&lt;/li&gt;&lt;li&gt;âž¤ MCD&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A child presents to the emergency department with a history of ingestion of 10-20 ferrous sulfate tablets. Arterial blood gas reveals acidosis. Which of the following can be used in the management of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Whole Bowel Irrigation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Activated Charcoal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dimercaprol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Penicillamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Whole Bowel Irrigation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Whole Bowel Irrigation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of iron intoxication , Whole Bowel Irrigation is recommended, particularly if there are visible iron pills on abdominal X-ray. Activated charcoal is ineffective for iron overdose, and other chelators like Dimercaprol or Penicillamine are not used for iron toxicity.&lt;/li&gt;&lt;li&gt;âž¤ iron intoxication&lt;/li&gt;&lt;li&gt;âž¤ Whole Bowel Irrigation&lt;/li&gt;&lt;li&gt;âž¤ Activated charcoal&lt;/li&gt;&lt;li&gt;âž¤ Dimercaprol&lt;/li&gt;&lt;li&gt;âž¤ Penicillamine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the expected MCV in the CBC based on the peripheral smear (PS) image?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 80 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 60 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;80-100 fL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 100 fL&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. &gt; 100 fL&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102621.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) &amp;gt; 100 fL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The presence of hypersegmented neutrophils and macrocytes on the peripheral smear suggests megaloblastic anemia , with an MCV typically &amp;gt; 100 fL . This condition is commonly caused by vitamin B12 or folate deficiency .&lt;/li&gt;&lt;li&gt;âž¤ hypersegmented neutrophils&lt;/li&gt;&lt;li&gt;âž¤ macrocytes&lt;/li&gt;&lt;li&gt;âž¤ peripheral smear&lt;/li&gt;&lt;li&gt;âž¤ megaloblastic anemia&lt;/li&gt;&lt;li&gt;âž¤ MCV&lt;/li&gt;&lt;li&gt;âž¤ &amp;gt; 100 fL&lt;/li&gt;&lt;li&gt;âž¤ vitamin B12&lt;/li&gt;&lt;li&gt;âž¤ folate deficiency&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 59-year-old man has an MI complicated by shock. He recovers well from the MI, but several days later, his renal function deteriorates. One week after his MI, he becomes oliguric with BUN of 53 mg/dL and creatinine of 3.9 mg/dL. What is the likely value of FeNa?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt; 2%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 1%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt; 35%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt; 50%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &gt; 2%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) &amp;gt; 2%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of acute tubular necrosis (ATN) , which is common after prolonged ischemia or shock, the FeNa is typically greater than 2% due to the loss of the kidneyâ€™s ability to properly reabsorb sodium.&lt;/li&gt;&lt;li&gt;âž¤ acute tubular necrosis (ATN)&lt;/li&gt;&lt;li&gt;âž¤ FeNa&lt;/li&gt;&lt;li&gt;âž¤ greater than 2%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 55-year-old male patient presented to the hospital with palpitations. Physical examination showed a diastolic murmur in the left 3rd intercostal space . What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Aortic stenosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Aortic regurgitation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mitral regurgitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tricuspid regurgitation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Aortic regurgitation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Aortic regurgitation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A diastolic murmur heard at the left 3rd intercostal space strongly suggests aortic regurgitation , where the aortic valve fails to close properly, allowing blood to flow back into the left ventricle during diastole.&lt;/li&gt;&lt;li&gt;âž¤ diastolic murmur&lt;/li&gt;&lt;li&gt;âž¤ left 3rd intercostal space&lt;/li&gt;&lt;li&gt;âž¤ aortic regurgitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the most likely mechanism of gentamicin-related AKI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute interstitial nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute tubular necrosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Glomerulonephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ischemic injury&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Acute tubular necrosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Acute tubular necrosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most likely mechanism of gentamicin-related acute kidney injury is acute tubular necrosis (ATN) , resulting from direct toxic damage to the proximal tubular cells of the kidney.&lt;/li&gt;&lt;li&gt;âž¤ gentamicin-related acute kidney injury&lt;/li&gt;&lt;li&gt;âž¤ acute tubular necrosis (ATN)&lt;/li&gt;&lt;li&gt;âž¤ toxic damage to the proximal tubular cells&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An elderly male patient was brought by his son because he was not using his left arm for day-to-day functioning. He has an unkempt appearance on the left side of his body and has a history of bumping into door frames while walking through them. The evaluation performed is shown in the image (clock drawing). Where does a lesion in the brain cause this presentation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right parietotemporal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left parietal&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Right parietal&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right premotor cortex&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Right parietal&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture7_Twkqvh4.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Right parietal&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Left-sided hemineglect results from a lesion in the right parietal lobe , particularly in the non-dominant hemisphere , which is responsible for spatial awareness and attention.&lt;/li&gt;&lt;li&gt;âž¤ Left-sided hemineglect&lt;/li&gt;&lt;li&gt;âž¤ right parietal lobe&lt;/li&gt;&lt;li&gt;âž¤ non-dominant hemisphere&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following would be important for the prevention of tumor lysis syndrome (TLS) EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Administration of allopurinol 300 mg/mÂ² daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Administration of IV fluids at a minimum of 3000 mL/mÂ² daily&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alkalinization of the urine by administration of NaHCO3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Frequent monitoring of serum chemistries every 4 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Alkalinization of the urine by administration of NaHCO3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Alkalinization of the urine by administration of NaHCO3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ While hydration , allopurinol , and frequent serum monitoring are critical in tumor lysis syndrome (TLS) prevention, urine alkalinization is not recommended because it increases the risk of kidney complications, such as calcium phosphate precipitation .&lt;/li&gt;&lt;li&gt;âž¤ hydration&lt;/li&gt;&lt;li&gt;âž¤ allopurinol&lt;/li&gt;&lt;li&gt;âž¤ frequent serum monitoring&lt;/li&gt;&lt;li&gt;âž¤ tumor lysis syndrome (TLS)&lt;/li&gt;&lt;li&gt;âž¤ urine alkalinization&lt;/li&gt;&lt;li&gt;âž¤ not recommended&lt;/li&gt;&lt;li&gt;âž¤ calcium phosphate precipitation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A person with dyspnea has a slight limitation in physical activity. Doing ordinary activities causes symptoms, but he is asymptomatic at rest. Which class of the New York Heart Association (NYHA) classification does he belong to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Class II&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A patient who has slight limitations in physical activity but is asymptomatic at rest falls under NYHA Class II . Ordinary activities, such as walking or climbing stairs, result in symptoms.&lt;/li&gt;&lt;li&gt;âž¤ slight limitations in physical activity&lt;/li&gt;&lt;li&gt;âž¤ asymptomatic at rest&lt;/li&gt;&lt;li&gt;âž¤ NYHA Class II&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 66-year-old woman comes to the ER complaining of bleeding due to Warfarin. She received IV vitamin K, 4 U PRBCs, and 4 U FFP. Eight hours later, she begins to complain of SOB. Her vitals are T - 39Â°C, RR 35/min, SpO2 84% on room air, and BP 100/52 mm Hg. Exam reveals bilateral crackles, and the patient was intubated for respiratory failure. A chest X-ray (CXR) is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anaphylaxis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;TACO&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TRALI&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspiration&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. TRALI&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102649.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) TRALI&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ TRALI presents as acute respiratory distress , hypoxemia , and bilateral pulmonary infiltrates within 6 hours of transfusion, and it is caused by an immune-mediated response to blood products like FFP or PRBCs . This is distinct from TACO , which is related to fluid overload.&lt;/li&gt;&lt;li&gt;âž¤ TRALI&lt;/li&gt;&lt;li&gt;âž¤ acute respiratory distress&lt;/li&gt;&lt;li&gt;âž¤ hypoxemia&lt;/li&gt;&lt;li&gt;âž¤ bilateral pulmonary infiltrates&lt;/li&gt;&lt;li&gt;âž¤ 6 hours&lt;/li&gt;&lt;li&gt;âž¤ FFP&lt;/li&gt;&lt;li&gt;âž¤ PRBCs&lt;/li&gt;&lt;li&gt;âž¤ TACO&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The patient has a fever, cough, and cold. The chest x-ray is given below. What will be the examination finding in the infra-scapular region?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hyperresonance on percussion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coarse crackles&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Dull note on percussion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural rub&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Dull note on percussion&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture1_q53ZiqE.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Dull note on percussion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of pleural effusion , a dull note on percussion is the key examination finding due to the accumulation of fluid in the pleural space.&lt;/li&gt;&lt;li&gt;âž¤ pleural effusion&lt;/li&gt;&lt;li&gt;âž¤ dull note on percussion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a 5-year history of ulcerative colitis (UC) presents with acute abdominal pain, fever, and leukocytosis. A plain film is shown below. What is the next management step?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Methylprednisolone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Infliximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ciclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subtotal colectomy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV Methylprednisolone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102706.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV Methylprednisolone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For severe ulcerative colitis flare-ups or early toxic megacolon , IV Methylprednisolone is the initial treatment of choice. Surgical options like subtotal colectomy are considered if there is no response to medical treatment within 48 hours or if complications arise.&lt;/li&gt;&lt;li&gt;âž¤ ulcerative colitis flare-ups&lt;/li&gt;&lt;li&gt;âž¤ toxic megacolon&lt;/li&gt;&lt;li&gt;âž¤ IV Methylprednisolone&lt;/li&gt;&lt;li&gt;âž¤ subtotal colectomy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman presents with headache and bitemporal hemianopia. Hormonal evaluation was normal. Which of the following is a likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gonadotroph adenoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mammotroph adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Corticotroph adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Somatotroph adenoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Gonadotroph adenoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Gonadotroph adenoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A patient with normal hormonal evaluation , headache , and bitemporal hemianopia is most likely to have a gonadotroph adenoma , which is the most common non-functioning pituitary adenoma .&lt;/li&gt;&lt;li&gt;âž¤ normal hormonal evaluation&lt;/li&gt;&lt;li&gt;âž¤ headache&lt;/li&gt;&lt;li&gt;âž¤ bitemporal hemianopia&lt;/li&gt;&lt;li&gt;âž¤ gonadotroph adenoma&lt;/li&gt;&lt;li&gt;âž¤ non-functioning pituitary adenoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hamman sign is seen in:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pneumoperitoneum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pneumopericardium&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumomediastinum&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hydropneumothorax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pneumomediastinum&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-10-28%20170410.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pneumomediastinum&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Hammanâ€™s sign is a crunching sound synchronous with the heartbeat, and it is most commonly associated with pneumomediastinum , often heard over the precordium.&lt;/li&gt;&lt;li&gt;âž¤ Hammanâ€™s sign&lt;/li&gt;&lt;li&gt;âž¤ pneumomediastinum&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the immune mechanism leading to organ damage in Goodpasture syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibody-dependent cellular cytotoxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Complement-activating autoantibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Inactivating autoantibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stimulating autoantibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Complement-activating autoantibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Complement-activating autoantibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The immune mechanism leading to organ damage in Goodpasture syndrome involves complement-activating autoantibodies against the basement membrane in the kidneys and lungs, causing glomerulonephritis and pulmonary hemorrhage .&lt;/li&gt;&lt;li&gt;âž¤ immune mechanism&lt;/li&gt;&lt;li&gt;âž¤ Goodpasture syndrome&lt;/li&gt;&lt;li&gt;âž¤ complement-activating autoantibodies&lt;/li&gt;&lt;li&gt;âž¤ basement membrane&lt;/li&gt;&lt;li&gt;âž¤ glomerulonephritis&lt;/li&gt;&lt;li&gt;âž¤ pulmonary hemorrhage&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A female presented with loss of pain and temperature, but her touch sensation was intact. Imaging showed cavitation around the central canal. What is the probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Brown-Sequard syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tabes dorsalis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute combined degeneration&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Syringomyelia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Syringomyelia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Syringomyelia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Syringomyelia causes a selective loss of pain and temperature sensation with preservation of touch and proprioception, due to damage near the central canal of the spinal cord where the spinothalamic tract fibers cross.&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 24-year-old woman presents with prolonged menstrual bleeding. Her investigations showed normal platelet count, PT, and aPTT, while bleeding time was increased. Ristocetin test was normal. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bernard-Soulier syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Glanzmann thrombasthenia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Haemophilia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Von Willebrand disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Glanzmann thrombasthenia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Glanzmann thrombasthenia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with prolonged menstrual bleeding , increased bleeding time , normal platelet count, and normal Ristocetin test , the most likely diagnosis is Glanzmann thrombasthenia , a platelet aggregation disorder.&lt;/li&gt;&lt;li&gt;âž¤ prolonged menstrual bleeding&lt;/li&gt;&lt;li&gt;âž¤ increased bleeding time&lt;/li&gt;&lt;li&gt;âž¤ normal Ristocetin test&lt;/li&gt;&lt;li&gt;âž¤ Glanzmann thrombasthenia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has muffled heart sounds with low BP and elevated JVP. What is the likely JVP finding?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Absent a wave&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Absent y descent&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prominent y descent&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Absent x descent&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Absent y descent&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Absent y descent&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cardiac tamponade , the y descent is absent due to impaired right atrial emptying caused by the external pressure from pericardial fluid. This finding, along with muffled heart sounds, hypotension, and elevated JVP, points to the diagnosis of cardiac tamponade.&lt;/li&gt;&lt;li&gt;âž¤ cardiac tamponade&lt;/li&gt;&lt;li&gt;âž¤ y descent is absent&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patients with rheumatoid arthritis (RA) are at higher risk for all of the following EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Colorectal Cancer&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Coronary Artery Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoandrogenism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lymphoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Colorectal Cancer&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Colorectal Cancer&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Patients with rheumatoid arthritis are at increased risk for several comorbid conditions, including coronary artery disease , hypoandrogenism , and lymphoma , but there is no clear evidence suggesting an increased risk of colorectal cancer .&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ coronary artery disease&lt;/li&gt;&lt;li&gt;âž¤ hypoandrogenism&lt;/li&gt;&lt;li&gt;âž¤ lymphoma&lt;/li&gt;&lt;li&gt;âž¤ no clear evidence&lt;/li&gt;&lt;li&gt;âž¤ colorectal cancer&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 52-year-old lady develops sudden onset facial deviation with slurring of speech and inability to raise right arm. The symptoms spontaneously begin to reduce and has significant improvement over the next 2 hours. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Transient Ischemic Attack&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hemorrhagic Stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cardio-embolic stroke&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Paradoxical embolism&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Transient Ischemic Attack&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Transient Ischemic Attack (TIA)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A Transient Ischemic Attack (TIA) is characterized by the sudden onset of focal neurological symptoms that resolve within 24 hours , usually within minutes to hours. It is important to recognize TIA as it is a warning sign of a potential future stroke.&lt;/li&gt;&lt;li&gt;âž¤ Transient Ischemic Attack (TIA)&lt;/li&gt;&lt;li&gt;âž¤ sudden onset of focal neurological symptoms&lt;/li&gt;&lt;li&gt;âž¤ 24 hours&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man presents with chronic pain in his hands, knees, and hips, which is aggravated by activities such as climbing stairs. He reports increased hand pain when writing or typing. He also experiences morning stiffness in his joints, lasting around 30 minutes. An X-ray of his knee shows narrowed joint space with osteophytes. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Osteoarthritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bone tumor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Osteoporosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Osteoarthritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Osteoarthritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of chronic joint pain , morning stiffness lasting less than 1 hour , and X-ray findings of narrowed joint space with osteophytes is most consistent with osteoarthritis , a common non-inflammatory degenerative joint disease.&lt;/li&gt;&lt;li&gt;âž¤ chronic joint pain&lt;/li&gt;&lt;li&gt;âž¤ morning stiffness lasting less than 1 hour&lt;/li&gt;&lt;li&gt;âž¤ X-ray findings&lt;/li&gt;&lt;li&gt;âž¤ narrowed joint space with osteophytes&lt;/li&gt;&lt;li&gt;âž¤ osteoarthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old alcoholic with ascites and jaundice presents with an acute upper gastrointestinal (UGI) bleed. All of the following are appropriate treatment options EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Endoscopic variceal ligation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;TIPS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Propranolol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Propranolol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For acute variceal bleeding, treatment options include endoscopic variceal ligation , octreotide , and possibly TIPS in refractory cases. Propranolol , although effective for prevention , is not appropriate for the acute management of an ongoing variceal bleed.&lt;/li&gt;&lt;li&gt;âž¤ endoscopic variceal ligation&lt;/li&gt;&lt;li&gt;âž¤ octreotide&lt;/li&gt;&lt;li&gt;âž¤ TIPS&lt;/li&gt;&lt;li&gt;âž¤ Propranolol&lt;/li&gt;&lt;li&gt;âž¤ prevention&lt;/li&gt;&lt;li&gt;âž¤ not appropriate&lt;/li&gt;&lt;li&gt;âž¤ acute management&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient had a drop in Systolic Blood Pressure of 15 mm Hg during inspiration. Which of the following is NOT associated with it?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cardiac Tamponade&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Status Asthmaticus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertrophic Cardiomyopathy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Tension Pneumothorax&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Hypertrophic Cardiomyopathy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) Hypertrophic Cardiomyopathy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Pulsus paradoxus is associated with conditions that significantly increase intrathoracic pressure during inspiration, such as cardiac tamponade , status asthmaticus , and tension pneumothorax , but not hypertrophic cardiomyopathy , which is more likely to cause pulsus bisferiens .&lt;/li&gt;&lt;li&gt;âž¤ Pulsus paradoxus&lt;/li&gt;&lt;li&gt;âž¤ intrathoracic pressure&lt;/li&gt;&lt;li&gt;âž¤ cardiac tamponade&lt;/li&gt;&lt;li&gt;âž¤ status asthmaticus&lt;/li&gt;&lt;li&gt;âž¤ tension pneumothorax&lt;/li&gt;&lt;li&gt;âž¤ not hypertrophic cardiomyopathy&lt;/li&gt;&lt;li&gt;âž¤ pulsus bisferiens&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with frequent urination, nocturia, and enuresis. A 24-hour urine volume was measured to be 7 liters, and the urine osmolarity was 260 mOsm/L. An ADH assay was performed, with a result of 0.8 pg/ml. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nephrogenic DI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mannitol infusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Primary polydipsia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Central DI&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Central DI&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Central Diabetes Insipidus (DI)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with low ADH levels , polyuria , and dilute urine , the most likely diagnosis is Central Diabetes Insipidus (DI) , where there is a deficiency of ADH leading to the inability of the kidneys to concentrate urine.&lt;/li&gt;&lt;li&gt;âž¤ low ADH levels&lt;/li&gt;&lt;li&gt;âž¤ polyuria&lt;/li&gt;&lt;li&gt;âž¤ dilute urine&lt;/li&gt;&lt;li&gt;âž¤ Central Diabetes Insipidus (DI)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An An HIV patient presents with fever and neck stiffness. Lumbar puncture was done and CSF examination shows lymphocytosis, reduced An HIV patient presents with fever and neck stiffness. Lumbar puncture was done and CSF examination shows lymphocytosis, reduced HIV patient presents with fever and neck stiffness. Lumbar puncture was done and CSF examination shows lymphocytosis, reduced glucose, and increased protein. What is NOT helpful in identifying the likely causative organism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CSF Cryptococcal Antigen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CSF Adenosine Deaminase Levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CSF Viral PCR Assay&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;CSF India Ink Staining&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. CSF Viral PCR Assay&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) CSF Viral PCR Assay&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In HIV patients with meningitis-like symptoms and CSF findings of reduced glucose and increased protein , tests for Cryptococcal meningitis and tuberculous meningitis are most useful. CSF Viral PCR Assay is not typically helpful in this context; as viral meningitis does not usually cause the same CSF abnormalities.&lt;/li&gt;&lt;li&gt;âž¤ reduced glucose&lt;/li&gt;&lt;li&gt;âž¤ increased protein&lt;/li&gt;&lt;li&gt;âž¤ Cryptococcal meningitis&lt;/li&gt;&lt;li&gt;âž¤ tuberculous meningitis&lt;/li&gt;&lt;li&gt;âž¤ CSF Viral PCR Assay&lt;/li&gt;&lt;li&gt;âž¤ not typically helpful&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with a diagnosis of diffuse cutaneous scleroderma presents with malignant hypertension, oliguria, hemolysis, and renal failure. Which of the following is the recommended treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Carvedilol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Clonidine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Captopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Captopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Captopril (an ACE inhibitor) is the first-line treatment for scleroderma renal crisis , addressing the hypertensive emergency and improving renal function by inhibiting the renin-angiotensin system . Other antihypertensives are less effective in this specific context.&lt;/li&gt;&lt;li&gt;âž¤ Captopril&lt;/li&gt;&lt;li&gt;âž¤ first-line treatment&lt;/li&gt;&lt;li&gt;âž¤ scleroderma renal crisis&lt;/li&gt;&lt;li&gt;âž¤ renin-angiotensin system&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month-pregnant female presents with swelling in her legs and is diagnosed with Deep Vein Thrombosis (DVT). She requires anticoagulation. Which of the following is preferred?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Apixaban&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Enoxaparin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Aspirin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Enoxaparin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In pregnancy, Enoxaparin (low molecular weight heparin) is the anticoagulant of choice for treating DVT due to its safety profile and effectiveness , while Warfarin and DOACs are contraindicated or not recommended during pregnancy.&lt;/li&gt;&lt;li&gt;âž¤ Enoxaparin (low molecular weight heparin)&lt;/li&gt;&lt;li&gt;âž¤ safety profile&lt;/li&gt;&lt;li&gt;âž¤ effectiveness&lt;/li&gt;&lt;li&gt;âž¤ Warfarin&lt;/li&gt;&lt;li&gt;âž¤ DOACs&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are effective in treating Psoriatic arthritis except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Adalimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Secukinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ustekinumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Rituximab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Rituximab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Rituximab is not effective for psoriatic arthritis , as it targets B cells rather than the TNF-alpha , IL-17 , or IL-12/23 pathways that are central to the inflammation in PsA. Effective biologic therapies for PsA typically target cytokine-mediated pathways.&lt;/li&gt;&lt;li&gt;âž¤ Rituximab&lt;/li&gt;&lt;li&gt;âž¤ not effective&lt;/li&gt;&lt;li&gt;âž¤ psoriatic arthritis&lt;/li&gt;&lt;li&gt;âž¤ TNF-alpha&lt;/li&gt;&lt;li&gt;âž¤ IL-17&lt;/li&gt;&lt;li&gt;âž¤ IL-12/23&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is confirmatory to ensure that a central line is in the jugular vein?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ETCO2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood pH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Blood color&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Chest X-ray&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Chest X-ray&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Chest X-ray&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most confirmatory method to ensure that a central line is placed correctly in the jugular vein or other central venous locations is a chest X-ray , which helps visualize the position of the catheter tip and detect any complications.&lt;/li&gt;&lt;li&gt;âž¤ jugular vein&lt;/li&gt;&lt;li&gt;âž¤ chest X-ray&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A chronic smoker presents with weight gain and hyperpigmentation. A high-dose dexamethasone suppression test was done, and ACTH remained high before and after the test. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pituitary adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ectopic ACTH-producing tumor&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Exogenous source&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal adenoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Ectopic ACTH-producing tumor&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ When ACTH remains high after a high-dose dexamethasone suppression test in a patient with signs of Cushing&#x27;s syndrome , the most likely diagnosis is an ectopic ACTH-producing tumor â€”a common source being small cell lung carcinoma in chronic smokers.&lt;/li&gt;&lt;li&gt;âž¤ ACTH remains high&lt;/li&gt;&lt;li&gt;âž¤ Cushing&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ ectopic ACTH-producing tumor&lt;/li&gt;&lt;li&gt;âž¤ small cell lung carcinoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A stale potato curry causes severe gastroenteritis in a picnic group. A 36-year-old man recovers from the diarrhea, but 2 weeks later develops arthritis in his right knee and severe left-sided Achilles tendinitis. What is the most likely organism implicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;C. jejuni&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S. flexneri&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;H. pylori&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;C. difficile&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S. flexneri&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) S. flexneri&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ S. flexneri is the most likely organism implicated in a case of reactive arthritis following a gastrointestinal infection, presenting with joint inflammation and tendinitis.&lt;/li&gt;&lt;li&gt;âž¤ S. flexneri&lt;/li&gt;&lt;li&gt;âž¤ reactive arthritis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The patient is having the following hand movements. Which of the following conditions is responsible?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyrotoxicosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypercarbia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hemiballismus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypoxia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypercarbia&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202024-10-28%20173813.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A flapping tremor (asterixis) is most commonly seen in hypercarbia and hepatic encephalopathy . It indicates underlying metabolic or toxic encephalopathy, particularly in conditions of CO2 retention.&lt;/li&gt;&lt;li&gt;âž¤ flapping tremor (asterixis)&lt;/li&gt;&lt;li&gt;âž¤ hypercarbia&lt;/li&gt;&lt;li&gt;âž¤ hepatic encephalopathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old medical student with a 2-month history of palpitations, sweating, restlessness, and complains of sweaty palms. Which of the following will help in diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thyroid receptor antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti-Thyroglobulin Antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ultrasensitive thyrotropin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti-thyroid peroxidase antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ultrasensitive thyrotropin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ultrasensitive thyrotropin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient presenting with symptoms suggestive of thyrotoxicosis , the most appropriate first step is to measure TSH with an ultrasensitive thyrotropin test to confirm the diagnosis before moving on to other investigations.&lt;/li&gt;&lt;li&gt;âž¤ thyrotoxicosis&lt;/li&gt;&lt;li&gt;âž¤ TSH&lt;/li&gt;&lt;li&gt;âž¤ ultrasensitive thyrotropin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman presented with unilateral pulsatile headache, photophobia, phonophobia, and nausea, which is exaggerated on skipping her meals. What is your diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Migraine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tension headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cluster headache&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Malingering&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Migraine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Migraine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A migraine typically presents with unilateral, pulsatile headache associated with nausea , photophobia , and phonophobia , and it may be triggered by factors like skipping meals or stress.&lt;/li&gt;&lt;li&gt;âž¤ migraine&lt;/li&gt;&lt;li&gt;âž¤ unilateral, pulsatile headache&lt;/li&gt;&lt;li&gt;âž¤ nausea&lt;/li&gt;&lt;li&gt;âž¤ photophobia&lt;/li&gt;&lt;li&gt;âž¤ phonophobia&lt;/li&gt;&lt;li&gt;âž¤ skipping meals&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is incorrect with regards to allopurinol in gout?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Allopurinol should not be used with Colchicine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Allopurinol dosing should be adjusted for renal function&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Allopurinol dosing should be titrated to a S. UA &amp;lt; 6&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Allopurinol hypersensitivity is associated with HLA B5801&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Allopurinol should not be used with Colchicine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Allopurinol should not be used with Colchicine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The incorrect statement is \&quot;Allopurinol should not be used with Colchicine,\&quot; as Colchicine is commonly co-prescribed with Allopurinol to prevent gout flares during the initiation of treatment.&lt;/li&gt;&lt;li&gt;âž¤ \&quot;Allopurinol should not be used with Colchicine,\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Colchicine&lt;/li&gt;&lt;li&gt;âž¤ Allopurinol&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old woman who recently received a kidney transplant 2 months ago developed a high-grade fever, dyspnea, and a hacking cough. Chest X-ray reveals bilateral interstitial infiltrates. Urine examination shows â€œowl eyeâ€ appearance of cells. Which of the following agents is most likely responsible for her condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Influenza virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory syncytial virus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cytomegalovirus&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adenovirus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Cytomegalovirus&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Cytomegalovirus&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a post-transplant patient with systemic symptoms and the characteristic \&quot;owl eye\&quot; inclusions , Cytomegalovirus (CMV) is the most likely causative agent, especially in the context of immunosuppression.&lt;/li&gt;&lt;li&gt;âž¤ \&quot;owl eye\&quot; inclusions&lt;/li&gt;&lt;li&gt;âž¤ Cytomegalovirus (CMV)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old patient has fever with severe shortness of breath and red currant jelly sputum. On examination, he has altered sensorium with respiratory rate of 35 breaths/min. Lab investigations show serum creatinine of 1.9 mg/dl. CXR is done and it shows multi-lobar infiltrates. What is correct regarding the management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;OPD management&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IPD management&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ICU management (oral drugs)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ICU management (IV drugs)&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. ICU management (IV drugs)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) ICU management (IV drugs)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Severe pneumonia with respiratory distress , altered sensorium , and multi-lobar infiltrates requires ICU management with IV antibiotics to ensure effective and rapid treatment, especially in suspected cases of Klebsiella pneumoniae pneumonia.&lt;/li&gt;&lt;li&gt;âž¤ respiratory distress&lt;/li&gt;&lt;li&gt;âž¤ altered sensorium&lt;/li&gt;&lt;li&gt;âž¤ multi-lobar infiltrates&lt;/li&gt;&lt;li&gt;âž¤ ICU management with IV antibiotics&lt;/li&gt;&lt;li&gt;âž¤ Klebsiella pneumoniae&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Management of Hepatorenal Syndrome includes all EXCEPT:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Volume expansion with IV albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Diuresis with furosemide + spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Midodrine and octreotide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Referral to liver transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Diuresis with furosemide + spironolactone&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Diuresis with furosemide + spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In hepatorenal syndrome , diuretics like furosemide and spironolactone are contraindicated as they can worsen renal hypoperfusion. The primary treatment involves volume expansion with IV albumin , vasoactive agents (e.g., midodrine and octreotide ), and consideration of liver transplantation for definitive management.&lt;/li&gt;&lt;li&gt;âž¤ hepatorenal syndrome&lt;/li&gt;&lt;li&gt;âž¤ diuretics&lt;/li&gt;&lt;li&gt;âž¤ furosemide and spironolactone&lt;/li&gt;&lt;li&gt;âž¤ contraindicated&lt;/li&gt;&lt;li&gt;âž¤ volume expansion with IV albumin&lt;/li&gt;&lt;li&gt;âž¤ vasoactive agents&lt;/li&gt;&lt;li&gt;âž¤ midodrine and octreotide&lt;/li&gt;&lt;li&gt;âž¤ liver transplantation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;60-year-old obese lady underwent cholecystectomy. After 3 days she develops respiratory distress. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Air embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Atelectasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Myocardial Infarction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary embolism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Pulmonary embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Post-operative respiratory distress, especially in an obese patient, should raise a high suspicion for pulmonary embolism , a common complication after surgery due to immobility and increased risk of thromboembolism. Early identification and management are crucial.&lt;/li&gt;&lt;li&gt;âž¤ pulmonary embolism&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 45-year-old presents with chest pain, dyspnea that worsens when lying down and is relieved when sitting upright. On examination, heart sounds are muffled and the lungs are clear. A chest X-ray is shown. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute Pulmonary edema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute Pulmonary embolism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute MI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cardiac Tamponade&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Cardiac Tamponade&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture8_yDBr35W.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Cardiac Tamponade&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of dyspnea, chest pain relieved by sitting upright , muffled heart sounds , and X-ray findings (likely showing an enlarged heart silhouette) strongly suggests cardiac tamponade . This is a medical emergency that requires prompt diagnosis and treatment.&lt;/li&gt;&lt;li&gt;âž¤ dyspnea, chest pain relieved by sitting upright&lt;/li&gt;&lt;li&gt;âž¤ muffled heart sounds&lt;/li&gt;&lt;li&gt;âž¤ cardiac tamponade&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following statements is false with regards to Klinefelterâ€™s syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Androgen supplementation is useful&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Patients are at increased risk for breast tumors&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Reduced plasma estrogen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Most cases are diagnosed after puberty&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Reduced plasma estrogen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Reduced plasma estrogen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The statement \&quot;Reduced plasma estrogen\&quot; is false in Klinefelter&#x27;s syndrome , as patients have increased estrogen levels due to testicular failure . Testosterone therapy is beneficial, and there is an increased risk of breast cancer in these patients. Most cases are diagnosed after puberty.&lt;/li&gt;&lt;li&gt;âž¤ \&quot;Reduced plasma estrogen\&quot;&lt;/li&gt;&lt;li&gt;âž¤ Klinefelter&#x27;s syndrome&lt;/li&gt;&lt;li&gt;âž¤ increased estrogen levels&lt;/li&gt;&lt;li&gt;âž¤ testicular failure&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following rules out Exudative pleural effusion?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;High Protein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low Fibrin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High Specific gravity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;High cellular content&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Low Fibrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Low fibrin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A low fibrin level would rule out exudative pleural effusion, as exudates are typically associated with high fibrin content due to inflammation.&lt;/li&gt;&lt;li&gt;âž¤ low fibrin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is a known case of hypertension is on multiple anti-hypertensive drugs. His ECG is shown below. Which drug is responsible for the following ECG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Spironolactone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prazosin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Spironolactone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture9_2Nn3yvQ.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Spironolactone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone can lead to hyperkalemia , which manifests on ECG with tall T waves , widened QRS complexes , and potential absent P waves . This is the most likely cause of the ECG changes in this hypertensive patient on multiple antihypertensive medications.&lt;/li&gt;&lt;li&gt;âž¤ Spironolactone&lt;/li&gt;&lt;li&gt;âž¤ hyperkalemia&lt;/li&gt;&lt;li&gt;âž¤ tall T waves&lt;/li&gt;&lt;li&gt;âž¤ widened QRS complexes&lt;/li&gt;&lt;li&gt;âž¤ absent P waves&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has neurosurgery for a pituitary tumor that requires resection of the gland. Which of the following functions of the adrenal gland will be preserved postoperatively?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Morning peak of plasma cortisol level&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Release of cortisol in response to stress&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Sodium retention in response to hypovolemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Synthesis of adrenal sex steroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Sodium retention in response to hypovolemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Sodium retention in response to hypovolemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The adrenal glandâ€™s ability to retain sodium in response to hypovolemia is preserved post-pituitary resection because it is governed by the renin-angiotensin-aldosterone system (RAAS) , which does not depend on ACTH . However, functions dependent on ACTH , such as cortisol production and adrenal androgen synthesis , will be compromised.&lt;/li&gt;&lt;li&gt;âž¤ sodium&lt;/li&gt;&lt;li&gt;âž¤ hypovolemia&lt;/li&gt;&lt;li&gt;âž¤ renin-angiotensin-aldosterone system (RAAS)&lt;/li&gt;&lt;li&gt;âž¤ ACTH&lt;/li&gt;&lt;li&gt;âž¤ ACTH&lt;/li&gt;&lt;li&gt;âž¤ cortisol production&lt;/li&gt;&lt;li&gt;âž¤ adrenal androgen synthesis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient had features of resting tremors, bradykinesia, and postural instability. He became bedridden and died due to respiratory failure. Brain biopsy is likely to show which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lewy bodies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hirano bodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Guarneri bodies&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Negri bodies&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Lewy bodies&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture3_uF6BqbJ.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â A) Lewy bodies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Lewy bodies, composed mainly of alpha-synuclein, are a hallmark of Parkinsonâ€™s disease and are typically seen on brain biopsy in patients with this neurodegenerative disorder.&lt;/li&gt;&lt;li&gt;âž¤ Parkinsonâ€™s disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is true regarding the management of pheochromocytoma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î²-blockers are contraindicated in pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Salt and fluid intake should be restricted&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV phentolamine is indicated for hypertensive crisis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Surgery is rarely required&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV phentolamine is indicated for hypertensive crisis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) IV phentolamine is indicated for hypertensive crisis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In pheochromocytoma , IV phentolamine is the first-line treatment for a hypertensive crisis . While beta-blockers can be used, they should only be given after alpha-blockade to avoid unopposed alpha stimulation. Surgery is the definitive treatment , and salt and fluid restriction should be avoided to prevent postoperative hypotension.&lt;/li&gt;&lt;li&gt;âž¤ pheochromocytoma&lt;/li&gt;&lt;li&gt;âž¤ IV phentolamine&lt;/li&gt;&lt;li&gt;âž¤ hypertensive crisis&lt;/li&gt;&lt;li&gt;âž¤ after alpha-blockade&lt;/li&gt;&lt;li&gt;âž¤ definitive treatment&lt;/li&gt;&lt;li&gt;âž¤ salt and fluid restriction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A morbidly obese diabetic woman was on Metformin but could not achieve glycemic control. She has had a previous osteoporotic fracture and has a history of pancreatitis. The patient does not want to take injections. Which of the following would be suitable to reduce her glucose levels?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Semaglutide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a morbidly obese diabetic patient with a history of osteoporosis and pancreatitis , Empagliflozin is the best choice for glucose management as it promotes weight loss , does not increase the risk of pancreatitis, and avoids worsening osteoporosis.&lt;/li&gt;&lt;li&gt;âž¤ morbidly obese&lt;/li&gt;&lt;li&gt;âž¤ osteoporosis&lt;/li&gt;&lt;li&gt;âž¤ pancreatitis&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin&lt;/li&gt;&lt;li&gt;âž¤ weight loss&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 27-year-old female develops eye pain and reduced visual acuity following the initiation of treatment for her recently diagnosed Graves&#x27; disease. Which one of the following treatments is likely to have been started?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Radioactive Iodine Ablation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Thyroidectomy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propylthiouracil&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Carbimazole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Radioactive Iodine Ablation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Radioactive Iodine Ablation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Radioactive iodine ablation is associated with an increased risk of worsening Graves&#x27; orbitopathy , especially in patients with existing eye symptoms. It is important to consider the risks of exacerbating eye problems when selecting treatment for patients with Graves&#x27; disease who have orbital involvement.&lt;/li&gt;&lt;li&gt;âž¤ Radioactive iodine ablation&lt;/li&gt;&lt;li&gt;âž¤ Graves&#x27; orbitopathy&lt;/li&gt;&lt;li&gt;âž¤ Graves&#x27; disease&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti-diabetic drug can cause euglycemic Ketoacidosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Glimepiride&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acarbose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Empagliflozin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Empagliflozin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Empagliflozin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin , an SGLT2 inhibitor, can cause euglycemic ketoacidosis , where ketoacidosis occurs with normal or mildly elevated blood glucose levels. This is a key side effect to monitor in patients treated with SGLT2 inhibitors.&lt;/li&gt;&lt;li&gt;âž¤ Empagliflozin&lt;/li&gt;&lt;li&gt;âž¤ euglycemic ketoacidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 31-year-old woman with rheumatoid arthritis (RA) gets pregnant. She is currently on hydroxychloroquine and sulfasalazine, but her disease is progressively worsening at 32 weeks of gestation. Which drug can she be started on?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Leflunomide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Methotrexate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NSAIDs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Certolizumab&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Certolizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Certolizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For pregnant women with rheumatoid arthritis , Certolizumab is the safest TNF-alpha inhibitor that can be used throughout pregnancy, particularly in the later stages, because it does not cross the placenta.&lt;/li&gt;&lt;li&gt;âž¤ rheumatoid arthritis&lt;/li&gt;&lt;li&gt;âž¤ Certolizumab&lt;/li&gt;&lt;li&gt;âž¤ TNF-alpha inhibitor&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 22-year-old man was brought to casualty with a history of GTCS, presented with 4-5 episodes of seizures and seizures are present for more than 45 minutes. The ambulance crew administered 4 mg of lorazepam already. What will be the management in the Emergency Room?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Valproate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lacosamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lorazepam&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Lorazepam&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â D) Lorazepam&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In status epilepticus, lorazepam is the first-line treatment. If the initial dose does not control the seizures, a repeat dose of lorazepam can be administered before moving on to second-line agents like phenytoin or valproate.&lt;/li&gt;&lt;li&gt;âž¤ lorazepam&lt;/li&gt;&lt;li&gt;âž¤ a repeat dose of lorazepam&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which is the characteristic pattern seen in Brown-Sequard syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Contralateral loss of joint sense and position&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Contralateral loss of pain sensation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ipsilateral loss of complete sensory functions&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Contralateral motor function loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Contralateral loss of pain sensation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Contralateral loss of pain sensation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Brown-Sequard syndrome , the classic characteristic is contralateral loss of pain and temperature sensation due to damage to the spinothalamic tract and ipsilateral loss of motor function and proprioception below the level of the lesion.&lt;/li&gt;&lt;li&gt;âž¤ Brown-Sequard syndrome&lt;/li&gt;&lt;li&gt;âž¤ contralateral loss of pain and temperature sensation&lt;/li&gt;&lt;li&gt;âž¤ spinothalamic tract&lt;/li&gt;&lt;li&gt;âž¤ ipsilateral loss of motor function and proprioception&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old patient with long-standing type 2 diabetes came to the OPD with complaints of fatigue and frequent urination. His FBS = 144 mg/dl &amp;amp; PPBS = 210 mg/dl. What is the target HbA1C for adequate control of diabetes?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 6.0&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 6.5&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt; 7.0&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt; 7.5&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &lt; 7.0&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â C) &amp;lt; 7.0&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The recommended target HbA1C for most patients with type 2 diabetes is &amp;lt; 7% , as it balances good glycemic control with minimizing the risk of hypoglycemia and long-term complications.&lt;/li&gt;&lt;li&gt;âž¤ &amp;lt; 7%&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with thalassemia has a history of multiple blood transfusions, iron overload, and cardiac arrhythmia. She has now come for a blood transfusion and during the process, complains of backache and looks very anxious. What would you do next?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stop the blood transfusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Continue the transfusion but do an ECG&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Stop the transfusion and wait for the patient to become normal to start it again&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Do a clerical check and get an ECG&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stop the blood transfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Stop the blood transfusion&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In any suspected acute transfusion reaction , such as in the case of backache and anxiety during a blood transfusion, the immediate step is to stop the transfusion to prevent further complications, followed by investigations to confirm the cause of the reaction.&lt;/li&gt;&lt;li&gt;âž¤ suspected acute transfusion reaction&lt;/li&gt;&lt;li&gt;âž¤ backache&lt;/li&gt;&lt;li&gt;âž¤ anxiety&lt;/li&gt;&lt;li&gt;âž¤ immediate step&lt;/li&gt;&lt;li&gt;âž¤ stop the transfusion&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are features of Connâ€™s syndrome except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metabolic alkalosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Metabolic acidosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertension&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Muscle cramps&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Metabolic acidosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans.Â B) Metabolic acidosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The hallmark features of Connâ€™s syndrome are metabolic alkalosis , hypertension , and hypokalemia , which can result in muscle cramps. Metabolic acidosis is not associated with Connâ€™s syndrome.&lt;/li&gt;&lt;li&gt;âž¤ metabolic alkalosis&lt;/li&gt;&lt;li&gt;âž¤ hypertension&lt;/li&gt;&lt;li&gt;âž¤ hypokalemia&lt;/li&gt;&lt;li&gt;âž¤ Metabolic acidosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 36-year-old woman is referred for evaluation due to a 5-year history of Raynaud phenomenon and thickening of the skin over her fingers. Routine laboratory tests are within normal limits. DLCO (diffusing capacity of the lungs for carbon monoxide) is 44% of normal, with normal lung volumes. What is the likely diagnosis in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pulmonary hypertension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic obstructive lung disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Interstitial Lung Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Restrictive lung disease secondary to pleural disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pulmonary hypertension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pulmonary hypertension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with systemic sclerosis , pulmonary arterial hypertension (PAH) is a common complication, especially when there is a reduced DLCO with normal lung volumes , as seen in this patient.&lt;/li&gt;&lt;li&gt;âž¤ systemic sclerosis&lt;/li&gt;&lt;li&gt;âž¤ pulmonary arterial hypertension (PAH)&lt;/li&gt;&lt;li&gt;âž¤ reduced DLCO&lt;/li&gt;&lt;li&gt;âž¤ normal lung volumes&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient has recurrent optic neuritis of both eyes with extensive transverse myelitis. Visual acuity in the right eye is 6/60 and visual acuity in the left eye 6/18. The patient showed a partial response to steroids. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neuromyelitis optica&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subacute combined degeneration of spinal cord&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Neurosyphilis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Neuromyelitis optica&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Neuromyelitis optica&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neuromyelitis optica (NMO) presents with recurrent bilateral optic neuritis and extensive transverse myelitis . It often requires more aggressive immunosuppressive therapy beyond steroids and is distinguished from multiple sclerosis by the pattern of spinal cord involvement and optic neuritis.&lt;/li&gt;&lt;li&gt;âž¤ Neuromyelitis optica (NMO)&lt;/li&gt;&lt;li&gt;âž¤ recurrent bilateral optic neuritis&lt;/li&gt;&lt;li&gt;âž¤ extensive transverse myelitis&lt;/li&gt;&lt;li&gt;âž¤ multiple sclerosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old woman has ptosis and limb weakness that worsens in the evening. She was diagnosed with myasthenia gravis. What is the first line drug used?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pyridostigmine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prednisolone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cyclosporine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Plasma exchange&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pyridostigmine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pyridostigmine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In myasthenia gravis , the first-line treatment is pyridostigmine , a cholinesterase inhibitor that improves muscle strength by increasing acetylcholine levels at the neuromuscular junction. Immunosuppressive therapies like prednisolone or cyclosporine are reserved for more severe or refractory cases. Plasma exchange is used in acute exacerbations or pre-surgical management.&lt;/li&gt;&lt;li&gt;âž¤ myasthenia gravis&lt;/li&gt;&lt;li&gt;âž¤ pyridostigmine&lt;/li&gt;&lt;li&gt;âž¤ prednisolone&lt;/li&gt;&lt;li&gt;âž¤ cyclosporine&lt;/li&gt;&lt;li&gt;âž¤ Plasma exchange&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 47-year-old man with a diagnosis of acute myeloid leukemia with a blood type O negative presents to the transplant clinic to discuss proceeding with an allogeneic stem cell transplant. Which of the following would be an optimal donor?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;His identical twin brother&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Umbilical cord transplant&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;An HLA identical matched unrelated donor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;His HLA identical 50-year-old brother&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. His HLA identical 50-year-old brother&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) His HLA identical 50-year-old brother&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The optimal donor for an allogeneic stem cell transplant is typically an HLA identical sibling , as this provides the best balance between minimizing the risk of complications (such as graft-versus-host disease) and maintaining the graft-versus-leukemia effect. An HLA identical sibling is the preferred choice over unrelated donors or umbilical cord transplants.&lt;/li&gt;&lt;li&gt;âž¤ optimal donor&lt;/li&gt;&lt;li&gt;âž¤ HLA identical sibling&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Preferred sample for testing random blood sugar is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Venous&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Arterial&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Capillary&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arteriole&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Venous&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Venous&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The preferred sample for testing random blood sugar is venous blood because it provides the most accurate and consistent results in clinical settings. Capillary blood is often used for home monitoring and quick testing, but venous samples remain the standard for laboratory diagnostics.&lt;/li&gt;&lt;li&gt;âž¤ preferred sample&lt;/li&gt;&lt;li&gt;âž¤ random blood sugar&lt;/li&gt;&lt;li&gt;âž¤ venous blood&lt;/li&gt;&lt;li&gt;âž¤ Capillary blood&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 30-year-old female patient with chronic hepatitis B who is HBeAg negative is evaluated for treatment. ALT is normal and HBV DNA is 800 IU/mL. Which of the following would you recommend for treatment?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Peg-interferon&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lamivudine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adefovir&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Observation&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Observation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Observation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In chronic hepatitis B patients who are HBeAg negative , with HBV DNA &amp;lt; 2000 IU/mL and normal ALT , the correct management is observation and periodic monitoring. No immediate antiviral treatment is needed unless there is a change in viral load or liver enzyme levels.&lt;/li&gt;&lt;li&gt;âž¤ chronic hepatitis B&lt;/li&gt;&lt;li&gt;âž¤ HBeAg negative&lt;/li&gt;&lt;li&gt;âž¤ HBV DNA &amp;lt; 2000 IU/mL&lt;/li&gt;&lt;li&gt;âž¤ normal ALT&lt;/li&gt;&lt;li&gt;âž¤ observation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which value is derived in ABG?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Ph&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;pO2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;pCO2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bicarbonate&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Bicarbonate&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Bicarbonate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In ABG analysis , the values for pH, pO2, and pCO2 are directly measured, while bicarbonate (HCOâ‚ƒâ») is derived using formulas based on the measured values.&lt;/li&gt;&lt;li&gt;âž¤ ABG analysis&lt;/li&gt;&lt;li&gt;âž¤ pH, pO2, and pCO2&lt;/li&gt;&lt;li&gt;âž¤ bicarbonate (HCOâ‚ƒâ»)&lt;/li&gt;&lt;li&gt;âž¤ derived&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young child presented with nocturnal chest pain and a history of syncope, has the ECG shown below. What is the most probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Myocardial infarction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HOCM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Brugada syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;DCM&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Brugada syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102826.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Brugada syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Brugada syndrome presents with characteristic ST-segment elevation in leads V1-V3 and is associated with a risk of sudden cardiac death due to ventricular arrhythmias. It should be suspected in young individuals with syncope and nocturnal chest pain, especially if these characteristic ECG findings are present.&lt;/li&gt;&lt;li&gt;âž¤ Brugada syndrome&lt;/li&gt;&lt;li&gt;âž¤ ST-segment elevation in leads V1-V3&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 23-year-old male presented with infertility, and he has chronic sinusitis, bronchiectasis, and situs inversus. What is the likely disorder?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Kartagenerâ€™s syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cystic fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Mucoviscidosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Klinefelter syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Kartagenerâ€™s syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Kartagenerâ€™s syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Kartagenerâ€™s syndrome is characterized by infertility , chronic sinusitis , bronchiectasis , and situs inversus , all due to defective ciliary movement.&lt;/li&gt;&lt;li&gt;âž¤ Kartagenerâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ infertility&lt;/li&gt;&lt;li&gt;âž¤ chronic sinusitis&lt;/li&gt;&lt;li&gt;âž¤ bronchiectasis&lt;/li&gt;&lt;li&gt;âž¤ situs inversus&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;An old man presents with dyspnea and swelling of his feet. On examination, rales are heard and he is found to have an enlarged heart on chest x-ray. Which of the following will delay the progression?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vericiguat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Digoxin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Captopril&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Captopril&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Captopril&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with heart failure, Captopril (an ACE inhibitor) delays disease progression by reducing ventricular remodeling, afterload, and the progression of heart failure. It is a key drug that improves survival, unlike diuretics or digoxin, which mainly provide symptom relief.&lt;/li&gt;&lt;li&gt;âž¤ Captopril (an ACE inhibitor)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is likely with ascitic fluid protein 1.9 g/dL and a SAAG (Serum-Ascites Albumin Gradient) of 1.4?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic cirrhosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Peritoneal malignancy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Constrictive pericarditis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Veno-occlusive disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Alcoholic cirrhosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Alcoholic cirrhosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A SAAG â‰¥ 1.1 g/dL and ascitic fluid protein &amp;lt; 2.5 g/dL are most consistent with portal hypertension due to alcoholic cirrhosis .&lt;/li&gt;&lt;li&gt;âž¤ SAAG â‰¥ 1.1 g/dL&lt;/li&gt;&lt;li&gt;âž¤ ascitic fluid protein &amp;lt; 2.5 g/dL&lt;/li&gt;&lt;li&gt;âž¤ portal hypertension&lt;/li&gt;&lt;li&gt;âž¤ alcoholic cirrhosis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old with a history of COPD is brought to the ER with worsening dyspnea. ABG was done and pH was 7.3, pCO2 was 60 mmHg with HCO3- being 28 mEq/L. Which of the following is seen in this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Respiratory acidosis, hyperventilation, inadequate metabolic compensation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Respiratory alkalosis, hypoventilation, inadequate metabolic compensation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Respiratory acidosis, hypoventilation, inadequate metabolic compensation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Respiratory acidosis, hypoventilation, adequate metabolic compensation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Respiratory acidosis, hypoventilation, inadequate metabolic compensation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Respiratory acidosis, hypoventilation, inadequate metabolic compensation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The patient with COPD presents with respiratory acidosis due to hypoventilation and inadequate metabolic compensation , which is expected in an acute or decompensated state. The pH of 7.3 and pCO2 of 60 mmHg confirm the diagnosis of respiratory acidosis, and the mildly elevated bicarbonate (HCO3-) suggests that compensation is incomplete.&lt;/li&gt;&lt;li&gt;âž¤ respiratory acidosis due to hypoventilation&lt;/li&gt;&lt;li&gt;âž¤ inadequate metabolic compensation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 72-year-old pilot presents to a neurologist with rapidly progressive dementia, myoclonus, ataxia, and visual disturbances. EEG showed periodic complexes. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Creutzfeldt-Jakob Disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Alzheimer&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Whipple disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vascular dementia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Creutzfeldt-Jakob Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Creutzfeldt-Jakob Disease (CJD)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with rapidly progressive dementia , myoclonus , ataxia , and periodic complexes on EEG, the most likely diagnosis is Creutzfeldt-Jakob Disease (CJD) , a rapidly fatal neurodegenerative disease caused by prions.&lt;/li&gt;&lt;li&gt;âž¤ rapidly progressive dementia&lt;/li&gt;&lt;li&gt;âž¤ myoclonus&lt;/li&gt;&lt;li&gt;âž¤ ataxia&lt;/li&gt;&lt;li&gt;âž¤ periodic complexes&lt;/li&gt;&lt;li&gt;âž¤ Creutzfeldt-Jakob Disease (CJD)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the diagnosis in the ECG shown below?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;First degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Third degree heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Wenckebach heart block&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Mobitz type 2 block&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Mobitz type 2 block&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102855.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Mobitz type 2 block&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Mobitz type 2 block is characterized by a constant PR interval with intermittent dropped QRS complexes and grouped beats. It is a more severe type of AV block compared to Wenckebach and often requires pacemaker insertion due to the risk of progressing to complete heart block.&lt;/li&gt;&lt;li&gt;âž¤ Mobitz type 2 block&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A young female presented with wheezing and shortness of breath with the use of accessory muscles. She complains of similar episodes in the past in early mornings. Spirometry findings are as follows: FEV1/FVC ratio &amp;lt; 0.7 and FEV1 &amp;lt; 80% of the predicted value in a female patient.&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Asthma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Interstitial Lung Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Idiopathic Pulmonary Fibrosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Silicosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Asthma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Asthma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Asthma typically presents with wheezing , reversible airflow obstruction , and diurnal variation, such as worsening symptoms in the early morning . Spirometry reveals an FEV1/FVC ratio &amp;lt; 0.7 and a decreased FEV1 indicative of obstructive lung disease.&lt;/li&gt;&lt;li&gt;âž¤ wheezing&lt;/li&gt;&lt;li&gt;âž¤ reversible airflow obstruction&lt;/li&gt;&lt;li&gt;âž¤ worsening symptoms in the early morning&lt;/li&gt;&lt;li&gt;âž¤ FEV1/FVC ratio &amp;lt; 0.7&lt;/li&gt;&lt;li&gt;âž¤ decreased FEV1&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 26-year-old female presents to the ER with menorrhagia. She mentions that her father and sister also suffer from bleeding disorders. Which of the following is likely?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Factor X deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Factor VIII deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Factor IX deficiency&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Von Willebrand Disease&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Von Willebrand Disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Von Willebrand Disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Von Willebrand Disease (VWD) is the most common inherited bleeding disorder, presenting with mucosal bleeding like menorrhagia, and it affects both males and females due to its autosomal dominant inheritance pattern.&lt;/li&gt;&lt;li&gt;âž¤ Von Willebrand Disease (VWD)&lt;/li&gt;&lt;li&gt;âž¤ autosomal dominant&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient having hypertension, is on thiazides and is complaining of fatigue and hypokalemia. Which of the following drug can prevent potassium loss?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Furosemide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiloride&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetazolamide&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Indapamide&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Amiloride&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Amiloride&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amiloride , a potassium-sparing diuretic , can be used to prevent potassium loss in patients taking thiazide diuretics for hypertension, as it inhibits potassium excretion.&lt;/li&gt;&lt;li&gt;âž¤ Amiloride&lt;/li&gt;&lt;li&gt;âž¤ potassium-sparing diuretic&lt;/li&gt;&lt;li&gt;âž¤ potassium loss&lt;/li&gt;&lt;li&gt;âž¤ thiazide diuretics&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with hemolytic anemia presents with index finger pain and chest pain. The patient has Hb of 5.6 gm/dl and an increase in unconjugated bilirubin in serum. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Microangiopathic anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sickling crisis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Thalassemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Autoimmune hemolytic anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Sickling crisis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Sickling crisis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell crisis (sickling crisis) is characterized by acute pain due to vaso-occlusive episodes affecting bones and organs, such as dactylitis and acute chest syndrome. These crises are accompanied by hemolytic anemia and elevated unconjugated bilirubin levels due to increased RBC destruction.&lt;/li&gt;&lt;li&gt;âž¤ Sickle cell crisis&lt;/li&gt;&lt;li&gt;âž¤ acute pain&lt;/li&gt;&lt;li&gt;âž¤ vaso-occlusive episodes&lt;/li&gt;&lt;li&gt;âž¤ hemolytic anemia&lt;/li&gt;&lt;li&gt;âž¤ unconjugated bilirubin&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A woman comes with complaints of hyperpigmentation of her palms after an adrenalectomy. She also has new onset vision deficits. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nelson syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Sheehan syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Conn&#x27;s syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Addisonâ€™s disease&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nelson syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nelson syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Nelson syndrome is characterized by hyperpigmentation and visual disturbances following bilateral adrenalectomy due to the unregulated growth of an ACTH-secreting pituitary adenoma.&lt;/li&gt;&lt;li&gt;âž¤ Nelson syndrome&lt;/li&gt;&lt;li&gt;âž¤ hyperpigmentation&lt;/li&gt;&lt;li&gt;âž¤ visual disturbances&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient came to the emergency with severe breathlessness. CXR is taken and shown below. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pneumothorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Consolidation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Collapse&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pleural effusion&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Collapse&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture4_U8DIyUl.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Collapse&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In lung collapse (atelectasis) , the key features include tracheal shift towards the side of the collapse and hyperinflation of the contralateral lung . These findings, along with an opaque hemithorax, help differentiate collapse from other conditions like pneumothorax and pleural effusion.&lt;/li&gt;&lt;li&gt;âž¤ lung collapse (atelectasis)&lt;/li&gt;&lt;li&gt;âž¤ tracheal shift towards the side of the collapse&lt;/li&gt;&lt;li&gt;âž¤ hyperinflation of the contralateral lung&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 40-year-old female with a history of recurrent headaches presented for further evaluation. Laboratory tests revealed normal hemoglobin and WBC counts, with an elevated platelet count. Bone marrow evaluation showed increased megakaryocytes and a JAK2 mutation. What is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Essential thrombocytosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polycythemia vera&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Chronic myelogenous leukemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary myelofibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Essential thrombocytosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Essential thrombocytosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The combination of an elevated platelet count , normal hemoglobin and WBC counts , increased megakaryocytes in the bone marrow, and a JAK2 mutation is most consistent with Essential Thrombocytosis (ET) , a myeloproliferative disorder characterized by excessive platelet production.&lt;/li&gt;&lt;li&gt;âž¤ elevated platelet count&lt;/li&gt;&lt;li&gt;âž¤ normal hemoglobin and WBC counts&lt;/li&gt;&lt;li&gt;âž¤ increased megakaryocytes&lt;/li&gt;&lt;li&gt;âž¤ JAK2 mutation&lt;/li&gt;&lt;li&gt;âž¤ Essential Thrombocytosis (ET)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common cause of hypercalcemia in hospitalized patients is -&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Malignancy&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin D toxicity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Familial hypocalciuric hypercalcemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Malignancy&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Malignancy&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Malignancy is the most common cause of hypercalcemia in hospitalized patients due to mechanisms like PTHrP secretion , osteolytic metastases , or increased calcitriol production .&lt;/li&gt;&lt;li&gt;âž¤ Malignancy&lt;/li&gt;&lt;li&gt;âž¤ hypercalcemia&lt;/li&gt;&lt;li&gt;âž¤ PTHrP secretion&lt;/li&gt;&lt;li&gt;âž¤ osteolytic metastases&lt;/li&gt;&lt;li&gt;âž¤ increased calcitriol production&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the likely ECG change associated with Fluroquinolones?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;QT prolongation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PR prolongation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ST elevation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Wide QRS&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. QT prolongation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) QT prolongation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Fluoroquinolones, such as levofloxacin and ciprofloxacin, are associated with QT interval prolongation , which can predispose patients to potentially serious arrhythmias like Torsades de Pointes, especially in individuals with predisposing conditions.&lt;/li&gt;&lt;li&gt;âž¤ QT interval prolongation&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Based on the ECG given below, which of the following drugs is not used in the management of the condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metoprolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Adenosine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diltiazem&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Adenosine&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/screenshot-2024-02-13-102929.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Adenosine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Adenosine is not used in the management of atrial fibrillation , while beta-blockers, calcium channel blockers, and amiodarone are commonly used to control the rate or rhythm in AF.&lt;/li&gt;&lt;li&gt;âž¤ Adenosine&lt;/li&gt;&lt;li&gt;âž¤ atrial fibrillation&lt;/li&gt;&lt;li&gt;âž¤ beta-blockers, calcium channel blockers, and amiodarone&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 65-year-old man is evaluated for shortness of breath on exertion and dry cough that have worsened over the course of 6 months. He has clubbing, and his vitals are stable. Pulmonary function tests (PFT) reveal: FEV1: 65% FVC: 67% FEV1/FVC: 74% TLC: 68% DLCO: 62% Which test is most likely to determine the etiology?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bronchoscopy with transbronchial lung biopsy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Echocardiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HRCT chest&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;PET CT of whole body&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. HRCT chest&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) HRCT chest&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with progressive dyspnea , cough , and PFT findings suggestive of a restrictive lung disease , the most appropriate next step to determine the etiology is HRCT of the chest . This imaging modality is particularly useful in diagnosing interstitial lung diseases , including idiopathic pulmonary fibrosis (IPF) .&lt;/li&gt;&lt;li&gt;âž¤ progressive dyspnea&lt;/li&gt;&lt;li&gt;âž¤ cough&lt;/li&gt;&lt;li&gt;âž¤ restrictive lung disease&lt;/li&gt;&lt;li&gt;âž¤ HRCT of the chest&lt;/li&gt;&lt;li&gt;âž¤ interstitial lung diseases&lt;/li&gt;&lt;li&gt;âž¤ idiopathic pulmonary fibrosis (IPF)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Reiterâ€™s syndrome is associated with:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HLA B51&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;HLA B27&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;HLA DR4&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;HLA B8&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. HLA B27&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) HLA B27&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Reiterâ€™s syndrome (reactive arthritis) is strongly associated with HLA-B27 , a genetic marker found in many patients with seronegative spondyloarthropathies.&lt;/li&gt;&lt;li&gt;âž¤ Reiterâ€™s syndrome&lt;/li&gt;&lt;li&gt;âž¤ HLA-B27&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A person is admitted in hospital with history of stroke. He is unable to understand what his friend is talking but he is speaking fluently. Which part of brain is most likely to be injured in this case?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wernicke&#x27;s area&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Broca&#x27;s area&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Angular gyrus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Arcuate Fasciculus&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Wernicke&#x27;s area&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Wernicke&#x27;s area&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is seen in MEN 2B syndrome?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Cafe au lait spot&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Medullary thyroid carcinoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Parathyroid adenoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Optic nerve glioma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Medullary thyroid carcinoma&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Medullary thyroid carcinoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma is a key feature of MEN 2B syndrome , while cafe au lait spots, parathyroid adenoma, and optic nerve glioma are associated with other genetic disorders, particularly neurofibromatosis or MEN 1/2A .&lt;/li&gt;&lt;li&gt;âž¤ Medullary thyroid carcinoma&lt;/li&gt;&lt;li&gt;âž¤ MEN 2B syndrome&lt;/li&gt;&lt;li&gt;âž¤ cafe au lait spots, parathyroid adenoma, and optic nerve glioma&lt;/li&gt;&lt;li&gt;âž¤ neurofibromatosis&lt;/li&gt;&lt;li&gt;âž¤ MEN 1/2A&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A physician reviewed a patientâ€™s chest X-ray and diagnosed COPD. The patientâ€™s room air SaO2 is 88% and paO2 is 54 mm Hg. Which of the following will improve survival?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LAMA&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pulmonary rehabilitation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Supplemental O2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inhaled Corticosteroids&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Supplemental O2&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Supplemental O2&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In patients with COPD and significant hypoxemia , the intervention that has been shown to improve survival is long-term supplemental oxygen therapy .&lt;/li&gt;&lt;li&gt;âž¤ COPD&lt;/li&gt;&lt;li&gt;âž¤ hypoxemia&lt;/li&gt;&lt;li&gt;âž¤ improve survival&lt;/li&gt;&lt;li&gt;âž¤ long-term supplemental oxygen therapy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What will be the most common karyotype of a patient with primary amenorrhea?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;46XXY&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;45XX&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;45X0&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;46XY&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 45X0&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 45X0&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The most common karyotype associated with primary amenorrhea is 45X0 , which is seen in Turner syndrome .&lt;/li&gt;&lt;li&gt;âž¤ primary amenorrhea&lt;/li&gt;&lt;li&gt;âž¤ 45X0&lt;/li&gt;&lt;li&gt;âž¤ Turner syndrome&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 43-year-old patient with history of mitral valve replacement on anticoagulation with warfarin is about to undergo hernioplasty for inguinal hernia. What is the target INR prior to surgery?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.5-0.8&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt; 1.5&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;1.5-2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;2-3&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. &lt; 1.5&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) &amp;lt; 1.5&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For patients on warfarin who are undergoing elective surgery, the target INR prior to surgery should be less than 1.5 to minimize bleeding risk.&lt;/li&gt;&lt;li&gt;âž¤ warfarin&lt;/li&gt;&lt;li&gt;âž¤ less than 1.5&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient is brought to the OPD by his wife who reports that he has difficulty expressing emotions. On examination, resting tremors and rigidity are present. Which part of the brain among the following options is primarily affected in this disease?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Basal Ganglia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Substantia Nigra&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hippocampus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Substantia Nigra&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Substantia Nigra&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In Parkinson&#x27;s disease , the primary site of pathology is the substantia nigra , where the loss of dopaminergic neurons leads to the characteristic motor symptoms such as resting tremors , rigidity , and bradykinesia .&lt;/li&gt;&lt;li&gt;âž¤ Parkinson&#x27;s disease&lt;/li&gt;&lt;li&gt;âž¤ substantia nigra&lt;/li&gt;&lt;li&gt;âž¤ resting tremors&lt;/li&gt;&lt;li&gt;âž¤ rigidity&lt;/li&gt;&lt;li&gt;âž¤ bradykinesia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with fatigue, pallor. Investigations show Hb = 5.8 gm/dl, low MCV, low ferritin, high TIBC, and high RDW. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Iron Deficiency Anemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Megaloblastic Anemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anemia of Chronic Disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sideroblastic Anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Iron Deficiency Anemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Iron Deficiency Anemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Iron deficiency anemia is characterized by low hemoglobin , low MCV , low ferritin , high TIBC , and high RDW , which together point towards iron deficiency as the cause of the anemia.&lt;/li&gt;&lt;li&gt;âž¤ Iron deficiency anemia&lt;/li&gt;&lt;li&gt;âž¤ low hemoglobin&lt;/li&gt;&lt;li&gt;âž¤ low MCV&lt;/li&gt;&lt;li&gt;âž¤ low ferritin&lt;/li&gt;&lt;li&gt;âž¤ high TIBC&lt;/li&gt;&lt;li&gt;âž¤ high RDW&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A chronic alcoholic presented with pruritic eczematous rash on the neck and dorsum of the hands. What is the likely nutritional deficiency?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vitamin B3&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Vitamin B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Vitamin D&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Vitamin C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Vitamin B3&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Vitamin B3&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A pruritic, photosensitive rash in a chronic alcoholic is most suggestive of pellagra , which results from Vitamin B3 (Niacin) deficiency. Alcoholism is a known risk factor for this deficiency.&lt;/li&gt;&lt;li&gt;âž¤ pellagra&lt;/li&gt;&lt;li&gt;âž¤ Vitamin B3 (Niacin)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presents with sensory loss and weakness of limbs for 3 months. He also has angular stomatitis. On examination, there is loss of proprioception and vibration sensations, UMN-type weakness of the lower limbs, and absent ankle reflexes. What is the probable diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Amyotrophic Lateral Sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Multiple Sclerosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Intramedullary tumour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Subacute combined degeneration of the cord&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Subacute combined degeneration of the cord&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Subacute combined degeneration of the cord&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Subacute combined degeneration of the cord due to vitamin B12 deficiency is characterized by loss of proprioception , vibration sensation , UMN-type weakness , and absent reflexes , along with other signs of nutritional deficiency like angular stomatitis .&lt;/li&gt;&lt;li&gt;âž¤ Subacute combined degeneration of the cord&lt;/li&gt;&lt;li&gt;âž¤ vitamin B12 deficiency&lt;/li&gt;&lt;li&gt;âž¤ loss of proprioception&lt;/li&gt;&lt;li&gt;âž¤ vibration sensation&lt;/li&gt;&lt;li&gt;âž¤ UMN-type weakness&lt;/li&gt;&lt;li&gt;âž¤ absent reflexes&lt;/li&gt;&lt;li&gt;âž¤ angular stomatitis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient was given 0.5% bupivacaine for a supraclavicular brachial plexus block and suddenly developed hypotension and arrhythmias. Which of the following is the 1st line of management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV Epinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;20% IV Intralipid&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Soda Bicarbonate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 20% IV Intralipid&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 20% IV Intralipid&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In cases of bupivacaine toxicity resulting in cardiovascular complications like hypotension and arrhythmias, 20% IV Intralipid is the first-line therapy. It acts by sequestering the local anesthetic, thereby reducing its toxicity to the heart and other organs.&lt;/li&gt;&lt;li&gt;âž¤ bupivacaine toxicity&lt;/li&gt;&lt;li&gt;âž¤ 20% IV Intralipid&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient with suspected tuberculosis underwent CBNAAT testing and is started on HRZE. CBNAAT is helpful for which of the following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mycobacterium tuberculosis (MTB)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MTB + Rifampicin resistance&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;MTB + Isoniazid resistance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;MTB + Ethambutol and Rifampicin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. MTB + Rifampicin resistance&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) MTB + Rifampicin resistance&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ CBNAAT is a valuable tool for detecting Mycobacterium tuberculosis and rifampicin resistance , but it does not provide information on resistance to other drugs like isoniazid or ethambutol. For broader drug resistance testing, other methods such as line probe assays are required.&lt;/li&gt;&lt;li&gt;âž¤ CBNAAT&lt;/li&gt;&lt;li&gt;âž¤ Mycobacterium tuberculosis&lt;/li&gt;&lt;li&gt;âž¤ rifampicin resistance&lt;/li&gt;&lt;li&gt;âž¤ line probe assays&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A pregnant female who is a known case of bronchial asthma presented to hospital with blood pressure of 210/110 mm Hg. Which of the following is the preferred drug for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Nifedipine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Oral Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Labetalol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ramipril&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Nifedipine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Nifedipine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In pregnant women with hypertension and a history of bronchial asthma , Nifedipine is the preferred treatment as it effectively lowers blood pressure without causing bronchospasm, while beta-blockers like labetalol and ACE inhibitors like ramipril are contraindicated.&lt;/li&gt;&lt;li&gt;âž¤ bronchial asthma&lt;/li&gt;&lt;li&gt;âž¤ Nifedipine&lt;/li&gt;&lt;li&gt;âž¤ beta-blockers&lt;/li&gt;&lt;li&gt;âž¤ labetalol&lt;/li&gt;&lt;li&gt;âž¤ ACE inhibitors&lt;/li&gt;&lt;li&gt;âž¤ ramipril&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In primary accidental hypothermia, what is the usual rate of rewarming with passive external rewarming?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;0.5-1Â°C per hour&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;0.5-1Â°C per 2 hours&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;0.5-2Â°C per hour&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;0.5-2Â°C per 4 hours&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 0.5-2Â°C per hour&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 0.5-2Â°C per hour&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The usual rate of rewarming with passive external rewarming in primary accidental hypothermia is 0.5-2Â°C per hour , allowing the body to generate its own heat and recover gradually.&lt;/li&gt;&lt;li&gt;âž¤ passive external rewarming&lt;/li&gt;&lt;li&gt;âž¤ primary accidental hypothermia&lt;/li&gt;&lt;li&gt;âž¤ 0.5-2Â°C per hour&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following when consumed with oral iron reduces its absorption?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Lemon juice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amla juice&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tea&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Sprouts&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Tea&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Tea&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Tea consumption along with oral iron can reduce its absorption due to the presence of tannins, whereas foods rich in vitamin C, such as lemon or amla juice, enhance iron absorption.&lt;/li&gt;&lt;li&gt;âž¤ Tea&lt;/li&gt;&lt;li&gt;âž¤ reduce its absorption&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Patient after road traffic accident was brought to the emergency. His pulse rate was 50 beats per minute, Blood pressure was 80/ 60 mm of Hg. On evaluation his ECG was normal, eFAST was negative and chest X-Ray was normal. This status of patient could be best classified under which type of shock?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hemorrhagic shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cardiogenic shock&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Neurogenic shock&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anaphylactic shock&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Neurogenic shock&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Neurogenic shock&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Neurogenic shock is characterized by bradycardia and hypotension in the absence of blood loss or cardiac issues, often following trauma, particularly spinal injury.&lt;/li&gt;&lt;li&gt;âž¤ Neurogenic shock&lt;/li&gt;&lt;li&gt;âž¤ bradycardia&lt;/li&gt;&lt;li&gt;âž¤ hypotension&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;CT scan given in the image is suggestive of:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Extradural hematoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subdural hematoma&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subarachnoid haemorrhage&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Intraparenchymal hemorrhage&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Subdural hematoma&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture5_0OorTav.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Subdural hematoma&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A crescent-shaped hyperdense lesion on a CT scan is characteristic of a subdural hematoma , typically resulting from venous bleeding following trauma.&lt;/li&gt;&lt;li&gt;âž¤ crescent-shaped hyperdense lesion&lt;/li&gt;&lt;li&gt;âž¤ subdural hematoma&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the lesion in the chest X-ray:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Septic emboli&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cannon ball metastases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tuberculosis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung abscess&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Cannon ball metastases&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture6_2cDz386.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Cannon ball metastases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Cannon ball metastases are large, round nodules seen in both lung fields on a chest X-ray and are associated with metastatic cancer, most commonly from renal cell carcinoma and other malignancies.&lt;/li&gt;&lt;li&gt;âž¤ Cannon ball metastases&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Plasmodium species that commonly cause Membranous nephropathy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Vivax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Falciparum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Malariae&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ovale&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Malariae&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Malariae&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Plasmodium malariae is the species most commonly linked to membranous nephropathy in malaria-endemic regions, causing immune complex-mediated kidney damage leading to nephrotic syndrome.&lt;/li&gt;&lt;li&gt;âž¤ Plasmodium malariae&lt;/li&gt;&lt;li&gt;âž¤ membranous nephropathy&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 2-month-old pregnant female presented with vivax malaria. What is the most appropriate management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Quinine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chloroquine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Doxycycline&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Artemisinin Combination Therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Chloroquine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Chloroquine&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For the treatment of Plasmodium vivax malaria in early pregnancy, chloroquine is the drug of choice due to its safety profile for both the mother and fetus.&lt;/li&gt;&lt;li&gt;âž¤ chloroquine&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What adverse effect is NOT seen with amiodarone?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypothyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperthyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Gynaecomastia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pulmonary fibrosis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Gynaecomastia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Gynaecomastia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Amiodarone is associated with multiple adverse effects, including thyroid dysfunction (both hypo- and hyperthyroidism) and pulmonary fibrosis. Gynaecomastia is not a typical side effect of amiodarone.&lt;/li&gt;&lt;li&gt;âž¤ Gynaecomastia&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A schizophrenic patient after receiving haloperidol developed torticollis and dystonia. What will be the best drug in this situation?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increase haloperidol dose&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Change haloperidol to clozapine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Give benzhexol&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Change haloperidol to fluphenazine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Give benzhexol&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Give benzhexol&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ The best treatment for acute dystonia caused by typical antipsychotics like haloperidol is to administer an anticholinergic medication such as benzhexol (trihexyphenidyl) , which can quickly relieve the symptoms.&lt;/li&gt;&lt;li&gt;âž¤ acute dystonia&lt;/li&gt;&lt;li&gt;âž¤ anticholinergic medication&lt;/li&gt;&lt;li&gt;âž¤ benzhexol (trihexyphenidyl)&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the pathology from the given flow-volume loop:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fixed distal airway obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Fixed central airway obstruction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Variable intrathoracic obstruction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Variable extrathoracic obstruction&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Fixed central airway obstruction&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture7_eiyU3Em.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Fixed central airway obstruction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ A flow-volume loop showing flattening of both the inspiratory and expiratory limbs indicates a fixed central airway obstruction , which can be caused by tracheal stenosis or large airway tumors.&lt;/li&gt;&lt;li&gt;âž¤ flow-volume loop&lt;/li&gt;&lt;li&gt;âž¤ fixed central airway obstruction&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Identify the urinary crystal shown below:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium oxalate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Calcium phosphate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Uric acid&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Cysteine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Calcium oxalate&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/13/picture8_ZxDEfqE.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Calcium oxalate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ Calcium oxalate crystals have a distinct envelope shape and are commonly found in various urinary conditions, particularly in patients with kidney stones.&lt;/li&gt;&lt;li&gt;âž¤ envelope shape&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old man suddenly developed right-sided weakness and aphasia within 2 hours. His BP recorded was 160/100 mmHg and NCCT was normal. What is the next step in management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CT angiography to look for large vessel occlusion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;MRI to look for infarct&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Tab labetalol 10 mg stat&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Thrombolysis&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Thrombolysis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Thrombolysis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ In a patient with acute ischemic stroke presenting within the therapeutic window and a normal NCCT, thrombolysis is the immediate next step in management, aiming to restore blood flow and improve outcomes.&lt;/li&gt;&lt;li&gt;âž¤ thrombolysis&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For the diagnosis of resistant hypertension, the patient should have uncontrolled hypertension despite taking three antihypertensive drugs. This should include at least one:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Calcium channel blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Beta blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Alpha blocker&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diuretic&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Diuretic&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Diuretic&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;&lt;strong&gt;Educational Objective:&lt;/strong&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;âž¤ Educational Objective:&lt;/li&gt;&lt;li&gt;âž¤ For a diagnosis of resistant hypertension , the patient must have uncontrolled blood pressure despite taking three antihypertensive agents, including at least one diuretic .&lt;/li&gt;&lt;li&gt;âž¤ resistant hypertension&lt;/li&gt;&lt;li&gt;âž¤ one diuretic&lt;/li&gt;&lt;/ul&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 160 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

<div id="test14" class="iframe-container" style="display:none;">
    <iframe srcdoc="&lt;!DOCTYPE html&gt;

&lt;html lang=&quot;en&quot;&gt;
&lt;head&gt;
&lt;meta charset=&quot;utf-8&quot;/&gt;
&lt;meta content=&quot;width=device-width, initial-scale=1.0&quot; nameag=&quot;viewport&quot;/&gt;
&lt;title&gt;Medicine Test (The Champion Batch Hyderabad)   25 09 2024   2024 09 25&lt;/title&gt;
&lt;script src=&quot;https://cdn.tailwindcss.com&quot;&gt;&lt;/script&gt;
&lt;link rel=&quot;stylesheet&quot; href=&quot;https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css&quot;&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/hls.js@latest&quot;&gt;&lt;/script&gt;
&lt;script src=&quot;https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js&quot;&gt;&lt;/script&gt;
&lt;style&gt;
  /* Fix for table overflow in results */
  #results-content {
    overflow-x: auto;
    max-width: 100%;
  }
  
  #results-content table {
    min-width: 100%;
    white-space: nowrap;
  }
      /* Add this to your CSS */
      .overflow-x-auto table {
          min-width: 100%;
          border-collapse: collapse;
      }
      
      .overflow-x-auto th, 
      .overflow-x-auto td {
          padding: 8px 12px;
          border: 1px solid #ddd;
          white-space: nowrap;
      }
      
      .overflow-x-auto th {
          background-color: #f8f8f8;
          font-weight: bold;
      }
        /* Custom styles for enhanced aesthetics and responsiveness */
    .option-btn {
        transition: all 0.3s ease;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
    }
    .option-btn:hover, .option-btn:active {
        transform: scale(1.02);
        box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
    }
    .option-btn.selected {
        background-color: #2c5282;
        color: white;
    }
    .marked {
        background-color: #f59e0b;
    }
    .progress-bar {
        transition: width 0.5s ease-in-out;
        background: #2c5281;
        box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
        animation: pulse 2s infinite;
    }
    @keyframes pulse {
        0% { opacity: 1; }
        50% { opacity: 0.8; }
        100% { opacity: 1; }
    }
    .question-nav-btn, .result-nav-btn-grid {
        width: 40px;
        height: 40px;
        display: flex;
        align-items: center;
        justify-content: center;
        border-radius: 8px;
        font-size: 16px;
        touch-action: manipulation;
        transition: all 0.2s ease;
    }
    .question-nav-btn:hover, .question-nav-btn:active, 
    .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
        transform: scale(1.05);
    }
    .answered {
        background-color: #2c5281;
        color: white;
    }
    .unanswered {
        background-color: #e5e7eb;
    }
    .marked-nav {
        border: 2px solid #f59e0b;
    }
    .video-container, .audio-container {
        display: none;
        position: relative;
    }
    .video-container.active, .audio-container.active {
        display: block;
        animation: fadeIn 0.5s ease-in;
    }
    @keyframes fadeIn {
        from { opacity: 0; }
        to { opacity: 1; }
    }
    .section-transition {
        transition: opacity 0.3s ease;
    }
    .section-transition.hidden {
        opacity: 0;
        pointer-events: none;
    }
    .result-nav {
        display: flex;
        justify-content: space-between;
        align-items: center;
        margin-top: 1rem;
    }
    .result-nav-btn {
        background-color: #374151;
        color: white;
        padding: 0.5rem 1rem;
        border-radius: 8px;
        transition: all 0.2s ease;
    }
    .result-nav-btn:hover, .result-nav-btn:active {
        background-color: #2d3748;
        transform: scale(1.05);
    }
    .result-nav-btn:disabled {
        background-color: #e5e7eb;
        cursor: not-allowed;
    }
    .error-message {
        color: #ef4444;
        font-weight: bold;
        margin-top: 1rem;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 60px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }

.bg-white.rounded-lg.shadow-md.p-4.md\:p-6 {
      margin-bottom: 50px;
      height: auto;
      display: block;
      margin: 10px auto;
      border-radius: 4px;
      object-fit: contain;
    }
    img {
        max-width: 100%;
        max-height: 400px;
        width: auto;
        height: auto;
        display: block;
        margin: 10px auto;
        border-radius: 4px;
        object-fit: contain;
    }
    
    /* For question images specifically */
    .question_images img,
    .explanation_images img {
        max-height: 350px;
        border: 1px solid #e5e7eb;
        box-shadow: 0 2px 6px rgba(0,0,0,0.1);
    }
    /* Mobile-specific adjustments */
    @media (max-width: 640px) {
        .question-nav-btn, .result-nav-btn-grid {
            width: 38px;
            height: 38px;
            font-size: 14px;
        }
        .nav-panel, .results-nav-panel {
            width: 100%;
            max-width: 100%;
            overscroll-behavior: contain;
        }
        .option-btn {
            padding: 12px;
            font-size: 14px;
        }
        .header-text {
            font-size: 1.5rem;
        }
        .subheader-text {
            font-size: 0.875rem;
        }
        .button-group, .result-nav {
            flex-direction: column;
            gap: 0.5rem;
        }
        .result-nav-btn {
            width: 100%;
            text-align: center;
        }
    }
      img {
            max-height: 300px;
        }
        .question_images img,
        .explanation_images img {
            max-height: 250px;
        }
    }
    .video-placeholder {
        width: 400px;
        height: 300px;
        background-color: #e5e7eb;
        display: flex;
        align-items: center;
        justify-content: center;
        cursor: pointer;
        margin-top: 10px;
        border-radius: 8px;
        border: 1px solid #d1d5db;
    }
    .play-icon {
        font-size: 40px;
        color: #2c5282;
    }
    .video-loading {
        position: absolute;
        top: 50%;
        left: 50%;
        transform: translate(-50%, -50%);
        border: 4px solid #e5e7eb;
        border-top: 4px solid #2c5282;
        border-radius: 50%;
        width: 40px;
        height: 40px;
        animation: spin 1s linear infinite;
    }
    @keyframes spin {
        0% { transform: translate(-50%, -50%) rotate(0deg); }
        100% { transform: translate(-50%, -50%) rotate(360deg); }
    }
    body, html {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
    #quiz, #results, #instructions {
      padding-bottom: 0 !important;
      margin-bottom: 0 !important;
    }
&lt;/style&gt;

&lt;/head&gt;
&lt;body class=&quot;bg-gray-100 font-sans transition-colors duration-300&quot;&gt;
&lt;!-- Header Section --&gt;
&lt;header class=&quot;bg-[#2c5281] text-white p-4 pt-14 shadow-lg&quot;&gt;
&lt;div class=&quot;container mx-auto&quot;&gt;
&lt;h1 class=&quot;text-2xl md:text-3xl font-bold header-text&quot;&gt;Medicine Test (The Champion Batch Hyderabad)   25 09 2024   2024 09 25&lt;/h1&gt;
&lt;p class=&quot;mt-2 text-sm md:text-base subheader-text&quot;&gt;
                100 Questions | 400 Total Marks | 110 min Duration | ~66.0 sec/question
            &lt;/p&gt;
&lt;/div&gt;
&lt;/header&gt;
&lt;!-- Instructions Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 section-transition&quot; id=&quot;instructions&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Instructions&lt;/h2&gt;
&lt;h4 class=&quot;text-gray-800 text-lg font-semibold mt-6 mb-4&quot;&gt;Test Features:&lt;/h4&gt;
&lt;ul class=&quot;space-y-3&quot;&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Multiple choice questions with single correct answers
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Timer-based testing for realistic exam conditions
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mark questions for review functionality
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Comprehensive results and performance analysis
  &lt;/li&gt;
  &lt;li class=&quot;flex items-center gap-3&quot;&gt;
    &lt;i class=&quot;fa-solid fa-circle-check text-green-500&quot;&gt;&lt;/i&gt;
    Mobile-optimized interface for learning on-the-go
  &lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;start-test&quot;&gt;Start Test&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;error-message hidden&quot; id=&quot;error-message&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;


&lt;!-- Quiz Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;quiz&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;!-- Progress Bar --&gt;
&lt;div class=&quot;w-full bg-gray-200 rounded-full h-3 mb-4&quot;&gt;
&lt;div class=&quot;progress-bar h-3 rounded-full&quot; id=&quot;progress-bar&quot; style=&quot;width: 0%&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Question Header --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center mb-4&quot;&gt;
&lt;h2 class=&quot;text-lg font-semibold&quot; id=&quot;question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h2&gt;
&lt;p class=&quot;text-lg font-semibold mt-2 md:mt-0&quot; id=&quot;timer&quot;&gt;Time Remaining: &lt;span&gt;00:00&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;!-- Question Content --&gt;
&lt;div class=&quot;mb-6&quot; id=&quot;question-content&quot;&gt;
&lt;p class=&quot;text-gray-800 mb-4&quot; id=&quot;question-text&quot;&gt;&lt;/p&gt;
&lt;div class=&quot;flex flex-wrap gap-4 mb-4&quot; id=&quot;question-images&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;space-y-3&quot; id=&quot;options&quot;&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;!-- Navigation Buttons --&gt;
&lt;div class=&quot;flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4&quot;&gt;
&lt;div class=&quot;flex gap-2 w-full md:w-auto&quot;&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;previous-btn&quot;&gt;Previous&lt;/button&gt;
  &lt;button class=&quot;bg-[#2c5281] text-white px-4 py-3 w-full md:w-32 h-14 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-btn&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;flex items-center gap-2&quot;&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;mark-review&quot;&gt;
    Review
    &lt;svg xmlns=&quot;http://www.w3.org/2000/svg&quot; class=&quot;h-5 w-5&quot; viewBox=&quot;0 0 20 20&quot; fill=&quot;currentColor&quot;&gt;
      &lt;path d=&quot;M10 2a1 1 0 00-1 1v14l3.293-3.293a1 1 0 011.414 0L17 17V3a1 1 0 00-1-1H10z&quot; /&gt;
    &lt;/svg&gt;
  &lt;/button&gt;
  &lt;button class=&quot;bg-transparent text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-100 transition flex items-center gap-1&quot; id=&quot;nav-toggle&quot;&gt;
    Question ðŸ§­
  &lt;/button&gt;
  &lt;button class=&quot;bg-green-500 text-white px-6 py-3 w-44 h-14 rounded-lg hover:bg-green-600 transition w-full md:w-auto&quot; id=&quot;submit-test&quot;&gt;Submit Test&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Results Section --&gt;
&lt;section class=&quot;container mx-auto px-4 md:px-6 pt-4 md:pt-6 pb-1 hidden section-transition&quot; id=&quot;results&quot;&gt;
&lt;div class=&quot;bg-white rounded-lg shadow-md p-4 md:p-6&quot;&gt;
&lt;h2 class=&quot;text-2xl font-semibold mb-4&quot;&gt;Anaesthesia Machine - Results&lt;/h2&gt;
&lt;div class=&quot;grid grid-cols-1 md:grid-cols-2 gap-4 mb-6&quot;&gt;
&lt;p&gt;&lt;strong&gt;Correct:&lt;/strong&gt; &lt;span id=&quot;correct-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Wrong:&lt;/strong&gt; &lt;span id=&quot;wrong-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Unanswered:&lt;/strong&gt; &lt;span id=&quot;unanswered-count&quot; class=&quot;text-[#000000]-500&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Marked for Review:&lt;/strong&gt; &lt;span id=&quot;marked-count&quot; class=&quot;text-[#000000]&quot;&gt;0&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 class=&quot;text-lg font-semibold mb-4&quot; id=&quot;result-question-number&quot;&gt;Question &lt;span&gt;1&lt;/span&gt; of 4&lt;/h3&gt;
&lt;div class=&quot;space-y-6&quot; id=&quot;results-content&quot;&gt;&lt;/div&gt;
&lt;div class=&quot;result-nav&quot;&gt;
&lt;button aria-label=&quot;Previous question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; disabled=&quot;&quot; id=&quot;prev-result&quot;&gt;Previous&lt;/button&gt;
&lt;button aria-label=&quot;Toggle results navigation panel&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;results-nav-toggle&quot;&gt;Result ðŸ§­&lt;/button&gt;
&lt;button aria-label=&quot;Next question result&quot; class=&quot;result-nav-btn bg-[#2c5281] text-white px-6 py-2 rounded-lg hover:bg-[#2c5281] transition&quot; id=&quot;next-result&quot;&gt;Next&lt;/button&gt;
&lt;/div&gt;
&lt;div class=&quot;mt-6 flex space-x-4 button-group md:flex-row flex-col&quot;&gt;
&lt;button class=&quot;bg-green-500 text-white px-6 py-2 rounded-lg hover:bg-green-600 transition&quot; id=&quot;take-again&quot;&gt;Take Again&lt;/button&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;/section&gt;

&lt;!-- Exit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;exit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Leave Test?&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;Your progress will be lost if you leave this page. Are you sure you want to exit?&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;continue-test&quot;&gt;No, Continue&lt;/button&gt;
      &lt;button class=&quot;bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition&quot; id=&quot;exit-test&quot;&gt;Yes, Exit&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Submit Confirmation Modal --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 hidden&quot; id=&quot;submit-modal&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white rounded-lg p-6 max-w-sm w-full&quot;&gt;
    &lt;h2 class=&quot;text-xl font-semibold mb-4&quot;&gt;Confirm Submission&lt;/h2&gt;
    &lt;p class=&quot;text-gray-700 mb-2&quot;&gt;You have attempted &lt;span id=&quot;attempted-count&quot;&gt;0&lt;/span&gt; of 4 questions.&lt;/p&gt;
    &lt;p class=&quot;text-gray-700 mb-4&quot;&gt;&lt;span id=&quot;unattempted-count&quot;&gt;0&lt;/span&gt; questions are unattempted.&lt;/p&gt;
    &lt;div class=&quot;flex justify-end space-x-4&quot;&gt;
      &lt;button class=&quot;bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition&quot; id=&quot;cancel-submit&quot;&gt;Cancel&lt;/button&gt;
      &lt;button class=&quot;text-white px-4 py-2 rounded-lg hover:bg-[#1a365d] transition&quot; style=&quot;background-color: #2c5281;&quot; id=&quot;confirm-submit&quot;&gt;Submit Test&lt;/button&gt;
    &lt;/div&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Quiz Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 nav-panel hidden overflow-y-auto&quot; id=&quot;nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Questions Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- Results Navigation Panel --&gt;
&lt;div class=&quot;fixed inset-0 bg-black bg-opacity-50 flex items-start justify-center p-4 z-50 results-nav-panel hidden overflow-y-auto&quot; id=&quot;results-nav-panel&quot; style=&quot;align-items: flex-start; padding-top: 33vh;&quot;&gt;
  &lt;div class=&quot;bg-white shadow-lg p-4 rounded-lg w-full max-w-2xl max-h-[80vh] overflow-y-auto&quot;&gt;
    &lt;h2 class=&quot;text-lg font-semibold mb-4&quot;&gt;Results Navigation&lt;/h2&gt;
    &lt;div class=&quot;mb-4&quot;&gt;
      &lt;select class=&quot;w-full p-2 border rounded-lg text-gray-700&quot; id=&quot;results-nav-filter&quot;&gt;
        &lt;option value=&quot;all&quot;&gt;All Questions&lt;/option&gt;
        &lt;option value=&quot;answered&quot;&gt;Answered&lt;/option&gt;
        &lt;option value=&quot;unanswered&quot;&gt;Unanswered&lt;/option&gt;
        &lt;option value=&quot;marked&quot;&gt;Marked for Review&lt;/option&gt;
      &lt;/select&gt;
    &lt;/div&gt;
    &lt;div class=&quot;grid grid-cols-5 gap-2 md:gap-3&quot; id=&quot;results-nav-grid&quot;&gt;&lt;/div&gt;
    &lt;button class=&quot;mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full&quot; id=&quot;close-results-nav&quot;&gt;Close&lt;/button&gt;
  &lt;/div&gt;
&lt;/div&gt;

&lt;!-- JavaScript Logic --&gt;

&lt;script&gt;
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog(&quot;Attempting to parse questions_json&quot;);
            questions = [{&quot;text&quot;: &quot;Which of the following findings are seen in patients with stable angina?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;â†‘TropI â†‘Myoglobin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;â†‘CKMB, Normal Trop I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;â†‘Myoglobin, Normal CK-MB&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Normal cardiac enzymes.&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Normal cardiac enzymes.&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the maximum predicted heart rate in a 45-year-old gentleman on exercise tolerance test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;165/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;175/min&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;185/min&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;195/min&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 175/min&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 175/min&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following statements regarding myocardial stunning are true EXCEPT&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Stunning is a state of depressed myocardial function due to chronic hypoperfusion&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Stunning can be global or regional&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen free radicals and excess intracellular calcium likely contribute to stunning&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Stunning affects both systolic and diastolic function&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Stunning is a state of depressed myocardial function due to chronic hypoperfusion&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is the earliest finding in patient with suspect acute MI?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Prolonged QT interval&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Tall T wave&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Terminal QRS Distortion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ST depression&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Tall T wave&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;45 year is brought to the ER with sudden onset chest pain, dipahoresis and giddiness. On arrival BP 86/60mmHg. Immediate ECG performed given below. Which of the following is useful in the management of this condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sublingual nitrate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV nitrates&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Morphine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV fluids&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. IV fluids&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-102431.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Falsely low BNP values can be seen in which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Advanced age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Obesity&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Female gender&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Smoking&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Obesity&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Risk of sudden cardiac death in heart failure is maximum among which of the following NYHA class?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Class II&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Class III&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Class II&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following disorders is characterised by myocyte disarray on myocardial biopsy?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Fabry disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pheochromocytoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Keshan&#x27;s disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hypereosinophilic syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Fabry disease&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Brockenbrough-Braunwald-Morrow sign is seen in which of the following condition?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HCM&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;DCM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Restrictive cardiomyopathy&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Takotsubo cardiomyopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. HCM&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) HCM&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year-old male with Marfans syndrome developed worsening chest pain and dyspnea. On examination asymmetrical pulses was noted. CXR showed widened mediastinum. CT angio was done to evaluate this patient. Which of the following is true regarding management of the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Operative repair indicated if diameter &amp;gt;5.5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Operative repair if diameter &amp;gt;4-5 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Operative repair if diameter &amp;gt;6 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Operative repair if diameter &amp;gt;4.5 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Operative repair if diameter &gt;4-5 cm&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-102943.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Operative repair if diameter &amp;gt;4-5 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Class IV Lupus Nephritis consist of ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Mesangial Proliferative Lupus Nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Focal Lupus Nephritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse Lupus Nephritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Membranous Lupus Nephritis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diffuse Lupus Nephritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diffuse Lupus Nephritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following autoantibody is detected by Dilute Russel viper venom test?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antibodies against cardiolipin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Antibodies against Î²2 GPI&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Lupus anticoagulant&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Antiphosphatidylserine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Lupus anticoagulant&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Lupus anticoagulant&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;What is the likely cardiac axis marked A in the image given below?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Right axis deviation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Left axis deviation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Extreme axis deviation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Physiological left axis deviation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Right axis deviation&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-103255.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-103430.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following vasculitis are due to Production of antineutrophilic cytoplasmic antibodies, except ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Granulomatosis with polyangiitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IgA vasculitis (Henoch-SchÃ¶nlein)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Microscopic polyangiitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Eosinophilic granulomatosis with polyangiitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. IgA vasculitis (Henoch-SchÃ¶nlein)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) IgA vasculitis (Henoch-SchÃ¶nlein)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;40-year-old on anti-depressants presented with giddiness and fatigue. On arrival Bp 80/60mmhg. ECG done showed the following. Which of the following drugs is appropriate in the management of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Antiarrhythmics&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intravenous sodium bicarbonate&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Propranolol&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Phenytoin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Intravenous sodium bicarbonate&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-103538.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Intravenous sodium bicarbonate&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are involved in Polyarteritis nodosa, except ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Renal arteries&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Heart vasculature&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary arteries&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Pulmonary arteries&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Pulmonary arteries&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;40-year-old male with recent post CABG status presented with chest pain. On arrival BP was found to be 60/30mmHg with HR of 30/min. ECG showed narrow complex arrhythmia. Patient immediately received three boluses of IV atropine. While awaiting Transcutaneous pacing, which of the following is next appropriate step in the management?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Another bolus of atropine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV Norepinephrine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV Dopamine&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;IV Dobutamine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. IV Dopamine&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-103743.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are true about Isolated polymyalgia rheumatica, except ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-cyclic citrullinated peptide (CCP) is negative&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Prompt therapeutic response to low-dose prednisone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Rheumatoid factor is positive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased ESR&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Rheumatoid factor is positive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Rheumatoid factor is positive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common cause of myositis in those aged &amp;gt;50 years ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dermatomyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Inclusion body myositis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Polymyositis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Immune mediated necrotizing myopathy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Inclusion body myositis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Inclusion body myositis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;30-year-old IT employee developed sudden loss of consciousness on listening to ambulance alarm. On arrival to ER patient was hemodynamically stable. She gives h/o similar episodes in the past. ECG done which is given below. What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Congenital Long QT type 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Congenital Long QT syndrome type 2&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Catecholaminergic polymorphic VT&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Short QT syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Congenital Long QT syndrome type 2&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-104058.png&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-104318.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 25-year old female evaluated for Iron deficiency anemia. Her iron studies revealed following?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Normal iron balance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Negative iron balance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Iron deficient erythropoiesis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Iron deficiency anemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Iron deficient erythropoiesis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-135939.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-104234.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Iron deficient erythropoiesis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;P-selectin-blocking monoclonal antibody used in sickle cell anemia ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Teplizumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Voxelotor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Crizanlizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ofatumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Crizanlizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Crizanlizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A Pregnant lady G2P1L1 currently 37 week POG presented with worsening headache, blurring of vision, reduced perception of fetal movements. On arrival BP was 200/100mmHg. Patient ECG given below. Which of the following is the best management for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;IV MgSO4&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IV lignocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IV amiodarone&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Defibrillation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. IV MgSO4&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-104431.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) IV MgSO4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hb Bartâ€™s is defined as ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Î±3 Î³1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Î± Î³3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î±2 Î³2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Î³4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Î³4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Î³4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Puff of smoke appearance is seen in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Necrotizing arteritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Moyamoya disease&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Fibromuscular dysplasia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Primary central nervous system vasculitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Moyamoya disease&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-104556.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Moyamoya disease&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Imerslundâ€™s Syndrome is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Selective Malabsorption of folate with Proteinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Selective Malabsorption of Cobalamin with folate&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Selective Malabsorption of Cobalamin with Proteinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Selective Malabsorption of Cobalamin with Lymphopenia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Selective Malabsorption of Cobalamin with Proteinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Selective Malabsorption of Cobalamin with Proteinuria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Donath-Landsteiner antibody is characteristic of ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Paroxysmal nocturnal hemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;March hemoglobinuria&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Paroxysmal cold hemoglobinuria&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WAIHA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Paroxysmal cold hemoglobinuria&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Paroxysmal cold hemoglobinuria&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are components of ABCD2 score, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Age&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Blood pressure&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Creatinine levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Diabetes&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Creatinine levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-104800.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Creatinine levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Antibodies implicated in pathogenesis of Heparin-Induced Thrombocytopenia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Platelet factor 1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Platelet factor 2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Platelet factor 3&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Platelet factor 4&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Platelet factor 4&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Platelet factor 4&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common site for hypertensive hemorrhage?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Thalamus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Putamen&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Cerebellum&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pons&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Putamen&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Putamen&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;ADAMTS13 activity levels of diagnostic of TTP?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt;5%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;lt;15%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;lt;10%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt;5%&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &lt;10%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;lt;10%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Giant aneurysms have diameter?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;gt;1.5 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;&amp;gt;2.0 cm&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt;2.5 cm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;gt;3.0 cm&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &gt;2.5 cm&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;gt;2.5 cm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All are true regarding Henoch-SchÃ¶nlein purpura, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Often preceded by an upper respiratory infection, commonly with streptococcal pharyngitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Renal impairment may occur&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;PT, aPTT are increased&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glucocorticoids can provide symptomatic relief&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. PT, aPTT are increased&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) PT, aPTT are increased&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are seen in fasting state, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Increased gluconeogenesis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Increased glycogenolysis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Increased glucose uptake in skeletal muscle and fat&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased lipolysis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Increased glucose uptake in skeletal muscle and fat&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Increased glucose uptake in skeletal muscle and fat&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Antonâ€™s syndrome is produced due to lesion in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal ACAs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal MCAs&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bilateral infarction in the distal PCAs&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Any of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Bilateral infarction in the distal PCAs&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Bilateral infarction in the distal PCAs&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Drug approved in delaying the onset of stage 3 T1D in high-risk individuals?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rituximab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Teplizumab&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Golimumab&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Teprotumumab&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Teplizumab&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Teplizumab&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Virtually no VWF protein and usually FVIII levels &amp;lt;10% is seen in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 1 VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Type 2 VWD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Type 3 VWD&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Type 4 VWD&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Type 3 VWD&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Type 3 VWD&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Subclavian steal is seen in which of the following lesions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Occlusion distal to the origin of the vertebral artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Occlusion in V1 segment of vertebral artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Occlusion proximal to the origin of the vertebral artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Occlusion in V2 segment of vertebral artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Occlusion proximal to the origin of the vertebral artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Occlusion proximal to the origin of the vertebral artery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The fructosamine assay reflects the glycemic status for the prior?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;1 Week&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;2 Weeks&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;3 Weeks&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;4 Weeks&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 2 Weeks&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 2 Weeks&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Cytogenetic rearrangement in Acute promyelocytic leukemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;t(9;22)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;t(8;14)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;t(15;17)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;t(8;16)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. t(15;17)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) t(15;17)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are cardinal motor features of Parkinsonâ€™s disease, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Rest tremor&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bradykinesia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Masked facies&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postural instability&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Masked facies&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Masked facies&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following anti Diabetic medication is contraindicated in individuals with medullary carcinoma of the thyroid or multiple endocrine neoplasia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Metformin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Liraglutide&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Canagliflozin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Pioglitazone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Liraglutide&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Liraglutide&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;TKI active in the setting of T315I mutation in CML?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dasatinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Nilotinib&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Ponatinib&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bosutinib&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Ponatinib&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Ponatinib&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Levodopa-induced motor complications are seen more commonly in all of the following patients, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Old patients&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Severe disease&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Higher doses of levodopa&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Women&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Old patients&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Old patients&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In a Parkinsonâ€™s patient who developed Dementia, which of the following drugs are stopped first?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Dopamine agonists&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Amantadine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anticholinergics&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;COMT inhibitors&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anticholinergics&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anticholinergics&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of DKA, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sodium concentration of 125mmol/L&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Serum osmolality of 300 mOsm/mL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Urine ketones positive&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Serum bicarbonate &amp;gt;18mmol/L&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Serum bicarbonate &gt;18mmol/L&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-130323.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Serum bicarbonate &amp;gt;18mmol/L&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Doubling time in Burkittâ€™s lymphoma is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt;24 h&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;48 h&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;72 h&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;96 h&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. &lt;24 h&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) &amp;lt;24 h&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Familial hemiplegic migraine type 1 is caused due to mutation in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CACNA1A&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ATP1A2&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SCN1A&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;SCN2A&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. CACNA1A&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common feature of MEN 1 is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Gastrinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Primary hyperparathyroidism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolactinoma&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal cortical tumor&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Primary hyperparathyroidism&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Primary hyperparathyroidism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following is/are expressed in cells with Hairy cell leukemia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;CD22&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CD103&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;CD25&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Treatment of choice for Acute attack of Cluster headache is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oral sumatriptan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Lidocaine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Oxygen inhalation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Topiramate&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Oxygen inhalation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Oxygen inhalation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;First manifestation of APS 1?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Type 1 DM&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Mucocutaneous candidiasis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypoparathyroidism&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Adrenal insufficiency&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Mucocutaneous candidiasis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Mucocutaneous candidiasis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Single most powerful predictor of survival in Multiple myeloma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Elevated LDH&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;High-risk gene expression profile&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Î²2-microglobulin&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;De novo plasma cell leukemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Î²2-microglobulin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Î²2-microglobulin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following parameters can be obtained by the following graph?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Residual volume&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Total lung capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Functional residual capacity&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FEV1/FVC&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. FEV1/FVC&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-105759.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) FEV1/FVC&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common blood vessel involved in trigeminal neuralgia?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Basilar artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Posterior communicating artery&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Superior cerebellar artery&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Inferior cerebellar artery&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Superior cerebellar artery&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Superior cerebellar artery&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Maddrey discriminant function is calculated with ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. 4.6 Ã— [The prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) 4.6 Ã— [the prolongation of the prothrombin time above control {seconds}] + serum bilirubin [mg/dL]&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Bulbar weakness and more frequent episodes of respiratory depression can be especially prominent in Myasthenia gravis with antibodies to?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti AChR antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti MuSK antibody&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti LRP 4 antibody&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti GQ1b antibody&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Anti MuSK antibody&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Anti MuSK antibody&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;True statement regarding Repetitive nerve stimulation for Myasthenia gravis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-AChE medication should be stopped 6â€“12 h before testing&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;It is best to test weak muscles or proximal muscle groups&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;In myasthenic patients, there is a rapid reduction of &amp;gt;10% in the amplitude of the evoked responses&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All are true&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All are true&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All are true&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 74-year-old man is evaluated for a 5-year history of gradually progressive dyspnea and dry cough without wheezing or hemoptysis. For the past 2 years he has had pain and occasional swelling in both knees. He has not had fever or lost weight. He smoked one pack of cigarettes a day from the age of 18 to 60 years. He worked as a roofer for 40 years. Physical examination shows no digital clubbing or cyanosis. Auscultation of the lungs reveals bilateral end-inspiratory crackles. Pulmonary function testing shows: Total lung capacity - 67% of predicted Residual volume - 72% of predicted FVC - 65% of predicted FEV1 - 75% of predicted FEV1/FVC ratio - 89% (Normal) DLCO - 52% of predicted His chest radiograph is suggestive of Bilateral lower zone predominant lesions. Which of the following is the most likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Emphysema&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Asbestosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Bronchogenic Carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Asbestosis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-105950.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Asbestosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following hormone uses JAK/STAT signalling pathway ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;BMP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;PRL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Activin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. PRL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-110141.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) PRL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;60-year-old male being treated for Carcinoma prostrate presented with worsening breathlessness, chest pain and syncope. On arrival HR 125 with Shock index &amp;gt;1. CTPA confirmed diagnosis of pulmonary embolism. Cardiac troponin, BNP levels are normal. ECHO shows reduced RV function. Which of the following is recommended for in-hospital treatment of this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;LMWH&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Warfarin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Bivalirudin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Alteplase&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. LMWH&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) LMWH&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Nephrogenic diabetes insipidus is caused due to mutation in ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;XL, activating Arginine vasopressin receptor 2 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;XL, inactivating Arginine vasopressin receptor 2 mutation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;AD, activating Arginine vasopressin receptor 2 mutation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;AD, inactivating Arginine vasopressin receptor 2 mutation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. XL, inactivating Arginine vasopressin receptor 2 mutation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) XL, inactivating Arginine vasopressin receptor 2 mutation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old gentleman with a family history of colorectal cancer presented with palpitations and syncope. On arrival ECG given below. What is not true about ECG finding in Pulmonary embolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sinus tachycardia is the most common finding&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;S1Q3T3 is pathognomonic of Pulmonary embolism&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;T-wave inversion in septal and inferior leads suggest PE&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Above ECG shows RV strain&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. S1Q3T3 is pathognomonic of Pulmonary embolism&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-110302.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) S1Q3T3 is pathognomonic of pulmonary embolism&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Lymphocytic Hypophysitis most commonly occurs in which of the following patients ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;HIV AIDS&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Intracranial Metastasis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Postpartum women&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Postmenopausal women&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Postpartum women&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Postpartum women&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hyâ€™s Law is used in ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Alcoholic hepatitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Chronic Hepatitis B&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Drug induced liver injury&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Liver carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Drug induced liver injury&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Drug induced liver injury&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are true about Pituitary tumors, except ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pituitary adenomas frequently extend in a suprasellar direction&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Headache is a common feature&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Headache severity correlates with adenoma size or extension&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Suprasellar extension can lead to visual loss&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Headache severity correlates with adenoma size or extension&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Headache severity correlates with adenoma size or extension&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Screening test for Acromegaly ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Serum GH levels&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;ACTH reserve&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Serum IGF-1 levels&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Insulin tolerance test&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Serum IGF-1 levels&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Serum IGF-1 levels&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;45-year-old banker complaints of SOB on climbing 2 flight of stairs. After 1 flight he develops chest tightness and has multiple syncopal episodes in the past. Past history was significant for DVT due to limb immobilization 5 years ago. PFT is normal, DLCO is reduced. ECHO shows RVSP 50mmHg, with normal LV function. What is the most appropriate management strategy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;MRI angio of the thorax&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CTPA (CT pulmonary angio)&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Coronary angiography&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Start oral prostacyclin therapy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. CTPA (CT pulmonary angio)&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) CTPA (CT pulmonary angio)&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following features are characteristic of Maturity-onset diabetes of the young (MODY) ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Autosomal dominant inheritance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Early onset of hyperglycemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Impaired insulin secretion&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;All of the above&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. All of the above&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) All of the above&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;60-year-old smoker presented with progressive breathlessness over 1 year. CXR reveals hyperinflated lungs. PFT shows moderate obstruction. ECHO showed RVSP 60mmHg. Which category of pulmonary hypertension does this patient belong?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;WHO Class I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;WHO class II&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;WHO Class III&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;WHO Class IV&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. WHO Class III&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) WHO Class III&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Thrombosis in which of the following is least likely to cause pulmonary embolism?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Superficial femoral vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Great saphenous vein&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Common femoral vein&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Popliteal vein&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Great saphenous vein&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Great saphenous vein&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Gene defective in Dubin Johnson syndrome ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ABCCA&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;SLCO1B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;ATP8B1&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;ABCB11&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. ABCCA&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-110804.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) ABCCA&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Clinically significant portal hypertension is defined as HVPG of ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;&amp;lt; 5mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;5-10mmHg&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;&amp;gt;10mmHg&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;&amp;lt;10mmHg&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. &gt;10mmHg&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) &amp;gt;10mmHg&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following strategies does not have a mortality benefit in ARDS?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Corticosteroids&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Low tidal volume ventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;High PEEP&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prone ventilation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Corticosteroids&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Corticosteroids&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;60-year reformed smoker with COPD with GOLD (Cat E) presented with worsening dyspnea, cough. Patient was started on salbutamol nebulizations, IV antibiotics, corticosteroids. Repeat ABG pH 7.25, pCO 2 60mmHg, pO 2 49.5mmHg, RR 26/min. Which is the next step in the management of the patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Oxygen with NIV&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CPAP and Oxygen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Invasive Mechanical ventilation&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;i.v. salbutamol, morphine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Oxygen with NIV&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Oxygen and NIV&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following Endoscopic image is diagnostic of?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Reflux esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Herpes simplex virus esophagitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Eosinophilic esophagitis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Candida esophagitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Eosinophilic esophagitis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-111119.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Eosinophilic esophagitis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 70-year-old woman appears with a 4 week history of dry coughing and dyspnea with exertion. She has been receiving treatment for her swollen joints and morning stiffness for a few years. Inspiratory fine crackles were audible on auscultation. A basilar, subpleural, and bilateral honeycombing pattern was visible on the HRCT, which was ordered. Which of the following patterns is the PFT of the patient most likely to display?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;lt;0.7 and DLCO increases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;lt;0.7 and DLCO decreases&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;gt;0.7 and DLCO decreases&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;FEV1/FVC ratio &amp;gt;0.7 and DLCO increases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. FEV1/FVC ratio &gt;0.7 and DLCO decreases&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-111324.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) FEV1/FVC ratio &amp;gt;0.7 and DLCO decreases&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Following Esophageal pressure topography is suggestive of ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Jackhammer esophagus&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Achalasia cardia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Diffuse esophageal spasm&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Esophageal carcinoma&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Diffuse esophageal spasm&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-111355.jpg&quot;], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-111435.jpg&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Diffuse esophageal spasm&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Hamman-Rich syndrome, characterized by rapid onset of respiratory failure, is clinically associated with which of the following conditions?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Usual interstitial pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Cryptogenic organising pneumonia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Respiratory bronchiolitis associated ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Acute interstitial pneumonia&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Acute interstitial pneumonia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Acute interstitial pneumonia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Granulomatous colitis, oculocutaneous albinism, platelet dysfunction, pulmonary fibrosis are seen in ?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Wiskott-Aldrich syndrome (WAS)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hermansky-Pudlak syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Immune dysregulation polyendocrinopathy, enteropathy X-linked (IPEX)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Glycogen storage disease type B1&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hermansky-Pudlak syndrome&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hermansky-Pudlak syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 50-year-old lady presented with significant weight loss, fatigue, myalgia, and difficulty to get up from bed, squatting position. Physical examination revealed papular lesions over the knuckles and fine crackles on auscultation with restrictive PFT pattern. HRCT done showed the following. What is the expected lung biopsy finding in this patient? What is the likely diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti-Synthetase syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;CREST Syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;NERDS syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hermansky Pudlak syndrome&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Anti-Synthetase syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-111727.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Anti-synthetase syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Presence of scleral icterus indicates a serum bilirubin level of at least?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;2 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;3 mg/dL&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;4 mg/dL&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;5 mg/dL&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. 3 mg/dL&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) 3 mg/dL&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Mechanism of action of Vedolizumab?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Sphingosine-1-phosphate (S1P1) receptor modulator&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Recombinant humanized IgG4 antibody against Î±4-integrin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;IgG1 monoclonal antibody, blocks the biologic activity of IL-12 and IL-23&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Monoclonal antibody directed against Î±4Î²7-integrin&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Monoclonal antibody directed against Î±4Î²7-integrin&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Monoclonal antibody directed against Î±4Î²7-integrin&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following describes the best method to diagnose bronchial asthma?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Chest Xray&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Skin prick test&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1 measurement&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Reversible obstruction demonstration on PFT&quot;, &quot;correct&quot;: true}], &quot;correct_answer&quot;: &quot;D. Reversible obstruction demonstration on PFT&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. D) Reversible obstruction demonstration on PFT&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The Gold&#x27;s criteria for very severe COPD is:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt; 30%&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt;70%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;FEV1/FVC&amp;lt;0.7 and FEV1&amp;lt; 50%&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Both A and C&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. FEV1/FVC &lt;0.7 and FEV1 &lt; 30%&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-112044.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) FEV1/FVC &amp;lt;0.7 and FEV1 &amp;lt; 30%&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;In which of the following situations would NIV considered to be contraindicated?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Acute exacerbation of chronic obstructive pulmonary disease (COPD)&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Acute hypoxemic respiratory failure in an individual with acute respiratory distress syndrome&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acute myocardial infarction&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Decompensated systolic heart failure without acute myocardial ischemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Acute myocardial infarction&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Acute myocardial infarction&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;For each statement, match the corresponding anti-coagulant?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;A-i, B-ii, C-iii, D-iv&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;A-iii, B-i, C-iv, D-ii&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;A-iii, B-i, C-ii, D-iv&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;A-ii, B-iii, C-iv, D-i&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. A-iii, B-i, C-iv, D-ii&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-112227.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) A-iii, B-i, C-iv, D-ii&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A 60-year-old female is referred for chronic cough and dyspnea with exertion. Over the past year, her cough and dyspnea have steadily gotten worse. According to pulmonary function testing, the FVC:72%, FEV1: 80%, DLCO: 38%. CT given below. Lung biopsy done to evaluate cause of CT abnormalities reveals foci of scarring that are dispersed and surrounded by healthy lung parenchyma and fibroblasts. Which of the following is the appropriate therapy for this patient?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pirfenidone&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Bosentan&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Acetylcysteine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Prednisolone/azathioprine&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Pirfenidone&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-112429.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Pirfenidone&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;The definitive treatment for Hepato-renal syndrome is?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Terlipressin + Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Terlipressin + Octreotide + Albumin&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Orthotopic liver transplantation&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Simultaneous liver-kidney transplantation&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Orthotopic liver transplantation&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Orthotopic liver transplantation&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All the following are complications due to peritoneal dialysis therapy except:&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Hypoproteinemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hypoglycemia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Hypertriglyceridemia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Hyperphosphatemia&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hypoglycemia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hypoglycemia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Placement of hemodialysis catheter at which site is associated with GREATER risk of Stenosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Femoral&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Subclavian&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Left Internal jugular&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Right Internal jugular&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Subclavian&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Subclavian&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Swan-neck deformity in Rheumatoid arthritis is defined as?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Flexion of the PIP joint with hyperextension of the DIP joint&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Hyperextension of the PIP joint with flexion of the DIP joint&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Subluxation of the first MCP joint with hyperextension of the first interphalangeal (IP) joint&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;None of the above&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Hyperextension of the PIP joint with flexion of the DIP joint&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Hyperextension of the PIP joint with flexion of the DIP joint&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Feltyâ€™s syndrome is characterized by all of the following except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Neutropenia&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Neutrophilia&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Splenomegaly&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Nodular RA&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Neutrophilia&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Neutrophilia&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Most common pulmonary manifestation of Rheumatoid arthritis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;ILD&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Pleuritis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Pulmonary nodules&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Lung malignancy&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;B. Pleuritis&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. B) Pleuritis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of Noninflammatory joint disorders, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Pain without synovial swelling&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Absence of inflammatory or systemic features&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Prolonged morning stiffness&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Negative laboratory investigations&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Prolonged morning stiffness&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Prolonged morning stiffness&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Which of the following ANA has Speckled pattern?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Anti RNA polymerase I&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Anti Kinetochore&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Anti Scl-70&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Anti histone&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Anti Scl-70&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-113315.png&quot;], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Anti Scl-70&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are features of Inflammatory fluid in synovial fluid analysis, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Inflammatory fluid is turbid and yellow&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Polymorphonuclear leukocyte predominance&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Presence of stringing effect&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Increased WBC count (2000â€“50,000/Î¼L)&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Presence of stringing effect&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Presence of stringing effect&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;A patient presented with neck and back pain and the Xray is shown. What is the diagnosis?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Diffuse idiopathic skeletal hyperostosis&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;TB spine&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spine metastases&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;A. Diffuse idiopathic skeletal hyperostosis&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-113523.png&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. A) Diffuse idiopathic skeletal hyperostosis&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;All of the following are in favour of Psoriatic arthritis when compared to Rheumatoid arthritis, except?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Distal interphalangeal (DIP) joint is involved&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;Familial aggregation is seen&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;Arthritis is usually seropositive&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Spine and sacroiliac joints are involved&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. Arthritis is usually seropositive&quot;, &quot;question_images&quot;: [], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) Arthritis is usually seropositive&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}, {&quot;text&quot;: &quot;Bullâ€™s head sign on Radionuclide bone scan is seen in?&quot;, &quot;options&quot;: [{&quot;label&quot;: &quot;A&quot;, &quot;text&quot;: &quot;Psoriatic arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;B&quot;, &quot;text&quot;: &quot;IBD-Associated Arthritis&quot;, &quot;correct&quot;: false}, {&quot;label&quot;: &quot;C&quot;, &quot;text&quot;: &quot;SAPHO syndrome&quot;, &quot;correct&quot;: true}, {&quot;label&quot;: &quot;D&quot;, &quot;text&quot;: &quot;Ankylosing spondylitis&quot;, &quot;correct&quot;: false}], &quot;correct_answer&quot;: &quot;C. SAPHO syndrome&quot;, &quot;question_images&quot;: [&quot;https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/24/screenshot-2024-09-24-131934.jpg&quot;], &quot;explanation_images&quot;: [], &quot;explanation&quot;: &quot;&lt;p&gt;&lt;strong&gt;Ans. C) SAPHO syndrome&lt;/strong&gt;&lt;/p&gt;\n&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;, &quot;bot&quot;: &quot;@futuredoctor&quot;, &quot;video&quot;: &quot;&quot;}];
            if (!Array.isArray(questions) || questions.length === 0) {
                throw new Error(&quot;Questions data is empty or invalid&quot;);
            }
            debugLog(`Successfully parsed ${questions.length} questions`);
        } catch (e) {
            console.error(&quot;Failed to parse questions_json:&quot;, e);
            document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error loading quiz data. Please check the console for details or contact support.&quot;;
            document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            document.getElementById(&#x27;start-test&#x27;).disabled = true;
            // Fallback to sample questions for testing
            questions = [
                {
                    text: &quot;What is 2 + 2?&quot;,
                    options: [
                        { label: &quot;A&quot;, text: &quot;3&quot;, correct: false },
                        { label: &quot;B&quot;, text: &quot;4&quot;, correct: true },
                        { label: &quot;C&quot;, text: &quot;5&quot;, correct: false },
                        { label: &quot;D&quot;, text: &quot;6&quot;, correct: false }
                    ],
                    correct_answer: &quot;B. 4&quot;,
                    question_images: [],
                    explanation_images: [],
                    explanation: &quot;&lt;p&gt;2 + 2 = 4&lt;/p&gt;&lt;p&gt;@futuredoctor&lt;/p&gt;&quot;,
                    bot: &quot;@futuredoctor&quot;,
                    audio: &quot;&quot;,
                    video: &quot;&quot;
                }
            ];
            debugLog(&quot;Loaded fallback questions&quot;);
        }

        // Quiz state
        let currentQuestion = 0;
        let answers = new Array(questions.length).fill(null);
        let markedForReview = new Array(questions.length).fill(false);
        let timeRemaining = 110 * 60; // Duration in seconds
        let timerInterval = null;
        const quizId = `{title.replace(/\s+/g, &#x27;_&#x27;).toLowerCase()}`; // Unique ID for local storage

        // Load saved progress
        function loadProgress() {
            try {
                debugLog(&quot;Loading progress from localStorage&quot;);
                const saved = localStorage.getItem(`quiz_${quizId}`);
                if (saved) {
                    const { savedAnswers, savedMarked, savedTime } = JSON.parse(saved);
                    answers = savedAnswers || answers;
                    markedForReview = savedMarked || markedForReview;
                    timeRemaining = savedTime !== undefined ? savedTime : timeRemaining;
                    debugLog(&quot;Progress loaded successfully&quot;);
                } else {
                    debugLog(&quot;No saved progress found&quot;);
                }
            } catch (e) {
                console.error(&quot;Error loading progress:&quot;, e);
                debugLog(&quot;Failed to load progress: &quot; + e.message);
            }
        }

        // Save progress
        function saveProgress() {
            try {
                debugLog(&quot;Saving progress to localStorage&quot;);
                localStorage.setItem(`quiz_${quizId}`, JSON.stringify({
                    savedAnswers: answers,
                    savedMarked: markedForReview,
                    savedTime: timeRemaining
                }));
                debugLog(&quot;Progress saved successfully&quot;);
            } catch (e) {
                console.error(&quot;Error saving progress:&quot;, e);
                debugLog(&quot;Failed to save progress: &quot; + e.message);
            }
        }

        // Initialize quiz
        function initQuiz() {
            try {
                debugLog(&quot;Initializing quiz&quot;);
                loadProgress();
                const startButton = document.getElementById(&#x27;start-test&#x27;);
                if (!startButton) {
                    throw new Error(&quot;Start test button not found&quot;);
                }
                startButton.addEventListener(&#x27;click&#x27;, startQuiz);
                debugLog(&quot;Start test button listener attached&quot;);
                document.getElementById(&#x27;previous-btn&#x27;).addEventListener(&#x27;click&#x27;, showPreviousQuestion);
                document.getElementById(&#x27;next-btn&#x27;).addEventListener(&#x27;click&#x27;, showNextQuestion);
                document.getElementById(&#x27;mark-review&#x27;).addEventListener(&#x27;click&#x27;, toggleMarkForReview);
                document.getElementById(&#x27;nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;submit-test&#x27;).addEventListener(&#x27;click&#x27;, showSubmitModal);
                document.getElementById(&#x27;continue-test&#x27;).addEventListener(&#x27;click&#x27;, closeExitModal);
                document.getElementById(&#x27;exit-test&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Exiting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;cancel-submit&#x27;).addEventListener(&#x27;click&#x27;, closeSubmitModal);
                document.getElementById(&#x27;confirm-submit&#x27;).addEventListener(&#x27;click&#x27;, submitTest);
                document.getElementById(&#x27;take-again&#x27;).addEventListener(&#x27;click&#x27;, () =&gt; {
                    debugLog(&quot;Restarting test&quot;);
                    localStorage.removeItem(`quiz_${quizId}`);
                    window.location.reload();
                });
                document.getElementById(&#x27;close-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleNavPanel);
                document.getElementById(&#x27;nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateNavPanel);
                document.getElementById(&#x27;prev-result&#x27;).addEventListener(&#x27;click&#x27;, showPreviousResult);
                document.getElementById(&#x27;next-result&#x27;).addEventListener(&#x27;click&#x27;, showNextResult);
                document.getElementById(&#x27;results-nav-toggle&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;close-results-nav&#x27;).addEventListener(&#x27;click&#x27;, toggleResultsNavPanel);
                document.getElementById(&#x27;results-nav-filter&#x27;).addEventListener(&#x27;change&#x27;, updateResultsNavPanel);
                debugLog(&quot;Quiz initialized successfully&quot;);
            } catch (e) {
                console.error(&quot;Failed to initialize quiz:&quot;, e);
                debugLog(&quot;Failed to initialize quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;start-test&#x27;).disabled = true;
            }
        }

        // Start quiz
        function startQuiz() {
            try {
                debugLog(&quot;Starting quiz&quot;);
                document.getElementById(&#x27;instructions&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.remove(&#x27;hidden&#x27;);
                showQuestion(currentQuestion);
                startTimer();
                updateNavPanel();
                debugLog(&quot;Quiz started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting quiz:&quot;, e);
                debugLog(&quot;Failed to start quiz: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error starting quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;instructions&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        }

        // Show question
        function showQuestion(index) {
            try {
                debugLog(`Showing question ${index + 1}`);
                currentQuestion = index;
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                document.getElementById(&#x27;question-number&#x27;).innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById(&#x27;question-text&#x27;).innerHTML = q.text || &quot;No question text available&quot;;
                const imagesDiv = document.getElementById(&#x27;question-images&#x27;);
                imagesDiv.innerHTML = q.question_images &amp;&amp; q.question_images.length &gt; 0
                    ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg&quot;&gt;`).join(&#x27;&#x27;)
                    : &#x27;&#x27;;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                optionsDiv.innerHTML = q.options &amp;&amp; q.options.length &gt; 0
                    ? q.options.map(opt =&gt; `
                        &lt;button class=&quot;option-btn w-full text-left p-3 border rounded-lg ${answers[index] === opt.label ? &#x27;selected&#x27; : &#x27;&#x27;}&quot; 
                                onclick=&quot;selectOption(${index}, &#x27;${opt.label}&#x27;)&quot; 
                                aria-label=&quot;Option ${opt.label}: ${opt.text}&quot;&gt;
                            ${opt.label}. ${opt.text}
                        &lt;/button&gt;
                    `).join(&#x27;&#x27;)
                    : &#x27;&lt;p class=&quot;text-red-500&quot;&gt;No options available&lt;/p&gt;&#x27;;
                document.getElementById(&#x27;previous-btn&#x27;).disabled = index === 0;
                document.getElementById(&#x27;next-btn&#x27;).disabled = index === questions.length - 1;
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[index]);
                updateProgressBar();
                saveProgress();
                window.scrollTo({ top: 0, behavior: &#x27;smooth&#x27; });
                debugLog(`Question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying question:&quot;, e);
                debugLog(&quot;Failed to display question: &quot; + e.message);
            }
        }


        // Select option
        function selectOption(index, label) {
            try {
                debugLog(`Selecting option ${label} for question ${index + 1}`);
                answers[index] = label;
                const optionsDiv = document.getElementById(&#x27;options&#x27;);
                const optionButtons = optionsDiv.querySelectorAll(&#x27;.option-btn&#x27;);
                optionButtons.forEach(btn =&gt; {
                    const btnLabel = btn.textContent.trim().split(&#x27;.&#x27;)[0];
                    btn.classList.toggle(&#x27;selected&#x27;, btnLabel === label);
                });
                updateNavPanel();
                saveProgress();
                debugLog(`Option ${label} selected for question ${index + 1}`);
            } catch (e) {
                console.error(&quot;Error selecting option:&quot;, e);
                debugLog(&quot;Failed to select option: &quot; + e.message);
            }
        }

        // Toggle mark for review
        function toggleMarkForReview() {
            try {
                debugLog(`Toggling mark for review on question ${currentQuestion + 1}`);
                markedForReview[currentQuestion] = !markedForReview[currentQuestion];
                document.getElementById(&#x27;mark-review&#x27;).classList.toggle(&#x27;marked&#x27;, markedForReview[currentQuestion]);
                updateNavPanel();
                saveProgress();
                debugLog(`Mark for review toggled for question ${currentQuestion + 1}`);
            } catch (e) {
                console.error(&quot;Error marking for review:&quot;, e);
                debugLog(&quot;Failed to mark for review: &quot; + e.message);
            }
        }

        // Navigate to previous question
        function showPreviousQuestion() {
            try {
                debugLog(`Navigating to previous question from ${currentQuestion + 1}`);
                if (currentQuestion &gt; 0) {
                    currentQuestion--;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous question:&quot;, e);
                debugLog(&quot;Failed to navigate to previous question: &quot; + e.message);
            }
        }

        // Navigate to next question
        function showNextQuestion() {
            try {
                debugLog(`Navigating to next question from ${currentQuestion + 1}`);
                if (currentQuestion &lt; questions.length - 1) {
                    currentQuestion++;
                    showQuestion(currentQuestion);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next question:&quot;, e);
                debugLog(&quot;Failed to navigate to next question: &quot; + e.message);
            }
        }

        // Handle question navigation click
        function handleQuestionNavClick(index) {
            try {
                debugLog(`Navigating to question ${index + 1} via nav panel`);
                showQuestion(index);
                toggleNavPanel();
            } catch (e) {
                console.error(&quot;Error handling navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate via nav panel: &quot; + e.message);
            }
        }

        // Start timer
        function startTimer() {
            try {
                debugLog(&quot;Starting timer&quot;);
                timerInterval = setInterval(() =&gt; {
                    if (timeRemaining &lt;= 0) {
                        debugLog(&quot;Timer expired, submitting test&quot;);
                        clearInterval(timerInterval);
                        submitTest();
                    } else {
                        timeRemaining--;
                        const minutes = Math.floor(timeRemaining / 60);
                        const seconds = timeRemaining % 60;
                        document.getElementById(&#x27;timer&#x27;).innerHTML = `Time Remaining: &lt;span&gt;${minutes.toString().padStart(2, &#x27;0&#x27;)}:${seconds.toString().padStart(2, &#x27;0&#x27;)}&lt;/span&gt;`;
                        saveProgress();
                    }
                }, 1000);
                debugLog(&quot;Timer started successfully&quot;);
            } catch (e) {
                console.error(&quot;Error starting timer:&quot;, e);
                debugLog(&quot;Failed to start timer: &quot; + e.message);
            }
        }

        // Update progress bar
        function updateProgressBar() {
            try {
                debugLog(&quot;Updating progress bar&quot;);
                const progress = ((currentQuestion + 1) / questions.length) * 100;
                document.getElementById(&#x27;progress-bar&#x27;).style.width = `${progress}%`;
                debugLog(&quot;Progress bar updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating progress bar:&quot;, e);
                debugLog(&quot;Failed to update progress bar: &quot; + e.message);
            }
        }

        // Update quiz navigation panel
        function updateNavPanel() {
            try {
                debugLog(&quot;Updating quiz navigation panel&quot;);
                const filter = document.getElementById(&#x27;nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;question-nav-btn ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleQuestionNavClick(${i})&quot;
                                aria-label=&quot;Go to Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Quiz navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to update quiz navigation panel: &quot; + e.message);
            }
        }

        // Update results navigation panel
        function updateResultsNavPanel() {
            try {
                debugLog(&quot;Updating results navigation panel&quot;);
                const filter = document.getElementById(&#x27;results-nav-filter&#x27;).value;
                const navGrid = document.getElementById(&#x27;results-nav-grid&#x27;);
                navGrid.innerHTML = questions.map((_, i) =&gt; {
                    if (filter === &#x27;answered&#x27; &amp;&amp; !answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;unanswered&#x27; &amp;&amp; answers[i]) return &#x27;&#x27;;
                    if (filter === &#x27;marked&#x27; &amp;&amp; !markedForReview[i]) return &#x27;&#x27;;
                    return `
                        &lt;button class=&quot;result-nav-btn-grid ${answers[i] ? &#x27;answered&#x27; : &#x27;unanswered&#x27;} ${markedForReview[i] ? &#x27;marked-nav&#x27; : &#x27;&#x27;}&quot;
                                onclick=&quot;handleResultNavClick(${i})&quot;
                                aria-label=&quot;Go to Result for Question ${i + 1}&quot;&gt;
                            ${i + 1}
                        &lt;/button&gt;
                    `;
                }).join(&#x27;&#x27;);
                debugLog(&quot;Results navigation panel updated&quot;);
            } catch (e) {
                console.error(&quot;Error updating results navigation panel:&quot;, e);
                debugLog(&quot;Failed to update results navigation panel: &quot; + e.message);
            }
        }

        // Toggle quiz navigation panel
        function toggleNavPanel() {
            try {
                debugLog(&quot;Toggling quiz navigation panel&quot;);
                const navPanel = document.getElementById(&#x27;nav-panel&#x27;);
                navPanel.classList.toggle(&#x27;hidden&#x27;);
                debugLog(&quot;Quiz navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling quiz navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle quiz navigation panel: &quot; + e.message);
            }
        }

        // Toggle results navigation panel
        function toggleResultsNavPanel() {
            try {
                debugLog(&quot;Toggling results navigation panel&quot;);
                const resultsNavPanel = document.getElementById(&#x27;results-nav-panel&#x27;);
                resultsNavPanel.classList.toggle(&#x27;hidden&#x27;);
                if (!resultsNavPanel.classList.contains(&#x27;hidden&#x27;)) {
                    updateResultsNavPanel();
                }
                debugLog(&quot;Results navigation panel toggled&quot;);
            } catch (e) {
                console.error(&quot;Error toggling results navigation panel:&quot;, e);
                debugLog(&quot;Failed to toggle results navigation panel: &quot; + e.message);
            }
        }

        // Handle result navigation click
        function handleResultNavClick(index) {
            try {
                debugLog(`Navigating to result for question ${index + 1} via nav panel`);
                showResults(index);
                toggleResultsNavPanel();
            } catch (e) {
                console.error(&quot;Error handling result navigation click:&quot;, e);
                debugLog(&quot;Failed to navigate to result: &quot; + e.message);
            }
        }

        // Show submit modal
        function showSubmitModal() {
            try {
                debugLog(&quot;Showing submit modal&quot;);
                const attempted = answers.filter(a =&gt; a !== null).length;
                document.getElementById(&#x27;attempted-count&#x27;).textContent = attempted;
                document.getElementById(&#x27;unattempted-count&#x27;).textContent = questions.length - attempted;
                document.getElementById(&#x27;submit-modal&#x27;).classList.remove(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal displayed&quot;);
            } catch (e) {
                console.error(&quot;Error showing submit modal:&quot;, e);
                debugLog(&quot;Failed to show submit modal: &quot; + e.message);
            }
        }

        // Close submit modal
        function closeSubmitModal() {
            try {
                debugLog(&quot;Closing submit modal&quot;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Submit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing submit modal:&quot;, e);
                debugLog(&quot;Failed to close submit modal: &quot; + e.message);
            }
        }

        // Close exit modal
        function closeExitModal() {
            try {
                debugLog(&quot;Closing exit modal&quot;);
                document.getElementById(&#x27;exit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                debugLog(&quot;Exit modal closed&quot;);
            } catch (e) {
                console.error(&quot;Error closing exit modal:&quot;, e);
                debugLog(&quot;Failed to close exit modal: &quot; + e.message);
            }
        }

        // Submit test
        function submitTest() {
            try {
                debugLog(&quot;Submitting test&quot;);
                clearInterval(timerInterval);
                document.getElementById(&#x27;quiz&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;submit-modal&#x27;).classList.add(&#x27;hidden&#x27;);
                document.getElementById(&#x27;results&#x27;).classList.remove(&#x27;hidden&#x27;);
                showResults(0); // Start with first question
                // Trigger confetti animation
                confetti({
                    particleCount: 100,
                    spread: 70,
                    origin: { y: 0.6 }
                });
                localStorage.removeItem(`quiz_${quizId}`);
                debugLog(&quot;Test submitted successfully&quot;);
            } catch (e) {
                console.error(&quot;Error submitting test:&quot;, e);
                debugLog(&quot;Failed to submit test: &quot; + e.message);
            }
        }

        function showResults(index) {
            try {
                debugLog(`Showing result for question ${index + 1}`);
                currentResultQuestion = index;
                let correct = 0, wrong = 0, unanswered = 0, marked = 0;
                answers.forEach((answer, i) =&gt; {
                    const isCorrect = answer &amp;&amp; questions[i].options.find(opt =&gt; opt.label === answer)?.correct;
                    if (answer === null) unanswered++;
                    else if (isCorrect) correct++;
                    else wrong++;
                    if (markedForReview[i]) marked++;
                });
                const q = questions[index];
                if (!q) {
                    throw new Error(`Question ${index} is undefined`);
                }
                const userAnswer = answers[index];
                const isCorrect = userAnswer &amp;&amp; q.options.find(opt =&gt; opt.label === userAnswer)?.correct;
                const resultsContent = document.getElementById('results-content');
                
                // Create scrollable container for explanation content
                resultsContent.innerHTML = `
                    &lt;div class=&quot;border-4 ${isCorrect ? 'border-green-600 bg-green-100' : userAnswer ? 'border-red-600 bg-red-100' : 'border-gray-400 bg-gray-50'} p-4 rounded-lg overflow-hidden&quot;&gt;
                        &lt;p class=&quot;font-semibold&quot;&gt;Question ${index + 1}: ${q.text || 'No question text'}&lt;/p&gt;
                        ${q.question_images &amp;&amp; q.question_images.length &gt; 0 ? q.question_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Question Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        &lt;p&gt;&lt;strong&gt;Your Answer:&lt;/strong&gt; ${userAnswer ? `${userAnswer}. ${q.options.find(opt =&gt; opt.label === userAnswer)?.text || 'Invalid option'}` : 'Unanswered'}&lt;/p&gt;
                        &lt;p&gt;&lt;strong&gt;Correct Answer:&lt;/strong&gt; ${q.correct_answer || 'Unknown'}&lt;/p&gt;
                        
                        &lt;!-- Scrollable container for explanation --&gt;
                        &lt;div class=&quot;mt-2 overflow-x-auto&quot;&gt;
                            ${q.explanation || 'No explanation available'}
                        &lt;/div&gt;
                        
                        ${q.explanation_images &amp;&amp; q.explanation_images.length &gt; 0 ? q.explanation_images.map(url =&gt; `&lt;img src=&quot;${url}&quot; alt=&quot;Explanation Image&quot; class=&quot;max-w-full h-auto rounded-lg my-2&quot;&gt;`).join('') : ''}
                        ${q.video ? `
                            &lt;button class=&quot;play-video bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadVideo(this, '${q.video}', 'video-${index}')&quot;
                                    aria-label=&quot;Play explanation video for Question ${index + 1}&quot;&gt;
                                Play Video Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;video-${index}&quot; class=&quot;video-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : '&lt;p class=&quot;text-gray-500 mt-2&quot;&gt;No video available&lt;/p&gt;'}
                        ${q.audio ? `
                            &lt;button class=&quot;play-audio bg-[#2c5281] text-white px-4 py-2 rounded-lg mt-2&quot; 
                                    onclick=&quot;loadAudio(this, '${q.audio}', 'audio-${index}')&quot;
                                    aria-label=&quot;Play audio explanation for Question ${index + 1}&quot;&gt;
                                Play Audio Explanation
                            &lt;/button&gt;
                            &lt;div id=&quot;audio-${index}&quot; class=&quot;audio-container mt-2&quot;&gt;&lt;/div&gt;
                        ` : ''}
                    &lt;/div&gt;
                `;
                
                document.getElementById('correct-count').textContent = correct;
                document.getElementById('wrong-count').textContent = wrong;
                document.getElementById('unanswered-count').textContent = unanswered;
                document.getElementById('marked-count').textContent = marked;
                document.getElementById('result-question-number').innerHTML = `Question &lt;span&gt;${index + 1}&lt;/span&gt; of ${questions.length}`;
                document.getElementById('prev-result').disabled = index === 0;
                document.getElementById('next-result').disabled = index === questions.length - 1;
                updateResultsNavPanel();
                window.scrollTo({ top: 0, behavior: 'smooth' });
                debugLog(`Result for question ${index + 1} displayed successfully`);
            } catch (e) {
                console.error(&quot;Error displaying result:&quot;, e);
                debugLog(&quot;Failed to display result: &quot; + e.message);
            }
        }


        // Navigate to previous result
        function showPreviousResult() {
            try {
                debugLog(`Navigating to previous result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &gt; 0) {
                    showResults(currentResultQuestion - 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to previous result:&quot;, e);
                debugLog(&quot;Failed to navigate to previous result: &quot; + e.message);
            }
        }

        // Navigate to next result
        function showNextResult() {
            try {
                debugLog(`Navigating to next result from question ${currentResultQuestion + 1}`);
                if (currentResultQuestion &lt; questions.length - 1) {
                    showResults(currentResultQuestion + 1);
                }
            } catch (e) {
                console.error(&quot;Error navigating to next result:&quot;, e);
                debugLog(&quot;Failed to navigate to next result: &quot; + e.message);
            }
        }

        // Lazy-load video
        function loadVideo(button, videoUrl, containerId) {
            try {
                debugLog(`Loading video for ${containerId}: ${videoUrl}`);
                if (!videoUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No video available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No video URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;div class=&quot;video-loading&quot;&gt;&lt;/div&gt;
                    &lt;video controls class=&quot;w-full max-w-[600px] rounded-lg&quot; preload=&quot;metadata&quot; aria-label=&quot;Video explanation&quot;&gt;
                        &lt;source src=&quot;${videoUrl}&quot; type=&quot;${videoUrl.endsWith(&#x27;.m3u8&#x27;) ? &#x27;application/x-mpegURL&#x27; : &#x27;video/mp4&#x27;}&quot;&gt;
                        Your browser does not support the video tag.
                    &lt;/video&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Initialize HLS.js for .m3u8 videos
                const video = container.querySelector(&#x27;video&#x27;);
                if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; Hls.isSupported()) {
                    const hls = new Hls();
                    hls.loadSource(videoUrl);
                    hls.attachMedia(video);
                    hls.on(Hls.Events.ERROR, (event, data) =&gt; {
                        console.error(&quot;HLS.js error:&quot;, data);
                        container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                        debugLog(&quot;HLS.js error: &quot; + JSON.stringify(data));
                    });
                } else if (videoUrl.endsWith(&#x27;.m3u8&#x27;) &amp;&amp; video.canPlayType(&#x27;application/vnd.apple.mpegurl&#x27;)) {
                    video.src = videoUrl;
                }
                // Handle video load errors
                video.onerror = () =&gt; {
                    console.error(&quot;Video load error for URL:&quot;, videoUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Video load error for URL: &quot; + videoUrl);
                };
                // Remove loading spinner when video is ready
                video.onloadedmetadata = () =&gt; {
                    container.querySelector(&#x27;.video-loading&#x27;).remove();
                    debugLog(&quot;Video loaded successfully&quot;);
                };
            } catch (e) {
                console.error(&quot;Error loading video:&quot;, e);
                debugLog(&quot;Failed to load video: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading video. &lt;a href=&quot;${videoUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open video in new tab&quot;&gt;Open video&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Lazy-load audio
        function loadAudio(button, audioUrl, containerId) {
            try {
                debugLog(`Loading audio for ${containerId}: ${audioUrl}`);
                if (!audioUrl) {
                    const container = document.getElementById(containerId);
                    container.innerHTML = `&lt;p class=&quot;text-gray-500&quot;&gt;No audio available&lt;/p&gt;`;
                    button.remove();
                    debugLog(&quot;No audio URL provided&quot;);
                    return;
                }
                const container = document.getElementById(containerId);
                container.innerHTML = `
                    &lt;audio controls class=&quot;w-full max-w-[600px]&quot; preload=&quot;metadata&quot; aria-label=&quot;Audio explanation&quot;&gt;
                        &lt;source src=&quot;${audioUrl}&quot; type=&quot;audio/mpeg&quot;&gt;
                        Your browser does not support the audio tag.
                    &lt;/audio&gt;
                `;
                container.classList.add(&#x27;active&#x27;);
                button.remove();
                // Handle audio load errors
                const audio = container.querySelector(&#x27;audio&#x27;);
                audio.onerror = () =&gt; {
                    console.error(&quot;Audio load error for URL:&quot;, audioUrl);
                    container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
                    debugLog(&quot;Audio load error for URL: &quot; + audioUrl);
                };
                debugLog(&quot;Audio loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading audio:&quot;, e);
                debugLog(&quot;Failed to load audio: &quot; + e.message);
                const container = document.getElementById(containerId);
                container.innerHTML = `&lt;p class=&quot;text-red-500&quot;&gt;Error loading audio. &lt;a href=&quot;${audioUrl}&quot; target=&quot;_blank&quot; aria-label=&quot;Open audio in new tab&quot;&gt;Open audio&lt;/a&gt;&lt;/p&gt;`;
            }
        }

        // Toggle dark mode
        function toggleTheme() {
            try {
                debugLog(&quot;Toggling theme&quot;);
                document.documentElement.classList.toggle(&#x27;dark&#x27;);
                localStorage.setItem(&#x27;theme&#x27;, document.documentElement.classList.contains(&#x27;dark&#x27;) ? &#x27;dark&#x27; : &#x27;light&#x27;);
                debugLog(&quot;Theme toggled successfully&quot;);
            } catch (e) {
                console.error(&quot;Error toggling theme:&quot;, e);
                debugLog(&quot;Failed to toggle theme: &quot; + e.message);
            }
        }

        // Load theme preference
        function loadTheme() {
            try {
                debugLog(&quot;Loading theme preference&quot;);
                const theme = localStorage.getItem(&#x27;theme&#x27;);
                if (theme === &#x27;dark&#x27;) {
                    document.documentElement.classList.add(&#x27;dark&#x27;);
                }
                debugLog(&quot;Theme loaded successfully&quot;);
            } catch (e) {
                console.error(&quot;Error loading theme:&quot;, e);
                debugLog(&quot;Failed to load theme: &quot; + e.message);
            }
        }

        // Initialize on DOM content loaded
        window.addEventListener(&#x27;DOMContentLoaded&#x27;, () =&gt; {
            try {
                debugLog(&quot;DOM content loaded, initializing quiz&quot;);
                loadTheme();
                initQuiz();
            } catch (e) {
                console.error(&quot;Error during DOMContentLoaded:&quot;, e);
                debugLog(&quot;Failed to initialize on DOMContentLoaded: &quot; + e.message);
                document.getElementById(&#x27;error-message&#x27;).innerHTML = &quot;Error initializing quiz. Please check the console for details or contact support.&quot;;
                document.getElementById(&#x27;error-message&#x27;).classList.remove(&#x27;hidden&#x27;);
            }
        });
    &lt;/script&gt;
&lt;/body&gt;
&lt;/html&gt;" frameborder="0" width="100%" height="2000px"></iframe>
</div>

</body>
</html>
